ID   GROA_HUMAN              Reviewed;         107 AA.
AC   P09341; Q9UCR7;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 1.
DT   02-NOV-2016, entry version 173.
DE   RecName: Full=Growth-regulated alpha protein;
DE   AltName: Full=C-X-C motif chemokine 1;
DE   AltName: Full=GRO-alpha(1-73);
DE   AltName: Full=Melanoma growth stimulatory activity;
DE            Short=MGSA;
DE   AltName: Full=Neutrophil-activating protein 3;
DE            Short=NAP-3;
DE   Contains:
DE     RecName: Full=GRO-alpha(4-73);
DE   Contains:
DE     RecName: Full=GRO-alpha(5-73);
DE   Contains:
DE     RecName: Full=GRO-alpha(6-73);
DE   Flags: Precursor;
GN   Name=CXCL1; Synonyms=GRO, GRO1, GROA, MGSA, SCYB1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2890161; DOI=10.1073/pnas.84.20.7188;
RA   Anisowicz A., Bardwell L., Sager R.;
RT   "Constitutive overexpression of a growth-regulated gene in transformed
RT   Chinese hamster and human cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:7188-7192(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2970963;
RA   Richmond A., Balentien E., Thomas H.G., Flaggs G., Barton D.E.,
RA   Spiess J., Bordoni R., Francke U., Derynck R.;
RT   "Molecular characterization and chromosomal mapping of melanoma growth
RT   stimulatory activity, a growth factor structurally related to beta-
RT   thromboglobulin.";
RL   EMBO J. 7:2025-2033(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Blood;
RX   PubMed=2129556; DOI=10.1093/nar/18.21.6453;
RA   Baker N.E., Kucera G., Richmond A.;
RT   "Nucleotide sequence of the human melanoma growth stimulatory activity
RT   (MGSA) gene.";
RL   Nucleic Acids Res. 18:6453-6453(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 35-107, IDENTIFICATION OF GRO-ALPHA(4-73);
RP   GRO-ALPHA(5-73) AND GRO-ALPHA(6-73), PROTEOLYTIC PROCESSING OF
RP   N-TERMINAL, AND FUNCTION.
RC   TISSUE=Peripheral blood monocyte;
RX   PubMed=10095777; DOI=10.1046/j.1432-1327.1999.00166.x;
RA   Wuyts A., Govaerts C., Struyf S., Lenaerts J.-P., Put W., Conings R.,
RA   Proost P., Van Damme J.;
RT   "Isolation of the CXC chemokines ENA-78, GRO alpha and GRO gamma from
RT   tumor cells and leukocytes reveals NH2-terminal heterogeneity.
RT   Functional comparison of different natural isoforms.";
RL   Eur. J. Biochem. 260:421-429(1999).
RN   [7]
RP   PROTEIN SEQUENCE OF 35-65.
RX   PubMed=2182761; DOI=10.1084/jem.171.4.1091;
RA   Schroeder J.-M., Persoon N.L.M., Christophers E.;
RT   "Lipopolysaccharide-stimulated human monocytes secrete, apart from
RT   neutrophil-activating peptide 1/interleukin 8, a second neutrophil-
RT   activating protein. NH2-terminal amino acid sequence identity with
RT   melanoma growth stimulatory activity.";
RL   J. Exp. Med. 171:1091-1100(1990).
RN   [8]
RP   PROTEIN SEQUENCE OF 35-57.
RX   PubMed=2655583; DOI=10.1042/bj2590585;
RA   Golds E.E., Mason P., Nyirkos P.;
RT   "Inflammatory cytokines induce synthesis and secretion of gro protein
RT   and a neutrophil chemotactic factor but not beta 2-microglobulin in
RT   human synovial cells and fibroblasts.";
RL   Biochem. J. 259:585-588(1989).
RN   [9]
RP   PROTEIN SEQUENCE OF 35-51.
RC   TISSUE=Skin;
RX   PubMed=1755384;
RA   Schroeder J.-M.;
RT   "Biochemical and biological characterization of NAP-1/IL-8-related
RT   cytokines in lesional psoriatic scale.";
RL   Adv. Exp. Med. Biol. 305:97-107(1991).
RN   [10]
RP   PROTEIN SEQUENCE OF 35-49.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally
RT   verified cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [11]
RP   POSSIBLE FUNCTION.
RX   PubMed=2670560;
RA   Wen D., Rowland A., Derynck R.;
RT   "Expression and secretion of gro/MGSA by stimulated human endothelial
RT   cells.";
RL   EMBO J. 8:1761-1766(1989).
RN   [12]
RP   STRUCTURE BY NMR.
RX   PubMed=8397104; DOI=10.1016/0014-5793(93)80893-Y;
RA   Fairbrother W.J., Reilly D., Colby T., Horuk R.;
RT   "1H assignment and secondary structure determination of human melanoma
RT   growth stimulating activity (MGSA) by NMR spectroscopy.";
RL   FEBS Lett. 330:302-306(1993).
RN   [13]
RP   STRUCTURE BY NMR.
RX   PubMed=8089846; DOI=10.1006/jmbi.1994.1577;
RA   Fairbrother W.J., Reilly D., Colby T., Hesselgesser J., Horuk R.;
RT   "The solution structure of melanoma growth stimulating activity.";
RL   J. Mol. Biol. 242:252-270(1994).
RN   [14]
RP   STRUCTURE BY NMR.
RX   PubMed=7806518;
RA   Kim K.S., Clark-Lewis I., Sykes B.D.;
RT   "Solution structure of GRO/melanoma growth stimulatory activity
RT   determined by 1H NMR spectroscopy.";
RL   J. Biol. Chem. 269:32909-32915(1994).
CC   -!- FUNCTION: Has chemotactic activity for neutrophils. May play a
CC       role in inflammation and exerts its effects on endothelial cells
CC       in an autocrine fashion. In vitro, the processed forms GRO-
CC       alpha(4-73), GRO-alpha(5-73) and GRO-alpha(6-73) show a 30-fold
CC       higher chemotactic activity. {ECO:0000269|PubMed:10095777}.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- PTM: N-terminal processed forms GRO-alpha(4-73), GRO-alpha(5-73)
CC       and GRO-alpha(6-73) are produced by proteolytic cleavage after
CC       secretion from peripheral blood monocytes.
CC       {ECO:0000269|PubMed:10095777}.
CC   -!- SIMILARITY: Belongs to the intercrine alpha (chemokine CxC)
CC       family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=CXCL1 entry;
CC       URL="https://en.wikipedia.org/wiki/CXCL1";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J03561; AAA35933.1; -; mRNA.
DR   EMBL; X12510; CAA31027.1; -; mRNA.
DR   EMBL; X54489; CAA38361.1; -; Genomic_DNA.
DR   EMBL; BT006880; AAP35526.1; -; mRNA.
DR   EMBL; BC011976; AAH11976.1; -; mRNA.
DR   CCDS; CCDS47074.1; -.
DR   PIR; S13669; A28414.
DR   RefSeq; NP_001502.1; NM_001511.3.
DR   UniGene; Hs.708652; -.
DR   UniGene; Hs.789; -.
DR   PDB; 1MGS; NMR; -; A/B=35-107.
DR   PDB; 1MSG; NMR; -; A/B=35-106.
DR   PDB; 1MSH; NMR; -; A/B=35-106.
DR   PDB; 1ROD; NMR; -; A/B=40-62, A/B=89-107.
DR   PDBsum; 1MGS; -.
DR   PDBsum; 1MSG; -.
DR   PDBsum; 1MSH; -.
DR   PDBsum; 1ROD; -.
DR   ProteinModelPortal; P09341; -.
DR   SMR; P09341; -.
DR   BioGrid; 109176; 8.
DR   DIP; DIP-5896N; -.
DR   IntAct; P09341; 5.
DR   STRING; 9606.ENSP00000379110; -.
DR   PhosphoSitePlus; P09341; -.
DR   SwissPalm; P09341; -.
DR   BioMuta; CXCL1; -.
DR   DMDM; 121622; -.
DR   MaxQB; P09341; -.
DR   PaxDb; P09341; -.
DR   PeptideAtlas; P09341; -.
DR   PRIDE; P09341; -.
DR   DNASU; 2919; -.
DR   Ensembl; ENST00000395761; ENSP00000379110; ENSG00000163739.
DR   GeneID; 2919; -.
DR   KEGG; hsa:2919; -.
DR   UCSC; uc003hhh.4; human.
DR   CTD; 2919; -.
DR   DisGeNET; 2919; -.
DR   GeneCards; CXCL1; -.
DR   H-InvDB; HIX0120073; -.
DR   HGNC; HGNC:4602; CXCL1.
DR   MIM; 155730; gene.
DR   neXtProt; NX_P09341; -.
DR   OpenTargets; ENSG00000163739; -.
DR   PharmGKB; PA35050; -.
DR   eggNOG; ENOG410J3WE; Eukaryota.
DR   eggNOG; ENOG410ZT1C; LUCA.
DR   GeneTree; ENSGT00530000062901; -.
DR   HOGENOM; HOG000220915; -.
DR   HOVERGEN; HBG107789; -.
DR   InParanoid; P09341; -.
DR   KO; K05505; -.
DR   OMA; LNCDKSN; -.
DR   OrthoDB; EOG091G14TE; -.
DR   PhylomeDB; P09341; -.
DR   TreeFam; TF333433; -.
DR   BioCyc; ZFISH:ENSG00000163739-MONOMER; -.
DR   Reactome; R-HSA-380108; Chemokine receptors bind chemokines.
DR   Reactome; R-HSA-418594; G alpha (i) signalling events.
DR   SIGNOR; P09341; -.
DR   ChiTaRS; CXCL1; human.
DR   EvolutionaryTrace; P09341; -.
DR   GeneWiki; CXCL1; -.
DR   GenomeRNAi; 2919; -.
DR   PMAP-CutDB; P09341; -.
DR   PRO; PR:P09341; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000163739; -.
DR   CleanEx; HS_CXCL1; -.
DR   Genevisible; P09341; HS.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; TAS:ProtInc.
DR   GO; GO:0005622; C:intracellular; IEA:GOC.
DR   GO; GO:0008009; F:chemokine activity; TAS:ProtInc.
DR   GO; GO:0045236; F:CXCR chemokine receptor binding; IBA:GO_Central.
DR   GO; GO:0008047; F:enzyme activator activity; TAS:ProtInc.
DR   GO; GO:0005102; F:receptor binding; TAS:ProtInc.
DR   GO; GO:0030036; P:actin cytoskeleton organization; TAS:ProtInc.
DR   GO; GO:0008283; P:cell proliferation; TAS:ProtInc.
DR   GO; GO:0070098; P:chemokine-mediated signaling pathway; IBA:GO_Central.
DR   GO; GO:0006935; P:chemotaxis; TAS:ProtInc.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; TAS:ProtInc.
DR   GO; GO:0006955; P:immune response; IBA:GO_Central.
DR   GO; GO:0006954; P:inflammatory response; TAS:ProtInc.
DR   GO; GO:0035556; P:intracellular signal transduction; TAS:ProtInc.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0090023; P:positive regulation of neutrophil chemotaxis; IBA:GO_Central.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IBA:GO_Central.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   InterPro; IPR001089; Chemokine_CXC.
DR   InterPro; IPR018048; Chemokine_CXC_CS.
DR   InterPro; IPR001811; Chemokine_IL8-like_dom.
DR   PANTHER; PTHR10179; PTHR10179; 1.
DR   Pfam; PF00048; IL8; 1.
DR   PRINTS; PR00437; SMALLCYTKCXC.
DR   SMART; SM00199; SCY; 1.
DR   SUPFAM; SSF54117; SSF54117; 1.
DR   PROSITE; PS00471; SMALL_CYTOKINES_CXC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Cytokine; Direct protein sequencing;
KW   Disulfide bond; Growth factor; Inflammatory response;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL        1     34       {ECO:0000269|PubMed:10095777,
FT                                ECO:0000269|PubMed:15340161,
FT                                ECO:0000269|PubMed:1755384,
FT                                ECO:0000269|PubMed:2182761,
FT                                ECO:0000269|PubMed:2655583}.
FT   CHAIN        35    107       Growth-regulated alpha protein.
FT                                /FTId=PRO_0000005049.
FT   CHAIN        38    107       GRO-alpha(4-73).
FT                                /FTId=PRO_0000005050.
FT   CHAIN        39    107       GRO-alpha(5-73).
FT                                /FTId=PRO_0000005051.
FT   CHAIN        40    107       GRO-alpha(6-73).
FT                                /FTId=PRO_0000005052.
FT   DISULFID     43     69
FT   DISULFID     45     85
FT   STRAND       41     43       {ECO:0000244|PDB:1MSG}.
FT   STRAND       49     51       {ECO:0000244|PDB:1MSG}.
FT   TURN         54     56       {ECO:0000244|PDB:1MGS}.
FT   STRAND       57     63       {ECO:0000244|PDB:1MGS}.
FT   STRAND       73     78       {ECO:0000244|PDB:1MGS}.
FT   STRAND       83     86       {ECO:0000244|PDB:1MGS}.
FT   HELIX        91    103       {ECO:0000244|PDB:1MGS}.
SQ   SEQUENCE   107 AA;  11301 MW;  17048A6B4D765CA2 CRC64;
     MARAALSAAP SNPRLLRVAL LLLLLVAAGR RAAGASVATE LRCQCLQTLQ GIHPKNIQSV
     NVKSPGPHCA QTEVIATLKN GRKACLNPAS PIVKKIIEKM LNSDKSN
//
ID   B4DNV3_HUMAN            Unreviewed;       122 AA.
AC   B4DNV3;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   02-NOV-2016, entry version 60.
DE   SubName: Full=Interleukin-6 {ECO:0000313|Ensembl:ENSP00000385718};
DE   SubName: Full=cDNA FLJ52006, moderately similar to Interleukin-6 {ECO:0000313|EMBL:BAG60365.1};
GN   Name=IL6 {ECO:0000313|Ensembl:ENSP00000385718};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG60365.1};
RN   [1] {ECO:0000313|Ensembl:ENSP00000385718, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [2] {ECO:0000313|EMBL:BAG60365.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Lung {ECO:0000313|EMBL:BAG60365.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|Ensembl:ENSP00000385718}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC073072; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK298077; BAG60365.1; -; mRNA.
DR   UniGene; Hs.654458; -.
DR   ProteinModelPortal; B4DNV3; -.
DR   STRING; 9606.ENSP00000258743; -.
DR   MaxQB; B4DNV3; -.
DR   Ensembl; ENST00000401651; ENSP00000385718; ENSG00000136244.
DR   UCSC; uc011jyp.2; human.
DR   HGNC; HGNC:6018; IL6.
DR   OpenTargets; ENSG00000136244; -.
DR   eggNOG; ENOG410IW11; Eukaryota.
DR   eggNOG; ENOG4112BXV; LUCA.
DR   GeneTree; ENSGT00390000000878; -.
DR   ChiTaRS; IL6; human.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000136244; -.
DR   ExpressionAtlas; B4DNV3; baseline and differential.
DR   GO; GO:0005576; C:extracellular region; IEA:InterPro.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   Gene3D; 1.20.1250.10; -; 1.
DR   InterPro; IPR009079; 4_helix_cytokine-like_core.
DR   InterPro; IPR012351; 4_helix_cytokine_core.
DR   InterPro; IPR003574; IL-6.
DR   InterPro; IPR030474; IL-6/GCSF/MGF.
DR   InterPro; IPR030473; IL6/GCSF/MGF_CS.
DR   PANTHER; PTHR11457; PTHR11457; 1.
DR   Pfam; PF00489; IL6; 1.
DR   SMART; SM00126; IL6; 1.
DR   SUPFAM; SSF47266; SSF47266; 1.
DR   PROSITE; PS00254; INTERLEUKIN_6; 1.
PE   2: Evidence at transcript level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   122 AA;  13934 MW;  234C9054AD2D1F88 CRC64;
     MCESSKEALA ENNLNLPKMA EKDGCFQSGF NEETCLVKII TGLLEFEVYL EYLQNRFESS
     EEQARAVQMS TKVLIQFLQK KVGVSSFPQL GVGEDRLKDS VLDNSGMQCH FQKRRLHVNK
     RV
//
ID   B5MC14_HUMAN            Unreviewed;       198 AA.
AC   B5MC14;
DT   14-OCT-2008, integrated into UniProtKB/TrEMBL.
DT   14-OCT-2008, sequence version 1.
DT   02-NOV-2016, entry version 58.
DE   SubName: Full=Interleukin-6 {ECO:0000313|Ensembl:ENSP00000385227};
GN   Name=IL6 {ECO:0000313|Ensembl:ENSP00000385227};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000385227, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000385227, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [2] {ECO:0000313|Ensembl:ENSP00000385227}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000385227}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC073072; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; B5MC14; -.
DR   STRING; 9606.ENSP00000258743; -.
DR   MaxQB; B5MC14; -.
DR   PaxDb; B5MC14; -.
DR   PRIDE; B5MC14; -.
DR   Ensembl; ENST00000406575; ENSP00000385227; ENSG00000136244.
DR   UCSC; uc011jyo.2; human.
DR   HGNC; HGNC:6018; IL6.
DR   OpenTargets; ENSG00000136244; -.
DR   eggNOG; ENOG410IW11; Eukaryota.
DR   eggNOG; ENOG4112BXV; LUCA.
DR   GeneTree; ENSGT00390000000878; -.
DR   HOVERGEN; HBG000471; -.
DR   ChiTaRS; IL6; human.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000136244; -.
DR   ExpressionAtlas; B5MC14; baseline and differential.
DR   GO; GO:0005576; C:extracellular region; IEA:InterPro.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   Gene3D; 1.20.1250.10; -; 1.
DR   InterPro; IPR009079; 4_helix_cytokine-like_core.
DR   InterPro; IPR012351; 4_helix_cytokine_core.
DR   InterPro; IPR003574; IL-6.
DR   InterPro; IPR030474; IL-6/GCSF/MGF.
DR   InterPro; IPR030473; IL6/GCSF/MGF_CS.
DR   PANTHER; PTHR11457; PTHR11457; 1.
DR   Pfam; PF00489; IL6; 1.
DR   PRINTS; PR00433; IL6GCSFMGF.
DR   SMART; SM00126; IL6; 1.
DR   SUPFAM; SSF47266; SSF47266; 1.
DR   PROSITE; PS00254; INTERLEUKIN_6; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:B5MC14};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     27       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        28    198       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002834328.
SQ   SEQUENCE   198 AA;  22056 MW;  57E3929C87E51FC6 CRC64;
     MNSFSTSAFG PVAFSLGLLL VLPAAFPAPV PPGEDSKDVA APHRQPLTSS ERIDKQIRYI
     LDGISALRKE TCNKSNMCES SKEALAENNL NLPKMAEKDG CFQSGFNEET CLVKIITGLL
     EFEVYLEYLQ NRFESSEEQA RAVQMSTKVL IQFLQKKVGV SSFPQLGVGE DRLKDSVLDN
     SGMQCHFQKR RLHVNKRV
//
ID   B5MC21_HUMAN            Unreviewed;       136 AA.
AC   B5MC21;
DT   14-OCT-2008, integrated into UniProtKB/TrEMBL.
DT   14-OCT-2008, sequence version 1.
DT   02-NOV-2016, entry version 61.
DE   SubName: Full=Interleukin-6 {ECO:0000313|Ensembl:ENSP00000385043};
GN   Name=IL6 {ECO:0000313|Ensembl:ENSP00000385043};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000385043, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000385043, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [2] {ECO:0000313|Ensembl:ENSP00000385043}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000385043}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC073072; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001305024.1; NM_001318095.1.
DR   UniGene; Hs.654458; -.
DR   ProteinModelPortal; B5MC21; -.
DR   STRING; 9606.ENSP00000258743; -.
DR   MaxQB; B5MC21; -.
DR   PaxDb; B5MC21; -.
DR   Ensembl; ENST00000407492; ENSP00000385043; ENSG00000136244.
DR   GeneID; 3569; -.
DR   UCSC; uc064bxv.1; human.
DR   CTD; 3569; -.
DR   HGNC; HGNC:6018; IL6.
DR   OpenTargets; ENSG00000136244; -.
DR   eggNOG; ENOG410IW11; Eukaryota.
DR   eggNOG; ENOG4112BXV; LUCA.
DR   GeneTree; ENSGT00390000000878; -.
DR   HOGENOM; HOG000236330; -.
DR   HOVERGEN; HBG000471; -.
DR   ChiTaRS; IL6; human.
DR   GenomeRNAi; 3569; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000136244; -.
DR   ExpressionAtlas; B5MC21; baseline and differential.
DR   GO; GO:0005576; C:extracellular region; IEA:InterPro.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   Gene3D; 1.20.1250.10; -; 1.
DR   InterPro; IPR009079; 4_helix_cytokine-like_core.
DR   InterPro; IPR012351; 4_helix_cytokine_core.
DR   InterPro; IPR003574; IL-6.
DR   InterPro; IPR030474; IL-6/GCSF/MGF.
DR   InterPro; IPR030473; IL6/GCSF/MGF_CS.
DR   PANTHER; PTHR11457; PTHR11457; 1.
DR   Pfam; PF00489; IL6; 1.
DR   PRINTS; PR00433; IL6GCSFMGF.
DR   SMART; SM00126; IL6; 1.
DR   SUPFAM; SSF47266; SSF47266; 1.
DR   PROSITE; PS00254; INTERLEUKIN_6; 1.
PE   4: Predicted;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   136 AA;  15596 MW;  DE6D1905F32FF15E CRC64;
     MCESSKEALA ENNLNLPKMA EKDGCFQSGF NEETCLVKII TGLLEFEVYL EYLQNRFESS
     EEQARAVQMS TKVLIQFLQK KAKNLDAITT PDPTTNASLL TKLQAQNQWL QDMTTHLILR
     SFKEFLQSSL RALRQM
//
ID   B5MCZ3_HUMAN            Unreviewed;       189 AA.
AC   B5MCZ3;
DT   14-OCT-2008, integrated into UniProtKB/TrEMBL.
DT   14-OCT-2008, sequence version 1.
DT   02-NOV-2016, entry version 52.
DE   SubName: Full=Interleukin-6 {ECO:0000313|Ensembl:ENSP00000384928};
GN   Name=IL6 {ECO:0000313|Ensembl:ENSP00000384928};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000384928, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000384928, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [2] {ECO:0000313|Ensembl:ENSP00000384928}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000384928}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC073072; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; B5MCZ3; -.
DR   STRING; 9606.ENSP00000258743; -.
DR   MaxQB; B5MCZ3; -.
DR   PaxDb; B5MCZ3; -.
DR   Ensembl; ENST00000401630; ENSP00000384928; ENSG00000136244.
DR   UCSC; uc064bxw.1; human.
DR   HGNC; HGNC:6018; IL6.
DR   OpenTargets; ENSG00000136244; -.
DR   eggNOG; ENOG410IW11; Eukaryota.
DR   eggNOG; ENOG4112BXV; LUCA.
DR   GeneTree; ENSGT00390000000878; -.
DR   HOGENOM; HOG000236330; -.
DR   HOVERGEN; HBG000471; -.
DR   ChiTaRS; IL6; human.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000136244; -.
DR   ExpressionAtlas; B5MCZ3; baseline and differential.
DR   GO; GO:0005576; C:extracellular region; IEA:InterPro.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   Gene3D; 1.20.1250.10; -; 1.
DR   InterPro; IPR009079; 4_helix_cytokine-like_core.
DR   InterPro; IPR012351; 4_helix_cytokine_core.
DR   InterPro; IPR003574; IL-6.
DR   InterPro; IPR030474; IL-6/GCSF/MGF.
DR   InterPro; IPR030473; IL6/GCSF/MGF_CS.
DR   PANTHER; PTHR11457; PTHR11457; 1.
DR   Pfam; PF00489; IL6; 1.
DR   PIRSF; PIRSF001935; IL6_MGF_GCSF; 1.
DR   PRINTS; PR00433; IL6GCSFMGF.
DR   SMART; SM00126; IL6; 1.
DR   SUPFAM; SSF47266; SSF47266; 1.
DR   PROSITE; PS00254; INTERLEUKIN_6; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Disulfide bond {ECO:0000256|PIRSR:PIRSR001935-1};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:B5MCZ3};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DISULFID     49     55       {ECO:0000256|PIRSR:PIRSR001935-1}.
FT   DISULFID     78     88       {ECO:0000256|PIRSR:PIRSR001935-1}.
SQ   SEQUENCE   189 AA;  21495 MW;  9A0A922AC92581AE CRC64;
     MNSFSTIPPG EDSKDVAAPH RQPLTSSERI DKQIRYILDG ISALRKETCN KSNMCESSKE
     ALAENNLNLP KMAEKDGCFQ SGFNEETCLV KIITGLLEFE VYLEYLQNRF ESSEEQARAV
     QMSTKVLIQF LQKKAKNLDA ITTPDPTTNA SLLTKLQAQN QWLQDMTTHL ILRSFKEFLQ
     SSLRALRQM
//
ID   C9J5B0_HUMAN            Unreviewed;       152 AA.
AC   C9J5B0;
DT   03-NOV-2009, integrated into UniProtKB/TrEMBL.
DT   03-NOV-2009, sequence version 1.
DT   02-NOV-2016, entry version 51.
DE   SubName: Full=Interleukin-6 {ECO:0000313|Ensembl:ENSP00000405150};
DE   Flags: Fragment;
GN   Name=IL6 {ECO:0000313|Ensembl:ENSP00000405150};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000405150, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000405150, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [2] {ECO:0000313|Ensembl:ENSP00000405150}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000405150}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC073072; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; C9J5B0; -.
DR   STRING; 9606.ENSP00000258743; -.
DR   MaxQB; C9J5B0; -.
DR   PaxDb; C9J5B0; -.
DR   Ensembl; ENST00000426291; ENSP00000405150; ENSG00000136244.
DR   UCSC; uc064bxt.1; human.
DR   HGNC; HGNC:6018; IL6.
DR   OpenTargets; ENSG00000136244; -.
DR   eggNOG; ENOG410IW11; Eukaryota.
DR   eggNOG; ENOG4112BXV; LUCA.
DR   GeneTree; ENSGT00390000000878; -.
DR   HOGENOM; HOG000236330; -.
DR   ChiTaRS; IL6; human.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000136244; -.
DR   ExpressionAtlas; C9J5B0; baseline and differential.
DR   GO; GO:0005576; C:extracellular region; IEA:InterPro.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   Gene3D; 1.20.1250.10; -; 1.
DR   InterPro; IPR009079; 4_helix_cytokine-like_core.
DR   InterPro; IPR012351; 4_helix_cytokine_core.
DR   InterPro; IPR003574; IL-6.
DR   InterPro; IPR030474; IL-6/GCSF/MGF.
DR   InterPro; IPR030473; IL6/GCSF/MGF_CS.
DR   PANTHER; PTHR11457; PTHR11457; 1.
DR   Pfam; PF00489; IL6; 1.
DR   PRINTS; PR00433; IL6GCSFMGF.
DR   SMART; SM00126; IL6; 1.
DR   SUPFAM; SSF47266; SSF47266; 1.
DR   PROSITE; PS00254; INTERLEUKIN_6; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:C9J5B0};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     27       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        28    152       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002996523.
FT   NON_TER     152    152       {ECO:0000313|Ensembl:ENSP00000405150}.
SQ   SEQUENCE   152 AA;  16791 MW;  EE1562147E15AF4F CRC64;
     MNSFSTSAFG PVAFSLGLLL VLPAAFPAPV PPGEDSKDVA APHRQPLTSS ERIDKQIRYI
     LDGISALRKE TCNKSNMCES SKEALAENNL NLPKMAEKDG CFQSGFNEET CLVKIITGLL
     EFEVYLEYLQ NRFESSEEQA RAVQMSTKVL IQ
//
ID   IL6_HUMAN               Reviewed;         212 AA.
AC   P05231; Q9UCU2; Q9UCU3; Q9UCU4;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-1987, sequence version 1.
DT   02-NOV-2016, entry version 199.
DE   RecName: Full=Interleukin-6;
DE            Short=IL-6;
DE   AltName: Full=B-cell stimulatory factor 2;
DE            Short=BSF-2;
DE   AltName: Full=CTL differentiation factor;
DE            Short=CDF;
DE   AltName: Full=Hybridoma growth factor;
DE   AltName: Full=Interferon beta-2;
DE            Short=IFN-beta-2;
DE   Flags: Precursor;
GN   Name=IL6; Synonyms=IFNB2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=3491322; DOI=10.1038/324073a0;
RA   Hirano T., Yasukawa K., Harada H., Taga T., Watanabe Y., Matsuda T.,
RA   Kashiwamura S., Nakajima K., Koyama K., Iwamatsu A., Tsunasawa S.,
RA   Sakiyama F., Matsui H., Takahara Y., Taniguchi T., Kishimoto T.;
RT   "Complementary DNA for a novel human interleukin (BSF-2) that induces
RT   B lymphocytes to produce immunoglobulin.";
RL   Nature 324:73-76(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3500852;
RA   Yasukawa K., Hirano T., Watanabe Y., Muratani K., Matsuda T.,
RA   Nakai S., Kishimoto T.;
RT   "Structure and expression of human B cell stimulatory factor-2 (BSF-
RT   2/IL-6) gene.";
RL   EMBO J. 6:2939-2945(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3538015; DOI=10.1073/pnas.83.23.8957;
RA   May L.T., Helfgott D.C., Sehgal P.B.;
RT   "Anti-beta-interferon antibodies inhibit the increased expression of
RT   HLA-B7 mRNA in tumor necrosis factor-treated human fibroblasts:
RT   structural studies of the beta 2 interferon involved.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:8957-8961(1986).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3023045;
RA   Zilberstein A., Ruggieri R., Korn J.H., Revel M.;
RT   "Structure and expression of cDNA and genes for human interferon-beta-
RT   2, a distinct species inducible by growth-stimulatory cytokines.";
RL   EMBO J. 5:2529-2537(1986).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3320204;
RA   Brakenhoff J.P.J., de Groot E.R., Evers R.F., Pannekoek H.,
RA   Aarden L.A.;
RT   "Molecular cloning and expression of hybridoma growth factor in
RT   Escherichia coli.";
RL   J. Immunol. 139:4116-4121(1987).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2789513; DOI=10.1016/0006-291X(89)92328-0;
RA   Tonouchi N., Miwa K., Karasuyama H., Matsui H.;
RT   "Deletion of 3' untranslated region of human BSF-2 mRNA causes
RT   stabilization of the mRNA and high-level expression in mouse NIH3T3
RT   cells.";
RL   Biochem. Biophys. Res. Commun. 163:1056-1062(1989).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   TISSUE=Fibroblast;
RX   PubMed=3758081; DOI=10.1111/j.1432-1033.1986.tb09931.x;
RA   Haegeman G., Content J., Volckaert G., Derynck R., Tavernier J.,
RA   Fiers W.;
RT   "Structural analysis of the sequence coding for an inducible 26-kDa
RT   protein in human fibroblasts.";
RL   Eur. J. Biochem. 159:625-632(1986).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3266463;
RA   Wong G., Witek-Giannotti J., Hewick R., Clark S., Ogawa M.;
RT   "Interleukin 6: identification as a hematopoietic colony-stimulating
RT   factor.";
RL   Behring Inst. Mitt. 83:40-47(1988).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1291290;
RA   Chen Q.Y.;
RT   "Stable and efficient expression of human interleukin-6 cDNA in
RT   mammalian cells after gene transfer.";
RL   Zhonghua Zhong Liu Za Zhi 14:340-344(1992).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS SER-32 AND VAL-162.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   PROTEIN SEQUENCE OF 30-63.
RX   PubMed=3279116;
RA   van Damme J., van Beeumen J., Decock B., van Snick J., de Ley M.,
RA   Billiau A.;
RT   "Separation and comparison of two monokines with lymphocyte-activating
RT   factor activity: IL-1 beta and hybridoma growth factor (HGF).
RT   Identification of leukocyte-derived HGF as IL-6.";
RL   J. Immunol. 140:1534-1541(1988).
RN   [13]
RP   PROTEIN SEQUENCE OF 30-50.
RX   PubMed=2610854;
RA   Ming J.E., Cernetti C., Steinman R.M., Granelli-Piperno A.;
RT   "Interleukin 6 is the principal cytolytic T lymphocyte differentiation
RT   factor for thymocytes in human leukocyte conditioned medium.";
RL   J. Mol. Cell. Immunol. 4:203-211(1989).
RN   [14]
RP   PROTEIN SEQUENCE OF 30-40, AND GLYCOSYLATION.
RX   PubMed=1883960; DOI=10.1016/1043-4666(91)90018-9;
RA   May L.T., Shaw J.E., Khanna A.K., Zabriskie J.B., Sehgal P.B.;
RT   "Marked cell-type-specific differences in glycosylation of human
RT   interleukin-6.";
RL   Cytokine 3:204-211(1991).
RN   [15]
RP   PROTEIN SEQUENCE OF 50-212 OF RECOMBINANT FORM LACKING FIRST DISULFIDE
RP   BOND.
RX   PubMed=7851440; DOI=10.1111/j.1432-1033.1995.tb20427.x;
RA   Breton J., la Fiura A., Bertolero F., Orsini G., Valsasina B.,
RA   Ziliotto R., de Filippis V., Polverino de Laureto P., Fontana A.;
RT   "Structure, stability and biological properties of a N-terminally
RT   truncated form of recombinant human interleukin-6 containing a single
RT   disulfide bond.";
RL   Eur. J. Biochem. 227:573-581(1995).
RN   [16]
RP   DISULFIDE BONDS.
RX   PubMed=2472117; DOI=10.1016/0003-9861(89)90205-1;
RA   Clogston C.L., Boone T.C., Crandall B.C., Mendiaz E.A., Lu H.S.;
RT   "Disulfide structures of human interleukin-6 are similar to those of
RT   human granulocyte colony stimulating factor.";
RL   Arch. Biochem. Biophys. 272:144-151(1989).
RN   [17]
RP   MUTAGENESIS.
RX   PubMed=2037043; DOI=10.1016/0014-5793(91)80491-K;
RA   Luetticken C., Kruettgen A., Moeller C., Heinrich P.C., Rose-John S.;
RT   "Evidence for the importance of a positive charge and an alpha-helical
RT   structure of the C-terminus for biological activity of human IL-6.";
RL   FEBS Lett. 282:265-267(1991).
RN   [18]
RP   STRUCTURE BY NMR.
RX   PubMed=8555185; DOI=10.1021/bi951949e;
RA   Nishimura C., Watanabe A., Gouda H., Shimada I., Arata Y.;
RT   "Folding topologies of human interleukin-6 and its mutants as studied
RT   by NMR spectroscopy.";
RL   Biochemistry 35:273-281(1996).
RN   [19]
RP   STRUCTURE BY NMR.
RX   PubMed=9159484; DOI=10.1006/jmbi.1997.0933;
RA   Xu G.-Y., Yu H.-A., Hong J., Stahl M., McDonagh T., Kay L.E.,
RA   Cumming D.A.;
RT   "Solution structure of recombinant human interleukin-6.";
RL   J. Mol. Biol. 268:468-481(1997).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS).
RX   PubMed=9118960; DOI=10.1093/emboj/16.5.989;
RA   Somers W., Stahl M., Seehra J.S.;
RT   "1.9-A crystal structure of interleukin 6: implications for a novel
RT   mode of receptor dimerization and signaling.";
RL   EMBO J. 16:989-997(1997).
RN   [21]
RP   INVOLVEMENT IN RASJ.
RX   PubMed=9769329; DOI=10.1172/JCI2629;
RA   Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S.,
RA   Humphries S., Woo P.;
RT   "The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on
RT   IL-6 transcription and plasma IL-6 levels, and an association with
RT   systemic-onset juvenile chronic arthritis.";
RL   J. Clin. Invest. 102:1369-1376(1998).
RN   [22]
RP   INVOLVEMENT IN SUSCEPTIBILITY TO KAPOSI SARCOMA.
RX   PubMed=11001912;
RA   Foster C.B., Lehrnbecher T., Samuels S., Stein S., Mol F.,
RA   Metcalf J.A., Wyvill K., Steinberg S.M., Kovacs J., Blauvelt A.,
RA   Yarchoan R., Chanock S.J.;
RT   "An IL6 promoter polymorphism is associated with a lifetime risk of
RT   development of Kaposi sarcoma in men infected with human
RT   immunodeficiency virus.";
RL   Blood 96:2562-2567(2000).
RN   [23]
RP   INVOLVEMENT IN BMD.
RX   PubMed=11355017; DOI=10.1007/s100380170077;
RA   Ota N., Nakajima T., Nakazawa I., Suzuki T., Hosoi T., Orimo H.,
RA   Inoue S., Shirai Y., Emi M.;
RT   "A nucleotide variant in the promoter region of the interleukin-6 gene
RT   associated with decreased bone mineral density.";
RL   J. Hum. Genet. 46:267-272(2001).
RN   [24]
RP   INVOLVEMENT IN BMD.
RX   PubMed=12768442; DOI=10.1007/s10038-003-0020-8;
RA   Chung H.W., Seo J.-S., Hur S.E., Kim H.L., Kim J.Y., Jung J.H.,
RA   Kim L.H., Park B.L., Shin H.D.;
RT   "Association of interleukin-6 promoter variant with bone mineral
RT   density in pre-menopausal women.";
RL   J. Hum. Genet. 48:243-248(2003).
RN   [25]
RP   PHOSPHORYLATION AT SER-81.
RX   PubMed=26091039; DOI=10.1016/j.cell.2015.05.028;
RA   Tagliabracci V.S., Wiley S.E., Guo X., Kinch L.N., Durrant E., Wen J.,
RA   Xiao J., Cui J., Nguyen K.B., Engel J.L., Coon J.J., Grishin N.,
RA   Pinna L.A., Pagliarini D.J., Dixon J.E.;
RT   "A single kinase generates the majority of the secreted
RT   phosphoproteome.";
RL   Cell 161:1619-1632(2015).
CC   -!- FUNCTION: Cytokine with a wide variety of biological functions. It
CC       is a potent inducer of the acute phase response. Plays an
CC       essential role in the final differentiation of B-cells into Ig-
CC       secreting cells Involved in lymphocyte and monocyte
CC       differentiation. Acts on B-cells, T-cells, hepatocytes,
CC       hematopoietic progenitor cells and cells of the CNS. Required for
CC       the generation of T(H)17 cells. Also acts as a myokine. It is
CC       discharged into the bloodstream after muscle contraction and acts
CC       to increase the breakdown of fats and to improve insulin
CC       resistance. It induces myeloma and plasmacytoma growth and induces
CC       nerve cells differentiation.
CC   -!- INTERACTION:
CC       P08887:IL6R; NbExp=6; IntAct=EBI-720533, EBI-299383;
CC       Q05516:ZBTB16; NbExp=2; IntAct=EBI-720533, EBI-711925;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- PTM: N- and O-glycosylated. {ECO:0000269|PubMed:1883960}.
CC   -!- POLYMORPHISM: Genetic variations in IL6 may be correlated with
CC       bone mineral density (BMD). Low BMD is a risk factor for
CC       osteoporotic fracture. Osteoporosis is characterized by reduced
CC       bone mineral density, disrutption of bone microarchitecture, and
CC       the alteration of the amount and variety of non-collagenous
CC       proteins in bone. Osteoporotic bones are more at risk of fracture.
CC       {ECO:0000269|PubMed:11355017, ECO:0000269|PubMed:12768442}.
CC   -!- DISEASE: Rheumatoid arthritis systemic juvenile (RASJ)
CC       [MIM:604302]: An inflammatory articular disorder with systemic-
CC       onset beginning before the age of 16. It represents a subgroup of
CC       juvenile arthritis associated with severe extraarticular features
CC       and occasionally fatal complications. During active phases of the
CC       disorder, patients display a typical daily spiking fever, an
CC       evanescent macular rash, lymphadenopathy, hepatosplenomegaly,
CC       serositis, myalgia and arthritis. {ECO:0000269|PubMed:9769329}.
CC       Note=Disease susceptibility is associated with variations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Note=A IL6 promoter polymorphism is associated with a
CC       lifetime risk of development of Kaposi sarcoma in HIV-infected
CC       men. {ECO:0000269|PubMed:11001912}.
CC   -!- SIMILARITY: Belongs to the IL-6 superfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Interleukin-6 entry;
CC       URL="https://en.wikipedia.org/wiki/Interleukin_6";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/il6/";
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=IL6";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/IL6ID519ch7p15.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X04430; CAA28026.1; -; mRNA.
DR   EMBL; M14584; AAA52728.1; -; mRNA.
DR   EMBL; X04602; CAA28268.1; -; mRNA.
DR   EMBL; Y00081; CAA68278.1; -; Genomic_DNA.
DR   EMBL; M18403; AAA52729.1; -; mRNA.
DR   EMBL; M29150; AAA59154.1; -; mRNA.
DR   EMBL; X04402; CAA27990.1; -; Genomic_DNA.
DR   EMBL; X04403; CAA27991.1; -; mRNA.
DR   EMBL; M54894; AAC41704.1; -; mRNA.
DR   EMBL; S56892; AAD13886.1; -; mRNA.
DR   EMBL; AF372214; AAK48987.1; -; Genomic_DNA.
DR   EMBL; BC015511; AAH15511.1; -; mRNA.
DR   CCDS; CCDS5375.1; -.
DR   PIR; A32648; IVHUB2.
DR   RefSeq; NP_000591.1; NM_000600.4.
DR   RefSeq; XP_011513692.1; XM_011515390.2.
DR   UniGene; Hs.654458; -.
DR   PDB; 1ALU; X-ray; 1.90 A; A=28-212.
DR   PDB; 1IL6; NMR; -; A=28-212.
DR   PDB; 1N2Q; Model; -; E/F=30-212.
DR   PDB; 1P9M; X-ray; 3.65 A; B=29-212.
DR   PDB; 2IL6; NMR; -; A=28-212.
DR   PDB; 4CNI; X-ray; 2.20 A; C/D=42-212.
DR   PDB; 4J4L; X-ray; 2.30 A; C/D=47-212.
DR   PDB; 4NI7; X-ray; 2.40 A; A=28-212.
DR   PDB; 4NI9; X-ray; 2.55 A; A/C=28-212.
DR   PDB; 4O9H; X-ray; 2.42 A; A=28-212.
DR   PDB; 4ZS7; X-ray; 2.93 A; A=42-212.
DR   PDBsum; 1ALU; -.
DR   PDBsum; 1IL6; -.
DR   PDBsum; 1N2Q; -.
DR   PDBsum; 1P9M; -.
DR   PDBsum; 2IL6; -.
DR   PDBsum; 4CNI; -.
DR   PDBsum; 4J4L; -.
DR   PDBsum; 4NI7; -.
DR   PDBsum; 4NI9; -.
DR   PDBsum; 4O9H; -.
DR   PDBsum; 4ZS7; -.
DR   ProteinModelPortal; P05231; -.
DR   SMR; P05231; -.
DR   BioGrid; 109783; 4.
DR   DIP; DIP-482N; -.
DR   IntAct; P05231; 5.
DR   MINT; MINT-190042; -.
DR   STRING; 9606.ENSP00000258743; -.
DR   BindingDB; P05231; -.
DR   ChEMBL; CHEMBL1795129; -.
DR   DrugBank; DB01404; Ginseng.
DR   DrugBank; DB09036; Siltuximab.
DR   iPTMnet; P05231; -.
DR   PhosphoSitePlus; P05231; -.
DR   BioMuta; IL6; -.
DR   DMDM; 124347; -.
DR   EPD; P05231; -.
DR   PaxDb; P05231; -.
DR   PeptideAtlas; P05231; -.
DR   PRIDE; P05231; -.
DR   DNASU; 3569; -.
DR   Ensembl; ENST00000258743; ENSP00000258743; ENSG00000136244.
DR   Ensembl; ENST00000404625; ENSP00000385675; ENSG00000136244.
DR   GeneID; 3569; -.
DR   KEGG; hsa:3569; -.
DR   CTD; 3569; -.
DR   DisGeNET; 3569; -.
DR   GeneCards; IL6; -.
DR   H-InvDB; HIX0167872; -.
DR   HGNC; HGNC:6018; IL6.
DR   HPA; CAB023406; -.
DR   MalaCards; IL6; -.
DR   MIM; 147620; gene.
DR   MIM; 148000; phenotype.
DR   MIM; 604302; phenotype.
DR   neXtProt; NX_P05231; -.
DR   OpenTargets; ENSG00000136244; -.
DR   Orphanet; 206; Crohn disease.
DR   Orphanet; 85414; Systemic-onset juvenile idiopathic arthritis.
DR   PharmGKB; PA198; -.
DR   eggNOG; ENOG410IW11; Eukaryota.
DR   eggNOG; ENOG4112BXV; LUCA.
DR   GeneTree; ENSGT00390000000878; -.
DR   HOGENOM; HOG000236330; -.
DR   HOVERGEN; HBG000471; -.
DR   InParanoid; P05231; -.
DR   KO; K05405; -.
DR   OMA; FNQETCL; -.
DR   OrthoDB; EOG091G0NW5; -.
DR   PhylomeDB; P05231; -.
DR   TreeFam; TF335984; -.
DR   BioCyc; ZFISH:ENSG00000136244-MONOMER; -.
DR   Reactome; R-HSA-1059683; Interleukin-6 signaling.
DR   Reactome; R-HSA-110056; MAPK3 (ERK1) activation.
DR   Reactome; R-HSA-112411; MAPK1 (ERK2) activation.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   SignaLink; P05231; -.
DR   SIGNOR; P05231; -.
DR   ChiTaRS; IL6; human.
DR   EvolutionaryTrace; P05231; -.
DR   GeneWiki; Interleukin_6; -.
DR   GenomeRNAi; 3569; -.
DR   PMAP-CutDB; P05231; -.
DR   PRO; PR:P05231; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000136244; -.
DR   CleanEx; HS_IL6; -.
DR   ExpressionAtlas; P05231; baseline and differential.
DR   Genevisible; P05231; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:0005896; C:interleukin-6 receptor complex; IDA:BHF-UCL.
DR   GO; GO:0005125; F:cytokine activity; IDA:BHF-UCL.
DR   GO; GO:0008083; F:growth factor activity; IDA:BHF-UCL.
DR   GO; GO:0005138; F:interleukin-6 receptor binding; NAS:UniProtKB.
DR   GO; GO:0006953; P:acute-phase response; TAS:BHF-UCL.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0046849; P:bone remodeling; IEA:Ensembl.
DR   GO; GO:0060445; P:branching involved in salivary gland morphogenesis; IEA:Ensembl.
DR   GO; GO:0016049; P:cell growth; IEA:Ensembl.
DR   GO; GO:0045454; P:cell redox homeostasis; IEA:Ensembl.
DR   GO; GO:0071549; P:cellular response to dexamethasone stimulus; IEA:Ensembl.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; IEA:Ensembl.
DR   GO; GO:0035729; P:cellular response to hepatocyte growth factor stimulus; IEA:Ensembl.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IDA:BHF-UCL.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEA:Ensembl.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IMP:MGI.
DR   GO; GO:0031669; P:cellular response to nutrient levels; IEA:Ensembl.
DR   GO; GO:1990646; P:cellular response to prolactin; IEA:Ensembl.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0050829; P:defense response to Gram-negative bacterium; TAS:BHF-UCL.
DR   GO; GO:0050830; P:defense response to Gram-positive bacterium; TAS:BHF-UCL.
DR   GO; GO:0042832; P:defense response to protozoan; IEA:Ensembl.
DR   GO; GO:0051607; P:defense response to virus; IDA:BHF-UCL.
DR   GO; GO:0031018; P:endocrine pancreas development; ISS:BHF-UCL.
DR   GO; GO:0060664; P:epithelial cell proliferation involved in salivary gland morphogenesis; IEA:Ensembl.
DR   GO; GO:0070091; P:glucagon secretion; ISS:BHF-UCL.
DR   GO; GO:0042593; P:glucose homeostasis; IEA:Ensembl.
DR   GO; GO:0002384; P:hepatic immune response; IDA:BHF-UCL.
DR   GO; GO:0006959; P:humoral immune response; IC:BHF-UCL.
DR   GO; GO:0006954; P:inflammatory response; IDA:BHF-UCL.
DR   GO; GO:0070102; P:interleukin-6-mediated signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0002548; P:monocyte chemotaxis; IC:BHF-UCL.
DR   GO; GO:0046716; P:muscle cell cellular homeostasis; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0045779; P:negative regulation of bone resorption; ISS:BHF-UCL.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; TAS:ProtInc.
DR   GO; GO:0045079; P:negative regulation of chemokine biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0032966; P:negative regulation of collagen biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl.
DR   GO; GO:0050710; P:negative regulation of cytokine secretion; IEA:Ensembl.
DR   GO; GO:0045599; P:negative regulation of fat cell differentiation; NAS:BHF-UCL.
DR   GO; GO:0045721; P:negative regulation of gluconeogenesis; IEA:Ensembl.
DR   GO; GO:0046888; P:negative regulation of hormone secretion; IEA:Ensembl.
DR   GO; GO:2000660; P:negative regulation of interleukin-1-mediated signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0010888; P:negative regulation of lipid storage; NAS:BHF-UCL.
DR   GO; GO:0045837; P:negative regulation of membrane potential; IEA:Ensembl.
DR   GO; GO:0048635; P:negative regulation of muscle organ development; IEA:Ensembl.
DR   GO; GO:1901215; P:negative regulation of neuron death; IEA:Ensembl.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IEA:Ensembl.
DR   GO; GO:0031175; P:neuron projection development; IMP:BHF-UCL.
DR   GO; GO:0001781; P:neutrophil apoptotic process; IDA:UniProtKB.
DR   GO; GO:0002446; P:neutrophil mediated immunity; TAS:BHF-UCL.
DR   GO; GO:0030168; P:platelet activation; TAS:BHF-UCL.
DR   GO; GO:0002675; P:positive regulation of acute inflammatory response; IDA:BHF-UCL.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0050871; P:positive regulation of B cell activation; IDA:BHF-UCL.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IDA:BHF-UCL.
DR   GO; GO:0071864; P:positive regulation of cell proliferation in bone marrow; IEA:Ensembl.
DR   GO; GO:0032722; P:positive regulation of chemokine production; IDA:BHF-UCL.
DR   GO; GO:0045740; P:positive regulation of DNA replication; IEA:Ensembl.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl.
DR   GO; GO:0010628; P:positive regulation of gene expression; IDA:BHF-UCL.
DR   GO; GO:0051024; P:positive regulation of immunoglobulin secretion; IDA:BHF-UCL.
DR   GO; GO:0032755; P:positive regulation of interleukin-6 production; IDA:BHF-UCL.
DR   GO; GO:0046427; P:positive regulation of JAK-STAT cascade; IDA:BHF-UCL.
DR   GO; GO:0002690; P:positive regulation of leukocyte chemotaxis; TAS:BHF-UCL.
DR   GO; GO:0043410; P:positive regulation of MAPK cascade; IDA:BHF-UCL.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl.
DR   GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IEA:Ensembl.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; TAS:BHF-UCL.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:MGI.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:MGI.
DR   GO; GO:0033160; P:positive regulation of protein import into nucleus, translocation; IEA:Ensembl.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl.
DR   GO; GO:0051091; P:positive regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IDA:BHF-UCL.
DR   GO; GO:2000366; P:positive regulation of STAT protein import into nucleus; IC:BHF-UCL.
DR   GO; GO:0042102; P:positive regulation of T cell proliferation; IDA:BHF-UCL.
DR   GO; GO:2000553; P:positive regulation of T-helper 2 cell cytokine production; ISS:BHF-UCL.
DR   GO; GO:0045630; P:positive regulation of T-helper 2 cell differentiation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL.
DR   GO; GO:0045727; P:positive regulation of translation; IDA:UniProtKB.
DR   GO; GO:0051971; P:positive regulation of transmission of nerve impulse; IEA:Ensembl.
DR   GO; GO:2000676; P:positive regulation of type B pancreatic cell apoptotic process; TAS:BHF-UCL.
DR   GO; GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; IDA:BHF-UCL.
DR   GO; GO:0045765; P:regulation of angiogenesis; IC:BHF-UCL.
DR   GO; GO:0008360; P:regulation of cell shape; IEA:Ensembl.
DR   GO; GO:0045188; P:regulation of circadian sleep/wake cycle, non-REM sleep; IEA:Ensembl.
DR   GO; GO:0010574; P:regulation of vascular endothelial growth factor production; IDA:BHF-UCL.
DR   GO; GO:0043200; P:response to amino acid; IEA:Ensembl.
DR   GO; GO:0046677; P:response to antibiotic; IEA:Ensembl.
DR   GO; GO:0010996; P:response to auditory stimulus; IEA:Ensembl.
DR   GO; GO:0031000; P:response to caffeine; IEA:Ensembl.
DR   GO; GO:0051592; P:response to calcium ion; IEA:Ensembl.
DR   GO; GO:0009409; P:response to cold; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0051602; P:response to electrical stimulus; IEA:Ensembl.
DR   GO; GO:0051384; P:response to glucocorticoid; IDA:BHF-UCL.
DR   GO; GO:0009408; P:response to heat; IEA:Ensembl.
DR   GO; GO:0032868; P:response to insulin; IEA:Ensembl.
DR   GO; GO:0032494; P:response to peptidoglycan; NAS:BHF-UCL.
DR   GO; GO:0001878; P:response to yeast; IEA:Ensembl.
DR   GO; GO:0072540; P:T-helper 17 cell lineage commitment; ISS:UniProtKB.
DR   Gene3D; 1.20.1250.10; -; 1.
DR   InterPro; IPR009079; 4_helix_cytokine-like_core.
DR   InterPro; IPR012351; 4_helix_cytokine_core.
DR   InterPro; IPR003574; IL-6.
DR   InterPro; IPR030474; IL-6/GCSF/MGF.
DR   InterPro; IPR030473; IL6/GCSF/MGF_CS.
DR   PANTHER; PTHR11457; PTHR11457; 1.
DR   Pfam; PF00489; IL6; 1.
DR   PIRSF; PIRSF001935; IL6_MGF_GCSF; 1.
DR   PRINTS; PR00433; IL6GCSFMGF.
DR   SMART; SM00126; IL6; 1.
DR   SUPFAM; SSF47266; SSF47266; 1.
DR   PROSITE; PS00254; INTERLEUKIN_6; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acute phase; Complete proteome; Cytokine;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Growth factor; Phosphoprotein; Polymorphism; Reference proteome;
KW   Secreted; Signal.
FT   SIGNAL        1     29       {ECO:0000269|PubMed:1883960,
FT                                ECO:0000269|PubMed:2610854,
FT                                ECO:0000269|PubMed:3279116}.
FT   CHAIN        30    212       Interleukin-6.
FT                                /FTId=PRO_0000015582.
FT   MOD_RES      81     81       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:26091039}.
FT   CARBOHYD     73     73       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:1883960}.
FT   DISULFID     72     78       {ECO:0000269|PubMed:2472117}.
FT   DISULFID    101    111       {ECO:0000269|PubMed:2472117}.
FT   VARIANT      32     32       P -> S (in dbSNP:rs2069830).
FT                                {ECO:0000269|Ref.10}.
FT                                /FTId=VAR_013075.
FT   VARIANT     162    162       D -> E (in dbSNP:rs13306435).
FT                                /FTId=VAR_029266.
FT   VARIANT     162    162       D -> V (in dbSNP:rs2069860).
FT                                {ECO:0000269|Ref.10}.
FT                                /FTId=VAR_013076.
FT   MUTAGEN     173    173       A->V: Almost no loss of activity.
FT                                {ECO:0000269|PubMed:2037043}.
FT   MUTAGEN     185    185       W->R: No loss of activity.
FT                                {ECO:0000269|PubMed:2037043}.
FT   MUTAGEN     204    204       S->P: 87% loss of activity.
FT                                {ECO:0000269|PubMed:2037043}.
FT   MUTAGEN     210    210       R->K,E,Q,T,A,P: Loss of activity.
FT                                {ECO:0000269|PubMed:2037043}.
FT   MUTAGEN     212    212       M->T,N,S,R: Loss of activity.
FT                                {ECO:0000269|PubMed:2037043}.
FT   HELIX        49     75       {ECO:0000244|PDB:1ALU}.
FT   STRAND       76     79       {ECO:0000244|PDB:2IL6}.
FT   TURN         81     83       {ECO:0000244|PDB:4CNI}.
FT   HELIX        84     87       {ECO:0000244|PDB:4CNI}.
FT   HELIX        97     99       {ECO:0000244|PDB:1ALU}.
FT   STRAND      102    105       {ECO:0000244|PDB:4J4L}.
FT   HELIX       108    132       {ECO:0000244|PDB:1ALU}.
FT   STRAND      134    136       {ECO:0000244|PDB:4J4L}.
FT   HELIX       137    157       {ECO:0000244|PDB:1ALU}.
FT   STRAND      159    161       {ECO:0000244|PDB:1ALU}.
FT   HELIX       169    180       {ECO:0000244|PDB:1ALU}.
FT   HELIX       184    209       {ECO:0000244|PDB:1ALU}.
SQ   SEQUENCE   212 AA;  23718 MW;  1F1ED1FE1B734079 CRC64;
     MNSFSTSAFG PVAFSLGLLL VLPAAFPAPV PPGEDSKDVA APHRQPLTSS ERIDKQIRYI
     LDGISALRKE TCNKSNMCES SKEALAENNL NLPKMAEKDG CFQSGFNEET CLVKIITGLL
     EFEVYLEYLQ NRFESSEEQA RAVQMSTKVL IQFLQKKAKN LDAITTPDPT TNASLLTKLQ
     AQNQWLQDMT THLILRSFKE FLQSSLRALR QM
//
ID   Q75MH2_HUMAN            Unreviewed;       212 AA.
AC   Q75MH2;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   02-NOV-2016, entry version 112.
DE   SubName: Full=IL6 protein {ECO:0000313|EMBL:CAG29292.1};
DE   SubName: Full=Interleukin 6 (Interferon, beta 2) {ECO:0000313|EMBL:AAV38553.1};
DE   SubName: Full=Interleukin 6 (Interferon, beta 2), isoform CRA_a {ECO:0000313|EMBL:EAW93756.1};
DE   SubName: Full=Putative uncharacterized protein IL6 {ECO:0000313|EMBL:AAS07539.1};
GN   Name=IL6 {ECO:0000313|EMBL:AAS07539.1};
GN   ORFNames=hCG_38231 {ECO:0000313|EMBL:EAW93756.1},
GN   tcag7.131 {ECO:0000313|EMBL:EAL24265.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAS07539.1};
RN   [1] {ECO:0000313|EMBL:AAS07539.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Haakenson W., Nguyen C., Yoakum M.;
RT   "The sequence of Homo sapiens BAC clone RP11-240H8.";
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000313|EMBL:EAW93756.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [3] {ECO:0000313|EMBL:AAS07539.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Waterston R.;
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:AAS07539.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [5] {ECO:0000313|EMBL:EAL24265.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D., Zhang Q., Gu Z., Lu F.,
RA   Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J., Grzeschik K.H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Dohner H., Dohner K.,
RA   Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [6] {ECO:0000313|EMBL:AAS07539.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wilson R.;
RL   Submitted (JAN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7] {ECO:0000313|EMBL:CAG29292.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8] {ECO:0000313|EMBL:EAL24265.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Nusskern D., Zhang Q., Gu Z., Lu F.,
RA   Zeesman S., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P., Lococo F., Belloni E.,
RA   Shaffer L.G., Morton C.C., Pober B., Gusella J., Bruns G., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M.,
RA   Gripp K.W., Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H.,
RA   Teebi A., Minassian B.A., Kere J., Armengol L., Pujana M.Angel.,
RA   Estivill X., Wilson M.D., Koop B.F., Tosi S., Moore G.E.,
RA   Boright A.P., Zlotorynski E., Kerem B., Kroisel P.M., Petek E.,
RA   Oscier D.G., Mould S.J., Doehner H., Doehner K., Rommens J.M.,
RA   Vincent J.B., Venter J.C., Li P.W., Mural R.J., Adams M.D.,
RA   Tsui L.-C.;
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [9] {ECO:0000313|EMBL:AAV38553.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) System Donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [10] {ECO:0000313|EMBL:EAW93756.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC073072; AAS07539.1; -; Genomic_DNA.
DR   EMBL; BT019748; AAV38553.1; -; mRNA.
DR   EMBL; BT019749; AAV38554.1; -; mRNA.
DR   EMBL; CR450296; CAG29292.1; -; mRNA.
DR   EMBL; CH236948; EAL24265.1; -; Genomic_DNA.
DR   EMBL; CH471073; EAW93756.1; -; Genomic_DNA.
DR   EMBL; CH471073; EAW93758.1; -; Genomic_DNA.
DR   RefSeq; NP_000591.1; NM_000600.4.
DR   RefSeq; XP_011513692.1; XM_011515390.2.
DR   UniGene; Hs.654458; -.
DR   STRING; 9606.ENSP00000258743; -.
DR   DNASU; 3569; -.
DR   GeneID; 3569; -.
DR   KEGG; hsa:3569; -.
DR   UCSC; uc003svj.5; human.
DR   CTD; 3569; -.
DR   PharmGKB; PA198; -.
DR   eggNOG; ENOG410IW11; Eukaryota.
DR   eggNOG; ENOG4112BXV; LUCA.
DR   HOVERGEN; HBG000471; -.
DR   KO; K05405; -.
DR   OMA; FNQETCL; -.
DR   OrthoDB; EOG091G0NW5; -.
DR   ChiTaRS; IL6; human.
DR   GenomeRNAi; 3569; -.
DR   Bgee; ENSG00000136244; -.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0005615; C:extracellular space; IEA:Ensembl.
DR   GO; GO:0002526; P:acute inflammatory response; IEA:Ensembl.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0046849; P:bone remodeling; IEA:Ensembl.
DR   GO; GO:0060445; P:branching involved in salivary gland morphogenesis; IEA:Ensembl.
DR   GO; GO:0016049; P:cell growth; IEA:Ensembl.
DR   GO; GO:0045454; P:cell redox homeostasis; IEA:Ensembl.
DR   GO; GO:0071549; P:cellular response to dexamethasone stimulus; IEA:Ensembl.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; IEA:Ensembl.
DR   GO; GO:0035729; P:cellular response to hepatocyte growth factor stimulus; IEA:Ensembl.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEA:Ensembl.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0031669; P:cellular response to nutrient levels; IEA:Ensembl.
DR   GO; GO:1990646; P:cellular response to prolactin; IEA:Ensembl.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl.
DR   GO; GO:0042832; P:defense response to protozoan; IEA:Ensembl.
DR   GO; GO:0031018; P:endocrine pancreas development; IEA:Ensembl.
DR   GO; GO:0060664; P:epithelial cell proliferation involved in salivary gland morphogenesis; IEA:Ensembl.
DR   GO; GO:0070091; P:glucagon secretion; IEA:Ensembl.
DR   GO; GO:0042593; P:glucose homeostasis; IEA:Ensembl.
DR   GO; GO:0070102; P:interleukin-6-mediated signaling pathway; IEA:Ensembl.
DR   GO; GO:0046716; P:muscle cell cellular homeostasis; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0045079; P:negative regulation of chemokine biosynthetic process; IEA:Ensembl.
DR   GO; GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl.
DR   GO; GO:0050710; P:negative regulation of cytokine secretion; IEA:Ensembl.
DR   GO; GO:0045721; P:negative regulation of gluconeogenesis; IEA:Ensembl.
DR   GO; GO:0046888; P:negative regulation of hormone secretion; IEA:Ensembl.
DR   GO; GO:0045837; P:negative regulation of membrane potential; IEA:Ensembl.
DR   GO; GO:0048635; P:negative regulation of muscle organ development; IEA:Ensembl.
DR   GO; GO:1901215; P:negative regulation of neuron death; IEA:Ensembl.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IEA:Ensembl.
DR   GO; GO:0001781; P:neutrophil apoptotic process; IEA:Ensembl.
DR   GO; GO:0071864; P:positive regulation of cell proliferation in bone marrow; IEA:Ensembl.
DR   GO; GO:0045740; P:positive regulation of DNA replication; IEA:Ensembl.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl.
DR   GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IEA:Ensembl.
DR   GO; GO:0033160; P:positive regulation of protein import into nucleus, translocation; IEA:Ensembl.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; IEA:Ensembl.
DR   GO; GO:0045630; P:positive regulation of T-helper 2 cell differentiation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IEA:Ensembl.
DR   GO; GO:0051971; P:positive regulation of transmission of nerve impulse; IEA:Ensembl.
DR   GO; GO:0042517; P:positive regulation of tyrosine phosphorylation of Stat3 protein; IEA:Ensembl.
DR   GO; GO:0008360; P:regulation of cell shape; IEA:Ensembl.
DR   GO; GO:0045188; P:regulation of circadian sleep/wake cycle, non-REM sleep; IEA:Ensembl.
DR   GO; GO:0043200; P:response to amino acid; IEA:Ensembl.
DR   GO; GO:0046677; P:response to antibiotic; IEA:Ensembl.
DR   GO; GO:0010996; P:response to auditory stimulus; IEA:Ensembl.
DR   GO; GO:0031000; P:response to caffeine; IEA:Ensembl.
DR   GO; GO:0051592; P:response to calcium ion; IEA:Ensembl.
DR   GO; GO:0009409; P:response to cold; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0051602; P:response to electrical stimulus; IEA:Ensembl.
DR   GO; GO:0009408; P:response to heat; IEA:Ensembl.
DR   GO; GO:0032868; P:response to insulin; IEA:Ensembl.
DR   GO; GO:0001878; P:response to yeast; IEA:Ensembl.
DR   GO; GO:0072540; P:T-helper 17 cell lineage commitment; IEA:Ensembl.
DR   GO; GO:0042060; P:wound healing; IEA:Ensembl.
DR   Gene3D; 1.20.1250.10; -; 1.
DR   InterPro; IPR009079; 4_helix_cytokine-like_core.
DR   InterPro; IPR012351; 4_helix_cytokine_core.
DR   InterPro; IPR003574; IL-6.
DR   InterPro; IPR030474; IL-6/GCSF/MGF.
DR   InterPro; IPR030473; IL6/GCSF/MGF_CS.
DR   PANTHER; PTHR11457; PTHR11457; 1.
DR   Pfam; PF00489; IL6; 1.
DR   PIRSF; PIRSF001935; IL6_MGF_GCSF; 1.
DR   PRINTS; PR00433; IL6GCSFMGF.
DR   SMART; SM00126; IL6; 1.
DR   SUPFAM; SSF47266; SSF47266; 1.
DR   PROSITE; PS00254; INTERLEUKIN_6; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|PIRSR:PIRSR001935-1};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     27       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        28    212       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5008427232.
FT   DISULFID     72     78       {ECO:0000256|PIRSR:PIRSR001935-1}.
FT   DISULFID    101    111       {ECO:0000256|PIRSR:PIRSR001935-1}.
FT   NON_TER     212    212       {ECO:0000313|EMBL:CAG29292.1}.
SQ   SEQUENCE   212 AA;  23718 MW;  1F1ED1FE1B734079 CRC64;
     MNSFSTSAFG PVAFSLGLLL VLPAAFPAPV PPGEDSKDVA APHRQPLTSS ERIDKQIRYI
     LDGISALRKE TCNKSNMCES SKEALAENNL NLPKMAEKDG CFQSGFNEET CLVKIITGLL
     EFEVYLEYLQ NRFESSEEQA RAVQMSTKVL IQFLQKKAKN LDAITTPDPT TNASLLTKLQ
     AQNQWLQDMT THLILRSFKE FLQSSLRALR QM
//
ID   A0A024RDD9_HUMAN        Unreviewed;       107 AA.
AC   A0A024RDD9;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   02-NOV-2016, entry version 19.
DE   RecName: Full=C-X-C motif chemokine {ECO:0000256|RuleBase:RU361149};
GN   Name=CXCL2 {ECO:0000313|EMBL:EAX05701.1};
GN   ORFNames=hCG_16361 {ECO:0000313|EMBL:EAX05701.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAX05701.1};
RN   [1] {ECO:0000313|EMBL:EAX05701.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX05701.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000256|RuleBase:RU361149,
CC       ECO:0000256|SAAS:SAAS00156280}.
CC   -!- SIMILARITY: Belongs to the intercrine alpha (chemokine CxC)
CC       family. {ECO:0000256|RuleBase:RU361149,
CC       ECO:0000256|SAAS:SAAS00547150}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471057; EAX05701.1; -; Genomic_DNA.
DR   RefSeq; NP_002080.1; NM_002089.3.
DR   UniGene; Hs.75765; -.
DR   ProteinModelPortal; A0A024RDD9; -.
DR   SMR; A0A024RDD9; -.
DR   STRING; 9606.ENSP00000427279; -.
DR   PaxDb; A0A024RDD9; -.
DR   PRIDE; A0A024RDD9; -.
DR   GeneID; 2920; -.
DR   KEGG; hsa:2920; -.
DR   CTD; 2920; -.
DR   eggNOG; ENOG410J3WE; Eukaryota.
DR   eggNOG; ENOG410ZT1C; LUCA.
DR   KO; K05505; -.
DR   OMA; TMQGIHL; -.
DR   OrthoDB; EOG091G14TE; -.
DR   PhylomeDB; A0A024RDD9; -.
DR   GenomeRNAi; 2920; -.
DR   ExpressionAtlas; A0A024RDD9; baseline and differential.
DR   GO; GO:0005615; C:extracellular space; IEA:UniProtKB-KW.
DR   GO; GO:0060326; P:cell chemotaxis; IEA:GOC.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0006954; P:inflammatory response; IEA:InterPro.
DR   InterPro; IPR001089; Chemokine_CXC.
DR   InterPro; IPR018048; Chemokine_CXC_CS.
DR   InterPro; IPR001811; Chemokine_IL8-like_dom.
DR   PANTHER; PTHR10179; PTHR10179; 1.
DR   Pfam; PF00048; IL8; 1.
DR   PRINTS; PR00437; SMALLCYTKCXC.
DR   SMART; SM00199; SCY; 1.
DR   SUPFAM; SSF54117; SSF54117; 1.
DR   PROSITE; PS00471; SMALL_CYTOKINES_CXC; 1.
PE   3: Inferred from homology;
KW   Chemotaxis {ECO:0000256|RuleBase:RU361149};
KW   Cytokine {ECO:0000256|RuleBase:RU361149,
KW   ECO:0000256|SAAS:SAAS00431841};
KW   Disulfide bond {ECO:0000256|SAAS:SAAS00431839};
KW   Secreted {ECO:0000256|RuleBase:RU361149,
KW   ECO:0000256|SAAS:SAAS00473543};
KW   Signal {ECO:0000256|RuleBase:RU361149}.
FT   SIGNAL        1     34       {ECO:0000256|RuleBase:RU361149}.
FT   CHAIN        35    107       C-X-C motif chemokine.
FT                                {ECO:0000256|RuleBase:RU361149}.
FT                                /FTId=PRO_5005101860.
FT   DOMAIN       40    100       SCY. {ECO:0000259|SMART:SM00199}.
SQ   SEQUENCE   107 AA;  11389 MW;  740F277E928571BA CRC64;
     MARATLSAAP SNPRLLRVAL LLLLLVAASR RAAGAPLATE LRCQCLQTLQ GIHLKNIQSV
     KVKSPGPHCA QTEVIATLKN GQKACLNPAS PMVKKIIEKM LKNGKSN
//
ID   CXCL2_HUMAN             Reviewed;         107 AA.
AC   P19875; Q6FGD6; Q9UPB8;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1991, sequence version 1.
DT   02-NOV-2016, entry version 164.
DE   RecName: Full=C-X-C motif chemokine 2;
DE   AltName: Full=Growth-regulated protein beta;
DE            Short=Gro-beta;
DE   AltName: Full=Macrophage inflammatory protein 2-alpha;
DE            Short=MIP2-alpha;
DE   Contains:
DE     RecName: Full=GRO-beta(5-73);
DE     AltName: Full=GRO-beta-T;
DE     AltName: Full=Hematopoietic synergistic factor;
DE              Short=HSF;
DE     AltName: Full=SB-251353;
DE   Flags: Precursor;
GN   Name=CXCL2; Synonyms=GRO2, GROB, MIP2A, SCYB2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Histiocytic lymphoma;
RX   PubMed=2201751; DOI=10.1084/jem.172.3.911;
RA   Tekamp-Olson P., Gallegos C., Bauer D., McClain J., Sherry B.,
RA   Fabre M., van Deventer S., Cerami A.;
RT   "Cloning and characterization of cDNAs for murine macrophage
RT   inflammatory protein 2 and its human homologues.";
RL   J. Exp. Med. 172:911-919(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2078213; DOI=10.1128/MCB.10.10.5596;
RA   Iida N., Grotendorst G.R.;
RT   "Cloning and sequencing of a new gro transcript from activated human
RT   monocytes: expression in leukocytes and wound tissue.";
RL   Mol. Cell. Biol. 10:5596-5599(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2217207; DOI=10.1073/pnas.87.19.7732;
RA   Haskill S., Peace A., Morris J., Sporn S.A., Anisowicz A., Lee S.W.,
RA   Smith T., Martin G., Ralph P., Sager R.;
RT   "Identification of three related human GRO genes encoding cytokine
RT   functions.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:7732-7736(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 35-107.
RA   Jang J.S., Kim B.E.;
RL   Submitted (JAN-1998) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 56-107.
RX   PubMed=2341726;
RA   Sporn S.A., Eierman D.F., Johnson C.E., Morris J., Martin G.,
RA   Ladner M., Haskill S.;
RT   "Monocyte adherence results in selective induction of novel genes
RT   sharing homology with mediators of inflammation and tissue repair.";
RL   J. Immunol. 144:4434-4441(1990).
RN   [9]
RP   PROTEIN SEQUENCE OF 39-56, IDENTIFICATION OF GRO-BETA(5-73) BY MASS
RP   SPECTROMETRY, PROTEOLYTIC PROCESSING OF N-TERMINUS, AND FUNCTION.
RX   PubMed=10725737; DOI=10.4049/jimmunol.164.7.3774;
RA   King A.G., Johanson K., Frey C.L., DeMarsh P.L., White J.R.,
RA   McDevitt P., McNulty D., Balcarek J., Jonak Z.L., Bhatnagar P.K.,
RA   Pelus L.M.;
RT   "Identification of unique truncated KC/GRO beta chemokines with potent
RT   hematopoietic and anti-infective activities.";
RL   J. Immunol. 164:3774-3782(2000).
RN   [10]
RP   STRUCTURE BY NMR OF 39-107.
RX   PubMed=10600366; DOI=10.1006/jmbi.1999.3333;
RA   Qian Y.Q., Johanson K.O., McDevitt P.;
RT   "Nuclear magnetic resonance solution structure of truncated human
RT   GRObeta [5-73] and its structural comparison with CXC chemokine family
RT   members GROalpha and IL-8.";
RL   J. Mol. Biol. 294:1065-1072(1999).
CC   -!- FUNCTION: Produced by activated monocytes and neutrophils and
CC       expressed at sites of inflammation. Hematoregulatory chemokine,
CC       which, in vitro, suppresses hematopoietic progenitor cell
CC       proliferation. GRO-beta(5-73) shows a highly enhanced
CC       hematopoietic activity. {ECO:0000269|PubMed:10725737}.
CC   -!- INTERACTION:
CC       P27487:DPP4; NbExp=2; IntAct=EBI-2114901, EBI-2871277;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- PTM: The N-terminal processed form GRO-beta(5-73) is produced by
CC       proteolytic cleavage after secretion from bone marrow stromal
CC       cells. {ECO:0000269|PubMed:10725737}.
CC   -!- PHARMACEUTICAL: GRO-beta(5-73) is available under the name
CC       Garnocestim as immunomodulator. It is used prior to hematopoietic
CC       transplantation for peripheral blood stem cell mobilization and
CC       reduction of incidence, duration, and/or severity of chemotherapy
CC       induced cytopenias.
CC   -!- SIMILARITY: Belongs to the intercrine alpha (chemokine CxC)
CC       family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=CXCL2 entry;
CC       URL="https://en.wikipedia.org/wiki/CXCL2";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X53799; CAA37808.1; -; mRNA.
DR   EMBL; M36820; AAA63183.1; -; mRNA.
DR   EMBL; M57731; AAA63182.1; -; mRNA.
DR   EMBL; CR542171; CAG46968.1; -; mRNA.
DR   EMBL; CH471057; EAX05700.1; -; Genomic_DNA.
DR   EMBL; BC015753; AAH15753.1; -; mRNA.
DR   EMBL; AF043340; AAC03540.1; -; mRNA.
DR   CCDS; CCDS34008.1; -.
DR   PIR; JH0281; JH0281.
DR   RefSeq; NP_002080.1; NM_002089.3.
DR   UniGene; Hs.75765; -.
DR   PDB; 1QNK; NMR; -; A/B=39-107.
DR   PDBsum; 1QNK; -.
DR   ProteinModelPortal; P19875; -.
DR   SMR; P19875; -.
DR   BioGrid; 109177; 3.
DR   DIP; DIP-5908N; -.
DR   IntAct; P19875; 3.
DR   MINT; MINT-6491498; -.
DR   STRING; 9606.ENSP00000427279; -.
DR   BindingDB; P19875; -.
DR   ChEMBL; CHEMBL3286076; -.
DR   BioMuta; CXCL2; -.
DR   DMDM; 127085; -.
DR   MaxQB; P19875; -.
DR   PaxDb; P19875; -.
DR   PeptideAtlas; P19875; -.
DR   PRIDE; P19875; -.
DR   DNASU; 2920; -.
DR   Ensembl; ENST00000508487; ENSP00000427279; ENSG00000081041.
DR   GeneID; 2920; -.
DR   KEGG; hsa:2920; -.
DR   UCSC; uc003hhm.5; human.
DR   CTD; 2920; -.
DR   DisGeNET; 2920; -.
DR   GeneCards; CXCL2; -.
DR   HGNC; HGNC:4603; CXCL2.
DR   MIM; 139110; gene.
DR   neXtProt; NX_P19875; -.
DR   OpenTargets; ENSG00000081041; -.
DR   PharmGKB; PA35051; -.
DR   eggNOG; ENOG410J3WE; Eukaryota.
DR   eggNOG; ENOG410ZT1C; LUCA.
DR   GeneTree; ENSGT00530000062901; -.
DR   HOGENOM; HOG000220915; -.
DR   HOVERGEN; HBG107789; -.
DR   InParanoid; P19875; -.
DR   KO; K05505; -.
DR   OMA; TMQGIHL; -.
DR   OrthoDB; EOG091G14TE; -.
DR   PhylomeDB; P19875; -.
DR   TreeFam; TF333433; -.
DR   BioCyc; ZFISH:ENSG00000081041-MONOMER; -.
DR   Reactome; R-HSA-380108; Chemokine receptors bind chemokines.
DR   Reactome; R-HSA-418594; G alpha (i) signalling events.
DR   EvolutionaryTrace; P19875; -.
DR   GenomeRNAi; 2920; -.
DR   PMAP-CutDB; P19875; -.
DR   PRO; PR:P19875; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000081041; -.
DR   CleanEx; HS_CXCL2; -.
DR   ExpressionAtlas; P19875; baseline and differential.
DR   Genevisible; P19875; HS.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; TAS:ProtInc.
DR   GO; GO:0008009; F:chemokine activity; TAS:ProtInc.
DR   GO; GO:0045236; F:CXCR chemokine receptor binding; IBA:GO_Central.
DR   GO; GO:0070098; P:chemokine-mediated signaling pathway; IBA:GO_Central.
DR   GO; GO:0006935; P:chemotaxis; TAS:ProtInc.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0006955; P:immune response; IBA:GO_Central.
DR   GO; GO:0006954; P:inflammatory response; TAS:ProtInc.
DR   GO; GO:0090023; P:positive regulation of neutrophil chemotaxis; IBA:GO_Central.
DR   GO; GO:0042127; P:regulation of cell proliferation; IBA:GO_Central.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IBA:GO_Central.
DR   GO; GO:0002237; P:response to molecule of bacterial origin; IDA:BHF-UCL.
DR   InterPro; IPR001089; Chemokine_CXC.
DR   InterPro; IPR018048; Chemokine_CXC_CS.
DR   InterPro; IPR001811; Chemokine_IL8-like_dom.
DR   PANTHER; PTHR10179; PTHR10179; 1.
DR   Pfam; PF00048; IL8; 1.
DR   PRINTS; PR00437; SMALLCYTKCXC.
DR   SMART; SM00199; SCY; 1.
DR   SUPFAM; SSF54117; SSF54117; 1.
DR   PROSITE; PS00471; SMALL_CYTOKINES_CXC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Chemotaxis; Complete proteome; Cytokine;
KW   Direct protein sequencing; Disulfide bond; Inflammatory response;
KW   Pharmaceutical; Reference proteome; Secreted; Signal.
FT   SIGNAL        1     34
FT   CHAIN        35    107       C-X-C motif chemokine 2.
FT                                /FTId=PRO_0000005063.
FT   CHAIN        39    107       GRO-beta(5-73).
FT                                /FTId=PRO_0000005064.
FT   DISULFID     43     69
FT   DISULFID     45     85
FT   STRAND       49     51       {ECO:0000244|PDB:1QNK}.
FT   TURN         54     56       {ECO:0000244|PDB:1QNK}.
FT   STRAND       57     63       {ECO:0000244|PDB:1QNK}.
FT   STRAND       73     78       {ECO:0000244|PDB:1QNK}.
FT   STRAND       83     86       {ECO:0000244|PDB:1QNK}.
FT   TURN         93     95       {ECO:0000244|PDB:1QNK}.
FT   TURN         98    102       {ECO:0000244|PDB:1QNK}.
SQ   SEQUENCE   107 AA;  11389 MW;  740F277E928571BA CRC64;
     MARATLSAAP SNPRLLRVAL LLLLLVAASR RAAGAPLATE LRCQCLQTLQ GIHLKNIQSV
     KVKSPGPHCA QTEVIATLKN GQKACLNPAS PMVKKIIEKM LKNGKSN
//
ID   D9MWI3_HUMAN            Unreviewed;        53 AA.
AC   D9MWI3;
DT   05-OCT-2010, integrated into UniProtKB/TrEMBL.
DT   05-OCT-2010, sequence version 1.
DT   07-SEP-2016, entry version 31.
DE   SubName: Full=Prostaglandin-endoperoxidase synthase 2 {ECO:0000313|EMBL:ADJ56342.1};
DE            EC=1.14.99.1 {ECO:0000313|EMBL:ADJ56342.1};
DE   Flags: Fragment;
GN   Name=PTGS2 {ECO:0000313|EMBL:ADJ56342.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADJ56342.1};
RN   [1] {ECO:0000313|EMBL:ADJ56342.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Esmaeili B., Rafatpanah H., Rezaee A., Layegh P., Esmaeili S.,
RA   Kalalinia F., Mosafa F., Negari S., Amani J.;
RT   "COX2 gene expression in peripheral blood leukocytes.";
RL   Submitted (JUN-2010) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; HM473188; ADJ56342.1; -; mRNA.
DR   UniGene; Hs.196384; -.
DR   STRING; 9606.ENSP00000356438; -.
DR   PaxDb; D9MWI3; -.
DR   PeptideAtlas; D9MWI3; -.
DR   eggNOG; KOG2408; Eukaryota.
DR   eggNOG; ENOG410XPZ3; LUCA.
DR   Bgee; ENSG00000073756; -.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0004601; F:peroxidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004666; F:prostaglandin-endoperoxide synthase activity; IEA:UniProtKB-EC.
DR   GO; GO:0019371; P:cyclooxygenase pathway; IEA:InterPro.
DR   GO; GO:0006954; P:inflammatory response; IEA:InterPro.
DR   GO; GO:0008217; P:regulation of blood pressure; IEA:InterPro.
DR   InterPro; IPR029576; COX-2.
DR   InterPro; IPR000742; EGF-like_dom.
DR   PANTHER; PTHR11903:SF8; PTHR11903:SF8; 1.
DR   PROSITE; PS50026; EGF_3; 1.
PE   2: Evidence at transcript level;
KW   Oxidoreductase {ECO:0000313|EMBL:ADJ56342.1};
KW   Peroxidase {ECO:0000313|EMBL:ADJ56342.1}.
FT   DOMAIN        1     27       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:ADJ56342.1}.
FT   NON_TER      53     53       {ECO:0000313|EMBL:ADJ56342.1}.
SQ   SEQUENCE   53 AA;  6137 MW;  2F521E820A121F80 CRC64;
     RGVCMSVGFD QYKCDCTRTG FYGENCSTPE FLTRIKLFLK PTPNTVHYIL THF
//
ID   PGH2_HUMAN              Reviewed;         604 AA.
AC   P35354; A8K802; Q16876;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   15-DEC-1998, sequence version 2.
DT   02-NOV-2016, entry version 182.
DE   RecName: Full=Prostaglandin G/H synthase 2;
DE            EC=1.14.99.1;
DE   AltName: Full=Cyclooxygenase-2;
DE            Short=COX-2;
DE   AltName: Full=PHS II;
DE   AltName: Full=Prostaglandin H2 synthase 2;
DE            Short=PGH synthase 2;
DE            Short=PGHS-2;
DE   AltName: Full=Prostaglandin-endoperoxide synthase 2;
DE   Flags: Precursor;
GN   Name=PTGS2; Synonyms=COX2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Endothelial cell;
RX   PubMed=8473346;
RA   Jones D.A., Carlton D.P., McIntyre T.M., Zimmerman G.A.,
RA   Prescott S.M.;
RT   "Molecular cloning of human prostaglandin endoperoxide synthase type
RT   II and demonstration of expression in response to cytokines.";
RL   J. Biol. Chem. 268:9049-9054(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Endothelial cell;
RX   PubMed=1380156; DOI=10.1073/pnas.89.16.7384;
RA   Hla T., Neilson K.;
RT   "Human cyclooxygenase-2 cDNA.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:7384-7388(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Peripheral blood;
RX   PubMed=8181472; DOI=10.1111/j.1432-1033.1994.tb18804.x;
RA   Kosaka T., Miyata A., Ihara H., Hara S., Sugimoto T., Takeda O.,
RA   Takahashi E., Tanabe T.;
RT   "Characterization of the human gene (PTGS2) encoding prostaglandin-
RT   endoperoxide synthase 2.";
RL   Eur. J. Biochem. 221:889-897(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=7945196; DOI=10.1042/bj3020723;
RA   Appleby S.B., Ristimaki A., Neilson K., Narko K., Hla T.;
RT   "Structure of the human cyclo-oxygenase-2 gene.";
RL   Biochem. J. 302:723-727(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RA   Sharma S.V., Aronstam R.S.;
RT   "cDNA clones of human proteins involved in signal transduction
RT   sequenced by the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (NOV-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS HIS-228; ALA-428;
RP   ALA-511 AND ARG-587.
RG   NIEHS SNPs program;
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   SeattleSNPs variation discovery resource;
RL   Submitted (SEP-2003) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   CHARACTERIZATION.
RX   PubMed=7947975; DOI=10.1016/0167-4838(94)90148-1;
RA   Barnett J., Chow J., Ives D., Chiou M., Mackenzie R., Osen E.,
RA   Nguyen B., Tsing S., Bach C., Freire J.;
RT   "Purification, characterization and selective inhibition of human
RT   prostaglandin G/H synthase 1 and 2 expressed in the baculovirus
RT   system.";
RL   Biochim. Biophys. Acta 1209:130-139(1994).
RN   [13]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES,
RP   S-NITROSYLATION AT CYS-526, AND MUTAGENESIS OF CYS-526; CYS-555 AND
RP   CYS-561.
RX   PubMed=16373578; DOI=10.1126/science.1119407;
RA   Kim S.F., Huri D.A., Snyder S.H.;
RT   "Inducible nitric oxide synthase binds, S-nitrosylates, and activates
RT   cyclooxygenase-2.";
RL   Science 310:1966-1970(2005).
RN   [14]
RP   GLYCOSYLATION AT ASN-580.
RX   PubMed=17113084; DOI=10.1016/j.febslet.2006.10.073;
RA   Sevigny M.B., Li C.F., Alas M., Hughes-Fulford M.;
RT   "Glycosylation regulates turnover of cyclooxygenase-2.";
RL   FEBS Lett. 580:6533-6536(2006).
RN   [15]
RP   VARIANT ALA-511.
RX   PubMed=15308583; DOI=10.1093/carcin/bgh260;
RA   Goodman J.E., Bowman E.D., Chanock S.J., Alberg A.J., Harris C.C.;
RT   "Arachidonate lipoxygenase (ALOX) and cyclooxygenase (COX)
RT   polymorphisms and colon cancer risk.";
RL   Carcinogenesis 25:2467-2472(2004).
RN   [16]
RP   REVIEW ON FUNCTION; TISSUE SPECIFICITY AND INHIBITION BY NSAIDS.
RX   PubMed=10966456; DOI=10.1146/annurev.biochem.69.1.145;
RA   Smith W.L., DeWitt D.L., Garavito R.M.;
RT   "Cyclooxygenases: structural, cellular, and molecular biology.";
RL   Annu. Rev. Biochem. 69:145-182(2000).
RN   [17]
RP   REVIEW ON FUNCTION; INHIBITION BY ASPIRIN AND INVOLVEMENT IN
RP   COLORECTAL CANCER.
RX   PubMed=24605250; DOI=10.4292/wjgpt.v5.i1.40;
RA   Sostres C., Gargallo C.J., Lanas A.;
RT   "Aspirin, cyclooxygenase inhibition and colorectal cancer.";
RL   World J. Gastrointest. Pharmacol. Ther. 5:40-49(2014).
CC   -!- FUNCTION: Converts arachidonate to prostaglandin H2 (PGH2), a
CC       committed step in prostanoid synthesis. Constitutively expressed
CC       in some tissues in physiological conditions, such as the
CC       endothelium, kidney and brain, and in pathological conditions,
CC       such as in cancer. PTGS2 is responsible for production of
CC       inflammatory prostaglandins. Up-regulation of PTGS2 is also
CC       associated with increased cell adhesion, phenotypic changes,
CC       resistance to apoptosis and tumor angiogenesis. In cancer cells,
CC       PTGS2 is a key step in the production of prostaglandin E2 (PGE2),
CC       which plays important roles in modulating motility, proliferation
CC       and resistance to apoptosis. {ECO:0000269|PubMed:16373578}.
CC   -!- CATALYTIC ACTIVITY: Arachidonate + AH(2) + 2 O(2) = prostaglandin
CC       H(2) + A + H(2)O. {ECO:0000269|PubMed:16373578}.
CC   -!- COFACTOR:
CC       Name=heme b; Xref=ChEBI:CHEBI:60344; Evidence={ECO:0000250};
CC       Note=Binds 1 heme b (iron(II)-protoporphyrin IX) group per
CC       subunit. {ECO:0000250};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=16.2 uM for arachidonate (in absence of sodium nitroprusside
CC         NO donor) {ECO:0000269|PubMed:16373578};
CC         KM=17.0 uM for arachidonate (in presence of sodium nitroprusside
CC         NO donor) {ECO:0000269|PubMed:16373578};
CC         Vmax=81.3 nmol/min/mg enzyme (in absence of sodium nitroprusside
CC         NO donor) {ECO:0000269|PubMed:16373578};
CC         Vmax=132 nmol/min/mg enzyme (in absence of sodium nitroprusside
CC         NO donor) {ECO:0000269|PubMed:16373578};
CC   -!- PATHWAY: Lipid metabolism; prostaglandin biosynthesis.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Microsome membrane; Peripheral membrane
CC       protein. Endoplasmic reticulum membrane; Peripheral membrane
CC       protein.
CC   -!- INDUCTION: By cytokines and mitogens.
CC   -!- PTM: S-nitrosylation by NOS2 (iNOS) activates enzyme activity. S-
CC       nitrosylation may take place on different Cys residues in addition
CC       to Cys-526. {ECO:0000269|PubMed:16373578}.
CC   -!- MISCELLANEOUS: The conversion of arachidonate to prostaglandin H2
CC       is a 2 step reaction: a cyclooxygenase (COX) reaction which
CC       converts arachidonate to prostaglandin G2 (PGG2) and a peroxidase
CC       reaction in which PGG2 is reduced to prostaglandin H2 (PGH2). The
CC       cyclooxygenase reaction occurs in a hydrophobic channel in the
CC       core of the enzyme. The peroxidase reaction occurs at a heme-
CC       containing active site located near the protein surface. The
CC       nonsteroidal anti-inflammatory drugs (NSAIDs) binding site
CC       corresponds to the cyclooxygenase active site.
CC   -!- MISCELLANEOUS: Conversion of arachidonate to prostaglandin H2 is
CC       mediated by 2 different isozymes: the constitutive PTGS1 and the
CC       inducible PTGS2. PGHS1 is expressed constitutively and generally
CC       produces prostanoids acutely in response to hormonal stimuli to
CC       fine-tune physiological processes requiring instantaneous,
CC       continuous regulation (e.g. hemostasis). PGHS2 is inducible and
CC       typically produces prostanoids that mediate responses to
CC       physiological stresses such as infection and inflammation.
CC   -!- MISCELLANEOUS: PTGS1 and PTGS2 are the targets of nonsteroidal
CC       anti-inflammatory drugs (NSAIDs) including aspirin and ibuprofen.
CC       Aspirin is able to produce an irreversible inactivation of the
CC       enzyme through a serine acetylation. Inhibition of the PGHSs with
CC       NSAIDs acutely reduces inflammation, pain, and fever, and long-
CC       term use of these drugs reduces fatal thrombotic events, as well
CC       as the development of colon cancer and Alzheimer's disease. PTGS2
CC       is the principal isozyme responsible for production of
CC       inflammatory prostaglandins. New generation PTGSs inhibitors
CC       strive to be selective for PTGS2, to avoid side effects such as
CC       gastrointestinal complications and ulceration.
CC   -!- SIMILARITY: Belongs to the prostaglandin G/H synthase family.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 EGF-like domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00076}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PTGS2ID509ch1q31.html";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/ptgs2/";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/ptgs2/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L15326; AAA35803.1; -; mRNA.
DR   EMBL; M90100; AAA58433.1; -; mRNA.
DR   EMBL; D28235; BAA05698.1; -; Genomic_DNA.
DR   EMBL; U04636; AAA57317.1; -; Genomic_DNA.
DR   EMBL; AY462100; AAR23927.1; -; mRNA.
DR   EMBL; AY229989; AAO38056.1; -; Genomic_DNA.
DR   EMBL; AY382629; AAQ75702.1; -; Genomic_DNA.
DR   EMBL; AK292167; BAF84856.1; -; mRNA.
DR   EMBL; AL033533; CAB41240.1; -; Genomic_DNA.
DR   EMBL; CH471067; EAW91216.1; -; Genomic_DNA.
DR   EMBL; BC013734; AAH13734.1; -; mRNA.
DR   CCDS; CCDS1371.1; -.
DR   PIR; A46150; A46150.
DR   RefSeq; NP_000954.1; NM_000963.3.
DR   UniGene; Hs.196384; -.
DR   PDB; 1V0X; Model; -; A=1-604.
DR   PDB; 5F19; X-ray; 2.04 A; A/B=19-569.
DR   PDB; 5F1A; X-ray; 2.38 A; A/B=19-570.
DR   PDB; 5IKQ; X-ray; 2.41 A; A/B=19-569.
DR   PDB; 5IKR; X-ray; 2.34 A; A/B=19-569.
DR   PDB; 5IKT; X-ray; 2.45 A; A/B=19-569.
DR   PDB; 5IKV; X-ray; 2.51 A; A/B=19-569.
DR   PDBsum; 1V0X; -.
DR   PDBsum; 5F19; -.
DR   PDBsum; 5F1A; -.
DR   PDBsum; 5IKQ; -.
DR   PDBsum; 5IKR; -.
DR   PDBsum; 5IKT; -.
DR   PDBsum; 5IKV; -.
DR   ProteinModelPortal; P35354; -.
DR   SMR; P35354; -.
DR   BioGrid; 111715; 32.
DR   DIP; DIP-28131N; -.
DR   IntAct; P35354; 2.
DR   MINT; MINT-203337; -.
DR   STRING; 9606.ENSP00000356438; -.
DR   BindingDB; P35354; -.
DR   ChEMBL; CHEMBL230; -.
DR   DrugBank; DB00316; Acetaminophen.
DR   DrugBank; DB00945; Acetylsalicylic acid.
DR   DrugBank; DB00041; Aldesleukin.
DR   DrugBank; DB00233; Aminosalicylic Acid.
DR   DrugBank; DB01435; Antipyrine.
DR   DrugBank; DB01419; Antrafenine.
DR   DrugBank; DB01014; Balsalazide.
DR   DrugBank; DB00963; Bromfenac.
DR   DrugBank; DB00887; Bumetanide.
DR   DrugBank; DB06774; Capsaicin.
DR   DrugBank; DB00821; Carprofen.
DR   DrugBank; DB00482; Celecoxib.
DR   DrugBank; DB00856; Chlorphenesin.
DR   DrugBank; DB00515; Cisplatin.
DR   DrugBank; DB00720; Clodronate.
DR   DrugBank; DB00250; Dapsone.
DR   DrugBank; DB00035; Desmopressin.
DR   DrugBank; DB00586; Diclofenac.
DR   DrugBank; DB00861; Diflunisal.
DR   DrugBank; DB00154; Dihomo-gamma-linolenic acid.
DR   DrugBank; DB01395; Drospirenone.
DR   DrugBank; DB00005; Etanercept.
DR   DrugBank; DB00749; Etodolac.
DR   DrugBank; DB00773; Etoposide.
DR   DrugBank; DB01628; Etoricoxib.
DR   DrugBank; DB00573; Fenoprofen.
DR   DrugBank; DB00712; Flurbiprofen.
DR   DrugBank; DB01404; Ginseng.
DR   DrugBank; DB01050; Ibuprofen.
DR   DrugBank; DB00159; Icosapent.
DR   DrugBank; DB00328; Indomethacin.
DR   DrugBank; DB01009; Ketoprofen.
DR   DrugBank; DB00465; Ketorolac.
DR   DrugBank; DB00480; Lenalidomide.
DR   DrugBank; DB06725; Lornoxicam.
DR   DrugBank; DB01283; Lumiracoxib.
DR   DrugBank; DB01397; Magnesium salicylate.
DR   DrugBank; DB00939; Meclofenamic acid.
DR   DrugBank; DB00784; Mefenamic acid.
DR   DrugBank; DB00814; Meloxicam.
DR   DrugBank; DB00244; Mesalazine.
DR   DrugBank; DB00461; Nabumetone.
DR   DrugBank; DB00788; Naproxen.
DR   DrugBank; DB06802; Nepafenac.
DR   DrugBank; DB04552; Niflumic Acid.
DR   DrugBank; DB04743; Nimesulide.
DR   DrugBank; DB06804; Nonoxynol-9.
DR   DrugBank; DB00991; Oxaprozin.
DR   DrugBank; DB08439; Parecoxib.
DR   DrugBank; DB00812; Phenylbutazone.
DR   DrugBank; DB00554; Piroxicam.
DR   DrugBank; DB08910; Pomalidomide.
DR   DrugBank; DB00884; Risedronate.
DR   DrugBank; DB00936; Salicylic acid.
DR   DrugBank; DB01399; Salsalate.
DR   DrugBank; DB00795; Sulfasalazine.
DR   DrugBank; DB00605; Sulindac.
DR   DrugBank; DB00870; Suprofen.
DR   DrugBank; DB08819; Tafluprost.
DR   DrugBank; DB00469; Tenoxicam.
DR   DrugBank; DB00360; Tetrahydrobiopterin.
DR   DrugBank; DB01041; Thalidomide.
DR   DrugBank; DB01600; Tiaprofenic acid.
DR   DrugBank; DB00500; Tolmetin.
DR   DrugBank; DB00620; Triamcinolone.
DR   DrugBank; DB01401; Trisalicylate-choline.
DR   GuidetoPHARMACOLOGY; 1376; -.
DR   SwissLipids; SLP:000000830; -.
DR   PeroxiBase; 3321; HsPGHS02.
DR   iPTMnet; P35354; -.
DR   PhosphoSitePlus; P35354; -.
DR   BioMuta; PTGS2; -.
DR   DMDM; 3915797; -.
DR   EPD; P35354; -.
DR   MaxQB; P35354; -.
DR   PaxDb; P35354; -.
DR   PeptideAtlas; P35354; -.
DR   PRIDE; P35354; -.
DR   DNASU; 5743; -.
DR   Ensembl; ENST00000367468; ENSP00000356438; ENSG00000073756.
DR   GeneID; 5743; -.
DR   KEGG; hsa:5743; -.
DR   UCSC; uc001gsb.4; human.
DR   CTD; 5743; -.
DR   DisGeNET; 5743; -.
DR   GeneCards; PTGS2; -.
DR   HGNC; HGNC:9605; PTGS2.
DR   HPA; CAB000113; -.
DR   HPA; HPA001335; -.
DR   MIM; 600262; gene.
DR   neXtProt; NX_P35354; -.
DR   OpenTargets; ENSG00000073756; -.
DR   PharmGKB; PA293; -.
DR   eggNOG; KOG2408; Eukaryota.
DR   eggNOG; ENOG410XPZ3; LUCA.
DR   GeneTree; ENSGT00390000010743; -.
DR   HOGENOM; HOG000013149; -.
DR   HOVERGEN; HBG000366; -.
DR   InParanoid; P35354; -.
DR   KO; K11987; -.
DR   OMA; CNNVKGC; -.
DR   OrthoDB; EOG091G03CD; -.
DR   PhylomeDB; P35354; -.
DR   TreeFam; TF329675; -.
DR   BioCyc; MetaCyc:HS01115-MONOMER; -.
DR   BioCyc; ZFISH:HS01115-MONOMER; -.
DR   BRENDA; 1.14.99.1; 2681.
DR   Reactome; R-HSA-197264; Nicotinamide salvaging.
DR   Reactome; R-HSA-2142770; Synthesis of 15-eicosatetraenoic acid derivatives.
DR   Reactome; R-HSA-2162123; Synthesis of Prostaglandins (PG) and Thromboxanes (TX).
DR   SABIO-RK; P35354; -.
DR   SIGNOR; P35354; -.
DR   UniPathway; UPA00662; -.
DR   GeneWiki; Prostaglandin-endoperoxide_synthase_2; -.
DR   GeneWiki; PTGS2; -.
DR   GenomeRNAi; 5743; -.
DR   PRO; PR:P35354; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000073756; -.
DR   CleanEx; HS_PTGS2; -.
DR   ExpressionAtlas; P35354; baseline and differential.
DR   Genevisible; P35354; HS.
DR   GO; GO:0005901; C:caveola; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0043005; C:neuron projection; IDA:MGI.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0031090; C:organelle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043234; C:protein complex; IEA:Ensembl.
DR   GO; GO:0050473; F:arachidonate 15-lipoxygenase activity; TAS:Reactome.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0020037; F:heme binding; ISS:UniProtKB.
DR   GO; GO:0008289; F:lipid binding; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004601; F:peroxidase activity; NAS:UniProtKB.
DR   GO; GO:0004666; F:prostaglandin-endoperoxide synthase activity; IDA:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; IEA:Ensembl.
DR   GO; GO:0030282; P:bone mineralization; IEA:Ensembl.
DR   GO; GO:0050873; P:brown fat cell differentiation; IEA:Ensembl.
DR   GO; GO:0071318; P:cellular response to ATP; IEA:Ensembl.
DR   GO; GO:0071498; P:cellular response to fluid shear stress; IEA:Ensembl.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:UniProtKB.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl.
DR   GO; GO:0034644; P:cellular response to UV; IEA:Ensembl.
DR   GO; GO:0019371; P:cyclooxygenase pathway; IDA:BHF-UCL.
DR   GO; GO:0046697; P:decidualization; IEA:Ensembl.
DR   GO; GO:0007566; P:embryo implantation; IEA:Ensembl.
DR   GO; GO:0042633; P:hair cycle; IEA:Ensembl.
DR   GO; GO:0006954; P:inflammatory response; IEA:Ensembl.
DR   GO; GO:0007612; P:learning; IEA:Ensembl.
DR   GO; GO:0019372; P:lipoxygenase pathway; TAS:Reactome.
DR   GO; GO:0035633; P:maintenance of blood-brain barrier; IEA:Ensembl.
DR   GO; GO:0007613; P:memory; IEA:Ensembl.
DR   GO; GO:0006928; P:movement of cell or subcellular component; TAS:ProtInc.
DR   GO; GO:0051926; P:negative regulation of calcium ion transport; IEA:Ensembl.
DR   GO; GO:0045786; P:negative regulation of cell cycle; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0045986; P:negative regulation of smooth muscle contraction; IEA:Ensembl.
DR   GO; GO:0032227; P:negative regulation of synaptic transmission, dopaminergic; IEA:Ensembl.
DR   GO; GO:0006769; P:nicotinamide metabolic process; TAS:Reactome.
DR   GO; GO:0030728; P:ovulation; IEA:Ensembl.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0090336; P:positive regulation of brown fat cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0090050; P:positive regulation of cell migration involved in sprouting angiogenesis; ISS:BHF-UCL.
DR   GO; GO:0031622; P:positive regulation of fever generation; ISS:BHF-UCL.
DR   GO; GO:0090271; P:positive regulation of fibroblast growth factor production; ISS:BHF-UCL.
DR   GO; GO:0042346; P:positive regulation of NF-kappaB import into nucleus; IEA:Ensembl.
DR   GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; ISS:BHF-UCL.
DR   GO; GO:0090362; P:positive regulation of platelet-derived growth factor production; ISS:BHF-UCL.
DR   GO; GO:0031394; P:positive regulation of prostaglandin biosynthetic process; NAS:BHF-UCL.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl.
DR   GO; GO:0045987; P:positive regulation of smooth muscle contraction; IEA:Ensembl.
DR   GO; GO:0031915; P:positive regulation of synaptic plasticity; IEA:Ensembl.
DR   GO; GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IEA:Ensembl.
DR   GO; GO:0071636; P:positive regulation of transforming growth factor beta production; ISS:BHF-UCL.
DR   GO; GO:0010575; P:positive regulation of vascular endothelial growth factor production; ISS:BHF-UCL.
DR   GO; GO:0045907; P:positive regulation of vasoconstriction; IEA:Ensembl.
DR   GO; GO:0001516; P:prostaglandin biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0006693; P:prostaglandin metabolic process; TAS:ProtInc.
DR   GO; GO:0008217; P:regulation of blood pressure; ISS:UniProtKB.
DR   GO; GO:0050727; P:regulation of inflammatory response; NAS:UniProtKB.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:0070542; P:response to fatty acid; IEA:Ensembl.
DR   GO; GO:0009750; P:response to fructose; IEA:Ensembl.
DR   GO; GO:0051384; P:response to glucocorticoid; IEA:Ensembl.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0010226; P:response to lithium ion; IEA:Ensembl.
DR   GO; GO:0010042; P:response to manganese ion; IEA:Ensembl.
DR   GO; GO:0006979; P:response to oxidative stress; IEA:InterPro.
DR   GO; GO:0034612; P:response to tumor necrosis factor; IEA:Ensembl.
DR   GO; GO:0033280; P:response to vitamin D; IEA:Ensembl.
DR   GO; GO:0019233; P:sensory perception of pain; IEA:Ensembl.
DR   Gene3D; 1.10.640.10; -; 1.
DR   InterPro; IPR029576; COX-2.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR010255; Haem_peroxidase.
DR   InterPro; IPR019791; Haem_peroxidase_animal.
DR   PANTHER; PTHR11903:SF8; PTHR11903:SF8; 1.
DR   Pfam; PF03098; An_peroxidase; 1.
DR   Pfam; PF00008; EGF; 1.
DR   PRINTS; PR00457; ANPEROXIDASE.
DR   SUPFAM; SSF48113; SSF48113; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS50292; PEROXIDASE_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Dioxygenase; Disulfide bond;
KW   Endoplasmic reticulum; Fatty acid biosynthesis; Fatty acid metabolism;
KW   Glycoprotein; Heme; Iron; Lipid biosynthesis; Lipid metabolism;
KW   Membrane; Metal-binding; Microsome; Oxidoreductase; Peroxidase;
KW   Polymorphism; Prostaglandin biosynthesis; Prostaglandin metabolism;
KW   Reference proteome; S-nitrosylation; Signal.
FT   SIGNAL        1     17       {ECO:0000255}.
FT   CHAIN        18    604       Prostaglandin G/H synthase 2.
FT                                /FTId=PRO_0000023875.
FT   DOMAIN       18     55       EGF-like. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   ACT_SITE    193    193       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00298}.
FT   ACT_SITE    371    371       For cyclooxygenase activity.
FT                                {ECO:0000250}.
FT   METAL       374    374       Iron (heme axial ligand).
FT                                {ECO:0000255|PROSITE-ProRule:PRU00298}.
FT   BINDING     106    106       Substrate. {ECO:0000250}.
FT   BINDING     341    341       Substrate. {ECO:0000250}.
FT   BINDING     371    371       Substrate. {ECO:0000250}.
FT   SITE        516    516       Aspirin-acetylated serine. {ECO:0000250}.
FT   MOD_RES     526    526       S-nitrosocysteine.
FT                                {ECO:0000305|PubMed:16373578}.
FT   CARBOHYD     53     53       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    130    130       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    396    396       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    580    580       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:17113084}.
FT   DISULFID     21     32       {ECO:0000250}.
FT   DISULFID     22    145       {ECO:0000250}.
FT   DISULFID     26     42       {ECO:0000250}.
FT   DISULFID     44     54       {ECO:0000250}.
FT   DISULFID    555    561       {ECO:0000250}.
FT   VARIANT     228    228       R -> H (in dbSNP:rs3218622).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_016262.
FT   VARIANT     428    428       P -> A (in dbSNP:rs4648279).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_016263.
FT   VARIANT     488    488       E -> G (in dbSNP:rs5272).
FT                                /FTId=VAR_011980.
FT   VARIANT     511    511       V -> A (in dbSNP:rs5273).
FT                                {ECO:0000269|PubMed:15308583,
FT                                ECO:0000269|Ref.6}.
FT                                /FTId=VAR_011981.
FT   VARIANT     587    587       G -> R (in dbSNP:rs3218625).
FT                                {ECO:0000269|Ref.6}.
FT                                /FTId=VAR_016264.
FT   MUTAGEN     526    526       C->S: Prevents activation by nitric oxid
FT                                (NO). {ECO:0000269|PubMed:16373578}.
FT   MUTAGEN     555    555       C->S: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:16373578}.
FT   MUTAGEN     561    561       C->S: Does not affect activation by
FT                                nitric oxid (NO).
FT                                {ECO:0000269|PubMed:16373578}.
FT   CONFLICT    165    165       E -> G (in Ref. 2; AAA58433).
FT                                {ECO:0000305}.
FT   CONFLICT    438    438       I -> T (in Ref. 1; AAA35803).
FT                                {ECO:0000305}.
FT   TURN         20     23       {ECO:0000244|PDB:5F19}.
FT   STRAND       31     35       {ECO:0000244|PDB:5F19}.
FT   TURN         36     38       {ECO:0000244|PDB:5F19}.
FT   STRAND       39     43       {ECO:0000244|PDB:5F19}.
FT   STRAND       47     50       {ECO:0000244|PDB:5F19}.
FT   TURN         51     54       {ECO:0000244|PDB:5F19}.
FT   HELIX        59     66       {ECO:0000244|PDB:5F19}.
FT   HELIX        71     78       {ECO:0000244|PDB:5F19}.
FT   HELIX        82     89       {ECO:0000244|PDB:5F19}.
FT   HELIX        92    107       {ECO:0000244|PDB:5F19}.
FT   STRAND      120    122       {ECO:0000244|PDB:5F19}.
FT   HELIX       125    129       {ECO:0000244|PDB:5F19}.
FT   STRAND      135    138       {ECO:0000244|PDB:5F19}.
FT   STRAND      150    153       {ECO:0000244|PDB:5F19}.
FT   HELIX       160    167       {ECO:0000244|PDB:5F19}.
FT   HELIX       182    192       {ECO:0000244|PDB:5F19}.
FT   TURN        193    195       {ECO:0000244|PDB:5F19}.
FT   TURN        200    202       {ECO:0000244|PDB:5F19}.
FT   STRAND      206    208       {ECO:0000244|PDB:5F19}.
FT   HELIX       217    220       {ECO:0000244|PDB:5F19}.
FT   HELIX       224    230       {ECO:0000244|PDB:5F19}.
FT   STRAND      241    243       {ECO:0000244|PDB:5F19}.
FT   STRAND      246    248       {ECO:0000244|PDB:5F19}.
FT   HELIX       252    255       {ECO:0000244|PDB:5F19}.
FT   HELIX       267    269       {ECO:0000244|PDB:5F19}.
FT   TURN        276    279       {ECO:0000244|PDB:5F19}.
FT   HELIX       282    305       {ECO:0000244|PDB:5F19}.
FT   HELIX       311    332       {ECO:0000244|PDB:5F19}.
FT   HELIX       334    339       {ECO:0000244|PDB:5F19}.
FT   HELIX       349    352       {ECO:0000244|PDB:5F19}.
FT   HELIX       365    370       {ECO:0000244|PDB:5F19}.
FT   HELIX       374    376       {ECO:0000244|PDB:5F19}.
FT   STRAND      379    383       {ECO:0000244|PDB:5F19}.
FT   STRAND      386    388       {ECO:0000244|PDB:5F19}.
FT   HELIX       390    393       {ECO:0000244|PDB:5F19}.
FT   HELIX       398    414       {ECO:0000244|PDB:5F19}.
FT   STRAND      420    424       {ECO:0000244|PDB:5F19}.
FT   HELIX       428    430       {ECO:0000244|PDB:5F19}.
FT   HELIX       431    443       {ECO:0000244|PDB:5F19}.
FT   HELIX       449    455       {ECO:0000244|PDB:5F19}.
FT   HELIX       464    468       {ECO:0000244|PDB:5F19}.
FT   STRAND      469    471       {ECO:0000244|PDB:5F19}.
FT   HELIX       472    481       {ECO:0000244|PDB:5F19}.
FT   HELIX       484    486       {ECO:0000244|PDB:5F19}.
FT   HELIX       489    495       {ECO:0000244|PDB:5F19}.
FT   STRAND      503    505       {ECO:0000244|PDB:5F19}.
FT   HELIX       506    521       {ECO:0000244|PDB:5F19}.
FT   HELIX       524    526       {ECO:0000244|PDB:5F19}.
FT   TURN        528    530       {ECO:0000244|PDB:5F19}.
FT   HELIX       533    536       {ECO:0000244|PDB:5F19}.
FT   HELIX       539    546       {ECO:0000244|PDB:5F19}.
FT   HELIX       550    557       {ECO:0000244|PDB:5F19}.
SQ   SEQUENCE   604 AA;  68996 MW;  72FBD699F6128519 CRC64;
     MLARALLLCA VLALSHTANP CCSHPCQNRG VCMSVGFDQY KCDCTRTGFY GENCSTPEFL
     TRIKLFLKPT PNTVHYILTH FKGFWNVVNN IPFLRNAIMS YVLTSRSHLI DSPPTYNADY
     GYKSWEAFSN LSYYTRALPP VPDDCPTPLG VKGKKQLPDS NEIVEKLLLR RKFIPDPQGS
     NMMFAFFAQH FTHQFFKTDH KRGPAFTNGL GHGVDLNHIY GETLARQRKL RLFKDGKMKY
     QIIDGEMYPP TVKDTQAEMI YPPQVPEHLR FAVGQEVFGL VPGLMMYATI WLREHNRVCD
     VLKQEHPEWG DEQLFQTSRL ILIGETIKIV IEDYVQHLSG YHFKLKFDPE LLFNKQFQYQ
     NRIAAEFNTL YHWHPLLPDT FQIHDQKYNY QQFIYNNSIL LEHGITQFVE SFTRQIAGRV
     AGGRNVPPAV QKVSQASIDQ SRQMKYQSFN EYRKRFMLKP YESFEELTGE KEMSAELEAL
     YGDIDAVELY PALLVEKPRP DAIFGETMVE VGAPFSLKGL MGNVICSPAY WKPSTFGGEV
     GFQIINTASI QSLICNNVKG CPFTSFSVPD PELIKTVTIN ASSSRSGLDD INPTVLLKER
     STEL
//
ID   Q6ZYK7_HUMAN            Unreviewed;       163 AA.
AC   Q6ZYK7;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 1.
DT   02-NOV-2016, entry version 94.
DE   SubName: Full=Prostaglandin G/H synthase 2 {ECO:0000313|Ensembl:ENSP00000454130};
DE   SubName: Full=Putative cyclooxygenase-2 {ECO:0000313|EMBL:CAG25548.1};
GN   Name=COX-2 {ECO:0000313|EMBL:CAG25548.1};
GN   Synonyms=PTGS2 {ECO:0000313|Ensembl:ENSP00000454130};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAG25548.1};
RN   [1] {ECO:0000313|EMBL:CAG25548.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Peripheral blood {ECO:0000313|EMBL:CAG25548.1};
RX   PubMed=15543317; DOI=10.1267/THRO04050925;
RA   Censarek P., Freidel K., Udelhoven M., Ku S.J., Hohlfeld T.,
RA   Meyer-Kirchrath J., Schror K., Weber A.A.;
RT   "Cyclooxygenase COX-2a, a novel COX-2 mRNA variant, in platelets from
RT   patients after coronary artery bypass grafting.";
RL   Thromb. Haemost. 92:925-928(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000454130, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S., Hart E., Haugen E., Heath P.D., Holmes S.,
RA   Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J.,
RA   James R., Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K.,
RA   Kibukawa M., Kimberley A.M., King A., Knights A.J., Lad H., Laird G.,
RA   Lawlor S., Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J.,
RA   Lush M.J., Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L.,
RA   Matthews N.S., McLaren S., Milne S., Mistry S., Moore M.J.,
RA   Nickerson T., O'Dell C.N., Oliver K., Palmeiri A., Palmer S.A.,
RA   Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S., Phelps K.,
RA   Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N.,
RA   Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S.,
RA   Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H., Wilming L.,
RA   Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E., Durbin R.,
RA   Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G., Ross M.T.,
RA   Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R., Banerjee R.,
RA   Bryant S.P., Burford D.C., Burrill W.D., Clegg S.M., Dhami P.,
RA   Dovey O., Faulkner L.M., Gribble S.M., Langford C.F., Pandian R.D.,
RA   Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3] {ECO:0000313|Ensembl:ENSP00000454130}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL033533; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF455116; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AJ634912; CAG25548.1; -; mRNA.
DR   UniGene; Hs.196384; -.
DR   ProteinModelPortal; Q6ZYK7; -.
DR   STRING; 9606.ENSP00000356438; -.
DR   MaxQB; Q6ZYK7; -.
DR   PeptideAtlas; Q6ZYK7; -.
DR   PRIDE; Q6ZYK7; -.
DR   Ensembl; ENST00000559627; ENSP00000454130; ENSG00000073756.
DR   UCSC; uc057nzn.1; human.
DR   HGNC; HGNC:9605; PTGS2.
DR   OpenTargets; ENSG00000073756; -.
DR   eggNOG; KOG2408; Eukaryota.
DR   eggNOG; ENOG410XPZ3; LUCA.
DR   GeneTree; ENSGT00390000010743; -.
DR   HOGENOM; HOG000202438; -.
DR   HOVERGEN; HBG065765; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000073756; -.
DR   ExpressionAtlas; Q6ZYK7; baseline and differential.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0004601; F:peroxidase activity; IEA:InterPro.
DR   GO; GO:0004666; F:prostaglandin-endoperoxide synthase activity; IEA:InterPro.
DR   GO; GO:0019371; P:cyclooxygenase pathway; IEA:InterPro.
DR   GO; GO:0006954; P:inflammatory response; IEA:InterPro.
DR   GO; GO:0008217; P:regulation of blood pressure; IEA:InterPro.
DR   GO; GO:0006979; P:response to oxidative stress; IEA:InterPro.
DR   Gene3D; 1.10.640.10; -; 1.
DR   InterPro; IPR029576; COX-2.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR010255; Haem_peroxidase.
DR   InterPro; IPR019791; Haem_peroxidase_animal.
DR   PANTHER; PTHR11903:SF8; PTHR11903:SF8; 1.
DR   Pfam; PF00008; EGF; 1.
DR   SUPFAM; SSF48113; SSF48113; 1.
DR   PROSITE; PS50026; EGF_3; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|MaxQB:Q6ZYK7,
KW   ECO:0000213|PeptideAtlas:Q6ZYK7};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     23       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        24    163       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5007709999.
FT   DOMAIN       17     55       EGF-like. {ECO:0000259|PROSITE:PS50026}.
SQ   SEQUENCE   163 AA;  18335 MW;  6E318D53967591D8 CRC64;
     MLARALLLCA VLALSHTANP CCSHPCQNRG VCMSVGFDQY KCDCTRTGFY GENCSTPEFL
     TRIKLFLKPT PNTVHYILTH FKGFWNVVNN IPFLRNAIMS YVLTSRSHLI DSPPTYNADY
     GYKSWEAFSN LSYYTRALPP VPDDCPTPLG VKALHASVFQ DRS
//
ID   Q9NNY7_HUMAN            Unreviewed;        22 AA.
AC   Q9NNY7;
DT   01-OCT-2000, integrated into UniProtKB/TrEMBL.
DT   01-OCT-2000, sequence version 1.
DT   05-OCT-2016, entry version 40.
DE   SubName: Full=Cyclooxygenase-2 {ECO:0000313|EMBL:AAF85977.1};
DE            EC=1.14.99.1 {ECO:0000313|EMBL:AAF85977.1};
DE   Flags: Fragment;
GN   Name=PTGS2 {ECO:0000313|EMBL:AAF85977.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAF85977.1};
RN   [1] {ECO:0000313|EMBL:AAF85977.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Epidermal keratinocytes in primary culture
RC   {ECO:0000313|EMBL:AAF85977.1};
RX   PubMed=9520467; DOI=10.1073/pnas.95.7.3914;
RA   Lukiw W.J., Pelaez R.P., Martinez J., Bazan N.G.;
RT   "Budesonide epimer R or dexamethasone selectively inhibit platelet-
RT   activating factor-induced or interleukin 1beta-induced DNA binding
RT   activity of cis-acting transcription factors and cyclooxygenase-2 gene
RT   expression in human epidermal keratinocytes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:3914-3919(1998).
RN   [2] {ECO:0000313|EMBL:AAF85977.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Epidermal keratinocytes in primary culture
RC   {ECO:0000313|EMBL:AAF85977.1};
RX   PubMed=12050157; DOI=10.1074/jbc.M203201200;
RA   Bazan N.G., Lukiw W.J.;
RT   "Cyclooxygenase-2 and presenilin-1 gene expression induced by
RT   interleukin-1beta and amyloid beta 42 peptide is potentiated by
RT   hypoxia in primary human neural cells.";
RL   J. Biol. Chem. 277:30359-30367(2002).
RN   [3] {ECO:0000313|EMBL:AAF85977.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Epidermal keratinocytes in primary culture
RC   {ECO:0000313|EMBL:AAF85977.1};
RA   Lukiw W.J., Bazan N.G.;
RL   Submitted (FEB-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF276953; AAF85977.1; -; Genomic_DNA.
DR   UniGene; Hs.196384; -.
DR   GO; GO:0004666; F:prostaglandin-endoperoxide synthase activity; IEA:UniProtKB-EC.
PE   4: Predicted;
KW   Oxidoreductase {ECO:0000313|EMBL:AAF85977.1}.
FT   NON_TER      22     22       {ECO:0000313|EMBL:AAF85977.1}.
SQ   SEQUENCE   22 AA;  2370 MW;  A9B972BF5E5281E7 CRC64;
     MLARALLLCA VLXLSHTGEY LA
//
ID   A0A024QZM9_HUMAN        Unreviewed;       431 AA.
AC   A0A024QZM9;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   02-NOV-2016, entry version 24.
DE   SubName: Full=Plasminogen activator, urokinase, isoform CRA_a {ECO:0000313|EMBL:EAW54545.1};
GN   Name=PLAU {ECO:0000313|EMBL:EAW54545.1};
GN   ORFNames=hCG_20537 {ECO:0000313|EMBL:EAW54545.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW54545.1};
RN   [1] {ECO:0000313|EMBL:EAW54545.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW54545.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000256|SAAS:SAAS00558208}.
CC   -!- SIMILARITY: Belongs to the peptidase S1 family.
CC       {ECO:0000256|SAAS:SAAS00559343}.
CC   -!- SIMILARITY: Contains 1 peptidase S1 domain.
CC       {ECO:0000256|RuleBase:RU363034}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471083; EAW54545.1; -; Genomic_DNA.
DR   RefSeq; NP_002649.1; NM_002658.4.
DR   UniGene; Hs.77274; -.
DR   ProteinModelPortal; A0A024QZM9; -.
DR   SMR; A0A024QZM9; -.
DR   STRING; 9606.ENSP00000361850; -.
DR   PaxDb; A0A024QZM9; -.
DR   GeneID; 5328; -.
DR   KEGG; hsa:5328; -.
DR   CTD; 5328; -.
DR   eggNOG; ENOG410IGFI; Eukaryota.
DR   eggNOG; COG5640; LUCA.
DR   KO; K01348; -.
DR   PhylomeDB; A0A024QZM9; -.
DR   GenomeRNAi; 5328; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0016301; F:kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro.
DR   CDD; cd00190; Tryp_SPc; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000001; Kringle.
DR   InterPro; IPR013806; Kringle-like.
DR   InterPro; IPR018056; Kringle_CS.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR001314; Peptidase_S1A.
DR   InterPro; IPR001254; Trypsin_dom.
DR   InterPro; IPR018114; TRYPSIN_HIS.
DR   InterPro; IPR033116; TRYPSIN_SER.
DR   Pfam; PF00051; Kringle; 1.
DR   Pfam; PF00089; Trypsin; 1.
DR   PRINTS; PR00722; CHYMOTRYPSIN.
DR   SMART; SM00130; KR; 1.
DR   SMART; SM00020; Tryp_SPc; 1.
DR   SUPFAM; SSF50494; SSF50494; 1.
DR   SUPFAM; SSF57440; SSF57440; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS00021; KRINGLE_1; 1.
DR   PROSITE; PS50070; KRINGLE_2; 1.
DR   PROSITE; PS50240; TRYPSIN_DOM; 1.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
PE   3: Inferred from homology;
KW   Disulfide bond {ECO:0000256|SAAS:SAAS00037407};
KW   EGF-like domain {ECO:0000256|SAAS:SAAS00524722};
KW   Hydrolase {ECO:0000256|RuleBase:RU363034,
KW   ECO:0000256|SAAS:SAAS00526611}; Kinase {ECO:0000313|EMBL:EAW54545.1};
KW   Kringle {ECO:0000256|SAAS:SAAS00439700};
KW   Protease {ECO:0000256|RuleBase:RU363034,
KW   ECO:0000256|SAAS:SAAS00526611};
KW   Secreted {ECO:0000256|SAAS:SAAS00526105};
KW   Serine protease {ECO:0000256|RuleBase:RU363034,
KW   ECO:0000256|SAAS:SAAS00526611}; Signal {ECO:0000256|SAM:SignalP};
KW   Transferase {ECO:0000313|EMBL:EAW54545.1}.
FT   SIGNAL        1     20       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        21    431       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5001536528.
FT   DOMAIN       27     63       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN       69    151       Kringle. {ECO:0000259|PROSITE:PS50070}.
FT   DOMAIN      179    424       Peptidase S1.
FT                                {ECO:0000259|PROSITE:PS50240}.
SQ   SEQUENCE   431 AA;  48507 MW;  62C72400BC23115F CRC64;
     MRALLARLLL CVLVVSDSKG SNELHQVPSN CDCLNGGTCV SNKYFSNIHW CNCPKKFGGQ
     HCEIDKSKTC YEGNGHFYRG KASTDTMGRP CLPWNSATVL QQTYHAHRSD ALQLGLGKHN
     YCRNPDNRRR PWCYVQVGLK PLVQECMVHD CADGKKPSSP PEELKFQCGQ KTLRPRFKII
     GGEFTTIENQ PWFAAIYRRH RGGSVTYVCG GSLISPCWVI SATHCFIDYP KKEDYIVYLG
     RSRLNSNTQG EMKFEVENLI LHKDYSADTL AHHNDIALLK IRSKEGRCAQ PSRTIQTICL
     PSMYNDPQFG TSCEITGFGK ENSTDYLYPE QLKMTVVKLI SHRECQQPHY YGSEVTTKML
     CAADPQWKTD SCQGDSGGPL VCSLQGRMTL TGIVSWGRGC ALKDKPGVYT RVSHFLPWIR
     SHTKEENGLA L
//
ID   E7ET40_HUMAN            Unreviewed;       414 AA.
AC   E7ET40;
DT   28-JUN-2011, integrated into UniProtKB/TrEMBL.
DT   28-JUN-2011, sequence version 1.
DT   02-NOV-2016, entry version 46.
DE   SubName: Full=Urokinase-type plasminogen activator {ECO:0000313|Ensembl:ENSP00000388474};
GN   Name=PLAU {ECO:0000313|Ensembl:ENSP00000388474};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000388474, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000388474, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000388474}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000256|SAAS:SAAS00558208}.
CC   -!- SIMILARITY: Belongs to the peptidase S1 family.
CC       {ECO:0000256|SAAS:SAAS00559343}.
CC   -!- SIMILARITY: Contains 1 peptidase S1 domain.
CC       {ECO:0000256|RuleBase:RU363034}.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000388474}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL596247; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; E7ET40; -.
DR   STRING; 9606.ENSP00000361850; -.
DR   MaxQB; E7ET40; -.
DR   PaxDb; E7ET40; -.
DR   PeptideAtlas; E7ET40; -.
DR   Ensembl; ENST00000446342; ENSP00000388474; ENSG00000122861.
DR   UCSC; uc010qkw.3; human.
DR   HGNC; HGNC:9052; PLAU.
DR   OpenTargets; ENSG00000122861; -.
DR   eggNOG; ENOG410IGFI; Eukaryota.
DR   eggNOG; COG5640; LUCA.
DR   GeneTree; ENSGT00760000119133; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000122861; -.
DR   ExpressionAtlas; E7ET40; baseline and differential.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro.
DR   CDD; cd00190; Tryp_SPc; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000001; Kringle.
DR   InterPro; IPR013806; Kringle-like.
DR   InterPro; IPR018056; Kringle_CS.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR001314; Peptidase_S1A.
DR   InterPro; IPR001254; Trypsin_dom.
DR   InterPro; IPR018114; TRYPSIN_HIS.
DR   InterPro; IPR033116; TRYPSIN_SER.
DR   Pfam; PF00051; Kringle; 1.
DR   Pfam; PF00089; Trypsin; 1.
DR   PRINTS; PR00722; CHYMOTRYPSIN.
DR   SMART; SM00130; KR; 1.
DR   SMART; SM00020; Tryp_SPc; 1.
DR   SUPFAM; SSF50494; SSF50494; 1.
DR   SUPFAM; SSF57440; SSF57440; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS00021; KRINGLE_1; 1.
DR   PROSITE; PS50070; KRINGLE_2; 1.
DR   PROSITE; PS50240; TRYPSIN_DOM; 1.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Disulfide bond {ECO:0000256|SAAS:SAAS00037407};
KW   EGF-like domain {ECO:0000256|SAAS:SAAS00524722};
KW   Hydrolase {ECO:0000256|RuleBase:RU363034,
KW   ECO:0000256|SAAS:SAAS00526611};
KW   Kringle {ECO:0000256|SAAS:SAAS00439700};
KW   Protease {ECO:0000256|RuleBase:RU363034,
KW   ECO:0000256|SAAS:SAAS00526611};
KW   Proteomics identification {ECO:0000213|EPD:E7ET40,
KW   ECO:0000213|MaxQB:E7ET40, ECO:0000213|PeptideAtlas:E7ET40};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Secreted {ECO:0000256|SAAS:SAAS00526105};
KW   Serine protease {ECO:0000256|RuleBase:RU363034,
KW   ECO:0000256|SAAS:SAAS00526611}.
FT   DOMAIN       10     46       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN       52    134       Kringle. {ECO:0000259|PROSITE:PS50070}.
FT   DOMAIN      162    407       Peptidase S1.
FT                                {ECO:0000259|PROSITE:PS50240}.
SQ   SEQUENCE   414 AA;  46925 MW;  B68C9FE67482AA52 CRC64;
     MVFHLRTRYE QANCDCLNGG TCVSNKYFSN IHWCNCPKKF GGQHCEIDKS KTCYEGNGHF
     YRGKASTDTM GRPCLPWNSA TVLQQTYHAH RSDALQLGLG KHNYCRNPDN RRRPWCYVQV
     GLKLLVQECM VHDCADGKKP SSPPEELKFQ CGQKTLRPRF KIIGGEFTTI ENQPWFAAIY
     RRHRGGSVTY VCGGSLISPC WVISATHCFI DYPKKEDYIV YLGRSRLNSN TQGEMKFEVE
     NLILHKDYSA DTLAHHNDIA LLKIRSKEGR CAQPSRTIQT ICLPSMYNDP QFGTSCEITG
     FGKENSTDYL YPEQLKMTVV KLISHRECQQ PHYYGSEVTT KMLCAADPQW KTDSCQGDSG
     GPLVCSLQGR MTLTGIVSWG RGCALKDKPG VYTRVSHFLP WIRSHTKEEN GLAL
//
ID   UROK_HUMAN              Reviewed;         431 AA.
AC   P00749; B4DPZ2; Q15844; Q16618; Q53XS3; Q5SWW9; Q969W6;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   28-JUL-2009, sequence version 2.
DT   02-NOV-2016, entry version 216.
DE   RecName: Full=Urokinase-type plasminogen activator;
DE            Short=U-plasminogen activator;
DE            Short=uPA;
DE            EC=3.4.21.73;
DE   Contains:
DE     RecName: Full=Urokinase-type plasminogen activator long chain A;
DE   Contains:
DE     RecName: Full=Urokinase-type plasminogen activator short chain A;
DE   Contains:
DE     RecName: Full=Urokinase-type plasminogen activator chain B;
DE   Flags: Precursor;
GN   Name=PLAU;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Holmes W.E., Pennica D., Blaber M., Rey M.W., Guenzler W.A.,
RA   Steffens G.J., Heyneker H.L.;
RT   "Cloning and expression of the gene for pro-urokinase in Escherichia
RT   coli.";
RL   Biotechnology (N.Y.) 3:923-929(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3888571; DOI=10.1089/dna.1985.4.139;
RA   Jacobs P., Cravador A., Loriau R., Brockly F., Colau B., Chuchana P.,
RA   van Elsen A., Herzog A., Bollen A.;
RT   "Molecular cloning, sequencing, and expression in Escherichia coli of
RT   human preprourokinase cDNA.";
RL   DNA 4:139-146(1985).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2415429; DOI=10.1016/0378-1119(85)90084-8;
RA   Nagai M., Hiramatsu R., Kaneda T., Hayasuke N., Arimura H.,
RA   Nishida M., Suyama T.;
RT   "Molecular cloning of cDNA coding for human preprourokinase.";
RL   Gene 36:183-188(1985).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT MET-214.
RX   PubMed=2987867; DOI=10.1093/nar/13.8.2759;
RA   Riccio A., Grimaldi G., Verde P., Sebastio G., Boast S., Blasi F.;
RT   "The human urokinase-plasminogen activator gene and its promoter.";
RL   Nucleic Acids Res. 13:2759-2771(1985).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) System Donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Mesangial cell;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LEU-15; LEU-141 AND
RP   GLN-231.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT LEU-141.
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 21-431, AND VARIANT LEU-141.
RX   PubMed=8652631;
RA   Yoshimoto M., Ushiyama Y., Sakai M., Tamaki S., Hara H., Takahashi K.,
RA   Sawasaki Y., Hanada K.;
RT   "Characterization of single chain urokinase-type plasminogen activator
RT   with a novel amino-acid substitution in the kringle structure.";
RL   Biochim. Biophys. Acta 1293:83-89(1996).
RN   [12]
RP   PROTEIN SEQUENCE OF 21-43, GLYCOSYLATION AT THR-38, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RX   PubMed=2023947; DOI=10.1073/pnas.88.9.3992;
RA   Buko A.M., Kentzer E.J., Petros A., Menon G., Zuiderweg E.R.,
RA   Sarin V.K.;
RT   "Characterization of a posttranslational fucosylation in the growth
RT   factor domain of urinary plasminogen activator.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:3992-3996(1991).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 66-431, AND VARIANT
RP   MET-214.
RX   PubMed=6589620; DOI=10.1073/pnas.81.15.4727;
RA   Verde P., Stoppelli M.P., Galeffi P., di Nocera P., Blasi F.;
RT   "Identification and primary sequence of an unspliced human urokinase
RT   poly(A)+ RNA.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:4727-4731(1984).
RN   [14]
RP   PROTEIN SEQUENCE OF 21-177.
RX   PubMed=6754569;
RA   Gunzler W.A., Steffens G.J., Otting F., Kim S.-M.A., Frankus E.,
RA   Flohe L.;
RT   "The primary structure of high molecular mass urokinase from human
RT   urine. The complete amino acid sequence of the A chain.";
RL   Hoppe-Seyler's Z. Physiol. Chem. 363:1155-1165(1982).
RN   [15]
RP   PROTEIN SEQUENCE OF 156-176 AND 179-224.
RX   PubMed=6749491; DOI=10.1111/j.1432-1033.1982.tb06676.x;
RA   Schaller J., Nick H., Rickli E.E., Gillessen D., Lergier W.,
RA   Studer R.O.;
RT   "Human low-molecular-weight urinary urokinase. Partial
RT   characterization and preliminary sequence data of the two polypeptide
RT   chains.";
RL   Eur. J. Biochem. 125:251-257(1982).
RN   [16]
RP   PROTEIN SEQUENCE OF 158-410.
RX   PubMed=6754572;
RA   Steffens G.J., Gunzler W.A., Otting F., Frankus E., Flohe L.;
RT   "The complete amino acid sequence of low molecular mass urokinase from
RT   human urine.";
RL   Hoppe-Seyler's Z. Physiol. Chem. 363:1043-1058(1982).
RN   [17]
RP   ENZYME REGULATION, AND HETERODIMER WITH SERPINA5.
RX   PubMed=3501295;
RA   Stief T.W., Radtke K.P., Heimburger N.;
RT   "Inhibition of urokinase by protein C-inhibitor (PCI). Evidence for
RT   identity of PCI and plasminogen activator inhibitor 3.";
RL   Biol. Chem. Hoppe-Seyler 368:1427-1433(1987).
RN   [18]
RP   PHOSPHORYLATION AT SER-158 AND SER-323, AND MUTAGENESIS OF SER-158 AND
RP   SER-323.
RX   PubMed=9151681; DOI=10.1083/jcb.137.3.779;
RA   Franco P., Iaccarino C., Chiaradonna F., Brandazza A., Iavarone C.,
RA   Mastronicola M.R., Nolli M.L., Stoppelli M.P.;
RT   "Phosphorylation of human pro-urokinase on Ser138/303 impairs its
RT   receptor-dependent ability to promote myelomonocytic adherence and
RT   motility.";
RL   J. Cell Biol. 137:779-791(1997).
RN   [19]
RP   HETERODIMER WITH SERPINA5.
RX   PubMed=10340997; DOI=10.1093/molehr/5.6.513;
RA   He S., Lin Y.L., Liu Y.X.;
RT   "Functionally inactive protein C inhibitor in seminal plasma may be
RT   associated with infertility.";
RL   Mol. Hum. Reprod. 5:513-519(1999).
RN   [20]
RP   INTERACTION WITH MRC2.
RX   PubMed=10636902; DOI=10.1074/jbc.275.3.1993;
RA   Behrendt N., Jensen O.N., Engelholm L.H., Moertz E., Mann M.,
RA   Danoe K.;
RT   "A urokinase receptor-associated protein with specific collagen
RT   binding properties.";
RL   J. Biol. Chem. 275:1993-2002(2000).
RN   [21]
RP   INTERACTION WITH LRP1B.
RX   PubMed=11384978; DOI=10.1074/jbc.M102727200;
RA   Liu C.-X., Li Y., Obermoeller-McCormick L.M., Schwartz A.L., Bu G.;
RT   "The putative tumor suppressor LRP1B, a novel member of the low
RT   density lipoprotein (LDL) receptor family, exhibits both overlapping
RT   and distinct properties with the LDL receptor-related protein.";
RL   J. Biol. Chem. 276:28889-28896(2001).
RN   [22]
RP   ENZYME REGULATION, AND HETERODIMER WITH SERPINA5.
RX   PubMed=14696115; DOI=10.1002/ijc.11594;
RA   Wakita T., Hayashi T., Nishioka J., Tamaru H., Akita N., Asanuma K.,
RA   Kamada H., Gabazza E.C., Ido M., Kawamura J., Suzuki K.;
RT   "Regulation of carcinoma cell invasion by protein C inhibitor whose
RT   expression is decreased in renal cell carcinoma.";
RL   Int. J. Cancer 108:516-523(2004).
RN   [23]
RP   TISSUE SPECIFICITY.
RX   PubMed=15988036; DOI=10.1128/MCB.25.14.6279-6288.2005;
RA   Ustach C.V., Kim H.-R.C.;
RT   "Platelet-derived growth factor D is activated by urokinase
RT   plasminogen activator in prostate carcinoma cells.";
RL   Mol. Cell. Biol. 25:6279-6288(2005).
RN   [24]
RP   INVOLVEMENT IN QPD.
RX   PubMed=20007542; DOI=10.1182/blood-2009-07-233965;
RA   Paterson A.D., Rommens J.M., Bharaj B., Blavignac J., Wong I.,
RA   Diamandis M., Waye J.S., Rivard G.E., Hayward C.P.;
RT   "Persons with Quebec platelet disorder have a tandem duplication of
RT   PLAU, the urokinase plasminogen activator gene.";
RL   Blood 115:1264-1266(2010).
RN   [25]
RP   STRUCTURE BY NMR.
RX   PubMed=2536903; DOI=10.1038/337579a0;
RA   Oswald R.E., Bogusky M.J., Bamberger M., Smith R.A.G., Dobson C.M.;
RT   "Dynamics of the multidomain fibrinolytic protein urokinase from two-
RT   dimensional NMR.";
RL   Nature 337:579-582(1989).
RN   [26]
RP   STRUCTURE BY NMR OF 67-155.
RX   PubMed=1327118; DOI=10.1021/bi00155a008;
RA   Li X., Smith R.A.G., Dobson C.M.;
RT   "Sequential 1H NMR assignments and secondary structure of the kringle
RT   domain from urokinase.";
RL   Biochemistry 31:9562-9571(1992).
RN   [27]
RP   STRUCTURE BY NMR OF 67-155.
RX   PubMed=8107091; DOI=10.1006/jmbi.1994.1106;
RA   Li X., Bokman A.M., Llinas M., Smith R.A.G., Dobson C.M.;
RT   "Solution structure of the kringle domain from urokinase-type
RT   plasminogen activator.";
RL   J. Mol. Biol. 235:1548-1559(1994).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
RX   PubMed=8591045; DOI=10.1016/S0969-2126(01)00203-9;
RA   Spraggon G., Phillips C., Nowak U.K., Ponting C.P., Saunders D.,
RA   Dobson C.M., Stuart D.I., Jones E.Y.;
RT   "The crystal structure of the catalytic domain of human urokinase-type
RT   plasminogen activator.";
RL   Structure 3:681-691(1995).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 159-411.
RX   PubMed=10805774; DOI=10.1073/pnas.97.10.5113;
RA   Sperl S., Jacob U., Arroyo de Prada N., Sturzebecher J., Wilhelm O.G.,
RA   Bode W., Magdolen V., Huber R., Moroder L.;
RT   "(4-aminomethyl)phenylguanidine derivatives as nonpeptidic highly
RT   selective inhibitors of human urokinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:5113-5118(2000).
RN   [30]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 31-152 IN COMPLEX WITH PLAUR.
RX   PubMed=16456079; DOI=10.1126/science.1121143;
RA   Huai Q., Mazar A.P., Kuo A., Parry G.C., Shaw D.E., Callahan J.,
RA   Li Y., Yuan C., Bian C., Chen L., Furie B., Furie B.C., Cines D.B.,
RA   Huang M.;
RT   "Structure of human urokinase plasminogen activator in complex with
RT   its receptor.";
RL   Science 311:656-659(2006).
RN   [31]
RP   VARIANT LEU-141.
RX   PubMed=9065988;
RA   Conne B., Berczy M., Belin D.;
RT   "Detection of polymorphisms in the human urokinase-type plasminogen
RT   activator gene.";
RL   Thromb. Haemost. 77:434-435(1997).
RN   [32]
RP   ERRATUM.
RA   Conne B., Berczy M., Belin D.;
RL   Thromb. Haemost. 78:973-973(1997).
RN   [33]
RP   VARIANT LEU-141.
RX   PubMed=9194591; DOI=10.1002/elps.1150180505;
RA   Turkmen B., Schmitt M., Schmalfeldt B., Trommler P., Hell W.,
RA   Creutzburg S., Graeff H., Magdolen V.;
RT   "Mutational analysis of the genes encoding urokinase-type plasminogen
RT   activator (uPA) and its inhibitor PAI-1 in advanced ovarian cancer.";
RL   Electrophoresis 18:686-689(1997).
RN   [34]
RP   VARIANT [LARGE SCALE ANALYSIS] LEU-141.
RX   PubMed=18987736; DOI=10.1038/nature07485;
RA   Ley T.J., Mardis E.R., Ding L., Fulton B., McLellan M.D., Chen K.,
RA   Dooling D., Dunford-Shore B.H., McGrath S., Hickenbotham M., Cook L.,
RA   Abbott R., Larson D.E., Koboldt D.C., Pohl C., Smith S., Hawkins A.,
RA   Abbott S., Locke D., Hillier L.W., Miner T., Fulton L., Magrini V.,
RA   Wylie T., Glasscock J., Conyers J., Sander N., Shi X., Osborne J.R.,
RA   Minx P., Gordon D., Chinwalla A., Zhao Y., Ries R.E., Payton J.E.,
RA   Westervelt P., Tomasson M.H., Watson M., Baty J., Ivanovich J.,
RA   Heath S., Shannon W.D., Nagarajan R., Walter M.J., Link D.C.,
RA   Graubert T.A., DiPersio J.F., Wilson R.K.;
RT   "DNA sequencing of a cytogenetically normal acute myeloid leukaemia
RT   genome.";
RL   Nature 456:66-72(2008).
CC   -!- FUNCTION: Specifically cleaves the zymogen plasminogen to form the
CC       active enzyme plasmin.
CC   -!- CATALYTIC ACTIVITY: Specific cleavage of Arg-|-Val bond in
CC       plasminogen to form plasmin.
CC   -!- ENZYME REGULATION: Inhibited by SERPINA5.
CC       {ECO:0000269|PubMed:14696115, ECO:0000269|PubMed:3501295}.
CC   -!- SUBUNIT: Found in high and low molecular mass forms. Each consists
CC       of two chains, A and B. The high molecular mass form contains a
CC       long chain A which is cleaved to yield a short chain A. Forms
CC       heterodimer with SERPINA5. Binds LRP1B; binding is followed by
CC       internalization and degradation. Interacts with MRC2. Interacts
CC       with PLAUR. {ECO:0000269|PubMed:10636902,
CC       ECO:0000269|PubMed:11384978, ECO:0000269|PubMed:16456079}.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P00749-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P00749-2; Sequence=VSP_038368;
CC   -!- TISSUE SPECIFICITY: Expressed in the prostate gland and prostate
CC       cancers. {ECO:0000269|PubMed:15988036}.
CC   -!- PTM: Phosphorylation of Ser-158 and Ser-323 abolishes proadhesive
CC       ability but does not interfere with receptor binding.
CC       {ECO:0000269|PubMed:9151681}.
CC   -!- DISEASE: Quebec platelet disorder (QPD) [MIM:601709]: An autosomal
CC       dominant bleeding disorder due to a gain-of-function defect in
CC       fibrinolysis. Although affected individuals do not exhibit
CC       systemic fibrinolysis, they show delayed onset bleeding after
CC       challenge, such as surgery. The hallmark of the disorder is
CC       markedly increased PLAU levels within platelets, which causes
CC       intraplatelet plasmin generation and secondary degradation of
CC       alpha-granule proteins. {ECO:0000269|PubMed:20007542}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- PHARMACEUTICAL: Available under the name Abbokinase (Abbott). Used
CC       in Pulmonary Embolism (PE) to initiate fibrinolysis. Clinically
CC       used for therapy of thrombolytic disorders.
CC   -!- SIMILARITY: Belongs to the peptidase S1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00274}.
CC   -!- SIMILARITY: Contains 1 EGF-like domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00076}.
CC   -!- SIMILARITY: Contains 1 kringle domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00121}.
CC   -!- SIMILARITY: Contains 1 peptidase S1 domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00274}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Urokinase entry;
CC       URL="https://en.wikipedia.org/wiki/Urokinase";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/plau/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M15476; AAA61253.1; -; mRNA.
DR   EMBL; X02760; CAA26535.1; -; mRNA.
DR   EMBL; D00244; BAA00175.1; -; mRNA.
DR   EMBL; K03226; AAC97138.1; -; mRNA.
DR   EMBL; X02419; CAA26268.1; -; Genomic_DNA.
DR   EMBL; AF377330; AAK53822.1; -; Genomic_DNA.
DR   EMBL; BT007391; AAP36055.1; -; mRNA.
DR   EMBL; AK298560; BAG60754.1; -; mRNA.
DR   EMBL; AL596247; CAI13969.1; -; Genomic_DNA.
DR   EMBL; CH471083; EAW54544.1; -; Genomic_DNA.
DR   EMBL; BC013575; AAH13575.1; -; mRNA.
DR   EMBL; D11143; BAA01919.1; -; mRNA.
DR   EMBL; K02286; AAA61252.1; -; Genomic_DNA.
DR   CCDS; CCDS44442.1; -. [P00749-2]
DR   CCDS; CCDS7339.1; -. [P00749-1]
DR   PIR; A00931; UKHU.
DR   RefSeq; NP_001138503.1; NM_001145031.2. [P00749-2]
DR   RefSeq; NP_001306120.1; NM_001319191.1.
DR   RefSeq; NP_002649.1; NM_002658.4. [P00749-1]
DR   UniGene; Hs.77274; -.
DR   PDB; 1C5W; X-ray; 1.94 A; A=156-178, B=179-431.
DR   PDB; 1C5X; X-ray; 1.75 A; A=156-178, B=179-431.
DR   PDB; 1C5Y; X-ray; 1.65 A; A=156-178, B=179-431.
DR   PDB; 1C5Z; X-ray; 1.85 A; A=156-178, B=179-431.
DR   PDB; 1EJN; X-ray; 1.80 A; A=179-431.
DR   PDB; 1F5K; X-ray; 1.80 A; U=179-431.
DR   PDB; 1F5L; X-ray; 2.10 A; A=179-431.
DR   PDB; 1F92; X-ray; 2.60 A; A=179-431.
DR   PDB; 1FV9; X-ray; 3.00 A; A=179-423.
DR   PDB; 1GI7; X-ray; 1.79 A; A=156-178, B=179-423.
DR   PDB; 1GI8; X-ray; 1.75 A; A=156-178, B=179-423.
DR   PDB; 1GI9; X-ray; 1.80 A; A=156-178, B=179-423.
DR   PDB; 1GJ7; X-ray; 1.50 A; A=156-178, B=179-431.
DR   PDB; 1GJ8; X-ray; 1.64 A; A=156-178, B=179-431.
DR   PDB; 1GJ9; X-ray; 1.80 A; A=156-178, B=179-431.
DR   PDB; 1GJA; X-ray; 1.56 A; A=156-178, B=179-431.
DR   PDB; 1GJB; X-ray; 1.90 A; A=156-178, B=179-431.
DR   PDB; 1GJC; X-ray; 1.73 A; A=156-178, B=179-431.
DR   PDB; 1GJD; X-ray; 1.75 A; A=156-178, B=179-431.
DR   PDB; 1KDU; NMR; -; A=69-153.
DR   PDB; 1LMW; X-ray; 2.50 A; A/C=156-178, B/D=179-431.
DR   PDB; 1O3P; X-ray; 1.81 A; A=156-178, B=179-431.
DR   PDB; 1O5A; X-ray; 1.68 A; A=156-178, B=179-431.
DR   PDB; 1O5B; X-ray; 1.85 A; A=156-178, B=179-431.
DR   PDB; 1O5C; X-ray; 1.63 A; A=156-178, B=179-431.
DR   PDB; 1OWD; X-ray; 2.32 A; A=179-423.
DR   PDB; 1OWE; X-ray; 1.60 A; A=179-423.
DR   PDB; 1OWH; X-ray; 1.61 A; A=179-410.
DR   PDB; 1OWI; X-ray; 2.93 A; A=179-423.
DR   PDB; 1OWJ; X-ray; 3.10 A; A=179-423.
DR   PDB; 1OWK; X-ray; 2.80 A; A=179-423.
DR   PDB; 1SC8; X-ray; 2.40 A; U=164-425.
DR   PDB; 1SQA; X-ray; 2.00 A; A=179-423.
DR   PDB; 1SQO; X-ray; 1.84 A; A=179-423.
DR   PDB; 1SQT; X-ray; 1.90 A; A=179-423.
DR   PDB; 1U6Q; X-ray; 2.02 A; A=179-423.
DR   PDB; 1URK; NMR; -; A=26-155.
DR   PDB; 1VJ9; X-ray; 2.40 A; U=164-425.
DR   PDB; 1VJA; X-ray; 2.00 A; U=164-425.
DR   PDB; 1W0Z; X-ray; 1.90 A; U=179-425.
DR   PDB; 1W10; X-ray; 2.00 A; U=179-425.
DR   PDB; 1W11; X-ray; 2.00 A; U=179-425.
DR   PDB; 1W12; X-ray; 2.40 A; U=179-425.
DR   PDB; 1W13; X-ray; 2.00 A; U=179-425.
DR   PDB; 1W14; X-ray; 2.20 A; U=179-425.
DR   PDB; 2FD6; X-ray; 1.90 A; A=31-152.
DR   PDB; 2I9A; X-ray; 1.90 A; A/B/C/D=21-163.
DR   PDB; 2I9B; X-ray; 2.80 A; A/B/C/D=21-163.
DR   PDB; 2NWN; X-ray; 2.15 A; A=179-431.
DR   PDB; 2O8T; X-ray; 1.45 A; A=179-431.
DR   PDB; 2O8U; X-ray; 1.70 A; A=179-431.
DR   PDB; 2O8W; X-ray; 1.86 A; A=179-431.
DR   PDB; 2R2W; X-ray; 2.01 A; U=179-431.
DR   PDB; 2VIN; X-ray; 1.90 A; A=179-431.
DR   PDB; 2VIO; X-ray; 1.80 A; A=179-431.
DR   PDB; 2VIP; X-ray; 1.72 A; A=179-431.
DR   PDB; 2VIQ; X-ray; 2.00 A; A=179-431.
DR   PDB; 2VIV; X-ray; 1.72 A; A=179-431.
DR   PDB; 2VIW; X-ray; 2.05 A; A=179-431.
DR   PDB; 2VNT; X-ray; 2.20 A; A/B/C/D/E/F=156-431.
DR   PDB; 3BT1; X-ray; 2.80 A; A=21-153.
DR   PDB; 3BT2; X-ray; 2.50 A; A=21-153.
DR   PDB; 3IG6; X-ray; 1.83 A; A/C=156-178, B/D=179-431.
DR   PDB; 3KGP; X-ray; 2.35 A; A=179-431.
DR   PDB; 3KHV; X-ray; 2.35 A; A=179-431.
DR   PDB; 3KID; X-ray; 2.71 A; U=179-431.
DR   PDB; 3M61; X-ray; 1.68 A; U=179-431.
DR   PDB; 3MHW; X-ray; 1.45 A; U=179-425.
DR   PDB; 3MWI; X-ray; 2.03 A; U=179-424.
DR   PDB; 3OX7; X-ray; 1.58 A; U=179-431.
DR   PDB; 3OY5; X-ray; 2.31 A; U=179-431.
DR   PDB; 3OY6; X-ray; 2.31 A; U=179-431.
DR   PDB; 3PB1; X-ray; 2.30 A; E=179-431.
DR   PDB; 3QN7; X-ray; 1.90 A; A=179-431.
DR   PDB; 3U73; X-ray; 3.19 A; A=21-152.
DR   PDB; 4DVA; X-ray; 1.94 A; U=179-424.
DR   PDB; 4DW2; X-ray; 2.97 A; U=179-424.
DR   PDB; 4FU7; X-ray; 2.00 A; A=179-424.
DR   PDB; 4FU8; X-ray; 2.20 A; A=179-424.
DR   PDB; 4FU9; X-ray; 1.60 A; A=179-424.
DR   PDB; 4FUB; X-ray; 1.90 A; A=179-424.
DR   PDB; 4FUC; X-ray; 1.72 A; A=179-424.
DR   PDB; 4FUD; X-ray; 2.00 A; A=179-424.
DR   PDB; 4FUE; X-ray; 2.00 A; A=179-424.
DR   PDB; 4FUF; X-ray; 2.00 A; A=179-424.
DR   PDB; 4FUG; X-ray; 1.80 A; A=179-424.
DR   PDB; 4FUH; X-ray; 1.60 A; A=179-424.
DR   PDB; 4FUI; X-ray; 2.00 A; A=179-424.
DR   PDB; 4FUJ; X-ray; 2.05 A; A=179-424.
DR   PDB; 4GLY; X-ray; 1.52 A; A=179-423.
DR   PDB; 4H42; X-ray; 2.01 A; U=179-426.
DR   PDB; 4JK5; X-ray; 1.55 A; A=179-423.
DR   PDB; 4JK6; X-ray; 2.20 A; A=179-423.
DR   PDB; 4JNI; X-ray; 1.17 A; U=179-425.
DR   PDB; 4JNL; X-ray; 2.00 A; U=179-425.
DR   PDB; 4K24; X-ray; 4.50 A; A=21-153.
DR   PDB; 4MNV; X-ray; 1.80 A; A=179-423.
DR   PDB; 4MNW; X-ray; 1.49 A; A=179-423.
DR   PDB; 4MNX; X-ray; 1.85 A; A=179-423.
DR   PDB; 4MNY; X-ray; 1.70 A; A/B=179-423.
DR   PDB; 4OS1; X-ray; 2.20 A; A=179-423.
DR   PDB; 4OS2; X-ray; 1.79 A; A=179-423.
DR   PDB; 4OS4; X-ray; 2.00 A; A=179-423.
DR   PDB; 4OS5; X-ray; 2.26 A; A=179-423.
DR   PDB; 4OS6; X-ray; 1.75 A; A=179-423.
DR   PDB; 4OS7; X-ray; 2.00 A; A=179-423.
DR   PDB; 4X0W; X-ray; 2.10 A; U=179-425.
DR   PDB; 4X1N; X-ray; 1.80 A; U=179-425.
DR   PDB; 4X1P; X-ray; 1.60 A; U=179-425.
DR   PDB; 4X1Q; X-ray; 2.28 A; U=179-425.
DR   PDB; 4X1R; X-ray; 2.10 A; U=179-425.
DR   PDB; 4X1S; X-ray; 1.90 A; U=179-425.
DR   PDB; 4XSK; X-ray; 1.50 A; U=179-424.
DR   PDB; 4ZHL; X-ray; 2.06 A; U=179-425.
DR   PDB; 4ZHM; X-ray; 1.90 A; U=179-425.
DR   PDB; 4ZKN; X-ray; 1.36 A; U=179-425.
DR   PDB; 4ZKO; X-ray; 1.29 A; U=179-425.
DR   PDB; 4ZKR; X-ray; 1.36 A; U=179-425.
DR   PDB; 4ZKS; X-ray; 1.85 A; U=179-425.
DR   PDB; 5HGG; X-ray; 1.97 A; A/B=179-424.
DR   PDBsum; 1C5W; -.
DR   PDBsum; 1C5X; -.
DR   PDBsum; 1C5Y; -.
DR   PDBsum; 1C5Z; -.
DR   PDBsum; 1EJN; -.
DR   PDBsum; 1F5K; -.
DR   PDBsum; 1F5L; -.
DR   PDBsum; 1F92; -.
DR   PDBsum; 1FV9; -.
DR   PDBsum; 1GI7; -.
DR   PDBsum; 1GI8; -.
DR   PDBsum; 1GI9; -.
DR   PDBsum; 1GJ7; -.
DR   PDBsum; 1GJ8; -.
DR   PDBsum; 1GJ9; -.
DR   PDBsum; 1GJA; -.
DR   PDBsum; 1GJB; -.
DR   PDBsum; 1GJC; -.
DR   PDBsum; 1GJD; -.
DR   PDBsum; 1KDU; -.
DR   PDBsum; 1LMW; -.
DR   PDBsum; 1O3P; -.
DR   PDBsum; 1O5A; -.
DR   PDBsum; 1O5B; -.
DR   PDBsum; 1O5C; -.
DR   PDBsum; 1OWD; -.
DR   PDBsum; 1OWE; -.
DR   PDBsum; 1OWH; -.
DR   PDBsum; 1OWI; -.
DR   PDBsum; 1OWJ; -.
DR   PDBsum; 1OWK; -.
DR   PDBsum; 1SC8; -.
DR   PDBsum; 1SQA; -.
DR   PDBsum; 1SQO; -.
DR   PDBsum; 1SQT; -.
DR   PDBsum; 1U6Q; -.
DR   PDBsum; 1URK; -.
DR   PDBsum; 1VJ9; -.
DR   PDBsum; 1VJA; -.
DR   PDBsum; 1W0Z; -.
DR   PDBsum; 1W10; -.
DR   PDBsum; 1W11; -.
DR   PDBsum; 1W12; -.
DR   PDBsum; 1W13; -.
DR   PDBsum; 1W14; -.
DR   PDBsum; 2FD6; -.
DR   PDBsum; 2I9A; -.
DR   PDBsum; 2I9B; -.
DR   PDBsum; 2NWN; -.
DR   PDBsum; 2O8T; -.
DR   PDBsum; 2O8U; -.
DR   PDBsum; 2O8W; -.
DR   PDBsum; 2R2W; -.
DR   PDBsum; 2VIN; -.
DR   PDBsum; 2VIO; -.
DR   PDBsum; 2VIP; -.
DR   PDBsum; 2VIQ; -.
DR   PDBsum; 2VIV; -.
DR   PDBsum; 2VIW; -.
DR   PDBsum; 2VNT; -.
DR   PDBsum; 3BT1; -.
DR   PDBsum; 3BT2; -.
DR   PDBsum; 3IG6; -.
DR   PDBsum; 3KGP; -.
DR   PDBsum; 3KHV; -.
DR   PDBsum; 3KID; -.
DR   PDBsum; 3M61; -.
DR   PDBsum; 3MHW; -.
DR   PDBsum; 3MWI; -.
DR   PDBsum; 3OX7; -.
DR   PDBsum; 3OY5; -.
DR   PDBsum; 3OY6; -.
DR   PDBsum; 3PB1; -.
DR   PDBsum; 3QN7; -.
DR   PDBsum; 3U73; -.
DR   PDBsum; 4DVA; -.
DR   PDBsum; 4DW2; -.
DR   PDBsum; 4FU7; -.
DR   PDBsum; 4FU8; -.
DR   PDBsum; 4FU9; -.
DR   PDBsum; 4FUB; -.
DR   PDBsum; 4FUC; -.
DR   PDBsum; 4FUD; -.
DR   PDBsum; 4FUE; -.
DR   PDBsum; 4FUF; -.
DR   PDBsum; 4FUG; -.
DR   PDBsum; 4FUH; -.
DR   PDBsum; 4FUI; -.
DR   PDBsum; 4FUJ; -.
DR   PDBsum; 4GLY; -.
DR   PDBsum; 4H42; -.
DR   PDBsum; 4JK5; -.
DR   PDBsum; 4JK6; -.
DR   PDBsum; 4JNI; -.
DR   PDBsum; 4JNL; -.
DR   PDBsum; 4K24; -.
DR   PDBsum; 4MNV; -.
DR   PDBsum; 4MNW; -.
DR   PDBsum; 4MNX; -.
DR   PDBsum; 4MNY; -.
DR   PDBsum; 4OS1; -.
DR   PDBsum; 4OS2; -.
DR   PDBsum; 4OS4; -.
DR   PDBsum; 4OS5; -.
DR   PDBsum; 4OS6; -.
DR   PDBsum; 4OS7; -.
DR   PDBsum; 4X0W; -.
DR   PDBsum; 4X1N; -.
DR   PDBsum; 4X1P; -.
DR   PDBsum; 4X1Q; -.
DR   PDBsum; 4X1R; -.
DR   PDBsum; 4X1S; -.
DR   PDBsum; 4XSK; -.
DR   PDBsum; 4ZHL; -.
DR   PDBsum; 4ZHM; -.
DR   PDBsum; 4ZKN; -.
DR   PDBsum; 4ZKO; -.
DR   PDBsum; 4ZKR; -.
DR   PDBsum; 4ZKS; -.
DR   PDBsum; 5HGG; -.
DR   ProteinModelPortal; P00749; -.
DR   SMR; P00749; -.
DR   BioGrid; 111344; 19.
DR   DIP; DIP-46387N; -.
DR   IntAct; P00749; 4.
DR   STRING; 9606.ENSP00000361850; -.
DR   BindingDB; P00749; -.
DR   ChEMBL; CHEMBL3286; -.
DR   DrugBank; DB00594; Amiloride.
DR   DrugBank; DB00013; Urokinase.
DR   GuidetoPHARMACOLOGY; 2393; -.
DR   MEROPS; S01.231; -.
DR   iPTMnet; P00749; -.
DR   PhosphoSitePlus; P00749; -.
DR   UniCarbKB; P00749; -.
DR   BioMuta; PLAU; -.
DR   DMDM; 254763341; -.
DR   EPD; P00749; -.
DR   MaxQB; P00749; -.
DR   PaxDb; P00749; -.
DR   PeptideAtlas; P00749; -.
DR   PRIDE; P00749; -.
DR   DNASU; 5328; -.
DR   Ensembl; ENST00000372764; ENSP00000361850; ENSG00000122861.
DR   Ensembl; ENST00000496777; ENSP00000431795; ENSG00000122861.
DR   GeneID; 5328; -.
DR   KEGG; hsa:5328; -.
DR   UCSC; uc001jwa.4; human. [P00749-1]
DR   CTD; 5328; -.
DR   DisGeNET; 5328; -.
DR   GeneCards; PLAU; -.
DR   HGNC; HGNC:9052; PLAU.
DR   HPA; HPA008719; -.
DR   MalaCards; PLAU; -.
DR   MIM; 191840; gene.
DR   MIM; 601709; phenotype.
DR   neXtProt; NX_P00749; -.
DR   Orphanet; 220436; Quebec platelet disorder.
DR   PharmGKB; PA33382; -.
DR   eggNOG; ENOG410IGFI; Eukaryota.
DR   eggNOG; COG5640; LUCA.
DR   HOVERGEN; HBG008633; -.
DR   InParanoid; P00749; -.
DR   KO; K01348; -.
DR   OrthoDB; EOG091G0AH5; -.
DR   PhylomeDB; P00749; -.
DR   TreeFam; TF329901; -.
DR   BioCyc; ZFISH:HS04608-MONOMER; -.
DR   BRENDA; 3.4.21.73; 2681.
DR   Reactome; R-HSA-75205; Dissolution of Fibrin Clot.
DR   SABIO-RK; P00749; -.
DR   SIGNOR; P00749; -.
DR   EvolutionaryTrace; P00749; -.
DR   GeneWiki; PLAU; -.
DR   GenomeRNAi; 5328; -.
DR   PMAP-CutDB; Q53XS3; -.
DR   PRO; PR:P00749; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000122861; -.
DR   CleanEx; HS_PLAU; -.
DR   ExpressionAtlas; P00749; baseline and differential.
DR   Genevisible; P00749; HS.
DR   GO; GO:0009986; C:cell surface; IDA:BHF-UCL.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IBA:GO_Central.
DR   GO; GO:0007596; P:blood coagulation; IEA:UniProtKB-KW.
DR   GO; GO:0006935; P:chemotaxis; TAS:ProtInc.
DR   GO; GO:0042730; P:fibrinolysis; TAS:Reactome.
DR   GO; GO:0030335; P:positive regulation of cell migration; IDA:MGI.
DR   GO; GO:0006508; P:proteolysis; TAS:ProtInc.
DR   GO; GO:0033628; P:regulation of cell adhesion mediated by integrin; IDA:BHF-UCL.
DR   GO; GO:0042127; P:regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0010469; P:regulation of receptor activity; IDA:BHF-UCL.
DR   GO; GO:0014910; P:regulation of smooth muscle cell migration; IDA:BHF-UCL.
DR   GO; GO:2000097; P:regulation of smooth muscle cell-matrix adhesion; IDA:BHF-UCL.
DR   GO; GO:0061041; P:regulation of wound healing; IC:BHF-UCL.
DR   GO; GO:0001666; P:response to hypoxia; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0014909; P:smooth muscle cell migration; IEA:Ensembl.
DR   CDD; cd00190; Tryp_SPc; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000001; Kringle.
DR   InterPro; IPR013806; Kringle-like.
DR   InterPro; IPR018056; Kringle_CS.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR001314; Peptidase_S1A.
DR   InterPro; IPR001254; Trypsin_dom.
DR   InterPro; IPR018114; TRYPSIN_HIS.
DR   InterPro; IPR033116; TRYPSIN_SER.
DR   Pfam; PF00051; Kringle; 1.
DR   Pfam; PF00089; Trypsin; 1.
DR   PRINTS; PR00722; CHYMOTRYPSIN.
DR   SMART; SM00130; KR; 1.
DR   SMART; SM00020; Tryp_SPc; 1.
DR   SUPFAM; SSF50494; SSF50494; 1.
DR   SUPFAM; SSF57440; SSF57440; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS00021; KRINGLE_1; 1.
DR   PROSITE; PS50070; KRINGLE_2; 1.
DR   PROSITE; PS50240; TRYPSIN_DOM; 1.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Blood coagulation;
KW   Complete proteome; Direct protein sequencing; Disulfide bond;
KW   EGF-like domain; Fibrinolysis; Glycoprotein; Hemostasis; Hydrolase;
KW   Kringle; Pharmaceutical; Phosphoprotein; Plasminogen activation;
KW   Polymorphism; Protease; Reference proteome; Secreted; Serine protease;
KW   Signal; Zymogen.
FT   SIGNAL        1     20       {ECO:0000269|PubMed:2023947,
FT                                ECO:0000269|PubMed:6754569}.
FT   CHAIN        21    431       Urokinase-type plasminogen activator.
FT                                /FTId=PRO_0000028318.
FT   CHAIN        21    177       Urokinase-type plasminogen activator long
FT                                chain A.
FT                                /FTId=PRO_0000028319.
FT   CHAIN       156    177       Urokinase-type plasminogen activator
FT                                short chain A.
FT                                /FTId=PRO_0000028320.
FT   CHAIN       179    431       Urokinase-type plasminogen activator
FT                                chain B.
FT                                /FTId=PRO_0000028321.
FT   DOMAIN       27     63       EGF-like. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN       70    151       Kringle. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00121}.
FT   DOMAIN      179    424       Peptidase S1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00274}.
FT   REGION       34     57       Binds urokinase plasminogen activator
FT                                surface receptor. {ECO:0000250}.
FT   REGION      152    177       Connecting peptide.
FT   ACT_SITE    224    224       Charge relay system.
FT   ACT_SITE    275    275       Charge relay system.
FT   ACT_SITE    376    376       Charge relay system.
FT   SITE        177    178       Cleavage; during zymogen activation.
FT   MOD_RES     158    158       Phosphoserine.
FT                                {ECO:0000269|PubMed:9151681}.
FT   MOD_RES     323    323       Phosphoserine.
FT                                {ECO:0000269|PubMed:9151681}.
FT   CARBOHYD     38     38       O-linked (Fuc).
FT                                {ECO:0000269|PubMed:2023947}.
FT   CARBOHYD    322    322       N-linked (GlcNAc...).
FT                                /FTId=CAR_000026.
FT   DISULFID     31     39
FT   DISULFID     33     51
FT   DISULFID     53     62
FT   DISULFID     70    151
FT   DISULFID     91    133
FT   DISULFID    122    146
FT   DISULFID    168    299       Interchain (between A and B chains).
FT   DISULFID    209    225
FT   DISULFID    217    288
FT   DISULFID    313    382
FT   DISULFID    345    361
FT   DISULFID    372    400
FT   VAR_SEQ       1     29       MRALLARLLLCVLVVSDSKGSNELHQVPS -> MVFHLRTR
FT                                YEQA (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_038368.
FT   VARIANT      15     15       V -> L (in dbSNP:rs2227580).
FT                                {ECO:0000269|Ref.7}.
FT                                /FTId=VAR_038730.
FT   VARIANT     141    141       P -> L (in dbSNP:rs2227564).
FT                                {ECO:0000269|PubMed:15164054,
FT                                ECO:0000269|PubMed:18987736,
FT                                ECO:0000269|PubMed:8652631,
FT                                ECO:0000269|PubMed:9065988,
FT                                ECO:0000269|PubMed:9194591,
FT                                ECO:0000269|Ref.7}.
FT                                /FTId=VAR_006722.
FT   VARIANT     214    214       I -> M. {ECO:0000269|PubMed:2987867,
FT                                ECO:0000269|PubMed:6589620}.
FT                                /FTId=VAR_013102.
FT   VARIANT     231    231       K -> Q (in dbSNP:rs2227567).
FT                                {ECO:0000269|Ref.7}.
FT                                /FTId=VAR_038731.
FT   MUTAGEN     158    158       S->E: Abolishes phosphorylation,
FT                                proadhesive function and ability to
FT                                induce chemotactic response; when
FT                                associated with E-323.
FT                                {ECO:0000269|PubMed:9151681}.
FT   MUTAGEN     323    323       S->E: Abolishes phosphorylation,
FT                                proadhesive function and ability to
FT                                induce chemotactic response; when
FT                                associated with E-158.
FT                                {ECO:0000269|PubMed:9151681}.
FT   CONFLICT    150    150       D -> G (in Ref. 6; BAG60754).
FT                                {ECO:0000305}.
FT   CONFLICT    151    151       C -> W (in Ref. 2; CAA26535).
FT                                {ECO:0000305}.
FT   CONFLICT    386    386       G -> C (in Ref. 2; CAA26535).
FT                                {ECO:0000305}.
FT   CONFLICT    430    430       A -> V (in Ref. 2; CAA26535).
FT                                {ECO:0000305}.
FT   STRAND       34     36       {ECO:0000244|PDB:1URK}.
FT   STRAND       38     41       {ECO:0000244|PDB:2FD6}.
FT   TURN         43     47       {ECO:0000244|PDB:2FD6}.
FT   STRAND       49     52       {ECO:0000244|PDB:2FD6}.
FT   STRAND       57     59       {ECO:0000244|PDB:2FD6}.
FT   STRAND       64     67       {ECO:0000244|PDB:2FD6}.
FT   STRAND       70     72       {ECO:0000244|PDB:2I9B}.
FT   STRAND       73     77       {ECO:0000244|PDB:3U73}.
FT   STRAND       86     89       {ECO:0000244|PDB:1URK}.
FT   STRAND       94     96       {ECO:0000244|PDB:1KDU}.
FT   HELIX        99    101       {ECO:0000244|PDB:2FD6}.
FT   STRAND      102    104       {ECO:0000244|PDB:2FD6}.
FT   STRAND      106    108       {ECO:0000244|PDB:3BT1}.
FT   HELIX       111    114       {ECO:0000244|PDB:2FD6}.
FT   STRAND      117    119       {ECO:0000244|PDB:2FD6}.
FT   STRAND      128    130       {ECO:0000244|PDB:2I9A}.
FT   STRAND      132    137       {ECO:0000244|PDB:2FD6}.
FT   STRAND      140    147       {ECO:0000244|PDB:2FD6}.
FT   HELIX       162    165       {ECO:0000244|PDB:1GJA}.
FT   STRAND      180    184       {ECO:0000244|PDB:4JNI}.
FT   HELIX       187    189       {ECO:0000244|PDB:4JNI}.
FT   STRAND      193    199       {ECO:0000244|PDB:4JNI}.
FT   STRAND      201    203       {ECO:0000244|PDB:4XSK}.
FT   STRAND      205    215       {ECO:0000244|PDB:4JNI}.
FT   STRAND      218    221       {ECO:0000244|PDB:4JNI}.
FT   HELIX       223    225       {ECO:0000244|PDB:4JNI}.
FT   TURN        226    228       {ECO:0000244|PDB:4JNI}.
FT   HELIX       232    234       {ECO:0000244|PDB:4JNI}.
FT   STRAND      235    240       {ECO:0000244|PDB:4JNI}.
FT   STRAND      243    246       {ECO:0000244|PDB:4JNI}.
FT   STRAND      252    261       {ECO:0000244|PDB:4JNI}.
FT   STRAND      268    271       {ECO:0000244|PDB:5HGG}.
FT   STRAND      272    274       {ECO:0000244|PDB:3MHW}.
FT   STRAND      277    282       {ECO:0000244|PDB:4JNI}.
FT   STRAND      293    295       {ECO:0000244|PDB:1LMW}.
FT   STRAND      312    318       {ECO:0000244|PDB:4JNI}.
FT   STRAND      329    331       {ECO:0000244|PDB:4DW2}.
FT   STRAND      333    340       {ECO:0000244|PDB:4JNI}.
FT   HELIX       342    345       {ECO:0000244|PDB:4JNI}.
FT   TURN        348    351       {ECO:0000244|PDB:4JNI}.
FT   HELIX       352    354       {ECO:0000244|PDB:4JNI}.
FT   TURN        356    358       {ECO:0000244|PDB:4DW2}.
FT   STRAND      359    363       {ECO:0000244|PDB:4JNI}.
FT   STRAND      365    367       {ECO:0000244|PDB:3KHV}.
FT   STRAND      379    384       {ECO:0000244|PDB:4JNI}.
FT   STRAND      387    396       {ECO:0000244|PDB:4JNI}.
FT   STRAND      398    402       {ECO:0000244|PDB:4JNI}.
FT   STRAND      407    411       {ECO:0000244|PDB:4JNI}.
FT   HELIX       412    414       {ECO:0000244|PDB:4JNI}.
FT   HELIX       416    422       {ECO:0000244|PDB:4JNI}.
SQ   SEQUENCE   431 AA;  48507 MW;  62C72400BC23115F CRC64;
     MRALLARLLL CVLVVSDSKG SNELHQVPSN CDCLNGGTCV SNKYFSNIHW CNCPKKFGGQ
     HCEIDKSKTC YEGNGHFYRG KASTDTMGRP CLPWNSATVL QQTYHAHRSD ALQLGLGKHN
     YCRNPDNRRR PWCYVQVGLK PLVQECMVHD CADGKKPSSP PEELKFQCGQ KTLRPRFKII
     GGEFTTIENQ PWFAAIYRRH RGGSVTYVCG GSLISPCWVI SATHCFIDYP KKEDYIVYLG
     RSRLNSNTQG EMKFEVENLI LHKDYSADTL AHHNDIALLK IRSKEGRCAQ PSRTIQTICL
     PSMYNDPQFG TSCEITGFGK ENSTDYLYPE QLKMTVVKLI SHRECQQPHY YGSEVTTKML
     CAADPQWKTD SCQGDSGGPL VCSLQGRMTL TGIVSWGRGC ALKDKPGVYT RVSHFLPWIR
     SHTKEENGLA L
//
ID   Q9UEJ5_HUMAN            Unreviewed;        17 AA.
AC   Q9UEJ5;
DT   01-MAY-2000, integrated into UniProtKB/TrEMBL.
DT   01-MAY-2000, sequence version 1.
DT   07-SEP-2016, entry version 55.
DE   SubName: Full=PLAU protein {ECO:0000313|EMBL:AAA61257.1};
DE   Flags: Fragment;
GN   Name=PLAU {ECO:0000313|EMBL:AAA61257.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAA61257.1};
RN   [1] {ECO:0000313|EMBL:AAA61257.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=3933505; DOI=10.1016/0006-291X(85)91170-2;
RA   Nagamine Y., Pearson D., Grattan M.;
RT   "Exon-intron boundary sliding in the generation of two mRNAs coding
RT   for porcine urokinase-like plasminogen activator.";
RL   Biochem. Biophys. Res. Commun. 132:563-569(1985).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; K03027; AAA61257.1; -; Genomic_DNA.
DR   UniGene; Hs.77274; -.
DR   STRING; 9606.ENSP00000361850; -.
DR   PaxDb; Q9UEJ5; -.
DR   PeptideAtlas; Q9UEJ5; -.
DR   eggNOG; ENOG410IGFI; Eukaryota.
DR   eggNOG; COG5640; LUCA.
DR   Bgee; ENSG00000122861; -.
PE   4: Predicted;
FT   NON_TER       1      1       {ECO:0000313|EMBL:AAA61257.1}.
FT   NON_TER      17     17       {ECO:0000313|EMBL:AAA61257.1}.
SQ   SEQUENCE   17 AA;  1801 MW;  9989927EA849E253 CRC64;
     ECMVHDCADG KKPSSPP
//
ID   S4R3G7_HUMAN            Unreviewed;       106 AA.
AC   S4R3G7;
DT   18-SEP-2013, integrated into UniProtKB/TrEMBL.
DT   18-SEP-2013, sequence version 1.
DT   02-NOV-2016, entry version 24.
DE   SubName: Full=Urokinase-type plasminogen activator {ECO:0000313|Ensembl:ENSP00000474318};
DE   Flags: Fragment;
GN   Name=PLAU {ECO:0000313|Ensembl:ENSP00000474318};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000474318, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000474318, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000474318}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2013) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000474318}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL596247; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; S4R3G7; -.
DR   STRING; 9606.ENSP00000361850; -.
DR   PaxDb; S4R3G7; -.
DR   PeptideAtlas; S4R3G7; -.
DR   Ensembl; ENST00000481390; ENSP00000474318; ENSG00000122861.
DR   UCSC; uc057uen.1; human.
DR   HGNC; HGNC:9052; PLAU.
DR   OpenTargets; ENSG00000122861; -.
DR   eggNOG; ENOG410IGFI; Eukaryota.
DR   eggNOG; COG5640; LUCA.
DR   GeneTree; ENSGT00760000119133; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000122861; -.
DR   ExpressionAtlas; S4R3G7; baseline and differential.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000001; Kringle.
DR   InterPro; IPR013806; Kringle-like.
DR   Pfam; PF00051; Kringle; 1.
DR   SUPFAM; SSF57440; SSF57440; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS50070; KRINGLE_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:S4R3G7};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     20       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        21    106       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5004532202.
FT   DOMAIN       27     63       EGF-like. {ECO:0000259|PROSITE:PS50026}.
FT   DOMAIN       69    106       Kringle. {ECO:0000259|PROSITE:PS50070}.
FT   NON_TER     106    106       {ECO:0000313|Ensembl:ENSP00000474318}.
SQ   SEQUENCE   106 AA;  11756 MW;  FB690A92FC318B0F CRC64;
     MRALLARLLL CVLVVSDSKG SNELHQVPSN CDCLNGGTCV SNKYFSNIHW CNCPKKFGGQ
     HCEIDKSKTC YEGNGHFYRG KASTDTMGRP CLPWNSATVL QQTYHA
//
ID   TM158_HUMAN             Reviewed;         300 AA.
AC   Q8WZ71; Q6PFW5; Q9Y4M1;
DT   01-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2012, sequence version 2.
DT   02-NOV-2016, entry version 83.
DE   RecName: Full=Transmembrane protein 158;
DE   AltName: Full=40 kDa BINP-binding protein;
DE            Short=p40BBP;
DE   AltName: Full=Ras-induced senescence protein 1;
DE   Flags: Precursor;
GN   Name=TMEM158; Synonyms=HBBP, RIS1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND INDUCTION.
RX   PubMed=11822868; DOI=10.1006/excr.2001.5434;
RA   Barradas M., Gonos E.S., Zebedee Z., Kolettas E., Petropoulou C.,
RA   Delgado M.D., Leon J., Hara E., Serrano M.;
RT   "Identification of a candidate tumor-suppressor gene specifically
RT   activated during Ras-induced senescence.";
RL   Exp. Cell Res. 273:127-137(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Hippocampus;
RA   Hama T.;
RT   "Isolation of human homologue of rat p40BBp (brain specific binding
RT   protein.";
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 151-300 (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
CC   -!- FUNCTION: Receptor for brain injury-derived neurotrophic peptide
CC       (BINP), a synthetic 13-mer peptide. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8WZ71-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8WZ71-2; Sequence=VSP_024826;
CC         Note=No experimental confirmation available.;
CC   -!- INDUCTION: Up-regulated during Ras-induced senesence.
CC       {ECO:0000269|PubMed:11822868}.
CC   -!- PTM: N-glycosylated. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the TMEM158 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF438313; AAL30845.1; -; mRNA.
DR   EMBL; AB078417; BAC05687.1; -; mRNA.
DR   EMBL; AC010170; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC057390; AAH57390.1; -; mRNA.
DR   EMBL; AL080235; CAB45781.1; -; mRNA.
DR   CCDS; CCDS54573.1; -. [Q8WZ71-1]
DR   PIR; T12547; T12547.
DR   RefSeq; NP_056259.2; NM_015444.2. [Q8WZ71-1]
DR   UniGene; Hs.740403; -.
DR   ProteinModelPortal; Q8WZ71; -.
DR   IntAct; Q8WZ71; 2.
DR   STRING; 9606.ENSP00000422431; -.
DR   PhosphoSitePlus; Q8WZ71; -.
DR   DMDM; 408360199; -.
DR   EPD; Q8WZ71; -.
DR   PaxDb; Q8WZ71; -.
DR   PRIDE; Q8WZ71; -.
DR   Ensembl; ENST00000503771; ENSP00000422431; ENSG00000249992. [Q8WZ71-1]
DR   GeneID; 25907; -.
DR   KEGG; hsa:25907; -.
DR   UCSC; uc011baf.3; human. [Q8WZ71-1]
DR   CTD; 25907; -.
DR   DisGeNET; 25907; -.
DR   GeneCards; TMEM158; -.
DR   H-InvDB; HIX0003239; -.
DR   HGNC; HGNC:30293; TMEM158.
DR   neXtProt; NX_Q8WZ71; -.
DR   OpenTargets; ENSG00000249992; -.
DR   PharmGKB; PA128395777; -.
DR   eggNOG; ENOG410IXR9; Eukaryota.
DR   eggNOG; ENOG410YHSY; LUCA.
DR   GeneTree; ENSGT00390000009719; -.
DR   HOVERGEN; HBG098266; -.
DR   InParanoid; Q8WZ71; -.
DR   OMA; STNAHGR; -.
DR   OrthoDB; EOG091G0IH2; -.
DR   PhylomeDB; Q8WZ71; -.
DR   TreeFam; TF339241; -.
DR   BioCyc; ZFISH:ENSG00000178550-MONOMER; -.
DR   ChiTaRS; TMEM158; human.
DR   GeneWiki; TMEM158; -.
DR   GenomeRNAi; 25907; -.
DR   PRO; PR:Q8WZ71; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000249992; -.
DR   CleanEx; HS_TMEM158; -.
DR   Genevisible; Q8WZ71; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042277; F:peptide binding; IEA:Ensembl.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Complete proteome; Glycoprotein; Membrane;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     20       {ECO:0000255}.
FT   CHAIN        21    300       Transmembrane protein 158.
FT                                /FTId=PRO_0000285128.
FT   TRANSMEM    231    251       Helical. {ECO:0000255}.
FT   TRANSMEM    273    293       Helical. {ECO:0000255}.
FT   COMPBIAS     67     72       Poly-Ala.
FT   COMPBIAS    165    172       Poly-Ala.
FT   COMPBIAS    263    292       Ala-rich.
FT   CARBOHYD     75     75       N-linked (GlcNAc...). {ECO:0000255}.
FT   VAR_SEQ     273    286       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_024826.
FT   CONFLICT     67     67       A -> T (in Ref. 1; AAL30845 and 2;
FT                                BAC05687). {ECO:0000305}.
SQ   SEQUENCE   300 AA;  30404 MW;  A555CC499B7FE0DC CRC64;
     MLPLLAALLA AACPLPPVRG GAADAPGLLG VPSNASVNAS SADEPIAPRL LASAAPGPPE
     RPGPEEAAAA AAPCNISVQR QMLSSLLVRW GRPRGFQCDL LLFSTNAHGR AFFAAAFHRV
     GPPLLIEHLG LAAGGAQQDL RLCVGCGWVR GRRTGRLRPA AAPSAAAATA GAPTALPAYP
     AAEPPGPLWL QGEPLHFCCL DFSLEELQGE PGWRLNRKPI ESTLVACFMT LVIVVWSVAA
     LIWPVPIIAG FLPNGMEQRR TTASTTAATP AAVPAGTTAA AAAAAAAAAA AAVTSGVATK
//
ID   A0A024R5M8_HUMAN        Unreviewed;       466 AA.
AC   A0A024R5M8;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   02-NOV-2016, entry version 16.
DE   SubName: Full=Polymerase (DNA-directed), delta 3, accessory subunit, isoform CRA_a {ECO:0000313|EMBL:EAW74943.1};
GN   Name=POLD3 {ECO:0000313|EMBL:EAW74943.1};
GN   ORFNames=hCG_27408 {ECO:0000313|EMBL:EAW74943.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW74943.1};
RN   [1] {ECO:0000313|EMBL:EAW74943.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW74943.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471076; EAW74943.1; -; Genomic_DNA.
DR   RefSeq; NP_006582.1; NM_006591.2.
DR   UniGene; Hs.82502; -.
DR   ProteinModelPortal; A0A024R5M8; -.
DR   SMR; A0A024R5M8; -.
DR   STRING; 9606.ENSP00000263681; -.
DR   PaxDb; A0A024R5M8; -.
DR   PRIDE; A0A024R5M8; -.
DR   GeneID; 10714; -.
DR   KEGG; hsa:10714; -.
DR   CTD; 10714; -.
DR   eggNOG; ENOG410IGGV; Eukaryota.
DR   eggNOG; ENOG410XSD1; LUCA.
DR   KO; K03504; -.
DR   OMA; FSAIQCA; -.
DR   OrthoDB; EOG091G11SX; -.
DR   PhylomeDB; A0A024R5M8; -.
DR   GenomeRNAi; 10714; -.
DR   ExpressionAtlas; A0A024R5M8; baseline and differential.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0006261; P:DNA-dependent DNA replication; IEA:Ensembl.
DR   InterPro; IPR019038; DNA_polymerase_subunit_Cdc27.
DR   Pfam; PF09507; CDC27; 1.
PE   4: Predicted;
SQ   SEQUENCE   466 AA;  51400 MW;  E9625E0188725F45 CRC64;
     MADQLYLENI DEFVTDQNKI VTYKWLSYTL GVHVNQAKQM LYDYVERKRK ENSGAQLHVT
     YLVSGSLIQN GHSCHKVAVV REDKLEAVKS KLAVTASIHV YSIQKAMLKD SGPLFNTDYD
     ILKSNLQNCS KFSAIQCAAA VPRAPAESSS SSKKFEQSHL HMSSETQANN ELTTNGHGPP
     ASKQVSQQPK GIMGMFASKA AAKTQETNKE TKTEAKEVTN ASAAGNKAPG KGNMMSNFFG
     KAAMNKFKVN LDSEQAVKEE KIVEQPTVSV TEPKLATPAG LKKSSKKAEP VKVLQKEKKR
     GKRVALSDDE TKETENMRKK RRRIKLPESD SSEDEVFPDS PGAYEAESPS PPPPPSPPLE
     PVPKTEPEPP SVKSSSGENK RKRKRVLKSK TYLDGEGCIV TEKVYESESC TDSEEELNMK
     TSSVHRPPAM TVKKEPREER KGPKKGTAAL GKANRQVSIT GFFQRK
//
ID   E9PM91_HUMAN            Unreviewed;       111 AA.
AC   E9PM91;
DT   05-APR-2011, integrated into UniProtKB/TrEMBL.
DT   05-APR-2011, sequence version 1.
DT   02-NOV-2016, entry version 33.
DE   SubName: Full=DNA polymerase delta subunit 3 {ECO:0000313|Ensembl:ENSP00000431239};
DE   Flags: Fragment;
GN   Name=POLD3 {ECO:0000313|Ensembl:ENSP00000431239};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000431239, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000431239, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [3] {ECO:0000313|Ensembl:ENSP00000431239}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000431239}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AP001104; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001324; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001372; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   STRING; 9606.ENSP00000263681; -.
DR   MaxQB; E9PM91; -.
DR   PaxDb; E9PM91; -.
DR   PeptideAtlas; E9PM91; -.
DR   PRIDE; E9PM91; -.
DR   Ensembl; ENST00000528481; ENSP00000431239; ENSG00000077514.
DR   UCSC; uc058fjz.1; human.
DR   HGNC; HGNC:20932; POLD3.
DR   OpenTargets; ENSG00000077514; -.
DR   eggNOG; ENOG410IGGV; Eukaryota.
DR   eggNOG; ENOG410XSD1; LUCA.
DR   GeneTree; ENSGT00390000015282; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000077514; -.
DR   ExpressionAtlas; E9PM91; baseline and differential.
DR   GO; GO:0005634; C:nucleus; IEA:InterPro.
DR   GO; GO:0006260; P:DNA replication; IEA:InterPro.
DR   InterPro; IPR019038; DNA_polymerase_subunit_Cdc27.
DR   Pfam; PF09507; CDC27; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:E9PM91,
KW   ECO:0000213|MaxQB:E9PM91, ECO:0000213|PeptideAtlas:E9PM91};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   NON_TER     111    111       {ECO:0000313|Ensembl:ENSP00000431239}.
SQ   SEQUENCE   111 AA;  12171 MW;  EA9D68EE42E16D0E CRC64;
     MLYDYVERKR KENSGAQLHV TYLVSGSLIQ NGHSCHKVAV VREDKLEAVK SKLAVTASIH
     VYSIQKAMLK DSGPLFNTDY DILKSNLQNC SKFSAIQCAA AVPRAPAESS S
//
ID   E9PNC0_HUMAN            Unreviewed;       138 AA.
AC   E9PNC0;
DT   05-APR-2011, integrated into UniProtKB/TrEMBL.
DT   05-APR-2011, sequence version 1.
DT   02-NOV-2016, entry version 33.
DE   SubName: Full=DNA polymerase delta subunit 3 {ECO:0000313|Ensembl:ENSP00000437231};
DE   Flags: Fragment;
GN   Name=POLD3 {ECO:0000313|Ensembl:ENSP00000437231};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000437231, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000437231, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [3] {ECO:0000313|Ensembl:ENSP00000437231}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000437231}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AP001104; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001324; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001372; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   STRING; 9606.ENSP00000263681; -.
DR   MaxQB; E9PNC0; -.
DR   PaxDb; E9PNC0; -.
DR   PeptideAtlas; E9PNC0; -.
DR   PRIDE; E9PNC0; -.
DR   Ensembl; ENST00000531615; ENSP00000437231; ENSG00000077514.
DR   UCSC; uc058fkd.1; human.
DR   HGNC; HGNC:20932; POLD3.
DR   OpenTargets; ENSG00000077514; -.
DR   eggNOG; ENOG410IGGV; Eukaryota.
DR   eggNOG; ENOG410XSD1; LUCA.
DR   GeneTree; ENSGT00390000015282; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000077514; -.
DR   ExpressionAtlas; E9PNC0; baseline and differential.
DR   GO; GO:0005634; C:nucleus; IEA:InterPro.
DR   GO; GO:0006260; P:DNA replication; IEA:InterPro.
DR   InterPro; IPR019038; DNA_polymerase_subunit_Cdc27.
DR   Pfam; PF09507; CDC27; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:E9PNC0,
KW   ECO:0000213|MaxQB:E9PNC0, ECO:0000213|PeptideAtlas:E9PNC0};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   NON_TER     138    138       {ECO:0000313|Ensembl:ENSP00000437231}.
SQ   SEQUENCE   138 AA;  15196 MW;  2A0816CC1EE129A6 CRC64;
     MLYDYVERKR KENSGAQLHV TYLVSGSLIQ NGHSCHKVAV VREDKLEAVK SKLAVTASIH
     VYSIQKAMLK DSGPLFNTDY DILKSNLQNC SKFSAIQCAA AVPRAPAESS SSSKKFEQSH
     LHMSSETQAN NELTTNGH
//
ID   E9PRK3_HUMAN            Unreviewed;       169 AA.
AC   E9PRK3;
DT   05-APR-2011, integrated into UniProtKB/TrEMBL.
DT   05-APR-2011, sequence version 1.
DT   02-NOV-2016, entry version 34.
DE   SubName: Full=DNA polymerase delta subunit 3 {ECO:0000313|Ensembl:ENSP00000432233};
DE   Flags: Fragment;
GN   Name=POLD3 {ECO:0000313|Ensembl:ENSP00000432233};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000432233, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000432233, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [3] {ECO:0000313|Ensembl:ENSP00000432233}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000432233}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AP001104; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001324; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001372; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   STRING; 9606.ENSP00000263681; -.
DR   MaxQB; E9PRK3; -.
DR   PaxDb; E9PRK3; -.
DR   PeptideAtlas; E9PRK3; -.
DR   PRIDE; E9PRK3; -.
DR   Ensembl; ENST00000530511; ENSP00000432233; ENSG00000077514.
DR   UCSC; uc058fkc.1; human.
DR   HGNC; HGNC:20932; POLD3.
DR   OpenTargets; ENSG00000077514; -.
DR   eggNOG; ENOG410IGGV; Eukaryota.
DR   eggNOG; ENOG410XSD1; LUCA.
DR   GeneTree; ENSGT00390000015282; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000077514; -.
DR   ExpressionAtlas; E9PRK3; baseline and differential.
DR   GO; GO:0005634; C:nucleus; IEA:InterPro.
DR   GO; GO:0006260; P:DNA replication; IEA:InterPro.
DR   InterPro; IPR019038; DNA_polymerase_subunit_Cdc27.
DR   Pfam; PF09507; CDC27; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:E9PRK3,
KW   ECO:0000213|MaxQB:E9PRK3, ECO:0000213|PeptideAtlas:E9PRK3};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   NON_TER     169    169       {ECO:0000313|Ensembl:ENSP00000432233}.
SQ   SEQUENCE   169 AA;  18368 MW;  695296F6A33223C1 CRC64;
     MLYDYVERKR KENSGAQLHV TYLVSGSLIQ NGHSCHKVAV VREDKLEAVK SKLAVTASIH
     VYSIQKAMLK DSGPLFNTDY DILKSNLQNC SKFSAIQCAA AVPRAPAESS SSSKKFEQSH
     LHMSSETQAN NELTTNGHGP PASKQVSQQP KGIMGMFASK AAAKTQETN
//
ID   H0YD46_HUMAN            Unreviewed;       149 AA.
AC   H0YD46;
DT   22-FEB-2012, integrated into UniProtKB/TrEMBL.
DT   22-FEB-2012, sequence version 1.
DT   02-NOV-2016, entry version 26.
DE   SubName: Full=DNA polymerase delta subunit 3 {ECO:0000313|Ensembl:ENSP00000432969};
DE   Flags: Fragment;
GN   Name=POLD3 {ECO:0000313|Ensembl:ENSP00000432969};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000432969, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000213|PubMed:17081983}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000432969, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [3] {ECO:0000213|PubMed:18691976}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [4] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [5] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [6] {ECO:0000213|PubMed:19369195}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [7] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [8] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [9] {ECO:0000313|Ensembl:ENSP00000432969}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2012) to UniProtKB.
RN   [10] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000432969}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AP001104; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001324; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001372; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; H0YD46; -.
DR   STRING; 9606.ENSP00000263681; -.
DR   MaxQB; H0YD46; -.
DR   PaxDb; H0YD46; -.
DR   PeptideAtlas; H0YD46; -.
DR   PRIDE; H0YD46; -.
DR   Ensembl; ENST00000524752; ENSP00000432969; ENSG00000077514.
DR   UCSC; uc058fke.1; human.
DR   HGNC; HGNC:20932; POLD3.
DR   OpenTargets; ENSG00000077514; -.
DR   eggNOG; ENOG410IGGV; Eukaryota.
DR   eggNOG; ENOG410XSD1; LUCA.
DR   GeneTree; ENSGT00390000015282; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   ExpressionAtlas; H0YD46; baseline and differential.
DR   GO; GO:0005634; C:nucleus; IEA:InterPro.
DR   GO; GO:0006260; P:DNA replication; IEA:InterPro.
DR   InterPro; IPR019038; DNA_polymerase_subunit_Cdc27.
DR   Pfam; PF09507; CDC27; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:H0YD46,
KW   ECO:0000213|MaxQB:H0YD46, ECO:0000213|PeptideAtlas:H0YD46};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   NON_TER       1      1       {ECO:0000313|Ensembl:ENSP00000432969}.
SQ   SEQUENCE   149 AA;  16792 MW;  EF41DCF4030FA421 CRC64;
     XPAGLKKSSK KAEPVKVLQK EKKRGKRVAL SDDETKETEN MRKKRRRIKL PESDSSEDEV
     FPDSPGAYEA ESPSPPPPPS PPLEPVPKTE PEPPSVKSSS GENKRKRKRV LKSKTYLDGE
     GCIVVLDMQS HSLDILEHYV EMPIQRLER
//
ID   H0YEX7_HUMAN            Unreviewed;        89 AA.
AC   H0YEX7;
DT   22-FEB-2012, integrated into UniProtKB/TrEMBL.
DT   22-FEB-2012, sequence version 1.
DT   02-NOV-2016, entry version 26.
DE   SubName: Full=DNA polymerase delta subunit 3 {ECO:0000313|Ensembl:ENSP00000436781};
DE   Flags: Fragment;
GN   Name=POLD3 {ECO:0000313|Ensembl:ENSP00000436781};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000436781, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000213|PubMed:17081983}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000436781, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [3] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [4] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5] {ECO:0000313|Ensembl:ENSP00000436781}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2012) to UniProtKB.
RN   [6] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000436781}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AP001104; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001324; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001372; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; H0YEX7; -.
DR   STRING; 9606.ENSP00000263681; -.
DR   MaxQB; H0YEX7; -.
DR   PaxDb; H0YEX7; -.
DR   PeptideAtlas; H0YEX7; -.
DR   PRIDE; H0YEX7; -.
DR   Ensembl; ENST00000532954; ENSP00000436781; ENSG00000077514.
DR   UCSC; uc058fkg.1; human.
DR   HGNC; HGNC:20932; POLD3.
DR   OpenTargets; ENSG00000077514; -.
DR   eggNOG; ENOG410IGGV; Eukaryota.
DR   eggNOG; ENOG410XSD1; LUCA.
DR   GeneTree; ENSGT00390000015282; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   ExpressionAtlas; H0YEX7; baseline and differential.
DR   GO; GO:0005634; C:nucleus; IEA:InterPro.
DR   GO; GO:0006260; P:DNA replication; IEA:InterPro.
DR   InterPro; IPR019038; DNA_polymerase_subunit_Cdc27.
DR   Pfam; PF09507; CDC27; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:H0YEX7,
KW   ECO:0000213|MaxQB:H0YEX7, ECO:0000213|PeptideAtlas:H0YEX7};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   NON_TER       1      1       {ECO:0000313|Ensembl:ENSP00000436781}.
SQ   SEQUENCE   89 AA;  10076 MW;  B72C742D7D19E1C7 CRC64;
     XNAFEDACEM EVVFWGLIAE RIVTEKVYES ESCTDSEEEL NMKTSSVHRP PAMTVKKEPR
     EERKGPKKGT AALGKANRQV SITGFFQRK
//
ID   Q05BV7_HUMAN            Unreviewed;       384 AA.
AC   Q05BV7;
DT   14-NOV-2006, integrated into UniProtKB/TrEMBL.
DT   14-NOV-2006, sequence version 1.
DT   06-JUL-2016, entry version 35.
DE   SubName: Full=POLD3 protein {ECO:0000313|EMBL:AAH32636.1};
DE   Flags: Fragment;
GN   Name=POLD3 {ECO:0000313|EMBL:AAH32636.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH32636.1};
RN   [1] {ECO:0000313|EMBL:AAH32636.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph {ECO:0000313|EMBL:AAH32636.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC032636; AAH32636.1; -; mRNA.
DR   UniGene; Hs.82502; -.
DR   STRING; 9606.ENSP00000263681; -.
DR   PaxDb; Q05BV7; -.
DR   PeptideAtlas; Q05BV7; -.
DR   PRIDE; Q05BV7; -.
DR   eggNOG; ENOG410IGGV; Eukaryota.
DR   eggNOG; ENOG410XSD1; LUCA.
DR   HOVERGEN; HBG051397; -.
DR   GO; GO:0005634; C:nucleus; IEA:InterPro.
DR   GO; GO:0006260; P:DNA replication; IEA:InterPro.
DR   InterPro; IPR019038; DNA_polymerase_subunit_Cdc27.
DR   Pfam; PF09507; CDC27; 1.
PE   2: Evidence at transcript level;
FT   NON_TER     384    384       {ECO:0000313|EMBL:AAH32636.1}.
SQ   SEQUENCE   384 AA;  42159 MW;  768DA5A0C25A5187 CRC64;
     MADQLYLENI DEFVTDQNKI VTYKWLSYTL GVHVNQAKQM LYDYVERKRK ENSGAQLHVT
     YLVSGSLIQN GHSCHKVAVV REDKLEAVKS KLAVTASIHV YSIQKAMLKD SGPLFNTDYD
     ILKSNLQNCS KFSAIQCAAA VPRAPAESSS SSKKFEQSHL HMSSETQANN ELTTNGHGPP
     ASKQVSQQPK GIMGMFASKA AAKTQETNKE TKTEAKEVTN ASAAGNKAPG KGNMMSNFFG
     KAAMNKFKVN LDSEQAVKEE KIVEQPTVSV TEPKLATPAG LKKSSKKAEP VKVLQKEKKR
     GKRVALSDDE TKETENMRKK RRRIKLPESD SSEDEVFPDS PGAYEAESPS PPPPPSPPLE
     PVPKTEPEPP SVKSSSGENK KKKK
//
ID   DPOD3_HUMAN             Reviewed;         466 AA.
AC   Q15054; B7ZAI6; Q32MZ9; Q32N00;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   26-SEP-2001, sequence version 2.
DT   02-NOV-2016, entry version 148.
DE   RecName: Full=DNA polymerase delta subunit 3;
DE   AltName: Full=DNA polymerase delta subunit p66;
GN   Name=POLD3; Synonyms=KIAA0039;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   PubMed=7584026; DOI=10.1093/dnares/1.1.27;
RA   Nomura N., Miyajima N., Sazuka T., Tanaka A., Kawarabayasi Y.,
RA   Sato S., Nagase T., Seki N., Ishikawa K., Tabata S.;
RT   "Prediction of the coding sequences of unidentified human genes. I.
RT   The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by
RT   analysis of randomly sampled cDNA clones from human immature myeloid
RT   cell line KG-1.";
RL   DNA Res. 1:27-35(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-19 AND 110-123, CLEAVAGE OF INITIATOR
RP   METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RA   Bienvenut W.V., Waridel P., Quadroni M.;
RL   Submitted (MAR-2009) to UniProtKB.
RN   [7]
RP   FUNCTION.
RX   PubMed=10219083; DOI=10.1093/nar/27.10.2108;
RA   Hughes P., Tratner I., Ducoux M., Piard K., Baldacci G.;
RT   "Isolation and identification of the third subunit of mammalian DNA
RT   polymerase delta by PCNA-affinity chromatography of mouse FM3A cell
RT   extracts.";
RL   Nucleic Acids Res. 27:2108-2114(1999).
RN   [8]
RP   FUNCTION.
RX   PubMed=10852724; DOI=10.1021/bi0000871;
RA   Mo J.-Y., Liu L., Leon A., Mazloum N., Lee M.Y.W.T.;
RT   "Evidence that DNA polymerase delta isolated by immunoaffinity
RT   chromatography exhibits high-molecular weight characteristics and is
RT   associated with the KIAA0039 protein and RPA.";
RL   Biochemistry 39:7245-7254(2000).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH PCNA.
RX   PubMed=16510448; DOI=10.1074/jbc.M600322200;
RA   Li H., Xie B., Zhou Y., Rahmeh A., Trusa S., Zhang S., Gao Y.,
RA   Lee E.Y., Lee M.Y.;
RT   "Functional roles of p12, the fourth subunit of human DNA polymerase
RT   delta.";
RL   J. Biol. Chem. 281:14748-14755(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307; SER-407; SER-409;
RP   THR-411; SER-413 AND SER-458, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-307, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-277; SER-307 AND
RP   SER-458, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-258, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [21]
RP   VARIANTS VAL-194 AND LEU-195.
RX   PubMed=21248752; DOI=10.1038/nature09639;
RA   Varela I., Tarpey P., Raine K., Huang D., Ong C.K., Stephens P.,
RA   Davies H., Jones D., Lin M.L., Teague J., Bignell G., Butler A.,
RA   Cho J., Dalgliesh G.L., Galappaththige D., Greenman C., Hardy C.,
RA   Jia M., Latimer C., Lau K.W., Marshall J., McLaren S., Menzies A.,
RA   Mudie L., Stebbings L., Largaespada D.A., Wessels L.F.A., Richard S.,
RA   Kahnoski R.J., Anema J., Tuveson D.A., Perez-Mancera P.A.,
RA   Mustonen V., Fischer A., Adams D.J., Rust A., Chan-On W., Subimerb C.,
RA   Dykema K., Furge K., Campbell P.J., Teh B.T., Stratton M.R.,
RA   Futreal P.A.;
RT   "Exome sequencing identifies frequent mutation of the SWI/SNF complex
RT   gene PBRM1 in renal carcinoma.";
RL   Nature 469:539-542(2011).
CC   -!- FUNCTION: Required for optimal DNA polymerase delta activity.
CC       {ECO:0000269|PubMed:10219083, ECO:0000269|PubMed:10852724,
CC       ECO:0000269|PubMed:16510448}.
CC   -!- SUBUNIT: Heterotetramer composed of subunits of 125 kDa, 50 kDa,
CC       66 kDa and 12 kDa. Interacts with POLD2. Interacts with PCNA.
CC       {ECO:0000269|PubMed:16510448}.
CC   -!- INTERACTION:
CC       P12004:PCNA; NbExp=5; IntAct=EBI-864956, EBI-358311;
CC       P49005:POLD2; NbExp=5; IntAct=EBI-864956, EBI-372354;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q15054-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15054-2; Sequence=VSP_054150;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q15054-3; Sequence=VSP_054149;
CC         Note=No experimental confirmation available.;
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA05039.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D26018; BAA05039.1; ALT_INIT; mRNA.
DR   EMBL; AK316301; BAH14672.1; -; mRNA.
DR   EMBL; AP001104; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001324; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001372; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471076; EAW74942.1; -; Genomic_DNA.
DR   EMBL; BC108908; AAI08909.1; -; mRNA.
DR   EMBL; BC108909; AAI08910.1; -; mRNA.
DR   CCDS; CCDS8233.1; -. [Q15054-1]
DR   RefSeq; NP_006582.1; NM_006591.2. [Q15054-1]
DR   UniGene; Hs.82502; -.
DR   PDB; 1U76; X-ray; 2.60 A; B/D/F=452-466.
DR   PDB; 2N1G; NMR; -; B=231-246.
DR   PDB; 3E0J; X-ray; 3.00 A; B/D/F/H=1-144.
DR   PDBsum; 1U76; -.
DR   PDBsum; 2N1G; -.
DR   PDBsum; 3E0J; -.
DR   ProteinModelPortal; Q15054; -.
DR   SMR; Q15054; -.
DR   BioGrid; 115940; 28.
DR   DIP; DIP-35772N; -.
DR   IntAct; Q15054; 8.
DR   MINT; MINT-2789689; -.
DR   STRING; 9606.ENSP00000263681; -.
DR   iPTMnet; Q15054; -.
DR   PhosphoSitePlus; Q15054; -.
DR   BioMuta; POLD3; -.
DR   DMDM; 17375506; -.
DR   EPD; Q15054; -.
DR   MaxQB; Q15054; -.
DR   PaxDb; Q15054; -.
DR   PeptideAtlas; Q15054; -.
DR   PRIDE; Q15054; -.
DR   Ensembl; ENST00000263681; ENSP00000263681; ENSG00000077514. [Q15054-1]
DR   Ensembl; ENST00000527458; ENSP00000432951; ENSG00000077514. [Q15054-2]
DR   Ensembl; ENST00000532497; ENSP00000436018; ENSG00000077514. [Q15054-3]
DR   GeneID; 10714; -.
DR   KEGG; hsa:10714; -.
DR   UCSC; uc001ovf.3; human. [Q15054-1]
DR   CTD; 10714; -.
DR   DisGeNET; 10714; -.
DR   GeneCards; POLD3; -.
DR   HGNC; HGNC:20932; POLD3.
DR   HPA; HPA039627; -.
DR   HPA; HPA058846; -.
DR   MIM; 611415; gene.
DR   neXtProt; NX_Q15054; -.
DR   OpenTargets; ENSG00000077514; -.
DR   PharmGKB; PA134868595; -.
DR   eggNOG; ENOG410IGGV; Eukaryota.
DR   eggNOG; ENOG410XSD1; LUCA.
DR   GeneTree; ENSGT00390000015282; -.
DR   HOGENOM; HOG000008055; -.
DR   HOVERGEN; HBG051397; -.
DR   InParanoid; Q15054; -.
DR   KO; K03504; -.
DR   OMA; FSAIQCA; -.
DR   OrthoDB; EOG091G11SX; -.
DR   PhylomeDB; Q15054; -.
DR   TreeFam; TF103006; -.
DR   BioCyc; ZFISH:ENSG00000077514-MONOMER; -.
DR   Reactome; R-HSA-110314; Recognition of DNA damage by PCNA-containing replication complex.
DR   Reactome; R-HSA-174411; Polymerase switching on the C-strand of the telomere.
DR   Reactome; R-HSA-174414; Processive synthesis on the C-strand of the telomere.
DR   Reactome; R-HSA-174417; Telomere C-strand (Lagging Strand) Synthesis.
DR   Reactome; R-HSA-174437; Removal of the Flap Intermediate from the C-strand.
DR   Reactome; R-HSA-5358565; Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha).
DR   Reactome; R-HSA-5358606; Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta).
DR   Reactome; R-HSA-5651801; PCNA-Dependent Long Patch Base Excision Repair.
DR   Reactome; R-HSA-5656169; Termination of translesion DNA synthesis.
DR   Reactome; R-HSA-5685942; HDR through Homologous Recombination (HRR).
DR   Reactome; R-HSA-5696397; Gap-filling DNA repair synthesis and ligation in GG-NER.
DR   Reactome; R-HSA-5696400; Dual Incision in GG-NER.
DR   Reactome; R-HSA-6782135; Dual incision in TC-NER.
DR   Reactome; R-HSA-6782210; Gap-filling DNA repair synthesis and ligation in TC-NER.
DR   Reactome; R-HSA-69091; Polymerase switching.
DR   Reactome; R-HSA-69166; Removal of the Flap Intermediate.
DR   Reactome; R-HSA-69183; Processive synthesis on the lagging strand.
DR   SIGNOR; Q15054; -.
DR   EvolutionaryTrace; Q15054; -.
DR   GeneWiki; POLD3; -.
DR   GenomeRNAi; 10714; -.
DR   PRO; PR:Q15054; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000077514; -.
DR   ExpressionAtlas; Q15054; baseline and differential.
DR   Genevisible; Q15054; HS.
DR   GO; GO:0043625; C:delta DNA polymerase complex; NAS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0003887; F:DNA-directed DNA polymerase activity; NAS:UniProtKB.
DR   GO; GO:0042769; P:DNA damage response, detection of DNA damage; TAS:Reactome.
DR   GO; GO:0006271; P:DNA strand elongation involved in DNA replication; TAS:Reactome.
DR   GO; GO:0000731; P:DNA synthesis involved in DNA repair; NAS:UniProtKB.
DR   GO; GO:0006298; P:mismatch repair; NAS:UniProtKB.
DR   GO; GO:0006297; P:nucleotide-excision repair, DNA gap filling; IMP:UniProtKB.
DR   GO; GO:0033683; P:nucleotide-excision repair, DNA incision; TAS:Reactome.
DR   GO; GO:0006296; P:nucleotide-excision repair, DNA incision, 5'-to lesion; TAS:Reactome.
DR   GO; GO:0000723; P:telomere maintenance; TAS:Reactome.
DR   GO; GO:0000722; P:telomere maintenance via recombination; TAS:Reactome.
DR   GO; GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome.
DR   GO; GO:0019985; P:translesion synthesis; TAS:Reactome.
DR   InterPro; IPR019038; DNA_polymerase_subunit_Cdc27.
DR   Pfam; PF09507; CDC27; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; DNA replication;
KW   DNA-directed DNA polymerase; Isopeptide bond; Nucleotidyltransferase;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transferase; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22223895,
FT                                ECO:0000269|Ref.6}.
FT   CHAIN         2    466       DNA polymerase delta subunit 3.
FT                                /FTId=PRO_0000186047.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22223895,
FT                                ECO:0000269|Ref.6}.
FT   MOD_RES     277    277       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     307    307       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     407    407       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     409    409       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     411    411       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     413    413       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     458    458       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   CROSSLNK    258    258       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447}.
FT   VAR_SEQ       1    106       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054149.
FT   VAR_SEQ       1     39       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_054150.
FT   VARIANT     194    194       G -> V (found in a renal cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:21248752}.
FT                                /FTId=VAR_064745.
FT   VARIANT     195    195       M -> L (found in a renal cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:21248752}.
FT                                /FTId=VAR_064746.
FT   HELIX         3     14       {ECO:0000244|PDB:3E0J}.
FT   TURN         15     17       {ECO:0000244|PDB:3E0J}.
FT   HELIX        23     30       {ECO:0000244|PDB:3E0J}.
FT   HELIX        34     52       {ECO:0000244|PDB:3E0J}.
FT   STRAND       58     81       {ECO:0000244|PDB:3E0J}.
FT   TURN         82     84       {ECO:0000244|PDB:3E0J}.
FT   HELIX        85     91       {ECO:0000244|PDB:3E0J}.
FT   STRAND       93    106       {ECO:0000244|PDB:3E0J}.
FT   STRAND      109    111       {ECO:0000244|PDB:3E0J}.
FT   HELIX       113    125       {ECO:0000244|PDB:3E0J}.
FT   HELIX       129    131       {ECO:0000244|PDB:3E0J}.
FT   STRAND      134    136       {ECO:0000244|PDB:3E0J}.
FT   STRAND      238    244       {ECO:0000244|PDB:2N1G}.
FT   HELIX       459    461       {ECO:0000244|PDB:1U76}.
SQ   SEQUENCE   466 AA;  51400 MW;  E9625E0188725F45 CRC64;
     MADQLYLENI DEFVTDQNKI VTYKWLSYTL GVHVNQAKQM LYDYVERKRK ENSGAQLHVT
     YLVSGSLIQN GHSCHKVAVV REDKLEAVKS KLAVTASIHV YSIQKAMLKD SGPLFNTDYD
     ILKSNLQNCS KFSAIQCAAA VPRAPAESSS SSKKFEQSHL HMSSETQANN ELTTNGHGPP
     ASKQVSQQPK GIMGMFASKA AAKTQETNKE TKTEAKEVTN ASAAGNKAPG KGNMMSNFFG
     KAAMNKFKVN LDSEQAVKEE KIVEQPTVSV TEPKLATPAG LKKSSKKAEP VKVLQKEKKR
     GKRVALSDDE TKETENMRKK RRRIKLPESD SSEDEVFPDS PGAYEAESPS PPPPPSPPLE
     PVPKTEPEPP SVKSSSGENK RKRKRVLKSK TYLDGEGCIV TEKVYESESC TDSEEELNMK
     TSSVHRPPAM TVKKEPREER KGPKKGTAAL GKANRQVSIT GFFQRK
//
ID   Q569I8_HUMAN            Unreviewed;       267 AA.
AC   Q569I8;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   05-OCT-2016, entry version 43.
DE   SubName: Full=POLD3 protein {ECO:0000313|EMBL:AAH92454.1};
DE   Flags: Fragment;
GN   Name=POLD3 {ECO:0000313|EMBL:AAH92454.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH92454.1};
RN   [1] {ECO:0000313|EMBL:AAH92454.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain {ECO:0000313|EMBL:AAH92454.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC092454; AAH92454.1; -; mRNA.
DR   UniGene; Hs.82502; -.
DR   STRING; 9606.ENSP00000263681; -.
DR   PaxDb; Q569I8; -.
DR   PeptideAtlas; Q569I8; -.
DR   eggNOG; ENOG410IGGV; Eukaryota.
DR   eggNOG; ENOG410XSD1; LUCA.
DR   HOVERGEN; HBG051397; -.
DR   GO; GO:0005634; C:nucleus; IEA:InterPro.
DR   GO; GO:0006260; P:DNA replication; IEA:InterPro.
DR   InterPro; IPR019038; DNA_polymerase_subunit_Cdc27.
DR   Pfam; PF09507; CDC27; 1.
PE   2: Evidence at transcript level;
FT   NON_TER     267    267       {ECO:0000313|EMBL:AAH92454.1}.
SQ   SEQUENCE   267 AA;  29423 MW;  87B560830041FAF7 CRC64;
     MADQLYLENI DEFVTDQNKI VTYKWLSYTL GVHVNQAKQM LYDYVERKRK ENSGAQLHVT
     YLVSGSLIQN GHSCHKVAVV REDKLEAVKS KLAVTASIHV YSIQKAMLKD SGPLFNTDYD
     ILKSNLQNCS KFSAIQCAAA VPRAPAESSS SSKKFEQSHL HMSSETQANN ELTTNGHGPP
     ASKQVSQQPK GIMGMFASKA AAKTQETNKE TKTEAKEVTN ASAAGNKAPG KGNMMSNFFG
     KAAMNKFKVN LDSEQAVKKK KKKKKKK
//
ID   Q8WUF6_HUMAN            Unreviewed;       168 AA.
AC   Q8WUF6;
DT   01-MAR-2002, integrated into UniProtKB/TrEMBL.
DT   01-MAR-2002, sequence version 1.
DT   06-JUL-2016, entry version 52.
DE   SubName: Full=POLD3 protein {ECO:0000313|EMBL:AAH20587.1};
DE   Flags: Fragment;
GN   Name=POLD3 {ECO:0000313|EMBL:AAH20587.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH20587.1};
RN   [1] {ECO:0000313|EMBL:AAH20587.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Duodenum {ECO:0000313|EMBL:AAH20587.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC020587; AAH20587.1; -; mRNA.
DR   UniGene; Hs.82502; -.
DR   STRING; 9606.ENSP00000263681; -.
DR   PaxDb; Q8WUF6; -.
DR   PeptideAtlas; Q8WUF6; -.
DR   eggNOG; ENOG410IGGV; Eukaryota.
DR   eggNOG; ENOG410XSD1; LUCA.
DR   HOVERGEN; HBG102848; -.
DR   GO; GO:0005634; C:nucleus; IEA:InterPro.
DR   GO; GO:0006260; P:DNA replication; IEA:InterPro.
DR   InterPro; IPR019038; DNA_polymerase_subunit_Cdc27.
DR   Pfam; PF09507; CDC27; 1.
PE   2: Evidence at transcript level;
FT   NON_TER       1      1       {ECO:0000313|EMBL:AAH20587.1}.
SQ   SEQUENCE   168 AA;  18791 MW;  05E9103C605AED2B CRC64;
     NRGKRVALSD DEIKETENMR KKRRRIKLPE SDSSEDEVFP DSPGAYEAES PSPPPPPSPP
     LEPVPKTEPE PPSVKSSSGE NKRKRKRVLK SKTYLDGEGC IVTEKVYESE SCTDSEEELN
     MKTSSVHRPP AMTVKKEPRE ERKGPKKGTA ALGKANRQVS ITGFFQRK
//
ID   CXCL3_HUMAN             Reviewed;         107 AA.
AC   P19876; Q4W5H9;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1991, sequence version 1.
DT   02-NOV-2016, entry version 150.
DE   RecName: Full=C-X-C motif chemokine 3;
DE   AltName: Full=GRO-gamma(1-73);
DE   AltName: Full=Growth-regulated protein gamma;
DE            Short=GRO-gamma;
DE   AltName: Full=Macrophage inflammatory protein 2-beta;
DE            Short=MIP2-beta;
DE   Contains:
DE     RecName: Full=GRO-gamma(5-73);
DE   Flags: Precursor;
GN   Name=CXCL3; Synonyms=GRO3, GROG, SCYB3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Histiocytic lymphoma;
RX   PubMed=2201751; DOI=10.1084/jem.172.3.911;
RA   Tekamp-Olson P., Gallegos C., Bauer D., McClain J., Sherry B.,
RA   Fabre M., van Deventer S., Cerami A.;
RT   "Cloning and characterization of cDNAs for murine macrophage
RT   inflammatory protein 2 and its human homologues.";
RL   J. Exp. Med. 172:911-919(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2217207; DOI=10.1073/pnas.87.19.7732;
RA   Haskill S., Peace A., Morris J., Sporn S.A., Anisowicz A., Lee S.W.,
RA   Smith T., Martin G., Ralph P., Sager R.;
RT   "Identification of three related human GRO genes encoding cytokine
RT   functions.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:7732-7736(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 35-49.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally
RT   verified cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 39-45, IDENTIFICATION OF GRO-GAMMA(5-73),
RP   PROTEOLYTIC PROCESSING OF N-TERMINUS, AND FUNCTION.
RC   TISSUE=Peripheral blood monocyte;
RX   PubMed=10095777; DOI=10.1046/j.1432-1327.1999.00166.x;
RA   Wuyts A., Govaerts C., Struyf S., Lenaerts J.-P., Put W., Conings R.,
RA   Proost P., Van Damme J.;
RT   "Isolation of the CXC chemokines ENA-78, GRO alpha and GRO gamma from
RT   tumor cells and leukocytes reveals NH2-terminal heterogeneity.
RT   Functional comparison of different natural isoforms.";
RL   Eur. J. Biochem. 260:421-429(1999).
CC   -!- FUNCTION: Ligand for CXCR2 (By similarity). Has chemotactic
CC       activity for neutrophils. May play a role in inflammation and
CC       exert its effects on endothelial cells in an autocrine fashion. In
CC       vitro, the processed form GRO-gamma(5-73) shows a fivefold higher
CC       chemotactic activity for neutrophilic granulocytes. {ECO:0000250,
CC       ECO:0000269|PubMed:10095777}.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- PTM: N-terminal processed form GRO-gamma(5-73) is produced by
CC       proteolytic cleavage after secretion from peripheral blood
CC       monocytes. {ECO:0000269|PubMed:10095777}.
CC   -!- SIMILARITY: Belongs to the intercrine alpha (chemokine CxC)
CC       family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=CXCL3 entry;
CC       URL="https://en.wikipedia.org/wiki/CXCL3";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X53800; CAA37809.1; -; mRNA.
DR   EMBL; M36821; AAA63184.1; -; mRNA.
DR   EMBL; AC097709; AAY41006.1; -; Genomic_DNA.
DR   EMBL; CH471057; EAX05698.1; -; Genomic_DNA.
DR   EMBL; BC016308; AAH16308.1; -; mRNA.
DR   EMBL; BC065743; AAH65743.1; -; mRNA.
DR   CCDS; CCDS34007.1; -.
DR   PIR; JH0282; B38290.
DR   RefSeq; NP_002081.2; NM_002090.2.
DR   UniGene; Hs.89690; -.
DR   ProteinModelPortal; P19876; -.
DR   SMR; P19876; -.
DR   DIP; DIP-5909N; -.
DR   STRING; 9606.ENSP00000296026; -.
DR   BioMuta; CXCL3; -.
DR   DMDM; 127086; -.
DR   PaxDb; P19876; -.
DR   PeptideAtlas; P19876; -.
DR   PRIDE; P19876; -.
DR   DNASU; 2921; -.
DR   Ensembl; ENST00000296026; ENSP00000296026; ENSG00000163734.
DR   GeneID; 2921; -.
DR   KEGG; hsa:2921; -.
DR   UCSC; uc003hhl.5; human.
DR   CTD; 2921; -.
DR   DisGeNET; 2921; -.
DR   GeneCards; CXCL3; -.
DR   HGNC; HGNC:4604; CXCL3.
DR   MIM; 139111; gene.
DR   neXtProt; NX_P19876; -.
DR   OpenTargets; ENSG00000163734; -.
DR   PharmGKB; PA35052; -.
DR   eggNOG; ENOG410J3WE; Eukaryota.
DR   eggNOG; ENOG410ZT1C; LUCA.
DR   GeneTree; ENSGT00530000062901; -.
DR   HOGENOM; HOG000220915; -.
DR   HOVERGEN; HBG107789; -.
DR   InParanoid; P19876; -.
DR   KO; K05505; -.
DR   OMA; NGKKACL; -.
DR   OrthoDB; EOG091G14TE; -.
DR   PhylomeDB; P19876; -.
DR   TreeFam; TF333433; -.
DR   BioCyc; ZFISH:ENSG00000163734-MONOMER; -.
DR   Reactome; R-HSA-380108; Chemokine receptors bind chemokines.
DR   Reactome; R-HSA-418594; G alpha (i) signalling events.
DR   GeneWiki; CXCL3; -.
DR   GenomeRNAi; 2921; -.
DR   PRO; PR:P19876; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000163734; -.
DR   CleanEx; HS_CXCL3; -.
DR   Genevisible; P19876; HS.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0008009; F:chemokine activity; ISS:UniProtKB.
DR   GO; GO:0045236; F:CXCR chemokine receptor binding; IBA:GO_Central.
DR   GO; GO:0070098; P:chemokine-mediated signaling pathway; IBA:GO_Central.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0006955; P:immune response; IBA:GO_Central.
DR   GO; GO:0006954; P:inflammatory response; IBA:GO_Central.
DR   GO; GO:0030593; P:neutrophil chemotaxis; ISS:UniProtKB.
DR   GO; GO:0090023; P:positive regulation of neutrophil chemotaxis; IBA:GO_Central.
DR   GO; GO:0042127; P:regulation of cell proliferation; IBA:GO_Central.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IBA:GO_Central.
DR   InterPro; IPR001089; Chemokine_CXC.
DR   InterPro; IPR018048; Chemokine_CXC_CS.
DR   InterPro; IPR001811; Chemokine_IL8-like_dom.
DR   PANTHER; PTHR10179; PTHR10179; 1.
DR   Pfam; PF00048; IL8; 1.
DR   PRINTS; PR00437; SMALLCYTKCXC.
DR   SMART; SM00199; SCY; 1.
DR   SUPFAM; SSF54117; SSF54117; 1.
DR   PROSITE; PS00471; SMALL_CYTOKINES_CXC; 1.
PE   1: Evidence at protein level;
KW   Chemotaxis; Complete proteome; Cytokine; Direct protein sequencing;
KW   Disulfide bond; Inflammatory response; Polymorphism;
KW   Reference proteome; Secreted; Signal.
FT   SIGNAL        1     34       {ECO:0000269|PubMed:15340161}.
FT   CHAIN        35    107       C-X-C motif chemokine 3.
FT                                /FTId=PRO_0000005065.
FT   CHAIN        39    107       GRO-gamma(5-73).
FT                                /FTId=PRO_0000005066.
FT   DISULFID     43     69       {ECO:0000250}.
FT   DISULFID     45     85       {ECO:0000250}.
FT   VARIANT       3      3       H -> R (in dbSNP:rs352043).
FT                                /FTId=VAR_059210.
FT   CONFLICT     27     28       AA -> G (in Ref. 2; AAA63184).
FT                                {ECO:0000305}.
SQ   SEQUENCE   107 AA;  11342 MW;  97A69946B7F1F070 CRC64;
     MAHATLSAAP SNPRLLRVAL LLLLLVAASR RAAGASVVTE LRCQCLQTLQ GIHLKNIQSV
     NVRSPGPHCA QTEVIATLKN GKKACLNPAS PMVQKIIEKI LNKGSTN
//
ID   C0STK4_HUMAN            Unreviewed;        40 AA.
AC   C0STK4;
DT   26-MAY-2009, integrated into UniProtKB/TrEMBL.
DT   26-MAY-2009, sequence version 1.
DT   07-SEP-2016, entry version 43.
DE   SubName: Full=CD44 molecule {ECO:0000313|EMBL:BAH30705.1};
DE   Flags: Fragment;
GN   Name=CD44 {ECO:0000313|EMBL:BAH30705.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH30705.1};
RN   [1] {ECO:0000313|EMBL:BAH30705.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Suga T., Ishikawa A., Otsuka Y., Imai T.;
RT   "Identification of novel polymorphisms in CD44 gene.";
RL   Submitted (SEP-2008) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB462491; BAH30705.1; -; Genomic_DNA.
DR   UniGene; Hs.502328; -.
DR   ProteinModelPortal; C0STK4; -.
DR   STRING; 9606.ENSP00000398632; -.
DR   PaxDb; C0STK4; -.
DR   PeptideAtlas; C0STK4; -.
DR   eggNOG; ENOG410IZCP; Eukaryota.
DR   eggNOG; ENOG4111S6T; LUCA.
DR   ChiTaRS; CD44; human.
DR   Bgee; ENSG00000026508; -.
DR   GO; GO:0005540; F:hyaluronic acid binding; IEA:InterPro.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR016186; C-type_lectin-like.
DR   InterPro; IPR016187; C-type_lectin_fold.
DR   InterPro; IPR000538; Link_dom.
DR   Pfam; PF00193; Xlink; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS50963; LINK_2; 1.
PE   4: Predicted;
FT   DOMAIN        1     38       Link. {ECO:0000259|PROSITE:PS50963}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:BAH30705.1}.
FT   NON_TER      40     40       {ECO:0000313|EMBL:BAH30705.1}.
SQ   SEQUENCE   40 AA;  4372 MW;  FFF309733B615141 CRC64;
     EGHVVIPRIH PNSICAANNT GVYILTSNTS QYDTYCFNAS
//
ID   C1PHC2_HUMAN            Unreviewed;        42 AA.
AC   C1PHC2;
DT   16-JUN-2009, integrated into UniProtKB/TrEMBL.
DT   16-JUN-2009, sequence version 1.
DT   06-JUL-2016, entry version 25.
DE   SubName: Full=CD44 molecule {ECO:0000313|EMBL:BAH57527.1};
DE   Flags: Fragment;
GN   Name=CD44 {ECO:0000313|EMBL:BAH57527.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH57527.1};
RN   [1] {ECO:0000313|EMBL:BAH57527.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Suga T., Ishikawa A., Otsuka Y., Imai T.;
RT   "Identification of polymorphisms in CD44 gene.";
RL   Submitted (OCT-2008) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB468969; BAH57527.1; -; Genomic_DNA.
DR   UniGene; Hs.502328; -.
DR   STRING; 9606.ENSP00000398632; -.
DR   PaxDb; C1PHC2; -.
DR   PeptideAtlas; C1PHC2; -.
DR   eggNOG; ENOG410IZCP; Eukaryota.
DR   eggNOG; ENOG4111S6T; LUCA.
DR   ChiTaRS; CD44; human.
PE   4: Predicted;
FT   NON_TER       1      1       {ECO:0000313|EMBL:BAH57527.1}.
FT   NON_TER      42     42       {ECO:0000313|EMBL:BAH57527.1}.
SQ   SEQUENCE   42 AA;  4796 MW;  A1BA343826EEBF87 CRC64;
     QATPSSTTEE TATQKEQWFG NRWHEGYRQT PREDSHSTTG TA
//
ID   C1PHC3_HUMAN            Unreviewed;        45 AA.
AC   C1PHC3;
DT   16-JUN-2009, integrated into UniProtKB/TrEMBL.
DT   16-JUN-2009, sequence version 1.
DT   07-SEP-2016, entry version 42.
DE   SubName: Full=CD44 molecule {ECO:0000313|EMBL:BAH57528.1};
DE   Flags: Fragment;
GN   Name=CD44 {ECO:0000313|EMBL:BAH57528.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH57528.1};
RN   [1] {ECO:0000313|EMBL:BAH57528.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Suga T., Ishikawa A., Otsuka Y., Imai T.;
RT   "Identification of polymorphisms in CD44 gene.";
RL   Submitted (OCT-2008) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB469006; BAH57528.1; -; Genomic_DNA.
DR   UniGene; Hs.502328; -.
DR   ProteinModelPortal; C1PHC3; -.
DR   STRING; 9606.ENSP00000398632; -.
DR   PaxDb; C1PHC3; -.
DR   PeptideAtlas; C1PHC3; -.
DR   eggNOG; ENOG410IZCP; Eukaryota.
DR   eggNOG; ENOG4111S6T; LUCA.
DR   HOGENOM; HOG000231746; -.
DR   ChiTaRS; CD44; human.
DR   Bgee; ENSG00000026508; -.
DR   GO; GO:0005540; F:hyaluronic acid binding; IEA:InterPro.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR016186; C-type_lectin-like.
DR   InterPro; IPR016187; C-type_lectin_fold.
DR   InterPro; IPR000538; Link_dom.
DR   Pfam; PF00193; Xlink; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS50963; LINK_2; 1.
PE   4: Predicted;
FT   DOMAIN        9     45       Link. {ECO:0000259|PROSITE:PS50963}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:BAH57528.1}.
FT   NON_TER      45     45       {ECO:0000313|EMBL:BAH57528.1}.
SQ   SEQUENCE   45 AA;  5051 MW;  C50D54284EF63A38 CRC64;
     LNITCRFAGV FHVEKNGRYS ISRTEAADLC KAFNSTLPTM AQMEK
//
ID   C1PHC4_HUMAN            Unreviewed;        44 AA.
AC   C1PHC4;
DT   16-JUN-2009, integrated into UniProtKB/TrEMBL.
DT   16-JUN-2009, sequence version 1.
DT   07-SEP-2016, entry version 44.
DE   SubName: Full=CD44 molecule {ECO:0000313|EMBL:BAH57857.1};
DE   Flags: Fragment;
GN   Name=CD44 {ECO:0000313|EMBL:BAH57857.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH57857.1};
RN   [1] {ECO:0000313|EMBL:BAH57857.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Suga T., Ishikawa A., Otsuka Y., Imai T.;
RT   "Identification of polymorphisms in CD44 gene.";
RL   Submitted (OCT-2008) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB469162; BAH57857.1; -; Genomic_DNA.
DR   UniGene; Hs.502328; -.
DR   ProteinModelPortal; C1PHC4; -.
DR   STRING; 9606.ENSP00000398632; -.
DR   PaxDb; C1PHC4; -.
DR   PeptideAtlas; C1PHC4; -.
DR   eggNOG; ENOG410IZCP; Eukaryota.
DR   eggNOG; ENOG4111S6T; LUCA.
DR   ChiTaRS; CD44; human.
DR   Bgee; ENSG00000026508; -.
DR   GO; GO:0005540; F:hyaluronic acid binding; IEA:InterPro.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR016186; C-type_lectin-like.
DR   InterPro; IPR016187; C-type_lectin_fold.
DR   InterPro; IPR000538; Link_dom.
DR   Pfam; PF00193; Xlink; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS50963; LINK_2; 1.
PE   4: Predicted;
FT   DOMAIN        1     42       Link. {ECO:0000259|PROSITE:PS50963}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:BAH57857.1}.
FT   NON_TER      44     44       {ECO:0000313|EMBL:BAH57857.1}.
SQ   SEQUENCE   44 AA;  4852 MW;  A02AC5F80533FC41 CRC64;
     YGFIEGHVVI PRIHPNSICA ANNTGVYILT SNTSQYDTYC FNAS
//
ID   C1PHE6_HUMAN            Unreviewed;        29 AA.
AC   C1PHE6;
DT   16-JUN-2009, integrated into UniProtKB/TrEMBL.
DT   16-JUN-2009, sequence version 1.
DT   07-SEP-2016, entry version 35.
DE   SubName: Full=CD44 molecule {ECO:0000313|EMBL:BAH57879.1};
DE   Flags: Fragment;
GN   Name=CD44 {ECO:0000313|EMBL:BAH57879.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH57879.1};
RN   [1] {ECO:0000313|EMBL:BAH57879.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Suga T., Ishikawa A., Otsuka Y., Imai T.;
RT   "Identification of polymorphisms in CD44 gene.";
RL   Submitted (OCT-2008) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB469191; BAH57879.1; -; Genomic_DNA.
DR   UniGene; Hs.502328; -.
DR   STRING; 9606.ENSP00000398632; -.
DR   PaxDb; C1PHE6; -.
DR   eggNOG; ENOG410IZCP; Eukaryota.
DR   eggNOG; ENOG4111S6T; LUCA.
DR   ChiTaRS; CD44; human.
DR   Bgee; ENSG00000026508; -.
PE   4: Predicted;
FT   NON_TER       1      1       {ECO:0000313|EMBL:BAH57879.1}.
FT   NON_TER      29     29       {ECO:0000313|EMBL:BAH57879.1}.
SQ   SEQUENCE   29 AA;  3388 MW;  18BF3F6DE88C18B6 CRC64;
     VDRNGTTAYE GNWNPEAHPP LIHHEHHEE
//
ID   E9PKC6_HUMAN            Unreviewed;        78 AA.
AC   E9PKC6;
DT   05-APR-2011, integrated into UniProtKB/TrEMBL.
DT   05-APR-2011, sequence version 1.
DT   02-NOV-2016, entry version 38.
DE   SubName: Full=CD44 antigen {ECO:0000313|Ensembl:ENSP00000435377};
GN   Name=CD44 {ECO:0000313|Ensembl:ENSP00000435377};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000435377, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000435377, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [4] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5] {ECO:0000313|Ensembl:ENSP00000435377}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [6] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000435377}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL133330; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136989; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356215; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; E9PKC6; -.
DR   STRING; 9606.ENSP00000398632; -.
DR   MaxQB; E9PKC6; -.
DR   PaxDb; E9PKC6; -.
DR   PeptideAtlas; E9PKC6; -.
DR   PRIDE; E9PKC6; -.
DR   Ensembl; ENST00000526025; ENSP00000435377; ENSG00000026508.
DR   UCSC; uc058aik.1; human.
DR   HGNC; HGNC:1681; CD44.
DR   OpenTargets; ENSG00000026508; -.
DR   eggNOG; ENOG410IZCP; Eukaryota.
DR   eggNOG; ENOG4111S6T; LUCA.
DR   GeneTree; ENSGT00530000063822; -.
DR   ChiTaRS; CD44; human.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000026508; -.
DR   ExpressionAtlas; E9PKC6; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:InterPro.
DR   GO; GO:0005540; F:hyaluronic acid binding; IEA:InterPro.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR016186; C-type_lectin-like.
DR   InterPro; IPR016187; C-type_lectin_fold.
DR   InterPro; IPR001231; CD44_antigen.
DR   InterPro; IPR000538; Link_dom.
DR   Pfam; PF00193; Xlink; 1.
DR   PRINTS; PR00658; CD44.
DR   SMART; SM00445; LINK; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS50963; LINK_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:E9PKC6,
KW   ECO:0000213|MaxQB:E9PKC6, ECO:0000213|PeptideAtlas:E9PKC6};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     20       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        21     78       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5003245107.
FT   DOMAIN       32     78       Link. {ECO:0000259|PROSITE:PS50963}.
SQ   SEQUENCE   78 AA;  8812 MW;  47F418A5EB56939D CRC64;
     MDKFWWHAAW GLCLVPLSLA QIDLNITCRF AGVFHVEKNG RYSISRTEAA DLCKAFNSTL
     PTMAQMEKAL SIGFETCR
//
ID   H0Y2P0_HUMAN            Unreviewed;       287 AA.
AC   H0Y2P0;
DT   22-FEB-2012, integrated into UniProtKB/TrEMBL.
DT   22-FEB-2012, sequence version 1.
DT   02-NOV-2016, entry version 33.
DE   SubName: Full=CD44 antigen {ECO:0000313|Ensembl:ENSP00000279452};
DE   Flags: Fragment;
GN   Name=CD44 {ECO:0000313|Ensembl:ENSP00000279452};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000279452, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000213|PubMed:17081983}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000279452, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [3] {ECO:0000213|PubMed:19367720}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using
RT   sequential IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [4] {ECO:0000213|PubMed:18691976}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [5] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [7] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [8] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [10] {ECO:0000313|Ensembl:ENSP00000279452}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2012) to UniProtKB.
RN   [11] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000279452}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL133330; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136989; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356215; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; H0Y2P0; -.
DR   STRING; 9606.ENSP00000398632; -.
DR   MaxQB; H0Y2P0; -.
DR   PaxDb; H0Y2P0; -.
DR   PeptideAtlas; H0Y2P0; -.
DR   PRIDE; H0Y2P0; -.
DR   Ensembl; ENST00000279452; ENSP00000279452; ENSG00000026508.
DR   UCSC; uc058air.1; human.
DR   HGNC; HGNC:1681; CD44.
DR   OpenTargets; ENSG00000026508; -.
DR   eggNOG; ENOG410IZCP; Eukaryota.
DR   eggNOG; ENOG4111S6T; LUCA.
DR   GeneTree; ENSGT00530000063822; -.
DR   ChiTaRS; CD44; human.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000026508; -.
DR   ExpressionAtlas; H0Y2P0; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005540; F:hyaluronic acid binding; IEA:InterPro.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR016186; C-type_lectin-like.
DR   InterPro; IPR016187; C-type_lectin_fold.
DR   InterPro; IPR001231; CD44_antigen.
DR   InterPro; IPR000538; Link_dom.
DR   Pfam; PF00193; Xlink; 1.
DR   PRINTS; PR00658; CD44.
DR   PRINTS; PR01265; LINKMODULE.
DR   SMART; SM00445; LINK; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS01241; LINK_1; 1.
DR   PROSITE; PS50963; LINK_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|EPD:H0Y2P0,
KW   ECO:0000213|MaxQB:H0Y2P0, ECO:0000213|PeptideAtlas:H0Y2P0};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    198    219       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN        1     80       Link. {ECO:0000259|PROSITE:PS50963}.
FT   NON_TER       1      1       {ECO:0000313|Ensembl:ENSP00000279452}.
FT   NON_TER     287    287       {ECO:0000313|Ensembl:ENSP00000279452}.
SQ   SEQUENCE   287 AA;  30952 MW;  85A18A5EB11AEFBC CRC64;
     RYSISRTEAA DLCKAFNSTL PTMAQMEKAL SIGFETCRYG FIEGHVVIPR IHPNSICAAN
     NTGVYILTSN TSQYDTYCFN ASAPPEEDCT SVTDLPNAFD GPITITIVNR DGTRYVQKGE
     YRTNPEDIYP SNPTDDDVSS GSSSERSSTS GGDQDTFHPS GGSHTTHGSE SDGHSHGSQE
     GGANTTSGPI RTPQIPEWLI ILASLLALAL ILAVCIAVNS RRRCGQKKKL VINSGNGAVE
     DRKPSGLNGE ASKSQEMVHL VNKESSETPD QFMTADETRN LQNVDMK
//
ID   H0Y5E4_HUMAN            Unreviewed;       294 AA.
AC   H0Y5E4;
DT   22-FEB-2012, integrated into UniProtKB/TrEMBL.
DT   22-FEB-2012, sequence version 1.
DT   02-NOV-2016, entry version 32.
DE   SubName: Full=CD44 antigen {ECO:0000313|Ensembl:ENSP00000398099};
DE   Flags: Fragment;
GN   Name=CD44 {ECO:0000313|Ensembl:ENSP00000398099};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000398099, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000398099, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [4] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5] {ECO:0000313|Ensembl:ENSP00000398099}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2012) to UniProtKB.
RN   [6] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000398099}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL133330; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136989; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356215; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; H0Y5E4; -.
DR   STRING; 9606.ENSP00000398632; -.
DR   MaxQB; H0Y5E4; -.
DR   PaxDb; H0Y5E4; -.
DR   PeptideAtlas; H0Y5E4; -.
DR   PRIDE; H0Y5E4; -.
DR   Ensembl; ENST00000442151; ENSP00000398099; ENSG00000026508.
DR   UCSC; uc058aio.1; human.
DR   HGNC; HGNC:1681; CD44.
DR   OpenTargets; ENSG00000026508; -.
DR   eggNOG; ENOG410IZCP; Eukaryota.
DR   eggNOG; ENOG4111S6T; LUCA.
DR   GeneTree; ENSGT00530000063822; -.
DR   ChiTaRS; CD44; human.
DR   Proteomes; UP000005640; Chromosome 11.
DR   ExpressionAtlas; H0Y5E4; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005540; F:hyaluronic acid binding; IEA:InterPro.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR016186; C-type_lectin-like.
DR   InterPro; IPR016187; C-type_lectin_fold.
DR   InterPro; IPR001231; CD44_antigen.
DR   InterPro; IPR000538; Link_dom.
DR   Pfam; PF00193; Xlink; 1.
DR   PRINTS; PR00658; CD44.
DR   PRINTS; PR01265; LINKMODULE.
DR   SMART; SM00445; LINK; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS01241; LINK_1; 1.
DR   PROSITE; PS50963; LINK_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|EPD:H0Y5E4,
KW   ECO:0000213|MaxQB:H0Y5E4, ECO:0000213|PeptideAtlas:H0Y5E4};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     20       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        21    294       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5003546039.
FT   TRANSMEM    269    289       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       32    120       Link. {ECO:0000259|PROSITE:PS50963}.
FT   NON_TER       1      1       {ECO:0000313|Ensembl:ENSP00000398099}.
SQ   SEQUENCE   294 AA;  32055 MW;  B5052B38FF104ECC CRC64;
     XDKFWWHAAW GLCLVPLSLA QIDLNITCRF AGVFHVEKNG RYSISRTEAA DLCKAFNSTL
     PTMAQMEKAL SIGFETCRYG FIEGHVVIPR IHPNSICAAN NTGVYILTSN TSQYDTYCFN
     ASAPPEEDCT SVTDLPNAFD GPITITIVNR DGTRYVQKGE YRTNPEDIYP SNPTDDDVSS
     GSSSERSSTS GGYIFYTFST VHPIPDEDSP WITDSTDRIP ATRDQDTFHP SGGSHTTHGS
     ESDGHSHGSQ EGGANTTSGP IRTPQIPEWL IILASLLALA LILAVCIAVN SRRS
//
ID   H0YCL4_HUMAN            Unreviewed;       195 AA.
AC   H0YCL4;
DT   22-FEB-2012, integrated into UniProtKB/TrEMBL.
DT   22-FEB-2012, sequence version 1.
DT   02-NOV-2016, entry version 26.
DE   SubName: Full=CD44 antigen {ECO:0000313|Ensembl:ENSP00000431860};
DE   Flags: Fragment;
GN   Name=CD44 {ECO:0000313|Ensembl:ENSP00000431860};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000431860, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000431860, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000431860}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2012) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000431860}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL133330; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136989; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356215; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; H0YCL4; -.
DR   MaxQB; H0YCL4; -.
DR   PeptideAtlas; H0YCL4; -.
DR   Ensembl; ENST00000528672; ENSP00000431860; ENSG00000026508.
DR   UCSC; uc058ajk.1; human.
DR   HGNC; HGNC:1681; CD44.
DR   OpenTargets; ENSG00000026508; -.
DR   GeneTree; ENSGT00530000063822; -.
DR   ChiTaRS; CD44; human.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000026508; -.
DR   ExpressionAtlas; H0YCL4; baseline and differential.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|MaxQB:H0YCL4,
KW   ECO:0000213|PeptideAtlas:H0YCL4};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   NON_TER       1      1       {ECO:0000313|Ensembl:ENSP00000431860}.
FT   NON_TER     195    195       {ECO:0000313|Ensembl:ENSP00000431860}.
SQ   SEQUENCE   195 AA;  21500 MW;  FDBE67E0A2D953A5 CRC64;
     RNGTTAYEGN WNPEAHPPLI HHEHHEEEET PHSTSTIQAT PSSTTEETAT QKEQWFGNRW
     HEGYRQTPKE DSHSTTGTAD MDSSHSITLQ PTANPNTGLV EDLDRTGPLS MTTQQSNSQS
     FSTSHEGLEE DKDHPTTSTL TSSNRNDVTG GRRDPNHSEG STTLLEGYTS HYPHTKESRT
     FIPVTSAKTG SFGVT
//
ID   H0YCV9_HUMAN            Unreviewed;       249 AA.
AC   H0YCV9;
DT   22-FEB-2012, integrated into UniProtKB/TrEMBL.
DT   22-FEB-2012, sequence version 1.
DT   02-NOV-2016, entry version 33.
DE   SubName: Full=CD44 antigen {ECO:0000313|Ensembl:ENSP00000432405};
DE   Flags: Fragment;
GN   Name=CD44 {ECO:0000313|Ensembl:ENSP00000432405};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000432405, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000432405, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [4] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5] {ECO:0000313|Ensembl:ENSP00000432405}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2012) to UniProtKB.
RN   [6] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000432405}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL133330; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136989; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356215; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; H0YCV9; -.
DR   SMR; H0YCV9; -.
DR   STRING; 9606.ENSP00000398632; -.
DR   MaxQB; H0YCV9; -.
DR   PaxDb; H0YCV9; -.
DR   PeptideAtlas; H0YCV9; -.
DR   PRIDE; H0YCV9; -.
DR   Ensembl; ENST00000525211; ENSP00000432405; ENSG00000026508.
DR   UCSC; uc058aip.1; human.
DR   HGNC; HGNC:1681; CD44.
DR   OpenTargets; ENSG00000026508; -.
DR   eggNOG; ENOG410IZCP; Eukaryota.
DR   eggNOG; ENOG4111S6T; LUCA.
DR   GeneTree; ENSGT00530000063822; -.
DR   ChiTaRS; CD44; human.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000026508; -.
DR   ExpressionAtlas; H0YCV9; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:InterPro.
DR   GO; GO:0005540; F:hyaluronic acid binding; IEA:InterPro.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR016186; C-type_lectin-like.
DR   InterPro; IPR016187; C-type_lectin_fold.
DR   InterPro; IPR001231; CD44_antigen.
DR   InterPro; IPR000538; Link_dom.
DR   Pfam; PF00193; Xlink; 1.
DR   PRINTS; PR00658; CD44.
DR   PRINTS; PR01265; LINKMODULE.
DR   SMART; SM00445; LINK; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS01241; LINK_1; 1.
DR   PROSITE; PS50963; LINK_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:H0YCV9,
KW   ECO:0000213|MaxQB:H0YCV9, ECO:0000213|PeptideAtlas:H0YCV9};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN       11     99       Link. {ECO:0000259|PROSITE:PS50963}.
FT   NON_TER       1      1       {ECO:0000313|Ensembl:ENSP00000432405}.
FT   NON_TER     249    249       {ECO:0000313|Ensembl:ENSP00000432405}.
SQ   SEQUENCE   249 AA;  27326 MW;  10C5708E674C167B CRC64;
     IDLNITCRFA GVFHVEKNGR YSISRTEAAD LCKAFNSTLP TMAQMEKALS IGFETCRYGF
     IEGHVVIPRI HPNSICAANN TGVYILTSNT SQYDTYCFNA SAPPEEDCTS VTDLPNAFDG
     PITITIVNRD GTRYVQKGEY RTNPEDIYPS NPTDDDVSSG SSSERSSTSG GYIFYTFSTV
     HPIPDEDSPW ITDSTDRIPA TTASAHTSHP MQGRTTPSPE DSSWTDFFNP ISHPMGRGHQ
     AGRRMGNSL
//
ID   H0YD13_HUMAN            Unreviewed;       206 AA.
AC   H0YD13;
DT   22-FEB-2012, integrated into UniProtKB/TrEMBL.
DT   18-SEP-2013, sequence version 2.
DT   02-NOV-2016, entry version 36.
DE   SubName: Full=CD44 antigen {ECO:0000313|Ensembl:ENSP00000432704};
GN   Name=CD44 {ECO:0000313|Ensembl:ENSP00000432704};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000432704, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000213|PubMed:17081983}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000432704, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [3] {ECO:0000213|PubMed:19367720}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using
RT   sequential IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [4] {ECO:0000213|PubMed:18691976}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [5] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [7] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [8] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [10] {ECO:0000313|Ensembl:ENSP00000432704}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2012) to UniProtKB.
RN   [11] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000432704}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL133330; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136989; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356215; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; H0YD13; -.
DR   STRING; 9606.ENSP00000398632; -.
DR   EPD; H0YD13; -.
DR   MaxQB; H0YD13; -.
DR   PaxDb; H0YD13; -.
DR   PeptideAtlas; H0YD13; -.
DR   PRIDE; H0YD13; -.
DR   Ensembl; ENST00000526669; ENSP00000432704; ENSG00000026508.
DR   UCSC; uc058aim.1; human.
DR   HGNC; HGNC:1681; CD44.
DR   OpenTargets; ENSG00000026508; -.
DR   eggNOG; ENOG410IZCP; Eukaryota.
DR   eggNOG; ENOG4111S6T; LUCA.
DR   GeneTree; ENSGT00530000063822; -.
DR   ChiTaRS; CD44; human.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000026508; -.
DR   ExpressionAtlas; H0YD13; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005540; F:hyaluronic acid binding; IEA:InterPro.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR016186; C-type_lectin-like.
DR   InterPro; IPR016187; C-type_lectin_fold.
DR   InterPro; IPR001231; CD44_antigen.
DR   InterPro; IPR000538; Link_dom.
DR   Pfam; PF00193; Xlink; 1.
DR   PRINTS; PR00658; CD44.
DR   PRINTS; PR01265; LINKMODULE.
DR   SMART; SM00445; LINK; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS01241; LINK_1; 1.
DR   PROSITE; PS50963; LINK_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|EPD:H0YD13,
KW   ECO:0000213|MaxQB:H0YD13, ECO:0000213|PeptideAtlas:H0YD13};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     20       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        21    206       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5003545893.
FT   TRANSMEM    114    135       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN       32    120       Link. {ECO:0000259|PROSITE:PS50963}.
SQ   SEQUENCE   206 AA;  22683 MW;  183E8D4517C4B980 CRC64;
     MDKFWWHAAW GLCLVPLSLA QIDLNITCRF AGVFHVEKNG RYSISRTEAA DLCKAFNSTL
     PTMAQMEKAL SIGFETCRYG FIEGHVVIPR IHPNSICGAN TTSGPIRTPQ IPEWLIILAS
     LLALALILAV CIAVNSRRRC GQKKKLVINS GNGAVEDRKP SGLNGEASKS QEMVHLVNKE
     SSETPDQFMT ADETRNLQNV DMKIGV
//
ID   H0YD17_HUMAN            Unreviewed;       229 AA.
AC   H0YD17;
DT   22-FEB-2012, integrated into UniProtKB/TrEMBL.
DT   05-OCT-2016, sequence version 8.
DT   02-NOV-2016, entry version 36.
DE   SubName: Full=CD44 antigen {ECO:0000313|Ensembl:ENSP00000432718};
DE   Flags: Fragment;
GN   Name=CD44 {ECO:0000313|Ensembl:ENSP00000432718};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000432718, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000432718, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [3] {ECO:0000313|Ensembl:ENSP00000432718}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2012) to UniProtKB.
RN   [4] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [5] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000432718}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL133330; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136989; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356215; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   PeptideAtlas; H0YD17; -.
DR   PRIDE; H0YD17; -.
DR   Ensembl; ENST00000528455; ENSP00000432718; ENSG00000026508.
DR   UCSC; uc058aiu.1; human.
DR   HGNC; HGNC:1681; CD44.
DR   OpenTargets; ENSG00000026508; -.
DR   GeneTree; ENSGT00530000063822; -.
DR   ChiTaRS; CD44; human.
DR   Proteomes; UP000005640; Chromosome 11.
DR   ExpressionAtlas; H0YD17; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:InterPro.
DR   GO; GO:0005540; F:hyaluronic acid binding; IEA:InterPro.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR016186; C-type_lectin-like.
DR   InterPro; IPR016187; C-type_lectin_fold.
DR   InterPro; IPR001231; CD44_antigen.
DR   InterPro; IPR000538; Link_dom.
DR   Pfam; PF00193; Xlink; 1.
DR   PRINTS; PR00658; CD44.
DR   PRINTS; PR01265; LINKMODULE.
DR   SMART; SM00445; LINK; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS50963; LINK_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:H0YD17,
KW   ECO:0000213|MaxQB:H0YD17, ECO:0000213|PeptideAtlas:H0YD17};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN        1     57       Link. {ECO:0000259|PROSITE:PS50963}.
FT   NON_TER       1      1       {ECO:0000313|Ensembl:ENSP00000432718}.
FT   NON_TER     229    229       {ECO:0000313|Ensembl:ENSP00000432718}.
SQ   SEQUENCE   229 AA;  25670 MW;  F4D60442DF81719D CRC64;
     XQMEKALSIG FETCRYGFIE GHVVIPRIHP NSICAANNTG VYILTSNTSQ YDTYCFNASA
     PPEEDCTSVT DLPNAFDGPI TITIVNRDGT RYVQKGEYRT NPEDIYPSNP TDDDVSSGSS
     SERSSTSGGY IFYTFSTVHP IPDEDSPWIT DSTDRIPATI STTPRAFDHT KQNQDWTQWN
     PSHSNPEVLL QTTTRMTDVD RNGTTAYEGN WNPEAHPPLI HHEHHEEEE
//
ID   H0YD90_HUMAN            Unreviewed;       195 AA.
AC   H0YD90;
DT   22-FEB-2012, integrated into UniProtKB/TrEMBL.
DT   22-FEB-2012, sequence version 1.
DT   02-NOV-2016, entry version 27.
DE   SubName: Full=CD44 antigen {ECO:0000313|Ensembl:ENSP00000433189};
DE   Flags: Fragment;
GN   Name=CD44 {ECO:0000313|Ensembl:ENSP00000433189};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000433189, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000433189, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000433189}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2012) to UniProtKB.
RN   [3] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [4] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000433189}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL133330; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136989; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356215; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; H0YD90; -.
DR   STRING; 9606.ENSP00000398632; -.
DR   MaxQB; H0YD90; -.
DR   PaxDb; H0YD90; -.
DR   PeptideAtlas; H0YD90; -.
DR   PRIDE; H0YD90; -.
DR   Ensembl; ENST00000531873; ENSP00000433189; ENSG00000026508.
DR   UCSC; uc058aiv.1; human.
DR   HGNC; HGNC:1681; CD44.
DR   OpenTargets; ENSG00000026508; -.
DR   eggNOG; ENOG410IZCP; Eukaryota.
DR   eggNOG; ENOG4111S6T; LUCA.
DR   GeneTree; ENSGT00530000063822; -.
DR   ChiTaRS; CD44; human.
DR   Proteomes; UP000005640; Chromosome 11.
DR   ExpressionAtlas; H0YD90; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:InterPro.
DR   GO; GO:0005540; F:hyaluronic acid binding; IEA:InterPro.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   GO; GO:0033674; P:positive regulation of kinase activity; IDA:CACAO.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR016186; C-type_lectin-like.
DR   InterPro; IPR016187; C-type_lectin_fold.
DR   InterPro; IPR001231; CD44_antigen.
DR   InterPro; IPR000538; Link_dom.
DR   PRINTS; PR00658; CD44.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS50963; LINK_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|MaxQB:H0YD90,
KW   ECO:0000213|PeptideAtlas:H0YD90};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN        1     41       Link. {ECO:0000259|PROSITE:PS50963}.
FT   NON_TER       1      1       {ECO:0000313|Ensembl:ENSP00000433189}.
FT   NON_TER     195    195       {ECO:0000313|Ensembl:ENSP00000433189}.
SQ   SEQUENCE   195 AA;  21288 MW;  67EB60C010AE3956 CRC64;
     XFIEGHVVIP RIHPNSICAA NNTGVYILTS NTSQYDTYCF NASAPPEEDC TSVTDLPNAF
     DGPITITIVN RDGTRYVQKG EYRTNPEDIY PSNPTDDDVS SGSSSERSST SGGYIFYTFS
     TVHPIPDEDS PWITDSTDRI PATKQSNSQS FSTSHEGLEE DKDHPTTSTL TSSNRNDVTG
     GRRDPNHSEG STTLL
//
ID   H0YDV8_HUMAN            Unreviewed;       191 AA.
AC   H0YDV8;
DT   22-FEB-2012, integrated into UniProtKB/TrEMBL.
DT   22-FEB-2012, sequence version 1.
DT   02-NOV-2016, entry version 21.
DE   SubName: Full=CD44 antigen {ECO:0000313|Ensembl:ENSP00000434418};
DE   Flags: Fragment;
GN   Name=CD44 {ECO:0000313|Ensembl:ENSP00000434418};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000434418, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000434418, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000434418}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2012) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000434418}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL133330; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136989; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356215; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; H0YDV8; -.
DR   MaxQB; H0YDV8; -.
DR   PeptideAtlas; H0YDV8; -.
DR   Ensembl; ENST00000526553; ENSP00000434418; ENSG00000026508.
DR   UCSC; uc058ajh.1; human.
DR   HGNC; HGNC:1681; CD44.
DR   OpenTargets; ENSG00000026508; -.
DR   GeneTree; ENSGT00530000063822; -.
DR   ChiTaRS; CD44; human.
DR   Proteomes; UP000005640; Chromosome 11.
DR   ExpressionAtlas; H0YDV8; baseline and differential.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:H0YDV8};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   NON_TER       1      1       {ECO:0000313|Ensembl:ENSP00000434418}.
FT   NON_TER     191    191       {ECO:0000313|Ensembl:ENSP00000434418}.
SQ   SEQUENCE   191 AA;  21237 MW;  8435D08AAC9E80ED CRC64;
     XSTTPRAFDH TKQNQDWTQW NPSHSNPEVL LQTTTRMTVQ ATPSSTTEET ATQKEQWFGN
     RWHEGYRQTP KEDSHSTTGT AASAHTSHPM QGRTTPSPED SSWTDFFNPI SHPMGRGHQA
     GRRMDMDSSH SITLQPTANP NTGLVEDLDR TGPLSMTTQQ SNSQSFSTSH EGLEEDKDHP
     TTSTLTSSSK D
//
ID   H0YDW7_HUMAN            Unreviewed;       240 AA.
AC   H0YDW7;
DT   22-FEB-2012, integrated into UniProtKB/TrEMBL.
DT   22-FEB-2012, sequence version 1.
DT   02-NOV-2016, entry version 32.
DE   SubName: Full=CD44 antigen {ECO:0000313|Ensembl:ENSP00000434465};
DE   Flags: Fragment;
GN   Name=CD44 {ECO:0000313|Ensembl:ENSP00000434465};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000434465, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000434465, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [4] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5] {ECO:0000313|Ensembl:ENSP00000434465}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2012) to UniProtKB.
RN   [6] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000434465}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL133330; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136989; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356215; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; H0YDW7; -.
DR   SMR; H0YDW7; -.
DR   STRING; 9606.ENSP00000398632; -.
DR   MaxQB; H0YDW7; -.
DR   PaxDb; H0YDW7; -.
DR   PeptideAtlas; H0YDW7; -.
DR   PRIDE; H0YDW7; -.
DR   Ensembl; ENST00000526000; ENSP00000434465; ENSG00000026508.
DR   UCSC; uc058aiq.1; human.
DR   HGNC; HGNC:1681; CD44.
DR   OpenTargets; ENSG00000026508; -.
DR   eggNOG; ENOG410IZCP; Eukaryota.
DR   eggNOG; ENOG4111S6T; LUCA.
DR   GeneTree; ENSGT00530000063822; -.
DR   ChiTaRS; CD44; human.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000026508; -.
DR   ExpressionAtlas; H0YDW7; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:InterPro.
DR   GO; GO:0005540; F:hyaluronic acid binding; IEA:InterPro.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR016186; C-type_lectin-like.
DR   InterPro; IPR016187; C-type_lectin_fold.
DR   InterPro; IPR001231; CD44_antigen.
DR   InterPro; IPR000538; Link_dom.
DR   Pfam; PF00193; Xlink; 1.
DR   PRINTS; PR00658; CD44.
DR   PRINTS; PR01265; LINKMODULE.
DR   SMART; SM00445; LINK; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS01241; LINK_1; 1.
DR   PROSITE; PS50963; LINK_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:H0YDW7,
KW   ECO:0000213|MaxQB:H0YDW7, ECO:0000213|PeptideAtlas:H0YDW7};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN       10     98       Link. {ECO:0000259|PROSITE:PS50963}.
FT   NON_TER       1      1       {ECO:0000313|Ensembl:ENSP00000434465}.
FT   NON_TER     240    240       {ECO:0000313|Ensembl:ENSP00000434465}.
SQ   SEQUENCE   240 AA;  26021 MW;  C31CE4EB35C08A14 CRC64;
     DLNITCRFAG VFHVEKNGRY SISRTEAADL CKAFNSTLPT MAQMEKALSI GFETCRYGFI
     EGHVVIPRIH PNSICAANNT GVYILTSNTS QYDTYCFNAS APPEEDCTSV TDLPNAFDGP
     ITITIVNRDG TRYVQKGEYR TNPEDIYPSN PTDDDVSSGS SSERSSTSGD RNDVTGGRRD
     PNHSEGSTTL LEGYTSHYPH TKESRTFIPV TSAKTGSFGV TAVTVGDSNS NVNRSLSGDQ
//
ID   H0YDX6_HUMAN            Unreviewed;       181 AA.
AC   H0YDX6;
DT   22-FEB-2012, integrated into UniProtKB/TrEMBL.
DT   22-FEB-2012, sequence version 1.
DT   02-NOV-2016, entry version 32.
DE   SubName: Full=CD44 antigen {ECO:0000313|Ensembl:ENSP00000434530};
DE   Flags: Fragment;
GN   Name=CD44 {ECO:0000313|Ensembl:ENSP00000434530};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000434530, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000434530, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [3] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [4] {ECO:0000313|Ensembl:ENSP00000434530}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2012) to UniProtKB.
RN   [5] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [6] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000434530}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL133330; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136989; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356215; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; H0YDX6; -.
DR   STRING; 9606.ENSP00000398632; -.
DR   MaxQB; H0YDX6; -.
DR   PaxDb; H0YDX6; -.
DR   PeptideAtlas; H0YDX6; -.
DR   PRIDE; H0YDX6; -.
DR   Ensembl; ENST00000527889; ENSP00000434530; ENSG00000026508.
DR   UCSC; uc058ais.1; human.
DR   HGNC; HGNC:1681; CD44.
DR   OpenTargets; ENSG00000026508; -.
DR   eggNOG; ENOG410IZCP; Eukaryota.
DR   eggNOG; ENOG4111S6T; LUCA.
DR   GeneTree; ENSGT00530000063822; -.
DR   ChiTaRS; CD44; human.
DR   Proteomes; UP000005640; Chromosome 11.
DR   ExpressionAtlas; H0YDX6; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:InterPro.
DR   GO; GO:0005540; F:hyaluronic acid binding; IEA:InterPro.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR016186; C-type_lectin-like.
DR   InterPro; IPR016187; C-type_lectin_fold.
DR   InterPro; IPR001231; CD44_antigen.
DR   InterPro; IPR000538; Link_dom.
DR   Pfam; PF00193; Xlink; 1.
DR   PRINTS; PR00658; CD44.
DR   PRINTS; PR01265; LINKMODULE.
DR   SMART; SM00445; LINK; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS01241; LINK_1; 1.
DR   PROSITE; PS50963; LINK_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:H0YDX6,
KW   ECO:0000213|MaxQB:H0YDX6, ECO:0000213|PeptideAtlas:H0YDX6};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN        1     76       Link. {ECO:0000259|PROSITE:PS50963}.
FT   NON_TER       1      1       {ECO:0000313|Ensembl:ENSP00000434530}.
FT   NON_TER     181    181       {ECO:0000313|Ensembl:ENSP00000434530}.
SQ   SEQUENCE   181 AA;  19572 MW;  FE47209D4B2E5608 CRC64;
     XRTEAADLCK AFNSTLPTMA QMEKALSIGF ETCRYGFIEG HVVIPRIHPN SICAANNTGV
     YILTSNTSQY DTYCFNASAP PEEDCTSVTD LPNAFDGPIT ITIVNRDGTR YVQKGEYRTN
     PEDIYPSNPT DDDVSSGSSS ERSSTSGDMD SSHSITLQPT ANPNTGLVED LDRTGPLSMT
     T
//
ID   H0YE40_HUMAN            Unreviewed;        82 AA.
AC   H0YE40;
DT   22-FEB-2012, integrated into UniProtKB/TrEMBL.
DT   22-FEB-2012, sequence version 1.
DT   02-NOV-2016, entry version 29.
DE   SubName: Full=CD44 antigen {ECO:0000313|Ensembl:ENSP00000434920};
DE   Flags: Fragment;
GN   Name=CD44 {ECO:0000313|Ensembl:ENSP00000434920};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000434920, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000213|PubMed:17081983}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000434920, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [3] {ECO:0000213|PubMed:19367720}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using
RT   sequential IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [4] {ECO:0000213|PubMed:18691976}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [5] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [7] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [9] {ECO:0000313|Ensembl:ENSP00000434920}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2012) to UniProtKB.
RN   [10] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000434920}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL133330; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136989; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356215; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   STRING; 9606.ENSP00000398632; -.
DR   MaxQB; H0YE40; -.
DR   PaxDb; H0YE40; -.
DR   PeptideAtlas; H0YE40; -.
DR   PRIDE; H0YE40; -.
DR   Ensembl; ENST00000525469; ENSP00000434920; ENSG00000026508.
DR   UCSC; uc058ajq.1; human.
DR   HGNC; HGNC:1681; CD44.
DR   OpenTargets; ENSG00000026508; -.
DR   eggNOG; ENOG410IZCP; Eukaryota.
DR   eggNOG; ENOG4111S6T; LUCA.
DR   GeneTree; ENSGT00530000063822; -.
DR   ChiTaRS; CD44; human.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000026508; -.
DR   ExpressionAtlas; H0YE40; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:InterPro.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   InterPro; IPR001231; CD44_antigen.
DR   PRINTS; PR00658; CD44.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:H0YE40,
KW   ECO:0000213|MaxQB:H0YE40, ECO:0000213|PeptideAtlas:H0YE40};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   NON_TER       1      1       {ECO:0000313|Ensembl:ENSP00000434920}.
SQ   SEQUENCE   82 AA;  9105 MW;  275DC4281028B759 CRC64;
     SKHNLWSYKD TPNSRCGQKK KLVINSGNGA VEDRKPSGLN GEASKSQEMV HLVNKESSET
     PDQFMTADET RNLQNVDMKI GV
//
ID   H0YEA1_HUMAN            Unreviewed;       193 AA.
AC   H0YEA1;
DT   22-FEB-2012, integrated into UniProtKB/TrEMBL.
DT   22-FEB-2012, sequence version 1.
DT   02-NOV-2016, entry version 25.
DE   SubName: Full=CD44 antigen {ECO:0000313|Ensembl:ENSP00000435321};
DE   Flags: Fragment;
GN   Name=CD44 {ECO:0000313|Ensembl:ENSP00000435321};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000435321, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000435321, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000435321}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2012) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000435321}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL133330; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136989; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356215; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; H0YEA1; -.
DR   STRING; 9606.ENSP00000398632; -.
DR   MaxQB; H0YEA1; -.
DR   PaxDb; H0YEA1; -.
DR   PeptideAtlas; H0YEA1; -.
DR   Ensembl; ENST00000533222; ENSP00000435321; ENSG00000026508.
DR   UCSC; uc058ajc.1; human.
DR   HGNC; HGNC:1681; CD44.
DR   OpenTargets; ENSG00000026508; -.
DR   eggNOG; ENOG410IZCP; Eukaryota.
DR   eggNOG; ENOG4111S6T; LUCA.
DR   GeneTree; ENSGT00530000063822; -.
DR   ChiTaRS; CD44; human.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000026508; -.
DR   ExpressionAtlas; H0YEA1; baseline and differential.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|MaxQB:H0YEA1,
KW   ECO:0000213|PeptideAtlas:H0YEA1};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   NON_TER       1      1       {ECO:0000313|Ensembl:ENSP00000435321}.
FT   NON_TER     193    193       {ECO:0000313|Ensembl:ENSP00000435321}.
SQ   SEQUENCE   193 AA;  20971 MW;  7DD61DB5C13A9E8A CRC64;
     IYPSNPTDDD VSSGSSSERS STSGGYIFYT FSTVHPIPDE DSPWITDSTD RIPATSTSSN
     TISAGWEPNE ENEDERDRHL SFSGSGIDDD EDFISSTNMD SSHSITLQPT ANPNTGLVED
     LDRTGPLSMT TQQSNSQSFS TSHEGLEEDK DHPTTSTLTS SNRNDVTGGR RDPNHSEGST
     TLLEGYTSHY PHT
//
ID   H0YES0_HUMAN            Unreviewed;       118 AA.
AC   H0YES0;
DT   22-FEB-2012, integrated into UniProtKB/TrEMBL.
DT   22-FEB-2012, sequence version 1.
DT   02-NOV-2016, entry version 16.
DE   SubName: Full=CD44 antigen {ECO:0000313|Ensembl:ENSP00000436451};
DE   Flags: Fragment;
GN   Name=CD44 {ECO:0000313|Ensembl:ENSP00000436451};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000436451, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000436451, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000436451}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2012) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000436451}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL133330; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136989; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356215; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; H0YES0; -.
DR   Ensembl; ENST00000524922; ENSP00000436451; ENSG00000026508.
DR   UCSC; uc058aje.1; human.
DR   HGNC; HGNC:1681; CD44.
DR   OpenTargets; ENSG00000026508; -.
DR   GeneTree; ENSGT00530000063822; -.
DR   ChiTaRS; CD44; human.
DR   Proteomes; UP000005640; Chromosome 11.
DR   ExpressionAtlas; H0YES0; baseline and differential.
PE   4: Predicted;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   NON_TER       1      1       {ECO:0000313|Ensembl:ENSP00000436451}.
FT   NON_TER     118    118       {ECO:0000313|Ensembl:ENSP00000436451}.
SQ   SEQUENCE   118 AA;  13602 MW;  3C3B32087C6EFC2E CRC64;
     XPDEDSPWIT DSTDRIPATS WEPNEENEDE RDRHLSFSGS GIDDDEDFIS STISTTPRAF
     DHTKQNQDWT QWNPSHSNPE VLLQTTTRMT DVDRNGTTAY EGNWNPEAHP PLIHHEHH
//
ID   H0YEU1_HUMAN            Unreviewed;       249 AA.
AC   H0YEU1;
DT   22-FEB-2012, integrated into UniProtKB/TrEMBL.
DT   22-FEB-2012, sequence version 1.
DT   02-NOV-2016, entry version 29.
DE   SubName: Full=CD44 antigen {ECO:0000313|Ensembl:ENSP00000436549};
DE   Flags: Fragment;
GN   Name=CD44 {ECO:0000313|Ensembl:ENSP00000436549};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000436549, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000436549, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000436549}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2012) to UniProtKB.
RN   [3] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [4] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000436549}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL133330; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136989; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356215; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; H0YEU1; -.
DR   SMR; H0YEU1; -.
DR   STRING; 9606.ENSP00000398632; -.
DR   MaxQB; H0YEU1; -.
DR   PaxDb; H0YEU1; -.
DR   PeptideAtlas; H0YEU1; -.
DR   PRIDE; H0YEU1; -.
DR   Ensembl; ENST00000531110; ENSP00000436549; ENSG00000026508.
DR   UCSC; uc058aix.1; human.
DR   HGNC; HGNC:1681; CD44.
DR   OpenTargets; ENSG00000026508; -.
DR   eggNOG; ENOG410IZCP; Eukaryota.
DR   eggNOG; ENOG4111S6T; LUCA.
DR   GeneTree; ENSGT00530000063822; -.
DR   ChiTaRS; CD44; human.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000026508; -.
DR   ExpressionAtlas; H0YEU1; baseline and differential.
DR   InterPro; IPR016187; C-type_lectin_fold.
DR   SUPFAM; SSF56436; SSF56436; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|MaxQB:H0YEU1,
KW   ECO:0000213|PeptideAtlas:H0YEU1};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   NON_TER       1      1       {ECO:0000313|Ensembl:ENSP00000436549}.
FT   NON_TER     249    249       {ECO:0000313|Ensembl:ENSP00000436549}.
SQ   SEQUENCE   249 AA;  27281 MW;  615211109CBE2197 CRC64;
     EDCTSVTDLP NAFDGPITIT IVNRDGTRYV QKGEYRTNPE DIYPSNPTDD DVSSGSSSER
     SSTSGGYIFY TFSTVHPIPD EDSPWITDST DRIPATIQAT PSSTTEETAT QKEQWFGNRW
     HEGYRQTPKE DSHSTTGTAA ASAHTSHPMQ GRTTPSPEDS SWTDFFNPIS HPMGRGHQAG
     RRMDMDSSHS ITLQPTANPN TGLVEDLDRT GPLSMTTQQS NSQSFSTSHE GLEEDKDHPT
     TSTLTSSSK
//
ID   H0YEV3_HUMAN            Unreviewed;       243 AA.
AC   H0YEV3;
DT   22-FEB-2012, integrated into UniProtKB/TrEMBL.
DT   22-FEB-2012, sequence version 1.
DT   02-NOV-2016, entry version 27.
DE   SubName: Full=CD44 antigen {ECO:0000313|Ensembl:ENSP00000436623};
DE   Flags: Fragment;
GN   Name=CD44 {ECO:0000313|Ensembl:ENSP00000436623};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000436623, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000436623, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000436623}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2012) to UniProtKB.
RN   [3] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [4] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000436623}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL133330; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136989; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356215; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; H0YEV3; -.
DR   STRING; 9606.ENSP00000398632; -.
DR   MaxQB; H0YEV3; -.
DR   PaxDb; H0YEV3; -.
DR   PeptideAtlas; H0YEV3; -.
DR   PRIDE; H0YEV3; -.
DR   Ensembl; ENST00000525685; ENSP00000436623; ENSG00000026508.
DR   UCSC; uc058aiy.1; human.
DR   HGNC; HGNC:1681; CD44.
DR   OpenTargets; ENSG00000026508; -.
DR   eggNOG; ENOG410IZCP; Eukaryota.
DR   eggNOG; ENOG4111S6T; LUCA.
DR   GeneTree; ENSGT00530000063822; -.
DR   ChiTaRS; CD44; human.
DR   Proteomes; UP000005640; Chromosome 11.
DR   ExpressionAtlas; H0YEV3; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:InterPro.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   InterPro; IPR001231; CD44_antigen.
DR   PRINTS; PR00658; CD44.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|MaxQB:H0YEV3,
KW   ECO:0000213|PeptideAtlas:H0YEV3};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   NON_TER       1      1       {ECO:0000313|Ensembl:ENSP00000436623}.
FT   NON_TER     243    243       {ECO:0000313|Ensembl:ENSP00000436623}.
SQ   SEQUENCE   243 AA;  26798 MW;  02145784C0A3D74F CRC64;
     XDLPNAFDGP ITITIVNRDG TRYVQKGEYR TNPEDIYPSN PTDDDVSSGS SSERSSTSGG
     YIFYTFSTVH PIPDEDSPWI TDSTDRIPAT TLMSTSATAT ETATKRQETW DWFSWLFLPS
     ESKNHLHTTT QMAGTSSNTI SAGWEPNEEN EDERDRHLSF SGSGIDDDED FISSTNMDSS
     HSITLQPTAN PNTGLVEDLD RTGPLSMTTQ QSNSQSFSTS HEGLEEDKDH PTTSTLTSSS
     KDY
//
ID   H0YF08_HUMAN            Unreviewed;       186 AA.
AC   H0YF08;
DT   22-FEB-2012, integrated into UniProtKB/TrEMBL.
DT   05-OCT-2016, sequence version 8.
DT   02-NOV-2016, entry version 34.
DE   SubName: Full=CD44 antigen {ECO:0000313|Ensembl:ENSP00000436980};
DE   Flags: Fragment;
GN   Name=CD44 {ECO:0000313|Ensembl:ENSP00000436980};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000436980, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000436980, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000436980}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2012) to UniProtKB.
RN   [3] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000436980}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL133330; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136989; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356215; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   STRING; 9606.ENSP00000398632; -.
DR   PaxDb; H0YF08; -.
DR   PeptideAtlas; H0YF08; -.
DR   PRIDE; H0YF08; -.
DR   Ensembl; ENST00000525688; ENSP00000436980; ENSG00000026508.
DR   UCSC; uc058aja.1; human.
DR   HGNC; HGNC:1681; CD44.
DR   OpenTargets; ENSG00000026508; -.
DR   eggNOG; ENOG410IZCP; Eukaryota.
DR   eggNOG; ENOG4111S6T; LUCA.
DR   GeneTree; ENSGT00530000063822; -.
DR   ChiTaRS; CD44; human.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000026508; -.
DR   ExpressionAtlas; H0YF08; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   InterPro; IPR001231; CD44_antigen.
DR   PRINTS; PR00658; CD44.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|MaxQB:H0YF08,
KW   ECO:0000213|PeptideAtlas:H0YF08};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    150    171       Helical. {ECO:0000256|SAM:Phobius}.
FT   NON_TER       1      1       {ECO:0000313|Ensembl:ENSP00000436980}.
FT   NON_TER     186    186       {ECO:0000313|Ensembl:ENSP00000436980}.
SQ   SEQUENCE   186 AA;  20065 MW;  D39A0D2C52DACFB7 CRC64;
     RTNPEDIYPS NPTDDDVSSG SSSERSSTSG GYIFYTFSTV HPIPDEDSPW ITDSTDRIPA
     TSTSSNTISA GWEPNEENED ERDRHLSFSG SGIDDDEDFI SSTRDQDTFH PSGGSHTTHG
     SESDGHSHGS QEGGANTTSG PIRTPQIPEW LIILASLLAL ALILAVCIAV NSRRRCGQKK
     KLVINS
//
ID   J3KN83_HUMAN            Unreviewed;       232 AA.
AC   J3KN83;
DT   03-OCT-2012, integrated into UniProtKB/TrEMBL.
DT   03-OCT-2012, sequence version 1.
DT   02-NOV-2016, entry version 30.
DE   SubName: Full=CD44 antigen {ECO:0000313|Ensembl:ENSP00000278385};
DE   Flags: Fragment;
GN   Name=CD44 {ECO:0000313|Ensembl:ENSP00000278385};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000278385, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000213|PubMed:17081983}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000278385, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [3] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [4] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [5] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6] {ECO:0000313|Ensembl:ENSP00000278385}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (AUG-2012) to UniProtKB.
RN   [7] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000278385}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL133330; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136989; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356215; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; J3KN83; -.
DR   SMR; J3KN83; -.
DR   STRING; 9606.ENSP00000398632; -.
DR   MaxQB; J3KN83; -.
DR   PaxDb; J3KN83; -.
DR   PeptideAtlas; J3KN83; -.
DR   PRIDE; J3KN83; -.
DR   Ensembl; ENST00000278385; ENSP00000278385; ENSG00000026508.
DR   UCSC; uc058ajb.1; human.
DR   HGNC; HGNC:1681; CD44.
DR   OpenTargets; ENSG00000026508; -.
DR   eggNOG; ENOG410IZCP; Eukaryota.
DR   eggNOG; ENOG4111S6T; LUCA.
DR   GeneTree; ENSGT00530000063822; -.
DR   ChiTaRS; CD44; human.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000026508; -.
DR   ExpressionAtlas; J3KN83; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   InterPro; IPR001231; CD44_antigen.
DR   PRINTS; PR00658; CD44.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|EPD:J3KN83,
KW   ECO:0000213|MaxQB:J3KN83, ECO:0000213|PeptideAtlas:J3KN83};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    169    190       Helical. {ECO:0000256|SAM:Phobius}.
FT   NON_TER       1      1       {ECO:0000313|Ensembl:ENSP00000278385}.
FT   NON_TER     232    232       {ECO:0000313|Ensembl:ENSP00000278385}.
SQ   SEQUENCE   232 AA;  24715 MW;  6695436CB4C54D67 CRC64;
     PEDIYPSNPT DDDVSSGSSS ERSSTSGGYI FYTFSTVHPI PDEDSPWITD STDRIPATNM
     DSSHSITLQP TANPNTGLVE DLDRTGPLSM TTQQSNSQSF STSHEGLEED KDHPTTSTLT
     SSRDQDTFHP SGGSHTTHGS ESDGHSHGSQ EGGANTTSGP IRTPQIPEWL IILASLLALA
     LILAVCIAVN SRRRCGQKKK LVINSGNGAV EDRKPSGLNG EASKSQEMVH LV
//
ID   O95658_HUMAN            Unreviewed;        31 AA.
AC   O95658;
DT   01-MAY-1999, integrated into UniProtKB/TrEMBL.
DT   01-MAY-1999, sequence version 1.
DT   08-JUN-2016, entry version 30.
DE   SubName: Full=Soluble CD44 {ECO:0000313|EMBL:AAD00765.1};
DE   Flags: Fragment;
GN   Name=CD44 {ECO:0000313|EMBL:AAD00765.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAD00765.1};
RN   [1] {ECO:0000313|EMBL:AAD00765.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Yu Q., Toole B.P.;
RT   "Soluble CD44 is generated by a different pattern of alternative
RT   splicing between exons v9 and v10 in the human and mouse.";
RL   Submitted (MAR-1997) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U94902; AAD00765.1; -; mRNA.
DR   ChiTaRS; CD44; human.
PE   2: Evidence at transcript level;
FT   NON_TER       1      1       {ECO:0000313|EMBL:AAD00765.1}.
SQ   SEQUENCE   31 AA;  3942 MW;  2818017019AC6F44 CRC64;
     VRIIKPSWLQ LLIRINQLWV LLQCLWWRCI H
//
ID   O95659_HUMAN            Unreviewed;        33 AA.
AC   O95659;
DT   01-MAY-1999, integrated into UniProtKB/TrEMBL.
DT   01-MAY-1999, sequence version 1.
DT   08-JUN-2016, entry version 24.
DE   SubName: Full=Soluble CD44 {ECO:0000313|EMBL:AAD00766.1};
DE   Flags: Fragment;
GN   Name=CD44 {ECO:0000313|EMBL:AAD00766.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAD00766.1};
RN   [1] {ECO:0000313|EMBL:AAD00766.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Yu Q., Toole B.P.;
RL   Submitted (MAR-1997) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U94903; AAD00766.1; -; mRNA.
DR   UniGene; Hs.502328; -.
DR   ChiTaRS; CD44; human.
PE   2: Evidence at transcript level;
FT   NON_TER       1      1       {ECO:0000313|EMBL:AAD00766.1}.
SQ   SEQUENCE   33 AA;  3464 MW;  E6AEFB3104A6DD3E CRC64;
     WKAFAAIVCS GDKHMVGGDL TNTGSSLIPP PHR
//
ID   CD44_HUMAN              Reviewed;         742 AA.
AC   P16070; A5YRN9; B6EAT9; D3DR12; D3DR13; O95370; P22511; Q04858;
AC   Q13419; Q13957; Q13958; Q13959; Q13960; Q13961; Q13967; Q13968;
AC   Q13980; Q15861; Q16064; Q16065; Q16066; Q16208; Q16522; Q86T72;
AC   Q86Z27; Q8N694; Q92493; Q96J24; Q9H5A5; Q9UC28; Q9UC29; Q9UC30;
AC   Q9UCB0; Q9UJ36;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   05-OCT-2010, sequence version 3.
DT   02-NOV-2016, entry version 206.
DE   RecName: Full=CD44 antigen;
DE   AltName: Full=CDw44;
DE   AltName: Full=Epican;
DE   AltName: Full=Extracellular matrix receptor III;
DE            Short=ECMR-III;
DE   AltName: Full=GP90 lymphocyte homing/adhesion receptor;
DE   AltName: Full=HUTCH-I;
DE   AltName: Full=Heparan sulfate proteoglycan;
DE   AltName: Full=Hermes antigen;
DE   AltName: Full=Hyaluronate receptor;
DE   AltName: Full=Phagocytic glycoprotein 1;
DE            Short=PGP-1;
DE   AltName: Full=Phagocytic glycoprotein I;
DE            Short=PGP-I;
DE   AltName: CD_antigen=CD44;
DE   Flags: Precursor;
GN   Name=CD44; Synonyms=LHR, MDU2, MDU3, MIC4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 12).
RX   PubMed=2466575; DOI=10.1016/0092-8674(89)90638-7;
RA   Stamenkovic I., Amiot M., Pesando J.M., Seed B.;
RT   "A lymphocyte molecule implicated in lymph node homing is a member of
RT   the cartilage link protein family.";
RL   Cell 56:1057-1062(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 12).
RC   TISSUE=Reticulocyte;
RX   PubMed=1840487; DOI=10.1016/0006-291X(91)91009-2;
RA   Harn H.-J., Isola N., Cooper D.L.;
RT   "The multispecific cell adhesion molecule CD44 is represented in
RT   reticulocyte cDNA.";
RL   Biochem. Biophys. Res. Commun. 178:1127-1134(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 10), AND VARIANT THR-479.
RX   PubMed=1991450;
RA   Stamenkovic I., Aruffo A., Amiot M., Seed B.;
RT   "The hematopoietic and epithelial forms of CD44 are distinct
RT   polypeptides with different adhesion potentials for hyaluronate-
RT   bearing cells.";
RL   EMBO J. 10:343-348(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 10 AND 11), AND VARIANT THR-479.
RC   TISSUE=Myeloid leukemia cell;
RX   PubMed=2056274; DOI=10.1084/jem.174.1.1;
RA   Dougherty G.J., Lansdorp P.M., Cooper D.L., Humphries R.K.;
RT   "Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the
RT   human CD44 lymphocyte 'homing' receptor expressed by hemopoietic
RT   cells.";
RL   J. Exp. Med. 174:1-5(1991).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), AND VARIANT THR-479.
RC   TISSUE=Keratinocyte;
RX   PubMed=1281868; DOI=10.1111/1523-1747.ep12614896;
RA   Kugelman L.C., Ganguly S., Haggerty J.G., Weissman S.M.,
RA   Milstone L.M.;
RT   "The core protein of epican, a heparan sulfate proteoglycan on
RT   keratinocytes, is an alternative form of CD44.";
RL   J. Invest. Dermatol. 99:886-891(1992).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING, AND VARIANTS
RP   ARG-417 AND THR-479.
RC   TISSUE=Lymphoblast;
RX   PubMed=1465456; DOI=10.1073/pnas.89.24.12160;
RA   Screaton G.R., Bell M.V., Jackson D.G., Cornelis F.B., Gerth U.,
RA   Bell J.I.;
RT   "Genomic structure of DNA encoding the lymphocyte homing receptor CD44
RT   reveals at least 12 alternatively spliced exons.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:12160-12164(1992).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS ARG-417; THR-479
RP   AND HIS-494.
RX   PubMed=7508842;
RA   Gunthert U.;
RT   "CD44: a multitude of isoforms with diverse functions.";
RL   Curr. Top. Microbiol. Immunol. 184:47-63(1993).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 13 AND 14), AND VARIANT
RP   THR-479.
RC   TISSUE=Mammary carcinoma;
RX   PubMed=8352881; DOI=10.1002/mc.2940070403;
RA   Tanabe K.K., Nishi T., Saya H.;
RT   "Novel variants of CD44 arising from alternative splicing: changes in
RT   the CD44 alternative splicing pattern of MCF-7 breast carcinoma cells
RT   treated with hyaluronidase.";
RL   Mol. Carcinog. 7:212-220(1993).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 19).
RX   PubMed=10933060; DOI=10.1038/sj.neo.7900045;
RA   Chiu R.K., Carpenito C., Dougherty S.T., Hayes G.M., Dougherty G.J.;
RT   "Identification and characterization of CD44RC, a novel alternatively
RT   spliced soluble CD44 isoform that can potentiate the hyaluronan
RT   binding activity of cell surface CD44.";
RL   Neoplasia 1:446-452(1999).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 12).
RC   TISSUE=Articular cartilage;
RA   Bosch P.P., Stevens J.W., Buckwalter J.A., Midura R.J.;
RT   "CD44 in normal and neoplastic human cartilage.";
RL   Submitted (DEC-1995) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 10 AND 12), AND VARIANT THR-479.
RC   TISSUE=Colon adenocarcinoma, and Retinal pigment epithelium;
RA   Wiebe G.J., Freund D., Corbeil D.;
RT   "Sequence analysis of the human CD44 antigen.";
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 11).
RA   Xiang Q., Wang J., Fan C., He X., Huang L., Zhu H., Qiu X., Luo W.;
RT   "Sequence analysis of a novel human CD44 variant.";
RL   Submitted (APR-2007) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 18).
RA   Fang X., Xu W., Zhang X.;
RT   "Construction of human CD44 eukaryotic vector and its expression in
RT   mammary carcinoma cells MCF-7.";
RL   Submitted (SEP-2008) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 12).
RC   TISSUE=Spinal cord;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [17]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4 AND 12), AND
RP   VARIANTS ARG-417 AND THR-479.
RC   TISSUE=Pancreas, and Retinal pigment epithelium;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [18]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-22.
RC   TISSUE=Lymphoblast;
RX   PubMed=1922057; DOI=10.1128/MCB.11.11.5446;
RA   Shtivelman E., Bishop J.M.;
RT   "Expression of CD44 is repressed in neuroblastoma cells.";
RL   Mol. Cell. Biol. 11:5446-5453(1991).
RN   [19]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2-742 (ISOFORM 15).
RX   PubMed=2466576; DOI=10.1016/0092-8674(89)90639-9;
RA   Goldstein L.A., Zhou D.F.H., Picker L.J., Minty C.N., Bargatze R.F.,
RA   Ding J.F., Butcher E.C.;
RT   "A human lymphocyte homing receptor, the hermes antigen, is related to
RT   cartilage proteoglycan core and link proteins.";
RL   Cell 56:1063-1072(1989).
RN   [20]
RP   PROTEIN SEQUENCE OF 55-108.
RC   TISSUE=Glial tumor;
RX   PubMed=7527301; DOI=10.1007/BF01519984;
RA   Okada H., Yoshida J., Seo H., Wakabayashi T., Sugita K., Hagiwara M.;
RT   "Anti-(glioma surface antigen) monoclonal antibody G-22 recognizes
RT   overexpressed CD44 in glioma cells.";
RL   Cancer Immunol. Immunother. 39:313-317(1994).
RN   [21]
RP   PROTEIN SEQUENCE OF 67-89.
RC   TISSUE=Peripheral blood;
RX   PubMed=7508992;
RA   Shepley M.P., Racaniello V.R.;
RT   "A monoclonal antibody that blocks poliovirus attachment recognizes
RT   the lymphocyte homing receptor CD44.";
RL   J. Virol. 68:1301-1308(1994).
RN   [22]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 184-625 (ISOFORM 10), AND VARIANT
RP   THR-479.
RC   TISSUE=Foreskin;
RX   PubMed=2007624; DOI=10.1083/jcb.113.1.207;
RA   Brown T.A., Bouchard T., St John T., Wayner E., Carter W.G.;
RT   "Human keratinocytes express a new CD44 core protein (CD44E) as a
RT   heparan-sulfate intrinsic membrane proteoglycan with additional
RT   exons.";
RL   J. Cell Biol. 113:207-221(1991).
RN   [23]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 221-267.
RX   PubMed=8148709; DOI=10.1136/bmj.308.6929.619;
RA   Matsumura Y., Hanbury D., Smith J., Tarin D.;
RT   "Non-invasive detection of malignancy by identification of unusual
RT   CD44 gene activity in exfoliated cancer cells.";
RL   BMJ 308:619-624(1994).
RN   [24]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 267-603 (ISOFORM 1), AND VARIANT
RP   ARG-417.
RC   TISSUE=Lung;
RX   PubMed=1717145;
RA   Hofmann M., Rudy W., Zoeller M., Toelg C., Ponta H., Herrlich P.,
RA   Guenthert U.;
RT   "CD44 splice variants confer metastatic behavior in rats: homologous
RT   sequences are expressed in human tumor cell lines.";
RL   Cancer Res. 51:5292-5297(1991).
RN   [25]
RP   REVIEW ON FUNCTION, AND POST-TRANSLATIONAL MODIFICATIONS.
RX   PubMed=12511867; DOI=10.1038/nrm1004;
RA   Ponta H., Sherman L., Herrlich P.A.;
RT   "CD44: from adhesion molecules to signalling regulators.";
RL   Nat. Rev. Mol. Cell Biol. 4:33-45(2003).
RN   [26]
RP   PHOSPHORYLATION AT SER-706.
RX   PubMed=9580567;
RA   Peck D., Isacke C.M.;
RT   "Hyaluronan-dependent cell migration can be blocked by a CD44
RT   cytoplasmic domain peptide containing a phosphoserine at position
RT   325.";
RL   J. Cell Sci. 111:1595-1601(1998).
RN   [27]
RP   PHOSPHORYLATION AT SER-672.
RX   PubMed=12032545; DOI=10.1038/ncb797;
RA   Legg J.W., Lewis C.A., Parsons M., Ng T., Isacke C.M.;
RT   "A novel PKC-regulated mechanism controls CD44 ezrin association and
RT   directional cell motility.";
RL   Nat. Cell Biol. 4:399-407(2002).
RN   [28]
RP   GLYCOSYLATION, AND PROTEOLYTIC PROCESSING.
RX   PubMed=12883358; DOI=10.1097/00008390-200308000-00001;
RA   Bartolazzi A.;
RT   "CD44s adhesive function spontaneous and PMA-inducible CD44 cleavage
RT   are regulated at post-translational level in cells of melanocytic
RT   lineage.";
RL   Melanoma Res. 13:325-337(2003).
RN   [29]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-57.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-686 AND SER-706, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [31]
RP   FUNCTION.
RX   PubMed=16541107; DOI=10.1038/sj.emboj.7601039;
RA   Vikesaa J., Hansen T.V., Joenson L., Borup R., Wewer U.M.,
RA   Christiansen J., Nielsen F.C.;
RT   "RNA-binding IMPs promote cell adhesion and invadopodia formation.";
RL   EMBO J. 25:1456-1468(2006).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-706, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using
RT   sequential IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-706, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [34]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [35]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-57 AND ASN-110.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [36]
RP   INTERACTION WITH UNC119.
RX   PubMed=19381274; DOI=10.1371/journal.pone.0005211;
RA   Vepachedu R., Karim Z., Patel O., Goplen N., Alam R.;
RT   "Unc119 protects from Shigella infection by inhibiting the Abl family
RT   kinases.";
RL   PLoS ONE 4:E5211-E5211(2009).
RN   [37]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [38]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-686 AND SER-706, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [39]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [40]
RP   GLYCOSYLATION AT THR-637 AND THR-638, STRUCTURE OF CARBOHYDRATES, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=22171320; DOI=10.1074/mcp.M111.013649;
RA   Halim A., Nilsson J., Ruetschi U., Hesse C., Larson G.;
RT   "Human urinary glycoproteomics; attachment site specific analysis of
RT   N-and O-linked glycosylations by CID and ECD.";
RL   Mol. Cell. Proteomics 0:0-0(2011).
RN   [41]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-706, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [42]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-686 AND SER-706, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [43]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [44]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [45]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 20-178, STRUCTURE BY NMR OF
RP   20-178, AND INTERACTION WITH HA.
RX   PubMed=14992719; DOI=10.1016/S1097-2765(04)00080-2;
RA   Teriete P., Banerji S., Noble M., Blundell C.D., Wright A.J.,
RA   Pickford A.R., Lowe E., Mahoney D.J., Tammi M.I., Kahmann J.D.,
RA   Campbell I.D., Day A.J., Jackson D.G.;
RT   "Structure of the regulatory hyaluronan binding domain in the
RT   inflammatory leukocyte homing receptor CD44.";
RL   Mol. Cell 13:483-496(2004).
RN   [46]
RP   STRUCTURE BY NMR OF 20-178 IN COMPLEX WITH HA.
RX   PubMed=17085435; DOI=10.1074/jbc.M608425200;
RA   Takeda M., Ogino S., Umemoto R., Sakakura M., Kajiwara M.,
RA   Sugahara K.N., Hayasaka H., Miyasaka M., Terasawa H., Shimada I.;
RT   "Ligand-induced structural changes of the CD44 hyaluronan-binding
RT   domain revealed by NMR.";
RL   J. Biol. Chem. 281:40089-40095(2006).
RN   [47]
RP   VARIANT BLOOD GROUP INDIAN PRO-46.
RX   PubMed=8636151; DOI=10.1074/jbc.271.12.7147;
RA   Telen M.J., Udani M., Washington M.K., Levesque M.C., Lloyd E.,
RA   Rao N.;
RT   "A blood group-related polymorphism of CD44 abolishes a hyaluronan-
RT   binding consensus sequence without preventing hyaluronan binding.";
RL   J. Biol. Chem. 271:7147-7153(1996).
CC   -!- FUNCTION: Receptor for hyaluronic acid (HA). Mediates cell-cell
CC       and cell-matrix interactions through its affinity for HA, and
CC       possibly also through its affinity for other ligands such as
CC       osteopontin, collagens, and matrix metalloproteinases (MMPs).
CC       Adhesion with HA plays an important role in cell migration, tumor
CC       growth and progression. In cancer cells, may play an important
CC       role in invadopodia formation. Also involved in lymphocyte
CC       activation, recirculation and homing, and in hematopoiesis.
CC       Altered expression or dysfunction causes numerous pathogenic
CC       phenotypes. Great protein heterogeneity due to numerous
CC       alternative splicing and post-translational modification events.
CC       Receptor for LGALS9; the interaction enhances binding of SMAD3 to
CC       the FOXP3 promoter, leading to up-regulation of FOXP3 expression
CC       and increased induced regulatory T (iTreg) cell stability and
CC       suppressive function (By similarity).
CC       {ECO:0000250|UniProtKB:P15379, ECO:0000269|PubMed:16541107}.
CC   -!- SUBUNIT: Interacts with PKN2 (By similarity). Interacts with TIAM1
CC       and TIAM2 (By similarity). Interacts with HA, as well as other
CC       glycosaminoglycans, collagen, laminin, and fibronectin via its N-
CC       terminal segment (PubMed:14992719, PubMed:17085435). Interacts
CC       with ANK, the ERM proteins (VIL2, RDX and MSN), and NF2 via its C-
CC       terminal segment. Interacts with UNC119 (PubMed:19381274).
CC       {ECO:0000250|UniProtKB:P15379, ECO:0000269|PubMed:14992719,
CC       ECO:0000269|PubMed:17085435, ECO:0000269|PubMed:19381274}.
CC   -!- INTERACTION:
CC       P18011:ipaB (xeno); NbExp=4; IntAct=EBI-490245, EBI-490239;
CC       P26038:MSN; NbExp=6; IntAct=EBI-490245, EBI-528768;
CC       Q9UPY5:SLC7A11; NbExp=4; IntAct=EBI-490245, EBI-3843348;
CC       P10451:SPP1; NbExp=4; IntAct=EBI-490245, EBI-723648;
CC   -!- SUBCELLULAR LOCATION: Cell membrane
CC       {ECO:0000250|UniProtKB:P15379}; Single-pass type I membrane
CC       protein {ECO:0000250|UniProtKB:P15379}. Note=Colocalizes with
CC       actin in membrane protrusions at wounding edges.
CC       {ECO:0000250|UniProtKB:P15379}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=19;
CC         Comment=Additional isoforms seem to exist. Additional isoforms
CC         are produced by alternative splicing of 10 out of 19 exons
CC         within the extracellular domain. Additional diversity is
CC         generated through the utilization of internal splice donor and
CC         acceptor sites within 2 of the exons. A variation in the
CC         cytoplasmic domain was shown to result from the alternative
CC         splicing of 2 exons. Isoform CD44 is expected to be expressed in
CC         normal cells. Splice variants have been found in many tumor cell
CC         lines. Exons 5, 6, 7, 8, 9, 10, 11, 13, 14 and 19 are
CC         alternatively spliced. Experimental confirmation may be lacking
CC         for some isoforms. {ECO:0000269|PubMed:1465456};
CC       Name=1; Synonyms=CD44;
CC         IsoId=P16070-1; Sequence=Displayed;
CC         Note=Corresponds to the largest isoform.;
CC       Name=2; Synonyms=CD44SP;
CC         IsoId=P16070-2; Sequence=VSP_005303, VSP_005304;
CC       Name=3;
CC         IsoId=P16070-3; Sequence=VSP_005305, VSP_005306;
CC         Note=Alternative splice donor/acceptor on exon 5.;
CC       Name=4; Synonyms=Epidermal;
CC         IsoId=P16070-4; Sequence=VSP_005307, VSP_005308;
CC         Note=Lacks exon 6.;
CC       Name=5;
CC         IsoId=P16070-5; Sequence=VSP_005313;
CC         Note=Alternative splice donor/acceptor on exon 7.;
CC       Name=6;
CC         IsoId=P16070-6; Sequence=VSP_005314, VSP_005315;
CC         Note=Lacks exon 10.;
CC       Name=7;
CC         IsoId=P16070-7; Sequence=VSP_005316, VSP_005317;
CC         Note=Lacks exon 13.;
CC       Name=8;
CC         IsoId=P16070-8; Sequence=VSP_005318, VSP_005319;
CC         Note=Lacks exon 14.;
CC       Name=9;
CC         IsoId=P16070-9; Sequence=VSP_005320, VSP_005321;
CC         Note=Lacks exon 19.;
CC       Name=10; Synonyms=CD44E, CD44R1, Epithelial, Keratinocyte;
CC         IsoId=P16070-10; Sequence=VSP_005309, VSP_005310;
CC         Note=Lacks exons 6-11.;
CC       Name=11; Synonyms=CD44R2;
CC         IsoId=P16070-11; Sequence=VSP_022797;
CC         Note=Lacks exons 6-13.;
CC       Name=12; Synonyms=CDw44, Reticulocyte;
CC         IsoId=P16070-12; Sequence=VSP_005311, VSP_005312;
CC         Note=Lacks exons 6-14.;
CC       Name=13; Synonyms=CD44R4;
CC         IsoId=P16070-13; Sequence=VSP_005309, VSP_005310, VSP_005318,
CC                                   VSP_005319;
CC         Note=Lacks exons 6-11 and exon 14.;
CC       Name=14; Synonyms=CD44R5;
CC         IsoId=P16070-14; Sequence=VSP_005309, VSP_005310, VSP_005316,
CC                                   VSP_005317, VSP_005318, VSP_005319;
CC         Note=Lacks exons 6-11, exon 13 and exon 14.;
CC       Name=15; Synonyms=Hermes;
CC         IsoId=P16070-15; Sequence=VSP_005311, VSP_005312, VSP_005320,
CC                                   VSP_005321;
CC         Note=Lacks exons 6-14 and exon 19.;
CC       Name=16;
CC         IsoId=P16070-16; Sequence=VSP_005305, VSP_005306, VSP_005314,
CC                                   VSP_005315;
CC         Note=Alternative splice donor/acceptor on exon 5 and lacks exon
CC         10.;
CC       Name=17;
CC         IsoId=P16070-17; Sequence=VSP_005313, VSP_005314, VSP_005315;
CC         Note=Alternative splice donor/acceptor on exon 7 and lacks exon
CC         10.;
CC       Name=18;
CC         IsoId=P16070-18; Sequence=VSP_005311, VSP_005312, VSP_043575;
CC         Note=No experimental confirmation available.;
CC       Name=19; Synonyms=CD44RC;
CC         IsoId=P16070-19; Sequence=VSP_043870, VSP_043871;
CC         Note=Soluble isoform, has enhanced hyaluronan binding.;
CC   -!- TISSUE SPECIFICITY: Isoform 10 (epithelial isoform) is expressed
CC       by cells of epithelium and highly expressed by carcinomas.
CC       Expression is repressed in neuroblastoma cells.
CC   -!- DOMAIN: The lectin-like LINK domain is responsible for hyaluronan
CC       binding. {ECO:0000250}.
CC   -!- PTM: Proteolytically cleaved in the extracellular matrix by
CC       specific proteinases (possibly MMPs) in several cell lines and
CC       tumors. {ECO:0000269|PubMed:12883358}.
CC   -!- PTM: N- and O-glycosylated. O-glycosylation contains more-or-less-
CC       sulfated chondroitin sulfate glycans, whose number may affect the
CC       accessibility of specific proteinases to their cleavage site(s).
CC       It is uncertain if O-glycosylation occurs on Thr-637 or Thr-638.
CC       {ECO:0000269|PubMed:12883358, ECO:0000269|PubMed:16335952,
CC       ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:22171320}.
CC   -!- PTM: Phosphorylated; activation of PKC results in the
CC       dephosphorylation of Ser-706 (constitutive phosphorylation site),
CC       and the phosphorylation of Ser-672. {ECO:0000269|PubMed:12032545,
CC       ECO:0000269|PubMed:9580567}.
CC   -!- POLYMORPHISM: CD44 is responsible for the Indian blood group
CC       system. The molecular basis of the In(A)=In1/In(B)=In2 blood group
CC       antigens is a single variation in position 46; In(B), the most
CC       frequent allele, has Arg-46. {ECO:0000269|PubMed:8636151}.
CC   -!- SIMILARITY: Contains 1 Link domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00323}.
CC   -!- WEB RESOURCE: Name=dbRBC/BGMUT; Note=Blood group antigen gene
CC       mutation database;
CC       URL="https://www.ncbi.nlm.nih.gov/gv/mhc/xslcgi.cgi?cmd=bgmut/systems_info&system=indian";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=CD44 entry;
CC       URL="https://en.wikipedia.org/wiki/CD44";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CD44ID980CH11p13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M24915; AAA35674.1; -; mRNA.
DR   EMBL; M59040; AAA51950.1; -; mRNA.
DR   EMBL; X55150; CAA38951.1; -; mRNA.
DR   EMBL; X56794; CAA40133.1; -; mRNA.
DR   EMBL; X66733; CAA47271.1; -; mRNA.
DR   EMBL; L05423; AAB13622.1; -; Genomic_DNA.
DR   EMBL; L05407; AAB13622.1; JOINED; Genomic_DNA.
DR   EMBL; L05408; AAB13622.1; JOINED; Genomic_DNA.
DR   EMBL; L05409; AAB13622.1; JOINED; Genomic_DNA.
DR   EMBL; L05410; AAB13622.1; JOINED; Genomic_DNA.
DR   EMBL; L05420; AAB13622.1; JOINED; Genomic_DNA.
DR   EMBL; L05421; AAB13622.1; JOINED; Genomic_DNA.
DR   EMBL; L05422; AAB13622.1; JOINED; Genomic_DNA.
DR   EMBL; M69215; AAB13622.1; JOINED; Genomic_DNA.
DR   EMBL; L05423; AAB13623.1; -; Genomic_DNA.
DR   EMBL; L05407; AAB13623.1; JOINED; Genomic_DNA.
DR   EMBL; L05408; AAB13623.1; JOINED; Genomic_DNA.
DR   EMBL; L05410; AAB13623.1; JOINED; Genomic_DNA.
DR   EMBL; L05411; AAB13623.1; JOINED; Genomic_DNA.
DR   EMBL; L05412; AAB13623.1; JOINED; Genomic_DNA.
DR   EMBL; L05414; AAB13623.1; JOINED; Genomic_DNA.
DR   EMBL; L05415; AAB13623.1; JOINED; Genomic_DNA.
DR   EMBL; L05416; AAB13623.1; JOINED; Genomic_DNA.
DR   EMBL; L05417; AAB13623.1; JOINED; Genomic_DNA.
DR   EMBL; L05418; AAB13623.1; JOINED; Genomic_DNA.
DR   EMBL; L05419; AAB13623.1; JOINED; Genomic_DNA.
DR   EMBL; L05420; AAB13623.1; JOINED; Genomic_DNA.
DR   EMBL; L05421; AAB13623.1; JOINED; Genomic_DNA.
DR   EMBL; L05422; AAB13623.1; JOINED; Genomic_DNA.
DR   EMBL; M69215; AAB13623.1; JOINED; Genomic_DNA.
DR   EMBL; L05424; AAB13624.1; -; Genomic_DNA.
DR   EMBL; L05407; AAB13624.1; JOINED; Genomic_DNA.
DR   EMBL; L05408; AAB13624.1; JOINED; Genomic_DNA.
DR   EMBL; L05410; AAB13624.1; JOINED; Genomic_DNA.
DR   EMBL; L05420; AAB13624.1; JOINED; Genomic_DNA.
DR   EMBL; L05421; AAB13624.1; JOINED; Genomic_DNA.
DR   EMBL; L05422; AAB13624.1; JOINED; Genomic_DNA.
DR   EMBL; M69215; AAB13624.1; JOINED; Genomic_DNA.
DR   EMBL; L05424; AAB13625.1; -; Genomic_DNA.
DR   EMBL; L05407; AAB13625.1; JOINED; Genomic_DNA.
DR   EMBL; L05408; AAB13625.1; JOINED; Genomic_DNA.
DR   EMBL; L05410; AAB13625.1; JOINED; Genomic_DNA.
DR   EMBL; L05411; AAB13625.1; JOINED; Genomic_DNA.
DR   EMBL; L05412; AAB13625.1; JOINED; Genomic_DNA.
DR   EMBL; L05414; AAB13625.1; JOINED; Genomic_DNA.
DR   EMBL; L05416; AAB13625.1; JOINED; Genomic_DNA.
DR   EMBL; L05417; AAB13625.1; JOINED; Genomic_DNA.
DR   EMBL; L05418; AAB13625.1; JOINED; Genomic_DNA.
DR   EMBL; L05419; AAB13625.1; JOINED; Genomic_DNA.
DR   EMBL; L05420; AAB13625.1; JOINED; Genomic_DNA.
DR   EMBL; L05421; AAB13625.1; JOINED; Genomic_DNA.
DR   EMBL; L05422; AAB13625.1; JOINED; Genomic_DNA.
DR   EMBL; M69215; AAB13625.1; JOINED; Genomic_DNA.
DR   EMBL; L05424; AAB13626.1; -; Genomic_DNA.
DR   EMBL; L05407; AAB13626.1; JOINED; Genomic_DNA.
DR   EMBL; L05408; AAB13626.1; JOINED; Genomic_DNA.
DR   EMBL; L05410; AAB13626.1; JOINED; Genomic_DNA.
DR   EMBL; L05411; AAB13626.1; JOINED; Genomic_DNA.
DR   EMBL; L05412; AAB13626.1; JOINED; Genomic_DNA.
DR   EMBL; L05414; AAB13626.1; JOINED; Genomic_DNA.
DR   EMBL; L05416; AAB13626.1; JOINED; Genomic_DNA.
DR   EMBL; L05417; AAB13626.1; JOINED; Genomic_DNA.
DR   EMBL; L05418; AAB13626.1; JOINED; Genomic_DNA.
DR   EMBL; L05419; AAB13626.1; JOINED; Genomic_DNA.
DR   EMBL; L05420; AAB13626.1; JOINED; Genomic_DNA.
DR   EMBL; L05421; AAB13626.1; JOINED; Genomic_DNA.
DR   EMBL; L05422; AAB13626.1; JOINED; Genomic_DNA.
DR   EMBL; M69215; AAB13626.1; JOINED; Genomic_DNA.
DR   EMBL; L05424; AAB13627.1; -; Genomic_DNA.
DR   EMBL; L05407; AAB13627.1; JOINED; Genomic_DNA.
DR   EMBL; L05408; AAB13627.1; JOINED; Genomic_DNA.
DR   EMBL; L05410; AAB13627.1; JOINED; Genomic_DNA.
DR   EMBL; L05417; AAB13627.1; JOINED; Genomic_DNA.
DR   EMBL; L05418; AAB13627.1; JOINED; Genomic_DNA.
DR   EMBL; L05420; AAB13627.1; JOINED; Genomic_DNA.
DR   EMBL; L05421; AAB13627.1; JOINED; Genomic_DNA.
DR   EMBL; L05422; AAB13627.1; JOINED; Genomic_DNA.
DR   EMBL; M69215; AAB13627.1; JOINED; Genomic_DNA.
DR   EMBL; L05424; AAB13628.1; -; Genomic_DNA.
DR   EMBL; L05407; AAB13628.1; JOINED; Genomic_DNA.
DR   EMBL; L05408; AAB13628.1; JOINED; Genomic_DNA.
DR   EMBL; L05410; AAB13628.1; JOINED; Genomic_DNA.
DR   EMBL; L05411; AAB13628.1; JOINED; Genomic_DNA.
DR   EMBL; L05412; AAB13628.1; JOINED; Genomic_DNA.
DR   EMBL; L05414; AAB13628.1; JOINED; Genomic_DNA.
DR   EMBL; L05415; AAB13628.1; JOINED; Genomic_DNA.
DR   EMBL; L05416; AAB13628.1; JOINED; Genomic_DNA.
DR   EMBL; L05417; AAB13628.1; JOINED; Genomic_DNA.
DR   EMBL; L05418; AAB13628.1; JOINED; Genomic_DNA.
DR   EMBL; L05419; AAB13628.1; JOINED; Genomic_DNA.
DR   EMBL; L05420; AAB13628.1; JOINED; Genomic_DNA.
DR   EMBL; L05421; AAB13628.1; JOINED; Genomic_DNA.
DR   EMBL; L05422; AAB13628.1; JOINED; Genomic_DNA.
DR   EMBL; M69215; AAB13628.1; JOINED; Genomic_DNA.
DR   EMBL; AJ251595; CAB61878.1; -; mRNA.
DR   EMBL; S66400; AAB27917.1; -; mRNA.
DR   EMBL; S66400; AAB27918.2; -; mRNA.
DR   EMBL; S66400; AAB27919.1; -; mRNA.
DR   EMBL; AF098641; AAC70782.1; -; mRNA.
DR   EMBL; U40373; AAA82949.1; -; mRNA.
DR   EMBL; AY101192; AAM50040.1; -; mRNA.
DR   EMBL; AY101193; AAM50041.1; -; mRNA.
DR   EMBL; EF581837; ABQ59315.1; -; mRNA.
DR   EMBL; FJ216964; ACI46596.1; -; mRNA.
DR   EMBL; AL832642; CAD89965.1; -; mRNA.
DR   EMBL; AL133330; CAC10347.1; -; Genomic_DNA.
DR   EMBL; AL136989; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356215; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471064; EAW68147.1; -; Genomic_DNA.
DR   EMBL; CH471064; EAW68148.1; -; Genomic_DNA.
DR   EMBL; CH471064; EAW68149.1; -; Genomic_DNA.
DR   EMBL; CH471064; EAW68151.1; -; Genomic_DNA.
DR   EMBL; CH471064; EAW68152.1; -; Genomic_DNA.
DR   EMBL; BC004372; AAH04372.1; -; mRNA.
DR   EMBL; BC067348; AAH67348.1; -; mRNA.
DR   EMBL; M25078; AAA36138.1; -; mRNA.
DR   EMBL; X55938; CAA39404.1; -; mRNA.
DR   EMBL; S72928; AAB30429.1; -; Genomic_DNA.
DR   EMBL; X62739; CAA44602.1; -; mRNA.
DR   CCDS; CCDS31455.1; -. [P16070-4]
DR   CCDS; CCDS31456.1; -. [P16070-10]
DR   CCDS; CCDS31457.1; -. [P16070-12]
DR   CCDS; CCDS31458.1; -. [P16070-19]
DR   CCDS; CCDS55754.1; -. [P16070-11]
DR   CCDS; CCDS55755.1; -. [P16070-18]
DR   CCDS; CCDS7897.1; -. [P16070-1]
DR   PIR; A47195; A47195.
DR   PIR; I37369; I37369.
DR   PIR; I77371; I77371.
DR   PIR; I77372; I77372.
DR   PIR; JH0417; JH0417.
DR   PIR; JH0518; JH0518.
DR   PIR; S13530; S13530.
DR   PIR; S24222; S24222.
DR   RefSeq; NP_000601.3; NM_000610.3. [P16070-1]
DR   RefSeq; NP_001001389.1; NM_001001389.1. [P16070-4]
DR   RefSeq; NP_001001390.1; NM_001001390.1. [P16070-10]
DR   RefSeq; NP_001001391.1; NM_001001391.1. [P16070-12]
DR   RefSeq; NP_001001392.1; NM_001001392.1. [P16070-19]
DR   RefSeq; NP_001189484.1; NM_001202555.1. [P16070-11]
DR   RefSeq; NP_001189485.1; NM_001202556.1. [P16070-18]
DR   RefSeq; NP_001189486.1; NM_001202557.1. [P16070-15]
DR   RefSeq; XP_011518790.1; XM_011520488.1. [P16070-13]
DR   UniGene; Hs.502328; -.
DR   PDB; 1POZ; NMR; -; A=20-178.
DR   PDB; 1UUH; X-ray; 2.20 A; A/B=20-178.
DR   PDB; 2I83; NMR; -; A=21-178.
DR   PDB; 4PZ3; X-ray; 1.08 A; A/B=18-170.
DR   PDB; 4PZ4; X-ray; 1.60 A; A/B=18-171.
DR   PDBsum; 1POZ; -.
DR   PDBsum; 1UUH; -.
DR   PDBsum; 2I83; -.
DR   PDBsum; 4PZ3; -.
DR   PDBsum; 4PZ4; -.
DR   ProteinModelPortal; P16070; -.
DR   SMR; P16070; -.
DR   BioGrid; 107398; 101.
DR   DIP; DIP-1121N; -.
DR   IntAct; P16070; 53.
DR   MINT; MINT-5000740; -.
DR   STRING; 9606.ENSP00000398632; -.
DR   BindingDB; P16070; -.
DR   ChEMBL; CHEMBL3232692; -.
DR   DrugBank; DB08818; Hyaluronic acid.
DR   iPTMnet; P16070; -.
DR   PhosphoSitePlus; P16070; -.
DR   SwissPalm; P16070; -.
DR   UniCarbKB; P16070; -.
DR   BioMuta; CD44; -.
DR   DMDM; 308153615; -.
DR   SWISS-2DPAGE; P16070; -.
DR   EPD; P16070; -.
DR   MaxQB; P16070; -.
DR   PaxDb; P16070; -.
DR   PeptideAtlas; P16070; -.
DR   PRIDE; P16070; -.
DR   TopDownProteomics; P16070-12; -. [P16070-12]
DR   TopDownProteomics; P16070-14; -. [P16070-14]
DR   TopDownProteomics; P16070-18; -. [P16070-18]
DR   TopDownProteomics; P16070-4; -. [P16070-4]
DR   TopDownProteomics; P16070-7; -. [P16070-7]
DR   DNASU; 960; -.
DR   Ensembl; ENST00000263398; ENSP00000263398; ENSG00000026508. [P16070-12]
DR   Ensembl; ENST00000278386; ENSP00000278386; ENSG00000026508. [P16070-19]
DR   Ensembl; ENST00000352818; ENSP00000309732; ENSG00000026508. [P16070-18]
DR   Ensembl; ENST00000415148; ENSP00000389830; ENSG00000026508. [P16070-4]
DR   Ensembl; ENST00000428726; ENSP00000398632; ENSG00000026508. [P16070-1]
DR   Ensembl; ENST00000433892; ENSP00000392331; ENSG00000026508. [P16070-10]
DR   Ensembl; ENST00000434472; ENSP00000404447; ENSG00000026508. [P16070-11]
DR   GeneID; 960; -.
DR   KEGG; hsa:960; -.
DR   UCSC; uc001mvu.4; human. [P16070-1]
DR   CTD; 960; -.
DR   DisGeNET; 960; -.
DR   GeneCards; CD44; -.
DR   HGNC; HGNC:1681; CD44.
DR   HPA; CAB000112; -.
DR   HPA; CAB000316; -.
DR   HPA; HPA005785; -.
DR   MIM; 107269; gene.
DR   MIM; 172290; gene.
DR   MIM; 609027; phenotype.
DR   neXtProt; NX_P16070; -.
DR   OpenTargets; ENSG00000026508; -.
DR   PharmGKB; PA26221; -.
DR   eggNOG; ENOG410IZCP; Eukaryota.
DR   eggNOG; ENOG4111S6T; LUCA.
DR   GeneTree; ENSGT00530000063822; -.
DR   HOGENOM; HOG000115236; -.
DR   HOVERGEN; HBG003850; -.
DR   InParanoid; P16070; -.
DR   KO; K06256; -.
DR   OMA; SHPMGRG; -.
DR   OrthoDB; EOG091G0F98; -.
DR   PhylomeDB; P16070; -.
DR   TreeFam; TF334173; -.
DR   BioCyc; ZFISH:ENSG00000026508-MONOMER; -.
DR   Reactome; R-HSA-1474228; Degradation of the extracellular matrix.
DR   Reactome; R-HSA-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-2160916; Hyaluronan uptake and degradation.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   SIGNOR; P16070; -.
DR   ChiTaRS; CD44; human.
DR   EvolutionaryTrace; P16070; -.
DR   GeneWiki; CD44; -.
DR   GenomeRNAi; 960; -.
DR   PRO; PR:P16070; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000026508; -.
DR   ExpressionAtlas; P16070; baseline and differential.
DR   Genevisible; P16070; HS.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0035692; C:macrophage migration inhibitory factor receptor complex; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0005518; F:collagen binding; NAS:UniProtKB.
DR   GO; GO:0005540; F:hyaluronic acid binding; IDA:UniProtKB.
DR   GO; GO:0051216; P:cartilage development; IEP:UniProtKB.
DR   GO; GO:0007160; P:cell-matrix adhesion; NAS:UniProtKB.
DR   GO; GO:0044344; P:cellular response to fibroblast growth factor stimulus; IDA:UniProtKB.
DR   GO; GO:0022617; P:extracellular matrix disassembly; TAS:Reactome.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0030214; P:hyaluronan catabolic process; IDA:UniProtKB.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0070487; P:monocyte aggregation; IMP:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB.
DR   GO; GO:0043518; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; IDA:BHF-UCL.
DR   GO; GO:1902166; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IDA:BHF-UCL.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IDA:BHF-UCL.
DR   GO; GO:0034116; P:positive regulation of heterotypic cell-cell adhesion; IMP:UniProtKB.
DR   GO; GO:1900625; P:positive regulation of monocyte aggregation; IMP:BHF-UCL.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0016337; P:single organismal cell-cell adhesion; NAS:UniProtKB.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR016186; C-type_lectin-like.
DR   InterPro; IPR016187; C-type_lectin_fold.
DR   InterPro; IPR001231; CD44_antigen.
DR   InterPro; IPR000538; Link_dom.
DR   Pfam; PF00193; Xlink; 1.
DR   PRINTS; PR00658; CD44.
DR   PRINTS; PR01265; LINKMODULE.
DR   SMART; SM00445; LINK; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS01241; LINK_1; 1.
DR   PROSITE; PS50963; LINK_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Blood group antigen;
KW   Cell adhesion; Cell membrane; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Membrane;
KW   Phosphoprotein; Polymorphism; Proteoglycan;
KW   Pyrrolidone carboxylic acid; Receptor; Reference proteome; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     20       {ECO:0000250}.
FT   CHAIN        21    742       CD44 antigen.
FT                                /FTId=PRO_0000026687.
FT   TOPO_DOM     21    649       Extracellular. {ECO:0000255}.
FT   TRANSMEM    650    670       Helical. {ECO:0000255}.
FT   TOPO_DOM    671    742       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       32    120       Link. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00323}.
FT   REGION      224    649       Stem.
FT   COMPBIAS    150    158       Arg/Lys-rich (basic).
FT   BINDING      41     41       Hyaluronan. {ECO:0000250}.
FT   BINDING      78     78       Hyaluronan. {ECO:0000250}.
FT   BINDING      79     79       Hyaluronan. {ECO:0000250}.
FT   BINDING     105    105       Hyaluronan. {ECO:0000250}.
FT   MOD_RES      21     21       Pyrrolidone carboxylic acid.
FT                                {ECO:0000305}.
FT   MOD_RES     672    672       Phosphoserine; by PKC.
FT                                {ECO:0000269|PubMed:12032545}.
FT   MOD_RES     686    686       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     697    697       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P15379}.
FT   MOD_RES     706    706       Phosphoserine.
FT                                {ECO:0000244|PubMed:17081983,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19367720,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:9580567}.
FT   CARBOHYD     25     25       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD     57     57       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    100    100       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    110    110       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    120    120       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    350    350       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    548    548       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    599    599       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    636    636       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    637    637       O-linked (GalNAc...); or Thr-638.
FT                                {ECO:0000269|PubMed:22171320}.
FT   CARBOHYD    638    638       O-linked (GalNAc...); or Thr-637.
FT                                {ECO:0000269|PubMed:22171320}.
FT   DISULFID     28    129       {ECO:0000255|PROSITE-ProRule:PRU00323}.
FT   DISULFID     53    118       {ECO:0000255|PROSITE-ProRule:PRU00323}.
FT   DISULFID     77     97       {ECO:0000255|PROSITE-ProRule:PRU00323}.
FT   VAR_SEQ      23     29       DLNITCR -> GVGRRKS (in isoform 2).
FT                                {ECO:0000303|PubMed:8352881}.
FT                                /FTId=VSP_005303.
FT   VAR_SEQ      30    742       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:8352881}.
FT                                /FTId=VSP_005304.
FT   VAR_SEQ      78    139       RYGFIEGHVVIPRIHPNSICAANNTGVYILTSNTSQYDTYC
FT                                FNASAPPEEDCTSVTDLPNAF -> SLHCSQQSKKVWAEEK
FT                                ASDQQWQWSCGGQKAKWTQRRGQQVSGNGAFGEQGVVRNSR
FT                                PVYDS (in isoform 19).
FT                                {ECO:0000303|PubMed:10933060}.
FT                                /FTId=VSP_043870.
FT   VAR_SEQ     140    742       Missing (in isoform 19).
FT                                {ECO:0000303|PubMed:10933060}.
FT                                /FTId=VSP_043871.
FT   VAR_SEQ     192    192       G -> A (in isoform 3 and isoform 16).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_005305.
FT   VAR_SEQ     193    223       Missing (in isoform 3 and isoform 16).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_005306.
FT   VAR_SEQ     223    535       Missing (in isoform 11).
FT                                {ECO:0000303|PubMed:2056274,
FT                                ECO:0000303|Ref.12}.
FT                                /FTId=VSP_022797.
FT   VAR_SEQ     223    223       T -> N (in isoform 10, isoform 13 and
FT                                isoform 14). {ECO:0000303|PubMed:1991450,
FT                                ECO:0000303|PubMed:2007624,
FT                                ECO:0000303|PubMed:2056274,
FT                                ECO:0000303|PubMed:8352881,
FT                                ECO:0000303|Ref.11}.
FT                                /FTId=VSP_005309.
FT   VAR_SEQ     223    223       T -> R (in isoform 12, isoform 15 and
FT                                isoform 18).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005,
FT                                ECO:0000303|PubMed:1840487,
FT                                ECO:0000303|PubMed:2466575,
FT                                ECO:0000303|PubMed:2466576,
FT                                ECO:0000303|Ref.10, ECO:0000303|Ref.11,
FT                                ECO:0000303|Ref.13}.
FT                                /FTId=VSP_005311.
FT   VAR_SEQ     223    223       T -> S (in isoform 4).
FT                                {ECO:0000303|PubMed:1281868,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_005307.
FT   VAR_SEQ     224    604       Missing (in isoform 12, isoform 15 and
FT                                isoform 18).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:17974005,
FT                                ECO:0000303|PubMed:1840487,
FT                                ECO:0000303|PubMed:2466575,
FT                                ECO:0000303|PubMed:2466576,
FT                                ECO:0000303|Ref.10, ECO:0000303|Ref.11,
FT                                ECO:0000303|Ref.13}.
FT                                /FTId=VSP_005312.
FT   VAR_SEQ     224    472       Missing (in isoform 10, isoform 13 and
FT                                isoform 14). {ECO:0000303|PubMed:1991450,
FT                                ECO:0000303|PubMed:2007624,
FT                                ECO:0000303|PubMed:2056274,
FT                                ECO:0000303|PubMed:8352881,
FT                                ECO:0000303|Ref.11}.
FT                                /FTId=VSP_005310.
FT   VAR_SEQ     224    266       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:1281868,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_005308.
FT   VAR_SEQ     266    273       Missing (in isoform 5 and isoform 17).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_005313.
FT   VAR_SEQ     385    385       I -> T (in isoform 6, isoform 16 and
FT                                isoform 17). {ECO:0000305}.
FT                                /FTId=VSP_005314.
FT   VAR_SEQ     386    428       Missing (in isoform 6, isoform 16 and
FT                                isoform 17). {ECO:0000305}.
FT                                /FTId=VSP_005315.
FT   VAR_SEQ     506    506       Q -> R (in isoform 7 and isoform 14).
FT                                {ECO:0000303|PubMed:8352881}.
FT                                /FTId=VSP_005316.
FT   VAR_SEQ     507    535       Missing (in isoform 7 and isoform 14).
FT                                {ECO:0000303|PubMed:8352881}.
FT                                /FTId=VSP_005317.
FT   VAR_SEQ     536    536       N -> R (in isoform 8, isoform 13 and
FT                                isoform 14).
FT                                {ECO:0000303|PubMed:8352881}.
FT                                /FTId=VSP_005318.
FT   VAR_SEQ     537    604       Missing (in isoform 8, isoform 13 and
FT                                isoform 14).
FT                                {ECO:0000303|PubMed:8352881}.
FT                                /FTId=VSP_005319.
FT   VAR_SEQ     605    625       Missing (in isoform 18).
FT                                {ECO:0000303|Ref.13}.
FT                                /FTId=VSP_043575.
FT   VAR_SEQ     675    675       R -> S (in isoform 9 and isoform 15).
FT                                {ECO:0000303|PubMed:2466576}.
FT                                /FTId=VSP_005320.
FT   VAR_SEQ     676    742       Missing (in isoform 9 and isoform 15).
FT                                {ECO:0000303|PubMed:2466576}.
FT                                /FTId=VSP_005321.
FT   VARIANT      46     46       R -> P (in In(A) antigen;
FT                                dbSNP:rs369473842).
FT                                {ECO:0000269|PubMed:8636151}.
FT                                /FTId=VAR_006490.
FT   VARIANT     393    393       T -> M (in dbSNP:rs11607491).
FT                                /FTId=VAR_030325.
FT   VARIANT     417    417       K -> R (in dbSNP:rs9666607).
FT                                {ECO:0000269|PubMed:1465456,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:1717145,
FT                                ECO:0000269|PubMed:7508842}.
FT                                /FTId=VAR_021147.
FT   VARIANT     479    479       I -> T (in dbSNP:rs1467558).
FT                                {ECO:0000269|PubMed:1281868,
FT                                ECO:0000269|PubMed:1465456,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:1991450,
FT                                ECO:0000269|PubMed:2007624,
FT                                ECO:0000269|PubMed:2056274,
FT                                ECO:0000269|PubMed:7508842,
FT                                ECO:0000269|PubMed:8352881,
FT                                ECO:0000269|Ref.11}.
FT                                /FTId=VAR_030326.
FT   VARIANT     494    494       D -> H (in dbSNP:rs12273397).
FT                                {ECO:0000269|PubMed:7508842}.
FT                                /FTId=VAR_030327.
FT   CONFLICT     26     26       I -> M (in Ref. 10; AAA82949).
FT                                {ECO:0000305}.
FT   CONFLICT    109    109       S -> Y (in Ref. 1; AAA35674, 2; AAA51950,
FT                                3; CAA38951 and 7; CAB61878).
FT                                {ECO:0000305}.
FT   CONFLICT    221    221       A -> R (in Ref. 3; CAA38951).
FT                                {ECO:0000305}.
FT   CONFLICT    241    241       T -> A (in Ref. 7; CAB61878).
FT                                {ECO:0000305}.
FT   CONFLICT    410    410       E -> V (in Ref. 5; CAA47271).
FT                                {ECO:0000305}.
FT   CONFLICT    494    494       D -> N (in Ref. 7; CAB61878).
FT                                {ECO:0000305}.
FT   CONFLICT    555    555       T -> H (in Ref. 3; CAA38951).
FT                                {ECO:0000305}.
FT   CONFLICT    620    620       G -> E (in Ref. 1; AAA35674).
FT                                {ECO:0000305}.
FT   CONFLICT    697    697       S -> I (in Ref. 11; AAM50041 and 16;
FT                                AAH67348). {ECO:0000305}.
FT   STRAND       21     26       {ECO:0000244|PDB:4PZ3}.
FT   STRAND       33     38       {ECO:0000244|PDB:4PZ3}.
FT   HELIX        46     55       {ECO:0000244|PDB:4PZ3}.
FT   STRAND       57     59       {ECO:0000244|PDB:1POZ}.
FT   HELIX        63     71       {ECO:0000244|PDB:4PZ3}.
FT   STRAND       80     82       {ECO:0000244|PDB:4PZ3}.
FT   STRAND       85     92       {ECO:0000244|PDB:4PZ3}.
FT   HELIX        98    100       {ECO:0000244|PDB:4PZ3}.
FT   STRAND      103    106       {ECO:0000244|PDB:4PZ3}.
FT   STRAND      109    111       {ECO:0000244|PDB:1POZ}.
FT   STRAND      114    119       {ECO:0000244|PDB:4PZ3}.
FT   STRAND      121    123       {ECO:0000244|PDB:2I83}.
FT   STRAND      125    128       {ECO:0000244|PDB:4PZ3}.
FT   STRAND      130    132       {ECO:0000244|PDB:2I83}.
FT   STRAND      139    148       {ECO:0000244|PDB:4PZ3}.
FT   TURN        150    152       {ECO:0000244|PDB:1POZ}.
FT   STRAND      154    160       {ECO:0000244|PDB:4PZ3}.
FT   HELIX       165    168       {ECO:0000244|PDB:4PZ3}.
SQ   SEQUENCE   742 AA;  81538 MW;  BB9B66B19B970349 CRC64;
     MDKFWWHAAW GLCLVPLSLA QIDLNITCRF AGVFHVEKNG RYSISRTEAA DLCKAFNSTL
     PTMAQMEKAL SIGFETCRYG FIEGHVVIPR IHPNSICAAN NTGVYILTSN TSQYDTYCFN
     ASAPPEEDCT SVTDLPNAFD GPITITIVNR DGTRYVQKGE YRTNPEDIYP SNPTDDDVSS
     GSSSERSSTS GGYIFYTFST VHPIPDEDSP WITDSTDRIP ATTLMSTSAT ATETATKRQE
     TWDWFSWLFL PSESKNHLHT TTQMAGTSSN TISAGWEPNE ENEDERDRHL SFSGSGIDDD
     EDFISSTIST TPRAFDHTKQ NQDWTQWNPS HSNPEVLLQT TTRMTDVDRN GTTAYEGNWN
     PEAHPPLIHH EHHEEEETPH STSTIQATPS STTEETATQK EQWFGNRWHE GYRQTPKEDS
     HSTTGTAAAS AHTSHPMQGR TTPSPEDSSW TDFFNPISHP MGRGHQAGRR MDMDSSHSIT
     LQPTANPNTG LVEDLDRTGP LSMTTQQSNS QSFSTSHEGL EEDKDHPTTS TLTSSNRNDV
     TGGRRDPNHS EGSTTLLEGY TSHYPHTKES RTFIPVTSAK TGSFGVTAVT VGDSNSNVNR
     SLSGDQDTFH PSGGSHTTHG SESDGHSHGS QEGGANTTSG PIRTPQIPEW LIILASLLAL
     ALILAVCIAV NSRRRCGQKK KLVINSGNGA VEDRKPSGLN GEASKSQEMV HLVNKESSET
     PDQFMTADET RNLQNVDMKI GV
//
ID   Q86UZ1_HUMAN            Unreviewed;        80 AA.
AC   Q86UZ1;
DT   01-JUN-2003, integrated into UniProtKB/TrEMBL.
DT   01-JUN-2003, sequence version 1.
DT   02-NOV-2016, entry version 100.
DE   SubName: Full=CD44 antigen {ECO:0000313|Ensembl:ENSP00000395953};
DE   SubName: Full=CD44 protein {ECO:0000313|EMBL:AAH52287.1};
GN   Name=CD44 {ECO:0000313|EMBL:AAH52287.1,
GN   ECO:0000313|Ensembl:ENSP00000395953};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH52287.1};
RN   [1] {ECO:0000313|EMBL:AAH52287.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain {ECO:0000313|EMBL:AAH52287.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000395953, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [3] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [4] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [5] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6] {ECO:0000313|Ensembl:ENSP00000395953}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [7] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL133330; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL136989; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL356215; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC052287; AAH52287.1; -; mRNA.
DR   UniGene; Hs.502328; -.
DR   ProteinModelPortal; Q86UZ1; -.
DR   SMR; Q86UZ1; -.
DR   STRING; 9606.ENSP00000398632; -.
DR   MaxQB; Q86UZ1; -.
DR   PeptideAtlas; Q86UZ1; -.
DR   PRIDE; Q86UZ1; -.
DR   Ensembl; ENST00000425428; ENSP00000395953; ENSG00000026508.
DR   UCSC; uc058ain.1; human.
DR   HGNC; HGNC:1681; CD44.
DR   OpenTargets; ENSG00000026508; -.
DR   eggNOG; ENOG410IZCP; Eukaryota.
DR   eggNOG; ENOG4111S6T; LUCA.
DR   GeneTree; ENSGT00530000063822; -.
DR   ChiTaRS; CD44; human.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000026508; -.
DR   ExpressionAtlas; Q86UZ1; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:InterPro.
DR   GO; GO:0005540; F:hyaluronic acid binding; IEA:InterPro.
DR   GO; GO:0007155; P:cell adhesion; IEA:InterPro.
DR   Gene3D; 3.10.100.10; -; 1.
DR   InterPro; IPR016186; C-type_lectin-like.
DR   InterPro; IPR016187; C-type_lectin_fold.
DR   InterPro; IPR001231; CD44_antigen.
DR   InterPro; IPR000538; Link_dom.
DR   Pfam; PF00193; Xlink; 1.
DR   PRINTS; PR00658; CD44.
DR   SMART; SM00445; LINK; 1.
DR   SUPFAM; SSF56436; SSF56436; 1.
DR   PROSITE; PS50963; LINK_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:Q86UZ1,
KW   ECO:0000213|MaxQB:Q86UZ1, ECO:0000213|PeptideAtlas:Q86UZ1};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     20       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        21     80       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5007712719.
FT   DOMAIN       32     80       Link. {ECO:0000259|PROSITE:PS50963}.
SQ   SEQUENCE   80 AA;  8931 MW;  B0AC664418A5EB56 CRC64;
     MDKFWWHAAW GLCLVPLSLA QIDLNITCRF AGVFHVEKNG RYSISRTEAA DLCKAFNSTL
     PTMAQMEKAL SIGFETCSST
//
ID   Q99900_HUMAN            Unreviewed;       177 AA.
AC   Q99900;
DT   01-MAY-1997, integrated into UniProtKB/TrEMBL.
DT   01-MAY-1997, sequence version 1.
DT   06-JUL-2016, entry version 44.
DE   SubName: Full=CD44 protein {ECO:0000313|EMBL:AAD14389.1};
DE   Flags: Fragment;
GN   Name=CD44 {ECO:0000313|EMBL:AAD14389.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAD14389.1};
RN   [1] {ECO:0000313|EMBL:AAD14389.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=8640758;
RA   Ermak G., Jennings T., Robinson L., Ross J.S., Figge J.;
RT   "Restricted patterns of CD44 variant exon expression in human
RT   papillary thyroid carcinoma.";
RL   Cancer Res. 56:1037-1042(1996).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S82326; AAD14389.1; -; mRNA.
DR   UniGene; Hs.502328; -.
DR   ProteinModelPortal; Q99900; -.
DR   STRING; 9606.ENSP00000398632; -.
DR   PaxDb; Q99900; -.
DR   PeptideAtlas; Q99900; -.
DR   PRIDE; Q99900; -.
DR   eggNOG; ENOG410IZCP; Eukaryota.
DR   eggNOG; ENOG4111S6T; LUCA.
DR   HOVERGEN; HBG104192; -.
DR   ChiTaRS; CD44; human.
DR   GO; GO:0016021; C:integral component of membrane; IEA:InterPro.
DR   GO; GO:0007160; P:cell-matrix adhesion; NAS:UniProtKB.
DR   GO; GO:0016337; P:single organismal cell-cell adhesion; NAS:UniProtKB.
DR   InterPro; IPR001231; CD44_antigen.
DR   PRINTS; PR00658; CD44.
PE   2: Evidence at transcript level;
FT   NON_TER     177    177       {ECO:0000313|EMBL:AAD14389.1}.
SQ   SEQUENCE   177 AA;  18678 MW;  93A96F47E4D04B34 CRC64;
     DTYCFNASAP PEEDCTSVTG PLSMTTQQSN SQSFSTSHEG LEEDKDHPTT PTLTSSNRND
     VTGGRRDPNH SEGSTTLLEG YTSHYPHTKE SRTFIPVTSA KTGSFGVTAV TVGDSNSNVN
     RSLSGDQDTF HPSGGSHTTH GSESDGHSHG SQEGGANTTS GPIRTPQIPE WLIILAS
//
ID   Q9P2Z2_HUMAN            Unreviewed;       127 AA.
AC   Q9P2Z2;
DT   01-OCT-2000, integrated into UniProtKB/TrEMBL.
DT   01-OCT-2000, sequence version 1.
DT   02-NOV-2016, entry version 51.
DE   SubName: Full=CD44 epithelial domain {ECO:0000313|EMBL:AAD14279.2};
DE   Flags: Fragment;
GN   Name=CD44 {ECO:0000313|EMBL:AAD14279.2};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAD14279.2};
RN   [1] {ECO:0000313|EMBL:AAD14279.2}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=1734871; DOI=10.1016/0006-291X(92)91770-Q;
RA   Cooper D.L., Dougherty G., Harn H.J., Jackson S., Baptist E.W.,
RA   Byers J., Datta A., Phillips G., Isola N.R.;
RT   "The complex CD44 transcriptional unit; alternative splicing of three
RT   internal exons generates the epithelial form of CD44.";
RL   Biochem. Biophys. Res. Commun. 182:569-578(1992).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AH007369; AAD14279.2; -; Genomic_DNA.
DR   PIR; B42402; B42402.
DR   STRING; 9606.ENSP00000398632; -.
DR   PaxDb; Q9P2Z2; -.
DR   PeptideAtlas; Q9P2Z2; -.
DR   H-InvDB; HIX0009556; -.
DR   eggNOG; ENOG410IZCP; Eukaryota.
DR   eggNOG; ENOG4111S6T; LUCA.
DR   ChiTaRS; CD44; human.
PE   4: Predicted;
FT   NON_TER       1      1       {ECO:0000313|EMBL:AAD14279.2}.
FT   NON_TER     127    127       {ECO:0000313|EMBL:AAD14279.2}.
SQ   SEQUENCE   127 AA;  13542 MW;  9D4CF1E5D351B3E7 CRC64;
     MDSSHSTTLQ PTANPNTGLV EDLDRTGPLS MTTQQSNSQS FSTSHEGLEE DKDHPTTSTL
     TSSNRNDVTG GRRDPNHSEG STTLLEGYTS HYPHTKESRT FIPVTSAKTG SFGVTAVTVG
     DSNSNVN
//
ID   CEBPB_HUMAN             Reviewed;         345 AA.
AC   P17676; A8K671; Q96IH2; Q9H4Z5;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   22-AUG-2003, sequence version 2.
DT   02-NOV-2016, entry version 188.
DE   RecName: Full=CCAAT/enhancer-binding protein beta {ECO:0000312|HGNC:HGNC:1834};
DE            Short=C/EBP beta {ECO:0000312|HGNC:HGNC:1834};
DE   AltName: Full=Liver activator protein;
DE            Short=LAP;
DE   AltName: Full=Liver-enriched inhibitory protein;
DE            Short=LIP;
DE   AltName: Full=Nuclear factor NF-IL6 {ECO:0000303|PubMed:1741402};
DE   AltName: Full=Transcription factor 5;
DE            Short=TCF-5;
GN   Name=CEBPB {ECO:0000312|HGNC:HGNC:1834}; Synonyms=TCF5;
GN   ORFNames=PP9092;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND FUNCTION.
RC   TISSUE=Placenta;
RX   PubMed=2112087;
RA   Akira S., Isshiki H., Sugita T., Tanabe O., Kinoshita S., Nishio Y.,
RA   Nakajima T., Hirano T., Kishimoto T.;
RT   "A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP
RT   family.";
RL   EMBO J. 9:1897-1906(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15498874; DOI=10.1073/pnas.0404089101;
RA   Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H.,
RA   Qiu X., Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y.,
RA   Shu H., Chen X., Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S.,
RA   Gu J.;
RT   "Large-scale cDNA transfection screening for genes related to cancer
RT   development and progression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-195.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (DEC-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Muscle, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 241-323 (ISOFORMS 1/2/3).
RX   PubMed=7635140; DOI=10.1111/j.1432-1033.1995.tb20699.x;
RA   Toda K., Akira S., Kishimoto T., Sasaki H., Hashimoto K., Yamamoto Y.,
RA   Sagara Y., Shizuta Y.;
RT   "Identification of a transcriptional regulatory factor for human
RT   aromatase cytochrome P450 gene expression as nuclear factor
RT   interleukin-6 (NF-IL6), a member of the CCAAT/enhancer-binding protein
RT   family.";
RL   Eur. J. Biochem. 231:292-299(1995).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH CEBPD.
RX   PubMed=1741402; DOI=10.1073/pnas.89.4.1473;
RA   Kinoshita S., Akira S., Kishimoto T.;
RT   "A member of the C/EBP family, NF-IL6 beta, forms a heterodimer and
RT   transcriptionally synergizes with NF-IL6.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:1473-1476(1992).
RN   [10]
RP   FUNCTION, PHOSPHORYLATION AT SER-288, MUTAGENESIS OF SER-288, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=9374525; DOI=10.1074/jbc.272.48.30356;
RA   Chinery R., Brockman J.A., Dransfield D.T., Coffey R.J.;
RT   "Antioxidant-induced nuclear translocation of CCAAT/enhancer-binding
RT   protein beta. A critical role for protein kinase A-mediated
RT   phosphorylation of Ser299.";
RL   J. Biol. Chem. 272:30356-30361(1997).
RN   [11]
RP   INTERACTION WITH ATF4, AND DNA-BINDING.
RX   PubMed=11018027; DOI=10.1074/jbc.M005594200;
RA   Podust L.M., Krezel A.M., Kim Y.;
RT   "Crystal structure of the CCAAT box/enhancer-binding protein beta
RT   activating transcription factor-4 basic leucine zipper heterodimer in
RT   the absence of DNA.";
RL   J. Biol. Chem. 276:505-513(2001).
RN   [12]
RP   PHOSPHORYLATION AT THR-235.
RX   PubMed=11684016; DOI=10.1016/S1097-2765(01)00374-4;
RA   Buck M., Poli V., Hunter T., Chojkier M.;
RT   "C/EBPbeta phosphorylation by RSK creates a functional XEXD caspase
RT   inhibitory box critical for cell survival.";
RL   Mol. Cell 8:807-816(2001).
RN   [13]
RP   FUNCTION (ISOFORM 3), ALTERNATIVE SPLICING (ISOFORMS 1; 2 AND 3), AND
RP   DNA-BINDING.
RX   PubMed=11741938; DOI=10.1074/jbc.M108075200;
RA   Zhu Y., Saunders M.A., Yeh H., Deng W.G., Wu K.K.;
RT   "Dynamic regulation of cyclooxygenase-2 promoter activity by isoforms
RT   of CCAAT/enhancer-binding proteins.";
RL   J. Biol. Chem. 277:6923-6928(2002).
RN   [14]
RP   FUNCTION, AND MUTAGENESIS OF THR-235.
RX   PubMed=12048245; DOI=10.1073/pnas.122075799;
RA   Roy S.K., Hu J., Meng Q., Xia Y., Shapiro P.S., Reddy S.P.,
RA   Platanias L.C., Lindner D.J., Johnson P.F., Pritchard C., Pages G.,
RA   Pouyssegur J., Kalvakolanu D.V.;
RT   "MEKK1 plays a critical role in activating the transcription factor
RT   C/EBP-beta-dependent gene expression in response to IFN-gamma.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:7945-7950(2002).
RN   [15]
RP   SUMOYLATION AT LYS-174.
RX   PubMed=12810706; DOI=10.1074/jbc.M305680200;
RA   Eaton E.M., Sealy L.;
RT   "Modification of CCAAT/enhancer-binding protein-beta by the small
RT   ubiquitin-like modifier (SUMO) family members, SUMO-2 and SUMO-3.";
RL   J. Biol. Chem. 278:33416-33421(2003).
RN   [16]
RP   DOMAIN.
RX   PubMed=17467953; DOI=10.1016/j.ygeno.2007.02.003;
RA   Piskacek S., Gregor M., Nemethova M., Grabner M., Kovarik P.,
RA   Piskacek M.;
RT   "Nine-amino-acid transactivation domain: establishment and prediction
RT   utilities.";
RL   Genomics 89:756-768(2007).
RN   [17]
RP   FUNCTION, AND PHOSPHORYLATION AT THR-235.
RX   PubMed=18647749; DOI=10.1074/jbc.M802132200;
RA   Pless O., Kowenz-Leutz E., Knoblich M., Lausen J., Beyermann M.,
RA   Walsh M.J., Leutz A.;
RT   "G9a-mediated lysine methylation alters the function of
RT   CCAAT/enhancer-binding protein-beta.";
RL   J. Biol. Chem. 283:26357-26363(2008).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [19]
RP   INTERACTION WITH MED23; MED26; SMARCA2; SMARCB1 AND SMARCC1, AND
RP   METHYLATION AT ARG-3.
RX   PubMed=20111005; DOI=10.1038/emboj.2010.3;
RA   Kowenz-Leutz E., Pless O., Dittmar G., Knoblich M., Leutz A.;
RT   "Crosstalk between C/EBPbeta phosphorylation, arginine methylation,
RT   and SWI/SNF/Mediator implies an indexing transcription factor code.";
RL   EMBO J. 29:1105-1115(2010).
RN   [20]
RP   FUNCTION, INTERACTION WITH DDIT3, SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=20829347; DOI=10.1074/jbc.M110.136259;
RA   Park S.H., Choi H.J., Yang H., Do K.H., Kim J., Lee D.W., Moon Y.;
RT   "Endoplasmic reticulum stress-activated C/EBP homologous protein
RT   enhances nuclear factor-kappaB signals via repression of peroxisome
RT   proliferator-activated receptor gamma.";
RL   J. Biol. Chem. 285:35330-35339(2010).
RN   [21]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-133; LYS-174; LYS-187 AND
RP   LYS-260, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [22]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-133; LYS-174; LYS-187 AND
RP   LYS-260, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [23]
RP   REVIEW OF PTMS AND FUNCTION.
RX   PubMed=25451943; DOI=10.1074/jbc.R114.619957;
RA   Guo L., Li X., Tang Q.;
RT   "Transcriptional Regulation of Adipocyte Differentiation: A Central
RT   Role for CCAAT/Enhancer-binding Protein (C/EBP) beta.";
RL   J. Biol. Chem. 290:755-761(2015).
RN   [24]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-174, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 259-336 IN COMPLEXES WITH
RP   DNA, AND SUBUNIT.
RX   PubMed=11257229; DOI=10.1016/S0092-8674(01)00271-9;
RA   Tahirov T.H., Inoue-Bungo T., Morii H., Fujikawa A., Sasaki M.,
RA   Kimura K., Shiina M., Sato K., Kumasaka T., Yamamoto M., Ishii S.,
RA   Ogata K.;
RT   "Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain
RT   and its allosteric control by CBFbeta.";
RL   Cell 104:755-767(2001).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.23 ANGSTROMS) OF 259-345 IN COMPLEX WITH
RP   MOUSE MYB, SUBUNIT, INTERACTION WITH MYB, AND DNA-BINDING.
RX   PubMed=11792321; DOI=10.1016/S0092-8674(01)00636-5;
RA   Tahirov T.H., Sato K., Ichikawa-Iwata E., Sasaki M., Inoue-Bungo T.,
RA   Shiina M., Kimura K., Takata S., Fujikawa A., Morii H., Kumasaka T.,
RA   Yamamoto M., Ishii S., Ogata K.;
RT   "Mechanism of c-Myb-C/EBP beta cooperation from separated sites on a
RT   promoter.";
RL   Cell 108:57-70(2002).
CC   -!- FUNCTION: Important transcription factor regulating the expression
CC       of genes involved in immune and inflammatory responses
CC       (PubMed:1741402, PubMed:9374525, PubMed:12048245,
CC       PubMed:18647749). Plays also a significant role in adipogenesis,
CC       as well as in the gluconeogenic pathway, liver regeneration, and
CC       hematopoiesis. The consensus recognition site is 5'-
CC       T[TG]NNGNAA[TG]-3'. Its functional capacity is governed by protein
CC       interactions and post-translational protein modifications. During
CC       early embryogenesis, plays essential and redundant functions with
CC       CEBPA. Has a promitotic effect on many cell types such as
CC       hepatocytes and adipocytes but has an antiproliferative effect on
CC       T-cells by repressing MYC expression, facilitating differentiation
CC       along the T-helper 2 lineage. Binds to regulatory regions of
CC       several acute-phase and cytokines genes and plays a role in the
CC       regulation of acute-phase reaction and inflammation. Plays also a
CC       role in intracellular bacteria killing (By similarity). During
CC       adipogenesis, is rapidly expressed and, after activation by
CC       phosphorylation, induces CEBPA and PPARG, which turn on the series
CC       of adipocyte genes that give rise to the adipocyte phenotype. The
CC       delayed transactivation of the CEBPA and PPARG genes by CEBPB
CC       appears necessary to allow mitotic clonal expansion and thereby
CC       progression of terminal differentiation (PubMed:20829347).
CC       Essential for female reproduction because of a critical role in
CC       ovarian follicle development (By similarity). Restricts
CC       osteoclastogenesis (By similarity). {ECO:0000250|UniProtKB:P28033,
CC       ECO:0000269|PubMed:12048245, ECO:0000269|PubMed:18647749,
CC       ECO:0000269|PubMed:20829347, ECO:0000269|PubMed:9374525,
CC       ECO:0000303|PubMed:25451943}.
CC   -!- FUNCTION: Isoform 2: Essential for gene expression induction in
CC       activated macrophages. Plays a major role in immune responses such
CC       as CD4(+) T-cell response, granuloma formation and endotoxin
CC       shock. Not essential for intracellular bacteria killing.
CC       {ECO:0000250|UniProtKB:P28033}.
CC   -!- FUNCTION: Isoform 3: Acts as a dominant negative through
CC       heterodimerization with isoform 2 (PubMed:11741938). Promotes
CC       osteoblast differentiation and osteoclastogenesis (By similarity).
CC       {ECO:0000250|UniProtKB:P21272, ECO:0000250|UniProtKB:P28033,
CC       ECO:0000269|PubMed:11741938}.
CC   -!- SUBUNIT: Binds DNA as a homodimer and as a heterodimer
CC       (PubMed:11018027, PubMed:11257229, PubMed:11792321). Interacts
CC       with ATF4. Binds DNA as a heterodimer with ATF4 (PubMed:11018027).
CC       Interacts with MYB; within the complex, MYB and CEBPB bind to
CC       different promoter regions (PubMed:11792321). Can form stable
CC       heterodimers with CEBPD (PubMed:1741402). Can form stable
CC       heterodimers with CEBPA and CEBPE (By similarity). Isoform 2 and
CC       isoform 3 also form heterodimers. Interacts with TRIM28 and
CC       PTGES2. Interacts with PRDM16. Interacts with CCDC85B. Forms a
CC       complex with THOC5. Interacts with ZNF638; this interaction
CC       increases transcriptional activation. Interacts with CIDEA and
CC       CIDEC; these interactions increase transcriptional activation of a
CC       subset of CEBPB downstream target genes (By similarity). Interacts
CC       with DDIT3/CHOP (PubMed:20829347). Interacts with EP300; recruits
CC       EP300 to chromatin. Interacts with RORA; the interaction disrupts
CC       interaction with EP300. Interacts (not methylated) with MED23,
CC       MED26, SMARCA2, SMARCB1 and SMARCC1 (PubMed:20111005). Interacts
CC       with KAT2A and KAT2B (By similarity). Interacts with ATF5; EP300
CC       is required for ATF5 and CEBPB interaction and DNA binding (By
CC       similarity). {ECO:0000250|UniProtKB:P21272,
CC       ECO:0000250|UniProtKB:P28033, ECO:0000269|PubMed:11018027,
CC       ECO:0000269|PubMed:11257229, ECO:0000269|PubMed:11792321,
CC       ECO:0000269|PubMed:20111005, ECO:0000269|PubMed:20829347}.
CC   -!- INTERACTION:
CC       P18848:ATF4; NbExp=2; IntAct=EBI-969696, EBI-492498;
CC       Q16520:BATF; NbExp=2; IntAct=EBI-969696, EBI-749503;
CC       Q86X55:CARM1; NbExp=2; IntAct=EBI-969696, EBI-2339854;
CC       P49715:CEBPA; NbExp=2; IntAct=EBI-969696, EBI-1172054;
CC       P53567:CEBPG; NbExp=2; IntAct=EBI-969696, EBI-740209;
CC       P35638:DDIT3; NbExp=2; IntAct=EBI-969696, EBI-742651;
CC       P03120:E2 (xeno); NbExp=2; IntAct=EBI-969696, EBI-1779322;
CC       P03122:E2 (xeno); NbExp=3; IntAct=EBI-969696, EBI-7028618;
CC       P06422:E2 (xeno); NbExp=4; IntAct=EBI-969696, EBI-7136851;
CC       P06790:E2 (xeno); NbExp=4; IntAct=EBI-969696, EBI-7010629;
CC       P15941:MUC1; NbExp=8; IntAct=EBI-969696, EBI-10053698;
CC       P04637:TP53; NbExp=4; IntAct=EBI-969696, EBI-366083;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20829347}.
CC       Cytoplasm {ECO:0000269|PubMed:9374525}. Note=Translocates to the
CC       nucleus when phosphorylated at Ser-288. In T-cells when sumoylated
CC       drawn to pericentric heterochromatin thereby allowing
CC       proliferation (By similarity). {ECO:0000250|UniProtKB:P28033,
CC       ECO:0000269|PubMed:9374525}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative initiation; Named isoforms=3;
CC       Name=1; Synonyms=C/EBPbeta-FL;
CC         IsoId=P17676-1; Sequence=Displayed;
CC       Name=2; Synonyms=C/EBPbeta-LAP;
CC         IsoId=P17676-2; Sequence=VSP_053314;
CC       Name=3; Synonyms=C/EBPbeta-LIP;
CC         IsoId=P17676-3; Sequence=VSP_053313;
CC   -!- TISSUE SPECIFICITY: Expressed at low levels in the lung, kidney
CC       and spleen.
CC   -!- INDUCTION: By ER stress. {ECO:0000269|PubMed:20829347}.
CC   -!- DOMAIN: the 9aaTAD motif is a transactivation domain present in a
CC       large number of yeast and animal transcription factors.
CC       {ECO:0000269|PubMed:17467953}.
CC   -!- PTM: Methylated. Methylation at Arg-3 by CARM1 and at Lys-43 by
CC       EHMT2 inhibit transactivation activity. Methylation is probably
CC       inhibited by phosphorylation at Thr-235.
CC       {ECO:0000305|PubMed:18647749, ECO:0000305|PubMed:20111005}.
CC   -!- PTM: Sumoylated by polymeric chains of SUMO2 or SUMO3
CC       (PubMed:12810706). Sumoylation at Lys-174 is required for
CC       inhibition of T-cells proliferation. In adipocytes, sumoylation at
CC       Lys-174 by PIAS1 leads to ubiquitination and subsequent
CC       proteasomal degradation. Desumoylated by SENP2, which abolishes
CC       ubiquitination and stabilizes protein levels (By similarity).
CC       {ECO:0000250|UniProtKB:P28033, ECO:0000269|PubMed:12810706}.
CC   -!- PTM: Ubiquitinated, leading to proteasomal degradation.
CC       {ECO:0000250|UniProtKB:P28033}.
CC   -!- PTM: Phosphorylated at Thr-235 by MAPK and CDK2, serves to prime
CC       phosphorylation at Thr-226 and Ser-231 by GSK3B and acquire DNA-
CC       binding as well as transactivation activities, required to induce
CC       adipogenesis. MAPK and CDK2 act sequentially to maintain Thr-235
CC       in the primed phosphorylated state during mitotical cloning
CC       expansion and thereby progression of terminal differentiation.
CC       Phosphorylation at Thr-266 enhances transactivation activity.
CC       Phosphorylation at Ser-325 in response to calcium increases
CC       transactivation activity. Phosphorylated at Thr-235 by RPS6KA1
CC       (PubMed:11684016). {ECO:0000250|UniProtKB:P28033,
CC       ECO:0000269|PubMed:11684016}.
CC   -!- PTM: O-glycosylated, glycosylation at Ser-227 and Ser-228 prevents
CC       phosphorylation on Thr-235, Ser-231 and Thr-226 and DNA binding
CC       activity which delays the adipocyte differentiation program.
CC       {ECO:0000250|UniProtKB:P28033}.
CC   -!- PTM: Acetylated. Acetylation at Lys-43 is an important and dynamic
CC       regulatory event that contributes to its ability to transactivate
CC       target genes, including those associated with adipogenesis and
CC       adipocyte function. Deacetylation by HDAC1 represses its
CC       transactivation activity. Acetylated by KAT2A and KAT2B within a
CC       cluster of lysine residues between amino acids 129-133, this
CC       acetylation is strongly induced by glucocorticoid treatment and
CC       enhances transactivation activity. {ECO:0000250|UniProtKB:P28033}.
CC   -!- SIMILARITY: Belongs to the bZIP family. C/EBP subfamily.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 bZIP (basic-leucine zipper) domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00978}.
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/cebpb/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X52560; CAA36794.1; -; Genomic_DNA.
DR   EMBL; AF289608; AAL55792.1; -; mRNA.
DR   EMBL; AY193834; AAN86350.1; -; Genomic_DNA.
DR   EMBL; AK291536; BAF84225.1; -; mRNA.
DR   EMBL; AL161937; CAC14276.1; -; Genomic_DNA.
DR   EMBL; CH471077; EAW75629.1; -; Genomic_DNA.
DR   EMBL; BC007538; AAH07538.1; -; mRNA.
DR   EMBL; BC021931; AAH21931.1; -; mRNA.
DR   CCDS; CCDS13429.1; -. [P17676-1]
DR   PIR; S12788; S12788.
DR   PIR; S66246; S66246.
DR   RefSeq; NP_001272807.1; NM_001285878.1. [P17676-2]
DR   RefSeq; NP_001272808.1; NM_001285879.1. [P17676-3]
DR   RefSeq; NP_005185.2; NM_005194.3. [P17676-1]
DR   UniGene; Hs.517106; -.
DR   UniGene; Hs.719041; -.
DR   UniGene; Hs.720603; -.
DR   PDB; 1GTW; X-ray; 1.85 A; A/B=259-336.
DR   PDB; 1GU4; X-ray; 1.80 A; A/B=259-336.
DR   PDB; 1GU5; X-ray; 2.10 A; A/B=259-336.
DR   PDB; 1H88; X-ray; 2.80 A; A/B=259-336.
DR   PDB; 1H89; X-ray; 2.45 A; A/B=273-336.
DR   PDB; 1H8A; X-ray; 2.23 A; A/B=259-336.
DR   PDB; 1HJB; X-ray; 3.00 A; A/B/D/E=259-345.
DR   PDB; 1IO4; X-ray; 3.00 A; A/B=259-336.
DR   PDB; 2E42; X-ray; 1.80 A; A/B=259-336.
DR   PDB; 2E43; X-ray; 2.10 A; A/B=259-336.
DR   PDBsum; 1GTW; -.
DR   PDBsum; 1GU4; -.
DR   PDBsum; 1GU5; -.
DR   PDBsum; 1H88; -.
DR   PDBsum; 1H89; -.
DR   PDBsum; 1H8A; -.
DR   PDBsum; 1HJB; -.
DR   PDBsum; 1IO4; -.
DR   PDBsum; 2E42; -.
DR   PDBsum; 2E43; -.
DR   ProteinModelPortal; P17676; -.
DR   SMR; P17676; -.
DR   BioGrid; 107480; 67.
DR   DIP; DIP-35345N; -.
DR   IntAct; P17676; 24.
DR   MINT; MINT-230873; -.
DR   STRING; 9606.ENSP00000305422; -.
DR   iPTMnet; P17676; -.
DR   PhosphoSitePlus; P17676; -.
DR   BioMuta; CEBPB; -.
DR   DMDM; 34223718; -.
DR   EPD; P17676; -.
DR   MaxQB; P17676; -.
DR   PaxDb; P17676; -.
DR   PeptideAtlas; P17676; -.
DR   PRIDE; P17676; -.
DR   DNASU; 1051; -.
DR   Ensembl; ENST00000303004; ENSP00000305422; ENSG00000172216. [P17676-1]
DR   GeneID; 1051; -.
DR   KEGG; hsa:1051; -.
DR   UCSC; uc002xvi.4; human. [P17676-1]
DR   CTD; 1051; -.
DR   DisGeNET; 1051; -.
DR   GeneCards; CEBPB; -.
DR   H-InvDB; HIX0174729; -.
DR   HGNC; HGNC:1834; CEBPB.
DR   HPA; CAB004213; -.
DR   HPA; HPA061355; -.
DR   HPA; HPA062267; -.
DR   MIM; 189965; gene.
DR   neXtProt; NX_P17676; -.
DR   OpenTargets; ENSG00000172216; -.
DR   PharmGKB; PA26377; -.
DR   eggNOG; ENOG410ISXW; Eukaryota.
DR   eggNOG; ENOG410XX4P; LUCA.
DR   GeneTree; ENSGT00530000063192; -.
DR   HOGENOM; HOG000013112; -.
DR   HOVERGEN; HBG050879; -.
DR   InParanoid; P17676; -.
DR   KO; K10048; -.
DR   OMA; CKKPAEY; -.
DR   OrthoDB; EOG091G11FC; -.
DR   PhylomeDB; P17676; -.
DR   TreeFam; TF105008; -.
DR   BioCyc; ZFISH:ENSG00000172216-MONOMER; -.
DR   Reactome; R-HSA-2559582; Senescence-Associated Secretory Phenotype (SASP).
DR   Reactome; R-HSA-381340; Transcriptional regulation of white adipocyte differentiation.
DR   SignaLink; P17676; -.
DR   SIGNOR; P17676; -.
DR   EvolutionaryTrace; P17676; -.
DR   GeneWiki; CEBPB; -.
DR   GenomeRNAi; 1051; -.
DR   PRO; PR:P17676; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000172216; -.
DR   CleanEx; HS_CEBPB; -.
DR   Genevisible; P17676; HS.
DR   GO; GO:0036488; C:CHOP-C/EBP complex; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0000779; C:condensed chromosome, centromeric region; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0000790; C:nuclear chromatin; IEA:Ensembl.
DR   GO; GO:0016363; C:nuclear matrix; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0003677; F:DNA binding; TAS:ProtInc.
DR   GO; GO:0046982; F:protein heterodimerization activity; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II core promoter proximal region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0000979; F:RNA polymerase II core promoter sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:MGI.
DR   GO; GO:0003705; F:transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding; ISS:UniProtKB.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; NAS:ProtInc.
DR   GO; GO:0001077; F:transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding; IEA:Ensembl.
DR   GO; GO:0006953; P:acute-phase response; TAS:ProtInc.
DR   GO; GO:0050873; P:brown fat cell differentiation; IEA:Ensembl.
DR   GO; GO:0071230; P:cellular response to amino acid stimulus; IEA:Ensembl.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEA:Ensembl.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IEA:Ensembl.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:0042742; P:defense response to bacterium; ISS:UniProtKB.
DR   GO; GO:0001892; P:embryonic placenta development; IEA:Ensembl.
DR   GO; GO:0002432; P:granuloma formation; ISS:UniProtKB.
DR   GO; GO:0072574; P:hepatocyte proliferation; ISS:UniProtKB.
DR   GO; GO:0006955; P:immune response; TAS:ProtInc.
DR   GO; GO:0006954; P:inflammatory response; TAS:ProtInc.
DR   GO; GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0097421; P:liver regeneration; ISS:UniProtKB.
DR   GO; GO:0060644; P:mammary gland epithelial cell differentiation; IEA:Ensembl.
DR   GO; GO:0033598; P:mammary gland epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0007613; P:memory; IEA:Ensembl.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IEA:Ensembl.
DR   GO; GO:0042130; P:negative regulation of T cell proliferation; ISS:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl.
DR   GO; GO:0030182; P:neuron differentiation; IEA:Ensembl.
DR   GO; GO:0001541; P:ovarian follicle development; ISS:UniProtKB.
DR   GO; GO:0045600; P:positive regulation of fat cell differentiation; ISS:UniProtKB.
DR   GO; GO:0032753; P:positive regulation of interleukin-4 production; ISS:UniProtKB.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IDA:MGI.
DR   GO; GO:1990440; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0045408; P:regulation of interleukin-6 biosynthetic process; IEA:Ensembl.
DR   GO; GO:0045670; P:regulation of osteoclast differentiation; ISS:UniProtKB.
DR   GO; GO:0060850; P:regulation of transcription involved in cell fate commitment; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; IDA:UniProtKB.
DR   GO; GO:0035711; P:T-helper 1 cell activation; ISS:UniProtKB.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; TAS:ProtInc.
DR   InterPro; IPR004827; bZIP.
DR   InterPro; IPR031106; C/EBP.
DR   InterPro; IPR016468; C/EBP_chordates.
DR   PANTHER; PTHR23334; PTHR23334; 1.
DR   Pfam; PF07716; bZIP_2; 1.
DR   PIRSF; PIRSF005879; CCAAT/enhancer-binding; 1.
DR   SMART; SM00338; BRLZ; 1.
DR   PROSITE; PS50217; BZIP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Alternative initiation;
KW   Complete proteome; Cytoplasm; Differentiation; DNA-binding;
KW   Glycoprotein; Isopeptide bond; Methylation; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN         1    345       CCAAT/enhancer-binding protein beta.
FT                                /FTId=PRO_0000076617.
FT   DOMAIN      271    334       bZIP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00978}.
FT   REGION        1     24       Required for Lys-174 sumoylation.
FT   REGION       24    135       Required for MYC transcriptional
FT                                repression.
FT                                {ECO:0000250|UniProtKB:P28033}.
FT   REGION      275    295       Basic motif. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00978}.
FT   REGION      297    304       Leucine-zipper. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00978}.
FT   MOTIF       116    124       9aaTAD.
FT   COMPBIAS    162    170       Poly-Pro.
FT   MOD_RES       3      3       Omega-N-methylated arginine; by CARM1.
FT                                {ECO:0000305|PubMed:20111005}.
FT   MOD_RES      43     43       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P28033}.
FT   MOD_RES     129    129       N6-acetyllysine; by KAT2A and KAT2B.
FT                                {ECO:0000250|UniProtKB:P28033}.
FT   MOD_RES     132    132       N6-acetyllysine; by KAT2A and KAT2B.
FT                                {ECO:0000250|UniProtKB:P28033}.
FT   MOD_RES     133    133       N6-acetyllysine; by KAT2A and KAT2B;
FT                                alternate.
FT                                {ECO:0000250|UniProtKB:P28033}.
FT   MOD_RES     226    226       Phosphothreonine; by GSK3-beta.
FT                                {ECO:0000250|UniProtKB:P28033}.
FT   MOD_RES     231    231       Phosphoserine; by GSK3-beta.
FT                                {ECO:0000250|UniProtKB:P28033}.
FT   MOD_RES     235    235       Phosphothreonine; by RPS6KA1, CDK2 and
FT                                MAPK. {ECO:0000250|UniProtKB:P28033,
FT                                ECO:0000269|PubMed:11684016,
FT                                ECO:0000269|PubMed:18647749}.
FT   MOD_RES     266    266       Phosphothreonine; by RPS6KA1 and
FT                                PKC/PRKCA.
FT                                {ECO:0000250|UniProtKB:P28033}.
FT   MOD_RES     288    288       Phosphoserine; by PKC/PRKCA.
FT                                {ECO:0000305|PubMed:9374525}.
FT   MOD_RES     325    325       Phosphoserine; by CaMK2.
FT                                {ECO:0000250|UniProtKB:P28033}.
FT   CARBOHYD    227    227       O-linked (GlcNAc).
FT                                {ECO:0000250|UniProtKB:P28033}.
FT   CARBOHYD    228    228       O-linked (GlcNAc).
FT                                {ECO:0000250|UniProtKB:P28033}.
FT   CROSSLNK    133    133       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25772364}.
FT   CROSSLNK    174    174       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO);
FT                                alternate. {ECO:0000269|PubMed:12810706}.
FT   CROSSLNK    174    174       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364}.
FT   CROSSLNK    187    187       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25772364}.
FT   CROSSLNK    260    260       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25772364}.
FT   VAR_SEQ       1    198       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_053313.
FT   VAR_SEQ       1     23       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_053314.
FT   VARIANT     195    195       G -> S (in dbSNP:rs4253440).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_016300.
FT   MUTAGEN     235    235       T->S: Loss of transactivation activity in
FT                                response to IFNG.
FT                                {ECO:0000269|PubMed:12048245}.
FT   MUTAGEN     288    288       S->A: Loss of nuclear translocation.
FT                                {ECO:0000269|PubMed:9374525}.
FT   CONFLICT    241    241       A -> P (in Ref. 8; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT    253    253       A -> G (in Ref. 1; CAA36794).
FT                                {ECO:0000305}.
FT   STRAND      269    271       {ECO:0000244|PDB:1H8A}.
FT   HELIX       272    328       {ECO:0000244|PDB:1GU4}.
FT   TURN        329    331       {ECO:0000244|PDB:1GU4}.
SQ   SEQUENCE   345 AA;  36106 MW;  9B725BD6CCAA771D CRC64;
     MQRLVAWDPA CLPLPPPPPA FKSMEVANFY YEADCLAAAY GGKAAPAAPP AARPGPRPPA
     GELGSIGDHE RAIDFSPYLE PLGAPQAPAP ATATDTFEAA PPAPAPAPAS SGQHHDFLSD
     LFSDDYGGKN CKKPAEYGYV SLGRLGAAKG ALHPGCFAPL HPPPPPPPPP AELKAEPGFE
     PADCKRKEEA GAPGGGAGMA AGFPYALRAY LGYQAVPSGS SGSLSTSSSS SPPGTPSPAD
     AKAPPTACYA GAAPAPSQVK SKAKKTVDKH SDEYKIRRER NNIAVRKSRD KAKMRNLETQ
     HKVLELTAEN ERLQKKVEQL SRELSTLRNL FKQLPEPLLA SSGHC
//
ID   Q9BSC0_HUMAN            Unreviewed;       137 AA.
AC   Q9BSC0;
DT   01-JUN-2001, integrated into UniProtKB/TrEMBL.
DT   01-MAR-2004, sequence version 2.
DT   05-OCT-2016, entry version 93.
DE   SubName: Full=CEBPB protein {ECO:0000313|EMBL:AAH05132.2};
DE   Flags: Fragment;
GN   Name=CEBPB {ECO:0000313|EMBL:AAH05132.2};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH05132.2};
RN   [1] {ECO:0000313|EMBL:AAH05132.2}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary {ECO:0000313|EMBL:AAH05132.2};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC005132; AAH05132.2; -; mRNA.
DR   PIR; S66246; S66246.
DR   UniGene; Hs.517106; -.
DR   UniGene; Hs.719041; -.
DR   UniGene; Hs.720603; -.
DR   STRING; 9606.ENSP00000305422; -.
DR   PaxDb; Q9BSC0; -.
DR   PeptideAtlas; Q9BSC0; -.
DR   PRIDE; Q9BSC0; -.
DR   eggNOG; ENOG410ISXW; Eukaryota.
DR   eggNOG; ENOG410XX4P; LUCA.
DR   HOVERGEN; HBG050880; -.
DR   Bgee; ENSG00000172216; -.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:InterPro.
DR   InterPro; IPR004827; bZIP.
DR   InterPro; IPR031106; C/EBP.
DR   PANTHER; PTHR23334; PTHR23334; 1.
DR   Pfam; PF07716; bZIP_2; 1.
DR   SMART; SM00338; BRLZ; 1.
DR   PROSITE; PS50217; BZIP; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN       63    126       BZIP (basic-leucine zipper).
FT                                {ECO:0000259|PROSITE:PS50217}.
FT   COILED       86    122       {ECO:0000256|SAM:Coils}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:AAH05132.2}.
SQ   SEQUENCE   137 AA;  14860 MW;  86108F55B335242A CRC64;
     AYLGYQAVPS GSSGSLSTSS SSSPPGTPSP ADAKAPPTAC YAGAAPAPSQ VKSKAKKTVD
     KHSDEYKIRR ERNNIAVRKS RDKAKMRNLE TQHKVLELTA ENERLQKKVE QLSRELSTLR
     NLFKQLPEPL LASSGHC
//
ID   W8SNU6_HUMAN            Unreviewed;        92 AA.
AC   W8SNU6;
DT   14-MAY-2014, integrated into UniProtKB/TrEMBL.
DT   14-MAY-2014, sequence version 1.
DT   06-JUL-2016, entry version 8.
DE   SubName: Full=Transcription factor C/EBP beta {ECO:0000313|EMBL:AHM26745.1};
DE   Flags: Fragment;
GN   Name=CEBPB {ECO:0000313|EMBL:AHM26745.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AHM26745.1};
RN   [1] {ECO:0000313|EMBL:AHM26745.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mahatme P., Apte I., Kotwal S.;
RT   "Identification of probable C/EBP-beta activation domain polymorphism
RT   in Indian women diagnosed with PCOS and NAFLD.";
RL   Submitted (JAN-2014) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KJ161467; AHM26744.1; -; mRNA.
DR   EMBL; KJ161468; AHM26745.1; -; mRNA.
DR   EMBL; KJ161469; AHM26746.1; -; mRNA.
DR   UniGene; Hs.517106; -.
DR   UniGene; Hs.719041; -.
DR   UniGene; Hs.720603; -.
DR   STRING; 9606.ENSP00000305422; -.
DR   PeptideAtlas; W8SNU6; -.
DR   eggNOG; ENOG410ISXW; Eukaryota.
DR   eggNOG; ENOG410XX4P; LUCA.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:InterPro.
DR   InterPro; IPR031106; C/EBP.
DR   PANTHER; PTHR23334; PTHR23334; 1.
PE   2: Evidence at transcript level;
FT   NON_TER       1      1       {ECO:0000313|EMBL:AHM26745.1}.
FT   NON_TER      92     92       {ECO:0000313|EMBL:AHM26745.1}.
SQ   SEQUENCE   92 AA;  9372 MW;  DB20C23302CE179E CRC64;
     ACLPLPPPPP AFKSMEVANF YYEADCLAAA YGGKAAPAAP PAARPGPRPP AGELGSIGDH
     ERAIDFSPYL EPLGAPQAPA PATATDTFEE AP
//
ID   W8SNV5_HUMAN            Unreviewed;        92 AA.
AC   W8SNV5;
DT   14-MAY-2014, integrated into UniProtKB/TrEMBL.
DT   14-MAY-2014, sequence version 1.
DT   06-JUL-2016, entry version 10.
DE   SubName: Full=Transcription factor C/EBP beta {ECO:0000313|EMBL:AHM26755.1};
DE   Flags: Fragment;
GN   Name=CEBPB {ECO:0000313|EMBL:AHM26755.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AHM26755.1};
RN   [1] {ECO:0000313|EMBL:AHM26755.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mahatme P., Apte I., Kotwal S.;
RT   "Identification of probable C/EBP-beta activation domain polymorphism
RT   in Indian women diagnosed with PCOS and NAFLD.";
RL   Submitted (JAN-2014) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; KJ161450; AHM26727.1; -; mRNA.
DR   EMBL; KJ161451; AHM26728.1; -; mRNA.
DR   EMBL; KJ161452; AHM26729.1; -; mRNA.
DR   EMBL; KJ161453; AHM26730.1; -; mRNA.
DR   EMBL; KJ161454; AHM26731.1; -; mRNA.
DR   EMBL; KJ161455; AHM26732.1; -; mRNA.
DR   EMBL; KJ161456; AHM26733.1; -; mRNA.
DR   EMBL; KJ161457; AHM26734.1; -; mRNA.
DR   EMBL; KJ161458; AHM26735.1; -; mRNA.
DR   EMBL; KJ161459; AHM26736.1; -; mRNA.
DR   EMBL; KJ161460; AHM26737.1; -; mRNA.
DR   EMBL; KJ161461; AHM26738.1; -; mRNA.
DR   EMBL; KJ161462; AHM26739.1; -; mRNA.
DR   EMBL; KJ161463; AHM26740.1; -; mRNA.
DR   EMBL; KJ161464; AHM26741.1; -; mRNA.
DR   EMBL; KJ161465; AHM26742.1; -; mRNA.
DR   EMBL; KJ161466; AHM26743.1; -; mRNA.
DR   EMBL; KJ161470; AHM26747.1; -; mRNA.
DR   EMBL; KJ161471; AHM26748.1; -; mRNA.
DR   EMBL; KJ161472; AHM26749.1; -; mRNA.
DR   EMBL; KJ161473; AHM26750.1; -; mRNA.
DR   EMBL; KJ161474; AHM26751.1; -; mRNA.
DR   EMBL; KJ161475; AHM26752.1; -; mRNA.
DR   EMBL; KJ161476; AHM26753.1; -; mRNA.
DR   EMBL; KJ161477; AHM26754.1; -; mRNA.
DR   EMBL; KJ161478; AHM26755.1; -; mRNA.
DR   EMBL; KJ161479; AHM26756.1; -; mRNA.
DR   EMBL; KJ161480; AHM26757.1; -; mRNA.
DR   EMBL; KJ161481; AHM26758.1; -; mRNA.
DR   UniGene; Hs.517106; -.
DR   UniGene; Hs.719041; -.
DR   UniGene; Hs.720603; -.
DR   STRING; 9606.ENSP00000305422; -.
DR   PeptideAtlas; W8SNV5; -.
DR   eggNOG; ENOG410ISXW; Eukaryota.
DR   eggNOG; ENOG410XX4P; LUCA.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:InterPro.
DR   InterPro; IPR031106; C/EBP.
DR   PANTHER; PTHR23334; PTHR23334; 1.
PE   2: Evidence at transcript level;
FT   NON_TER       1      1       {ECO:0000313|EMBL:AHM26755.1}.
FT   NON_TER      92     92       {ECO:0000313|EMBL:AHM26755.1}.
SQ   SEQUENCE   92 AA;  9314 MW;  DB20C4F302CE179E CRC64;
     ACLPLPPPPP AFKSMEVANF YYEADCLAAA YGGKAAPAAP PAARPGPRPP AGELGSIGDH
     ERAIDFSPYL EPLGAPQAPA PATATDTFEA AP
//
ID   BHE40_HUMAN             Reviewed;         412 AA.
AC   O14503; Q96TD3;
DT   05-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   02-NOV-2016, entry version 149.
DE   RecName: Full=Class E basic helix-loop-helix protein 40;
DE            Short=bHLHe40;
DE   AltName: Full=Class B basic helix-loop-helix protein 2;
DE            Short=bHLHb2;
DE   AltName: Full=Differentially expressed in chondrocytes protein 1;
DE            Short=DEC1;
DE   AltName: Full=Enhancer-of-split and hairy-related protein 2;
DE            Short=SHARP-2;
DE   AltName: Full=Stimulated by retinoic acid gene 13 protein;
GN   Name=BHLHE40; Synonyms=BHLHB2, DEC1, SHARP2, STRA13;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Cartilage;
RX   PubMed=9240428; DOI=10.1006/bbrc.1997.6960;
RA   Shen M., Kawamoto T., Yan W., Nakamasu K., Tamagami M., Koyano Y.,
RA   Noshiro M., Kato Y.;
RT   "Molecular characterization of the novel basic helix-loop-helix
RT   protein DEC1 expressed in differentiated human embryo chondrocytes.";
RL   Biochem. Biophys. Res. Commun. 236:294-298(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Leukocyte;
RX   PubMed=11226878; DOI=10.1093/oxfordjournals.jbchem.a002869;
RA   Teramoto M., Nakamasu K., Noshiro M., Matsuda Y., Gotoh O., Shen M.,
RA   Tsutsumi S., Kawamoto T., Iwamoto Y., Kato Y.;
RT   "Gene structure and chromosomal location of a human bHLH
RT   transcriptional factor DEC1 x Stra13 x SHARP-2/BHLHB2.";
RL   J. Biochem. 129:391-396(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 4-412.
RA   Ivanov S.V., Lerman M.I.;
RT   "Exon-intron structure of the human STRA13(DEC1) bHLH transcription
RT   factor gene.";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   UBIQUITINATION, INTERACTION WITH UBE2I, AND SUBCELLULAR LOCATION.
RX   PubMed=11278694; DOI=10.1074/jbc.M010516200;
RA   Ivanova A.V., Ivanov S.V., Danilkovitch-Miagkova A., Lerman M.I.;
RT   "Regulation of STRA13 by the von Hippel-Lindau tumor suppressor
RT   protein, hypoxia, and the UBC9/ubiquitin proteasome degradation
RT   pathway.";
RL   J. Biol. Chem. 276:15306-15315(2001).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH ARNTL.
RX   PubMed=12397359; DOI=10.1038/nature01123;
RA   Honma S., Kawamoto T., Takagi Y., Fujimoto K., Sato F., Noshiro M.,
RA   Kato Y., Honma K.I.;
RT   "Dec1 and Dec2 are regulators of the mammalian molecular clock.";
RL   Nature 419:841-844(2002).
RN   [7]
RP   FUNCTION.
RX   PubMed=14672706; DOI=10.1016/j.bbrc.2003.11.099;
RA   Kawamoto T., Noshiro M., Sato F., Maemura K., Takeda N., Nagai R.,
RA   Iwata T., Fujimoto K., Furukawa M., Miyazaki K., Honma S., Honma K.I.,
RA   Kato Y.;
RT   "A novel autofeedback loop of Dec1 transcription involved in circadian
RT   rhythm regulation.";
RL   Biochem. Biophys. Res. Commun. 313:117-124(2004).
RN   [8]
RP   FUNCTION, HETERODIMERIZATION WITH BHLHE41/DEC2, AND INTERACTION WITH
RP   ARNTL.
RX   PubMed=15193144;
RA   Li Y., Song X., Ma Y., Liu J., Yang D., Yan B.;
RT   "DNA binding, but not interaction with Bmal1, is responsible for DEC1-
RT   mediated transcription regulation of the circadian gene mPer1.";
RL   Biochem. J. 382:895-904(2004).
RN   [9]
RP   FUNCTION, INTERACTION WITH ARNTL, AND MUTAGENESIS OF HIS-57 AND
RP   ARG-65.
RX   PubMed=15560782; DOI=10.1111/j.1432-1033.2004.04379.x;
RA   Sato F., Kawamoto T., Fujimoto K., Noshiro M., Honda K.K., Honma S.,
RA   Honma K., Kato Y.;
RT   "Functional analysis of the basic helix-loop-helix transcription
RT   factor DEC1 in circadian regulation. Interaction with BMAL1.";
RL   Eur. J. Biochem. 271:4409-4419(2004).
RN   [10]
RP   FUNCTION.
RX   PubMed=18411297; DOI=10.1128/MCB.02168-07;
RA   Nakashima A., Kawamoto T., Honda K.K., Ueshima T., Noshiro M.,
RA   Iwata T., Fujimoto K., Kubo H., Honma S., Yorioka N., Kohno N.,
RA   Kato Y.;
RT   "DEC1 modulates the circadian phase of clock gene expression.";
RL   Mol. Cell. Biol. 28:4080-4092(2008).
RN   [11]
RP   FUNCTION, INTERACTION WITH RXRA, AND MUTAGENESIS OF 78-LEU-LEU-79.
RX   PubMed=19786558; DOI=10.1124/mol.109.057000;
RA   Cho Y., Noshiro M., Choi M., Morita K., Kawamoto T., Fujimoto K.,
RA   Kato Y., Makishima M.;
RT   "The basic helix-loop-helix proteins differentiated embryo chondrocyte
RT   (DEC) 1 and DEC2 function as corepressors of retinoid X receptors.";
RL   Mol. Pharmacol. 76:1360-1369(2009).
RN   [12]
RP   SUMOYLATION AT LYS-159 AND LYS-279, INTERACTION WITH HDAC1 AND SUMO1,
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-159 AND LYS-279.
RX   PubMed=21829689; DOI=10.1371/journal.pone.0023046;
RA   Hong Y., Xing X., Li S., Bi H., Yang C., Zhao F., Liu Y., Ao X.,
RA   Chang A.K., Wu H.;
RT   "SUMOylation of DEC1 protein regulates its transcriptional activity
RT   and enhances its stability.";
RL   PLoS ONE 6:E23046-E23046(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-235, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-279, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [15]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-279, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [16]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-279, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [17]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-279, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
CC   -!- FUNCTION: Transcriptional repressor involved in the regulation of
CC       the circadian rhythm by negatively regulating the activity of the
CC       clock genes and clock-controlled genes. Acts as the negative limb
CC       of a novel autoregulatory feedback loop (DEC loop) which differs
CC       from the one formed by the PER and CRY transcriptional repressors
CC       (PER/CRY loop). Both these loops are interlocked as it represses
CC       the expression of PER1/2 and in turn is repressed by PER1/2 and
CC       CRY1/2. Represses the activity of the circadian transcriptional
CC       activator: CLOCK-ARNTL/BMAL1|ARNTL2/BMAL2 heterodimer by competing
CC       for the binding to E-box elements (5'-CACGTG-3') found within the
CC       promoters of its target genes. Negatively regulates its own
CC       expression and the expression of DBP and BHLHE41/DEC2. Acts as a
CC       corepressor of RXR and the RXR-LXR heterodimers and represses the
CC       ligand-induced RXRA and NR1H3/LXRA transactivation activity. May
CC       be involved in the regulation of chondrocyte differentiation via
CC       the cAMP pathway. {ECO:0000269|PubMed:12397359,
CC       ECO:0000269|PubMed:14672706, ECO:0000269|PubMed:15193144,
CC       ECO:0000269|PubMed:15560782, ECO:0000269|PubMed:18411297,
CC       ECO:0000269|PubMed:19786558}.
CC   -!- SUBUNIT: Homodimer. Heterodimer with BHLHE41/DEC2. Interacts with
CC       TCF3/E47. Interacts with ubiquitin-conjugating enzyme UBE2I/UBC9.
CC       Interacts with HDAC1, SUMO1, RXRA and ARNTL/BMAL1.
CC       {ECO:0000269|PubMed:11278694, ECO:0000269|PubMed:12397359,
CC       ECO:0000269|PubMed:15193144, ECO:0000269|PubMed:15560782,
CC       ECO:0000269|PubMed:19786558, ECO:0000269|PubMed:21829689}.
CC   -!- INTERACTION:
CC       P0C206:- (xeno); NbExp=3; IntAct=EBI-711810, EBI-9675596;
CC       C9JG97:AAMP; NbExp=3; IntAct=EBI-711810, EBI-10176499;
CC       Q16613:AANAT; NbExp=3; IntAct=EBI-711810, EBI-7451846;
CC       Q08117:AES; NbExp=3; IntAct=EBI-711810, EBI-717810;
CC       O75909:CCNK; NbExp=3; IntAct=EBI-711810, EBI-739806;
CC       Q6NVV7:CDPF1; NbExp=3; IntAct=EBI-711810, EBI-2802782;
CC       P10606:COX5B; NbExp=3; IntAct=EBI-711810, EBI-1053725;
CC       O75553:DAB1; NbExp=3; IntAct=EBI-711810, EBI-7875264;
CC       Q08426:EHHADH; NbExp=3; IntAct=EBI-711810, EBI-2339219;
CC       Q8NEA9:GMCL1P1; NbExp=3; IntAct=EBI-711810, EBI-745707;
CC       A1A580:KRTAP23-1; NbExp=3; IntAct=EBI-711810, EBI-10171734;
CC       Q71RC2-6:LARP4; NbExp=3; IntAct=EBI-711810, EBI-10255841;
CC       Q9Y5V3:MAGED1; NbExp=3; IntAct=EBI-711810, EBI-716006;
CC       Q9GZZ1:NAA50; NbExp=3; IntAct=EBI-711810, EBI-1052523;
CC       Q9BVI4:NOC4L; NbExp=3; IntAct=EBI-711810, EBI-395927;
CC       P18545:PDE6G; NbExp=3; IntAct=EBI-711810, EBI-2622029;
CC       Q96CS7:PLEKHB2; NbExp=3; IntAct=EBI-711810, EBI-373552;
CC       Q13131:PRKAA1; NbExp=3; IntAct=EBI-711810, EBI-1181405;
CC       Q86U06:RBM23; NbExp=3; IntAct=EBI-711810, EBI-780319;
CC       Q86U06-2:RBM23; NbExp=3; IntAct=EBI-711810, EBI-10258579;
CC       Q93062:RBPMS; NbExp=3; IntAct=EBI-711810, EBI-740322;
CC       O94955:RHOBTB3; NbExp=3; IntAct=EBI-711810, EBI-2367123;
CC       Q9H4E5:RHOJ; NbExp=3; IntAct=EBI-711810, EBI-6285694;
CC       Q8NB12:SMYD1; NbExp=3; IntAct=EBI-711810, EBI-8463848;
CC       O60248:SOX15; NbExp=3; IntAct=EBI-711810, EBI-5452954;
CC       B7ZLI8:STK19; NbExp=3; IntAct=EBI-711810, EBI-10176124;
CC       Q14106:TOB2; NbExp=3; IntAct=EBI-711810, EBI-2562000;
CC       P04637:TP53; NbExp=5; IntAct=EBI-711810, EBI-366083;
CC       Q5W5X9:TTC23; NbExp=3; IntAct=EBI-711810, EBI-6447954;
CC       Q9NX01:TXNL4B; NbExp=3; IntAct=EBI-711810, EBI-10309345;
CC       P63279:UBE2I; NbExp=3; IntAct=EBI-711810, EBI-80168;
CC       Q08AM6:VAC14; NbExp=3; IntAct=EBI-711810, EBI-2107455;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:21829689}.
CC       Nucleus {ECO:0000269|PubMed:11278694,
CC       ECO:0000269|PubMed:21829689}. Note=Predominantly localized in the
CC       nucleus (PubMed:11278694). {ECO:0000269|PubMed:11278694}.
CC   -!- TISSUE SPECIFICITY: Expressed in cartilage, spleen, intestine,
CC       lung, and to a lesser extent in heart, brain, liver, muscle and
CC       stomach.
CC   -!- PTM: Ubiquitinated; which may lead to proteasomal degradation.
CC       {ECO:0000269|PubMed:11278694}.
CC   -!- PTM: Sumoylation inhibits its ubiquitination and promotes its
CC       negative regulation of the CLOCK-ARNTL/BMAL1 heterodimer
CC       transcriptional activator activity. {ECO:0000269|PubMed:11278694,
CC       ECO:0000269|PubMed:21829689}.
CC   -!- SIMILARITY: Contains 1 bHLH (basic helix-loop-helix) domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00981}.
CC   -!- SIMILARITY: Contains 1 Orange domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00380}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB004066; BAA21720.1; -; mRNA.
DR   EMBL; AB043885; BAB18565.1; -; Genomic_DNA.
DR   EMBL; BC082238; AAH82238.1; -; mRNA.
DR   EMBL; AH010709; AAK49525.1; -; Genomic_DNA.
DR   CCDS; CCDS2565.1; -.
DR   PIR; JC5547; JC5547.
DR   RefSeq; NP_003661.1; NM_003670.2.
DR   UniGene; Hs.744856; -.
DR   ProteinModelPortal; O14503; -.
DR   SMR; O14503; -.
DR   BioGrid; 114123; 56.
DR   DIP; DIP-36698N; -.
DR   IntAct; O14503; 78.
DR   MINT; MINT-1374397; -.
DR   STRING; 9606.ENSP00000256495; -.
DR   iPTMnet; O14503; -.
DR   PhosphoSitePlus; O14503; -.
DR   BioMuta; BHLHE40; -.
DR   PaxDb; O14503; -.
DR   PeptideAtlas; O14503; -.
DR   PRIDE; O14503; -.
DR   DNASU; 8553; -.
DR   Ensembl; ENST00000256495; ENSP00000256495; ENSG00000134107.
DR   GeneID; 8553; -.
DR   KEGG; hsa:8553; -.
DR   CTD; 8553; -.
DR   DisGeNET; 8553; -.
DR   GeneCards; BHLHE40; -.
DR   HGNC; HGNC:1046; BHLHE40.
DR   HPA; HPA028921; -.
DR   HPA; HPA028922; -.
DR   MIM; 604256; gene.
DR   neXtProt; NX_O14503; -.
DR   OpenTargets; ENSG00000134107; -.
DR   PharmGKB; PA25347; -.
DR   eggNOG; KOG4304; Eukaryota.
DR   eggNOG; ENOG4111F0X; LUCA.
DR   GeneTree; ENSGT00510000046898; -.
DR   HOGENOM; HOG000234381; -.
DR   InParanoid; O14503; -.
DR   KO; K03729; -.
DR   OMA; AMDFKEK; -.
DR   OrthoDB; EOG091G0D3I; -.
DR   PhylomeDB; O14503; -.
DR   TreeFam; TF330859; -.
DR   BioCyc; ZFISH:ENSG00000134107-MONOMER; -.
DR   Reactome; R-HSA-1368108; BMAL1:CLOCK,NPAS2 activates circadian gene expression.
DR   SignaLink; O14503; -.
DR   ChiTaRS; BHLHE40; human.
DR   GeneWiki; BHLHB2; -.
DR   GenomeRNAi; 8553; -.
DR   PRO; PR:O14503; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000134107; -.
DR   CleanEx; HS_DEC1; -.
DR   CleanEx; HS_STRA13; -.
DR   ExpressionAtlas; O14503; baseline and differential.
DR   Genevisible; O14503; HS.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; NAS:UniProtKB.
DR   GO; GO:0043425; F:bHLH transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0070888; F:E-box binding; IDA:BHF-UCL.
DR   GO; GO:0043426; F:MRF binding; ISS:BHF-UCL.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:BHF-UCL.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL.
DR   GO; GO:0001102; F:RNA polymerase II activating transcription factor binding; ISS:BHF-UCL.
DR   GO; GO:0000981; F:RNA polymerase II transcription factor activity, sequence-specific DNA binding; IDA:BHF-UCL.
DR   GO; GO:0003714; F:transcription corepressor activity; IDA:UniProtKB.
DR   GO; GO:0003705; F:transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding; ISS:BHF-UCL.
DR   GO; GO:0003700; F:transcription factor activity, sequence-specific DNA binding; NAS:UniProtKB.
DR   GO; GO:0001078; F:transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding; IDA:BHF-UCL.
DR   GO; GO:0001191; F:transcriptional repressor activity, RNA polymerase II transcription factor binding; IDA:BHF-UCL.
DR   GO; GO:0032922; P:circadian regulation of gene expression; IDA:BHF-UCL.
DR   GO; GO:0043153; P:entrainment of circadian clock by photoperiod; ISS:BHF-UCL.
DR   GO; GO:0043433; P:negative regulation of sequence-specific DNA binding transcription factor activity; IDA:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   Gene3D; 4.10.280.10; -; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR003650; Orange_dom.
DR   Pfam; PF07527; Hairy_orange; 1.
DR   Pfam; PF00010; HLH; 1.
DR   SMART; SM00353; HLH; 1.
DR   SMART; SM00511; ORANGE; 1.
DR   SUPFAM; SSF47459; SSF47459; 1.
DR   PROSITE; PS50888; BHLH; 1.
DR   PROSITE; PS51054; ORANGE; 1.
PE   1: Evidence at protein level;
KW   Biological rhythms; Complete proteome; Cytoplasm; DNA-binding;
KW   Isopeptide bond; Nucleus; Phosphoprotein; Reference proteome;
KW   Repressor; Transcription; Transcription regulation; Ubl conjugation.
FT   CHAIN         1    412       Class E basic helix-loop-helix protein
FT                                40.
FT                                /FTId=PRO_0000127144.
FT   DOMAIN       52    107       bHLH. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00981}.
FT   DOMAIN      142    175       Orange. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00380}.
FT   REGION        1    139       Essential for interaction with
FT                                ARNTL/BMAL1, E-box binding and repressor
FT                                activity against the CLOCK-ARNTL/BMAL1
FT                                heterodimer.
FT   REGION       75     79       Necessary for interaction with RXRA and
FT                                repressor activity against RXRA.
FT                                {ECO:0000269|PubMed:19786558}.
FT   MOD_RES     235    235       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     383    383       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O35185}.
FT   CROSSLNK    159    159       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1, SUMO2
FT                                and SUMO3).
FT                                {ECO:0000269|PubMed:21829689}.
FT   CROSSLNK    279    279       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1);
FT                                alternate. {ECO:0000244|PubMed:25114211}.
FT   CROSSLNK    279    279       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1, SUMO2
FT                                and SUMO3); alternate.
FT   CROSSLNK    279    279       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2);
FT                                alternate. {ECO:0000244|PubMed:25218447,
FT                                ECO:0000244|PubMed:25755297,
FT                                ECO:0000244|PubMed:25772364}.
FT   MUTAGEN      57     57       H->A: No effect on its interaction with
FT                                ARNTL/BMAL1 or its repressor activity
FT                                against the CLOCK-ARNTL/BMAL1
FT                                heterodimer. Significant reduction in E-
FT                                box binding.
FT                                {ECO:0000269|PubMed:15560782}.
FT   MUTAGEN      65     65       R->A: Loss of interaction with
FT                                ARNTL/BMAL1 and E-box binding.
FT                                Significant reduction in its repressor
FT                                activity against the CLOCK-ARNTL/BMAL1
FT                                heterodimer.
FT                                {ECO:0000269|PubMed:15560782}.
FT   MUTAGEN      78     79       LL->AA: Abolishes RXRA repression.
FT                                {ECO:0000269|PubMed:19786558}.
FT   MUTAGEN     159    159       K->R: Partial loss of sumoylation.
FT                                Complete loss of sumoylation; when
FT                                associated with R-279.
FT                                {ECO:0000269|PubMed:21829689}.
FT   MUTAGEN     279    279       K->R: Partial loss of sumoylation.
FT                                Complete loss of sumoylation; when
FT                                associated with R-159.
FT                                {ECO:0000269|PubMed:21829689}.
SQ   SEQUENCE   412 AA;  45510 MW;  2D73A3D4980793E5 CRC64;
     MERIPSAQPP PACLPKAPGL EHGDLPGMYP AHMYQVYKSR RGIKRSEDSK ETYKLPHRLI
     EKKRRDRINE CIAQLKDLLP EHLKLTTLGH LEKAVVLELT LKHVKALTNL IDQQQQKIIA
     LQSGLQAGEL SGRNVETGQE MFCSGFQTCA REVLQYLAKH ENTRDLKSSQ LVTHLHRVVS
     ELLQGGTSRK PSDPAPKVMD FKEKPSSPAK GSEGPGKNCV PVIQRTFAHS SGEQSGSDTD
     TDSGYGGESE KGDLRSEQPC FKSDHGRRFT MGERIGAIKQ ESEEPPTKKN RMQLSDDEGH
     FTSSDLISSP FLGPHPHQPP FCLPFYLIPP SATAYLPMLE KCWYPTSVPV LYPGLNASAA
     ALSSFMNPDK ISAPLLMPQR LPSPLPAHPS VDSSVLLQAL KPIPPLNLET KD
//
ID   A0A024QYT5_HUMAN        Unreviewed;       402 AA.
AC   A0A024QYT5;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   02-NOV-2016, entry version 22.
DE   SubName: Full=Serpin peptidase inhibitor, clade E (Nexin, plasminogen activator inhibitor type 1), member 1, isoform CRA_b {ECO:0000313|EMBL:EAW50197.1};
GN   Name=SERPINE1 {ECO:0000313|EMBL:EAW50197.1};
GN   ORFNames=hCG_17353 {ECO:0000313|EMBL:EAW50197.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW50197.1};
RN   [1] {ECO:0000313|EMBL:EAW50197.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW50197.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the serpin family.
CC       {ECO:0000256|RuleBase:RU000411, ECO:0000256|SAAS:SAAS00539174}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471197; EAW50196.1; -; Genomic_DNA.
DR   EMBL; CH471197; EAW50197.1; -; Genomic_DNA.
DR   RefSeq; NP_000593.1; NM_000602.4.
DR   UniGene; Hs.414795; -.
DR   UniGene; Hs.713079; -.
DR   UniGene; Hs.741440; -.
DR   STRING; 9606.ENSP00000223095; -.
DR   GeneID; 5054; -.
DR   KEGG; hsa:5054; -.
DR   CTD; 5054; -.
DR   eggNOG; KOG2392; Eukaryota.
DR   eggNOG; COG4826; LUCA.
DR   KO; K03982; -.
DR   OMA; IVNDWVK; -.
DR   OrthoDB; EOG091G0ION; -.
DR   GenomeRNAi; 5054; -.
DR   GO; GO:0005615; C:extracellular space; IEA:InterPro.
DR   InterPro; IPR023795; Serpin_CS.
DR   InterPro; IPR023796; Serpin_dom.
DR   InterPro; IPR000215; Serpin_fam.
DR   PANTHER; PTHR11461; PTHR11461; 1.
DR   Pfam; PF00079; Serpin; 1.
DR   SMART; SM00093; SERPIN; 1.
DR   SUPFAM; SSF56574; SSF56574; 1.
DR   PROSITE; PS00284; SERPIN; 1.
PE   3: Inferred from homology;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     23       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        24    402       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5008194898.
FT   DOMAIN       40    402       SERPIN. {ECO:0000259|SMART:SM00093}.
SQ   SEQUENCE   402 AA;  45060 MW;  A2E181ED28DD6082 CRC64;
     MQMSPALTCL VLGLALVFGE GSAVHHPPSY VAHLASDFGV RVFQQVAQAS KDRNVVFSPY
     GVASVLAMLQ LTTGGETQQQ IQAAMGFKID DKGMAPALRH LYKELMGPWN KDEISTTDAI
     FVQRDLKLVQ GFMPHFFRLF RSTVKQVDFS EVERARFIIN DWVKTHTKGM ISNLLGKGAV
     DQLTRLVLVN ALYFNGQWKT PFPDSSTHRR LFHKSDGSTV SVPMMAQTNK FNYTEFTTPD
     GHYYDILELP YHGDTLSMFI AAPYEKEVPL SALTNILSAQ LISHWKGNMT RLPRLLVLPK
     FSLETEVDLR KPLENLGMTD MFRQFQADFT SLSDQEPLHV AQALQKVKIE VNESGTVASS
     STAVIVSARM APEEIIMDRP FLFVVRHNPT GTVLFMGQVM EP
//
ID   PAI1_HUMAN              Reviewed;         402 AA.
AC   P05121; B7Z4S0; F8WD53;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-1987, sequence version 1.
DT   02-NOV-2016, entry version 203.
DE   RecName: Full=Plasminogen activator inhibitor 1;
DE            Short=PAI;
DE            Short=PAI-1;
DE   AltName: Full=Endothelial plasminogen activator inhibitor;
DE   AltName: Full=Serpin E1;
DE   Flags: Precursor;
GN   Name=SERPINE1; Synonyms=PAI1, PLANH1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2430793;
RA   Pannekoek H., Veerman H., Lambers H., Diergaarde P., Verweij C.L.,
RA   van Zonneveld A.-J., van Mourik J.A.;
RT   "Endothelial plasminogen activator inhibitor (PAI): a new member of
RT   the Serpin gene family.";
RL   EMBO J. 5:2539-2544(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2820474; DOI=10.1021/bi00387a004;
RA   Loskutoff D.J., Linders M., Keijer J., Veerman H.,
RA   van Heerikhuizen H., Pannekoek H.;
RT   "Structure of the human plasminogen activator inhibitor 1 gene:
RT   nonrandom distribution of introns.";
RL   Biochemistry 26:3763-3768(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3097076; DOI=10.1172/JCI112761;
RA   Ginsburg D., Zeheb R., Yang A.Y., Rafferty U.M., Andreasen P.A.,
RA   Nielsen L., Dano K., Lebo R.V., Gelehrter T.D.;
RT   "cDNA cloning of human plasminogen activator-inhibitor from
RT   endothelial cells.";
RL   J. Clin. Invest. 78:1673-1680(1986).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2612914; DOI=10.1016/0378-1119(89)90519-2;
RA   Follo M., Ginsburg D.;
RT   "Structure and expression of the human gene encoding plasminogen
RT   activator inhibitor, PAI-1.";
RL   Gene 84:447-453(1989).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3262512; DOI=10.1111/j.1432-1033.1988.tb14320.x;
RA   Strandberg L., Lawrence D., Ny T.;
RT   "The organization of the human-plasminogen-activator-inhibitor-1 gene.
RT   Implications on the evolution of the serine-protease inhibitor
RT   family.";
RL   Eur. J. Biochem. 176:609-616(1988).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3132455;
RA   Bosma P.J., van den Berg E.A., Kooistra T., Siemieniak D.R.,
RA   Slightom J.L.;
RT   "Human plasminogen activator inhibitor-1 gene. Promoter and structural
RT   gene nucleotide sequences.";
RL   J. Biol. Chem. 263:9129-9141(1988).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Pannekoek H.;
RL   Submitted (FEB-1992) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS THR-15; ILE-17;
RP   PRO-25; HIS-209 AND ASN-255.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 20-402 (ISOFORM 1).
RX   PubMed=3092219; DOI=10.1073/pnas.83.18.6776;
RA   Ny T., Sawdey M., Lawrence D., Millan J.L., Loskutoff D.J.;
RT   "Cloning and sequence of a cDNA coding for the human beta-migrating
RT   endothelial-cell-type plasminogen activator inhibitor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:6776-6780(1986).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-47 AND 364-402 (ISOFORM 1).
RX   PubMed=3025016; DOI=10.1016/0014-5793(86)81113-9;
RA   Andreasen P.A., Riccio A., Welinder K.G., Douglas R., Sartorio R.,
RA   Nielsen L.S., Oppenheimer C., Blasi F., Danoe K.;
RT   "Plasminogen activator inhibitor type-1: reactive center and amino-
RT   terminal heterogeneity determined by protein and cDNA sequencing.";
RL   FEBS Lett. 209:213-218(1986).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 17-402 (ISOFORM 1), AND PARTIAL PROTEIN
RP   SEQUENCE.
RC   TISSUE=Placenta;
RX   PubMed=3026837; DOI=10.1016/0014-5793(87)81288-7;
RA   Wun T.C., Kretzmer K.K.;
RT   "cDNA cloning and expression in E. coli of a plasminogen activator
RT   inhibitor (PAI) related to a PAI produced by Hep G2 hepatoma cell.";
RL   FEBS Lett. 210:11-16(1987).
RN   [15]
RP   INTERACTION WITH VTN.
RX   PubMed=7522053; DOI=10.1016/0167-4838(94)90166-X;
RA   Sigurdardottir O., Wiman B.;
RT   "Identification of a PAI-1 binding site in vitronectin.";
RL   Biochim. Biophys. Acta 1208:104-110(1994).
RN   [16]
RP   INVOLVEMENT IN PAI-1D.
RX   PubMed=9207454;
RA   Fay W.P., Parker A.C., Condrey L.R., Shapiro A.D.;
RT   "Human plasminogen activator inhibitor-1 (PAI-1) deficiency:
RT   characterization of a large kindred with a null mutation in the PAI-1
RT   gene.";
RL   Blood 90:204-208(1997).
RN   [17]
RP   INTERACTION WITH LRP1B.
RX   PubMed=11384978; DOI=10.1074/jbc.M102727200;
RA   Liu C.-X., Li Y., Obermoeller-McCormick L.M., Schwartz A.L., Bu G.;
RT   "The putative tumor suppressor LRP1B, a novel member of the low
RT   density lipoprotein (LDL) receptor family, exhibits both overlapping
RT   and distinct properties with the LDL receptor-related protein.";
RL   J. Biol. Chem. 276:28889-28896(2001).
RN   [18]
RP   FUNCTION IN MEMBRANE-ANCHORED SERINE PROTEASE TMPRSS7 INHIBITION, AND
RP   HETERODIMER WITH TMPRSS7.
RX   PubMed=15853774; DOI=10.1042/BJ20050299;
RA   Szabo R., Netzel-Arnett S., Hobson J.P., Antalis T.M., Bugge T.H.;
RT   "Matriptase-3 is a novel phylogenetically preserved membrane-anchored
RT   serine protease with broad serpin reactivity.";
RL   Biochem. J. 390:231-242(2005).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S.,
RA   Fischer-Posovszky P., Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion
RT   profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS).
RX   PubMed=1731226; DOI=10.1038/355270a0;
RA   Mottonen J., Strand A., Symersky J., Sweet R.M., Danley D.E.,
RA   Geoghegan K.F., Gerard R.D., Goldsmith E.J.;
RT   "Structural basis of latency in plasminogen activator inhibitor-1.";
RL   Nature 355:270-273(1992).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS).
RX   PubMed=7552714; DOI=10.1038/nsb1095-891;
RA   Aertgeerts K., de Bondt H.L., de Ranter C.J., Declerck P.J.;
RT   "Mechanisms contributing to the conformational and functional
RT   flexibility of plasminogen activator inhibitor-1.";
RL   Nat. Struct. Biol. 2:891-897(1995).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS).
RX   PubMed=9634700; DOI=10.1016/S0969-2126(98)00064-1;
RA   Xue Y., Bjoerquist P., Inghardt T., Linschoten M., Musil D.,
RA   Sjoelin L., Deinum J.;
RT   "Interfering with the inhibitory mechanism of serpins: crystal
RT   structure of a complex formed between cleaved plasminogen activator
RT   inhibitor type 1 and a reactive-centre loop peptide.";
RL   Structure 6:627-636(1998).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.99 ANGSTROMS).
RX   PubMed=10368279; DOI=10.1016/S0969-2126(99)80018-5;
RA   Sharp A.M., Stein P.E., Pannu N.S., Carrell R.W., Berkenpas M.B.,
RA   Ginsburg D., Lawrence D.A., Read R.J.;
RT   "The active conformation of plasminogen activator inhibitor 1, a
RT   target for drugs to control fibrinolysis and cell adhesion.";
RL   Structure 7:111-118(1999).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS).
RX   PubMed=10731421; DOI=10.1006/jmbi.2000.3604;
RA   Nar H., Bauer M., Stassen J.M., Lang D., Gils A., Declerck P.J.;
RT   "Plasminogen activator inhibitor 1. Structure of the native serpin,
RT   comparison to its other conformers and implications for serpin
RT   inactivation.";
RL   J. Mol. Biol. 297:683-695(2000).
RN   [25]
RP   VARIANT THR-15.
RX   PubMed=9194591; DOI=10.1002/elps.1150180505;
RA   Turkmen B., Schmitt M., Schmalfeldt B., Trommler P., Hell W.,
RA   Creutzburg S., Graeff H., Magdolen V.;
RT   "Mutational analysis of the genes encoding urokinase-type plasminogen
RT   activator (uPA) and its inhibitor PAI-1 in advanced ovarian cancer.";
RL   Electrophoresis 18:686-689(1997).
RN   [26]
RP   VARIANTS THR-15 AND ILE-17.
RX   PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions
RT   of human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [27]
RP   ERRATUM.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
CC   -!- FUNCTION: Serine protease inhibitor. This inhibitor acts as 'bait'
CC       for tissue plasminogen activator, urokinase, protein C and
CC       matriptase-3/TMPRSS7. Its rapid interaction with PLAT may function
CC       as a major control point in the regulation of fibrinolysis.
CC       {ECO:0000269|PubMed:15853774}.
CC   -!- SUBUNIT: Forms protease inhibiting heterodimer with TMPRSS7.
CC       Interacts with VTN. Binds LRP1B; binding is followed by
CC       internalization and degradation. {ECO:0000269|PubMed:11384978,
CC       ECO:0000269|PubMed:7522053}.
CC   -!- INTERACTION:
CC       P02763:ORM1; NbExp=4; IntAct=EBI-953978, EBI-976767;
CC       O43765:SGTA; NbExp=3; IntAct=EBI-953978, EBI-347996;
CC       Q96EQ0:SGTB; NbExp=3; IntAct=EBI-953978, EBI-744081;
CC       Q9UMX0:UBQLN1; NbExp=3; IntAct=EBI-953978, EBI-741480;
CC       Q9UMX0-2:UBQLN1; NbExp=3; IntAct=EBI-953978, EBI-10173939;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P05121-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P05121-2; Sequence=VSP_045493;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Found in plasma and platelets and in
CC       endothelial, hepatoma and fibrosarcoma cells.
CC   -!- PTM: Inactivated by proteolytic attack of the urokinase-type (u-
CC       PA) and the tissue-type (TPA), cleaving the 369-Arg-|-Met-370
CC       bond.
CC   -!- DISEASE: Plasminogen activator inhibitor-1 deficiency (PAI-1D)
CC       [MIM:613329]: A hematologic disorder characterized by increased
CC       bleeding after trauma, injury, or surgery. Affected females have
CC       menorrhagia. The bleeding defect is due to increased fibrinolysis
CC       of fibrin blood clots due to deficiency of plasminogen activator
CC       inhibitor-1, which inhibits tissue and urinary activators of
CC       plasminogen. {ECO:0000269|PubMed:9207454}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=High concentrations of SERPINE1 seem to contribute
CC       to the development of venous but not arterial occlusions.
CC   -!- SIMILARITY: Belongs to the serpin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Plasminogen activator
CC       inhibitor-1 entry;
CC       URL="https://en.wikipedia.org/wiki/Plasminogen_activator_inhibitor-1";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/serpine1/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X04429; CAA28025.1; -; mRNA.
DR   EMBL; M14083; AAA60008.1; -; mRNA.
DR   EMBL; X04729; CAA28438.1; -; mRNA.
DR   EMBL; X04731; CAA28442.1; -; mRNA.
DR   EMBL; M16006; AAA60003.1; -; mRNA.
DR   EMBL; M22321; AAA60009.1; -; Genomic_DNA.
DR   EMBL; M22314; AAA60009.1; JOINED; Genomic_DNA.
DR   EMBL; M22315; AAA60009.1; JOINED; Genomic_DNA.
DR   EMBL; M22316; AAA60009.1; JOINED; Genomic_DNA.
DR   EMBL; M22317; AAA60009.1; JOINED; Genomic_DNA.
DR   EMBL; M22318; AAA60009.1; JOINED; Genomic_DNA.
DR   EMBL; M22319; AAA60009.1; JOINED; Genomic_DNA.
DR   EMBL; M22320; AAA60009.1; JOINED; Genomic_DNA.
DR   EMBL; X13323; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X13338; CAA31722.1; -; Genomic_DNA.
DR   EMBL; X13339; CAB51639.1; -; Genomic_DNA.
DR   EMBL; X13340; CAB51737.1; -; Genomic_DNA.
DR   EMBL; X13341; CAB51606.1; -; Genomic_DNA.
DR   EMBL; X13342; CAB51607.1; -; Genomic_DNA.
DR   EMBL; X13343; CAB51738.1; -; Genomic_DNA.
DR   EMBL; X13344; CAB51739.1; -; Genomic_DNA.
DR   EMBL; X13345; CAA31729.1; -; Genomic_DNA.
DR   EMBL; J03764; AAA60007.1; -; Genomic_DNA.
DR   EMBL; X12701; CAA31208.1; -; mRNA.
DR   EMBL; AF386492; AAK60338.1; -; Genomic_DNA.
DR   EMBL; AK297728; BAH12656.1; -; mRNA.
DR   EMBL; AC004876; AAD45828.1; -; Genomic_DNA.
DR   EMBL; BC010860; AAH10860.1; -; mRNA.
DR   EMBL; X04744; CAA28444.1; -; mRNA.
DR   CCDS; CCDS5711.1; -. [P05121-1]
DR   PIR; A28107; ITHUP1.
DR   RefSeq; NP_000593.1; NM_000602.4. [P05121-1]
DR   UniGene; Hs.414795; -.
DR   UniGene; Hs.713079; -.
DR   UniGene; Hs.741440; -.
DR   PDB; 1A7C; X-ray; 1.95 A; A=24-402.
DR   PDB; 1B3K; X-ray; 2.99 A; A/B/C/D=24-402.
DR   PDB; 1C5G; X-ray; 2.60 A; A=1-402.
DR   PDB; 1DB2; X-ray; 2.70 A; A/B=26-402.
DR   PDB; 1DVM; X-ray; 2.40 A; A/B/C/D=24-402.
DR   PDB; 1DVN; X-ray; 2.10 A; A=24-402.
DR   PDB; 1LJ5; X-ray; 1.80 A; A=24-402.
DR   PDB; 1OC0; X-ray; 2.28 A; A=24-402.
DR   PDB; 3CVM; X-ray; 2.02 A; A/B=21-402.
DR   PDB; 3EOX; X-ray; 2.61 A; A=24-402.
DR   PDB; 3PB1; X-ray; 2.30 A; I=24-402.
DR   PDB; 3Q02; X-ray; 2.30 A; A/B=24-402.
DR   PDB; 3Q03; X-ray; 2.64 A; A/B=24-402.
DR   PDB; 3R4L; X-ray; 2.70 A; A=24-402.
DR   PDB; 3UT3; X-ray; 2.42 A; A/B/C/D=28-402.
DR   PDB; 4AQH; X-ray; 2.40 A; A/B/C=24-402.
DR   PDB; 4G8O; X-ray; 2.71 A; A/B/C/D=28-402.
DR   PDB; 4G8R; X-ray; 2.19 A; A/B=28-402.
DR   PDB; 4IC0; X-ray; 2.32 A; A/B/C/D=24-402.
DR   PDB; 5BRR; X-ray; 3.16 A; I=24-402.
DR   PDB; 9PAI; X-ray; 2.70 A; A=24-369, B=370-402.
DR   PDBsum; 1A7C; -.
DR   PDBsum; 1B3K; -.
DR   PDBsum; 1C5G; -.
DR   PDBsum; 1DB2; -.
DR   PDBsum; 1DVM; -.
DR   PDBsum; 1DVN; -.
DR   PDBsum; 1LJ5; -.
DR   PDBsum; 1OC0; -.
DR   PDBsum; 3CVM; -.
DR   PDBsum; 3EOX; -.
DR   PDBsum; 3PB1; -.
DR   PDBsum; 3Q02; -.
DR   PDBsum; 3Q03; -.
DR   PDBsum; 3R4L; -.
DR   PDBsum; 3UT3; -.
DR   PDBsum; 4AQH; -.
DR   PDBsum; 4G8O; -.
DR   PDBsum; 4G8R; -.
DR   PDBsum; 4IC0; -.
DR   PDBsum; 5BRR; -.
DR   PDBsum; 9PAI; -.
DR   DisProt; DP00320; -.
DR   ProteinModelPortal; P05121; -.
DR   SMR; P05121; -.
DR   BioGrid; 111091; 16.
DR   IntAct; P05121; 9.
DR   MINT; MINT-202409; -.
DR   STRING; 9606.ENSP00000223095; -.
DR   BindingDB; P05121; -.
DR   ChEMBL; CHEMBL3475; -.
DR   DrugBank; DB00009; Alteplase.
DR   DrugBank; DB00029; Anistreplase.
DR   DrugBank; DB00055; Drotrecogin alfa.
DR   DrugBank; DB00015; Reteplase.
DR   DrugBank; DB00031; Tenecteplase.
DR   DrugBank; DB00013; Urokinase.
DR   MEROPS; I04.020; -.
DR   iPTMnet; P05121; -.
DR   PhosphoSitePlus; P05121; -.
DR   UniCarbKB; P05121; -.
DR   BioMuta; SERPINE1; -.
DR   DMDM; 129576; -.
DR   OGP; P05121; -.
DR   SWISS-2DPAGE; P05121; -.
DR   EPD; P05121; -.
DR   MaxQB; P05121; -.
DR   PaxDb; P05121; -.
DR   PeptideAtlas; P05121; -.
DR   PRIDE; P05121; -.
DR   DNASU; 5054; -.
DR   Ensembl; ENST00000223095; ENSP00000223095; ENSG00000106366. [P05121-1]
DR   GeneID; 5054; -.
DR   KEGG; hsa:5054; -.
DR   UCSC; uc003uxt.4; human. [P05121-1]
DR   CTD; 5054; -.
DR   DisGeNET; 5054; -.
DR   GeneCards; SERPINE1; -.
DR   HGNC; HGNC:8583; SERPINE1.
DR   HPA; HPA050039; -.
DR   MalaCards; SERPINE1; -.
DR   MIM; 173360; gene.
DR   MIM; 613329; phenotype.
DR   neXtProt; NX_P05121; -.
DR   OpenTargets; ENSG00000106366; -.
DR   Orphanet; 465; Congenital plasminogen activator inhibitor type 1 deficiency.
DR   PharmGKB; PA261; -.
DR   eggNOG; KOG2392; Eukaryota.
DR   eggNOG; COG4826; LUCA.
DR   GeneTree; ENSGT00760000118839; -.
DR   HOGENOM; HOG000238519; -.
DR   HOVERGEN; HBG106493; -.
DR   InParanoid; P05121; -.
DR   KO; K03982; -.
DR   OMA; IVNDWVK; -.
DR   OrthoDB; EOG091G0ION; -.
DR   PhylomeDB; P05121; -.
DR   TreeFam; TF352620; -.
DR   BioCyc; ZFISH:ENSG00000106366-MONOMER; -.
DR   Reactome; R-HSA-114608; Platelet degranulation.
DR   Reactome; R-HSA-1368108; BMAL1:CLOCK,NPAS2 activates circadian gene expression.
DR   Reactome; R-HSA-2173796; SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription.
DR   Reactome; R-HSA-3000178; ECM proteoglycans.
DR   Reactome; R-HSA-75205; Dissolution of Fibrin Clot.
DR   SIGNOR; P05121; -.
DR   ChiTaRS; SERPINE1; human.
DR   EvolutionaryTrace; P05121; -.
DR   GeneWiki; Plasminogen_activator_inhibitor-1; -.
DR   GenomeRNAi; 5054; -.
DR   PMAP-CutDB; P05121; -.
DR   PRO; PR:P05121; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000106366; -.
DR   CleanEx; HS_SERPINE1; -.
DR   ExpressionAtlas; P05121; baseline and differential.
DR   Genevisible; P05121; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0031012; C:extracellular matrix; IDA:BHF-UCL.
DR   GO; GO:0005576; C:extracellular region; IDA:BHF-UCL.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0031093; C:platelet alpha granule lumen; TAS:Reactome.
DR   GO; GO:0002020; F:protease binding; IPI:UniProtKB.
DR   GO; GO:0005102; F:receptor binding; IPI:BHF-UCL.
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IDA:BHF-UCL.
DR   GO; GO:0001525; P:angiogenesis; IEP:UniProtKB.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IMP:BHF-UCL.
DR   GO; GO:0001300; P:chronological cell aging; IEP:BHF-UCL.
DR   GO; GO:0007623; P:circadian rhythm; TAS:Reactome.
DR   GO; GO:0050829; P:defense response to Gram-negative bacterium; IGI:BHF-UCL.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0042730; P:fibrinolysis; TAS:Reactome.
DR   GO; GO:0030195; P:negative regulation of blood coagulation; IC:BHF-UCL.
DR   GO; GO:0033629; P:negative regulation of cell adhesion mediated by integrin; IDA:BHF-UCL.
DR   GO; GO:0030336; P:negative regulation of cell migration; IDA:BHF-UCL.
DR   GO; GO:0010951; P:negative regulation of endopeptidase activity; IDA:BHF-UCL.
DR   GO; GO:2000352; P:negative regulation of endothelial cell apoptotic process; IMP:BHF-UCL.
DR   GO; GO:1902042; P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors; IMP:BHF-UCL.
DR   GO; GO:0051918; P:negative regulation of fibrinolysis; IDA:BHF-UCL.
DR   GO; GO:0010757; P:negative regulation of plasminogen activation; IDA:BHF-UCL.
DR   GO; GO:0014912; P:negative regulation of smooth muscle cell migration; IDA:BHF-UCL.
DR   GO; GO:2000098; P:negative regulation of smooth muscle cell-matrix adhesion; IDA:BHF-UCL.
DR   GO; GO:0061044; P:negative regulation of vascular wound healing; IGI:BHF-UCL.
DR   GO; GO:0061045; P:negative regulation of wound healing; IC:BHF-UCL.
DR   GO; GO:0002576; P:platelet degranulation; TAS:Reactome.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; IMP:BHF-UCL.
DR   GO; GO:0030194; P:positive regulation of blood coagulation; IMP:BHF-UCL.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; IGI:BHF-UCL.
DR   GO; GO:0032757; P:positive regulation of interleukin-8 production; IMP:BHF-UCL.
DR   GO; GO:0035491; P:positive regulation of leukotriene production involved in inflammatory response; IMP:BHF-UCL.
DR   GO; GO:0090026; P:positive regulation of monocyte chemotaxis; IMP:BHF-UCL.
DR   GO; GO:0048260; P:positive regulation of receptor-mediated endocytosis; IDA:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:0010469; P:regulation of receptor activity; IDA:BHF-UCL.
DR   InterPro; IPR023795; Serpin_CS.
DR   InterPro; IPR023796; Serpin_dom.
DR   InterPro; IPR000215; Serpin_fam.
DR   PANTHER; PTHR11461; PTHR11461; 1.
DR   Pfam; PF00079; Serpin; 1.
DR   SMART; SM00093; SERPIN; 1.
DR   SUPFAM; SSF56574; SSF56574; 1.
DR   PROSITE; PS00284; SERPIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Glycoprotein; Polymorphism;
KW   Protease inhibitor; Reference proteome; Secreted;
KW   Serine protease inhibitor; Signal.
FT   SIGNAL        1     23
FT   CHAIN        24    402       Plasminogen activator inhibitor 1.
FT                                /FTId=PRO_0000032499.
FT   SITE        369    370       Reactive bond.
FT   CARBOHYD    232    232       N-linked (GlcNAc...).
FT   CARBOHYD    288    288       N-linked (GlcNAc...).
FT   CARBOHYD    352    352       N-linked (GlcNAc...). {ECO:0000255}.
FT   VAR_SEQ      31     45       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045493.
FT   VARIANT      15     15       A -> T (in dbSNP:rs6092).
FT                                {ECO:0000269|PubMed:10391209,
FT                                ECO:0000269|PubMed:9194591,
FT                                ECO:0000269|Ref.8}.
FT                                /FTId=VAR_007099.
FT   VARIANT      17     17       V -> I (in dbSNP:rs6090).
FT                                {ECO:0000269|PubMed:10391209,
FT                                ECO:0000269|Ref.8}.
FT                                /FTId=VAR_011750.
FT   VARIANT      25     25       H -> P (in dbSNP:rs2227647).
FT                                {ECO:0000269|Ref.8}.
FT                                /FTId=VAR_013086.
FT   VARIANT     209    209       R -> H (in dbSNP:rs2227669).
FT                                {ECO:0000269|Ref.8}.
FT                                /FTId=VAR_013087.
FT   VARIANT     255    255       T -> N (in dbSNP:rs2227685).
FT                                {ECO:0000269|Ref.8}.
FT                                /FTId=VAR_013088.
FT   CONFLICT     53     53       R -> A (in Ref. 7; CAA31208).
FT                                {ECO:0000305}.
FT   CONFLICT     55     55       V -> L (in Ref. 2; AAA60009).
FT                                {ECO:0000305}.
FT   CONFLICT     75     75       G -> V (in Ref. 7; CAA31208).
FT                                {ECO:0000305}.
FT   CONFLICT    138    138       R -> K (in Ref. 7; CAA31208).
FT                                {ECO:0000305}.
FT   CONFLICT    226    226       A -> V (in Ref. 9; BAH12656).
FT                                {ECO:0000305}.
FT   CONFLICT    280    282       QLI -> HVM (in Ref. 7; CAA31208).
FT                                {ECO:0000305}.
FT   HELIX        27     49       {ECO:0000244|PDB:1LJ5}.
FT   STRAND       51     53       {ECO:0000244|PDB:4IC0}.
FT   STRAND       55     57       {ECO:0000244|PDB:1LJ5}.
FT   HELIX        59     72       {ECO:0000244|PDB:1LJ5}.
FT   HELIX        75     85       {ECO:0000244|PDB:1LJ5}.
FT   HELIX        94    106       {ECO:0000244|PDB:1LJ5}.
FT   HELIX       108    110       {ECO:0000244|PDB:1LJ5}.
FT   STRAND      111    123       {ECO:0000244|PDB:1LJ5}.
FT   HELIX       132    140       {ECO:0000244|PDB:1LJ5}.
FT   STRAND      145    147       {ECO:0000244|PDB:1LJ5}.
FT   HELIX       149    151       {ECO:0000244|PDB:3UT3}.
FT   HELIX       152    165       {ECO:0000244|PDB:1LJ5}.
FT   TURN        166    169       {ECO:0000244|PDB:1LJ5}.
FT   STRAND      170    172       {ECO:0000244|PDB:9PAI}.
FT   HELIX       176    179       {ECO:0000244|PDB:4G8R}.
FT   STRAND      186    200       {ECO:0000244|PDB:1LJ5}.
FT   HELIX       204    206       {ECO:0000244|PDB:3CVM}.
FT   STRAND      209    213       {ECO:0000244|PDB:1LJ5}.
FT   STRAND      216    218       {ECO:0000244|PDB:1C5G}.
FT   STRAND      219    237       {ECO:0000244|PDB:1LJ5}.
FT   TURN        239    241       {ECO:0000244|PDB:1C5G}.
FT   STRAND      243    251       {ECO:0000244|PDB:1LJ5}.
FT   STRAND      254    265       {ECO:0000244|PDB:1LJ5}.
FT   HELIX       271    274       {ECO:0000244|PDB:1LJ5}.
FT   HELIX       279    288       {ECO:0000244|PDB:1LJ5}.
FT   STRAND      290    299       {ECO:0000244|PDB:1LJ5}.
FT   STRAND      301    308       {ECO:0000244|PDB:1LJ5}.
FT   HELIX       310    315       {ECO:0000244|PDB:1LJ5}.
FT   HELIX       320    322       {ECO:0000244|PDB:1LJ5}.
FT   TURN        324    326       {ECO:0000244|PDB:1LJ5}.
FT   TURN        330    332       {ECO:0000244|PDB:1LJ5}.
FT   STRAND      334    336       {ECO:0000244|PDB:1LJ5}.
FT   STRAND      340    351       {ECO:0000244|PDB:1LJ5}.
FT   STRAND      353    368       {ECO:0000244|PDB:1LJ5}.
FT   STRAND      374    376       {ECO:0000244|PDB:3CVM}.
FT   STRAND      380    387       {ECO:0000244|PDB:1LJ5}.
FT   TURN        388    391       {ECO:0000244|PDB:1LJ5}.
FT   STRAND      392    400       {ECO:0000244|PDB:1LJ5}.
SQ   SEQUENCE   402 AA;  45060 MW;  A2E181ED28DD6082 CRC64;
     MQMSPALTCL VLGLALVFGE GSAVHHPPSY VAHLASDFGV RVFQQVAQAS KDRNVVFSPY
     GVASVLAMLQ LTTGGETQQQ IQAAMGFKID DKGMAPALRH LYKELMGPWN KDEISTTDAI
     FVQRDLKLVQ GFMPHFFRLF RSTVKQVDFS EVERARFIIN DWVKTHTKGM ISNLLGKGAV
     DQLTRLVLVN ALYFNGQWKT PFPDSSTHRR LFHKSDGSTV SVPMMAQTNK FNYTEFTTPD
     GHYYDILELP YHGDTLSMFI AAPYEKEVPL SALTNILSAQ LISHWKGNMT RLPRLLVLPK
     FSLETEVDLR KPLENLGMTD MFRQFQADFT SLSDQEPLHV AQALQKVKIE VNESGTVASS
     STAVIVSARM APEEIIMDRP FLFVVRHNPT GTVLFMGQVM EP
//
ID   A0A024R755_HUMAN        Unreviewed;       315 AA.
AC   A0A024R755;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   02-NOV-2016, entry version 22.
DE   SubName: Full=Calumenin, isoform CRA_a {ECO:0000313|EMBL:EAW83676.1};
GN   Name=CALU {ECO:0000313|EMBL:EAW83676.1};
GN   ORFNames=hCG_41656 {ECO:0000313|EMBL:EAW83676.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW83676.1};
RN   [1] {ECO:0000313|EMBL:EAW83676.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW83676.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471070; EAW83674.1; -; Genomic_DNA.
DR   EMBL; CH471070; EAW83675.1; -; Genomic_DNA.
DR   EMBL; CH471070; EAW83676.1; -; Genomic_DNA.
DR   RefSeq; NP_001124146.1; NM_001130674.2.
DR   UniGene; Hs.743262; -.
DR   UniGene; Hs.7753; -.
DR   ProteinModelPortal; A0A024R755; -.
DR   SMR; A0A024R755; -.
DR   PRIDE; A0A024R755; -.
DR   GeneID; 813; -.
DR   KEGG; hsa:813; -.
DR   CTD; 813; -.
DR   GenomeRNAi; 813; -.
DR   ExpressionAtlas; A0A024R755; baseline and differential.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   Gene3D; 1.10.238.10; -; 2.
DR   InterPro; IPR027239; Calumenin.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   PANTHER; PTHR10827:SF34; PTHR10827:SF34; 1.
DR   Pfam; PF13202; EF-hand_5; 1.
DR   Pfam; PF13499; EF-hand_7; 1.
DR   Pfam; PF13833; EF-hand_8; 1.
DR   SMART; SM00054; EFh; 5.
DR   SUPFAM; SSF47473; SSF47473; 2.
DR   PROSITE; PS00018; EF_HAND_1; 4.
DR   PROSITE; PS50222; EF_HAND_2; 6.
PE   4: Predicted;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     19       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        20    315       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5007368686.
FT   DOMAIN       68    103       EF-hand. {ECO:0000259|PROSITE:PS50222}.
FT   DOMAIN      104    139       EF-hand. {ECO:0000259|PROSITE:PS50222}.
FT   DOMAIN      151    186       EF-hand. {ECO:0000259|PROSITE:PS50222}.
FT   DOMAIN      188    223       EF-hand. {ECO:0000259|PROSITE:PS50222}.
FT   DOMAIN      242    264       EF-hand. {ECO:0000259|PROSITE:PS50222}.
FT   DOMAIN      265    300       EF-hand. {ECO:0000259|PROSITE:PS50222}.
SQ   SEQUENCE   315 AA;  37135 MW;  E1BF415B25076676 CRC64;
     MDLRQFLMCL SLCTAFALSK PTEKKDRVHH EPQLSDKVHN DAQSFDYDHD AFLGAEEAKT
     FDQLTPEESK ERLGMIVDKI DADKDGFVTE GELKSWIKHA QKKYIYDNVE NQWQEFDMNQ
     DGLISWDEYR NVTYGTYLDD PDPDDGFNYK QMMVRDERRF KMADKDGDLI ATKEEFTAFL
     HPEEYDYMKD IVVQETMEDI DKNADGFIDL EEYIGDMYSH DGNTDEPEWV KTEREQFVEF
     RDKNRDGKMD KEETKDWILP SDYDHAEAEA RHLVYESDQN KDGKLTKEEI VDKYDLFVGS
     QATDFGEALV RHDEF
//
ID   H0Y875_HUMAN            Unreviewed;       147 AA.
AC   H0Y875;
DT   22-FEB-2012, integrated into UniProtKB/TrEMBL.
DT   22-FEB-2012, sequence version 1.
DT   02-NOV-2016, entry version 33.
DE   SubName: Full=Calumenin {ECO:0000313|Ensembl:ENSP00000417973};
DE   Flags: Fragment;
GN   Name=CALU {ECO:0000313|Ensembl:ENSP00000417973};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000417973, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000417973, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [2] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [3] {ECO:0000313|Ensembl:ENSP00000417973}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2012) to UniProtKB.
RN   [4] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [5] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000417973}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC024952; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; H0Y875; -.
DR   STRING; 9606.ENSP00000420381; -.
DR   MaxQB; H0Y875; -.
DR   PaxDb; H0Y875; -.
DR   PeptideAtlas; H0Y875; -.
DR   PRIDE; H0Y875; -.
DR   Ensembl; ENST00000493278; ENSP00000417973; ENSG00000128595.
DR   UCSC; uc064hvg.1; human.
DR   HGNC; HGNC:1458; CALU.
DR   OpenTargets; ENSG00000128595; -.
DR   eggNOG; KOG4223; Eukaryota.
DR   eggNOG; ENOG410XRVE; LUCA.
DR   GeneTree; ENSGT00550000074546; -.
DR   ChiTaRS; CALU; human.
DR   Proteomes; UP000005640; Chromosome 7.
DR   ExpressionAtlas; H0Y875; baseline and differential.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   Gene3D; 1.10.238.10; -; 1.
DR   InterPro; IPR027239; Calumenin.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   PANTHER; PTHR10827:SF34; PTHR10827:SF34; 1.
DR   Pfam; PF13202; EF-hand_5; 2.
DR   SMART; SM00054; EFh; 2.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 3.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:H0Y875,
KW   ECO:0000213|MaxQB:H0Y875, ECO:0000213|PeptideAtlas:H0Y875};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN       20     55       EF-hand. {ECO:0000259|PROSITE:PS50222}.
FT   DOMAIN       74     96       EF-hand. {ECO:0000259|PROSITE:PS50222}.
FT   DOMAIN       97    132       EF-hand. {ECO:0000259|PROSITE:PS50222}.
FT   NON_TER       1      1       {ECO:0000313|Ensembl:ENSP00000417973}.
SQ   SEQUENCE   147 AA;  17371 MW;  C2701826A1BCC844 CRC64;
     XIATKEEFTA FLHPEEYDYM KDIVVQETME DIDKNADGFI DLEEYIGDMY SHDGNTDEPE
     WVKTEREQFV EFRDKNRDGK MDKEETKDWI LPSDYDHAEA EARHLVYESD QNKDGKLTKE
     EIVDKYDLFV GSQATDFGEA LVRHDEF
//
ID   CALU_HUMAN              Reviewed;         315 AA.
AC   O43852; B3KPG9; D6QS48; D6QS49; D6QS50; D6QS51; D6QS52; D6QS53;
AC   D6QS54; D6QS55; D6QS56; D6QS57; D6QS58; D6QS59; F5H1Q9; F5H879;
AC   O60456; Q6FHB9; Q96RL3; Q9NR43;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1999, sequence version 2.
DT   02-NOV-2016, entry version 164.
DE   RecName: Full=Calumenin;
DE   AltName: Full=Crocalbin;
DE   AltName: Full=IEF SSP 9302;
DE   Flags: Precursor;
GN   Name=CALU;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PARTIAL PROTEIN SEQUENCE, AND
RP   CALCIUM-BINDING.
RC   TISSUE=Keratinocyte;
RX   PubMed=9675259; DOI=10.1016/S0167-4838(98)00089-2;
RA   Vorum H., Liu X., Madsen P., Rasmussen H.H., Honore B.;
RT   "Molecular cloning of a cDNA encoding human calumenin, expression in
RT   Escherichia coli and analysis of its Ca2+-binding activity.";
RL   Biochim. Biophys. Acta 1386:121-131(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9598325; DOI=10.1006/geno.1998.5245;
RA   Yabe D., Taniwaki M., Nakamura T., Kanazawa N., Tashiro K., Honjo T.;
RT   "Human calumenin gene (CALU): cDNA isolation and chromosomal mapping
RT   to 7q32.";
RL   Genomics 49:331-333(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Peterson R.E. Jr., Watson D.K.;
RT   "Novel splice variant of human calumenin.";
RL   Submitted (FEB-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3; 4; 5; 6; 7; 8; 9; 10; 11; 12;
RP   13; 14 AND 15), AND VARIANT GLN-4.
RA   Wang Q., Chen L., Shen B.R., Feng H., Zheng P.L., Teng J.L.,
RA   Chen J.G.;
RT   "Calumenin isoforms and their intracellular and extracellular
RT   function.";
RL   Submitted (MAR-2010) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 20-315 (ISOFORM 2).
RC   TISSUE=Brain;
RA   Hseu M.-J., Tzeng M.-C.;
RL   Submitted (APR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   PROTEIN SEQUENCE OF 20-27.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [12]
RP   SUBCELLULAR LOCATION.
RX   PubMed=10222138; DOI=10.1006/excr.1999.4431;
RA   Vorum H., Hager H., Christensen B.M., Nielsen S., Honore B.;
RT   "Human calumenin localizes to the secretory pathway and is secreted to
RT   the medium.";
RL   Exp. Cell Res. 248:473-481(1999).
RN   [13]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=12643545; DOI=10.1021/pr025562r;
RA   Basrur V., Yang F., Kushimoto T., Higashimoto Y., Yasumoto K.,
RA   Valencia J., Muller J., Vieira W.D., Watabe H., Shabanowitz J.,
RA   Hearing V.J., Hunt D.F., Appella E.;
RT   "Proteomic analysis of early melanosomes: identification of novel
RT   melanosomal proteins.";
RL   J. Proteome Res. 2:69-79(2003).
RN   [14]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H.,
RA   Mangini N.J., Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R.,
RA   Yamagishi S., Shabanowitz J., Hearing V.J., Wu C., Appella E.,
RA   Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-65, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44 AND THR-65, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [17]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-131.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [18]
RP   GLYCOSYLATION AT ASN-131.
RX   PubMed=19139490; DOI=10.1074/mcp.M800504-MCP200;
RA   Jia W., Lu Z., Fu Y., Wang H.P., Wang L.H., Chi H., Yuan Z.F.,
RA   Zheng Z.B., Song L.N., Han H.H., Liang Y.M., Wang J.L., Cai Y.,
RA   Zhang Y.K., Deng Y.L., Ying W.T., He S.M., Qian X.H.;
RT   "A strategy for precise and large scale identification of core
RT   fucosylated glycoproteins.";
RL   Mol. Cell. Proteomics 8:913-923(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44 AND THR-65, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-44; TYR-47; THR-254;
RP   SER-261 AND SER-277, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-65, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [23]
RP   PHOSPHORYLATION AT SER-69.
RX   PubMed=26091039; DOI=10.1016/j.cell.2015.05.028;
RA   Tagliabracci V.S., Wiley S.E., Guo X., Kinch L.N., Durrant E., Wen J.,
RA   Xiao J., Cui J., Nguyen K.B., Engel J.L., Coon J.J., Grishin N.,
RA   Pinna L.A., Pagliarini D.J., Dixon J.E.;
RT   "A single kinase generates the majority of the secreted
RT   phosphoproteome.";
RL   Cell 161:1619-1632(2015).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Involved in regulation of vitamin K-dependent
CC       carboxylation of multiple N-terminal glutamate residues. Seems to
CC       inhibit gamma-carboxylase GGCX. Binds 7 calcium ions with a low
CC       affinity (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with GGCX. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q9UMX0-2:UBQLN1; NbExp=3; IntAct=EBI-1171069, EBI-10173939;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:10222138}. Golgi apparatus
CC       {ECO:0000269|PubMed:10222138}. Secreted {ECO:0000305}. Melanosome
CC       {ECO:0000269|PubMed:12643545}. Sarcoplasmic reticulum lumen
CC       {ECO:0000305}. Note=Identified by mass spectrometry in melanosome
CC       fractions from stage I to stage IV. {ECO:0000269|PubMed:12643545}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=15;
CC       Name=1;
CC         IsoId=O43852-1; Sequence=Displayed;
CC       Name=2; Synonyms=Crocalbin;
CC         IsoId=O43852-2; Sequence=VSP_007317;
CC       Name=3;
CC         IsoId=O43852-3; Sequence=VSP_043570;
CC       Name=4;
CC         IsoId=O43852-4; Sequence=VSP_043570, VSP_007317;
CC       Name=5;
CC         IsoId=O43852-5; Sequence=VSP_045946;
CC       Name=6;
CC         IsoId=O43852-6; Sequence=VSP_045951;
CC       Name=7;
CC         IsoId=O43852-7; Sequence=VSP_007317, VSP_045944, VSP_045945;
CC       Name=8;
CC         IsoId=O43852-8; Sequence=VSP_007317, VSP_045949;
CC       Name=9;
CC         IsoId=O43852-9; Sequence=VSP_045941;
CC       Name=10;
CC         IsoId=O43852-10; Sequence=VSP_045950;
CC       Name=11;
CC         IsoId=O43852-11; Sequence=VSP_045947, VSP_045948;
CC       Name=12;
CC         IsoId=O43852-12; Sequence=VSP_045940;
CC       Name=13;
CC         IsoId=O43852-13; Sequence=VSP_045942, VSP_045943;
CC       Name=14;
CC         IsoId=O43852-14; Sequence=VSP_043570, VSP_045942, VSP_045943;
CC       Name=15;
CC         IsoId=O43852-15; Sequence=VSP_045939;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Expressed at high
CC       levels in heart, placenta and skeletal muscle, at lower levels in
CC       lung, kidney and pancreas and at very low levels in brain and
CC       liver.
CC   -!- SIMILARITY: Belongs to the CREC family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 6 EF-hand domains. {ECO:0000255|PROSITE-
CC       ProRule:PRU00448}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U67280; AAB97725.1; -; mRNA.
DR   EMBL; AF013759; AAC17216.1; -; mRNA.
DR   EMBL; AF345637; AAK72908.1; -; mRNA.
DR   EMBL; HM002604; ADG45004.1; -; mRNA.
DR   EMBL; HM002605; ADG45005.1; -; mRNA.
DR   EMBL; HM002606; ADG45006.1; -; mRNA.
DR   EMBL; HM002607; ADG45007.1; -; mRNA.
DR   EMBL; HM002608; ADG45008.1; -; mRNA.
DR   EMBL; HM002609; ADG45009.1; -; mRNA.
DR   EMBL; HM002610; ADG45010.1; -; mRNA.
DR   EMBL; HM002611; ADG45011.1; -; mRNA.
DR   EMBL; HM002612; ADG45012.1; -; mRNA.
DR   EMBL; HM002613; ADG45013.1; -; mRNA.
DR   EMBL; HM002614; ADG45014.1; -; mRNA.
DR   EMBL; HM002615; ADG45015.1; -; mRNA.
DR   EMBL; HM002616; ADG45016.1; -; mRNA.
DR   EMBL; AK056338; BAG51681.1; -; mRNA.
DR   EMBL; CR541835; CAG46634.1; -; mRNA.
DR   EMBL; AC024952; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471070; EAW83679.1; -; Genomic_DNA.
DR   EMBL; BC013383; AAH13383.1; -; mRNA.
DR   EMBL; AF257659; AAF76141.1; -; mRNA.
DR   CCDS; CCDS47703.1; -. [O43852-2]
DR   CCDS; CCDS56506.1; -. [O43852-3]
DR   CCDS; CCDS56507.1; -. [O43852-4]
DR   CCDS; CCDS56508.1; -. [O43852-10]
DR   CCDS; CCDS5805.1; -. [O43852-1]
DR   RefSeq; NP_001124146.1; NM_001130674.2. [O43852-2]
DR   RefSeq; NP_001186600.1; NM_001199671.1. [O43852-3]
DR   RefSeq; NP_001186601.1; NM_001199672.1. [O43852-4]
DR   RefSeq; NP_001186602.1; NM_001199673.1. [O43852-10]
DR   RefSeq; NP_001210.1; NM_001219.4. [O43852-1]
DR   RefSeq; XP_016868148.1; XM_017012659.1. [O43852-15]
DR   UniGene; Hs.743262; -.
DR   UniGene; Hs.7753; -.
DR   ProteinModelPortal; O43852; -.
DR   SMR; O43852; -.
DR   BioGrid; 107263; 121.
DR   IntAct; O43852; 38.
DR   STRING; 9606.ENSP00000420381; -.
DR   iPTMnet; O43852; -.
DR   PhosphoSitePlus; O43852; -.
DR   SwissPalm; O43852; -.
DR   BioMuta; CALU; -.
DR   DOSAC-COBS-2DPAGE; O43852; -.
DR   EPD; O43852; -.
DR   PaxDb; O43852; -.
DR   PeptideAtlas; O43852; -.
DR   PRIDE; O43852; -.
DR   TopDownProteomics; O43852-1; -. [O43852-1]
DR   TopDownProteomics; O43852-2; -. [O43852-2]
DR   TopDownProteomics; O43852-3; -. [O43852-3]
DR   TopDownProteomics; O43852-4; -. [O43852-4]
DR   TopDownProteomics; O43852-5; -. [O43852-5]
DR   TopDownProteomics; O43852-6; -. [O43852-6]
DR   TopDownProteomics; O43852-8; -. [O43852-8]
DR   TopDownProteomics; O43852-9; -. [O43852-9]
DR   DNASU; 813; -.
DR   Ensembl; ENST00000249364; ENSP00000249364; ENSG00000128595. [O43852-1]
DR   Ensembl; ENST00000449187; ENSP00000408838; ENSG00000128595. [O43852-2]
DR   Ensembl; ENST00000479257; ENSP00000420381; ENSG00000128595. [O43852-3]
DR   Ensembl; ENST00000535011; ENSP00000442110; ENSG00000128595. [O43852-10]
DR   Ensembl; ENST00000542996; ENSP00000438248; ENSG00000128595. [O43852-4]
DR   GeneID; 813; -.
DR   KEGG; hsa:813; -.
DR   UCSC; uc003vnr.4; human. [O43852-1]
DR   CTD; 813; -.
DR   DisGeNET; 813; -.
DR   GeneCards; CALU; -.
DR   HGNC; HGNC:1458; CALU.
DR   HPA; HPA006018; -.
DR   MIM; 603420; gene.
DR   neXtProt; NX_O43852; -.
DR   OpenTargets; ENSG00000128595; -.
DR   PharmGKB; PA26047; -.
DR   eggNOG; KOG4223; Eukaryota.
DR   eggNOG; ENOG410XRVE; LUCA.
DR   GeneTree; ENSGT00550000074546; -.
DR   HOGENOM; HOG000230934; -.
DR   HOVERGEN; HBG002834; -.
DR   InParanoid; O43852; -.
DR   OMA; NNDVDRT; -.
DR   OrthoDB; EOG091G0GUL; -.
DR   PhylomeDB; O43852; -.
DR   TreeFam; TF314849; -.
DR   BioCyc; ZFISH:ENSG00000128595-MONOMER; -.
DR   Reactome; R-HSA-114608; Platelet degranulation.
DR   ChiTaRS; CALU; human.
DR   GeneWiki; CALU_(gene); -.
DR   GenomeRNAi; 813; -.
DR   PRO; PR:O43852; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000128595; -.
DR   CleanEx; HS_CALU; -.
DR   ExpressionAtlas; O43852; baseline and differential.
DR   Genevisible; O43852; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; TAS:ProtInc.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0033018; C:sarcoplasmic reticulum lumen; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   Gene3D; 1.10.238.10; -; 2.
DR   InterPro; IPR027239; Calumenin.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   PANTHER; PTHR10827:SF34; PTHR10827:SF34; 1.
DR   Pfam; PF13202; EF-hand_5; 2.
DR   Pfam; PF13833; EF-hand_8; 1.
DR   SMART; SM00054; EFh; 4.
DR   SUPFAM; SSF47473; SSF47473; 2.
DR   PROSITE; PS00018; EF_HAND_1; 4.
DR   PROSITE; PS50222; EF_HAND_2; 6.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Calcium; Complete proteome;
KW   Direct protein sequencing; Endoplasmic reticulum; Glycoprotein;
KW   Golgi apparatus; Membrane; Metal-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat; Sarcoplasmic reticulum;
KW   Secreted; Signal.
FT   SIGNAL        1     19       {ECO:0000269|PubMed:12665801}.
FT   CHAIN        20    315       Calumenin.
FT                                /FTId=PRO_0000004153.
FT   DOMAIN       68    103       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      104    139       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      151    186       EF-hand 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      188    223       EF-hand 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      229    264       EF-hand 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      265    300       EF-hand 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND      81     92       1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     117    128       2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     164    175       3; possibly ancestral.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00448}.
FT   CA_BIND     201    212       4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     242    253       5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     278    289       6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   MOTIF       312    315       Prevents secretion from ER.
FT                                {ECO:0000250}.
FT   MOD_RES      44     44       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      47     47       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      65     65       Phosphothreonine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES      69     69       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:26091039}.
FT   MOD_RES     165    165       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:O35887}.
FT   MOD_RES     254    254       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     261    261       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     277    277       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CARBOHYD    131    131       N-linked (GlcNAc...) (complex).
FT                                {ECO:0000269|PubMed:19139490,
FT                                ECO:0000269|PubMed:19159218}.
FT   VAR_SEQ       1    151       Missing (in isoform 15).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_045939.
FT   VAR_SEQ       1      1       M -> MKETDLIIM (in isoform 3, isoform 4
FT                                and isoform 14).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.4}.
FT                                /FTId=VSP_043570.
FT   VAR_SEQ      75    315       Missing (in isoform 12).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_045940.
FT   VAR_SEQ      75    137       KIVSKIDGDKDGFVTVDELKDWIKFAQKRWIYEDVERQWKG
FT                                HDLNEDGLVSWEEYKNATYGYV -> MIVDKIDADKDGFVT
FT                                EGELKSWIKHAQKKYIYDNVENQWQEFDMNQDGLISWDEYR
FT                                NVTYGTY (in isoform 2, isoform 4, isoform
FT                                7 and isoform 8). {ECO:0000303|Ref.10,
FT                                ECO:0000303|Ref.3, ECO:0000303|Ref.4}.
FT                                /FTId=VSP_007317.
FT   VAR_SEQ      94    254       Missing (in isoform 9).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_045941.
FT   VAR_SEQ     139    139       D -> E (in isoform 13 and isoform 14).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_045942.
FT   VAR_SEQ     140    315       Missing (in isoform 13 and isoform 14).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_045943.
FT   VAR_SEQ     154    161       VRDERRFK -> GILMSRNG (in isoform 7).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_045944.
FT   VAR_SEQ     162    315       Missing (in isoform 7).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_045945.
FT   VAR_SEQ     164    249       Missing (in isoform 5).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_045946.
FT   VAR_SEQ     165    170       KDGDLI -> RARAVC (in isoform 11).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_045947.
FT   VAR_SEQ     171    315       Missing (in isoform 11).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_045948.
FT   VAR_SEQ     172    285       Missing (in isoform 8).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_045949.
FT   VAR_SEQ     216    315       DMYSHDGNTDEPEWVKTEREQFVEFRDKNRDGKMDKEETKD
FT                                WILPSDYDHAEAEARHLVYESDQNKDGKLTKEEIVDKYDLF
FT                                VGSQATDFGEALVRHDEF -> WQAYQGGDR (in
FT                                isoform 10). {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_045950.
FT   VAR_SEQ     226    275       Missing (in isoform 6).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_045951.
FT   VARIANT       4      4       R -> Q (in dbSNP:rs2290228).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_022051.
FT   CONFLICT     48     48       D -> G (in Ref. 4; ADG45013).
FT                                {ECO:0000305}.
FT   CONFLICT     84     84       K -> R (in Ref. 4; ADG45007).
FT                                {ECO:0000305}.
FT   CONFLICT     90     90       V -> A (in Ref. 4; ADG45010).
FT                                {ECO:0000305}.
FT   CONFLICT    117    117       D -> G (in Ref. 4; ADG45007).
FT                                {ECO:0000305}.
FT   CONFLICT    118    118       L -> H (in Ref. 4; ADG45011).
FT                                {ECO:0000305}.
FT   CONFLICT    147    147       F -> S (in Ref. 4; ADG45012).
FT                                {ECO:0000305}.
FT   CONFLICT    188    188       M -> V (in Ref. 4; ADG45015).
FT                                {ECO:0000305}.
FT   CONFLICT    207    207       F -> L (in Ref. 1; AAB97725).
FT                                {ECO:0000305}.
FT   CONFLICT    232    232       T -> S (in Ref. 4; ADG45015).
FT                                {ECO:0000305}.
FT   CONFLICT    267    267       E -> V (in Ref. 6; CAG46634).
FT                                {ECO:0000305}.
SQ   SEQUENCE   315 AA;  37107 MW;  25BAE5A99B527375 CRC64;
     MDLRQFLMCL SLCTAFALSK PTEKKDRVHH EPQLSDKVHN DAQSFDYDHD AFLGAEEAKT
     FDQLTPEESK ERLGKIVSKI DGDKDGFVTV DELKDWIKFA QKRWIYEDVE RQWKGHDLNE
     DGLVSWEEYK NATYGYVLDD PDPDDGFNYK QMMVRDERRF KMADKDGDLI ATKEEFTAFL
     HPEEYDYMKD IVVQETMEDI DKNADGFIDL EEYIGDMYSH DGNTDEPEWV KTEREQFVEF
     RDKNRDGKMD KEETKDWILP SDYDHAEAEA RHLVYESDQN KDGKLTKEEI VDKYDLFVGS
     QATDFGEALV RHDEF
//
ID   Q6IAW5_HUMAN            Unreviewed;       315 AA.
AC   Q6IAW5;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   02-NOV-2016, entry version 118.
DE   SubName: Full=CALU protein {ECO:0000313|EMBL:CAG33320.1};
DE   SubName: Full=Calumenin {ECO:0000313|EMBL:AAP35472.1};
DE   SubName: Full=Calumenin, isoform CRA_b {ECO:0000313|EMBL:EAW83677.1};
DE   SubName: Full=cDNA, FLJ92797, Homo sapiens calumenin (CALU), mRNA {ECO:0000313|EMBL:BAG35353.1};
GN   Name=CALU {ECO:0000313|EMBL:CAG33320.1};
GN   ORFNames=hCG_41656 {ECO:0000313|EMBL:EAW83677.1},
GN   tcag7.422 {ECO:0000313|EMBL:EAL24113.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAG33320.1};
RN   [1] {ECO:0000313|EMBL:EAW83677.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAL24113.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Lai Z., Nusskern D., Zhang Q., Gu Z., Lu F.,
RA   Zeesman S., Nowaczyk M.J., Teshima I., Chitayat D., Shuman C.,
RA   Weksberg R., Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J.,
RA   Rahman N., Friedman J.M., Heng H.H., Pelicci P.G., Lo-Coco F.,
RA   Belloni E., Shaffer L.G., Pober B., Morton C.C., Gusella J.F.,
RA   Bruns G.A., Korf B.R., Quade B.J., Ligon A.H., Ferguson H.,
RA   Higgins A.W., Leach N.T., Herrick S.R., Lemyre E., Farra C.G.,
RA   Kim H.G., Summers A.M., Gripp K.W., Roberts W., Szatmari P.,
RA   Winsor E.J., Grzeschik K.H., Teebi A., Minassian B.A., Kere J.,
RA   Armengol L., Pujana M.A., Estivill X., Wilson M.D., Koop B.F.,
RA   Tosi S., Moore G.E., Boright A.P., Zlotorynski E., Kerem B.,
RA   Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Dohner H., Dohner K.,
RA   Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [3] {ECO:0000313|EMBL:AAP35472.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) System Donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:CAG33320.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:EAL24113.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S.,
RA   Kwasnicka D., Zheng X.H., Nusskern D., Zhang Q., Gu Z., Lu F.,
RA   Zeesman S., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P., Lococo F., Belloni E.,
RA   Shaffer L.G., Morton C.C., Pober B., Gusella J., Bruns G., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M.,
RA   Gripp K.W., Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H.,
RA   Teebi A., Minassian B.A., Kere J., Armengol L., Pujana M.Angel.,
RA   Estivill X., Wilson M.D., Koop B.F., Tosi S., Moore G.E.,
RA   Boright A.P., Zlotorynski E., Kerem B., Kroisel P.M., Petek E.,
RA   Oscier D.G., Mould S.J., Doehner H., Doehner K., Rommens J.M.,
RA   Vincent J.B., Venter J.C., Li P.W., Mural R.J., Adams M.D.,
RA   Tsui L.-C.;
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000313|EMBL:AAV38945.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) System Donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7] {ECO:0000313|EMBL:EAW83677.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8] {ECO:0000313|EMBL:BAG35353.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Caudate nucleus {ECO:0000313|EMBL:BAG35353.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application
RT   project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BT006826; AAP35472.1; -; mRNA.
DR   EMBL; BT020143; AAV38945.1; -; mRNA.
DR   EMBL; AK312446; BAG35353.1; -; mRNA.
DR   EMBL; CR457039; CAG33320.1; -; mRNA.
DR   EMBL; CH236950; EAL24113.1; -; Genomic_DNA.
DR   EMBL; CH471070; EAW83677.1; -; Genomic_DNA.
DR   EMBL; CH471070; EAW83678.1; -; Genomic_DNA.
DR   RefSeq; NP_001210.1; NM_001219.4.
DR   UniGene; Hs.743262; -.
DR   UniGene; Hs.7753; -.
DR   STRING; 9606.ENSP00000420381; -.
DR   DNASU; 813; -.
DR   GeneID; 813; -.
DR   UCSC; uc003vnq.4; human.
DR   CTD; 813; -.
DR   PharmGKB; PA26047; -.
DR   eggNOG; KOG4223; Eukaryota.
DR   eggNOG; ENOG410XRVE; LUCA.
DR   HOVERGEN; HBG002834; -.
DR   ChiTaRS; CALU; human.
DR   GenomeRNAi; 813; -.
DR   Bgee; ENSG00000128595; -.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   Gene3D; 1.10.238.10; -; 2.
DR   InterPro; IPR027239; Calumenin.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   PANTHER; PTHR10827:SF34; PTHR10827:SF34; 1.
DR   Pfam; PF13202; EF-hand_5; 2.
DR   Pfam; PF13833; EF-hand_8; 1.
DR   SMART; SM00054; EFh; 4.
DR   SUPFAM; SSF47473; SSF47473; 2.
DR   PROSITE; PS00018; EF_HAND_1; 4.
DR   PROSITE; PS50222; EF_HAND_2; 6.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     19       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        20    315       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5008426569.
FT   DOMAIN       68    103       EF-hand. {ECO:0000259|PROSITE:PS50222}.
FT   DOMAIN      104    139       EF-hand. {ECO:0000259|PROSITE:PS50222}.
FT   DOMAIN      151    186       EF-hand. {ECO:0000259|PROSITE:PS50222}.
FT   DOMAIN      188    223       EF-hand. {ECO:0000259|PROSITE:PS50222}.
FT   DOMAIN      242    264       EF-hand. {ECO:0000259|PROSITE:PS50222}.
FT   DOMAIN      265    300       EF-hand. {ECO:0000259|PROSITE:PS50222}.
SQ   SEQUENCE   315 AA;  37107 MW;  25BAE5A99B527375 CRC64;
     MDLRQFLMCL SLCTAFALSK PTEKKDRVHH EPQLSDKVHN DAQSFDYDHD AFLGAEEAKT
     FDQLTPEESK ERLGKIVSKI DGDKDGFVTV DELKDWIKFA QKRWIYEDVE RQWKGHDLNE
     DGLVSWEEYK NATYGYVLDD PDPDDGFNYK QMMVRDERRF KMADKDGDLI ATKEEFTAFL
     HPEEYDYMKD IVVQETMEDI DKNADGFIDL EEYIGDMYSH DGNTDEPEWV KTEREQFVEF
     RDKNRDGKMD KEETKDWILP SDYDHAEAEA RHLVYESDQN KDGKLTKEEI VDKYDLFVGS
     QATDFGEALV RHDEF
//
ID   A0A0A0MSQ0_HUMAN        Unreviewed;       617 AA.
AC   A0A0A0MSQ0;
DT   07-JAN-2015, integrated into UniProtKB/TrEMBL.
DT   07-JAN-2015, sequence version 1.
DT   02-NOV-2016, entry version 18.
DE   SubName: Full=Plastin-3 {ECO:0000313|Ensembl:ENSP00000398945};
GN   Name=PLS3 {ECO:0000313|Ensembl:ENSP00000398945};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000398945, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000398945, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [4] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [6] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [7] {ECO:0000313|Ensembl:ENSP00000398945}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (NOV-2014) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000398945}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL589842; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; A0A0A0MSQ0; -.
DR   STRING; 9606.ENSP00000348163; -.
DR   PaxDb; A0A0A0MSQ0; -.
DR   PeptideAtlas; A0A0A0MSQ0; -.
DR   PRIDE; A0A0A0MSQ0; -.
DR   Ensembl; ENST00000420625; ENSP00000398945; ENSG00000102024.
DR   UCSC; uc065auq.1; human.
DR   HGNC; HGNC:9091; PLS3.
DR   OpenTargets; ENSG00000102024; -.
DR   eggNOG; KOG0046; Eukaryota.
DR   eggNOG; COG5069; LUCA.
DR   GeneTree; ENSGT00390000005691; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   ExpressionAtlas; A0A0A0MSQ0; baseline and differential.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   Gene3D; 1.10.238.10; -; 1.
DR   Gene3D; 1.10.418.10; -; 4.
DR   InterPro; IPR001589; Actinin_actin-bd_CS.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   Pfam; PF00307; CH; 4.
DR   Pfam; PF13499; EF-hand_7; 1.
DR   SMART; SM00033; CH; 4.
DR   SMART; SM00054; EFh; 1.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   PROSITE; PS00019; ACTININ_1; 2.
DR   PROSITE; PS00020; ACTININ_2; 2.
DR   PROSITE; PS50021; CH; 4.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 2.
PE   1: Evidence at protein level;
KW   Actin-binding {ECO:0000256|SAAS:SAAS00475740};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:A0A0A0MSQ0,
KW   ECO:0000213|MaxQB:A0A0A0MSQ0, ECO:0000213|PeptideAtlas:A0A0A0MSQ0};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Repeat {ECO:0000256|SAAS:SAAS00476138}.
FT   DOMAIN        1     25       EF-hand. {ECO:0000259|PROSITE:PS50222}.
FT   DOMAIN       30     65       EF-hand. {ECO:0000259|PROSITE:PS50222}.
FT   DOMAIN      101    217       Actin-binding.
FT                                {ECO:0000259|PROSITE:PS50021}.
FT   DOMAIN      245    365       Actin-binding.
FT                                {ECO:0000259|PROSITE:PS50021}.
FT   DOMAIN      384    493       Actin-binding.
FT                                {ECO:0000259|PROSITE:PS50021}.
FT   DOMAIN      505    614       Actin-binding.
FT                                {ECO:0000259|PROSITE:PS50021}.
SQ   SEQUENCE   617 AA;  69334 MW;  7FF8868398B2CCD2 CRC64;
     MIDLNSNGFI CDYELHELFK EANMPLPGYK VREIIQKLML DGDRNKDGKI SFDEFVYIFQ
     EVKSSDIAKT FRKAINRKEG ICALGGTSEL SSEGTQHSYS EEEKYAFVNW INKALENDPD
     CRHVIPMNPN TDDLFKAVGD GIVLCKMINL SVPDTIDERA INKKKLTPFI IQENLNLALN
     SASAIGCHVV NIGAEDLRAG KPHLVLGLLW QIIKIGLFAD IELSRNEALA ALLRDGETLE
     ELMKLSPEEL LLRWANFHLE NSGWQKINNF SADIKLIDFS NSVKDSKAYF HLLNQIAPKG
     QKEGEPRIDI NMSGFNETDD LKRAESMLQQ ADKLGCRQFV TPADVVSGNP KLNLAFVANL
     FNKYPALTKP ENQDIDWTLL EGETREERTF RNWMNSLGVN PHVNHLYADL QDALVILQLY
     ERIKVPVDWS KVNKPPYPKL GANMKKLENC NYAVELGKHP AKFSLVGIGG QDLNDGNQTL
     TLALVWQLMR RYTLNVLEDL GDGQKANDDI IVNWVNRTLS EAGKSTSIQS FKDKTISSSL
     AVVDLIDAIQ PGCINYDLVK SGNLTEDDKH NNAKYAVSMA RRIGARVYAL PEDLVEVKPK
     MVMTVFACLM GRGMKRV
//
ID   A7E2S2_HUMAN            Unreviewed;       150 AA.
AC   A7E2S2;
DT   11-SEP-2007, integrated into UniProtKB/TrEMBL.
DT   11-SEP-2007, sequence version 1.
DT   06-JUL-2016, entry version 39.
DE   SubName: Full=PLS3 protein {ECO:0000313|EMBL:AAI50495.1};
DE   Flags: Fragment;
GN   Name=PLS3 {ECO:0000313|EMBL:AAI50495.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAI50495.1};
RN   [1] {ECO:0000313|EMBL:AAI50495.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M.,
RA   Peck A.M., Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S.,
RA   Feolo M., Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F.,
RA   Schaefer C.F., Buetow K., Bonner T.I., Haussler D., Kent J.,
RA   Kiekhaus M., Furey T., Brent M., Prange C., Schreiber K., Shapiro N.,
RA   Bhat N.K., Hopkins R.F., Hsie F., Driscoll T., Soares M.B.,
RA   Casavant T.L., Scheetz T.E., Brown-stein M.J., Usdin T.B.,
RA   Toshiyuki S., Carninci P., Piao Y., Dudekula D.B., Ko M.S.,
RA   Kawakami K., Suzuki Y., Sugano S., Gruber C.E., Smith M.R.,
RA   Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y., Wei C.L.,
RA   Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W., Fuh E.,
RA   Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D.,
RA   Granite S.J., Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G.,
RA   Blakesly R.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J.,
RA   Schmutz J., Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L.,
RA   Krzywinski M.I., Liao N., Morin R., Morrin R., Palmquist D.,
RA   Petrescu A.S., Skalska U., Smailus D.E., Stott J.M., Schnerch A.,
RA   Schein J.E., Jones S.J., Holt R.A., Baross A., Marra M.A., Clifton S.,
RA   Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; BC150494; AAI50495.1; -; mRNA.
DR   UniGene; Hs.496622; -.
DR   ProteinModelPortal; A7E2S2; -.
DR   STRING; 9606.ENSP00000348163; -.
DR   PaxDb; A7E2S2; -.
DR   PeptideAtlas; A7E2S2; -.
DR   PRIDE; A7E2S2; -.
DR   eggNOG; KOG0046; Eukaryota.
DR   eggNOG; COG5069; LUCA.
DR   HOVERGEN; HBG003082; -.
DR   ChiTaRS; PLS3; human.
DR   Gene3D; 1.10.418.10; -; 2.
DR   InterPro; IPR001715; CH-domain.
DR   Pfam; PF00307; CH; 1.
DR   SMART; SM00033; CH; 1.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   PROSITE; PS50021; CH; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN       38    147       Actin-binding.
FT                                {ECO:0000259|PROSITE:PS50021}.
FT   NON_TER       1      1       {ECO:0000313|EMBL:AAI50495.1}.
SQ   SEQUENCE   150 AA;  16687 MW;  40B0DFF28C731D42 CRC64;
     SHWADLNDGN QTLTLALVWQ LMRRYTLNVL EDLGDGQKAN DDIIVNWVNR TLSEAGKSTS
     IQSFKDKTIS SSLAVVDLID AIQPGCINYD LVKSGNLTED DKHNNAKYAV SMARRIGARV
     YALPEDLVEV KPKMVMTVFA CLMGRGMKRV
//
ID   F2Z2Z9_HUMAN            Unreviewed;        42 AA.
AC   F2Z2Z9;
DT   31-MAY-2011, integrated into UniProtKB/TrEMBL.
DT   31-MAY-2011, sequence version 1.
DT   02-NOV-2016, entry version 40.
DE   SubName: Full=Plastin-3 {ECO:0000313|Ensembl:ENSP00000420458};
GN   Name=PLS3 {ECO:0000313|Ensembl:ENSP00000420458};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000420458, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000420458, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [2] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [3] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [4] {ECO:0000313|Ensembl:ENSP00000420458}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [5] {ECO:0000313|Ensembl:ENSP00000419051}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [6] {ECO:0000313|Ensembl:ENSP00000487343}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (APR-2015) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000420458}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL589842; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; F2Z2Z9; -.
DR   STRING; 9606.ENSP00000348163; -.
DR   MaxQB; F2Z2Z9; -.
DR   PeptideAtlas; F2Z2Z9; -.
DR   PRIDE; F2Z2Z9; -.
DR   Ensembl; ENST00000481823; ENSP00000419051; ENSG00000102024.
DR   Ensembl; ENST00000489283; ENSP00000420458; ENSG00000102024.
DR   Ensembl; ENST00000626746; ENSP00000487343; ENSG00000102024.
DR   UCSC; uc065aum.1; human.
DR   HGNC; HGNC:9091; PLS3.
DR   OpenTargets; ENSG00000102024; -.
DR   eggNOG; KOG0046; Eukaryota.
DR   eggNOG; COG5069; LUCA.
DR   GeneTree; ENSGT00390000005691; -.
DR   ChiTaRS; PLS3; human.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000102024; -.
DR   ExpressionAtlas; F2Z2Z9; baseline and differential.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:F2Z2Z9,
KW   ECO:0000213|MaxQB:F2Z2Z9, ECO:0000213|PeptideAtlas:F2Z2Z9};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   42 AA;  4771 MW;  331788ADE6109BE0 CRC64;
     MDEMATTQIS KDELDELKEA FAKVVETEFH RVSQDGLDLL TS
//
ID   H7C4N2_HUMAN            Unreviewed;       190 AA.
AC   H7C4N2;
DT   18-APR-2012, integrated into UniProtKB/TrEMBL.
DT   18-APR-2012, sequence version 1.
DT   02-NOV-2016, entry version 31.
DE   SubName: Full=Plastin-3 {ECO:0000313|Ensembl:ENSP00000417728};
DE   Flags: Fragment;
GN   Name=PLS3 {ECO:0000313|Ensembl:ENSP00000417728};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000417728, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000417728, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [4] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5] {ECO:0000313|Ensembl:ENSP00000417728}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [6] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [7] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000417728}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL589842; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; H7C4N2; -.
DR   STRING; 9606.ENSP00000348163; -.
DR   MaxQB; H7C4N2; -.
DR   PaxDb; H7C4N2; -.
DR   PeptideAtlas; H7C4N2; -.
DR   PRIDE; H7C4N2; -.
DR   Ensembl; ENST00000497870; ENSP00000417728; ENSG00000102024.
DR   UCSC; uc065aus.1; human.
DR   HGNC; HGNC:9091; PLS3.
DR   OpenTargets; ENSG00000102024; -.
DR   eggNOG; KOG0046; Eukaryota.
DR   eggNOG; COG5069; LUCA.
DR   GeneTree; ENSGT00390000005691; -.
DR   ChiTaRS; PLS3; human.
DR   Proteomes; UP000005640; Chromosome X.
DR   ExpressionAtlas; H7C4N2; baseline and differential.
DR   Gene3D; 1.10.418.10; -; 2.
DR   InterPro; IPR001589; Actinin_actin-bd_CS.
DR   InterPro; IPR001715; CH-domain.
DR   Pfam; PF00307; CH; 2.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   PROSITE; PS00019; ACTININ_1; 1.
DR   PROSITE; PS50021; CH; 2.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:H7C4N2,
KW   ECO:0000213|MaxQB:H7C4N2, ECO:0000213|PeptideAtlas:H7C4N2};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN       17     99       Actin-binding.
FT                                {ECO:0000259|PROSITE:PS50021}.
FT   DOMAIN      118    190       Actin-binding.
FT                                {ECO:0000259|PROSITE:PS50021}.
FT   NON_TER       1      1       {ECO:0000313|Ensembl:ENSP00000417728}.
FT   NON_TER     190    190       {ECO:0000313|Ensembl:ENSP00000417728}.
SQ   SEQUENCE   190 AA;  21801 MW;  255E1B431EB5899B CRC64;
     XFKLCFVELS TQPEFMLTDS KAYFHLLNQI APKGQKEGEP RIDINMSGFN ETDDLKRAES
     MLQQADKLGC RQFVTPADVV SGNPKLNLAF VANLFNKYPA LTKPENQDID WTLLEGETRE
     ERTFRNWMNS LGVNPHVNHL YADLQDALVI LQLYERIKVP VDWSKVNKPP YPKLGANMKK
     LENCNYAVEL
//
ID   PLST_HUMAN              Reviewed;         630 AA.
AC   P13797; A8K579; B1AQ09; B4DGB4; B7Z6M1; Q86YI6;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   14-APR-2009, sequence version 4.
DT   02-NOV-2016, entry version 186.
DE   RecName: Full=Plastin-3;
DE   AltName: Full=T-plastin;
GN   Name=PLS3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=3211125; DOI=10.1128/MCB.8.11.4659;
RA   Lin C.-S., Aebersold R.H., Kent S.B., Varma M., Leavitt J.;
RT   "Molecular cloning and characterization of plastin, a human leukocyte
RT   protein expressed in transformed human fibroblasts.";
RL   Mol. Cell. Biol. 8:4659-4668(1988).
RN   [2]
RP   SEQUENCE REVISION.
RX   PubMed=2378651; DOI=10.1128/MCB.10.4.1818;
RA   Lin C.-S., Aebersold R.H., Leavitt J.;
RT   "Correction of the N-terminal sequences of the human plastin isoforms
RT   by using anchored polymerase chain reaction: identification of a
RT   potential calcium-binding domain.";
RL   Mol. Cell. Biol. 10:1818-1821(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 588-630.
RX   PubMed=8428952;
RA   Lin C.-S., Park T., Chen Z.P., Leavitt J.;
RT   "Human plastin genes. Comparative gene structure, chromosome location,
RT   and differential expression in normal and neoplastic cells.";
RL   J. Biol. Chem. 268:2781-2792(1993).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-326 AND THR-391, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-293; SER-326 AND
RP   THR-391, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-293 AND SER-326, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   POSSIBLE FUNCTION AS REGULATOR OF BONE DEVELOPMENT, POLYMORPHISM, AND
RP   VARIANT OSTEOP ASN-253 INS.
RX   PubMed=24088043; DOI=10.1056/NEJMoa1308223;
RA   van Dijk F.S., Zillikens M.C., Micha D., Riessland M., Marcelis C.L.,
RA   de Die-Smulders C.E., Milbradt J., Franken A.A., Harsevoort A.J.,
RA   Lichtenbelt K.D., Pruijs H.E., Rubio-Gozalbo M.E., Zwertbroek R.,
RA   Moutaouakil Y., Egthuijsen J., Hammerschmidt M., Bijman R.,
RA   Semeins C.M., Bakker A.D., Everts V., Klein-Nulend J.,
RA   Campos-Obando N., Hofman A., te Meerman G.J., Verkerk A.J.,
RA   Uitterlinden A.G., Maugeri A., Sistermans E.A., Waisfisz Q.,
RA   Meijers-Heijboer H., Wirth B., Simon M.E., Pals G.;
RT   "PLS3 mutations in X-linked osteoporosis with fractures.";
RL   N. Engl. J. Med. 369:1529-1536(2013).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-339, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 101-375.
RX   PubMed=9302997; DOI=10.1038/nsb0997-708;
RA   Goldsmith S.C., Pokala N., Shen W., Fedorov A.A., Matsudaira P.,
RA   Almo S.C.;
RT   "The structure of an actin-crosslinking domain from human fimbrin.";
RL   Nat. Struct. Biol. 4:708-712(1997).
RN   [15]
RP   STRUCTURE BY NMR OF 520-630.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the fourth CH domain from human plastin 3 T-
RT   isoform.";
RL   Submitted (NOV-2004) to the PDB data bank.
RN   [16]
RP   VARIANT [LARGE SCALE ANALYSIS] ALA-488.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Actin-bundling protein found in intestinal microvilli,
CC       hair cell stereocilia, and fibroblast filopodia. May play a role
CC       in the regulation of bone development.
CC   -!- SUBUNIT: Monomer.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P13797-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P13797-2; Sequence=VSP_056236, VSP_056237;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P13797-3; Sequence=VSP_056235;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in a variety of organs, including
CC       muscle, brain, uterus and esophagus.
CC   -!- POLYMORPHISM: Genetic variations in PLS3 define the bone mineral
CC       density quantitative trait locus 18 (BMND18) [MIM:300910].
CC       Variance in bone mineral density influences bone mass, contributes
CC       to size determination in the general population, and is a
CC       susceptibility factor for osteoporotic fractures.
CC       {ECO:0000269|PubMed:24088043}.
CC   -!- DISEASE: Osteoporosis (OSTEOP) [MIM:166710]: A systemic skeletal
CC       disorder characterized by decreased bone mass and deterioration of
CC       bone microarchitecture without alteration in the composition of
CC       bone. The result is fragile bones and an increased risk of
CC       fractures, even after minimal trauma. Osteoporosis is a chronic
CC       condition of multifactorial etiology and is usually clinically
CC       silent until a fracture occurs. {ECO:0000269|PubMed:24088043}.
CC       Note=Disease susceptibility is associated with variations
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Contains 2 actin-binding domains. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 4 CH (calponin-homology) domains.
CC       {ECO:0000255|PROSITE-ProRule:PRU00044}.
CC   -!- SIMILARITY: Contains 2 EF-hand domains. {ECO:0000255|PROSITE-
CC       ProRule:PRU00448}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAI39884.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M22299; AAB02844.1; -; mRNA.
DR   EMBL; M34427; AAA36759.1; -; mRNA.
DR   EMBL; AK291194; BAF83883.1; -; mRNA.
DR   EMBL; AK294509; BAG57725.1; -; mRNA.
DR   EMBL; AK300575; BAH13307.1; -; mRNA.
DR   EMBL; AK312391; BAG35308.1; -; mRNA.
DR   EMBL; AC003983; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL589842; CAI39884.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AC005000; CAI39884.1; JOINED; Genomic_DNA.
DR   EMBL; CH471120; EAX02614.1; -; Genomic_DNA.
DR   EMBL; BC039049; AAH39049.1; -; mRNA.
DR   EMBL; BC056898; AAH56898.1; -; mRNA.
DR   EMBL; L05491; AAA61214.1; -; Genomic_DNA.
DR   CCDS; CCDS14568.1; -. [P13797-1]
DR   CCDS; CCDS78499.1; -. [P13797-2]
DR   PIR; A34789; A34789.
DR   RefSeq; NP_001129497.1; NM_001136025.4. [P13797-1]
DR   RefSeq; NP_001165806.1; NM_001172335.2.
DR   RefSeq; NP_001269266.1; NM_001282337.1. [P13797-2]
DR   RefSeq; NP_001269267.1; NM_001282338.1. [P13797-3]
DR   RefSeq; NP_005023.2; NM_005032.6. [P13797-1]
DR   RefSeq; XP_011535836.1; XM_011537534.1. [P13797-1]
DR   UniGene; Hs.496622; -.
DR   PDB; 1AOA; X-ray; 2.40 A; A=101-375.
DR   PDB; 1WJO; NMR; -; A=520-630.
DR   PDBsum; 1AOA; -.
DR   PDBsum; 1WJO; -.
DR   ProteinModelPortal; P13797; -.
DR   SMR; P13797; -.
DR   BioGrid; 111372; 49.
DR   IntAct; P13797; 14.
DR   MINT; MINT-3008106; -.
DR   STRING; 9606.ENSP00000348163; -.
DR   iPTMnet; P13797; -.
DR   PhosphoSitePlus; P13797; -.
DR   SwissPalm; P13797; -.
DR   BioMuta; PLS3; -.
DR   DMDM; 226694201; -.
DR   EPD; P13797; -.
DR   MaxQB; P13797; -.
DR   PaxDb; P13797; -.
DR   PeptideAtlas; P13797; -.
DR   PRIDE; P13797; -.
DR   DNASU; 5358; -.
DR   Ensembl; ENST00000289290; ENSP00000289290; ENSG00000102024. [P13797-2]
DR   Ensembl; ENST00000355899; ENSP00000348163; ENSG00000102024. [P13797-1]
DR   Ensembl; ENST00000539310; ENSP00000445339; ENSG00000102024. [P13797-1]
DR   GeneID; 5358; -.
DR   KEGG; hsa:5358; -.
DR   UCSC; uc004eqd.4; human. [P13797-1]
DR   CTD; 5358; -.
DR   DisGeNET; 5358; -.
DR   GeneCards; PLS3; -.
DR   HGNC; HGNC:9091; PLS3.
DR   HPA; HPA020433; -.
DR   MalaCards; PLS3; -.
DR   MIM; 166710; phenotype.
DR   MIM; 300131; gene.
DR   MIM; 300910; phenotype.
DR   neXtProt; NX_P13797; -.
DR   OpenTargets; ENSG00000102024; -.
DR   Orphanet; 391330; X-linked osteoporosis with fractures.
DR   PharmGKB; PA33418; -.
DR   eggNOG; KOG0046; Eukaryota.
DR   eggNOG; COG5069; LUCA.
DR   GeneTree; ENSGT00390000005691; -.
DR   HOGENOM; HOG000213447; -.
DR   HOVERGEN; HBG003082; -.
DR   InParanoid; P13797; -.
DR   KO; K17336; -.
DR   OMA; RNFNDPA; -.
DR   OrthoDB; EOG091G03YP; -.
DR   PhylomeDB; P13797; -.
DR   TreeFam; TF300680; -.
DR   BioCyc; ZFISH:ENSG00000102024-MONOMER; -.
DR   ChiTaRS; PLS3; human.
DR   EvolutionaryTrace; P13797; -.
DR   GeneWiki; PLS3; -.
DR   GenomeRNAi; 5358; -.
DR   PRO; PR:P13797; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000102024; -.
DR   CleanEx; HS_PLS3; -.
DR   ExpressionAtlas; P13797; baseline and differential.
DR   Genevisible; P13797; HS.
DR   GO; GO:0005884; C:actin filament; IBA:GO_Central.
DR   GO; GO:0032432; C:actin filament bundle; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0051015; F:actin filament binding; IBA:GO_Central.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0051764; P:actin crosslink formation; IBA:GO_Central.
DR   GO; GO:0051017; P:actin filament bundle assembly; IBA:GO_Central.
DR   GO; GO:0051639; P:actin filament network formation; IBA:GO_Central.
DR   GO; GO:0060348; P:bone development; IMP:UniProtKB.
DR   Gene3D; 1.10.238.10; -; 1.
DR   Gene3D; 1.10.418.10; -; 4.
DR   InterPro; IPR001589; Actinin_actin-bd_CS.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   Pfam; PF00307; CH; 4.
DR   Pfam; PF13499; EF-hand_7; 1.
DR   SMART; SM00033; CH; 4.
DR   SMART; SM00054; EFh; 2.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   PROSITE; PS00019; ACTININ_1; 2.
DR   PROSITE; PS00020; ACTININ_2; 2.
DR   PROSITE; PS50021; CH; 4.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Actin-binding; Alternative splicing;
KW   Calcium; Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Disease mutation; Isopeptide bond; Metal-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repeat.
FT   CHAIN         1    630       Plastin-3.
FT                                /FTId=PRO_0000073747.
FT   DOMAIN       12     47       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN       52     87       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      109    382       Actin-binding 1.
FT   DOMAIN      123    239       CH 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00044}.
FT   DOMAIN      267    378       CH 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00044}.
FT   DOMAIN      383    627       Actin-binding 2.
FT   DOMAIN      397    506       CH 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00044}.
FT   DOMAIN      518    627       CH 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00044}.
FT   CA_BIND      25     36       1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND      65     76       2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   MOD_RES      10     10       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P13796}.
FT   MOD_RES      91     91       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P13796}.
FT   MOD_RES     127    127       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P13796}.
FT   MOD_RES     268    268       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q99K51}.
FT   MOD_RES     293    293       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     297    297       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P13796}.
FT   MOD_RES     300    300       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P13796}.
FT   MOD_RES     326    326       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     339    339       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     364    364       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P13796}.
FT   MOD_RES     391    391       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     409    409       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P13796}.
FT   MOD_RES     475    475       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P13796}.
FT   MOD_RES     477    477       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P13796}.
FT   MOD_RES     545    545       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P13796}.
FT   MOD_RES     582    582       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P13796}.
FT   VAR_SEQ       1     45       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_056235.
FT   VAR_SEQ       1     24       MDEMATTQISKDELDELKEAFAKV -> ME (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056236.
FT   VAR_SEQ     296    296       I -> IKLIDFSNSV (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056237.
FT   VARIANT     253    253       A -> AN (in OSTEOP; associated with
FT                                disease susceptibility).
FT                                {ECO:0000269|PubMed:24088043}.
FT                                /FTId=VAR_070278.
FT   VARIANT     488    488       D -> A (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035462.
FT   HELIX       123    136       {ECO:0000244|PDB:1AOA}.
FT   TURN        137    139       {ECO:0000244|PDB:1AOA}.
FT   TURN        144    146       {ECO:0000244|PDB:1AOA}.
FT   TURN        151    154       {ECO:0000244|PDB:1AOA}.
FT   HELIX       155    159       {ECO:0000244|PDB:1AOA}.
FT   HELIX       160    162       {ECO:0000244|PDB:1AOA}.
FT   HELIX       164    173       {ECO:0000244|PDB:1AOA}.
FT   HELIX       180    182       {ECO:0000244|PDB:1AOA}.
FT   HELIX       190    206       {ECO:0000244|PDB:1AOA}.
FT   HELIX       216    220       {ECO:0000244|PDB:1AOA}.
FT   HELIX       224    244       {ECO:0000244|PDB:1AOA}.
FT   HELIX       261    265       {ECO:0000244|PDB:1AOA}.
FT   HELIX       269    283       {ECO:0000244|PDB:1AOA}.
FT   TURN        294    298       {ECO:0000244|PDB:1AOA}.
FT   HELIX       300    309       {ECO:0000244|PDB:1AOA}.
FT   STRAND      315    317       {ECO:0000244|PDB:1AOA}.
FT   TURN        326    329       {ECO:0000244|PDB:1AOA}.
FT   HELIX       333    344       {ECO:0000244|PDB:1AOA}.
FT   TURN        345    348       {ECO:0000244|PDB:1AOA}.
FT   HELIX       355    359       {ECO:0000244|PDB:1AOA}.
FT   HELIX       363    374       {ECO:0000244|PDB:1AOA}.
FT   HELIX       522    535       {ECO:0000244|PDB:1WJO}.
FT   HELIX       549    551       {ECO:0000244|PDB:1WJO}.
FT   HELIX       553    562       {ECO:0000244|PDB:1WJO}.
FT   TURN        569    571       {ECO:0000244|PDB:1WJO}.
FT   HELIX       579    595       {ECO:0000244|PDB:1WJO}.
FT   HELIX       604    609       {ECO:0000244|PDB:1WJO}.
FT   TURN        612    616       {ECO:0000244|PDB:1WJO}.
FT   HELIX       617    625       {ECO:0000244|PDB:1WJO}.
SQ   SEQUENCE   630 AA;  70811 MW;  631E6F803DC56A56 CRC64;
     MDEMATTQIS KDELDELKEA FAKVDLNSNG FICDYELHEL FKEANMPLPG YKVREIIQKL
     MLDGDRNKDG KISFDEFVYI FQEVKSSDIA KTFRKAINRK EGICALGGTS ELSSEGTQHS
     YSEEEKYAFV NWINKALEND PDCRHVIPMN PNTDDLFKAV GDGIVLCKMI NLSVPDTIDE
     RAINKKKLTP FIIQENLNLA LNSASAIGCH VVNIGAEDLR AGKPHLVLGL LWQIIKIGLF
     ADIELSRNEA LAALLRDGET LEELMKLSPE ELLLRWANFH LENSGWQKIN NFSADIKDSK
     AYFHLLNQIA PKGQKEGEPR IDINMSGFNE TDDLKRAESM LQQADKLGCR QFVTPADVVS
     GNPKLNLAFV ANLFNKYPAL TKPENQDIDW TLLEGETREE RTFRNWMNSL GVNPHVNHLY
     ADLQDALVIL QLYERIKVPV DWSKVNKPPY PKLGANMKKL ENCNYAVELG KHPAKFSLVG
     IGGQDLNDGN QTLTLALVWQ LMRRYTLNVL EDLGDGQKAN DDIIVNWVNR TLSEAGKSTS
     IQSFKDKTIS SSLAVVDLID AIQPGCINYD LVKSGNLTED DKHNNAKYAV SMARRIGARV
     YALPEDLVEV KPKMVMTVFA CLMGRGMKRV
//
ID   U3KQI3_HUMAN            Unreviewed;       164 AA.
AC   U3KQI3;
DT   13-NOV-2013, integrated into UniProtKB/TrEMBL.
DT   13-NOV-2013, sequence version 1.
DT   02-NOV-2016, entry version 20.
DE   SubName: Full=Plastin-3 {ECO:0000313|Ensembl:ENSP00000475900};
DE   Flags: Fragment;
GN   Name=PLS3 {ECO:0000313|Ensembl:ENSP00000475900};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000475900, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000475900, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [2] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [3] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [4] {ECO:0000313|Ensembl:ENSP00000475900}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2013) to UniProtKB.
RN   [5] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000475900}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AL589842; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; U3KQI3; -.
DR   MaxQB; U3KQI3; -.
DR   PeptideAtlas; U3KQI3; -.
DR   PRIDE; U3KQI3; -.
DR   Ensembl; ENST00000473026; ENSP00000475900; ENSG00000102024.
DR   UCSC; uc065aup.1; human.
DR   HGNC; HGNC:9091; PLS3.
DR   OpenTargets; ENSG00000102024; -.
DR   GeneTree; ENSGT00390000005691; -.
DR   ChiTaRS; PLS3; human.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000102024; -.
DR   ExpressionAtlas; U3KQI3; baseline and differential.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   Gene3D; 1.10.238.10; -; 1.
DR   Gene3D; 1.10.418.10; -; 1.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   Pfam; PF00307; CH; 1.
DR   Pfam; PF13499; EF-hand_7; 1.
DR   SMART; SM00054; EFh; 2.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   PROSITE; PS50021; CH; 1.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 2.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:U3KQI3,
KW   ECO:0000213|MaxQB:U3KQI3, ECO:0000213|PeptideAtlas:U3KQI3};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN       12     47       EF-hand. {ECO:0000259|PROSITE:PS50222}.
FT   DOMAIN       52     87       EF-hand. {ECO:0000259|PROSITE:PS50222}.
FT   DOMAIN       93    164       Actin-binding.
FT                                {ECO:0000259|PROSITE:PS50021}.
FT   NON_TER     164    164       {ECO:0000313|Ensembl:ENSP00000475900}.
SQ   SEQUENCE   164 AA;  18995 MW;  8B53B8C325D55A45 CRC64;
     MDEMATTQIS KDELDELKEA FAKVDLNSNG FICDYELHEL FKEANMPLPG YKVREIIQKL
     MLDGDRNKDG KISFDEFVYL WPKPFVLNSM FNKEEKYAFV NWINKALEND PDCRHVIPMN
     PNTDDLFKAV GDGIVLCKMI NLSVPDTIDE RAINKKKLTP FIIQ
//
ID   F5GYN6_HUMAN            Unreviewed;        93 AA.
AC   F5GYN6;
DT   28-JUN-2011, integrated into UniProtKB/TrEMBL.
DT   28-JUN-2011, sequence version 1.
DT   02-NOV-2016, entry version 33.
DE   SubName: Full=Interleukin-1 receptor-associated kinase 3 {ECO:0000313|Ensembl:ENSP00000441321};
GN   Name=IRAK3 {ECO:0000313|Ensembl:ENSP00000441321};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000441321, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000441321, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RG   Baylor College of Medicine Human Genome Sequencing Center Sequence Production Team;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A., null.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000441321}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000441321}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC078889; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC078927; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; F5GYN6; -.
DR   Ensembl; ENST00000545837; ENSP00000441321; ENSG00000090376.
DR   UCSC; uc001stg.3; human.
DR   HGNC; HGNC:17020; IRAK3.
DR   OpenTargets; ENSG00000090376; -.
DR   GeneTree; ENSGT00530000063073; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000090376; -.
DR   ExpressionAtlas; F5GYN6; baseline and differential.
DR   GO; GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; IEA:InterPro.
DR   GO; GO:0045824; P:negative regulation of innate immune response; IEA:InterPro.
DR   GO; GO:0034122; P:negative regulation of toll-like receptor signaling pathway; IEA:InterPro.
DR   Gene3D; 1.10.533.10; -; 1.
DR   InterPro; IPR011029; DEATH-like_dom.
DR   InterPro; IPR033610; IRAK3.
DR   PANTHER; PTHR24419:SF7; PTHR24419:SF7; 1.
DR   SUPFAM; SSF47986; SSF47986; 1.
PE   4: Predicted;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     25       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        26     93       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5003323025.
SQ   SEQUENCE   93 AA;  10047 MW;  74B22DCEB910EC67 CRC64;
     MAGNCGARGA LSAHTLLFDL PPALLGELCA VLDSCDGALG WRGLVSKNKL CENGVLILQG
     FWHVVVCKYK DSKYGCVALF EKTPSETYLH MET
//
ID   IRAK3_HUMAN             Reviewed;         596 AA.
AC   Q9Y616; B4DQ57;
DT   09-NOV-2004, integrated into UniProtKB/Swiss-Prot.
DT   08-FEB-2011, sequence version 2.
DT   02-NOV-2016, entry version 145.
DE   RecName: Full=Interleukin-1 receptor-associated kinase 3;
DE            Short=IRAK-3;
DE            EC=2.7.11.1;
DE   AltName: Full=IL-1 receptor-associated kinase M;
DE            Short=IRAK-M;
GN   Name=IRAK3 {ECO:0000312|EMBL:AAH57800.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAD40879.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, COFACTOR, TISSUE
RP   SPECIFICITY, AND VARIANT VAL-147.
RC   TISSUE=Peripheral blood lymphocyte;
RX   PubMed=10383454; DOI=10.1074/jbc.274.27.19403;
RA   Wesche H., Gao X., Li X., Kirschning C.J., Stark G.R., Cao Z.;
RT   "IRAK-M is a novel member of the Pelle/interleukin-1 receptor-
RT   associated kinase (IRAK) family.";
RL   J. Biol. Chem. 274:19403-19410(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT
RP   VAL-147.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4] {ECO:0000312|EMBL:AAH57800.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   VAL-147.
RC   TISSUE=Placenta {ECO:0000312|EMBL:AAH57800.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INVOLVEMENT IN ASRT5, AND VARIANTS LEU-22; ALA-111; MET-134; VAL-400
RP   AND GLN-429.
RX   PubMed=17503328; DOI=10.1086/518259;
RA   Balaci L., Spada M.C., Olla N., Sole G., Loddo L., Anedda F.,
RA   Naitza S., Zuncheddu M.A., Maschio A., Altea D., Uda M., Pilia S.,
RA   Sanna S., Masala M., Crisponi L., Fattori M., Devoto M.,
RA   Doratiotto S., Rassu S., Mereu S., Giua E., Cadeddu N.G., Atzeni R.,
RA   Pelosi U., Corrias A., Perra R., Torrazza P.L., Pirina P., Ginesu F.,
RA   Marcias S., Schintu M.G., Del Giacco G.S., Manconi P.E., Malerba G.,
RA   Bisognin A., Trabetti E., Boner A., Pescollderungg L., Pignatti P.F.,
RA   Schlessinger D., Cao A., Pilia G.;
RT   "IRAK-M is involved in the pathogenesis of early-onset persistent
RT   asthma.";
RL   Am. J. Hum. Genet. 80:1103-1114(2007).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-467, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [7]
RP   VARIANTS [LARGE SCALE ANALYSIS] ARG-57; SER-84; VAL-147; VAL-171;
RP   LEU-288; GLN-384; THR-391 AND ASN-482.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Inhibits dissociation of IRAK1 and IRAK4 from the Toll-
CC       like receptor signaling complex by either inhibiting the
CC       phosphorylation of IRAK1 and IRAK4 or stabilizing the receptor
CC       complex. {ECO:0000250|UniProtKB:Q8K4B2,
CC       ECO:0000269|PubMed:10383454}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000269|PubMed:10383454}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:10383454};
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Y616-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y616-2; Sequence=VSP_041020;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in peripheral blood
CC       lymphocytes. {ECO:0000269|PubMed:10383454}.
CC   -!- DISEASE: Asthma-related traits 5 (ASRT5) [MIM:611064]: Asthma-
CC       related traits include clinical symptoms of asthma, such as
CC       coughing, wheezing, dyspnea, bronchial hyperresponsiveness as
CC       assessed by methacholine challenge test, serum IgE levels, atopy
CC       and atopic dermatitis. {ECO:0000269|PubMed:17503328}. Note=Disease
CC       susceptibility is associated with variations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family. Pelle subfamily. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 death domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00064}.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -!- CAUTION: Ser-293 is present instead of the conserved Asp which is
CC       expected to be an active site residue. Low level
CC       autophosphorylation activity has been reported in PubMed:10383454,
CC       while other authors describe this as an inactive kinase.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF113136; AAD40879.1; -; mRNA.
DR   EMBL; AK298645; BAG60819.1; -; mRNA.
DR   EMBL; AC078889; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC078927; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC057800; AAH57800.1; -; mRNA.
DR   EMBL; BC069388; AAH69388.1; -; mRNA.
DR   CCDS; CCDS44937.1; -. [Q9Y616-2]
DR   CCDS; CCDS8975.1; -. [Q9Y616-1]
DR   RefSeq; NP_001135995.1; NM_001142523.1. [Q9Y616-2]
DR   RefSeq; NP_009130.2; NM_007199.2. [Q9Y616-1]
DR   UniGene; Hs.369265; -.
DR   ProteinModelPortal; Q9Y616; -.
DR   SMR; Q9Y616; -.
DR   BioGrid; 116382; 18.
DR   IntAct; Q9Y616; 15.
DR   MINT; MINT-97148; -.
DR   STRING; 9606.ENSP00000261233; -.
DR   BindingDB; Q9Y616; -.
DR   ChEMBL; CHEMBL5081; -.
DR   GuidetoPHARMACOLOGY; 2044; -.
DR   iPTMnet; Q9Y616; -.
DR   PhosphoSitePlus; Q9Y616; -.
DR   BioMuta; IRAK3; -.
DR   DMDM; 322510038; -.
DR   EPD; Q9Y616; -.
DR   PaxDb; Q9Y616; -.
DR   PeptideAtlas; Q9Y616; -.
DR   PRIDE; Q9Y616; -.
DR   DNASU; 11213; -.
DR   Ensembl; ENST00000261233; ENSP00000261233; ENSG00000090376. [Q9Y616-1]
DR   Ensembl; ENST00000457197; ENSP00000409852; ENSG00000090376. [Q9Y616-2]
DR   GeneID; 11213; -.
DR   KEGG; hsa:11213; -.
DR   UCSC; uc001sth.4; human. [Q9Y616-1]
DR   CTD; 11213; -.
DR   DisGeNET; 11213; -.
DR   GeneCards; IRAK3; -.
DR   HGNC; HGNC:17020; IRAK3.
DR   HPA; HPA043097; -.
DR   MalaCards; IRAK3; -.
DR   MIM; 604459; gene.
DR   MIM; 611064; phenotype.
DR   neXtProt; NX_Q9Y616; -.
DR   OpenTargets; ENSG00000090376; -.
DR   PharmGKB; PA38431; -.
DR   eggNOG; KOG1187; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00530000063073; -.
DR   HOGENOM; HOG000060319; -.
DR   HOVERGEN; HBG052146; -.
DR   InParanoid; Q9Y616; -.
DR   KO; K04732; -.
DR   OMA; KLTDFAM; -.
DR   OrthoDB; EOG091G0YKT; -.
DR   PhylomeDB; Q9Y616; -.
DR   TreeFam; TF328924; -.
DR   BioCyc; ZFISH:HS01686-MONOMER; -.
DR   Reactome; R-HSA-166058; MyD88:Mal cascade initiated on plasma membrane.
DR   Reactome; R-HSA-446652; Interleukin-1 signaling.
DR   SignaLink; Q9Y616; -.
DR   SIGNOR; Q9Y616; -.
DR   GeneWiki; IRAK3; -.
DR   GenomeRNAi; 11213; -.
DR   PRO; PR:Q9Y616; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000090376; -.
DR   CleanEx; HS_IRAK3; -.
DR   ExpressionAtlas; Q9Y616; baseline and differential.
DR   Genevisible; Q9Y616; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0070498; P:interleukin-1-mediated signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0002755; P:MyD88-dependent toll-like receptor signaling pathway; TAS:BHF-UCL.
DR   GO; GO:0001960; P:negative regulation of cytokine-mediated signaling pathway; IC:BHF-UCL.
DR   GO; GO:0045824; P:negative regulation of innate immune response; ISS:BHF-UCL.
DR   GO; GO:0032695; P:negative regulation of interleukin-12 production; IMP:BHF-UCL.
DR   GO; GO:0032715; P:negative regulation of interleukin-6 production; IMP:BHF-UCL.
DR   GO; GO:0010936; P:negative regulation of macrophage cytokine production; ISS:BHF-UCL.
DR   GO; GO:0043407; P:negative regulation of MAP kinase activity; IMP:BHF-UCL.
DR   GO; GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IMP:BHF-UCL.
DR   GO; GO:0042177; P:negative regulation of protein catabolic process; IMP:BHF-UCL.
DR   GO; GO:0043242; P:negative regulation of protein complex disassembly; IMP:BHF-UCL.
DR   GO; GO:0034122; P:negative regulation of toll-like receptor signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0032720; P:negative regulation of tumor necrosis factor production; IMP:BHF-UCL.
DR   GO; GO:0010933; P:positive regulation of macrophage tolerance induction; ISS:BHF-UCL.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IMP:BHF-UCL.
DR   GO; GO:0046777; P:protein autophosphorylation; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0043244; P:regulation of protein complex disassembly; ISS:UniProtKB.
DR   GO; GO:0043330; P:response to exogenous dsRNA; ISS:BHF-UCL.
DR   GO; GO:0070555; P:response to interleukin-1; IMP:BHF-UCL.
DR   GO; GO:0032496; P:response to lipopolysaccharide; ISS:BHF-UCL.
DR   GO; GO:0032494; P:response to peptidoglycan; ISS:BHF-UCL.
DR   GO; GO:0009615; P:response to virus; IC:BHF-UCL.
DR   Gene3D; 1.10.533.10; -; 1.
DR   InterPro; IPR011029; DEATH-like_dom.
DR   InterPro; IPR000488; Death_domain.
DR   InterPro; IPR033610; IRAK3.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   PANTHER; PTHR24419:SF7; PTHR24419:SF7; 1.
DR   Pfam; PF00531; Death; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00005; DEATH; 1.
DR   SUPFAM; SSF47986; SSF47986; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50017; DEATH_DOMAIN; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Asthma; ATP-binding; Complete proteome; Kinase;
KW   Magnesium; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    596       Interleukin-1 receptor-associated kinase
FT                                3.
FT                                /FTId=PRO_0000086033.
FT   DOMAIN       41    106       Death. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00064}.
FT   DOMAIN      165    452       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     171    179       ATP. {ECO:0000250|UniProtKB:P51617,
FT                                ECO:0000255|PROSITE-ProRule:PRU00159}.
FT   NP_BIND     295    298       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   BINDING     192    192       ATP. {ECO:0000250|UniProtKB:P51617,
FT                                ECO:0000255|PROSITE-ProRule:PRU00159}.
FT   BINDING     311    311       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     467    467       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   VAR_SEQ      45    105       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_041020.
FT   VARIANT      22     22       P -> L (may be associated with ASRT5;
FT                                dbSNP:rs536546109).
FT                                {ECO:0000269|PubMed:17503328}.
FT                                /FTId=VAR_035212.
FT   VARIANT      57     57       H -> R (in dbSNP:rs35239505).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040581.
FT   VARIANT      84     84       G -> S (in dbSNP:rs34443407).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040582.
FT   VARIANT     111    111       P -> A (may be associated with ASRT5;
FT                                dbSNP:rs373806603).
FT                                {ECO:0000269|PubMed:17503328}.
FT                                /FTId=VAR_035213.
FT   VARIANT     134    134       V -> M (may be associated with ASRT5;
FT                                dbSNP:rs138559915).
FT                                {ECO:0000269|PubMed:17503328}.
FT                                /FTId=VAR_035214.
FT   VARIANT     147    147       I -> V (in dbSNP:rs1152888).
FT                                {ECO:0000269|PubMed:10383454,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_019812.
FT   VARIANT     171    171       I -> V (in dbSNP:rs34682166).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040583.
FT   VARIANT     269    269       G -> S (in dbSNP:rs35823766).
FT                                /FTId=VAR_033901.
FT   VARIANT     270    270       I -> V (in dbSNP:rs11465972).
FT                                /FTId=VAR_031077.
FT   VARIANT     288    288       S -> L (in dbSNP:rs35574245).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040584.
FT   VARIANT     384    384       R -> Q (in dbSNP:rs34272472).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040585.
FT   VARIANT     391    391       M -> T (in dbSNP:rs35737689).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040586.
FT   VARIANT     400    400       L -> V (may be associated with ASRT5;
FT                                dbSNP:rs146120640).
FT                                {ECO:0000269|PubMed:17503328}.
FT                                /FTId=VAR_035215.
FT   VARIANT     429    429       R -> Q (may be associated with ASRT5;
FT                                dbSNP:rs140671957).
FT                                {ECO:0000269|PubMed:17503328}.
FT                                /FTId=VAR_035216.
FT   VARIANT     482    482       D -> N (in dbSNP:rs35756811).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040587.
FT   CONFLICT    560    560       N -> D (in Ref. 2; BAG60819).
FT                                {ECO:0000305}.
SQ   SEQUENCE   596 AA;  67767 MW;  D050150B7BDA5B9A CRC64;
     MAGNCGARGA LSAHTLLFDL PPALLGELCA VLDSCDGALG WRGLAERLSS SWLDVRHIEK
     YVDQGKSGTR ELLWSWAQKN KTIGDLLQVL QEMGHRRAIH LITNYGAVLS PSEKSYQEGG
     FPNILFKETA NVTVDNVLIP EHNEKGILLK SSISFQNIIE GTRNFHKDFL IGEGEIFEVY
     RVEIQNLTYA VKLFKQEKKM QCKKHWKRFL SELEVLLLFH HPNILELAAY FTETEKFCLI
     YPYMRNGTLF DRLQCVGDTA PLPWHIRIGI LIGISKAIHY LHNVQPCSVI CGSISSANIL
     LDDQFQPKLT DFAMAHFRSH LEHQSCTINM TSSSSKHLWY MPEEYIRQGK LSIKTDVYSF
     GIVIMEVLTG CRVVLDDPKH IQLRDLLREL MEKRGLDSCL SFLDKKVPPC PRNFSAKLFC
     LAGRCAATRA KLRPSMDEVL NTLESTQASL YFAEDPPTSL KSFRCPSPLF LENVPSIPVE
     DDESQNNNLL PSDEGLRIDR MTQKTPFECS QSEVMFLSLD KKPESKRNEE ACNMPSSSCE
     ESWFPKYIVP SQDLRPYKVN IDPSSEAPGH SCRSRPVESS CSSKFSWDEY EQYKKE
//
ID   H0YKB3_HUMAN            Unreviewed;       117 AA.
AC   H0YKB3;
DT   22-FEB-2012, integrated into UniProtKB/TrEMBL.
DT   22-FEB-2012, sequence version 1.
DT   02-NOV-2016, entry version 37.
DE   SubName: Full=Sorbitol dehydrogenase {ECO:0000313|Ensembl:ENSP00000452731};
GN   Name=SORD {ECO:0000313|Ensembl:ENSP00000452731};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000452731, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000452731, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [2] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [3] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [4] {ECO:0000313|Ensembl:ENSP00000452731}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2012) to UniProtKB.
RN   [5] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [6] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000256|RuleBase:RU361277};
CC   -!- SIMILARITY: Belongs to the zinc-containing alcohol dehydrogenase
CC       family. {ECO:0000256|RuleBase:RU361277}.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000452731}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC090888; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC091117; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KC877541; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; H0YKB3; -.
DR   STRING; 9606.ENSP00000267814; -.
DR   MaxQB; H0YKB3; -.
DR   PaxDb; H0YKB3; -.
DR   PeptideAtlas; H0YKB3; -.
DR   PRIDE; H0YKB3; -.
DR   Ensembl; ENST00000559230; ENSP00000452731; ENSG00000140263.
DR   UCSC; uc059irm.1; human.
DR   HGNC; HGNC:11184; SORD.
DR   OpenTargets; ENSG00000140263; -.
DR   eggNOG; KOG0024; Eukaryota.
DR   eggNOG; COG1063; LUCA.
DR   GeneTree; ENSGT00550000074781; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000140263; -.
DR   ExpressionAtlas; H0YKB3; baseline and differential.
DR   GO; GO:0016491; F:oxidoreductase activity; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   Gene3D; 3.90.180.10; -; 1.
DR   InterPro; IPR013154; ADH_N.
DR   InterPro; IPR002085; ADH_SF_Zn-type.
DR   InterPro; IPR002328; ADH_Zn_CS.
DR   InterPro; IPR011032; GroES-like.
DR   PANTHER; PTHR11695; PTHR11695; 1.
DR   Pfam; PF08240; ADH_N; 1.
DR   SUPFAM; SSF50129; SSF50129; 1.
DR   PROSITE; PS00059; ADH_ZINC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Metal-binding {ECO:0000256|RuleBase:RU361277};
KW   Proteomics identification {ECO:0000213|EPD:H0YKB3,
KW   ECO:0000213|MaxQB:H0YKB3, ECO:0000213|PeptideAtlas:H0YKB3};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Zinc {ECO:0000256|RuleBase:RU361277}.
FT   DOMAIN       32     91       ADH_N. {ECO:0000259|Pfam:PF08240}.
SQ   SEQUENCE   117 AA;  12711 MW;  34EACE4F5C4A7104 CRC64;
     MAAAAKPNNL SLVVHGPGDL RLENYPIPEP GPNEVLLRMH SVGICGSDVH YWEYGRIGNF
     IVKKPMVLGH EASGTVEKVG SSVKHLKPGW KTKNQTKERA DSAPTLGHGA IFVFLSR
//
ID   H0YLA4_HUMAN            Unreviewed;       336 AA.
AC   H0YLA4;
DT   22-FEB-2012, integrated into UniProtKB/TrEMBL.
DT   22-FEB-2012, sequence version 1.
DT   02-NOV-2016, entry version 37.
DE   SubName: Full=Sorbitol dehydrogenase {ECO:0000313|Ensembl:ENSP00000453122};
GN   Name=SORD {ECO:0000313|Ensembl:ENSP00000453122};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000453122, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000453122, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [2] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [3] {ECO:0000313|Ensembl:ENSP00000453122}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2012) to UniProtKB.
RN   [4] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000256|RuleBase:RU361277};
CC   -!- SIMILARITY: Belongs to the zinc-containing alcohol dehydrogenase
CC       family. {ECO:0000256|RuleBase:RU361277}.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000453122}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC090888; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC091117; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KC877541; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; H0YLA4; -.
DR   STRING; 9606.ENSP00000267814; -.
DR   EPD; H0YLA4; -.
DR   MaxQB; H0YLA4; -.
DR   PaxDb; H0YLA4; -.
DR   PeptideAtlas; H0YLA4; -.
DR   PRIDE; H0YLA4; -.
DR   Ensembl; ENST00000558580; ENSP00000453122; ENSG00000140263.
DR   UCSC; uc059irn.1; human.
DR   HGNC; HGNC:11184; SORD.
DR   OpenTargets; ENSG00000140263; -.
DR   eggNOG; KOG0024; Eukaryota.
DR   eggNOG; COG1063; LUCA.
DR   GeneTree; ENSGT00550000074781; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000140263; -.
DR   ExpressionAtlas; H0YLA4; baseline and differential.
DR   GO; GO:0016491; F:oxidoreductase activity; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   Gene3D; 3.40.50.720; -; 1.
DR   Gene3D; 3.90.180.10; -; 1.
DR   InterPro; IPR013149; ADH_C.
DR   InterPro; IPR013154; ADH_N.
DR   InterPro; IPR002085; ADH_SF_Zn-type.
DR   InterPro; IPR002328; ADH_Zn_CS.
DR   InterPro; IPR011032; GroES-like.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR020843; PKS_ER.
DR   PANTHER; PTHR11695; PTHR11695; 1.
DR   Pfam; PF08240; ADH_N; 1.
DR   Pfam; PF00107; ADH_zinc_N; 1.
DR   SMART; SM00829; PKS_ER; 1.
DR   SUPFAM; SSF50129; SSF50129; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS00059; ADH_ZINC; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Metal-binding {ECO:0000256|RuleBase:RU361277};
KW   Proteomics identification {ECO:0000213|EPD:H0YLA4,
KW   ECO:0000213|MaxQB:H0YLA4, ECO:0000213|PeptideAtlas:H0YLA4};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Zinc {ECO:0000256|RuleBase:RU361277}.
FT   DOMAIN        2    327       PKS_ER. {ECO:0000259|SMART:SM00829}.
SQ   SEQUENCE   336 AA;  36229 MW;  6B83DC8376E5162B CRC64;
     MENYPIPEPG PNEVLLRMHS VGICGSDVHY WEYGRIGNFI VKKPMVLGHE ASGTVEKVGS
     SVKHLKPGDR VAIEPGAPRE NDEFCKMGRY NLSPSIFFCA TPPDDGNLCR FYKHNAAFCY
     KLPDNVTFEE GALIEPLSVG IHACRRGGVT LGHKVLVCGA GPIGMVTLLV AKAMGAAQVV
     VTDLSATRLS KAKEIGADLV LQISKESPQE IARKVEGQLG CKPEVTIECT GAEASIQAGI
     YATRSGGNLV LVGLGSEMTT VPLLHAAIRE VDIKGVFRYC NTWPVAISML ASKSVNVKPL
     VTHRFPLEKA LEAFETFKKG LGLKIMLKCD PSDQNP
//
ID   DHSO_HUMAN              Reviewed;         357 AA.
AC   Q00796; B2R655; B7Z3A6; J3JZZ5; Q16682; Q9UMD6;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   23-MAR-2010, sequence version 4.
DT   02-NOV-2016, entry version 182.
DE   RecName: Full=Sorbitol dehydrogenase;
DE            EC=1.1.1.14;
DE   AltName: Full=L-iditol 2-dehydrogenase;
GN   Name=SORD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT THR-269.
RC   TISSUE=Liver;
RX   PubMed=8088829; DOI=10.1006/geno.1994.1276;
RA   Lee F.K., Cheung M.C., Chung S.;
RT   "The human sorbitol dehydrogenase gene: cDNA cloning, sequence
RT   determination, and mapping by fluorescence in situ hybridization.";
RL   Genomics 21:354-358(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), AND VARIANTS
RP   LEU-239 AND THR-269.
RX   PubMed=7782086; DOI=10.1016/0888-7543(95)80082-W;
RA   Iwata T., Popescu N.C., Zimonjic D.B., Karlsson C., Hoeoeg J.-O.,
RA   Vaca G., Rodriguez I.R., Carper D.;
RT   "Structural organization of the human sorbitol dehydrogenase gene
RT   (SORD).";
RL   Genomics 26:55-62(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT THR-269.
RX   PubMed=9183016; DOI=10.1111/j.1432-1033.1997.00760.x;
RA   Carr I.M., Markham A.F., Coletta P.L.;
RT   "Identification and characterisation of a sequence related to human
RT   sorbitol dehydrogenase.";
RL   Eur. J. Biochem. 245:760-767(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   THR-269.
RC   TISSUE=Brain, and Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   THR-269.
RC   TISSUE=Brain, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-357.
RC   TISSUE=Liver;
RX   PubMed=2691249; DOI=10.1111/j.1432-1033.1989.tb15240.x;
RA   Karlsson C., Maret W., Auld D.S., Hoeoeg J.-O., Joernvall H.;
RT   "Variability within mammalian sorbitol dehydrogenases. The primary
RT   structure of the human liver enzyme.";
RL   Eur. J. Biochem. 186:543-550(1989).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-21.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [9]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=16278369; DOI=10.2164/jandrol.05108;
RA   Frenette G., Thabet M., Sullivan R.;
RT   "Polyol pathway in human epididymis and semen.";
RL   J. Androl. 27:233-239(2006).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=20372835;
RA   Szabo Z., Hamalainen J., Loikkanen I., Moilanen A.M., Hirvikoski P.,
RA   Vaisanen T., Paavonen T.K., Vaarala M.H.;
RT   "Sorbitol dehydrogenase expression is regulated by androgens in the
RT   human prostate.";
RL   Oncol. Rep. 23:1233-1239(2010).
RN   [12]
RP   TISSUE SPECIFICITY.
RX   PubMed=19423711; DOI=10.1074/jbc.M109.001792;
RA   Lanaspa M.A., Andres-Hernando A., Rivard C.J., Dai Y., Li N., Berl T.;
RT   "ZAC1 is up-regulated by hypertonicity and decreases sorbitol
RT   dehydrogenase expression, allowing accumulation of sorbitol in kidney
RT   cells.";
RL   J. Biol. Chem. 284:19974-19981(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-211 AND SER-225, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS), SUBUNIT, AND ZINC-BINDING
RP   SITES.
RX   PubMed=12962626; DOI=10.1016/S0969-2126(03)00167-9;
RA   Pauly T.A., Ekstrom J.L., Beebe D.A., Chrunyk B., Cunningham D.,
RA   Griffor M., Kamath A., Lee S.E., Madura R., Mcguire D., Subashi T.,
RA   Wasilko D., Watts P., Mylari B.L., Oates P.J., Adams P.D., Rath V.L.;
RT   "X-ray crystallographic and kinetic studies of human sorbitol
RT   dehydrogenase.";
RL   Structure 11:1071-1085(2003).
CC   -!- FUNCTION: Converts sorbitol to fructose. Part of the polyol
CC       pathway that plays an important role in sperm physiology. May play
CC       a role in the sperm motility by providing an energetic source for
CC       sperm. {ECO:0000250|UniProtKB:Q64442,
CC       ECO:0000269|PubMed:16278369}.
CC   -!- CATALYTIC ACTIVITY: L-iditol + NAD(+) = L-sorbose + NADH.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:12962626};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000269|PubMed:12962626};
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:12962626}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion membrane
CC       {ECO:0000250|UniProtKB:Q64442}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q64442}. Cell projection, cilium, flagellum
CC       {ECO:0000250|UniProtKB:Q64442}. Note=Associated with mitochondria
CC       of the midpiece and near the plasma membrane in the principal
CC       piece of the flagellum. Also found in the epididymosome, secreted
CC       by the epididymal epithelium and that transfers proteins from the
CC       epididymal fluid to the sperm surface.
CC       {ECO:0000250|UniProtKB:Q64442}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q00796-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q00796-2; Sequence=VSP_056353, VSP_056354;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in kidney and epithelial cells of
CC       both benign and malignant prostate tissue. Expressed in epididymis
CC       (at protein level). {ECO:0000269|PubMed:16278369,
CC       ECO:0000269|PubMed:19423711, ECO:0000269|PubMed:20372835}.
CC   -!- INDUCTION: Up-regulated by androgens and down-regulated by
CC       castration. {ECO:0000269|PubMed:20372835}.
CC   -!- MISCELLANEOUS: The polyol pathway is proposed to be involved the
CC       cellular toxicity of diabetic hyperglycemia.
CC   -!- SIMILARITY: Belongs to the zinc-containing alcohol dehydrogenase
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U07361; AAA66064.1; -; mRNA.
DR   EMBL; L29008; AAA80565.1; -; mRNA.
DR   EMBL; L29254; AAA80566.1; -; Genomic_DNA.
DR   EMBL; L29249; AAA80566.1; JOINED; Genomic_DNA.
DR   EMBL; L29250; AAA80566.1; JOINED; Genomic_DNA.
DR   EMBL; L29251; AAA80566.1; JOINED; Genomic_DNA.
DR   EMBL; L29252; AAA80566.1; JOINED; Genomic_DNA.
DR   EMBL; L29253; AAA80566.1; JOINED; Genomic_DNA.
DR   EMBL; U67243; AAB61898.1; -; Genomic_DNA.
DR   EMBL; U67236; AAB61898.1; JOINED; Genomic_DNA.
DR   EMBL; U67237; AAB61898.1; JOINED; Genomic_DNA.
DR   EMBL; U67238; AAB61898.1; JOINED; Genomic_DNA.
DR   EMBL; U67239; AAB61898.1; JOINED; Genomic_DNA.
DR   EMBL; U67240; AAB61898.1; JOINED; Genomic_DNA.
DR   EMBL; U67241; AAB61898.1; JOINED; Genomic_DNA.
DR   EMBL; U67242; AAB61898.1; JOINED; Genomic_DNA.
DR   EMBL; AK295656; BAH12142.1; -; mRNA.
DR   EMBL; AK312444; BAG35352.1; -; mRNA.
DR   EMBL; AC090888; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC091117; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC021085; AAH21085.1; -; mRNA.
DR   EMBL; BC025295; AAH25295.1; -; mRNA.
DR   CCDS; CCDS10116.1; -. [Q00796-1]
DR   PIR; A54674; A54674.
DR   RefSeq; NP_003095.2; NM_003104.5. [Q00796-1]
DR   UniGene; Hs.878; -.
DR   PDB; 1PL6; X-ray; 2.00 A; A/B/C/D=2-357.
DR   PDB; 1PL7; X-ray; 2.20 A; A/B/C/D=2-357.
DR   PDB; 1PL8; X-ray; 1.90 A; A/B/C/D=2-357.
DR   PDBsum; 1PL6; -.
DR   PDBsum; 1PL7; -.
DR   PDBsum; 1PL8; -.
DR   ProteinModelPortal; Q00796; -.
DR   SMR; Q00796; -.
DR   BioGrid; 112535; 56.
DR   IntAct; Q00796; 5.
DR   MINT; MINT-5004436; -.
DR   STRING; 9606.ENSP00000267814; -.
DR   BindingDB; Q00796; -.
DR   ChEMBL; CHEMBL2275; -.
DR   iPTMnet; Q00796; -.
DR   PhosphoSitePlus; Q00796; -.
DR   BioMuta; SORD; -.
DR   DMDM; 292495088; -.
DR   REPRODUCTION-2DPAGE; IPI00216057; -.
DR   EPD; Q00796; -.
DR   MaxQB; Q00796; -.
DR   PaxDb; Q00796; -.
DR   PeptideAtlas; Q00796; -.
DR   PRIDE; Q00796; -.
DR   DNASU; 6652; -.
DR   Ensembl; ENST00000267814; ENSP00000267814; ENSG00000140263. [Q00796-1]
DR   Ensembl; ENST00000558789; ENSP00000453904; ENSG00000140263. [Q00796-2]
DR   GeneID; 6652; -.
DR   KEGG; hsa:6652; -.
DR   UCSC; uc001zul.5; human. [Q00796-1]
DR   CTD; 6652; -.
DR   DisGeNET; 6652; -.
DR   GeneCards; SORD; -.
DR   HGNC; HGNC:11184; SORD.
DR   HPA; HPA040260; -.
DR   HPA; HPA040621; -.
DR   MIM; 182500; gene.
DR   neXtProt; NX_Q00796; -.
DR   OpenTargets; ENSG00000140263; -.
DR   PharmGKB; PA36021; -.
DR   eggNOG; KOG0024; Eukaryota.
DR   eggNOG; COG1063; LUCA.
DR   GeneTree; ENSGT00550000074781; -.
DR   HOGENOM; HOG000294670; -.
DR   HOVERGEN; HBG005484; -.
DR   InParanoid; Q00796; -.
DR   KO; K00008; -.
DR   OMA; MHNTREI; -.
DR   OrthoDB; EOG091G0AQY; -.
DR   PhylomeDB; Q00796; -.
DR   TreeFam; TF313060; -.
DR   BioCyc; ZFISH:HS06691-MONOMER; -.
DR   BRENDA; 1.1.1.14; 2681.
DR   Reactome; R-HSA-5652227; Fructose biosynthesis.
DR   Reactome; R-HSA-5661270; Catabolism of glucuronate to xylulose-5-phosphate.
DR   SABIO-RK; Q00796; -.
DR   EvolutionaryTrace; Q00796; -.
DR   GeneWiki; SORD; -.
DR   GenomeRNAi; 6652; -.
DR   PRO; PR:Q00796; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000140263; -.
DR   CleanEx; HS_SORD; -.
DR   ExpressionAtlas; Q00796; baseline and differential.
DR   Genevisible; Q00796; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; TAS:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0031966; C:mitochondrial membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0031514; C:motile cilium; ISS:UniProtKB.
DR   GO; GO:0030246; F:carbohydrate binding; NAS:UniProtKB.
DR   GO; GO:0046526; F:D-xylulose reductase activity; EXP:Reactome.
DR   GO; GO:0003939; F:L-iditol 2-dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0051287; F:NAD binding; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0030317; P:flagellated sperm motility; ISS:UniProtKB.
DR   GO; GO:0046370; P:fructose biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0006006; P:glucose metabolic process; TAS:UniProtKB.
DR   GO; GO:0019640; P:glucuronate catabolic process to xylulose 5-phosphate; TAS:Reactome.
DR   GO; GO:0051160; P:L-xylitol catabolic process; IDA:UniProtKB.
DR   GO; GO:0051164; P:L-xylitol metabolic process; IDA:UniProtKB.
DR   GO; GO:0046686; P:response to cadmium ion; IEA:Ensembl.
DR   GO; GO:0046688; P:response to copper ion; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0009725; P:response to hormone; IEA:Ensembl.
DR   GO; GO:0031667; P:response to nutrient levels; IEA:Ensembl.
DR   GO; GO:0006970; P:response to osmotic stress; IEA:Ensembl.
DR   GO; GO:0006062; P:sorbitol catabolic process; IDA:UniProtKB.
DR   Gene3D; 3.40.50.720; -; 1.
DR   Gene3D; 3.90.180.10; -; 1.
DR   InterPro; IPR013149; ADH_C.
DR   InterPro; IPR013154; ADH_N.
DR   InterPro; IPR002085; ADH_SF_Zn-type.
DR   InterPro; IPR002328; ADH_Zn_CS.
DR   InterPro; IPR011032; GroES-like.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR020843; PKS_ER.
DR   PANTHER; PTHR11695; PTHR11695; 1.
DR   Pfam; PF08240; ADH_N; 1.
DR   Pfam; PF00107; ADH_zinc_N; 1.
DR   SMART; SM00829; PKS_ER; 1.
DR   SUPFAM; SSF50129; SSF50129; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   PROSITE; PS00059; ADH_ZINC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cell projection;
KW   Cilium; Complete proteome; Direct protein sequencing; Flagellum;
KW   Membrane; Metal-binding; Mitochondrion; NAD; Oxidoreductase;
KW   Phosphoprotein; Polymorphism; Reference proteome; Zinc.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|PubMed:12665801,
FT                                ECO:0000269|PubMed:2691249}.
FT   CHAIN         2    357       Sorbitol dehydrogenase.
FT                                /FTId=PRO_0000160817.
FT   METAL        45     45       Zinc; catalytic.
FT                                {ECO:0000269|PubMed:12962626}.
FT   METAL        70     70       Zinc; catalytic.
FT                                {ECO:0000269|PubMed:12962626}.
FT   METAL        71     71       Zinc; catalytic.
FT                                {ECO:0000269|PubMed:12962626}.
FT   BINDING      51     51       Substrate.
FT                                {ECO:0000250|UniProtKB:P07846}.
FT   BINDING     156    156       Substrate.
FT                                {ECO:0000250|UniProtKB:P07846}.
FT   BINDING     299    299       Substrate.
FT                                {ECO:0000250|UniProtKB:P07846}.
FT   BINDING     300    300       Substrate.
FT                                {ECO:0000250|UniProtKB:P07846}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:25944712}.
FT   MOD_RES     211    211       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     225    225       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ      90     99       DRVAIEPGAP -> FLTMSPLRKA (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056353.
FT   VAR_SEQ     100    356       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056354.
FT   VARIANT     239    239       Q -> L (in dbSNP:rs55739437).
FT                                {ECO:0000269|PubMed:7782086}.
FT                                /FTId=VAR_000430.
FT   VARIANT     269    269       N -> T (in dbSNP:rs2229659).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:7782086,
FT                                ECO:0000269|PubMed:8088829,
FT                                ECO:0000269|PubMed:9183016}.
FT                                /FTId=VAR_060351.
FT   CONFLICT      5      5       Missing (in Ref. 7; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     59     59       N -> D (in Ref. 7; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    186    186       M -> E (in Ref. 7; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    281    281       T -> S (in Ref. 7; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    289    289       I -> T (in Ref. 7; AA sequence).
FT                                {ECO:0000305}.
FT   STRAND       10     16       {ECO:0000244|PDB:1PL8}.
FT   STRAND       19     24       {ECO:0000244|PDB:1PL8}.
FT   STRAND       34     44       {ECO:0000244|PDB:1PL8}.
FT   HELIX        46     54       {ECO:0000244|PDB:1PL8}.
FT   STRAND       55     57       {ECO:0000244|PDB:1PL8}.
FT   STRAND       71     79       {ECO:0000244|PDB:1PL8}.
FT   STRAND       91     94       {ECO:0000244|PDB:1PL8}.
FT   STRAND       96     98       {ECO:0000244|PDB:1PL8}.
FT   HELIX       104    107       {ECO:0000244|PDB:1PL8}.
FT   HELIX       111    113       {ECO:0000244|PDB:1PL8}.
FT   STRAND      130    136       {ECO:0000244|PDB:1PL8}.
FT   HELIX       137    139       {ECO:0000244|PDB:1PL8}.
FT   STRAND      140    142       {ECO:0000244|PDB:1PL8}.
FT   HELIX       149    168       {ECO:0000244|PDB:1PL8}.
FT   STRAND      175    179       {ECO:0000244|PDB:1PL8}.
FT   HELIX       183    194       {ECO:0000244|PDB:1PL8}.
FT   STRAND      198    205       {ECO:0000244|PDB:1PL8}.
FT   HELIX       207    215       {ECO:0000244|PDB:1PL8}.
FT   STRAND      219    223       {ECO:0000244|PDB:1PL8}.
FT   HELIX       229    240       {ECO:0000244|PDB:1PL8}.
FT   STRAND      245    249       {ECO:0000244|PDB:1PL8}.
FT   HELIX       254    263       {ECO:0000244|PDB:1PL8}.
FT   STRAND      269    272       {ECO:0000244|PDB:1PL8}.
FT   HELIX       284    289       {ECO:0000244|PDB:1PL8}.
FT   STRAND      293    296       {ECO:0000244|PDB:1PL8}.
FT   HELIX       304    312       {ECO:0000244|PDB:1PL8}.
FT   HELIX       319    321       {ECO:0000244|PDB:1PL8}.
FT   STRAND      322    327       {ECO:0000244|PDB:1PL8}.
FT   HELIX       328    330       {ECO:0000244|PDB:1PL8}.
FT   HELIX       331    339       {ECO:0000244|PDB:1PL8}.
FT   STRAND      344    349       {ECO:0000244|PDB:1PL8}.
SQ   SEQUENCE   357 AA;  38325 MW;  FF13DDD5EBE47754 CRC64;
     MAAAAKPNNL SLVVHGPGDL RLENYPIPEP GPNEVLLRMH SVGICGSDVH YWEYGRIGNF
     IVKKPMVLGH EASGTVEKVG SSVKHLKPGD RVAIEPGAPR ENDEFCKMGR YNLSPSIFFC
     ATPPDDGNLC RFYKHNAAFC YKLPDNVTFE EGALIEPLSV GIHACRRGGV TLGHKVLVCG
     AGPIGMVTLL VAKAMGAAQV VVTDLSATRL SKAKEIGADL VLQISKESPQ EIARKVEGQL
     GCKPEVTIEC TGAEASIQAG IYATRSGGNL VLVGLGSEMT TVPLLHAAIR EVDIKGVFRY
     CNTWPVAISM LASKSVNVKP LVTHRFPLEK ALEAFETFKK GLGLKIMLKC DPSDQNP
//
ID   A6NG45_HUMAN            Unreviewed;       186 AA.
AC   A6NG45;
DT   24-JUL-2007, integrated into UniProtKB/TrEMBL.
DT   24-JUL-2007, sequence version 1.
DT   02-NOV-2016, entry version 65.
DE   SubName: Full=Peroxiredoxin-4 {ECO:0000313|Ensembl:ENSP00000368635};
GN   Name=PRDX4 {ECO:0000313|Ensembl:ENSP00000368635};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000368635, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000368635, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [2] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [3] {ECO:0000313|Ensembl:ENSP00000368635}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [4] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [5] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000368635}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC093011; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; A6NG45; -.
DR   SMR; A6NG45; -.
DR   STRING; 9606.ENSP00000368646; -.
DR   MaxQB; A6NG45; -.
DR   PaxDb; A6NG45; -.
DR   PeptideAtlas; A6NG45; -.
DR   PRIDE; A6NG45; -.
DR   Ensembl; ENST00000379331; ENSP00000368635; ENSG00000123131.
DR   UCSC; uc064yik.1; human.
DR   HGNC; HGNC:17169; PRDX4.
DR   OpenTargets; ENSG00000123131; -.
DR   eggNOG; KOG0852; Eukaryota.
DR   eggNOG; COG0450; LUCA.
DR   GeneTree; ENSGT00390000004653; -.
DR   ChiTaRS; PRDX4; human.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000123131; -.
DR   ExpressionAtlas; A6NG45; baseline and differential.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0016209; F:antioxidant activity; IEA:InterPro.
DR   GO; GO:0016491; F:oxidoreductase activity; IEA:InterPro.
DR   GO; GO:0045454; P:cell redox homeostasis; IEA:InterPro.
DR   Gene3D; 3.40.30.10; -; 1.
DR   InterPro; IPR000866; AhpC/TSA.
DR   InterPro; IPR012336; Thioredoxin-like_fold.
DR   InterPro; IPR013766; Thioredoxin_domain.
DR   Pfam; PF00578; AhpC-TSA; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   PROSITE; PS51352; THIOREDOXIN_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:A6NG45,
KW   ECO:0000213|MaxQB:A6NG45, ECO:0000213|PeptideAtlas:A6NG45};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     37       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        38    186       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5002700217.
FT   DOMAIN       79    186       Thioredoxin.
FT                                {ECO:0000259|PROSITE:PS51352}.
SQ   SEQUENCE   186 AA;  21337 MW;  684E3FDBE8ED978A CRC64;
     MEALPLLAAT TPDHGRHRRL LLLPLLLFLL PAGAVQGWET EERPRTREEE CHFYAGGQVY
     PGEASRVSVA DHSLHLSKAK ISKPAPYWEG TAVIDGEFKE LKLTDYRGKY LVFFFYPLDF
     TFVCPTEIIA FGDRLEEFRS INTEVVACSV DSQFTHLAWS VSYTYIRRKK RMDLLLKHGQ
     ITLDMI
//
ID   A6NJJ0_HUMAN            Unreviewed;       185 AA.
AC   A6NJJ0;
DT   24-JUL-2007, integrated into UniProtKB/TrEMBL.
DT   24-JUL-2007, sequence version 1.
DT   02-NOV-2016, entry version 66.
DE   SubName: Full=Peroxiredoxin-4 {ECO:0000313|Ensembl:ENSP00000368654};
DE   Flags: Fragment;
GN   Name=PRDX4 {ECO:0000313|Ensembl:ENSP00000368654};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000368654, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000368654, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [2] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [3] {ECO:0000313|Ensembl:ENSP00000368654}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [4] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [5] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000368654}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC093011; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; A6NJJ0; -.
DR   SMR; A6NJJ0; -.
DR   STRING; 9606.ENSP00000368646; -.
DR   EPD; A6NJJ0; -.
DR   MaxQB; A6NJJ0; -.
DR   PaxDb; A6NJJ0; -.
DR   PeptideAtlas; A6NJJ0; -.
DR   PRIDE; A6NJJ0; -.
DR   Ensembl; ENST00000379349; ENSP00000368654; ENSG00000123131.
DR   UCSC; uc064yii.1; human.
DR   HGNC; HGNC:17169; PRDX4.
DR   OpenTargets; ENSG00000123131; -.
DR   eggNOG; KOG0852; Eukaryota.
DR   eggNOG; COG0450; LUCA.
DR   GeneTree; ENSGT00390000004653; -.
DR   HOGENOM; HOG000022343; -.
DR   ChiTaRS; PRDX4; human.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000123131; -.
DR   ExpressionAtlas; A6NJJ0; baseline and differential.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0016209; F:antioxidant activity; IEA:InterPro.
DR   GO; GO:0016491; F:oxidoreductase activity; IEA:InterPro.
DR   GO; GO:0045454; P:cell redox homeostasis; IEA:InterPro.
DR   Gene3D; 3.40.30.10; -; 1.
DR   InterPro; IPR000866; AhpC/TSA.
DR   InterPro; IPR012336; Thioredoxin-like_fold.
DR   InterPro; IPR013766; Thioredoxin_domain.
DR   Pfam; PF00578; AhpC-TSA; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   PROSITE; PS51352; THIOREDOXIN_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:A6NJJ0,
KW   ECO:0000213|MaxQB:A6NJJ0, ECO:0000213|PeptideAtlas:A6NJJ0};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN       65    185       Thioredoxin.
FT                                {ECO:0000259|PROSITE:PS51352}.
FT   NON_TER     185    185       {ECO:0000313|Ensembl:ENSP00000368654}.
SQ   SEQUENCE   185 AA;  21302 MW;  016797254864F33A CRC64;
     MDHRSRLRGT GLNRIPGTQS RAPRVPLPFH VQQEAREGED WEREPPRQRP PIYEPPESEE
     LPDNVMVSKP APYWEGTAVI DGEFKELKLT DYRGKYLVFF FYPLDFTFVC PTEIIAFGDR
     LEEFRSINTE VVACSVDSQF THLAWINTPR RQGGLGPIRI PLLSDLTHQI SKDYGVYLED
     SGHTL
//
ID   H7C3T4_HUMAN            Unreviewed;       161 AA.
AC   H7C3T4;
DT   18-APR-2012, integrated into UniProtKB/TrEMBL.
DT   18-APR-2012, sequence version 1.
DT   02-NOV-2016, entry version 29.
DE   SubName: Full=Peroxiredoxin-4 {ECO:0000313|Ensembl:ENSP00000413736};
DE   Flags: Fragment;
GN   Name=PRDX4 {ECO:0000313|Ensembl:ENSP00000413736};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000413736, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000413736, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [2] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [3] {ECO:0000313|Ensembl:ENSP00000413736}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [4] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [5] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000413736}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC093011; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; H7C3T4; -.
DR   STRING; 9606.ENSP00000368646; -.
DR   MaxQB; H7C3T4; -.
DR   PaxDb; H7C3T4; -.
DR   PeptideAtlas; H7C3T4; -.
DR   PRIDE; H7C3T4; -.
DR   Ensembl; ENST00000439422; ENSP00000413736; ENSG00000123131.
DR   UCSC; uc064yil.1; human.
DR   HGNC; HGNC:17169; PRDX4.
DR   OpenTargets; ENSG00000123131; -.
DR   eggNOG; KOG0852; Eukaryota.
DR   eggNOG; COG0450; LUCA.
DR   GeneTree; ENSGT00390000004653; -.
DR   ChiTaRS; PRDX4; human.
DR   Proteomes; UP000005640; Chromosome X.
DR   ExpressionAtlas; H7C3T4; baseline and differential.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0051920; F:peroxiredoxin activity; IEA:InterPro.
DR   GO; GO:0045454; P:cell redox homeostasis; IEA:InterPro.
DR   Gene3D; 3.40.30.10; -; 1.
DR   InterPro; IPR000866; AhpC/TSA.
DR   InterPro; IPR024706; Peroxiredoxin_AhpC-typ.
DR   InterPro; IPR019479; Peroxiredoxin_C.
DR   InterPro; IPR012336; Thioredoxin-like_fold.
DR   InterPro; IPR013766; Thioredoxin_domain.
DR   Pfam; PF10417; 1-cysPrx_C; 1.
DR   Pfam; PF00578; AhpC-TSA; 1.
DR   PIRSF; PIRSF000239; AHPC; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   PROSITE; PS51352; THIOREDOXIN_2; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:H7C3T4,
KW   ECO:0000213|MaxQB:H7C3T4, ECO:0000213|PeptideAtlas:H7C3T4};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN        1    115       Thioredoxin.
FT                                {ECO:0000259|PROSITE:PS51352}.
FT   NON_TER       1      1       {ECO:0000313|Ensembl:ENSP00000413736}.
SQ   SEQUENCE   161 AA;  18326 MW;  C4CD074AD4E33760 CRC64;
     XCPTEIIAFG DRLEEFRSIN TEVVACSVDS QFTHLAWINT PRRQGGLGPI RIPLLSDLTH
     QISKDYGVYL EDSGHTLRGL FIIDDKGILR QITLNDLPVG RSVDETLRLV QAFQYTDKHG
     EVCPAGWKPG SETIKPEDTM KAWWPRESYN PRSSWKAEVF R
//
ID   PRDX4_HUMAN             Reviewed;         271 AA.
AC   Q13162; Q6FHT3;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   02-NOV-2016, entry version 167.
DE   RecName: Full=Peroxiredoxin-4;
DE            EC=1.11.1.15;
DE   AltName: Full=Antioxidant enzyme AOE372;
DE            Short=AOE37-2;
DE   AltName: Full=Peroxiredoxin IV;
DE            Short=Prx-IV;
DE   AltName: Full=Thioredoxin peroxidase AO372;
DE   AltName: Full=Thioredoxin-dependent peroxide reductase A0372;
DE   Flags: Precursor;
GN   Name=PRDX4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND
RP   SUBUNIT.
RX   PubMed=9388242; DOI=10.1074/jbc.272.49.30952;
RA   Jin D.-Y., Chae H.Z., Rhee S.G., Jeang K.-T.;
RT   "Regulatory role for a novel human thioredoxin peroxidase in NF-kappaB
RT   activation.";
RL   J. Biol. Chem. 272:30952-30961(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE [LARGE SCALE ANALYSIS] OF 38-46.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19892738; DOI=10.1073/pnas.0908958106;
RA   Xu G., Shin S.B., Jaffrey S.R.;
RT   "Global profiling of protease cleavage sites by chemoselective
RT   labeling of protein N-termini.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:19310-19315(2009).
RN   [5]
RP   PROTEIN SEQUENCE OF 46-66; 81-99; 140-164; 174-208; 213-223 AND
RP   231-263, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [6]
RP   OVEROXIDATION AT CYS-124.
RX   PubMed=12059788; DOI=10.1042/BJ20020525;
RA   Wagner E., Luche S., Penna L., Chevallet M., van Dorsselaer A.,
RA   Leize-Wagner E., Rabilloud T.;
RT   "A method for detection of overoxidation of cysteines: peroxiredoxins
RT   are oxidized in vivo at the active-site cysteine during oxidative
RT   stress.";
RL   Biochem. J. 366:777-785(2002).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9]
RP   CLEAVAGE OF SIGNAL PEPTIDE [LARGE SCALE ANALYSIS] AFTER GLY-37, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Probably involved in redox regulation of the cell.
CC       Regulates the activation of NF-kappa-B in the cytosol by a
CC       modulation of I-kappa-B-alpha phosphorylation.
CC       {ECO:0000269|PubMed:9388242}.
CC   -!- CATALYTIC ACTIVITY: 2 R'-SH + ROOH = R'-S-S-R' + H(2)O + ROH.
CC   -!- SUBUNIT: Homodimer or heterodimer with PRDX1; disulfide-linked,
CC       upon oxidation. {ECO:0000250}.
CC   -!- INTERACTION:
CC       P18428:LBP; NbExp=4; IntAct=EBI-2211957, EBI-3927059;
CC       P07237:P4HB; NbExp=2; IntAct=EBI-2211957, EBI-395883;
CC       P30101:PDIA3; NbExp=2; IntAct=EBI-2211957, EBI-979862;
CC       Q15084:PDIA6; NbExp=2; IntAct=EBI-2211957, EBI-1043087;
CC       P21731:TBXA2R; NbExp=3; IntAct=EBI-2211957, EBI-2625082;
CC       Q8NBS9:TXNDC5; NbExp=2; IntAct=EBI-2211957, EBI-2510815;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9388242}.
CC       Secreted {ECO:0000269|PubMed:9388242}.
CC   -!- MISCELLANEOUS: The active site is the redox-active Cys-124
CC       oxidized to Cys-SOH. Cys-SOH rapidly reacts with Cys-245-SH of the
CC       other subunit to form an intermolecular disulfide with a
CC       concomitant homodimer formation. The enzyme may be subsequently
CC       regenerated by reduction of the disulfide by thioredoxin.
CC   -!- MISCELLANEOUS: Irreversibly inactivated by overoxidation of Cys-
CC       124 (to Cys-SO(3)H) upon oxidative stress.
CC   -!- SIMILARITY: Belongs to the AhpC/TSA family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 thioredoxin domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00691}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U25182; AAB95175.1; -; mRNA.
DR   EMBL; CR541668; CAG46469.1; -; mRNA.
DR   EMBL; CR541705; CAG46506.1; -; mRNA.
DR   EMBL; BC003609; AAH03609.1; -; mRNA.
DR   EMBL; BC007107; AAH07107.1; -; mRNA.
DR   EMBL; BC016770; AAH16770.1; -; mRNA.
DR   CCDS; CCDS14206.1; -.
DR   PIR; G01790; G01790.
DR   RefSeq; NP_006397.1; NM_006406.1.
DR   UniGene; Hs.83383; -.
DR   PDB; 2PN8; X-ray; 1.80 A; A/B/C/D/E/F/G/H/I/J=84-271.
DR   PDB; 3TJB; X-ray; 2.38 A; A/B/C/D/E=38-271.
DR   PDB; 3TJF; X-ray; 2.04 A; A/B/C/D/E=38-271.
DR   PDB; 3TJG; X-ray; 2.24 A; A/B/C/D/E=38-271.
DR   PDB; 3TJJ; X-ray; 1.91 A; A/B/C/D/E=38-271.
DR   PDB; 3TJK; X-ray; 2.09 A; A/B/C/D/E=38-271.
DR   PDB; 3TKP; X-ray; 2.49 A; A/B/C/D/E=38-271.
DR   PDB; 3TKQ; X-ray; 2.22 A; A/B/C/D/E=38-271.
DR   PDB; 3TKR; X-ray; 2.10 A; A/B/C/D/E/F/G/H/I/J=38-271.
DR   PDB; 3TKS; X-ray; 2.40 A; A/B/C/D/E=38-271.
DR   PDB; 4RQX; X-ray; 2.26 A; A/B/C/D/E=79-271.
DR   PDBsum; 2PN8; -.
DR   PDBsum; 3TJB; -.
DR   PDBsum; 3TJF; -.
DR   PDBsum; 3TJG; -.
DR   PDBsum; 3TJJ; -.
DR   PDBsum; 3TJK; -.
DR   PDBsum; 3TKP; -.
DR   PDBsum; 3TKQ; -.
DR   PDBsum; 3TKR; -.
DR   PDBsum; 3TKS; -.
DR   PDBsum; 4RQX; -.
DR   ProteinModelPortal; Q13162; -.
DR   SMR; Q13162; -.
DR   BioGrid; 115800; 54.
DR   IntAct; Q13162; 49.
DR   MINT; MINT-3027265; -.
DR   STRING; 9606.ENSP00000368646; -.
DR   PeroxiBase; 4530; Hs2CysPrx04.
DR   iPTMnet; Q13162; -.
DR   PhosphoSitePlus; Q13162; -.
DR   SwissPalm; Q13162; -.
DR   BioMuta; PRDX4; -.
DR   DMDM; 3024727; -.
DR   OGP; Q13162; -.
DR   REPRODUCTION-2DPAGE; IPI00011937; -.
DR   UCD-2DPAGE; Q13162; -.
DR   EPD; Q13162; -.
DR   PaxDb; Q13162; -.
DR   PeptideAtlas; Q13162; -.
DR   PRIDE; Q13162; -.
DR   TopDownProteomics; Q13162; -.
DR   DNASU; 10549; -.
DR   Ensembl; ENST00000379341; ENSP00000368646; ENSG00000123131.
DR   GeneID; 10549; -.
DR   KEGG; hsa:10549; -.
DR   CTD; 10549; -.
DR   DisGeNET; 10549; -.
DR   GeneCards; PRDX4; -.
DR   HGNC; HGNC:17169; PRDX4.
DR   HPA; CAB008659; -.
DR   HPA; CAB027389; -.
DR   MIM; 300927; gene.
DR   neXtProt; NX_Q13162; -.
DR   OpenTargets; ENSG00000123131; -.
DR   PharmGKB; PA33725; -.
DR   eggNOG; KOG0852; Eukaryota.
DR   eggNOG; COG0450; LUCA.
DR   GeneTree; ENSGT00390000004653; -.
DR   HOGENOM; HOG000022343; -.
DR   HOVERGEN; HBG000286; -.
DR   InParanoid; Q13162; -.
DR   KO; K03386; -.
DR   OMA; YAGGHVY; -.
DR   OrthoDB; EOG091G0IE5; -.
DR   PhylomeDB; Q13162; -.
DR   TreeFam; TF105181; -.
DR   BioCyc; ZFISH:HS04632-MONOMER; -.
DR   BRENDA; 1.11.1.15; 2681.
DR   ChiTaRS; PRDX4; human.
DR   EvolutionaryTrace; Q13162; -.
DR   GeneWiki; PRDX4; -.
DR   GenomeRNAi; 10549; -.
DR   PRO; PR:Q13162; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000123131; -.
DR   CleanEx; HS_PRDX4; -.
DR   ExpressionAtlas; Q13162; baseline and differential.
DR   Genevisible; Q13162; HS.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IEA:Ensembl.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005790; C:smooth endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0008379; F:thioredoxin peroxidase activity; TAS:ProtInc.
DR   GO; GO:0019471; P:4-hydroxyproline metabolic process; IEA:Ensembl.
DR   GO; GO:0045454; P:cell redox homeostasis; IEA:Ensembl.
DR   GO; GO:0030198; P:extracellular matrix organization; IEA:Ensembl.
DR   GO; GO:0007252; P:I-kappaB phosphorylation; TAS:ProtInc.
DR   GO; GO:0008584; P:male gonad development; IEA:Ensembl.
DR   GO; GO:2000255; P:negative regulation of male germ cell proliferation; IEA:Ensembl.
DR   GO; GO:0022417; P:protein maturation by protein folding; IEA:Ensembl.
DR   GO; GO:0072593; P:reactive oxygen species metabolic process; IEA:Ensembl.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   Gene3D; 3.40.30.10; -; 1.
DR   InterPro; IPR000866; AhpC/TSA.
DR   InterPro; IPR019479; Peroxiredoxin_C.
DR   InterPro; IPR012336; Thioredoxin-like_fold.
DR   InterPro; IPR013766; Thioredoxin_domain.
DR   Pfam; PF10417; 1-cysPrx_C; 1.
DR   Pfam; PF00578; AhpC-TSA; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   PROSITE; PS51352; THIOREDOXIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antioxidant; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Disulfide bond; Oxidoreductase; Peroxidase;
KW   Redox-active center; Reference proteome; Secreted; Signal.
FT   SIGNAL        1     37       {ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|PubMed:19892738}.
FT   CHAIN        38    271       Peroxiredoxin-4.
FT                                /FTId=PRO_0000135098.
FT   DOMAIN       79    237       Thioredoxin. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00691}.
FT   ACT_SITE    124    124       Cysteine sulfenic acid (-SOH)
FT                                intermediate. {ECO:0000250}.
FT   DISULFID    124    124       Interchain (with C-245); in linked form.
FT                                {ECO:0000250}.
FT   DISULFID    245    245       Interchain (with C-124); in linked form.
FT                                {ECO:0000250}.
FT   CONFLICT     12     12       P -> S (in Ref. 3; CAG46469).
FT                                {ECO:0000305}.
FT   CONFLICT     51     51       C -> Y (in Ref. 3; CAG46469).
FT                                {ECO:0000305}.
FT   STRAND       75     78       {ECO:0000244|PDB:3TJK}.
FT   STRAND       89     94       {ECO:0000244|PDB:2PN8}.
FT   STRAND       97    102       {ECO:0000244|PDB:2PN8}.
FT   HELIX       103    106       {ECO:0000244|PDB:2PN8}.
FT   STRAND      109    115       {ECO:0000244|PDB:2PN8}.
FT   HELIX       123    133       {ECO:0000244|PDB:2PN8}.
FT   HELIX       135    139       {ECO:0000244|PDB:2PN8}.
FT   TURN        140    142       {ECO:0000244|PDB:2PN8}.
FT   STRAND      143    151       {ECO:0000244|PDB:2PN8}.
FT   HELIX       153    160       {ECO:0000244|PDB:2PN8}.
FT   HELIX       164    166       {ECO:0000244|PDB:2PN8}.
FT   STRAND      176    178       {ECO:0000244|PDB:2PN8}.
FT   HELIX       183    187       {ECO:0000244|PDB:2PN8}.
FT   TURN        193    195       {ECO:0000244|PDB:2PN8}.
FT   STRAND      196    198       {ECO:0000244|PDB:2PN8}.
FT   STRAND      200    205       {ECO:0000244|PDB:2PN8}.
FT   STRAND      209    217       {ECO:0000244|PDB:2PN8}.
FT   HELIX       225    241       {ECO:0000244|PDB:2PN8}.
FT   TURN        260    262       {ECO:0000244|PDB:2PN8}.
FT   HELIX       263    267       {ECO:0000244|PDB:2PN8}.
FT   TURN        268    270       {ECO:0000244|PDB:3TKS}.
SQ   SEQUENCE   271 AA;  30540 MW;  7E56B580049FC60F CRC64;
     MEALPLLAAT TPDHGRHRRL LLLPLLLFLL PAGAVQGWET EERPRTREEE CHFYAGGQVY
     PGEASRVSVA DHSLHLSKAK ISKPAPYWEG TAVIDGEFKE LKLTDYRGKY LVFFFYPLDF
     TFVCPTEIIA FGDRLEEFRS INTEVVACSV DSQFTHLAWI NTPRRQGGLG PIRIPLLSDL
     THQISKDYGV YLEDSGHTLR GLFIIDDKGI LRQITLNDLP VGRSVDETLR LVQAFQYTDK
     HGEVCPAGWK PGSETIIPDP AGKLKYFDKL N
//
ID   V9HW63_HUMAN            Unreviewed;       271 AA.
AC   V9HW63;
DT   19-MAR-2014, integrated into UniProtKB/TrEMBL.
DT   19-MAR-2014, sequence version 1.
DT   02-NOV-2016, entry version 28.
DE   SubName: Full=Epididymis secretory sperm binding protein Li 97n {ECO:0000313|EMBL:ACI45989.1};
DE   SubName: Full=Peroxiredoxin 4 {ECO:0000313|EMBL:EAW98996.1};
GN   Name=HEL-S-97n {ECO:0000313|EMBL:ACI45989.1};
GN   Synonyms=PRDX4 {ECO:0000313|EMBL:EAW98996.1};
GN   ORFNames=hCG_17636 {ECO:0000313|EMBL:EAW98996.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACI45989.1};
RN   [1] {ECO:0000313|EMBL:EAW98996.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW98996.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ACI45989.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y., Wang H.Y., Liu J., Liu F.J.;
RL   Submitted (SEP-2008) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; FJ224297; ACI45989.1; -; mRNA.
DR   EMBL; CH471074; EAW98996.1; -; Genomic_DNA.
DR   RefSeq; NP_006397.1; NM_006406.1.
DR   UniGene; Hs.83383; -.
DR   STRING; 9606.ENSP00000368646; -.
DR   GeneID; 10549; -.
DR   KEGG; hsa:10549; -.
DR   UCSC; uc004dam.4; human.
DR   CTD; 10549; -.
DR   eggNOG; KOG0852; Eukaryota.
DR   eggNOG; COG0450; LUCA.
DR   KO; K03386; -.
DR   OMA; YAGGHVY; -.
DR   OrthoDB; EOG091G0IE5; -.
DR   ChiTaRS; PRDX4; human.
DR   GenomeRNAi; 10549; -.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005615; C:extracellular space; IEA:Ensembl.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005790; C:smooth endoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0051920; F:peroxiredoxin activity; IEA:InterPro.
DR   GO; GO:0019471; P:4-hydroxyproline metabolic process; IEA:Ensembl.
DR   GO; GO:0045454; P:cell redox homeostasis; IEA:Ensembl.
DR   GO; GO:0030198; P:extracellular matrix organization; IEA:Ensembl.
DR   GO; GO:0008584; P:male gonad development; IEA:Ensembl.
DR   GO; GO:2000255; P:negative regulation of male germ cell proliferation; IEA:Ensembl.
DR   GO; GO:0022417; P:protein maturation by protein folding; IEA:Ensembl.
DR   GO; GO:0072593; P:reactive oxygen species metabolic process; IEA:Ensembl.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   Gene3D; 3.40.30.10; -; 1.
DR   InterPro; IPR000866; AhpC/TSA.
DR   InterPro; IPR019479; Peroxiredoxin_C.
DR   InterPro; IPR012336; Thioredoxin-like_fold.
DR   InterPro; IPR013766; Thioredoxin_domain.
DR   Pfam; PF10417; 1-cysPrx_C; 1.
DR   Pfam; PF00578; AhpC-TSA; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   PROSITE; PS51352; THIOREDOXIN_2; 1.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL        1     37       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        38    271       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5008431883.
FT   DOMAIN       79    237       Thioredoxin.
FT                                {ECO:0000259|PROSITE:PS51352}.
SQ   SEQUENCE   271 AA;  30540 MW;  7E56B580049FC60F CRC64;
     MEALPLLAAT TPDHGRHRRL LLLPLLLFLL PAGAVQGWET EERPRTREEE CHFYAGGQVY
     PGEASRVSVA DHSLHLSKAK ISKPAPYWEG TAVIDGEFKE LKLTDYRGKY LVFFFYPLDF
     TFVCPTEIIA FGDRLEEFRS INTEVVACSV DSQFTHLAWI NTPRRQGGLG PIRIPLLSDL
     THQISKDYGV YLEDSGHTLR GLFIIDDKGI LRQITLNDLP VGRSVDETLR LVQAFQYTDK
     HGEVCPAGWK PGSETIIPDP AGKLKYFDKL N
//
ID   A0A0A1TSG4_HUMAN        Unreviewed;       293 AA.
AC   A0A0A1TSG4;
DT   04-FEB-2015, integrated into UniProtKB/TrEMBL.
DT   04-FEB-2015, sequence version 1.
DT   05-OCT-2016, entry version 12.
DE   SubName: Full=CD47 {ECO:0000313|EMBL:CEJ95640.1};
GN   Name=CD47 {ECO:0000313|EMBL:CEJ95640.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CEJ95640.1};
RN   [1] {ECO:0000313|EMBL:CEJ95640.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Aversa R., Sorrentino A., D'Apice L., Ciccodicola A., Costa V.;
RT   "Expression analysis of genes encoding adhesion and migration related
RT   proteins in breast cancer.";
RL   Submitted (NOV-2014) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; LN680437; CEJ95640.1; -; mRNA.
DR   RefSeq; XP_005247966.1; XM_005247909.1.
DR   UniGene; Hs.446414; -.
DR   STRING; 9606.ENSP00000355361; -.
DR   PaxDb; A0A0A1TSG4; -.
DR   PeptideAtlas; A0A0A1TSG4; -.
DR   PRIDE; A0A0A1TSG4; -.
DR   GeneID; 961; -.
DR   CTD; 961; -.
DR   eggNOG; ENOG410IJTS; Eukaryota.
DR   eggNOG; ENOG41113GI; LUCA.
DR   GenomeRNAi; 961; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR006704; CD47.
DR   InterPro; IPR013147; CD47_TM.
DR   InterPro; IPR013270; CD47_Vset.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   PANTHER; PTHR10613; PTHR10613; 1.
DR   Pfam; PF04549; CD47; 1.
DR   Pfam; PF08204; V-set_CD47; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL        1     18       {ECO:0000256|SAM:SignalP}.
FT   CHAIN        19    293       {ECO:0000256|SAM:SignalP}.
FT                                /FTId=PRO_5001990366.
FT   TRANSMEM    143    165       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    177    198       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    210    228       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    237    264       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM    270    289       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN        3    127       Ig-like (immunoglobulin-like).
FT                                {ECO:0000259|PROSITE:PS50835}.
SQ   SEQUENCE   293 AA;  31872 MW;  E841A2F6696D11F4 CRC64;
     MWPLVAALLL GSACCGSAQL LFNKTKSVEF TFCNDTVVIP CFVTNMEAQN TTEVYVKWKF
     KGRDIYTFDG ALNKSTVPTD FSSAKIEVSQ LLKGDASLKM DKSDAVSHTG NYTCEVTELT
     REGETIIELK YRVVSWFSPN ENILIVIFPI FAILLFWGQF GIKTLKYRSG GMDEKTIALL
     VAGLVITVIV IVGAILFVPG EYSLKNATGL GLIVTSTGIL ILLHYYVFST AIGLTSFVIA
     ILVIQVIAYI LAVVGLSLCI AACIPMHGPL LISGLSILAL AQLLGLVYMK FVE
//
ID   H0YC40_HUMAN            Unreviewed;       109 AA.
AC   H0YC40;
DT   22-FEB-2012, integrated into UniProtKB/TrEMBL.
DT   22-FEB-2012, sequence version 1.
DT   02-NOV-2016, entry version 26.
DE   SubName: Full=Leukocyte surface antigen CD47 {ECO:0000313|Ensembl:ENSP00000430843};
DE   Flags: Fragment;
GN   Name=CD47 {ECO:0000313|Ensembl:ENSP00000430843};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000430843, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000430843, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000430843}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2012) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000430843}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC012020; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; H0YC40; -.
DR   STRING; 9606.ENSP00000355361; -.
DR   MaxQB; H0YC40; -.
DR   PaxDb; H0YC40; -.
DR   PeptideAtlas; H0YC40; -.
DR   Ensembl; ENST00000517766; ENSP00000430843; ENSG00000196776.
DR   UCSC; uc062mfy.1; human.
DR   HGNC; HGNC:1682; CD47.
DR   OpenTargets; ENSG00000196776; -.
DR   eggNOG; ENOG410IJTS; Eukaryota.
DR   eggNOG; ENOG41113GI; LUCA.
DR   GeneTree; ENSGT00390000007697; -.
DR   ChiTaRS; CD47; human.
DR   Proteomes; UP000005640; Chromosome 3.
DR   ExpressionAtlas; H0YC40; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   InterPro; IPR006704; CD47.
DR   InterPro; IPR013147; CD47_TM.
DR   PANTHER; PTHR10613; PTHR10613; 1.
DR   Pfam; PF04549; CD47; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:H0YC40};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM      6     25       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     34     61       Helical. {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM     67     86       Helical. {ECO:0000256|SAM:Phobius}.
FT   DOMAIN        2     89       CD47. {ECO:0000259|Pfam:PF04549}.
FT   NON_TER       1      1       {ECO:0000313|Ensembl:ENSP00000430843}.
SQ   SEQUENCE   109 AA;  11543 MW;  440672FB9AF882EA CRC64;
     XKNATGLGLI VTSTGILILL HYYVFSTAIG LTSFVIAILV IQVIAYILAV VGLSLCIAAC
     IPMHGPLLIS GLSILALAQL LGLVYMKFVA SNQKTIQPPR KAVEEPLNE
//
ID   H7BYS8_HUMAN            Unreviewed;        86 AA.
AC   H7BYS8;
DT   18-APR-2012, integrated into UniProtKB/TrEMBL.
DT   18-APR-2012, sequence version 1.
DT   02-NOV-2016, entry version 20.
DE   SubName: Full=Leukocyte surface antigen CD47 {ECO:0000313|Ensembl:ENSP00000381309};
DE   Flags: Fragment;
GN   Name=CD47 {ECO:0000313|Ensembl:ENSP00000381309};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000381309, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000381309, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000381309}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000381309}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC012020; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; H7BYS8; -.
DR   MaxQB; H7BYS8; -.
DR   PeptideAtlas; H7BYS8; -.
DR   PRIDE; H7BYS8; -.
DR   Ensembl; ENST00000398258; ENSP00000381309; ENSG00000196776.
DR   UCSC; uc062mfx.1; human.
DR   HGNC; HGNC:1682; CD47.
DR   OpenTargets; ENSG00000196776; -.
DR   GeneTree; ENSGT00390000007697; -.
DR   ChiTaRS; CD47; human.
DR   Proteomes; UP000005640; Chromosome 3.
DR   ExpressionAtlas; H7BYS8; baseline and differential.
DR   InterPro; IPR006704; CD47.
DR   PANTHER; PTHR10613; PTHR10613; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|MaxQB:H7BYS8,
KW   ECO:0000213|PeptideAtlas:H7BYS8};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   NON_TER       1      1       {ECO:0000313|Ensembl:ENSP00000381309}.
SQ   SEQUENCE   86 AA;  9964 MW;  48FD75CCD6FACABA CRC64;
     XWTESLYCGV YTNAWPSSDF RFEYLSSSTI TWTSLYEICG VQRDTYSQLK GKKRQASNQK
     TIQPPRKAVE EPLNAFKESK GMMNDE
//
ID   CD47_HUMAN              Reviewed;         323 AA.
AC   Q08722; A8K198; D3DN59; Q53Y71; Q96A60;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   02-NOV-2016, entry version 158.
DE   RecName: Full=Leukocyte surface antigen CD47;
DE   AltName: Full=Antigenic surface determinant protein OA3;
DE   AltName: Full=Integrin-associated protein;
DE            Short=IAP;
DE   AltName: Full=Protein MER6;
DE   AltName: CD_antigen=CD47;
DE   Flags: Precursor;
GN   Name=CD47; Synonyms=MER6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM OA3-323).
RC   TISSUE=Ovary;
RX   PubMed=1394148;
RA   Campbell I.G., Freemont P.S., Foulkes W., Trowsdale J.;
RT   "An ovarian tumor marker with homology to vaccinia virus contains an
RT   IgV-like region and multiple transmembrane domains.";
RL   Cancer Res. 52:5416-5420(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM OA3-305), FUNCTION, SUBCELLULAR
RP   LOCATION, AND TOPOLOGY.
RC   TISSUE=Myelomonocyte;
RX   PubMed=7691831; DOI=10.1083/jcb.123.2.485;
RA   Lindberg F.P., Gresham H.D., Schwarz E., Brown E.J.;
RT   "Molecular cloning of integrin-associated protein: an immunoglobulin
RT   family member with multiple membrane spanning domains implicated in
RT   alpha-v beta-3-dependent ligand binding.";
RL   J. Cell Biol. 123:485-496(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM OA3-305).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM OA3-323).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM OA3-305).
RC   TISSUE=Hippocampus, Leiomyosarcoma, and Ovarian adenocarcinoma;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PARTIAL PROTEIN SEQUENCE, AND IDENTIFICATION AS CD47.
RC   TISSUE=Erythrocyte;
RX   PubMed=7998989; DOI=10.1042/bj3040525;
RA   Mawby W.J., Holmes C.H., Anstee D.J., Spring F.A., Tanner M.J.A.;
RT   "Isolation and characterization of CD47 glycoprotein: a multispanning
RT   membrane protein which is the same as integrin-associated protein
RT   (IAP) and the ovarian tumour marker OA3.";
RL   Biochem. J. 304:525-530(1994).
RN   [8]
RP   INTERACTION WITH UBQLN1 AND UBQLN2.
RX   PubMed=10549293; DOI=10.1016/S1097-2765(00)80212-9;
RA   Wu A.-L., Wang J., Zheleznyak A., Brown E.J.;
RT   "Ubiquitin-related proteins regulate interaction of vimentin
RT   intermediate filaments with the plasma membrane.";
RL   Mol. Cell 4:619-625(1999).
RN   [9]
RP   DISULFIDE BOND.
RX   PubMed=11454874; DOI=10.1074/jbc.M106107200;
RA   Rebres R.A., Vaz L.E., Green J.M., Brown E.J.;
RT   "Normal ligand binding and signaling by CD47 (integrin-associated
RT   protein) requires a long range disulfide bond between the
RT   extracellular and membrane-spanning domains.";
RL   J. Biol. Chem. 276:34607-34616(2001).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH SIRPA.
RX   PubMed=11509594; DOI=10.4049/jimmunol.167.5.2547;
RA   Latour S., Tanaka H., Demeure C., Mateo V., Rubio M., Brown E.J.,
RA   Maliszewski C., Lindberg F.P., Oldenborg A., Ullrich A.,
RA   Delespesse G., Sarfati M.;
RT   "Bidirectional negative regulation of human T and dendritic cells by
RT   CD47 and its cognate receptor signal-regulator protein-alpha: down-
RT   regulation of IL-12 responsiveness and inhibition of dendritic cell
RT   activation.";
RL   J. Immunol. 167:2547-2554(2001).
RN   [11]
RP   SPLICE ISOFORM(S) THAT ARE POTENTIAL NMD TARGET(S).
RX   PubMed=14759258; DOI=10.1186/gb-2004-5-2-r8;
RA   Hillman R.T., Green R.E., Brenner S.E.;
RT   "An unappreciated role for RNA surveillance.";
RL   Genome Biol. 5:R8.1-R8.16(2004).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH SIRPG.
RC   TISSUE=T-cell;
RX   PubMed=15383453; DOI=10.1182/blood-2004-07-2823;
RA   Piccio L., Vermi W., Boles K.S., Fuchs A., Strader C.A., Facchetti F.,
RA   Cella M., Colonna M.;
RT   "Adhesion of human T cells to antigen-presenting cells through
RT   SIRPbeta2-CD47 interaction costimulates T-cell proliferation.";
RL   Blood 105:2421-2427(2005).
RN   [13]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-73 AND ASN-111.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [14]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-50 AND ASN-73.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-
RT   linked cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 19-136 IN COMPLEX WITH
RP   SIRPA, DISULFIDE BOND, GLYCOSYLATION AT ASN-23; ASN-50; ASN-73 AND
RP   ASN-111, AND PYROGLUTAMATE FORMATION AT GLN-19.
RX   PubMed=18657508; DOI=10.1016/j.molcel.2008.05.026;
RA   Hatherley D., Graham S.C., Turner J., Harlos K., Stuart D.I.,
RA   Barclay A.N.;
RT   "Paired receptor specificity explained by structures of signal
RT   regulatory proteins alone and complexed with CD47.";
RL   Mol. Cell 31:266-277(2008).
CC   -!- FUNCTION: Has a role in both cell adhesion by acting as an
CC       adhesion receptor for THBS1 on platelets, and in the modulation of
CC       integrins. Plays an important role in memory formation and
CC       synaptic plasticity in the hippocampus (By similarity). Receptor
CC       for SIRPA, binding to which prevents maturation of immature
CC       dendritic cells and inhibits cytokine production by mature
CC       dendritic cells. Interaction with SIRPG mediates cell-cell
CC       adhesion, enhances superantigen-dependent T-cell-mediated
CC       proliferation and costimulates T-cell activation. May play a role
CC       in membrane transport and/or integrin dependent signal
CC       transduction. May prevent premature elimination of red blood
CC       cells. May be involved in membrane permeability changes induced
CC       following virus infection. {ECO:0000250,
CC       ECO:0000269|PubMed:11509594, ECO:0000269|PubMed:15383453,
CC       ECO:0000269|PubMed:7691831}.
CC   -!- SUBUNIT: Interacts with THBS1 and fibrinogen (By similarity).
CC       Monomer. Interacts with SIRPA, SIRPG, UBQLN1 and UBQLN2.
CC       {ECO:0000250, ECO:0000269|PubMed:10549293,
CC       ECO:0000269|PubMed:11509594, ECO:0000269|PubMed:15383453,
CC       ECO:0000269|PubMed:18657508}.
CC   -!- INTERACTION:
CC       Q9P1W8:SIRPG; NbExp=2; IntAct=EBI-1268321, EBI-1268284;
CC       Q8N205:SYNE4; NbExp=3; IntAct=EBI-1268321, EBI-7131783;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:7691831};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:7691831}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=OA3-323;
CC         IsoId=Q08722-1; Sequence=Displayed;
CC       Name=OA3-293;
CC         IsoId=Q08722-2; Sequence=VSP_002535;
CC       Name=OA3-305;
CC         IsoId=Q08722-3; Sequence=VSP_002536, VSP_002537;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC       Name=OA3-312;
CC         IsoId=Q08722-4; Sequence=VSP_002538;
CC   -!- TISSUE SPECIFICITY: Very broadly distributed on normal adult
CC       tissues, as well as ovarian tumors, being especially abundant in
CC       some epithelia and the brain.
CC   -!- SIMILARITY: Contains 1 Ig-like V-type (immunoglobulin-like)
CC       domain. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X69398; CAA49196.1; -; mRNA.
DR   EMBL; Z25521; CAA80977.1; -; mRNA.
DR   EMBL; BT006907; AAP35553.1; -; mRNA.
DR   EMBL; AK289813; BAF82502.1; -; mRNA.
DR   EMBL; CH471052; EAW79733.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79734.1; -; Genomic_DNA.
DR   EMBL; BC010016; AAH10016.1; -; mRNA.
DR   EMBL; BC012884; AAH12884.1; -; mRNA.
DR   EMBL; BC037306; AAH37306.1; -; mRNA.
DR   CCDS; CCDS43125.1; -. [Q08722-3]
DR   CCDS; CCDS43126.1; -. [Q08722-1]
DR   PIR; A48997; A48997.
DR   RefSeq; NP_001768.1; NM_001777.3. [Q08722-1]
DR   RefSeq; NP_942088.1; NM_198793.2. [Q08722-3]
DR   UniGene; Hs.446414; -.
DR   PDB; 2JJS; X-ray; 1.85 A; C/D=20-136.
DR   PDB; 2JJT; X-ray; 2.30 A; C/D=20-136.
DR   PDB; 2VSC; X-ray; 1.90 A; A/B/C/D=20-136.
DR   PDB; 4CMM; X-ray; 1.92 A; B=20-136.
DR   PDB; 4KJY; X-ray; 1.93 A; A/C=19-135.
DR   PDB; 5IWL; X-ray; 2.80 A; C/D=20-132.
DR   PDBsum; 2JJS; -.
DR   PDBsum; 2JJT; -.
DR   PDBsum; 2VSC; -.
DR   PDBsum; 4CMM; -.
DR   PDBsum; 4KJY; -.
DR   PDBsum; 5IWL; -.
DR   ProteinModelPortal; Q08722; -.
DR   SMR; Q08722; -.
DR   BioGrid; 107399; 19.
DR   DIP; DIP-39948N; -.
DR   IntAct; Q08722; 4.
DR   STRING; 9606.ENSP00000355361; -.
DR   iPTMnet; Q08722; -.
DR   PhosphoSitePlus; Q08722; -.
DR   SwissPalm; Q08722; -.
DR   BioMuta; CD47; -.
DR   DMDM; 1171879; -.
DR   EPD; Q08722; -.
DR   MaxQB; Q08722; -.
DR   PaxDb; Q08722; -.
DR   PeptideAtlas; Q08722; -.
DR   PRIDE; Q08722; -.
DR   DNASU; 961; -.
DR   Ensembl; ENST00000355354; ENSP00000347512; ENSG00000196776. [Q08722-3]
DR   Ensembl; ENST00000361309; ENSP00000355361; ENSG00000196776. [Q08722-1]
DR   GeneID; 961; -.
DR   KEGG; hsa:961; -.
DR   UCSC; uc003dwt.2; human. [Q08722-1]
DR   CTD; 961; -.
DR   DisGeNET; 961; -.
DR   GeneCards; CD47; -.
DR   HGNC; HGNC:1682; CD47.
DR   HPA; CAB016055; -.
DR   HPA; HPA044659; -.
DR   MIM; 601028; gene.
DR   neXtProt; NX_Q08722; -.
DR   OpenTargets; ENSG00000196776; -.
DR   PharmGKB; PA26222; -.
DR   eggNOG; ENOG410IJTS; Eukaryota.
DR   eggNOG; ENOG41113GI; LUCA.
DR   GeneTree; ENSGT00390000007697; -.
DR   HOGENOM; HOG000013020; -.
DR   HOVERGEN; HBG003808; -.
DR   InParanoid; Q08722; -.
DR   KO; K06266; -.
DR   OMA; VYMKFVA; -.
DR   OrthoDB; EOG091G0HUR; -.
DR   PhylomeDB; Q08722; -.
DR   TreeFam; TF336026; -.
DR   Reactome; R-HSA-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-HSA-216083; Integrin cell surface interactions.
DR   Reactome; R-HSA-391160; Signal regulatory protein (SIRP) family interactions.
DR   SIGNOR; Q08722; -.
DR   ChiTaRS; CD47; human.
DR   EvolutionaryTrace; Q08722; -.
DR   GeneWiki; CD47; -.
DR   GenomeRNAi; 961; -.
DR   PRO; PR:Q08722; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000196776; -.
DR   CleanEx; HS_CD47; -.
DR   ExpressionAtlas; Q08722; baseline and differential.
DR   Genevisible; Q08722; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0070053; F:thrombospondin receptor activity; IPI:BHF-UCL.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0030198; P:extracellular matrix organization; TAS:Reactome.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; TAS:ProtInc.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0008228; P:opsonization; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IDA:UniProtKB.
DR   GO; GO:0022409; P:positive regulation of cell-cell adhesion; IDA:UniProtKB.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; IEA:Ensembl.
DR   GO; GO:0050766; P:positive regulation of phagocytosis; IEA:Ensembl.
DR   GO; GO:0050870; P:positive regulation of T cell activation; IDA:UniProtKB.
DR   GO; GO:0009617; P:response to bacterium; IEA:Ensembl.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR006704; CD47.
DR   InterPro; IPR013147; CD47_TM.
DR   InterPro; IPR013270; CD47_Vset.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   PANTHER; PTHR10613; PTHR10613; 1.
DR   Pfam; PF04549; CD47; 1.
DR   Pfam; PF08204; V-set_CD47; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Cell membrane;
KW   Complete proteome; Direct protein sequencing; Disulfide bond;
KW   Glycoprotein; Immunoglobulin domain; Membrane; Phosphoprotein;
KW   Pyrrolidone carboxylic acid; Reference proteome; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   CHAIN        19    323       Leukocyte surface antigen CD47.
FT                                /FTId=PRO_0000014880.
FT   TOPO_DOM     19    141       Extracellular. {ECO:0000255}.
FT   TRANSMEM    142    162       Helical. {ECO:0000255}.
FT   TOPO_DOM    163    176       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    177    197       Helical. {ECO:0000255}.
FT   TOPO_DOM    198    207       Extracellular. {ECO:0000255}.
FT   TRANSMEM    208    228       Helical. {ECO:0000255}.
FT   TOPO_DOM    229    235       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    236    256       Helical. {ECO:0000255}.
FT   TOPO_DOM    257    268       Extracellular. {ECO:0000255}.
FT   TRANSMEM    269    289       Helical. {ECO:0000255}.
FT   TOPO_DOM    290    323       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       19    127       Ig-like V-type.
FT   MOD_RES      19     19       Pyrrolidone carboxylic acid.
FT                                {ECO:0000269|PubMed:18657508}.
FT   MOD_RES      89     89       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P97829}.
FT   CARBOHYD     23     23       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:18657508}.
FT   CARBOHYD     34     34       N-linked (GlcNAc...).
FT   CARBOHYD     50     50       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:18657508,
FT                                ECO:0000269|PubMed:19349973}.
FT   CARBOHYD     73     73       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:18657508,
FT                                ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19349973}.
FT   CARBOHYD    111    111       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:18657508,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    206    206       N-linked (GlcNAc...). {ECO:0000255}.
FT   DISULFID     33    263       {ECO:0000269|PubMed:11454874}.
FT   DISULFID     41    114       {ECO:0000269|PubMed:18657508}.
FT   VAR_SEQ     293    323       Missing (in isoform OA3-293).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_002535.
FT   VAR_SEQ     304    305       KA -> NN (in isoform OA3-305).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:7691831,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_002536.
FT   VAR_SEQ     306    323       Missing (in isoform OA3-305).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:7691831,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_002537.
FT   VAR_SEQ     312    323       Missing (in isoform OA3-312).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_002538.
FT   STRAND       26     30       {ECO:0000244|PDB:2JJS}.
FT   STRAND       35     39       {ECO:0000244|PDB:2JJS}.
FT   STRAND       42     45       {ECO:0000244|PDB:2JJS}.
FT   HELIX        51     53       {ECO:0000244|PDB:2JJS}.
FT   STRAND       54     60       {ECO:0000244|PDB:2JJS}.
FT   STRAND       63     69       {ECO:0000244|PDB:2JJS}.
FT   HELIX        70     72       {ECO:0000244|PDB:2JJS}.
FT   STRAND       74     76       {ECO:0000244|PDB:2JJS}.
FT   HELIX        79     81       {ECO:0000244|PDB:2JJS}.
FT   HELIX        88     93       {ECO:0000244|PDB:2JJS}.
FT   STRAND       98    101       {ECO:0000244|PDB:2JJS}.
FT   HELIX       102    106       {ECO:0000244|PDB:2JJS}.
FT   STRAND      110    118       {ECO:0000244|PDB:2JJS}.
FT   STRAND      121    131       {ECO:0000244|PDB:2JJS}.
SQ   SEQUENCE   323 AA;  35214 MW;  5D20730A2632D550 CRC64;
     MWPLVAALLL GSACCGSAQL LFNKTKSVEF TFCNDTVVIP CFVTNMEAQN TTEVYVKWKF
     KGRDIYTFDG ALNKSTVPTD FSSAKIEVSQ LLKGDASLKM DKSDAVSHTG NYTCEVTELT
     REGETIIELK YRVVSWFSPN ENILIVIFPI FAILLFWGQF GIKTLKYRSG GMDEKTIALL
     VAGLVITVIV IVGAILFVPG EYSLKNATGL GLIVTSTGIL ILLHYYVFST AIGLTSFVIA
     ILVIQVIAYI LAVVGLSLCI AACIPMHGPL LISGLSILAL AQLLGLVYMK FVASNQKTIQ
     PPRKAVEEPL NAFKESKGMM NDE
//
ID   A0A0D9SEN1_HUMAN        Unreviewed;       759 AA.
AC   A0A0D9SEN1;
DT   27-MAY-2015, integrated into UniProtKB/TrEMBL.
DT   27-MAY-2015, sequence version 1.
DT   02-NOV-2016, entry version 10.
DE   SubName: Full=Prolyl endopeptidase FAP {ECO:0000313|Ensembl:ENSP00000485844};
GN   Name=FAP {ECO:0000313|Ensembl:ENSP00000485844};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000485844, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000485844, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|Ensembl:ENSP00000485844}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (APR-2015) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000485844}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC007750; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   PeptideAtlas; A0A0D9SEN1; -.
DR   Ensembl; ENST00000627638; ENSP00000485844; ENSG00000078098.
DR   HGNC; HGNC:3590; FAP.
DR   OpenTargets; ENSG00000078098; -.
DR   GeneTree; ENSGT00760000119233; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   ExpressionAtlas; A0A0D9SEN1; baseline and differential.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro.
DR   Gene3D; 2.140.10.30; -; 1.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR031245; FAP/Dpf2.
DR   InterPro; IPR002471; Pept_S9_AS.
DR   InterPro; IPR001375; Peptidase_S9.
DR   InterPro; IPR002469; Peptidase_S9B_N.
DR   PANTHER; PTHR11731:SF136; PTHR11731:SF136; 1.
DR   Pfam; PF00930; DPPIV_N; 1.
DR   Pfam; PF00326; Peptidase_S9; 1.
DR   SUPFAM; SSF53474; SSF53474; 1.
DR   PROSITE; PS00708; PRO_ENDOPEP_SER; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:A0A0D9SEN1};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN      105    471       DPPIV_N. {ECO:0000259|Pfam:PF00930}.
FT   DOMAIN      554    756       Peptidase_S9. {ECO:0000259|Pfam:PF00326}.
SQ   SEQUENCE   759 AA;  87584 MW;  338E4E06CA6EA134 CRC64;
     MTWVKIVFGV ATSAVLALLV MCIVLRPSRV HNSEENTMRA LTLKDILNGT FSYKTFFPNW
     ISGQEYLHQS ADNNIVLYNI ETGQSYTILS NRTMKSVNAS NYGLSPDRQF VYLESDYSKL
     WRYSYTATYY IYDLSNGEFV RGNELPRPIQ YLCWSPVGSK LAYVYQNNIY LKQRPGDPPF
     QITFNGRENK IFNGIPDWVY EEEMLATKYA LWWSPNGKFL AYAEFNDTDI PVIAYSYYGD
     EQYPRTINIP YPKAGAKNPV VRIFIIDTTY PAYVGPQEVP VPAMIASSDY YFSWLTWVTD
     ERVCLQWLKR VQNVSVLSIC DFREDWQTWD CPKTQEHIEE SRTGWAGGFF VSTPVFSYDA
     ISYYKIFSDK DGYKHIHYIK DTVENAIQIT SGKWEAINIF RVTQDSLFYS SNEFEEYPGR
     RNIYRISIGS YPPSKKCVTC HLRKERCQYY TASFSDYAKY YALVCYGPGI PISTLHDGRT
     DQEIKILEEN KELENALKNI QLPKEEIKKL EVDEITLWYK MILPPQFDRS KKYPLLIQVY
     GGPCSQSVRS VFAVNWISYL ASKEGMVIAL VDGRGTAFQG DKLLYAVYRK LGVYEVEDQI
     TAVRKFIEMG FIDEKRIAIW GWSYGGYVSS LALASGTGLF KCGIAVAPVS SWEYYASVYT
     ERFMGLPTKD DNLEHYKNST VMARAEYFRN VDYLLIHGTA DDNVHFQNSA QIAKALVNAQ
     VDFQAMWYSD QNHGLSGLST NHLYTHMTHF LKQCFSLSD
//
ID   B4DLR2_HUMAN            Unreviewed;       735 AA.
AC   B4DLR2;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   02-NOV-2016, entry version 63.
DE   SubName: Full=Prolyl endopeptidase FAP {ECO:0000313|Ensembl:ENSP00000411391};
DE   SubName: Full=cDNA FLJ60298, highly similar to Seprase (EC 3.4.21.-) {ECO:0000313|EMBL:BAG59624.1};
GN   Name=FAP {ECO:0000313|Ensembl:ENSP00000411391};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG59624.1};
RN   [1] {ECO:0000313|Ensembl:ENSP00000411391, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|EMBL:BAG59624.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K.,
RA   Sugiyama A., Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y.,
RA   Kumagai A., Oishi Y., Yamamoto S., Ono Y., Komori Y., Yamazaki M.,
RA   Kisu Y., Nishikawa T., Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|Ensembl:ENSP00000411391}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC007750; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK297118; BAG59624.1; -; mRNA.
DR   RefSeq; NP_001278736.1; NM_001291807.1.
DR   UniGene; Hs.654370; -.
DR   ProteinModelPortal; B4DLR2; -.
DR   STRING; 9606.ENSP00000188790; -.
DR   ESTHER; human-FAP; DPP4N_Peptidase_S9.
DR   PeptideAtlas; B4DLR2; -.
DR   PRIDE; B4DLR2; -.
DR   Ensembl; ENST00000443424; ENSP00000411391; ENSG00000078098.
DR   GeneID; 2191; -.
DR   UCSC; uc010zct.3; human.
DR   CTD; 2191; -.
DR   HGNC; HGNC:3590; FAP.
DR   OpenTargets; ENSG00000078098; -.
DR   eggNOG; KOG2100; Eukaryota.
DR   eggNOG; COG1506; LUCA.
DR   GeneTree; ENSGT00760000119233; -.
DR   HOGENOM; HOG000231875; -.
DR   HOVERGEN; HBG005527; -.
DR   ChiTaRS; FAP; human.
DR   GenomeRNAi; 2191; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000078098; -.
DR   ExpressionAtlas; B4DLR2; baseline and differential.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro.
DR   Gene3D; 2.140.10.30; -; 1.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR031245; FAP/Dpf2.
DR   InterPro; IPR002471; Pept_S9_AS.
DR   InterPro; IPR001375; Peptidase_S9.
DR   InterPro; IPR002469; Peptidase_S9B_N.
DR   PANTHER; PTHR11731:SF136; PTHR11731:SF136; 1.
DR   Pfam; PF00930; DPPIV_N; 1.
DR   Pfam; PF00326; Peptidase_S9; 1.
DR   SUPFAM; SSF53474; SSF53474; 1.
DR   PROSITE; PS00708; PRO_ENDOPEP_SER; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:B4DLR2};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN       86    447       DPPIV_N. {ECO:0000259|Pfam:PF00930}.
FT   DOMAIN      530    732       Peptidase_S9. {ECO:0000259|Pfam:PF00326}.
SQ   SEQUENCE   735 AA;  84862 MW;  A6ABE4083721544D CRC64;
     MKTWVKIVFG VATSAVLALL VMCIVLRPSR VHNSEENTMR ALTLKDILNG TFSYKTFFPN
     WISGQEYLHQ SADNNIVLYN IETGQSYTIL SNRTMLWRYS YTATYYIYDL SNGEFVRGNE
     LPRPIQYLCW SPVGSKLAYV YQNNIYLKQR PGDPPFQITF NGRENKIFNG IPDWVYEEEM
     LATKYALWWS PNGKFLAYAE FNDTDIPVIA YSYYGDEQYP RTINIPYPKA GAKNPVVRIF
     IIDTTYPAYV GPQEVPVPAM IASSDYYFSW LTWVTDERVC LQWLKRVQNV SVLSICDFRE
     DWQTWDCPKT QEHIEESRTG WAGGFFVSTP VFSYDAISYY KIFSDKDGYK HIHYIKDTVE
     NAIQITSGKW EAINIFRVTQ DSLFYSSNEF EEYPGRRNIY RISIGSYPPS KKCVTCHLRK
     ERCQYYTASF SDYAKYYALV CYGPGIPIST LHDGRTDQEI KILEENKELE NALKNIQLPK
     EEIKKLEVDE ITLWYKMILP PQFDRSKKYP LLIQVYGGPC SQSVRSVFAV NWISYLASKE
     GMVIALVDGR GTAFQGDKLL YAVYRKLGVY EVEDQITAVR KFIEMGFIDE KRIAIWGWSY
     GGYVSSLALA SGTGLFKCGI AVAPVSSWEY YASVYTERFM GLPTKDDNLE HYKNSTVMAR
     AEYFRNVDYL LIHGTADDNV HFQNSAQIAK ALVNAQVDFQ AMWYSDQNHG LSGLSTNHLY
     THMTHFLKQC FSLSD
//
ID   C9J131_HUMAN            Unreviewed;       155 AA.
AC   C9J131;
DT   03-NOV-2009, integrated into UniProtKB/TrEMBL.
DT   03-NOV-2009, sequence version 1.
DT   02-NOV-2016, entry version 48.
DE   SubName: Full=Prolyl endopeptidase FAP {ECO:0000313|Ensembl:ENSP00000400137};
DE   Flags: Fragment;
GN   Name=FAP {ECO:0000313|Ensembl:ENSP00000400137};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000400137, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000400137, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|Ensembl:ENSP00000400137}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000400137}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC007750; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; C9J131; -.
DR   STRING; 9606.ENSP00000188790; -.
DR   PaxDb; C9J131; -.
DR   PeptideAtlas; C9J131; -.
DR   PRIDE; C9J131; -.
DR   Ensembl; ENST00000447386; ENSP00000400137; ENSG00000078098.
DR   UCSC; uc061pau.1; human.
DR   HGNC; HGNC:3590; FAP.
DR   OpenTargets; ENSG00000078098; -.
DR   eggNOG; KOG2100; Eukaryota.
DR   eggNOG; COG1506; LUCA.
DR   GeneTree; ENSGT00760000119233; -.
DR   HOGENOM; HOG000213767; -.
DR   ChiTaRS; FAP; human.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000078098; -.
DR   ExpressionAtlas; C9J131; baseline and differential.
DR   GO; GO:0008233; F:peptidase activity; IEA:InterPro.
DR   Gene3D; 2.140.10.30; -; 1.
DR   InterPro; IPR031245; FAP/Dpf2.
DR   InterPro; IPR002469; Peptidase_S9B_N.
DR   PANTHER; PTHR11731:SF136; PTHR11731:SF136; 1.
DR   Pfam; PF00930; DPPIV_N; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:C9J131};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN       85    153       DPPIV_N. {ECO:0000259|Pfam:PF00930}.
FT   NON_TER     155    155       {ECO:0000313|Ensembl:ENSP00000400137}.
SQ   SEQUENCE   155 AA;  18193 MW;  3EB00D2EE955D161 CRC64;
     MCIVLRPSRV HNSEENTMRA LTLKDILNGT FSYKTFFPNW ISGQEYLHQS ADNNIVLYNI
     ETGQSYTILS NRTMKSVNAS NYGLSPDRQF VYLESDYSKL WRYSYTATYY IYDLSNGEFV
     RGNELPRPIQ YLCWSPVGSK LAYVYQNNIY LKQRP
//
ID   F8WF29_HUMAN            Unreviewed;       121 AA.
AC   F8WF29;
DT   21-SEP-2011, integrated into UniProtKB/TrEMBL.
DT   21-SEP-2011, sequence version 1.
DT   02-NOV-2016, entry version 35.
DE   SubName: Full=Prolyl endopeptidase FAP {ECO:0000313|Ensembl:ENSP00000407404};
GN   Name=FAP {ECO:0000313|Ensembl:ENSP00000407404};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000407404, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000407404, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|Ensembl:ENSP00000407404}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000407404}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC007750; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; F8WF29; -.
DR   STRING; 9606.ENSP00000188790; -.
DR   PaxDb; F8WF29; -.
DR   PeptideAtlas; F8WF29; -.
DR   Ensembl; ENST00000450031; ENSP00000407404; ENSG00000078098.
DR   UCSC; uc061pav.1; human.
DR   HGNC; HGNC:3590; FAP.
DR   OpenTargets; ENSG00000078098; -.
DR   eggNOG; KOG2100; Eukaryota.
DR   eggNOG; COG1506; LUCA.
DR   GeneTree; ENSGT00760000119233; -.
DR   ChiTaRS; FAP; human.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000078098; -.
DR   ExpressionAtlas; F8WF29; baseline and differential.
DR   GO; GO:0008233; F:peptidase activity; IEA:InterPro.
DR   Gene3D; 2.140.10.30; -; 1.
DR   InterPro; IPR031245; FAP/Dpf2.
DR   InterPro; IPR002469; Peptidase_S9B_N.
DR   PANTHER; PTHR11731:SF136; PTHR11731:SF136; 1.
DR   Pfam; PF00930; DPPIV_N; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:F8WF29};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN       85    118       DPPIV_N. {ECO:0000259|Pfam:PF00930}.
SQ   SEQUENCE   121 AA;  14225 MW;  8915BFCEC62056C9 CRC64;
     MCIVLRPSRV HNSEENTMRA LTLKDILNGT FSYKTFFPNW ISGQEYLHQS ADNNIVLYNI
     ETGQSYTILS NRTMKSVNAS NYGLSPDRQF VYLESDYSKL WRYSYTATYY IYDLSNGKWQ
     L
//
ID   H0YG61_HUMAN            Unreviewed;        47 AA.
AC   H0YG61;
DT   22-FEB-2012, integrated into UniProtKB/TrEMBL.
DT   22-FEB-2012, sequence version 1.
DT   02-NOV-2016, entry version 28.
DE   SubName: Full=Prolyl endopeptidase FAP {ECO:0000313|Ensembl:ENSP00000441940};
DE   Flags: Fragment;
GN   Name=FAP {ECO:0000313|Ensembl:ENSP00000441940};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000441940, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000441940, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|Ensembl:ENSP00000441940}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2012) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000441940}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC007750; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; H0YG61; -.
DR   STRING; 9606.ENSP00000188790; -.
DR   PaxDb; H0YG61; -.
DR   PeptideAtlas; H0YG61; -.
DR   PRIDE; H0YG61; -.
DR   Ensembl; ENST00000462608; ENSP00000441940; ENSG00000078098.
DR   UCSC; uc061pal.1; human.
DR   HGNC; HGNC:3590; FAP.
DR   OpenTargets; ENSG00000078098; -.
DR   eggNOG; KOG2100; Eukaryota.
DR   eggNOG; COG1506; LUCA.
DR   GeneTree; ENSGT00760000119233; -.
DR   ChiTaRS; FAP; human.
DR   Proteomes; UP000005640; Chromosome 2.
DR   ExpressionAtlas; H0YG61; baseline and differential.
DR   GO; GO:0008236; F:serine-type peptidase activity; IEA:InterPro.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR031245; FAP/Dpf2.
DR   InterPro; IPR001375; Peptidase_S9.
DR   PANTHER; PTHR11731:SF136; PTHR11731:SF136; 1.
DR   Pfam; PF00326; Peptidase_S9; 1.
DR   SUPFAM; SSF53474; SSF53474; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:H0YG61};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN        2     47       Peptidase_S9. {ECO:0000259|Pfam:PF00326}.
FT   NON_TER       1      1       {ECO:0000313|Ensembl:ENSP00000441940}.
SQ   SEQUENCE   47 AA;  5493 MW;  4C836841AF7610D3 CRC64;
     XYTERFMGLP TKDDNLEHYK NSTVMARAEY FRNVDYLLIH GTADGEV
//
ID   H7C4D9_HUMAN            Unreviewed;        25 AA.
AC   H7C4D9;
DT   18-APR-2012, integrated into UniProtKB/TrEMBL.
DT   18-APR-2012, sequence version 1.
DT   02-NOV-2016, entry version 24.
DE   SubName: Full=Prolyl endopeptidase FAP {ECO:0000313|Ensembl:ENSP00000417028};
DE   Flags: Fragment;
GN   Name=FAP {ECO:0000313|Ensembl:ENSP00000417028};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000417028, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000417028, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000313|Ensembl:ENSP00000417028}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000417028}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC007750; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   STRING; 9606.ENSP00000188790; -.
DR   PaxDb; H7C4D9; -.
DR   PeptideAtlas; H7C4D9; -.
DR   Ensembl; ENST00000422436; ENSP00000417028; ENSG00000078098.
DR   UCSC; uc061pam.1; human.
DR   HGNC; HGNC:3590; FAP.
DR   OpenTargets; ENSG00000078098; -.
DR   eggNOG; KOG2100; Eukaryota.
DR   eggNOG; COG1506; LUCA.
DR   GeneTree; ENSGT00760000119233; -.
DR   ChiTaRS; FAP; human.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000078098; -.
DR   ExpressionAtlas; H7C4D9; baseline and differential.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:H7C4D9};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   NON_TER       1      1       {ECO:0000313|Ensembl:ENSP00000417028}.
SQ   SEQUENCE   25 AA;  3022 MW;  406775DA7AE10D6E CRC64;
     KERCQYYTAS FSDYAKYYAL VCYGE
//
ID   SEPR_HUMAN              Reviewed;         760 AA.
AC   Q12884; O00199; Q53TP5; Q86Z29; Q99998; Q9UID4;
DT   05-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   23-MAR-2010, sequence version 5.
DT   02-NOV-2016, entry version 166.
DE   RecName: Full=Prolyl endopeptidase FAP {ECO:0000305};
DE            EC=3.4.21.26 {ECO:0000269|PubMed:16223769};
DE   AltName: Full=170 kDa melanoma membrane-bound gelatinase {ECO:0000303|PubMed:2172980, ECO:0000303|PubMed:9065413};
DE   AltName: Full=Dipeptidyl peptidase FAP {ECO:0000305};
DE            EC=3.4.14.5 {ECO:0000269|PubMed:10347120};
DE   AltName: Full=Fibroblast activation protein alpha {ECO:0000303|PubMed:7911242};
DE            Short=FAPalpha {ECO:0000250|UniProtKB:P97321};
DE   AltName: Full=Gelatine degradation protease FAP {ECO:0000305};
DE            EC=3.4.21.- {ECO:0000269|PubMed:9065413};
DE   AltName: Full=Integral membrane serine protease {ECO:0000303|PubMed:9247085};
DE   AltName: Full=Post-proline cleaving enzyme {ECO:0000305};
DE   AltName: Full=Serine integral membrane protease {ECO:0000303|PubMed:9247085};
DE            Short=SIMP {ECO:0000303|PubMed:9247085};
DE   AltName: Full=Surface-expressed protease {ECO:0000303|PubMed:2172980};
DE            Short=Seprase {ECO:0000303|PubMed:7923219};
DE   Contains:
DE     RecName: Full=Antiplasmin-cleaving enzyme FAP, soluble form {ECO:0000303|PubMed:14751930};
DE              Short=APCE {ECO:0000303|PubMed:14751930};
DE              EC=3.4.14.5 {ECO:0000269|PubMed:14751930, ECO:0000269|PubMed:16223769};
DE              EC=3.4.21.- {ECO:0000269|PubMed:14751930, ECO:0000269|PubMed:16223769};
DE              EC=3.4.21.26 {ECO:0000269|PubMed:14751930, ECO:0000269|PubMed:16223769};
GN   Name=FAP {ECO:0000312|HGNC:HGNC:3590};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), GLYCOSYLATION, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Fibroblast;
RX   PubMed=7911242; DOI=10.1073/pnas.91.12.5657;
RA   Scanlan M.J., Raj B.K.M., Calvo B., Garin-Chesa P., Sanz-Moncasi M.P.,
RA   Healey J.H., Old L.J., Rettig W.J.;
RT   "Molecular cloning of fibroblast activation protein alpha, a member of
RT   the serine protease family selectively expressed in stromal
RT   fibroblasts of epithelial cancers.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:5657-5661(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Melanoma;
RX   PubMed=9247085; DOI=10.1016/S0925-4439(97)00032-X;
RA   Goldstein L.A., Ghersi G., Pineiro-Sanchez M.L., Salamone M., Yeh Y.,
RA   Flessate D., Chen W.-T.;
RT   "Molecular cloning of seprase: a serine integral membrane protease
RT   from human melanoma.";
RL   Biochim. Biophys. Acta 1361:11-19(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 220-229;
RP   461-472 AND 511-518, FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL
RP   PROPERTIES, ENZYME REGULATION, SUBUNIT, GLYCOSYLATION, AND SUBCELLULAR
RP   LOCATION.
RC   TISSUE=Melanoma;
RX   PubMed=9065413; DOI=10.1074/jbc.272.12.7595;
RA   Pineiro-Sanchez M.L., Goldstein L.A., Dodt J., Howard L., Yeh Y.,
RA   Chen W.-T.;
RT   "Identification of the 170-kDa melanoma membrane-bound gelatinase
RT   (seprase) as a serine integral membrane protease.";
RL   J. Biol. Chem. 272:7595-7601(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), SUBCELLULAR LOCATION,
RP   AND TISSUE SPECIFICITY.
RC   TISSUE=Melanoma;
RX   PubMed=10644713; DOI=10.1074/jbc.275.4.2554;
RA   Goldstein L.A., Chen W.-T.;
RT   "Identification of an alternatively spliced seprase mRNA that encodes
RT   a novel intracellular isoform.";
RL   J. Biol. Chem. 275:2554-2559(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 24-38; 210-219; 247-254; 487-499; 500-509 AND
RP   522-530, FUNCTION (SOLUBLE FORM), CATALYTIC ACTIVITY, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=14751930; DOI=10.1182/blood-2003-12-4240;
RA   Lee K.N., Jackson K.W., Christiansen V.J., Chung K.H., McKee P.A.;
RT   "A novel plasma proteinase potentiates alpha2-antiplasmin inhibition
RT   of fibrin digestion.";
RL   Blood 103:3783-3788(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 192-208; 220-240 AND 510-521, AND INDUCTION.
RX   PubMed=7519584; DOI=10.1002/ijc.2910580314;
RA   Rettig W.J., Su S.L., Fortunato S.R., Scanlan M.J., Raj B.K.M.,
RA   Garin-Chesa P., Healey J.H., Old L.J.;
RT   "Fibroblast activation protein: purification, epitope mapping and
RT   induction by growth factors.";
RL   Int. J. Cancer 58:385-392(1994).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, CATALYTIC ACTIVITY, ENZYME REGULATION,
RP   AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=2172980; DOI=10.1073/pnas.87.21.8296;
RA   Aoyama A., Chen W.T.;
RT   "A 170-kDa membrane-bound protease is associated with the expression
RT   of invasiveness by human malignant melanoma cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:8296-8300(1990).
RN   [11]
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=7923219;
RA   Monsky W.L., Lin C.Y., Aoyama A., Kelly T., Akiyama S.K.,
RA   Mueller S.C., Chen W.T.;
RT   "A potential marker protease of invasiveness, seprase, is localized on
RT   invadopodia of human malignant melanoma cells.";
RL   Cancer Res. 54:5702-5710(1994).
RN   [12]
RP   FUNCTION, CATALYTIC ACTIVITY, AND TISSUE SPECIFICITY.
RX   PubMed=10347120; DOI=10.1002/hep.510290631;
RA   Levy M.T., McCaughan G.W., Abbott C.A., Park J.E., Cunningham A.M.,
RA   Mueller E., Rettig W.J., Gorrell M.D.;
RT   "Fibroblast activation protein: a cell surface dipeptidyl peptidase
RT   and gelatinase expressed by stellate cells at the tissue remodelling
RT   interface in human cirrhosis.";
RL   Hepatology 29:1768-1778(1999).
RN   [13]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, ENZYME
RP   REGULATION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND MUTAGENESIS
RP   OF SER-624.
RX   PubMed=10593948; DOI=10.1074/jbc.274.51.36505;
RA   Park J.E., Lenter M.C., Zimmermann R.N., Garin-Chesa P., Old L.J.,
RA   Rettig W.J.;
RT   "Fibroblast activation protein, a dual specificity serine protease
RT   expressed in reactive human tumor stromal fibroblasts.";
RL   J. Biol. Chem. 274:36505-36512(1999).
RN   [14]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBUNIT, INTERACTION WITH ITGA3 AND
RP   ITGB1, ASSOCIATION WITH INTEGRIN ALPHA-3/BETA-1, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=10455171; DOI=10.1074/jbc.274.35.24947;
RA   Mueller S.C., Ghersi G., Akiyama S.K., Sang Q.X., Howard L.,
RA   Pineiro-Sanchez M., Nakahara H., Yeh Y., Chen W.T.;
RT   "A novel protease-docking function of integrin at invadopodia.";
RL   J. Biol. Chem. 274:24947-24952(1999).
RN   [15]
RP   FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH PLAUR, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=12376466; DOI=10.1093/carcin/23.10.1593;
RA   Artym V.V., Kindzelskii A.L., Chen W.T., Petty H.R.;
RT   "Molecular proximity of seprase and the urokinase-type plasminogen
RT   activator receptor on malignant melanoma cell membranes: dependence on
RT   beta1 integrins and the cytoskeleton.";
RL   Carcinogenesis 23:1593-1601(2002).
RN   [16]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND MUTAGENESIS OF GLU-203; GLU-204 AND SER-624.
RX   PubMed=16175601; DOI=10.1002/hep.20853;
RA   Wang X.M., Yu D.M., McCaughan G.W., Gorrell M.D.;
RT   "Fibroblast activation protein increases apoptosis, cell adhesion, and
RT   migration by the LX-2 human stellate cell line.";
RL   Hepatology 42:935-945(2005).
RN   [17]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-99 AND ASN-227.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [18]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=17105646; DOI=10.1186/ar2080;
RA   Bauer S., Jendro M.C., Wadle A., Kleber S., Stenner F., Dinser R.,
RA   Reich A., Faccin E., Goedde S., Dinges H., Mueller-Ladner U.,
RA   Renner C.;
RT   "Fibroblast activation protein is expressed by rheumatoid
RT   myofibroblast-like synoviocytes.";
RL   Arthritis Res. Ther. 8:R171-R171(2006).
RN   [19]
RP   FUNCTION (PLASMA MEMBRANE AND SOLUBLE FORMS), CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=16223769; DOI=10.1182/blood-2005-08-3452;
RA   Lee K.N., Jackson K.W., Christiansen V.J., Lee C.S., Chun J.G.,
RA   McKee P.A.;
RT   "Antiplasmin-cleaving enzyme is a soluble form of fibroblast
RT   activation protein.";
RL   Blood 107:1397-1404(2006).
RN   [20]
RP   FUNCTION, CATALYTIC ACTIVITY, HETERODIMERIZATION WITH DPP4, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=16651416; DOI=10.1158/0008-5472.CAN-05-1245;
RA   Ghersi G., Zhao Q., Salamone M., Yeh Y., Zucker S., Chen W.T.;
RT   "The protease complex consisting of dipeptidyl peptidase IV and
RT   seprase plays a role in the migration and invasion of human
RT   endothelial cells in collagenous matrices.";
RL   Cancer Res. 66:4652-4661(2006).
RN   [21]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   ENZYME REGULATION.
RX   PubMed=16480718; DOI=10.1016/j.febslet.2006.01.087;
RA   Edosada C.Y., Quan C., Tran T., Pham V., Wiesmann C., Fairbrother W.,
RA   Wolf B.B.;
RT   "Peptide substrate profiling defines fibroblast activation protein as
RT   an endopeptidase of strict Gly(2)-Pro(1)-cleaving specificity.";
RL   FEBS Lett. 580:1581-1586(2006).
RN   [22]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, ENZYME
RP   REGULATION, AND SUBUNIT.
RX   PubMed=16410248; DOI=10.1074/jbc.M511112200;
RA   Edosada C.Y., Quan C., Wiesmann C., Tran T., Sutherlin D.,
RA   Reynolds M., Elliott J.M., Raab H., Fairbrother W., Wolf B.B.;
RT   "Selective inhibition of fibroblast activation protein protease based
RT   on dipeptide substrate specificity.";
RL   J. Biol. Chem. 281:7437-7444(2006).
RN   [23]
RP   FUNCTION, MUTAGENESIS OF ARG-123; GLU-203; TYR-656; ALA-657 AND
RP   ASN-704, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND ENZYME
RP   REGULATION.
RX   PubMed=17381073; DOI=10.1021/bi062227y;
RA   Meadows S.A., Edosada C.Y., Mayeda M., Tran T., Quan C., Raab H.,
RA   Wiesmann C., Wolf B.B.;
RT   "Ala657 and conserved active site residues promote fibroblast
RT   activation protein endopeptidase activity via distinct mechanisms of
RT   transition state stabilization.";
RL   Biochemistry 46:4598-4605(2007).
RN   [24]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=18095711; DOI=10.1021/bi701921b;
RA   Aggarwal S., Brennen W.N., Kole T.P., Schneider E., Topaloglu O.,
RA   Yates M., Cotter R.J., Denmeade S.R.;
RT   "Fibroblast activation protein peptide substrates identified from
RT   human collagen I derived gelatin cleavage sites.";
RL   Biochemistry 47:1076-1086(2008).
RN   [25]
RP   REVIEW, AND FUNCTION.
RX   PubMed=18262497; DOI=10.1016/j.bbapap.2008.01.006;
RA   O'Brien P., O'Connor B.F.;
RT   "Seprase: an overview of an important matrix serine protease.";
RL   Biochim. Biophys. Acta 1784:1130-1145(2008).
RN   [26]
RP   FUNCTION, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=20707604; DOI=10.1515/BC.2010.119;
RA   Mentlein R., Hattermann K., Hemion C., Jungbluth A.A., Held-Feindt J.;
RT   "Expression and role of the cell surface protease seprase/fibroblast
RT   activation protein-alpha (FAP-alpha) in astroglial tumors.";
RL   Biol. Chem. 392:199-207(2011).
RN   [27]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=21314817; DOI=10.1111/j.1742-4658.2011.08051.x;
RA   Keane F.M., Nadvi N.A., Yao T.W., Gorrell M.D.;
RT   "Neuropeptide Y, B-type natriuretic peptide, substance P and peptide
RT   YY are novel substrates of fibroblast activation protein-alpha.";
RL   FEBS J. 278:1316-1332(2011).
RN   [28]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=21288888; DOI=10.1093/jb/mvr017;
RA   Huang C.H., Suen C.S., Lin C.T., Chien C.H., Lee H.Y., Chung K.M.,
RA   Tsai T.Y., Jiaang W.T., Hwang M.J., Chen X.;
RT   "Cleavage-site specificity of prolyl endopeptidase FAP investigated
RT   with a full-length protein substrate.";
RL   J. Biochem. 149:685-692(2011).
RN   [29]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND CHARACTERIZATION OF VARIANT LEU-363.
RX   PubMed=24371721; DOI=10.1016/j.fob.2013.12.001;
RA   Keane F.M., Yao T.W., Seelk S., Gall M.G., Chowdhury S.,
RA   Poplawski S.E., Lai J.H., Li Y., Wu W., Farrell P.,
RA   Vieira de Ribeiro A.J., Osborne B., Yu D.M., Seth D., Rahman K.,
RA   Haber P., Topaloglu A.K., Wang C., Thomson S., Hennessy A., Prins J.,
RA   Twigg S.M., McLennan S.V., McCaughan G.W., Bachovchin W.W.,
RA   Gorrell M.D.;
RT   "Quantitation of fibroblast activation protein (FAP)-specific protease
RT   activity in mouse, baboon and human fluids and organs.";
RL   FEBS Open Bio 4:43-54(2013).
RN   [30]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND
RP   CHARACTERIZATION OF VARIANT LEU-363.
RX   PubMed=24717288; DOI=10.1016/j.bbapap.2014.03.015;
RA   Osborne B., Yao T.W., Wang X.M., Chen Y., Kotan L.D., Nadvi N.A.,
RA   Herdem M., McCaughan G.W., Allen J.D., Yu D.M., Topaloglu A.K.,
RA   Gorrell M.D.;
RT   "A rare variant in human fibroblast activation protein associated with
RT   ER stress, loss of enzymatic function and loss of cell surface
RT   localisation.";
RL   Biochim. Biophys. Acta 1844:1248-1259(2014).
RN   [31]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 39-757, SUBSTRATE BINDING,
RP   SUBUNIT, DISULFIDE BONDS, ACTIVE SITE, AND GLYCOSYLATION AT ASN-49;
RP   ASN-92; ASN-227 AND ASN-314.
RX   PubMed=15809306; DOI=10.1074/jbc.C500092200;
RA   Aertgeerts K., Levin I., Shi L., Snell G.P., Jennings A., Prasad G.S.,
RA   Zhang Y., Kraus M.L., Salakian S., Sridhar V., Wijnands R.,
RA   Tennant M.G.;
RT   "Structural and kinetic analysis of the substrate specificity of human
RT   fibroblast activation protein alpha.";
RL   J. Biol. Chem. 280:19441-19444(2005).
CC   -!- FUNCTION: Cell surface glycoprotein serine protease that
CC       participates in extracellular matrix degradation and involved in
CC       many cellular processes including tissue remodeling, fibrosis,
CC       wound healing, inflammation and tumor growth. Both plasma membrane
CC       and soluble forms exhibit post-proline cleaving endopeptidase
CC       activity, with a marked preference for Ala/Ser-Gly-Pro-Ser/Asn/Ala
CC       consensus sequences, on substrate such as alpha-2-antiplasmin
CC       SERPINF2 and SPRY2 (PubMed:14751930, PubMed:16223769,
CC       PubMed:16480718, PubMed:16410248, PubMed:17381073,
CC       PubMed:18095711, PubMed:21288888, PubMed:24371721). Degrade also
CC       gelatin, heat-denatured type I collagen, but not native collagen
CC       type I and IV, vibronectin, tenascin, laminin, fibronectin, fibrin
CC       or casein (PubMed:9065413, PubMed:2172980, PubMed:7923219,
CC       PubMed:10347120, PubMed:10455171, PubMed:12376466,
CC       PubMed:16223769, PubMed:16651416, PubMed:18095711). Have also
CC       dipeptidyl peptidase activity, exhibiting the ability to hydrolyze
CC       the prolyl bond two residues from the N-terminus of synthetic
CC       dipeptide substrates provided that the penultimate residue is
CC       proline, with a preference for Ala-Pro, Ile-Pro, Gly-Pro, Arg-Pro
CC       and Pro-Pro (PubMed:10347120, PubMed:10593948, PubMed:16175601,
CC       PubMed:16223769, PubMed:16651416, PubMed:16410248,
CC       PubMed:17381073, PubMed:21314817, PubMed:24371721,
CC       PubMed:24717288). Natural neuropeptide hormones for dipeptidyl
CC       peptidase are the neuropeptide Y (NPY), peptide YY (PYY),
CC       substance P (TAC1) and brain natriuretic peptide 32 (NPPB)
CC       (PubMed:21314817). The plasma membrane form, in association with
CC       either DPP4, PLAUR or integrins, is involved in the pericellular
CC       proteolysis of the extracellular matrix (ECM), and hence promotes
CC       cell adhesion, migration and invasion through the ECM. Plays a
CC       role in tissue remodeling during development and wound healing.
CC       Participates in the cell invasiveness towards the ECM in malignant
CC       melanoma cancers. Enhances tumor growth progression by increasing
CC       angiogenesis, collagen fiber degradation and apoptosis and by
CC       reducing antitumor response of the immune system. Promotes glioma
CC       cell invasion through the brain parenchyma by degrading the
CC       proteoglycan brevican. Acts as a tumor suppressor in melanocytic
CC       cells through regulation of cell proliferation and survival in a
CC       serine protease activity-independent manner.
CC       {ECO:0000250|UniProtKB:P97321, ECO:0000269|PubMed:10347120,
CC       ECO:0000269|PubMed:10455171, ECO:0000269|PubMed:10593948,
CC       ECO:0000269|PubMed:12376466, ECO:0000269|PubMed:14751930,
CC       ECO:0000269|PubMed:16175601, ECO:0000269|PubMed:16223769,
CC       ECO:0000269|PubMed:16410248, ECO:0000269|PubMed:16480718,
CC       ECO:0000269|PubMed:16651416, ECO:0000269|PubMed:17105646,
CC       ECO:0000269|PubMed:17381073, ECO:0000269|PubMed:18095711,
CC       ECO:0000269|PubMed:20707604, ECO:0000269|PubMed:21288888,
CC       ECO:0000269|PubMed:21314817, ECO:0000269|PubMed:2172980,
CC       ECO:0000269|PubMed:24371721, ECO:0000269|PubMed:24717288,
CC       ECO:0000269|PubMed:7923219, ECO:0000269|PubMed:9065413}.
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of Pro-|-Xaa >> Ala-|-Xaa in
CC       oligopeptides. {ECO:0000269|PubMed:14751930,
CC       ECO:0000269|PubMed:16223769, ECO:0000269|PubMed:16410248,
CC       ECO:0000269|PubMed:17381073, ECO:0000269|PubMed:18095711,
CC       ECO:0000269|PubMed:21288888, ECO:0000269|PubMed:24371721}.
CC   -!- CATALYTIC ACTIVITY: Release of an N-terminal dipeptide, Xaa-Yaa-|-
CC       Zaa-, from a polypeptide, preferentially when Yaa is Pro, provided
CC       Zaa is neither Pro nor hydroxyproline. {ECO:0000255|PROSITE-
CC       ProRule:PRU10084, ECO:0000269|PubMed:10347120,
CC       ECO:0000269|PubMed:10593948, ECO:0000269|PubMed:16175601,
CC       ECO:0000269|PubMed:16223769, ECO:0000269|PubMed:16410248,
CC       ECO:0000269|PubMed:16651416, ECO:0000269|PubMed:17381073,
CC       ECO:0000269|PubMed:21314817, ECO:0000269|PubMed:24371721,
CC       ECO:0000269|PubMed:24717288}.
CC   -!- ENZYME REGULATION: Gelatinase activity is inhibited by serine-
CC       protease inhibitors, such as phenylmethylsulfonyl fluoride (PMSF),
CC       4-(2-aminoethyl)-benzenesulfonyl fluoride hydrochloride (AEBSF),
CC       4-amidino phenylsulfonyl fluoride (APSF) and diisopropyl
CC       fluorophosphate (DFP), N-ethylmaleimide (NEM) and
CC       phenylmethylsulfonyl fluoride (PMSF). Dipeptidyl peptidase
CC       activity is inhibited by 2,2'-azino-bis(3-ethylbenzthiazoline-6-
CC       sulfonic acid), diisopropylfluorophosphate (DFP). Prolyl
CC       endopeptidase activity is inhibited by the boronic acid peptide
CC       Ac-Gly-BoroPro, Ac-Gly-Pro-chloromethyl ketone and Thr-Ser-Gly-
CC       chloromethyl ketone. {ECO:0000269|PubMed:10593948,
CC       ECO:0000269|PubMed:16410248, ECO:0000269|PubMed:16480718,
CC       ECO:0000269|PubMed:17381073, ECO:0000269|PubMed:2172980,
CC       ECO:0000269|PubMed:9065413}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.46 mM for Ala-Pro (Dipeptidyl peptidase activity)
CC         {ECO:0000269|PubMed:10593948};
CC         KM=0.9 mM for Lys-Pro (Dipeptidyl peptidase activity)
CC         {ECO:0000269|PubMed:10593948};
CC         KM=1.15 mM for Gly-Pro (Dipeptidyl peptidase activity)
CC         {ECO:0000269|PubMed:10593948};
CC         KM=0.25 mM for Gly-Pro (Dipeptidyl peptidase activity)
CC         {ECO:0000269|PubMed:17381073};
CC         KM=0.24 mM for Ala-Pro (Dipeptidyl peptidase activity)
CC         {ECO:0000269|PubMed:16410248};
CC         KM=0.10 mM for Ile-Pro (Dipeptidyl peptidase activity)
CC         {ECO:0000269|PubMed:16410248};
CC         KM=0.24 mM for Phe-Pro (Dipeptidyl peptidase activity)
CC         {ECO:0000269|PubMed:16410248};
CC         KM=0.24 mM for Gly-Pro (Dipeptidyl peptidase activity)
CC         {ECO:0000269|PubMed:16410248};
CC         KM=0.33 mM for Ac-Gly-Pro (Prolyl endopeptidase activity)
CC         {ECO:0000269|PubMed:16410248, ECO:0000269|PubMed:17381073};
CC         KM=1.3 uM for Thr-Ser-Gly-Pro-Asn-Gln (Prolyl endopeptidase
CC         activity) {ECO:0000269|PubMed:16480718};
CC         KM=2.2 uM for Ala-Ser-Gly-Pro-Asn-Gln (Prolyl endopeptidase
CC         activity) {ECO:0000269|PubMed:16480718};
CC         KM=0.7 uM for Thr-Ala-Gly-Pro-Asn-Gln (Prolyl endopeptidase
CC         activity) {ECO:0000269|PubMed:16480718};
CC         KM=1.9 uM for Thr-Ser-Gly-Pro-Ser-Gln (Prolyl endopeptidase
CC         activity) {ECO:0000269|PubMed:16480718};
CC         KM=2.2 uM for Thr-Ser-Gly-Pro-Asn-Ser (Prolyl endopeptidase
CC         activity) {ECO:0000269|PubMed:16480718};
CC         KM=4.3 uM for Ala-Ser-Gly-Pro-Ser-Ser (Prolyl endopeptidase
CC         activity) {ECO:0000269|PubMed:16480718};
CC         KM=0.101 mM for Gly-Pro (FAP form, prolyl endopeptidase
CC         activity) {ECO:0000269|PubMed:16223769};
CC         KM=0.124 mM for Gly-Pro (Antiplasmin-cleaving enzyme FAP soluble
CC         form, prolyl endopeptidase activity)
CC         {ECO:0000269|PubMed:16223769};
CC         KM=0.323 mM for Gly-Pro (FAP form, dipeptidyl peptidase
CC         activity) {ECO:0000269|PubMed:16223769};
CC         KM=0.272 mM for Gly-Pro (Antiplasmin-cleaving enzyme FAP soluble
CC         form, dipeptidyl peptidase activity)
CC         {ECO:0000269|PubMed:16223769};
CC         KM=0.029 mM for Arg-Gly-Thr-Ser-Gly-Pro-Asn-Gln-Glu-Gln-Glu (FAP
CC         form, prolyl endopeptidase activity)
CC         {ECO:0000269|PubMed:16223769};
CC         KM=0.026 mM for Arg-Gly-Thr-Ser-Gly-Pro-Asn-Gln-Glu-Gln-Glu
CC         (Antiplasmin-cleaving enzyme FAP soluble form, prolyl
CC         endopeptidase activity) {ECO:0000269|PubMed:16223769};
CC       pH dependence:
CC         Optimum pH is 6-8.4 for gelatinase activity. At pH lower than 5
CC         inhibited gelatinase activity. {ECO:0000269|PubMed:2172980,
CC         ECO:0000269|PubMed:9065413};
CC       Temperature dependence:
CC         Optimum temperature is 37 degrees Celsius for gelatinase
CC         activity. Temperatures above 50 degrees Celsius inhibit
CC         gelatinase activity. {ECO:0000269|PubMed:2172980,
CC         ECO:0000269|PubMed:9065413};
CC   -!- SUBUNIT: Homodimer; homodimerization is required for activity of
CC       both plasma membrane and soluble forms. The monomer is inactive.
CC       Heterodimer with DPP4. Interacts with PLAUR; the interaction
CC       occurs at the cell surface of invadopodia membranes. Interacts
CC       with ITGB1. Interacts with ITGA3. Associates with integrin alpha-
CC       3/beta-1; the association occurs in a collagen-dependent manner at
CC       the cell surface of invadopodia membranes.
CC       {ECO:0000269|PubMed:10455171, ECO:0000269|PubMed:12376466,
CC       ECO:0000269|PubMed:15809306, ECO:0000269|PubMed:16223769,
CC       ECO:0000269|PubMed:16410248, ECO:0000269|PubMed:16651416,
CC       ECO:0000269|PubMed:9065413}.
CC   -!- INTERACTION:
CC       P01275:GCG; NbExp=4; IntAct=EBI-4319803, EBI-7629173;
CC       P01282:VIP; NbExp=2; IntAct=EBI-4319803, EBI-751454;
CC   -!- SUBCELLULAR LOCATION: Prolyl endopeptidase FAP: Cell surface
CC       {ECO:0000269|PubMed:10593948, ECO:0000269|PubMed:16175601,
CC       ECO:0000269|PubMed:17105646, ECO:0000269|PubMed:24717288,
CC       ECO:0000269|PubMed:7911242}. Cell membrane
CC       {ECO:0000269|PubMed:12376466, ECO:0000269|PubMed:16651416,
CC       ECO:0000269|PubMed:9065413, ECO:0000303|PubMed:10455171}; Single-
CC       pass type II membrane protein {ECO:0000255}. Cell projection,
CC       lamellipodium membrane {ECO:0000269|PubMed:16651416,
CC       ECO:0000269|PubMed:9065413}; Single-pass type II membrane protein
CC       {ECO:0000255}. Cell projection, invadopodium membrane
CC       {ECO:0000269|PubMed:12376466, ECO:0000269|PubMed:16651416,
CC       ECO:0000269|PubMed:7923219, ECO:0000269|PubMed:9065413,
CC       ECO:0000303|PubMed:10455171}; Single-pass type II membrane protein
CC       {ECO:0000255}. Cell projection, ruffle membrane
CC       {ECO:0000303|PubMed:10455171}; Single-pass type II membrane
CC       protein {ECO:0000255}. Membrane {ECO:0000269|PubMed:2172980};
CC       Single-pass type II membrane protein {ECO:0000255}. Note=Localized
CC       on cell surface with lamellipodia and invadopodia membranes and on
CC       shed vesicles. Colocalized with DPP4 at invadopodia and
CC       lamellipodia membranes of migratory activated endothelial cells in
CC       collagenous matrix. Colocalized with DPP4 on endothelial cells of
CC       capillary-like microvessels but not large vessels within invasive
CC       breast ductal carcinoma. Anchored and enriched preferentially by
CC       integrin alpha-3/beta-1 at invadopodia, plasma membrane
CC       protrusions that correspond to sites of cell invasion, in a
CC       collagen-dependent manner. Localized at plasma and ruffle
CC       membranes in a collagen-independent manner. Colocalized with PLAUR
CC       preferentially at the cell surface of invadopodia membranes in a
CC       cytoskeleton-, integrin- and vitronectin-dependent manner.
CC       Concentrated at invadopodia membranes, specialized protrusions of
CC       the ventral plasma membrane in a fibrobectin-dependent manner.
CC       Colocalizes with extracellular components (ECM), such as collagen
CC       fibers and fibronectin. {ECO:0000269|PubMed:10593948,
CC       ECO:0000269|PubMed:12376466, ECO:0000269|PubMed:16175601,
CC       ECO:0000269|PubMed:16651416, ECO:0000269|PubMed:17105646,
CC       ECO:0000269|PubMed:2172980, ECO:0000269|PubMed:24717288,
CC       ECO:0000269|PubMed:7911242, ECO:0000269|PubMed:7923219,
CC       ECO:0000269|PubMed:9065413, ECO:0000303|PubMed:10455171}.
CC   -!- SUBCELLULAR LOCATION: Antiplasmin-cleaving enzyme FAP, soluble
CC       form: Secreted {ECO:0000269|PubMed:14751930,
CC       ECO:0000269|PubMed:16223769, ECO:0000269|PubMed:24371721}.
CC       Note=Found in blood plasma and serum.
CC       {ECO:0000269|PubMed:14751930, ECO:0000269|PubMed:16223769,
CC       ECO:0000269|PubMed:24371721}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cytoplasm
CC       {ECO:0000303|PubMed:10644713}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=L, seprase-I {ECO:0000303|PubMed:10644713};
CC         IsoId=Q12884-1; Sequence=Displayed;
CC         Note=Major isoform.;
CC       Name=2 {ECO:0000269|PubMed:10644713}; Synonyms=S, Truncated,
CC       seprase-s {ECO:0000303|PubMed:10644713};
CC         IsoId=Q12884-2; Sequence=VSP_005367;
CC         Note=Upstream open reading frames ORF(s)-containing region
CC         inhibits the translation of its downstream ORF.
CC         {ECO:0000269|PubMed:10644713};
CC   -!- TISSUE SPECIFICITY: Expressed in adipose tissue. Expressed in the
CC       dermal fibroblasts in the fetal skin. Expressed in the granulation
CC       tissue of healing wounds and on reactive stromal fibroblast in
CC       epithelial cancers. Expressed in activated fibroblast-like
CC       synoviocytes from inflamed synovial tissues. Expressed in
CC       activated hepatic stellate cells (HSC) and myofibroblasts from
CC       cirrhotic liver, but not detected in normal liver. Expressed in
CC       glioma cells (at protein level). Expressed in glioblastomas and
CC       glioma cells. Isoform 1 and isoform 2 are expressed in melanoma,
CC       carcinoma and fibroblast cell lines. {ECO:0000269|PubMed:10347120,
CC       ECO:0000269|PubMed:10593948, ECO:0000269|PubMed:10644713,
CC       ECO:0000269|PubMed:16175601, ECO:0000269|PubMed:17105646,
CC       ECO:0000269|PubMed:20707604, ECO:0000269|PubMed:24371721,
CC       ECO:0000269|PubMed:7911242}.
CC   -!- INDUCTION: In fibroblasts at times and sites of tissue remodeling
CC       during development, tissue repair and carcinogenesis. Up-regulated
CC       upon tumor stem cell differentiation. Up-regulated by transforming
CC       growth factor-beta, 12-O-tetradecanoyl phorbol-13-acetate and
CC       retinoids. {ECO:0000269|PubMed:20707604,
CC       ECO:0000269|PubMed:7519584}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:15809306,
CC       ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:7911242,
CC       ECO:0000269|PubMed:9065413}.
CC   -!- PTM: The N-terminus may be blocked.
CC   -!- SIMILARITY: Belongs to the peptidase S9B family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U09278; AAB49652.1; -; mRNA.
DR   EMBL; U76833; AAC51668.1; -; mRNA.
DR   EMBL; AF007822; AAF21600.1; -; mRNA.
DR   EMBL; AC007750; AAY24205.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11353.1; -; Genomic_DNA.
DR   EMBL; BC026250; AAH26250.1; -; mRNA.
DR   CCDS; CCDS33311.1; -. [Q12884-1]
DR   RefSeq; NP_001278736.1; NM_001291807.1.
DR   RefSeq; NP_004451.2; NM_004460.3. [Q12884-1]
DR   UniGene; Hs.654370; -.
DR   PDB; 1Z68; X-ray; 2.60 A; A/B=39-757.
DR   PDBsum; 1Z68; -.
DR   ProteinModelPortal; Q12884; -.
DR   SMR; Q12884; -.
DR   BioGrid; 108485; 15.
DR   IntAct; Q12884; 10.
DR   MINT; MINT-4778828; -.
DR   STRING; 9606.ENSP00000188790; -.
DR   BindingDB; Q12884; -.
DR   ChEMBL; CHEMBL4683; -.
DR   GuidetoPHARMACOLOGY; 2365; -.
DR   ESTHER; human-FAP; DPP4N_Peptidase_S9.
DR   MEROPS; S09.007; -.
DR   iPTMnet; Q12884; -.
DR   PhosphoSitePlus; Q12884; -.
DR   SwissPalm; Q12884; -.
DR   BioMuta; FAP; -.
DR   DMDM; 292495099; -.
DR   PaxDb; Q12884; -.
DR   PeptideAtlas; Q12884; -.
DR   PRIDE; Q12884; -.
DR   Ensembl; ENST00000188790; ENSP00000188790; ENSG00000078098. [Q12884-1]
DR   GeneID; 2191; -.
DR   KEGG; hsa:2191; -.
DR   UCSC; uc002ucd.3; human. [Q12884-1]
DR   CTD; 2191; -.
DR   DisGeNET; 2191; -.
DR   GeneCards; FAP; -.
DR   H-InvDB; HIX0002548; -.
DR   HGNC; HGNC:3590; FAP.
DR   HPA; HPA059739; -.
DR   MIM; 600403; gene.
DR   neXtProt; NX_Q12884; -.
DR   OpenTargets; ENSG00000078098; -.
DR   PharmGKB; PA28003; -.
DR   eggNOG; KOG2100; Eukaryota.
DR   eggNOG; COG1506; LUCA.
DR   GeneTree; ENSGT00760000119233; -.
DR   HOGENOM; HOG000231875; -.
DR   HOVERGEN; HBG005527; -.
DR   InParanoid; Q12884; -.
DR   KO; K08674; -.
DR   OMA; KHLYTHM; -.
DR   OrthoDB; EOG091G0BU5; -.
DR   PhylomeDB; Q12884; -.
DR   TreeFam; TF313309; -.
DR   BioCyc; ZFISH:ENSG00000078098-MONOMER; -.
DR   BRENDA; 3.4.21.B28; 2681.
DR   ChiTaRS; FAP; human.
DR   EvolutionaryTrace; Q12884; -.
DR   GeneWiki; Fibroblast_activation_protein,_alpha; -.
DR   GenomeRNAi; 2191; -.
DR   PRO; PR:Q12884; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000078098; -.
DR   CleanEx; HS_FAP; -.
DR   ExpressionAtlas; Q12884; baseline and differential.
DR   Genevisible; Q12884; HS.
DR   GO; GO:0045177; C:apical part of cell; IEA:Ensembl.
DR   GO; GO:0045178; C:basal part of cell; IEA:Ensembl.
DR   GO; GO:0009986; C:cell surface; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0071438; C:invadopodium membrane; IDA:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; IDA:UniProtKB.
DR   GO; GO:0031258; C:lamellipodium membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0032587; C:ruffle membrane; NAS:UniProtKB.
DR   GO; GO:0008239; F:dipeptidyl-peptidase activity; IDA:UniProtKB.
DR   GO; GO:0004175; F:endopeptidase activity; IDA:BHF-UCL.
DR   GO; GO:0005178; F:integrin binding; IPI:UniProtKB.
DR   GO; GO:0004222; F:metalloendopeptidase activity; TAS:UniProtKB.
DR   GO; GO:0008233; F:peptidase activity; IDA:UniProtKB.
DR   GO; GO:0002020; F:protease binding; IPI:BHF-UCL.
DR   GO; GO:0046983; F:protein dimerization activity; NAS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IDA:UniProtKB.
DR   GO; GO:0008236; F:serine-type peptidase activity; IDA:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0043542; P:endothelial cell migration; IDA:UniProtKB.
DR   GO; GO:1902362; P:melanocyte apoptotic process; ISS:UniProtKB.
DR   GO; GO:0097325; P:melanocyte proliferation; ISS:UniProtKB.
DR   GO; GO:0071850; P:mitotic cell cycle arrest; ISS:UniProtKB.
DR   GO; GO:0060244; P:negative regulation of cell proliferation involved in contact inhibition; ISS:UniProtKB.
DR   GO; GO:0010716; P:negative regulation of extracellular matrix disassembly; IDA:UniProtKB.
DR   GO; GO:1903054; P:negative regulation of extracellular matrix organization; IDA:UniProtKB.
DR   GO; GO:0071158; P:positive regulation of cell cycle arrest; ISS:UniProtKB.
DR   GO; GO:1900119; P:positive regulation of execution phase of apoptosis; ISS:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; IDA:UniProtKB.
DR   GO; GO:0051603; P:proteolysis involved in cellular protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0010710; P:regulation of collagen catabolic process; IDA:UniProtKB.
DR   GO; GO:0051917; P:regulation of fibrinolysis; IC:BHF-UCL.
DR   Gene3D; 2.140.10.30; -; 1.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR002471; Pept_S9_AS.
DR   InterPro; IPR001375; Peptidase_S9.
DR   InterPro; IPR002469; Peptidase_S9B_N.
DR   Pfam; PF00930; DPPIV_N; 1.
DR   Pfam; PF00326; Peptidase_S9; 1.
DR   SUPFAM; SSF53474; SSF53474; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Angiogenesis; Apoptosis;
KW   Cell adhesion; Cell junction; Cell membrane; Cell projection;
KW   Cleavage on pair of basic residues; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Hydrolase;
KW   Membrane; Polymorphism; Protease; Reference proteome; Secreted;
KW   Serine protease; Signal-anchor; Transmembrane; Transmembrane helix.
FT   CHAIN         1    760       Prolyl endopeptidase FAP. {ECO:0000305}.
FT                                /FTId=PRO_0000122424.
FT   CHAIN        24    760       Antiplasmin-cleaving enzyme FAP, soluble
FT                                form. {ECO:0000303|PubMed:14751930}.
FT                                /FTId=PRO_0000430643.
FT   TOPO_DOM      1      4       Cytoplasmic. {ECO:0000255,
FT                                ECO:0000303|PubMed:14751930}.
FT   TRANSMEM      5     25       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     26    760       Extracellular. {ECO:0000255,
FT                                ECO:0000303|PubMed:14751930}.
FT   ACT_SITE    624    624       Charge relay system.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10084,
FT                                ECO:0000269|PubMed:15809306}.
FT   ACT_SITE    702    702       Charge relay system.
FT                                {ECO:0000269|PubMed:15809306}.
FT   ACT_SITE    734    734       Charge relay system.
FT                                {ECO:0000269|PubMed:15809306}.
FT   BINDING     203    203       Substrate. {ECO:0000303|PubMed:15809306}.
FT   BINDING     204    204       Substrate. {ECO:0000303|PubMed:15809306}.
FT   SITE         23     24       Cleavage. {ECO:0000303|PubMed:14751930}.
FT   CARBOHYD     49     49       N-linked (GlcNAc...).
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498,
FT                                ECO:0000269|PubMed:15809306}.
FT   CARBOHYD     92     92       N-linked (GlcNAc...).
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498,
FT                                ECO:0000269|PubMed:15809306}.
FT   CARBOHYD     99     99       N-linked (GlcNAc...).
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498,
FT                                ECO:0000269|PubMed:16335952}.
FT   CARBOHYD    227    227       N-linked (GlcNAc...).
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498,
FT                                ECO:0000269|PubMed:15809306,
FT                                ECO:0000269|PubMed:16335952}.
FT   CARBOHYD    314    314       N-linked (GlcNAc...).
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498,
FT                                ECO:0000269|PubMed:15809306}.
FT   CARBOHYD    679    679       N-linked (GlcNAc...).
FT                                {ECO:0000255|PROSITE-ProRule:PRU00498}.
FT   DISULFID    321    332       {ECO:0000269|PubMed:15809306}.
FT   DISULFID    438    441       {ECO:0000269|PubMed:15809306}.
FT   DISULFID    448    466       {ECO:0000269|PubMed:15809306}.
FT   DISULFID    643    755       {ECO:0000269|PubMed:15809306}.
FT   VAR_SEQ       1    521       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10644713}.
FT                                /FTId=VSP_005367.
FT   VARIANT     363    363       S -> L (decreased plasma membrane
FT                                expression; loss of homodimerization and
FT                                dipeptidyl peptidase activity;
FT                                mislocalized with the calnexin in the
FT                                endoplasmic reticulum; causes induction
FT                                of the unfolded protein response (UPR);
FT                                dbSNP:rs762738740).
FT                                {ECO:0000269|PubMed:24371721,
FT                                ECO:0000269|PubMed:24717288}.
FT                                /FTId=VAR_071264.
FT   MUTAGEN     123    123       R->A,M,E: Reduces dipeptidyl peptidase
FT                                and endopeptidase activities.
FT                                {ECO:0000269|PubMed:17381073}.
FT   MUTAGEN     203    203       E->A,D,Q: Reduces dipeptidyl peptidase
FT                                and endopeptidase activities. Does not
FT                                inhibit cell adhesion, migration and
FT                                invasion. Inhibits dipeptidyl peptidase
FT                                and endopeptidase activities; when
FT                                associated with A-204.
FT                                {ECO:0000269|PubMed:16175601,
FT                                ECO:0000269|PubMed:17381073}.
FT   MUTAGEN     204    204       E->A,D,Q: Reduces dipeptidyl peptidase
FT                                and endopeptidase activities. Does not
FT                                inhibit cell adhesion, migration and
FT                                invasion. Inhibits dipeptidyl peptidase
FT                                and endopeptidase activities; when
FT                                associated with A-203.
FT                                {ECO:0000269|PubMed:16175601,
FT                                ECO:0000269|PubMed:17381073}.
FT   MUTAGEN     624    624       S->A: Reduces dipeptidyl peptidase and
FT                                gelatinolytic activities. Does not
FT                                inhibit cell adhesion, migration and
FT                                invasion. {ECO:0000269|PubMed:10593948,
FT                                ECO:0000269|PubMed:16175601}.
FT   MUTAGEN     656    656       Y->F: Reduces dipeptidyl peptidase and
FT                                endopeptidase activities.
FT                                {ECO:0000269|PubMed:17381073}.
FT   MUTAGEN     657    657       A->D,N: Inhibits endopeptidase activity.
FT                                Increases dipeptidyl peptidase activity.
FT                                {ECO:0000269|PubMed:17381073}.
FT   MUTAGEN     657    657       A->F,V: Reduces dipeptidyl peptidase and
FT                                endopeptidase activities.
FT                                {ECO:0000269|PubMed:17381073}.
FT   MUTAGEN     657    657       A->Q: Inhibits endopeptidase activity. No
FT                                change in dipeptidyl peptidase activity.
FT                                {ECO:0000269|PubMed:17381073}.
FT   MUTAGEN     657    657       A->S,T: Reduces strongly endopeptidase
FT                                activity. No change in dipeptidyl
FT                                peptidase activity.
FT                                {ECO:0000269|PubMed:17381073}.
FT   MUTAGEN     704    704       N->A: Reduces dipeptidyl peptidase and
FT                                endopeptidase activities.
FT                                {ECO:0000269|PubMed:17381073}.
FT   CONFLICT    207    207       A -> P (in Ref. 1; AAB49652).
FT                                {ECO:0000305}.
FT   CONFLICT    229    229       T -> K (in Ref. 1; AAB49652).
FT                                {ECO:0000305}.
FT   CONFLICT    354    354       T -> R (in Ref. 1; AAB49652).
FT                                {ECO:0000305}.
FT   HELIX        44     49       {ECO:0000244|PDB:1Z68}.
FT   TURN         50     52       {ECO:0000244|PDB:1Z68}.
FT   STRAND       60     70       {ECO:0000244|PDB:1Z68}.
FT   STRAND       76     83       {ECO:0000244|PDB:1Z68}.
FT   STRAND       86     90       {ECO:0000244|PDB:1Z68}.
FT   HELIX        92     96       {ECO:0000244|PDB:1Z68}.
FT   TURN         97     99       {ECO:0000244|PDB:1Z68}.
FT   STRAND      101    105       {ECO:0000244|PDB:1Z68}.
FT   STRAND      109    120       {ECO:0000244|PDB:1Z68}.
FT   STRAND      122    124       {ECO:0000244|PDB:1Z68}.
FT   STRAND      126    134       {ECO:0000244|PDB:1Z68}.
FT   TURN        135    138       {ECO:0000244|PDB:1Z68}.
FT   STRAND      148    150       {ECO:0000244|PDB:1Z68}.
FT   STRAND      153    155       {ECO:0000244|PDB:1Z68}.
FT   STRAND      162    166       {ECO:0000244|PDB:1Z68}.
FT   STRAND      169    175       {ECO:0000244|PDB:1Z68}.
FT   TURN        189    191       {ECO:0000244|PDB:1Z68}.
FT   STRAND      192    196       {ECO:0000244|PDB:1Z68}.
FT   HELIX       199    204       {ECO:0000244|PDB:1Z68}.
FT   STRAND      212    214       {ECO:0000244|PDB:1Z68}.
FT   STRAND      218    227       {ECO:0000244|PDB:1Z68}.
FT   STRAND      233    238       {ECO:0000244|PDB:1Z68}.
FT   STRAND      241    244       {ECO:0000244|PDB:1Z68}.
FT   STRAND      246    251       {ECO:0000244|PDB:1Z68}.
FT   STRAND      261    270       {ECO:0000244|PDB:1Z68}.
FT   HELIX       272    275       {ECO:0000244|PDB:1Z68}.
FT   HELIX       284    287       {ECO:0000244|PDB:1Z68}.
FT   STRAND      291    312       {ECO:0000244|PDB:1Z68}.
FT   STRAND      315    323       {ECO:0000244|PDB:1Z68}.
FT   STRAND      325    331       {ECO:0000244|PDB:1Z68}.
FT   HELIX       334    336       {ECO:0000244|PDB:1Z68}.
FT   STRAND      337    341       {ECO:0000244|PDB:1Z68}.
FT   STRAND      343    345       {ECO:0000244|PDB:1Z68}.
FT   STRAND      347    351       {ECO:0000244|PDB:1Z68}.
FT   STRAND      364    369       {ECO:0000244|PDB:1Z68}.
FT   STRAND      375    382       {ECO:0000244|PDB:1Z68}.
FT   STRAND      393    395       {ECO:0000244|PDB:1Z68}.
FT   STRAND      397    403       {ECO:0000244|PDB:1Z68}.
FT   STRAND      405    413       {ECO:0000244|PDB:1Z68}.
FT   HELIX       415    417       {ECO:0000244|PDB:1Z68}.
FT   STRAND      422    428       {ECO:0000244|PDB:1Z68}.
FT   STRAND      430    433       {ECO:0000244|PDB:1Z68}.
FT   STRAND      436    440       {ECO:0000244|PDB:1Z68}.
FT   TURN        441    447       {ECO:0000244|PDB:1Z68}.
FT   STRAND      450    455       {ECO:0000244|PDB:1Z68}.
FT   HELIX       457    459       {ECO:0000244|PDB:1Z68}.
FT   STRAND      460    466       {ECO:0000244|PDB:1Z68}.
FT   STRAND      469    471       {ECO:0000244|PDB:1Z68}.
FT   STRAND      473    477       {ECO:0000244|PDB:1Z68}.
FT   STRAND      479    481       {ECO:0000244|PDB:1Z68}.
FT   STRAND      484    489       {ECO:0000244|PDB:1Z68}.
FT   HELIX       492    497       {ECO:0000244|PDB:1Z68}.
FT   STRAND      505    513       {ECO:0000244|PDB:1Z68}.
FT   STRAND      516    524       {ECO:0000244|PDB:1Z68}.
FT   STRAND      530    532       {ECO:0000244|PDB:1Z68}.
FT   STRAND      534    540       {ECO:0000244|PDB:1Z68}.
FT   HELIX       557    563       {ECO:0000244|PDB:1Z68}.
FT   STRAND      568    573       {ECO:0000244|PDB:1Z68}.
FT   STRAND      577    580       {ECO:0000244|PDB:1Z68}.
FT   HELIX       582    585       {ECO:0000244|PDB:1Z68}.
FT   HELIX       586    588       {ECO:0000244|PDB:1Z68}.
FT   HELIX       594    608       {ECO:0000244|PDB:1Z68}.
FT   STRAND      613    623       {ECO:0000244|PDB:1Z68}.
FT   HELIX       625    634       {ECO:0000244|PDB:1Z68}.
FT   STRAND      637    639       {ECO:0000244|PDB:1Z68}.
FT   STRAND      642    648       {ECO:0000244|PDB:1Z68}.
FT   TURN        653    655       {ECO:0000244|PDB:1Z68}.
FT   HELIX       658    665       {ECO:0000244|PDB:1Z68}.
FT   TURN        670    673       {ECO:0000244|PDB:1Z68}.
FT   HELIX       674    679       {ECO:0000244|PDB:1Z68}.
FT   HELIX       683    689       {ECO:0000244|PDB:1Z68}.
FT   STRAND      692    699       {ECO:0000244|PDB:1Z68}.
FT   STRAND      703    705       {ECO:0000244|PDB:1Z68}.
FT   HELIX       708    719       {ECO:0000244|PDB:1Z68}.
FT   STRAND      725    729       {ECO:0000244|PDB:1Z68}.
FT   HELIX       739    756       {ECO:0000244|PDB:1Z68}.
SQ   SEQUENCE   760 AA;  87713 MW;  7FF817B5A4F75142 CRC64;
     MKTWVKIVFG VATSAVLALL VMCIVLRPSR VHNSEENTMR ALTLKDILNG TFSYKTFFPN
     WISGQEYLHQ SADNNIVLYN IETGQSYTIL SNRTMKSVNA SNYGLSPDRQ FVYLESDYSK
     LWRYSYTATY YIYDLSNGEF VRGNELPRPI QYLCWSPVGS KLAYVYQNNI YLKQRPGDPP
     FQITFNGREN KIFNGIPDWV YEEEMLATKY ALWWSPNGKF LAYAEFNDTD IPVIAYSYYG
     DEQYPRTINI PYPKAGAKNP VVRIFIIDTT YPAYVGPQEV PVPAMIASSD YYFSWLTWVT
     DERVCLQWLK RVQNVSVLSI CDFREDWQTW DCPKTQEHIE ESRTGWAGGF FVSTPVFSYD
     AISYYKIFSD KDGYKHIHYI KDTVENAIQI TSGKWEAINI FRVTQDSLFY SSNEFEEYPG
     RRNIYRISIG SYPPSKKCVT CHLRKERCQY YTASFSDYAK YYALVCYGPG IPISTLHDGR
     TDQEIKILEE NKELENALKN IQLPKEEIKK LEVDEITLWY KMILPPQFDR SKKYPLLIQV
     YGGPCSQSVR SVFAVNWISY LASKEGMVIA LVDGRGTAFQ GDKLLYAVYR KLGVYEVEDQ
     ITAVRKFIEM GFIDEKRIAI WGWSYGGYVS SLALASGTGL FKCGIAVAPV SSWEYYASVY
     TERFMGLPTK DDNLEHYKNS TVMARAEYFR NVDYLLIHGT ADDNVHFQNS AQIAKALVNA
     QVDFQAMWYS DQNHGLSGLS TNHLYTHMTH FLKQCFSLSD
//
ID   D3DNW8_HUMAN            Unreviewed;       100 AA.
AC   D3DNW8;
DT   23-MAR-2010, integrated into UniProtKB/TrEMBL.
DT   23-MAR-2010, sequence version 1.
DT   08-JUN-2016, entry version 15.
DE   SubName: Full=Annexin A5, isoform CRA_a {ECO:0000313|EMBL:EAX05260.1};
DE   Flags: Fragment;
GN   Name=ANXA5 {ECO:0000313|EMBL:EAX05260.1};
GN   ORFNames=hCG_37353 {ECO:0000313|EMBL:EAX05260.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAX05260.1};
RN   [1] {ECO:0000313|EMBL:EAX05260.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX05260.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471056; EAX05256.1; -; Genomic_DNA.
DR   EMBL; CH471056; EAX05260.1; -; Genomic_DNA.
DR   UniGene; Hs.480653; -.
DR   ChiTaRS; ANXA5; human.
PE   4: Predicted;
FT   NON_TER       1      1       {ECO:0000313|EMBL:EAX05260.1}.
SQ   SEQUENCE   100 AA;  10553 MW;  24D8B726A493C74C CRC64;
     GAGAGPAGAA GLRLGPWRGW DGPSRAGPGW GRWRFRCLDQ SRCSCRILQR LHLGVAPRTV
     ARLSAALPGF RGTWVPQSGP ASPSPDLSSR HGTGSQRHCD
//
ID   D6RBE9_HUMAN            Unreviewed;       220 AA.
AC   D6RBE9;
DT   13-JUL-2010, integrated into UniProtKB/TrEMBL.
DT   13-JUL-2010, sequence version 1.
DT   02-NOV-2016, entry version 45.
DE   RecName: Full=Annexin {ECO:0000256|RuleBase:RU003540};
GN   Name=ANXA5 {ECO:0000313|Ensembl:ENSP00000424199};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000424199, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000424199, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [3] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [4] {ECO:0000313|Ensembl:ENSP00000424199}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [5] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [6] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- DOMAIN: A pair of annexin repeats may form one binding site for
CC       calcium and phospholipid. {ECO:0000256|RuleBase:RU003540}.
CC   -!- SIMILARITY: Belongs to the annexin family.
CC       {ECO:0000256|RuleBase:RU003540}.
CC   -!- SIMILARITY: Contains 3 annexin repeats.
CC       {ECO:0000256|RuleBase:RU003540}.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000424199}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC096730; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; D6RBE9; -.
DR   SMR; D6RBE9; -.
DR   STRING; 9606.ENSP00000296511; -.
DR   MaxQB; D6RBE9; -.
DR   PaxDb; D6RBE9; -.
DR   PeptideAtlas; D6RBE9; -.
DR   PRIDE; D6RBE9; -.
DR   Ensembl; ENST00000515017; ENSP00000424199; ENSG00000164111.
DR   UCSC; uc062zih.1; human.
DR   HGNC; HGNC:543; ANXA5.
DR   OpenTargets; ENSG00000164111; -.
DR   eggNOG; KOG0819; Eukaryota.
DR   eggNOG; ENOG410XPUN; LUCA.
DR   GeneTree; ENSGT00760000118972; -.
DR   HOGENOM; HOG000158803; -.
DR   ChiTaRS; ANXA5; human.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000164111; -.
DR   ExpressionAtlas; D6RBE9; baseline and differential.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005544; F:calcium-dependent phospholipid binding; IEA:UniProtKB-KW.
DR   GO; GO:0050819; P:negative regulation of coagulation; IEA:InterPro.
DR   Gene3D; 1.10.220.10; -; 3.
DR   InterPro; IPR001464; Annexin.
DR   InterPro; IPR018502; Annexin_repeat.
DR   InterPro; IPR018252; Annexin_repeat_CS.
DR   InterPro; IPR015473; Annexins_V.
DR   InterPro; IPR002392; AnnexinV.
DR   PANTHER; PTHR10502:SF26; PTHR10502:SF26; 1.
DR   Pfam; PF00191; Annexin; 2.
DR   PRINTS; PR00196; ANNEXIN.
DR   PRINTS; PR00201; ANNEXINV.
DR   SMART; SM00335; ANX; 3.
DR   PROSITE; PS00223; ANNEXIN; 2.
PE   1: Evidence at protein level;
KW   Annexin {ECO:0000256|RuleBase:RU003540,
KW   ECO:0000256|SAAS:SAAS00546016};
KW   Calcium {ECO:0000256|RuleBase:RU003540};
KW   Calcium/phospholipid-binding {ECO:0000256|RuleBase:RU003540};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:D6RBE9,
KW   ECO:0000213|MaxQB:D6RBE9, ECO:0000213|PeptideAtlas:D6RBE9};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Repeat {ECO:0000256|RuleBase:RU003540, ECO:0000256|SAAS:SAAS00429366}.
SQ   SEQUENCE   220 AA;  24698 MW;  E28295EE0AE66A35 CRC64;
     MAQVLRGTVT DFPGFDERAD AETLRKAMKG LEYGSSLEDD VVGDTSGYYQ RMLVVLLQAN
     RDPDAGIDEA QVEQDAQALF QAGELKWGTD EEKFITIFGT RSVSHLRKVF DKYMTISGFQ
     IEETIDRETS GNLEQLLLAV VKSIRSIPAY LAETLYYAMK GAGTDDHTLI RVMVSRSEID
     LFNIRKEFRK NFATSLYSMI KGDTSGDYKK ALLLLCGEDD
//
ID   D6RBL5_HUMAN            Unreviewed;       260 AA.
AC   D6RBL5;
DT   13-JUL-2010, integrated into UniProtKB/TrEMBL.
DT   13-JUL-2010, sequence version 1.
DT   02-NOV-2016, entry version 45.
DE   RecName: Full=Annexin {ECO:0000256|RuleBase:RU003540};
GN   Name=ANXA5 {ECO:0000313|Ensembl:ENSP00000424106};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000424106, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000424106, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000213|PubMed:16916647}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16916647; DOI=10.1016/j.molcel.2006.06.026;
RA   Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,
RA   Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.J., Zhao Y.;
RT   "Substrate and functional diversity of lysine acetylation revealed by
RT   a proteomics survey.";
RL   Mol. Cell 23:607-618(2006).
RN   [3] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [4] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5] {ECO:0000313|Ensembl:ENSP00000424106}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [6] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [7] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- DOMAIN: A pair of annexin repeats may form one binding site for
CC       calcium and phospholipid. {ECO:0000256|RuleBase:RU003540}.
CC   -!- SIMILARITY: Belongs to the annexin family.
CC       {ECO:0000256|RuleBase:RU003540}.
CC   -!- SIMILARITY: Contains 3 annexin repeats.
CC       {ECO:0000256|RuleBase:RU003540}.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000424106}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC096730; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; D6RBL5; -.
DR   STRING; 9606.ENSP00000296511; -.
DR   MaxQB; D6RBL5; -.
DR   PaxDb; D6RBL5; -.
DR   PeptideAtlas; D6RBL5; -.
DR   PRIDE; D6RBL5; -.
DR   Ensembl; ENST00000501272; ENSP00000424106; ENSG00000164111.
DR   UCSC; uc062zif.1; human.
DR   HGNC; HGNC:543; ANXA5.
DR   OpenTargets; ENSG00000164111; -.
DR   eggNOG; KOG0819; Eukaryota.
DR   eggNOG; ENOG410XPUN; LUCA.
DR   GeneTree; ENSGT00760000118972; -.
DR   HOGENOM; HOG000158803; -.
DR   ChiTaRS; ANXA5; human.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000164111; -.
DR   ExpressionAtlas; D6RBL5; baseline and differential.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005544; F:calcium-dependent phospholipid binding; IEA:UniProtKB-KW.
DR   GO; GO:0050819; P:negative regulation of coagulation; IEA:InterPro.
DR   Gene3D; 1.10.220.10; -; 3.
DR   InterPro; IPR001464; Annexin.
DR   InterPro; IPR018502; Annexin_repeat.
DR   InterPro; IPR018252; Annexin_repeat_CS.
DR   InterPro; IPR015473; Annexins_V.
DR   InterPro; IPR002392; AnnexinV.
DR   PANTHER; PTHR10502:SF26; PTHR10502:SF26; 1.
DR   Pfam; PF00191; Annexin; 3.
DR   PRINTS; PR00196; ANNEXIN.
DR   PRINTS; PR00201; ANNEXINV.
DR   SMART; SM00335; ANX; 3.
DR   PROSITE; PS00223; ANNEXIN; 3.
PE   1: Evidence at protein level;
KW   Annexin {ECO:0000256|RuleBase:RU003540,
KW   ECO:0000256|SAAS:SAAS00546016};
KW   Calcium {ECO:0000256|RuleBase:RU003540};
KW   Calcium/phospholipid-binding {ECO:0000256|RuleBase:RU003540};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:D6RBL5,
KW   ECO:0000213|MaxQB:D6RBL5, ECO:0000213|PeptideAtlas:D6RBL5};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Repeat {ECO:0000256|RuleBase:RU003540, ECO:0000256|SAAS:SAAS00429366}.
SQ   SEQUENCE   260 AA;  29337 MW;  C37BDDA14CF2A07C CRC64;
     MAQDLLDDLK SELTGKFEKL IVALMKPSRL YDAYELKHAL KGAGTNEKVL TEIIASRTPE
     ELRAIKQVYE EEYGSSLEDD VVGDTSGYYQ RMLVVLLQAN RDPDAGIDEA QVEQDAQALF
     QAGELKWGTD EEKFITIFGT RSVSHLRKVF DKYMTISGFQ IEETIDRETS GNLEQLLLAV
     VKSIRSIPAY LAETLYYAMK GAGTDDHTLI RVMVSRSEID LFNIRKEFRK NFATSLYSMI
     KGDTSGDYKK ALLLLCGEDD
//
ID   D6RCN3_HUMAN            Unreviewed;        35 AA.
AC   D6RCN3;
DT   13-JUL-2010, integrated into UniProtKB/TrEMBL.
DT   13-JUL-2010, sequence version 1.
DT   02-NOV-2016, entry version 40.
DE   SubName: Full=Annexin A5 {ECO:0000313|Ensembl:ENSP00000427135};
GN   Name=ANXA5 {ECO:0000313|Ensembl:ENSP00000427135};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000427135, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000427135, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [3] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [4] {ECO:0000313|Ensembl:ENSP00000427135}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [5] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000427135}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC096730; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; D6RCN3; -.
DR   STRING; 9606.ENSP00000296511; -.
DR   MaxQB; D6RCN3; -.
DR   PaxDb; D6RCN3; -.
DR   PeptideAtlas; D6RCN3; -.
DR   PRIDE; D6RCN3; -.
DR   Ensembl; ENST00000513728; ENSP00000427135; ENSG00000164111.
DR   UCSC; uc062zio.1; human.
DR   HGNC; HGNC:543; ANXA5.
DR   OpenTargets; ENSG00000164111; -.
DR   eggNOG; KOG0819; Eukaryota.
DR   eggNOG; ENOG410XPUN; LUCA.
DR   GeneTree; ENSGT00760000118972; -.
DR   ChiTaRS; ANXA5; human.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000164111; -.
DR   ExpressionAtlas; D6RCN3; baseline and differential.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005544; F:calcium-dependent phospholipid binding; IEA:InterPro.
DR   Gene3D; 1.10.220.10; -; 1.
DR   InterPro; IPR018502; Annexin_repeat.
DR   InterPro; IPR015473; Annexins_V.
DR   PANTHER; PTHR10502:SF26; PTHR10502:SF26; 1.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:D6RCN3,
KW   ECO:0000213|MaxQB:D6RCN3, ECO:0000213|PeptideAtlas:D6RCN3};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
SQ   SEQUENCE   35 AA;  3713 MW;  1C0B3A38B10AFFCB CRC64;
     MAQVLRGTVT DFPGFDERAD AETLRKAMKG LGSSG
//
ID   E9PHT9_HUMAN            Unreviewed;       163 AA.
AC   E9PHT9;
DT   05-APR-2011, integrated into UniProtKB/TrEMBL.
DT   05-APR-2011, sequence version 1.
DT   02-NOV-2016, entry version 39.
DE   RecName: Full=Annexin {ECO:0000256|RuleBase:RU003540};
GN   Name=ANXA5 {ECO:0000313|Ensembl:ENSP00000421421};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000421421, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000421421, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [2] {ECO:0000213|PubMed:16916647}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16916647; DOI=10.1016/j.molcel.2006.06.026;
RA   Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,
RA   Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.J., Zhao Y.;
RT   "Substrate and functional diversity of lysine acetylation revealed by
RT   a proteomics survey.";
RL   Mol. Cell 23:607-618(2006).
RN   [3] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [4] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [5] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Burckstummer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6] {ECO:0000313|Ensembl:ENSP00000421421}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [7] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8] {ECO:0000213|PubMed:25114211}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [9] {ECO:0000213|PubMed:25772364}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
CC   -!- DOMAIN: A pair of annexin repeats may form one binding site for
CC       calcium and phospholipid. {ECO:0000256|RuleBase:RU003540}.
CC   -!- SIMILARITY: Belongs to the annexin family.
CC       {ECO:0000256|RuleBase:RU003540}.
CC   -!- SIMILARITY: Contains 2 annexin repeats.
CC       {ECO:0000256|RuleBase:RU003540}.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000421421}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC096730; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; E9PHT9; -.
DR   STRING; 9606.ENSP00000296511; -.
DR   MaxQB; E9PHT9; -.
DR   PaxDb; E9PHT9; -.
DR   PeptideAtlas; E9PHT9; -.
DR   PRIDE; E9PHT9; -.
DR   Ensembl; ENST00000506395; ENSP00000421421; ENSG00000164111.
DR   UCSC; uc062zig.1; human.
DR   HGNC; HGNC:543; ANXA5.
DR   OpenTargets; ENSG00000164111; -.
DR   eggNOG; KOG0819; Eukaryota.
DR   eggNOG; ENOG410XPUN; LUCA.
DR   GeneTree; ENSGT00760000118972; -.
DR   ChiTaRS; ANXA5; human.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000164111; -.
DR   ExpressionAtlas; E9PHT9; baseline and differential.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005544; F:calcium-dependent phospholipid binding; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.220.10; -; 2.
DR   InterPro; IPR001464; Annexin.
DR   InterPro; IPR018502; Annexin_repeat.
DR   InterPro; IPR018252; Annexin_repeat_CS.
DR   InterPro; IPR015473; Annexins_V.
DR   PANTHER; PTHR10502:SF26; PTHR10502:SF26; 1.
DR   Pfam; PF00191; Annexin; 2.
DR   PRINTS; PR00196; ANNEXIN.
DR   SMART; SM00335; ANX; 2.
DR   PROSITE; PS00223; ANNEXIN; 2.
PE   1: Evidence at protein level;
KW   Annexin {ECO:0000256|RuleBase:RU003540,
KW   ECO:0000256|SAAS:SAAS00546016};
KW   Calcium {ECO:0000256|RuleBase:RU003540};
KW   Calcium/phospholipid-binding {ECO:0000256|RuleBase:RU003540};
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|EPD:E9PHT9,
KW   ECO:0000213|MaxQB:E9PHT9, ECO:0000213|PeptideAtlas:E9PHT9};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Repeat {ECO:0000256|RuleBase:RU003540, ECO:0000256|SAAS:SAAS00429366}.
SQ   SEQUENCE   163 AA;  18224 MW;  CC750F4F33259F18 CRC64;
     MAQVLRGTVT DFPGFDERAD AETLRKAMKG LGTDEESILT LLTSRSNAQR QEISAAFKTL
     FGRDLLDDLK SELTGKFEKL IVALMKPSRL YDAYELKHAL KGAGTNEKVL TEIIASRTPE
     ELRAIKQVYE EEYGSSLEDD VVGDTSGYYQ RMLVVLLQVL RGD
//
ID   ANXA5_HUMAN             Reviewed;         320 AA.
AC   P08758; D3DNW7; Q6FHB3; Q6FI16; Q8WV69; Q9UDH9;
DT   01-NOV-1988, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   02-NOV-2016, entry version 194.
DE   RecName: Full=Annexin A5;
DE   AltName: Full=Anchorin CII;
DE   AltName: Full=Annexin V;
DE   AltName: Full=Annexin-5;
DE   AltName: Full=Calphobindin I;
DE            Short=CBP-I;
DE   AltName: Full=Endonexin II;
DE   AltName: Full=Lipocortin V;
DE   AltName: Full=Placental anticoagulant protein 4;
DE            Short=PP4;
DE   AltName: Full=Placental anticoagulant protein I;
DE            Short=PAP-I;
DE   AltName: Full=Thromboplastin inhibitor;
DE   AltName: Full=Vascular anticoagulant-alpha;
DE            Short=VAC-alpha;
GN   Name=ANXA5; Synonyms=ANX5, ENX2, PP4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2964863; DOI=10.1021/bi00399a011;
RA   Funakoshi T., Hendrickson L.E., McMullen B.A., Fujikawa K.;
RT   "Primary structure of human placental anticoagulant protein.";
RL   Biochemistry 26:8087-8092(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 2-320.
RX   PubMed=2963810;
RA   Iwasaki A., Suda M., Nakao H., Nagoya T., Saino Y., Arai K.,
RA   Mizoguchi T., Sato F., Yoshizaki H., Hirata M., Miyata T., Shidara Y.,
RA   Murata M., Maki M.;
RT   "Structure and expression of cDNA for an inhibitor of blood
RT   coagulation isolated from human placenta: a new lipocortin-like
RT   protein.";
RL   J. Biochem. 102:1261-1273(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=2455636; DOI=10.1111/j.1432-1033.1988.tb14139.x;
RA   Maurer-Fogy I., Reutelingsperger C.P.M., Pieters J., Bodo G.,
RA   Stratowa C., Hauptmann R.;
RT   "Cloning and expression of cDNA for human vascular anticoagulant, a
RT   Ca2+-dependent phospholipid-binding protein.";
RL   Eur. J. Biochem. 174:585-592(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2967291;
RA   Kaplan R., Jaye M., Burgess W.H., Schlaepfer D.D., Haigler H.T.;
RT   "Cloning and expression of cDNA for human endonexin II, a Ca2+ and
RT   phospholipid binding protein.";
RL   J. Biol. Chem. 263:8037-8043(1988).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2968983;
RA   Pepinsky R.B., Tizard R., Mattaliano R.J., Sinclair L.K., Miller G.T.,
RA   Browning J.L., Chow E.P., Burne C., Huang K.-S., Pratt D., Wachter L.,
RA   Hession C., Frey A.Z., Wallner B.P.;
RT   "Five distinct calcium and phospholipid binding proteins share
RT   homology with lipocortin I.";
RL   J. Biol. Chem. 263:10799-10811(1988).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2967495; DOI=10.1073/pnas.85.11.3708;
RA   Grundmann U., Abel K.-J., Bohn H., Loebermann H., Lottspeich F.,
RA   Kuepper H.;
RT   "Characterization of cDNA encoding human placental anticoagulant
RT   protein (PP4): homology with the lipocortin family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:3708-3712(1988).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Lung;
RX   PubMed=7958998; DOI=10.1016/0378-1119(94)90157-0;
RA   Fernandez M.-P., Morgan R.O., Fernandez M.R., Carcedo M.-T.;
RT   "The gene encoding human annexin V has a TATA-less promoter with a
RT   high G+C content.";
RL   Gene 149:253-260(1994).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8034319; DOI=10.1006/geno.1994.1201;
RA   Cookson B.T., Engelhardt S., Smith C., Bamford H.A., Prochazka M.,
RA   Tait J.F.;
RT   "Organization of the human annexin V (ANX5) gene.";
RL   Genomics 20:463-467(1994).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Neuroblastoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Muscle, Ovary, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [14]
RP   PARTIAL PROTEIN SEQUENCE.
RX   PubMed=2532007; DOI=10.1042/bj2630929;
RA   Rothhut R., Comera C., Cortial S., Haumont P.-Y., Diep Le K.H.,
RA   Cavadore J.-C., Conard J., Russo-Marie F., Lederer F.;
RT   "A 32 kDa lipocortin from human mononuclear cells appears to be
RT   identical with the placental inhibitor of blood coagulation.";
RL   Biochem. J. 263:929-935(1989).
RN   [15]
RP   PROTEIN SEQUENCE OF 7-18; 30-45; 187-201 AND 277-286, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Melanoma;
RA   Quadroni M., Potts A., Barblan J., Bienvenut W.V.;
RL   Submitted (JAN-2005) to UniProtKB.
RN   [16]
RP   PROTEIN SEQUENCE OF 21-31; 93-108; 176-188 AND 304-319, AND
RP   INTERACTION WITH HBV.
RX   PubMed=8249278; DOI=10.1006/viro.1993.1628;
RA   Hertogs K., Leenders W.P., Depla E., De Bruin W.C., Meheus L.,
RA   Raymackers J., Moshage H., Yap S.H.;
RT   "Endonexin II, present on human liver plasma membranes, is a specific
RT   binding protein of small hepatitis B virus (HBV) envelope protein.";
RL   Virology 197:549-557(1993).
RN   [17]
RP   PROTEIN SEQUENCE OF 86-131; 259-297 AND 300-320.
RX   PubMed=2957692; DOI=10.1073/pnas.84.17.6078;
RA   Schlaepfer D.D., Mehlman T., Burgess W.H., Haigler H.T.;
RT   "Structural and functional characterization of endonexin II, a
RT   calcium- and phospholipid-binding protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:6078-6082(1987).
RN   [18]
RP   PROTEIN SEQUENCE OF 85-93.
RC   TISSUE=Placenta;
RX   PubMed=2974032;
RA   Ahn N.G., Teller D.C., Bienkowski M.J., McMullen B.A., Lipkin E.W.,
RA   de Haen C.;
RT   "Sedimentation equilibrium analysis of five lipocortin-related
RT   phospholipase A2 inhibitors from human placenta. Evidence against a
RT   mechanistically relevant association between enzyme and inhibitor.";
RL   J. Biol. Chem. 263:18657-18663(1988).
RN   [19]
RP   PROTEIN SEQUENCE OF 152-161 AND 246-260.
RC   TISSUE=Adipocyte;
RX   PubMed=15242332; DOI=10.1042/BJ20040647;
RA   Aboulaich N., Vainonen J.P., Stralfors P., Vener A.V.;
RT   "Vectorial proteomics reveal targeting, phosphorylation and specific
RT   fragmentation of polymerase I and transcript release factor (PTRF) at
RT   the surface of caveolae in human adipocytes.";
RL   Biochem. J. 383:237-248(2004).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-101, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16916647; DOI=10.1016/j.molcel.2006.06.026;
RA   Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,
RA   Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.;
RT   "Substrate and functional diversity of lysine acetylation revealed by
RT   a proteomics survey.";
RL   Mol. Cell 23:607-618(2006).
RN   [21]
RP   INVOLVEMENT IN RPRGL3.
RX   PubMed=17339269; DOI=10.1093/hmg/ddm017;
RA   Bogdanova N., Horst J., Chlystun M., Croucher P.J., Nebel A.,
RA   Bohring A., Todorova A., Schreiber S., Gerke V., Krawczak M.,
RA   Markoff A.;
RT   "A common haplotype of the annexin A5 (ANXA5) gene promoter is
RT   associated with recurrent pregnancy loss.";
RL   Hum. Mol. Genet. 16:573-578(2007).
RN   [22]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [23]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-70; LYS-76; LYS-79 AND
RP   LYS-97, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [25]
RP   S-NITROSYLATION, AND DOMAIN.
RX   PubMed=25417112; DOI=10.1016/j.cell.2014.09.032;
RA   Jia J., Arif A., Terenzi F., Willard B., Plow E.F., Hazen S.L.,
RA   Fox P.L.;
RT   "Target-selective protein S-nitrosylation by sequence motif
RT   recognition.";
RL   Cell 159:623-634(2014).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [27]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-29, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [28]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-29, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [29]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [30]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
RX   PubMed=2147412;
RA   Huber R., Roemisch J., Paques E.-P.;
RT   "The crystal and molecular structure of human annexin V, an
RT   anticoagulant protein that binds to calcium and membranes.";
RL   EMBO J. 9:3867-3874(1990).
RN   [31]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS).
RX   PubMed=2148156; DOI=10.1016/0014-5793(90)81428-Q;
RA   Huber R., Schneider M., Mayr I., Roemisch J., Paques E.-P.;
RT   "The calcium binding sites in human annexin V by crystal structure
RT   analysis at 2.0-A resolution. Implications for membrane binding and
RT   calcium channel activity.";
RL   FEBS Lett. 275:15-21(1990).
RN   [32]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS).
RX   PubMed=1311770; DOI=10.1016/0022-2836(92)90984-R;
RA   Huber R., Berendes R., Burger A., Schneider M., Karshikov A.,
RA   Luecke H., Roemisch J., Paques E.-P.;
RT   "Crystal and molecular structure of human annexin V after refinement.
RT   Implications for structure, membrane binding and ion channel formation
RT   of the annexin family of proteins.";
RL   J. Mol. Biol. 223:683-704(1992).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS).
RX   PubMed=9398511; DOI=10.1006/jmbi.1997.1375;
RA   Kaneko N., Ago H., Matsuda R., Inagaki E., Miyano M.;
RT   "Crystal structure of annexin V with its ligand K-201 as a calcium
RT   channel activity inhibitor.";
RL   J. Mol. Biol. 274:16-20(1997).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS).
RX   PubMed=9435213; DOI=10.1073/pnas.95.2.455;
RA   Budisa N., Minks C., Medrano F.J., Lutz J., Huber R., Moroder L.;
RT   "Residue-specific bioincorporation of non-natural, biologically active
RT   amino acids into proteins as possible drug carriers: structure and
RT   stability of the per-thiaproline mutant of annexin V.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:455-459(1998).
CC   -!- FUNCTION: This protein is an anticoagulant protein that acts as an
CC       indirect inhibitor of the thromboplastin-specific complex, which
CC       is involved in the blood coagulation cascade.
CC   -!- SUBUNIT: Monomer. Binds ATRX and EIF5B (By similarity). Interacts
CC       with hepatitis B virus (HBV). {ECO:0000250,
CC       ECO:0000269|PubMed:8249278}.
CC   -!- INTERACTION:
CC       Q9BSI4:TINF2; NbExp=2; IntAct=EBI-296601, EBI-717399;
CC   -!- DOMAIN: The [IL]-x-C-x-x-[DE] motif is a proposed target motif for
CC       cysteine S-nitrosylation mediated by the iNOS-S100A8/A9
CC       transnitrosylase complex. {ECO:0000305|PubMed:25417112}.
CC   -!- DOMAIN: A pair of annexin repeats may form one binding site for
CC       calcium and phospholipid.
CC   -!- PTM: S-nitrosylation is induced by interferon-gamma and
CC       oxidatively-modified low-densitity lipoprotein (LDL(ox)) possibly
CC       implicating the iNOS-S100A8/9 transnitrosylase complex.
CC       {ECO:0000305|PubMed:25417112}.
CC   -!- DISEASE: Pregnancy loss, recurrent, 3 (RPRGL3) [MIM:614391]: A
CC       common complication of pregnancy, resulting in spontaneous
CC       abortion before the fetus has reached viability. The term includes
CC       all miscarriages from the time of conception until 24 weeks of
CC       gestation. Recurrent pregnancy loss is defined as 3 or more
CC       consecutive spontaneous abortions. {ECO:0000269|PubMed:17339269}.
CC       Note=Disease susceptibility is associated with variations
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the annexin family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 4 annexin repeats. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M18366; AAA35570.1; -; mRNA.
DR   EMBL; D00172; BAA00122.1; -; mRNA.
DR   EMBL; X12454; CAA30985.1; -; mRNA.
DR   EMBL; J03745; AAA52386.1; -; mRNA.
DR   EMBL; M21731; AAA36166.1; -; mRNA.
DR   EMBL; M19384; AAB59545.1; -; mRNA.
DR   EMBL; U01691; AAB40047.1; -; Genomic_DNA.
DR   EMBL; U01681; AAB40047.1; JOINED; Genomic_DNA.
DR   EMBL; U01682; AAB40047.1; JOINED; Genomic_DNA.
DR   EMBL; U01683; AAB40047.1; JOINED; Genomic_DNA.
DR   EMBL; U01685; AAB40047.1; JOINED; Genomic_DNA.
DR   EMBL; U01686; AAB40047.1; JOINED; Genomic_DNA.
DR   EMBL; U01687; AAB40047.1; JOINED; Genomic_DNA.
DR   EMBL; U01689; AAB40047.1; JOINED; Genomic_DNA.
DR   EMBL; U01690; AAB40047.1; JOINED; Genomic_DNA.
DR   EMBL; U05770; AAB60648.1; -; Genomic_DNA.
DR   EMBL; U05760; AAB60648.1; JOINED; Genomic_DNA.
DR   EMBL; U05761; AAB60648.1; JOINED; Genomic_DNA.
DR   EMBL; U05762; AAB60648.1; JOINED; Genomic_DNA.
DR   EMBL; U05764; AAB60648.1; JOINED; Genomic_DNA.
DR   EMBL; U05765; AAB60648.1; JOINED; Genomic_DNA.
DR   EMBL; U05766; AAB60648.1; JOINED; Genomic_DNA.
DR   EMBL; U05767; AAB60648.1; JOINED; Genomic_DNA.
DR   EMBL; U05768; AAB60648.1; JOINED; Genomic_DNA.
DR   EMBL; U05769; AAB60648.1; JOINED; Genomic_DNA.
DR   EMBL; AK312644; BAG35528.1; -; mRNA.
DR   EMBL; CR536522; CAG38759.1; -; mRNA.
DR   EMBL; CR541842; CAG46640.1; -; mRNA.
DR   EMBL; AC096730; AAY40954.1; -; Genomic_DNA.
DR   EMBL; CH471056; EAX05257.1; -; Genomic_DNA.
DR   EMBL; CH471056; EAX05258.1; -; Genomic_DNA.
DR   EMBL; BC001429; AAH01429.1; -; mRNA.
DR   EMBL; BC004993; AAH04993.1; -; mRNA.
DR   EMBL; BC012804; AAH12804.1; -; mRNA.
DR   EMBL; BC012822; AAH12822.1; -; mRNA.
DR   EMBL; BC018671; AAH18671.1; -; mRNA.
DR   CCDS; CCDS3720.1; -.
DR   PIR; D29250; AQHUP.
DR   RefSeq; NP_001145.1; NM_001154.3.
DR   UniGene; Hs.480653; -.
DR   PDB; 1ANW; X-ray; 2.40 A; A/B=2-320.
DR   PDB; 1ANX; X-ray; 1.90 A; A/B/C=2-320.
DR   PDB; 1AVH; X-ray; 2.30 A; A/B=1-320.
DR   PDB; 1AVR; X-ray; 2.30 A; A=1-320.
DR   PDB; 1HAK; X-ray; 3.00 A; A/B=1-320.
DR   PDB; 1HVD; X-ray; 2.00 A; A=2-320.
DR   PDB; 1HVE; X-ray; 2.30 A; A=2-320.
DR   PDB; 1HVF; X-ray; 2.00 A; A=2-320.
DR   PDB; 1HVG; X-ray; 3.00 A; A=2-320.
DR   PDB; 1SAV; X-ray; 2.50 A; A=1-320.
DR   PDB; 2XO2; X-ray; 2.80 A; A=1-320.
DR   PDB; 2XO3; X-ray; 2.30 A; A=1-320.
DR   PDBsum; 1ANW; -.
DR   PDBsum; 1ANX; -.
DR   PDBsum; 1AVH; -.
DR   PDBsum; 1AVR; -.
DR   PDBsum; 1HAK; -.
DR   PDBsum; 1HVD; -.
DR   PDBsum; 1HVE; -.
DR   PDBsum; 1HVF; -.
DR   PDBsum; 1HVG; -.
DR   PDBsum; 1SAV; -.
DR   PDBsum; 2XO2; -.
DR   PDBsum; 2XO3; -.
DR   ProteinModelPortal; P08758; -.
DR   SMR; P08758; -.
DR   BioGrid; 106805; 41.
DR   IntAct; P08758; 21.
DR   MINT; MINT-1382250; -.
DR   STRING; 9606.ENSP00000296511; -.
DR   iPTMnet; P08758; -.
DR   PhosphoSitePlus; P08758; -.
DR   SwissPalm; P08758; -.
DR   BioMuta; ANXA5; -.
DR   DMDM; 113960; -.
DR   OGP; P08758; -.
DR   REPRODUCTION-2DPAGE; IPI00329801; -.
DR   REPRODUCTION-2DPAGE; P08758; -.
DR   EPD; P08758; -.
DR   PaxDb; P08758; -.
DR   PeptideAtlas; P08758; -.
DR   PRIDE; P08758; -.
DR   TopDownProteomics; P08758; -.
DR   DNASU; 308; -.
DR   Ensembl; ENST00000296511; ENSP00000296511; ENSG00000164111.
DR   GeneID; 308; -.
DR   KEGG; hsa:308; -.
DR   CTD; 308; -.
DR   DisGeNET; 308; -.
DR   GeneCards; ANXA5; -.
DR   HGNC; HGNC:543; ANXA5.
DR   HPA; CAB003677; -.
DR   HPA; HPA035330; -.
DR   MalaCards; ANXA5; -.
DR   MIM; 131230; gene.
DR   MIM; 614391; phenotype.
DR   neXtProt; NX_P08758; -.
DR   OpenTargets; ENSG00000164111; -.
DR   PharmGKB; PA24833; -.
DR   eggNOG; KOG0819; Eukaryota.
DR   eggNOG; ENOG410XPUN; LUCA.
DR   GeneTree; ENSGT00760000118972; -.
DR   HOGENOM; HOG000158803; -.
DR   HOVERGEN; HBG061815; -.
DR   InParanoid; P08758; -.
DR   KO; K16646; -.
DR   OMA; IRHEFRK; -.
DR   OrthoDB; EOG091G0H6H; -.
DR   PhylomeDB; P08758; -.
DR   TreeFam; TF105452; -.
DR   BioCyc; ZFISH:ENSG00000164111-MONOMER; -.
DR   Reactome; R-HSA-114608; Platelet degranulation.
DR   SignaLink; P08758; -.
DR   ChiTaRS; ANXA5; human.
DR   EvolutionaryTrace; P08758; -.
DR   GeneWiki; Annexin_A5; -.
DR   GenomeRNAi; 308; -.
DR   PRO; PR:P08758; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000164111; -.
DR   CleanEx; HS_ANXA5; -.
DR   ExpressionAtlas; P08758; baseline and differential.
DR   Genevisible; P08758; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:UniProtKB.
DR   GO; GO:0072563; C:endothelial microparticle; IEA:Ensembl.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0005622; C:intracellular; IDA:LIFEdb.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005544; F:calcium-dependent phospholipid binding; IDA:UniProtKB.
DR   GO; GO:0004859; F:phospholipase inhibitor activity; TAS:ProtInc.
DR   GO; GO:0005543; F:phospholipid binding; TAS:ProtInc.
DR   GO; GO:0007596; P:blood coagulation; IEA:UniProtKB-KW.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; TAS:UniProtKB.
DR   GO; GO:0050819; P:negative regulation of coagulation; IEA:InterPro.
DR   GO; GO:0010033; P:response to organic substance; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; TAS:UniProtKB.
DR   Gene3D; 1.10.220.10; -; 4.
DR   InterPro; IPR001464; Annexin.
DR   InterPro; IPR018502; Annexin_repeat.
DR   InterPro; IPR018252; Annexin_repeat_CS.
DR   InterPro; IPR015473; Annexins_V.
DR   InterPro; IPR002392; AnnexinV.
DR   PANTHER; PTHR10502:SF26; PTHR10502:SF26; 1.
DR   Pfam; PF00191; Annexin; 4.
DR   PRINTS; PR00196; ANNEXIN.
DR   PRINTS; PR00201; ANNEXINV.
DR   SMART; SM00335; ANX; 4.
DR   PROSITE; PS00223; ANNEXIN; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Annexin; Blood coagulation; Calcium;
KW   Calcium/phospholipid-binding; Complete proteome;
KW   Direct protein sequencing; Hemostasis; Isopeptide bond;
KW   Phosphoprotein; Reference proteome; Repeat; S-nitrosylation;
KW   Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000269|PubMed:2963810}.
FT   CHAIN         2    320       Annexin A5.
FT                                /FTId=PRO_0000067487.
FT   REPEAT       24     84       Annexin 1.
FT   REPEAT       96    156       Annexin 2.
FT   REPEAT      180    240       Annexin 3.
FT   REPEAT      255    315       Annexin 4.
FT   MOTIF       314    319       [IL]-x-C-x-x-[DE] motif.
FT                                {ECO:0000305|PubMed:25417112}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330}.
FT   MOD_RES      37     37       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P48036}.
FT   MOD_RES      70     70       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      76     76       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      79     79       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      97     97       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     101    101       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:16916647}.
FT   MOD_RES     290    290       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P48036}.
FT   CROSSLNK     29     29       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1).
FT                                {ECO:0000244|PubMed:25114211}.
FT   CROSSLNK     29     29       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25772364}.
FT   CONFLICT    135    135       S -> L (in Ref. 10; CAG38759).
FT                                {ECO:0000305}.
FT   CONFLICT    279    279       I -> T (in Ref. 13; AAH18671).
FT                                {ECO:0000305}.
FT   HELIX        17     28       {ECO:0000244|PDB:1ANX}.
FT   STRAND       29     32       {ECO:0000244|PDB:1ANX}.
FT   HELIX        35     43       {ECO:0000244|PDB:1ANX}.
FT   HELIX        47     61       {ECO:0000244|PDB:1ANX}.
FT   HELIX        65     72       {ECO:0000244|PDB:1ANX}.
FT   HELIX        75     85       {ECO:0000244|PDB:1ANX}.
FT   HELIX        88    100       {ECO:0000244|PDB:1ANX}.
FT   STRAND      102    104       {ECO:0000244|PDB:1ANX}.
FT   HELIX       107    116       {ECO:0000244|PDB:1ANX}.
FT   HELIX       119    133       {ECO:0000244|PDB:1ANX}.
FT   HELIX       137    144       {ECO:0000244|PDB:1ANX}.
FT   HELIX       147    157       {ECO:0000244|PDB:1ANX}.
FT   HELIX       169    182       {ECO:0000244|PDB:1ANX}.
FT   TURN        183    185       {ECO:0000244|PDB:1ANX}.
FT   STRAND      186    188       {ECO:0000244|PDB:1ANX}.
FT   HELIX       191    200       {ECO:0000244|PDB:1ANX}.
FT   HELIX       203    217       {ECO:0000244|PDB:1ANX}.
FT   HELIX       221    228       {ECO:0000244|PDB:1ANX}.
FT   HELIX       231    245       {ECO:0000244|PDB:1ANX}.
FT   HELIX       247    256       {ECO:0000244|PDB:1ANX}.
FT   HELIX       257    259       {ECO:0000244|PDB:1ANX}.
FT   STRAND      260    263       {ECO:0000244|PDB:1ANX}.
FT   HELIX       266    276       {ECO:0000244|PDB:1ANX}.
FT   TURN        277    280       {ECO:0000244|PDB:1ANX}.
FT   HELIX       281    290       {ECO:0000244|PDB:1ANX}.
FT   STRAND      292    294       {ECO:0000244|PDB:1HVG}.
FT   HELIX       296    303       {ECO:0000244|PDB:1ANX}.
FT   HELIX       306    316       {ECO:0000244|PDB:1ANX}.
SQ   SEQUENCE   320 AA;  35937 MW;  45E14E3964BA4D1A CRC64;
     MAQVLRGTVT DFPGFDERAD AETLRKAMKG LGTDEESILT LLTSRSNAQR QEISAAFKTL
     FGRDLLDDLK SELTGKFEKL IVALMKPSRL YDAYELKHAL KGAGTNEKVL TEIIASRTPE
     ELRAIKQVYE EEYGSSLEDD VVGDTSGYYQ RMLVVLLQAN RDPDAGIDEA QVEQDAQALF
     QAGELKWGTD EEKFITIFGT RSVSHLRKVF DKYMTISGFQ IEETIDRETS GNLEQLLLAV
     VKSIRSIPAY LAETLYYAMK GAGTDDHTLI RVMVSRSEID LFNIRKEFRK NFATSLYSMI
     KGDTSGDYKK ALLLLCGEDD
//
ID   M3K5_HUMAN              Reviewed;        1374 AA.
AC   Q99683; A6NIA0; B4DGB2; Q5THN3; Q99461;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   02-NOV-2016, entry version 179.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase 5;
DE            EC=2.7.11.25;
DE   AltName: Full=Apoptosis signal-regulating kinase 1;
DE            Short=ASK-1;
DE   AltName: Full=MAPK/ERK kinase kinase 5;
DE            Short=MEK kinase 5;
DE            Short=MEKK 5;
GN   Name=MAP3K5; Synonyms=ASK1, MAPKKK5, MEKK5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RX   PubMed=8940179; DOI=10.1074/jbc.271.49.31607;
RA   Wang X.S., Diener K., Jannuzzi D., Trollinger D., Tan T.-H.,
RA   Lichenstein H., Zukowski M., Yao Z.;
RT   "Molecular cloning and characterization of a novel protein kinase with
RT   a catalytic domain homologous to mitogen-activated protein kinase
RT   kinase kinase.";
RL   J. Biol. Chem. 271:31607-31611(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RX   PubMed=8974401; DOI=10.1126/science.275.5296.90;
RA   Ichijo H., Nishida E., Irie K., ten Dijke P., Saitoh M., Moriguchi T.,
RA   Takagi M., Matsumoto K., Miyazono K., Gotoh Y.;
RT   "Induction of apoptosis by ASK1, a mammalian MAPKKK that activates
RT   SAPK/JNK and p38 signaling pathways.";
RL   Science 275:90-94(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH TXN, ENZYME REGULATION, AND FUNCTION.
RX   PubMed=9564042; DOI=10.1093/emboj/17.9.2596;
RA   Saitoh M., Nishitoh H., Fujii M., Takeda K., Tobiume K., Sawada Y.,
RA   Kawabata M., Miyazono K., Ichijo H.;
RT   "Mammalian thioredoxin is a direct inhibitor of apoptosis signal-
RT   regulating kinase (ASK) 1.";
RL   EMBO J. 17:2596-2606(1998).
RN   [7]
RP   ENZYME REGULATION, INTERACTION WITH TRAF2, AND FUNCTION.
RX   PubMed=9774977; DOI=10.1016/S1097-2765(00)80283-X;
RA   Nishitoh H., Saitoh M., Mochida Y., Takeda K., Nakano H., Rothe M.,
RA   Miyazono K., Ichijo H.;
RT   "ASK1 is essential for JNK/SAPK activation by TRAF2.";
RL   Mol. Cell 2:389-395(1998).
RN   [8]
RP   INTERACTION WITH DAXX, AND MUTAGENESIS OF LYS-709.
RX   PubMed=9743501; DOI=10.1126/science.281.5384.1860;
RA   Chang H.Y., Nishitoh H., Yang X., Ichijo H., Baltimore D.;
RT   "Activation of apoptosis signal-regulating kinase 1 (ASK1) by the
RT   adapter protein Daxx.";
RL   Science 281:1860-1863(1998).
RN   [9]
RP   INTERACTION WITH 14-3-3 PROTEINS, ENZYME REGULATION, MUTAGENESIS OF
RP   SER-966, AND FUNCTION.
RX   PubMed=10411906; DOI=10.1073/pnas.96.15.8511;
RA   Zhang L., Chen J., Fu H.;
RT   "Suppression of apoptosis signal-regulating kinase 1-induced cell
RT   death by 14-3-3 proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:8511-8515(1999).
RN   [10]
RP   FUNCTION IN APOPTOSIS.
RX   PubMed=10849426; DOI=10.1074/jbc.M003412200;
RA   Hatai T., Matsuzawa A., Inoshita S., Mochida Y., Kuroda T.,
RA   Sakamaki K., Kuida K., Yonehara S., Ichijo H., Takeda K.;
RT   "Execution of apoptosis signal-regulating kinase 1 (ASK1)-induced
RT   apoptosis by the mitochondria-dependent caspase activation.";
RL   J. Biol. Chem. 275:26576-26581(2000).
RN   [11]
RP   SUBUNIT, INTERACTION WITH TRAF2, ENZYME REGULATION, AND FUNCTION.
RX   PubMed=10688666; DOI=10.1128/MCB.20.6.2198-2208.2000;
RA   Liu H., Nishitoh H., Ichijo H., Kyriakis J.M.;
RT   "Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor
RT   necrosis factor receptor-associated factor 2 requires prior
RT   dissociation of the ASK1 inhibitor thioredoxin.";
RL   Mol. Cell. Biol. 20:2198-2208(2000).
RN   [12]
RP   INTERACTION WITH ARRB2.
RX   PubMed=11090355; DOI=10.1126/science.290.5496.1574;
RA   McDonald P.H., Chow C.W., Miller W.E., Laporte S.A., Field M.E.,
RA   Lin F.-T., Davis R.J., Lefkowitz R.J.;
RT   "Beta-arrestin 2: a receptor-regulated MAPK scaffold for the
RT   activation of JNK3.";
RL   Science 290:1574-1577(2000).
RN   [13]
RP   INTERACTION WITH PPP5C, DEPHOSPHORYLATION AT THR-838, SUBCELLULAR
RP   LOCATION, ENZYME REGULATION, AND FUNCTION.
RX   PubMed=11689443; DOI=10.1093/emboj/20.21.6028;
RA   Morita K., Saitoh M., Tobiume K., Matsuura H., Enomoto S.,
RA   Nishitoh H., Ichijo H.;
RT   "Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5)
RT   in response to oxidative stress.";
RL   EMBO J. 20:6028-6036(2001).
RN   [14]
RP   FUNCTION IN KERATINOCYTE DIFFERENTIATION.
RX   PubMed=11029458; DOI=10.1074/jbc.M003425200;
RA   Sayama K., Hanakawa Y., Shirakata Y., Yamasaki K., Sawada Y., Sun L.,
RA   Yamanishi K., Ichijo H., Hashimoto K.;
RT   "Apoptosis signal-regulating kinase 1 (ASK1) is an intracellular
RT   inducer of keratinocyte differentiation.";
RL   J. Biol. Chem. 276:999-1004(2001).
RN   [15]
RP   PHOSPHORYLATION AT SER-83, ENZYME REGULATION, AND FUNCTION.
RX   PubMed=11154276; DOI=10.1128/MCB.21.3.893-901.2001;
RA   Kim A.H., Khursigara G., Sun X., Franke T.F., Chao M.V.;
RT   "Akt phosphorylates and negatively regulates apoptosis signal-
RT   regulating kinase 1.";
RL   Mol. Cell. Biol. 21:893-901(2001).
RN   [16]
RP   INTERACTION WITH HIV-1 NEF, AND INHIBITION BY HIV-1 NEF.
RX   PubMed=11298454; DOI=10.1038/35071111;
RA   Geleziunas R., Xu W., Takeda K., Ichijo H., Greene W.C.;
RT   "HIV-1 Nef inhibits ASK1-dependent death signalling providing a
RT   potential mechanism for protecting the infected host cell.";
RL   Nature 410:834-838(2001).
RN   [17]
RP   INTERACTION WITH RAF1.
RX   PubMed=11427728; DOI=10.1073/pnas.141224398;
RA   Chen J., Fujii K., Zhang L., Roberts T., Fu H.;
RT   "Raf-1 promotes cell survival by antagonizing apoptosis signal-
RT   regulating kinase 1 through a MEK-ERK independent mechanism.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:7783-7788(2001).
RN   [18]
RP   INTERACTION WITH TRAF2 AND ERN1, ENZYME REGULATION, AND FUNCTION IN ER
RP   STRESS RESPONSE.
RX   PubMed=14749717; DOI=10.1038/sj.embor.7400072;
RA   Takeda K., Matsuzawa A., Nishitoh H., Tobiume K., Kishida S.,
RA   Ninomiya-Tsuji J., Matsumoto K., Ichijo H.;
RT   "Involvement of ASK1 in Ca2+-induced p38 MAP kinase activation.";
RL   EMBO Rep. 5:161-166(2004).
RN   [19]
RP   FUNCTION, HOMODIMERIZATION, ENZYME REGULATION, AND PHOSPHORYLATION AT
RP   THR-838.
RX   PubMed=11920685; DOI=10.1002/jcp.10080;
RA   Tobiume K., Saitoh M., Ichijo H.;
RT   "Activation of apoptosis signal-regulating kinase 1 by the stress-
RT   induced activating phosphorylation of pre-formed oligomer.";
RL   J. Cell. Physiol. 191:95-104(2002).
RN   [20]
RP   INTERACTION WITH IGF1R, PHOSPHORYLATION, ENZYME REGULATION, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=12556535; DOI=10.1074/jbc.M211398200;
RA   Galvan V., Logvinova A., Sperandio S., Ichijo H., Bredesen D.E.;
RT   "Type 1 insulin-like growth factor receptor (IGF-IR) signaling
RT   inhibits apoptosis signal-regulating kinase 1 (ASK1).";
RL   J. Biol. Chem. 278:13325-13332(2003).
RN   [21]
RP   PHOSPHORYLATION AT SER-83, ENZYME REGULATION, AND FUNCTION.
RX   PubMed=12697749; DOI=10.1074/jbc.M302674200;
RA   Yuan Z.Q., Feldman R.I., Sussman G.E., Coppola D., Nicosia S.V.,
RA   Cheng J.Q.;
RT   "AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by
RT   phosphorylation of ASK1: implication of AKT2 in chemoresistance.";
RL   J. Biol. Chem. 278:23432-23440(2003).
RN   [22]
RP   INTERACTION WITH DAB2IP.
RX   PubMed=12813029; DOI=10.1172/JCI200317790;
RA   Zhang R., He X., Liu W., Lu M., Hsieh J.-T., Min W.;
RT   "AIP1 mediates TNF-alpha-induced ASK1 activation by facilitating
RT   dissociation of ASK1 from its inhibitor 14-3-3.";
RL   J. Clin. Invest. 111:1933-1943(2003).
RN   [23]
RP   INTERACTION WITH YWHAB; YWHAE; YWHAH; YWHAQ; YWHAZ AND SFN, FUNCTION,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=15023544; DOI=10.1016/j.yexcr.2003.12.009;
RA   Subramanian R.R., Zhang H., Wang H., Ichijo H., Miyashita T., Fu H.;
RT   "Interaction of apoptosis signal-regulating kinase 1 with isoforms of
RT   14-3-3 proteins.";
RL   Exp. Cell Res. 294:581-591(2004).
RN   [24]
RP   PHOSPHORYLATION AT SER-966, ENZYME REGULATION, AND FUNCTION.
RX   PubMed=14688258; DOI=10.1074/jbc.M311129200;
RA   Goldman E.H., Chen L., Fu H.;
RT   "Activation of apoptosis signal-regulating kinase 1 by reactive oxygen
RT   species through dephosphorylation at serine 967 and 14-3-3
RT   dissociation.";
RL   J. Biol. Chem. 279:10442-10449(2004).
RN   [25]
RP   INTERACTION WITH DAB2IP.
RX   PubMed=15310755; DOI=10.1074/jbc.M407617200;
RA   Zhang H., Zhang R., Luo Y., D'Alessio A., Pober J.S., Min W.;
RT   "AIP1/DAB2IP, a novel member of the Ras-GAP family, transduces TRAF2-
RT   induced ASK1-JNK activation.";
RL   J. Biol. Chem. 279:44955-44965(2004).
RN   [26]
RP   ENZYME REGULATION, PHOSPHORYLATION AT SER-966 AND SER-1033,
RP   MUTAGENESIS OF SER-966 AND SER-1033, AND INTERACTION WITH YWHAG.
RX   PubMed=15094778; DOI=10.1038/sj.onc.1207668;
RA   Fujii K., Goldman E.H., Park H.R., Zhang L., Chen J., Fu H.;
RT   "Negative control of apoptosis signal-regulating kinase 1 through
RT   phosphorylation of Ser-1034.";
RL   Oncogene 23:5099-5104(2004).
RN   [27]
RP   INTERACTION WITH STUB1, AND UBIQUITINATION.
RX   PubMed=16038411; DOI=10.1379/CSC-90R.1;
RA   Hwang J.R., Zhang C., Patterson C.;
RT   "C-terminus of heat shock protein 70-interacting protein facilitates
RT   degradation of apoptosis signal-regulating kinase 1 and inhibits
RT   apoptosis signal-regulating kinase 1-dependent apoptosis.";
RL   Cell Stress Chaperones 10:147-156(2005).
RN   [28]
RP   INTERACTION WITH HIPK1, AND SUBCELLULAR LOCATION.
RX   PubMed=15701637; DOI=10.1074/jbc.M414262200;
RA   Li X., Zhang R., Luo D., Park S.-J., Wang Q., Kim Y., Min W.;
RT   "Tumor necrosis factor alpha-induced desumoylation and cytoplasmic
RT   translocation of homeodomain-interacting protein kinase 1 are critical
RT   for apoptosis signal-regulating kinase 1-JNK/p38 activation.";
RL   J. Biol. Chem. 280:15061-15070(2005).
RN   [29]
RP   SUBUNIT, INTERACTION WITH TRAF2, AND FUNCTION.
RX   PubMed=16129676; DOI=10.1074/jbc.M506771200;
RA   Noguchi T., Takeda K., Matsuzawa A., Saegusa K., Nakano H., Gohda J.,
RA   Inoue J., Ichijo H.;
RT   "Recruitment of tumor necrosis factor receptor-associated factor
RT   family proteins to apoptosis signal-regulating kinase 1 signalosome is
RT   essential for oxidative stress-induced cell death.";
RL   J. Biol. Chem. 280:37033-37040(2005).
RN   [30]
RP   PHOSPHORYLATION AT TYR-718, INTERACTION WITH SOCS1, AND ENZYME
RP   REGULATION.
RX   PubMed=16407264; DOI=10.1074/jbc.M512338200;
RA   He Y., Zhang W., Zhang R., Zhang H., Min W.;
RT   "SOCS1 inhibits tumor necrosis factor-induced activation of ASK1-JNK
RT   inflammatory signaling by mediating ASK1 degradation.";
RL   J. Biol. Chem. 281:5559-5566(2006).
RN   [31]
RP   INTERACTION WITH PPM1L.
RX   PubMed=17456047; DOI=10.1042/BJ20070231;
RA   Saito J., Toriumi S., Awano K., Ichijo H., Sasaki K., Kobayashi T.,
RA   Tamura S.;
RT   "Regulation of apoptosis signal-regulating kinase 1 by protein
RT   phosphatase 2Cepsilon.";
RL   Biochem. J. 405:591-596(2007).
RN   [32]
RP   ENZYME REGULATION, INTERACTION WITH MAP3K5, PHOSPHORYLATION AT
RP   THR-838, AND MUTAGENESIS OF LYS-709.
RX   PubMed=17210579; DOI=10.1074/jbc.M607177200;
RA   Takeda K., Shimozono R., Noguchi T., Umeda T., Morimoto Y., Naguro I.,
RA   Tobiume K., Saitoh M., Matsuzawa A., Ichijo H.;
RT   "Apoptosis signal-regulating kinase (ASK) 2 functions as a mitogen-
RT   activated protein kinase kinase kinase in a heteromeric complex with
RT   ASK1.";
RL   J. Biol. Chem. 282:7522-7531(2007).
RN   [33]
RP   INTERACTION WITH BIRC2, UBIQUITINATION, AND FUNCTION.
RX   PubMed=17220297; DOI=10.1074/jbc.M609146200;
RA   Zhao Y., Conze D.B., Hanover J.A., Ashwell J.D.;
RT   "Tumor necrosis factor receptor 2 signaling induces selective c-IAP1-
RT   dependent ASK1 ubiquitination and terminates mitogen-activated protein
RT   kinase signaling.";
RL   J. Biol. Chem. 282:7777-7782(2007).
RN   [34]
RP   INTERACTION WITH DAB2IP.
RX   PubMed=17389591; DOI=10.1074/jbc.M701148200;
RA   Zhang H., Zhang H., Lin Y., Li J., Pober J.S., Min W.;
RT   "RIP1-mediated AIP1 phosphorylation at a 14-3-3-binding site is
RT   critical for tumor necrosis factor-induced ASK1-JNK/p38 activation.";
RL   J. Biol. Chem. 282:14788-14796(2007).
RN   [35]
RP   INTERACTION WITH TRAF2; TRAF6 AND TXN.
RX   PubMed=17724081; DOI=10.1128/MCB.00227-07;
RA   Fujino G., Noguchi T., Matsuzawa A., Yamauchi S., Saitoh M.,
RA   Takeda K., Ichijo H.;
RT   "Thioredoxin and TRAF family proteins regulate reactive oxygen
RT   species-dependent activation of ASK1 through reciprocal modulation of
RT   the N-terminal homophilic interaction of ASK1.";
RL   Mol. Cell. Biol. 27:8152-8163(2007).
RN   [36]
RP   INTERACTION WITH ARRB2.
RX   PubMed=18408005; DOI=10.1074/jbc.M710006200;
RA   Guo C., Whitmarsh A.J.;
RT   "The beta-arrestin-2 scaffold protein promotes c-Jun N-terminal
RT   kinase-3 activation by binding to its nonconserved N terminus.";
RL   J. Biol. Chem. 283:15903-15911(2008).
RN   [37]
RP   PHOSPHORYLATION AT THR-838.
RX   PubMed=18948261; DOI=10.1074/jbc.M807219200;
RA   Jung H., Seong H.A., Ha H.;
RT   "Murine protein serine/threonine kinase 38 activates apoptosis signal-
RT   regulating kinase 1 via Thr 838 phosphorylation.";
RL   J. Biol. Chem. 283:34541-34553(2008).
RN   [38]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1029 AND SER-1033, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [39]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1029 AND SER-1033, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [40]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1033, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [41]
RP   PHOSPHORYLATION AT SER-83 BY PIM1, AND INTERACTION WITH PIM1.
RX   PubMed=19749799; DOI=10.1038/onc.2009.276;
RA   Gu J.J., Wang Z., Reeves R., Magnuson N.S.;
RT   "PIM1 phosphorylates and negatively regulates ASK1-mediated
RT   apoptosis.";
RL   Oncogene 28:4261-4271(2009).
RN   [42]
RP   INTERACTION WITH PGAM5, AND PHOSPHORYLATION AT THR-838; SER-966 AND
RP   SER-1033.
RX   PubMed=19590015; DOI=10.1073/pnas.0901823106;
RA   Takeda K., Komuro Y., Hayakawa T., Oguchi H., Ishida Y., Murakami S.,
RA   Noguchi T., Kinoshita H., Sekine Y., Iemura S., Natsume T., Ichijo H.;
RT   "Mitochondrial phosphoglycerate mutase 5 uses alternate catalytic
RT   activity as a protein serine/threonine phosphatase to activate ASK1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:12301-12305(2009).
RN   [43]
RP   REVIEW ON ENZYME REGULATION, AND REVIEW ON FUNCTION.
RX   PubMed=17883330; DOI=10.1146/annurev.pharmtox.48.113006.094606;
RA   Takeda K., Noguchi T., Naguro I., Ichijo H.;
RT   "Apoptosis signal-regulating kinase 1 in stress and immune response.";
RL   Annu. Rev. Pharmacol. Toxicol. 48:199-225(2008).
RN   [44]
RP   REVIEW ON ENZYME REGULATION, AND REVIEW ON FUNCTION.
RX   PubMed=19389260; DOI=10.1186/1478-811X-7-9;
RA   Hattori K., Naguro I., Runchel C., Ichijo H.;
RT   "The roles of ASK family proteins in stress responses and diseases.";
RL   Cell Commun. Signal. 7:9-9(2009).
RN   [45]
RP   INTERACTION WITH DUSP13.
RX   PubMed=20358250; DOI=10.1007/s00018-010-0353-3;
RA   Park J.E., Park B.C., Kim H.A., Song M., Park S.G., Lee D.H.,
RA   Kim H.J., Choi H.K., Kim J.T., Cho S.;
RT   "Positive regulation of apoptosis signal-regulating kinase 1 by dual-
RT   specificity phosphatase 13A.";
RL   Cell. Mol. Life Sci. 67:2619-2629(2010).
RN   [46]
RP   FUNCTION, PHOSPHORYLATION AT THR-838, AND DEPHOSPHORYLATION AT THR-838
RP   BY PPP5C.
RX   PubMed=23102700; DOI=10.1016/j.molcel.2012.09.018;
RA   Sekine Y., Hatanaka R., Watanabe T., Sono N., Iemura S., Natsume T.,
RA   Kuranaga E., Miura M., Takeda K., Ichijo H.;
RT   "The Kelch repeat protein KLHDC10 regulates oxidative stress-induced
RT   ASK1 activation by suppressing PP5.";
RL   Mol. Cell 48:692-704(2012).
RN   [47]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-958, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [48]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [49]
RP   INTERACTION WITH RC3H2, AND MUTAGENESIS OF LYS-709.
RX   PubMed=24448648; DOI=10.1126/scisignal.2004822;
RA   Maruyama T., Araki T., Kawarazaki Y., Naguro I., Heynen S.,
RA   Aza-Blanc P., Ronai Z., Matsuzawa A., Ichijo H.;
RT   "Roquin-2 promotes ubiquitin-mediated degradation of ASK1 to regulate
RT   stress responses.";
RL   Sci. Signal. 7:RA8-RA8(2014).
RN   [50]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 659-951, AND PHOSPHORYLATION
RP   AT THR-813; THR-838 AND THR-842.
RX   PubMed=17937911; DOI=10.1016/j.str.2007.08.011;
RA   Bunkoczi G., Salah E., Filippakopoulos P., Fedorov O., Muller S.,
RA   Sobott F., Parker S.A., Zhang H., Min W., Turk B.E., Knapp S.;
RT   "Structural and functional characterization of the human protein
RT   kinase ASK1.";
RL   Structure 15:1215-1226(2007).
RN   [51]
RP   VARIANTS [LARGE SCALE ANALYSIS] ARG-1006; THR-1214; VAL-1250; ILE-1314
RP   AND ASN-1315.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine kinase which acts as an essential
CC       component of the MAP kinase signal transduction pathway. Plays an
CC       important role in the cascades of cellular responses evoked by
CC       changes in the environment. Mediates signaling for determination
CC       of cell fate such as differentiation and survival. Plays a crucial
CC       role in the apoptosis signal transduction pathway through
CC       mitochondria-dependent caspase activation. MAP3K5/ASK1 is required
CC       for the innate immune response, which is essential for host
CC       defense against a wide range of pathogens. Mediates signal
CC       transduction of various stressors like oxidative stress as well as
CC       by receptor-mediated inflammatory signals, such as the tumor
CC       necrosis factor (TNF) or lipopolysaccharide (LPS). Once activated,
CC       acts as an upstream activator of the MKK/JNK signal transduction
CC       cascade and the p38 MAPK signal transduction cascade through the
CC       phosphorylation and activation of several MAP kinase kinases like
CC       MAP2K4/SEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These
CC       MAP2Ks in turn activate p38 MAPKs and c-jun N-terminal kinases
CC       (JNKs). Both p38 MAPK and JNKs control the transcription factors
CC       activator protein-1 (AP-1). {ECO:0000269|PubMed:10411906,
CC       ECO:0000269|PubMed:10688666, ECO:0000269|PubMed:10849426,
CC       ECO:0000269|PubMed:11029458, ECO:0000269|PubMed:11154276,
CC       ECO:0000269|PubMed:11689443, ECO:0000269|PubMed:11920685,
CC       ECO:0000269|PubMed:12697749, ECO:0000269|PubMed:14688258,
CC       ECO:0000269|PubMed:14749717, ECO:0000269|PubMed:15023544,
CC       ECO:0000269|PubMed:16129676, ECO:0000269|PubMed:17220297,
CC       ECO:0000269|PubMed:23102700, ECO:0000269|PubMed:8940179,
CC       ECO:0000269|PubMed:8974401, ECO:0000269|PubMed:9564042,
CC       ECO:0000269|PubMed:9774977}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- ENZYME REGULATION: Activated by various stressors, including
CC       oxidative stress, endoplasmic reticulum stress, and calcium
CC       overload, as well as by receptor-mediated inflammatory signals,
CC       such as the tumor necrosis factor (TNF) and lipopolysaccharide
CC       (LPS). Homophilic association of MAP3K5/ASK1 through the C-
CC       terminal coiled-coil domains and the heteromeric complex formation
CC       of MAP3K5/ASK1 with the reduced form of thioredoxin (TXN),
CC       constitutes an inactive form of the kinase (PubMed:17210579,
CC       PubMed:9564042). Upon ROS-induced dissociation of TXN from
CC       MAP3K5/ASK1, TRAF2 and TRAF6 are reciprocally recruited to
CC       MAP3K5/ASK1 and form the active MAP3K5/ASK1 signalosome, in which
CC       TRAF2 and TRAF6 appear to facilitate the active configuration of
CC       MAP3K5/ASK1 (PubMed:9774977, PubMed:10688666, PubMed:11920685).
CC       MAP3K5/ASK1 activity is also regulated through several
CC       phosphorylation and dephosphorylation events. Thr-838 is an
CC       activating phosphorylation site that is autophosphorylated and
CC       phosphorylated by MAP3K6/ASK2 and dephosphorylated by PPP5C
CC       (PubMed:11689443). Ser-83 and Ser-1033 are inactivating
CC       phosphorylation sites, the former of which is phosphorylated by
CC       AKT1 and AKT2 (PubMed:11154276, PubMed:12697749, PubMed:15094778).
CC       Phosphorylation of Ser-966 induces association of MAP3K5/ASK1 with
CC       the 14-3-3 family proteins, which suppresses MAP3K5/ASK1 activity
CC       (PubMed:10411906, PubMed:14688258). Calcium/calmodulin-activated
CC       protein phosphatase calcineurin (PPP3CA) has been shown to
CC       directly dephosphorylate this site (PubMed:14749717). SOCS1 binds
CC       to ASK1 by recognizing phosphorylation of Tyr-718 and induces
CC       MAP3K5/ASK1 degradation in endothelial cells (PubMed:16407264).
CC       Also dephosphorylated and activated by PGAM5. Contains an N-
CC       terminal autoinhibitory domain. Once activated targeted for
CC       proteosomal degradation by RC3H2-mediated ubiquitination
CC       (PubMed:24448648). {ECO:0000269|PubMed:10411906,
CC       ECO:0000269|PubMed:10688666, ECO:0000269|PubMed:11154276,
CC       ECO:0000269|PubMed:11689443, ECO:0000269|PubMed:11920685,
CC       ECO:0000269|PubMed:12556535, ECO:0000269|PubMed:12697749,
CC       ECO:0000269|PubMed:14688258, ECO:0000269|PubMed:14749717,
CC       ECO:0000269|PubMed:15094778, ECO:0000269|PubMed:16407264,
CC       ECO:0000269|PubMed:17210579, ECO:0000269|PubMed:24448648,
CC       ECO:0000269|PubMed:9564042, ECO:0000269|PubMed:9774977}.
CC   -!- SUBUNIT: Homodimer when inactive. Binds both upstream activators
CC       and downstream substrates in multimolecular complexes. Associates
CC       with and inhibited by HIV-1 Nef (PubMed:11298454). Part of a
CC       cytoplasmic complex made of HIPK1, DAB2IP and MAP3K5 in response
CC       to TNF (PubMed:15310755, PubMed:15701637, PubMed:17210579,
CC       PubMed:17389591). This complex formation promotes MAP3K5-JNK
CC       activation and subsequent apoptosis. Interacts with SOCS1 which
CC       recognizes phosphorylation of Tyr-718 and induces MAP3K5/ASK1
CC       degradation in endothelial cells. Interacts with the 14-3-3 family
CC       proteins such as YWHAB, YWHAE, YWHAQ, YWHAH, YWHAZ and SFN
CC       (PubMed:10411906, PubMed:15023544, PubMed:15094778). Interacts
CC       with ARRB2, BIRC2, DAB2IP, IGF1R, MAP3K6/ASK2, PGAM5, PIM1, PPP5C,
CC       SOCS1, STUB1, TRAF2, TRAF6 and TXN (PubMed:9564042,PubMed:9774977,
CC       PubMed:10688666, PubMed:11090355, PubMed:11689443,
CC       PubMed:12556535, PubMed:12813029, PubMed:15310755,
CC       PubMed:16038411, PubMed:16129676, PubMed:16407264,
CC       PubMed:17220297, PubMed:17724081, PubMed:18408005,
CC       PubMed:19590015, PubMed:19749799). Interacts with ERN1 in a TRAF2-
CC       dependent manner (PubMed:14749717). Interacts with calcineurin
CC       subunit PPP3R1 and with PPM1L (PubMed:17456047) (By similarity).
CC       Interacts (via N-terminus) with RAF1 and this interaction inhibits
CC       the proapoptotic function of MAP3K5 (PubMed:11427728). Interacts
CC       with DAB2IP (via N-terminus C2 domain); the interaction occurs in
CC       a TNF-alpha-dependent manner (PubMed:15310755). Interacts with
CC       DUSP13/DUSP13A; may positively regulate apoptosis
CC       (PubMed:20358250). Interacts with DAXX (PubMed:9743501). Interacts
CC       with RC3H2 (PubMed:24448648). {ECO:0000250,
CC       ECO:0000269|PubMed:10411906, ECO:0000269|PubMed:10688666,
CC       ECO:0000269|PubMed:11090355, ECO:0000269|PubMed:11298454,
CC       ECO:0000269|PubMed:11427728, ECO:0000269|PubMed:11689443,
CC       ECO:0000269|PubMed:12556535, ECO:0000269|PubMed:12813029,
CC       ECO:0000269|PubMed:14749717, ECO:0000269|PubMed:15023544,
CC       ECO:0000269|PubMed:15094778, ECO:0000269|PubMed:15310755,
CC       ECO:0000269|PubMed:15701637, ECO:0000269|PubMed:16038411,
CC       ECO:0000269|PubMed:16129676, ECO:0000269|PubMed:16407264,
CC       ECO:0000269|PubMed:17210579, ECO:0000269|PubMed:17220297,
CC       ECO:0000269|PubMed:17389591, ECO:0000269|PubMed:17456047,
CC       ECO:0000269|PubMed:17724081, ECO:0000269|PubMed:18408005,
CC       ECO:0000269|PubMed:19590015, ECO:0000269|PubMed:19749799,
CC       ECO:0000269|PubMed:20358250, ECO:0000269|PubMed:24448648,
CC       ECO:0000269|PubMed:9564042, ECO:0000269|PubMed:9743501,
CC       ECO:0000269|PubMed:9774977}.
CC   -!- INTERACTION:
CC       P31749:AKT1; NbExp=2; IntAct=EBI-476263, EBI-296087;
CC       P05067:APP; NbExp=2; IntAct=EBI-476263, EBI-77613;
CC       P49407:ARRB1; NbExp=3; IntAct=EBI-476263, EBI-743313;
CC       P32121:ARRB2; NbExp=2; IntAct=EBI-476263, EBI-714559;
CC       Q5VWQ8:DAB2IP; NbExp=2; IntAct=EBI-476263, EBI-2871881;
CC       Q9UER7:DAXX; NbExp=7; IntAct=EBI-476263, EBI-77321;
CC       P25445:FAS; NbExp=2; IntAct=EBI-476263, EBI-494743;
CC       P46734:MAP2K3; NbExp=2; IntAct=EBI-476263, EBI-602462;
CC       Q9WTR2:Map3k6 (xeno); NbExp=3; IntAct=EBI-476263, EBI-1254790;
CC       Q96EZ8:MCRS1; NbExp=3; IntAct=EBI-476263, EBI-348259;
CC       P63098:PPP3R1; NbExp=2; IntAct=EBI-476263, EBI-915984;
CC       Q16637:SMN2; NbExp=3; IntAct=EBI-476263, EBI-395421;
CC       P10599:TXN; NbExp=2; IntAct=EBI-476263, EBI-594644;
CC       P31946:YWHAB; NbExp=3; IntAct=EBI-476263, EBI-359815;
CC       P63104:YWHAZ; NbExp=4; IntAct=EBI-476263, EBI-347088;
CC       Q969S3:ZNF622; NbExp=14; IntAct=EBI-476263, EBI-2687480;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Endoplasmic reticulum.
CC       Note=Interaction with 14-3-3 proteins alters the distribution of
CC       MAP3K5/ASK1 and restricts it to the perinuclear endoplasmic
CC       reticulum region.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q99683-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q99683-2; Sequence=VSP_056182;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Abundantly expressed in heart and pancreas.
CC   -!- INDUCTION: By TNF. Inhibited by HIV-1 Nef.
CC   -!- PTM: Phosphorylated at Thr-838 through autophosphorylation and by
CC       MAP3K6/ASK2 which leads to activation. Thr-838 is dephosphorylated
CC       by PPP5C. Ser-83 and Ser-1033 are inactivating phosphorylation
CC       sites, the former of which is phosphorylated by AKT1 and AKT2.
CC       Phosphorylated at Ser-966 which induces association of MAP3K5/ASK1
CC       with the 14-3-3 family proteins and suppresses MAP3K5/ASK1
CC       activity. Calcineurin (CN) dephosphorylates this site. Also
CC       dephosphorylated and activated by PGAM5.
CC       {ECO:0000269|PubMed:11154276, ECO:0000269|PubMed:11920685,
CC       ECO:0000269|PubMed:12556535, ECO:0000269|PubMed:12697749,
CC       ECO:0000269|PubMed:14688258, ECO:0000269|PubMed:15094778,
CC       ECO:0000269|PubMed:16407264, ECO:0000269|PubMed:17210579,
CC       ECO:0000269|PubMed:17937911, ECO:0000269|PubMed:18948261,
CC       ECO:0000269|PubMed:19590015, ECO:0000269|PubMed:19749799,
CC       ECO:0000269|PubMed:23102700}.
CC   -!- PTM: Ubiquitinated. Tumor necrosis factor (TNF) induces TNFR2-
CC       dependent ubiquitination leading to proteasomal degradation.
CC       {ECO:0000269|PubMed:16038411, ECO:0000269|PubMed:17220297}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase kinase subfamily.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U67156; AAC50894.1; -; mRNA.
DR   EMBL; D84476; BAA12684.2; -; mRNA.
DR   EMBL; AK294507; BAG57723.1; -; mRNA.
DR   EMBL; AL024508; CAI20176.1; -; Genomic_DNA.
DR   EMBL; AL121933; CAI20176.1; JOINED; Genomic_DNA.
DR   EMBL; AL121933; CAI15470.1; -; Genomic_DNA.
DR   EMBL; AL024508; CAI15470.1; JOINED; Genomic_DNA.
DR   EMBL; BC054503; AAH54503.1; -; mRNA.
DR   EMBL; BC088829; AAH88829.1; -; mRNA.
DR   CCDS; CCDS5179.1; -. [Q99683-1]
DR   RefSeq; NP_005914.1; NM_005923.3. [Q99683-1]
DR   UniGene; Hs.186486; -.
DR   PDB; 2CLQ; X-ray; 2.30 A; A/B=659-951.
DR   PDB; 3VW6; X-ray; 2.40 A; A/B=671-939.
DR   PDB; 4BF2; X-ray; 2.11 A; A/B=660-977.
DR   PDB; 4BHN; X-ray; 2.30 A; A/B=660-977.
DR   PDB; 4BIB; X-ray; 2.43 A; A/B=660-977.
DR   PDB; 4BIC; X-ray; 2.62 A; A/B=660-977.
DR   PDB; 4BID; X-ray; 2.80 A; A/B=660-977.
DR   PDB; 4BIE; X-ray; 2.36 A; A/B=660-977.
DR   PDBsum; 2CLQ; -.
DR   PDBsum; 3VW6; -.
DR   PDBsum; 4BF2; -.
DR   PDBsum; 4BHN; -.
DR   PDBsum; 4BIB; -.
DR   PDBsum; 4BIC; -.
DR   PDBsum; 4BID; -.
DR   PDBsum; 4BIE; -.
DR   ProteinModelPortal; Q99683; -.
DR   SMR; Q99683; -.
DR   BioGrid; 110381; 82.
DR   DIP; DIP-29516N; -.
DR   IntAct; Q99683; 41.
DR   MINT; MINT-99796; -.
DR   STRING; 9606.ENSP00000351908; -.
DR   BindingDB; Q99683; -.
DR   ChEMBL; CHEMBL5285; -.
DR   GuidetoPHARMACOLOGY; 2080; -.
DR   iPTMnet; Q99683; -.
DR   PhosphoSitePlus; Q99683; -.
DR   BioMuta; MAP3K5; -.
DR   DMDM; 6685617; -.
DR   EPD; Q99683; -.
DR   MaxQB; Q99683; -.
DR   PaxDb; Q99683; -.
DR   PeptideAtlas; Q99683; -.
DR   PRIDE; Q99683; -.
DR   DNASU; 4217; -.
DR   Ensembl; ENST00000359015; ENSP00000351908; ENSG00000197442. [Q99683-1]
DR   GeneID; 4217; -.
DR   KEGG; hsa:4217; -.
DR   UCSC; uc003qhc.4; human. [Q99683-1]
DR   CTD; 4217; -.
DR   DisGeNET; 4217; -.
DR   GeneCards; MAP3K5; -.
DR   HGNC; HGNC:6857; MAP3K5.
DR   HPA; CAB007824; -.
DR   MIM; 602448; gene.
DR   neXtProt; NX_Q99683; -.
DR   OpenTargets; ENSG00000197442; -.
DR   PharmGKB; PA30601; -.
DR   eggNOG; KOG4279; Eukaryota.
DR   eggNOG; ENOG410XQGS; LUCA.
DR   GeneTree; ENSGT00800000124036; -.
DR   HOGENOM; HOG000293286; -.
DR   HOVERGEN; HBG006305; -.
DR   InParanoid; Q99683; -.
DR   KO; K04426; -.
DR   OMA; TELHCKK; -.
DR   OrthoDB; EOG091G00SJ; -.
DR   PhylomeDB; Q99683; -.
DR   TreeFam; TF105115; -.
DR   BioCyc; ZFISH:HS00234-MONOMER; -.
DR   BRENDA; 2.7.12.2; 2681.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   SignaLink; Q99683; -.
DR   SIGNOR; Q99683; -.
DR   ChiTaRS; MAP3K5; human.
DR   EvolutionaryTrace; Q99683; -.
DR   GeneWiki; ASK1; -.
DR   GenomeRNAi; 4217; -.
DR   PRO; PR:Q99683; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000197442; -.
DR   CleanEx; HS_MAP3K5; -.
DR   Genevisible; Q99683; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:1990604; C:IRE1-TRAF2-ASK1 complex; IDA:ParkinsonsUK-UCL.
DR   GO; GO:1902911; C:protein kinase complex; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0004709; F:MAP kinase kinase kinase activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0019903; F:protein phosphatase binding; IPI:BHF-UCL.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; TAS:Reactome.
DR   GO; GO:0007257; P:activation of JUN kinase activity; TAS:ProtInc.
DR   GO; GO:0000186; P:activation of MAPKK activity; IDA:BHF-UCL.
DR   GO; GO:0097190; P:apoptotic signaling pathway; TAS:ProtInc.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IDA:BHF-UCL.
DR   GO; GO:1902170; P:cellular response to reactive nitrogen species; IEA:Ensembl.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl.
DR   GO; GO:0072577; P:endothelial cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; IDA:UniProtKB.
DR   GO; GO:0007254; P:JNK cascade; IDA:UniProtKB.
DR   GO; GO:0000165; P:MAPK cascade; IDA:UniProtKB.
DR   GO; GO:0038066; P:p38MAPK cascade; IEA:Ensembl.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0010666; P:positive regulation of cardiac muscle cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:BHF-UCL.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0043507; P:positive regulation of JUN kinase activity; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0045663; P:positive regulation of myoblast differentiation; IEA:Ensembl.
DR   GO; GO:1901216; P:positive regulation of neuron death; IGI:ParkinsonsUK-UCL.
DR   GO; GO:1900745; P:positive regulation of p38MAPK cascade; IEA:Ensembl.
DR   GO; GO:1904707; P:positive regulation of vascular smooth muscle cell proliferation; IEA:Ensembl.
DR   GO; GO:0097300; P:programmed necrotic cell death; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0002931; P:response to ischemia; IEA:Ensembl.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   GO; GO:0042060; P:wound healing; IEA:Ensembl.
DR   InterPro; IPR025136; DUF4071.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR013761; SAM/pointed.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF13281; DUF4071; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Apoptosis; ATP-binding;
KW   Coiled coil; Complete proteome; Cytoplasm; Endoplasmic reticulum;
KW   Host-virus interaction; Immunity; Innate immunity; Kinase; Magnesium;
KW   Metal-binding; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; Serine/threonine-protein kinase; Stress response;
KW   Transferase; Ubl conjugation.
FT   CHAIN         1   1374       Mitogen-activated protein kinase kinase
FT                                kinase 5.
FT                                /FTId=PRO_0000086249.
FT   DOMAIN      680    938       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     686    694       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   COILED     1245   1285       {ECO:0000255}.
FT   ACT_SITE    803    803       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     709    709       ATP.
FT   MOD_RES      83     83       Phosphoserine; by PIM1, PKB/AKT1 and
FT                                PKB/AKT2. {ECO:0000269|PubMed:11154276,
FT                                ECO:0000269|PubMed:12697749,
FT                                ECO:0000269|PubMed:19749799}.
FT   MOD_RES     718    718       Phosphotyrosine.
FT                                {ECO:0000269|PubMed:16407264}.
FT   MOD_RES     813    813       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000269|PubMed:17937911}.
FT   MOD_RES     838    838       Phosphothreonine; by autocatalysis, MELK
FT                                and MAP3K6. {ECO:0000269|PubMed:11920685,
FT                                ECO:0000269|PubMed:17210579,
FT                                ECO:0000269|PubMed:17937911,
FT                                ECO:0000269|PubMed:18948261,
FT                                ECO:0000269|PubMed:19590015,
FT                                ECO:0000269|PubMed:23102700}.
FT   MOD_RES     842    842       Phosphothreonine; by autocatalysis.
FT                                {ECO:0000269|PubMed:17937911}.
FT   MOD_RES     958    958       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     966    966       Phosphoserine.
FT                                {ECO:0000269|PubMed:14688258,
FT                                ECO:0000269|PubMed:15094778,
FT                                ECO:0000269|PubMed:19590015}.
FT   MOD_RES    1029   1029       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18669648}.
FT   MOD_RES    1033   1033       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000269|PubMed:15094778,
FT                                ECO:0000269|PubMed:19590015}.
FT   VAR_SEQ       1    753       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056182.
FT   VARIANT    1006   1006       G -> R (in dbSNP:rs45626535).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040693.
FT   VARIANT    1214   1214       I -> T (in dbSNP:rs56379668).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040694.
FT   VARIANT    1250   1250       I -> V (in dbSNP:rs35551087).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040695.
FT   VARIANT    1314   1314       T -> I (in dbSNP:rs45599539).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040696.
FT   VARIANT    1315   1315       D -> N (in dbSNP:rs41288957).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040697.
FT   MUTAGEN     709    709       K->M: Loss of kinase activity. Inhibits
FT                                activation of JNK and apoptosis mediated
FT                                by TNFRSF6 and DAXX.
FT                                {ECO:0000269|PubMed:17210579,
FT                                ECO:0000269|PubMed:9743501}.
FT   MUTAGEN     709    709       K->R: Loss of kinase activity. Abolishes
FT                                DAXX-mediated apoptosis. Loss of RC3H2-
FT                                mediated ubiquitination.
FT                                {ECO:0000269|PubMed:17210579,
FT                                ECO:0000269|PubMed:24448648,
FT                                ECO:0000269|PubMed:9743501}.
FT   MUTAGEN     966    966       S->A: Enhanced induction of apoptosis,
FT                                increased kinase activity, and loss of
FT                                YWHAG binding.
FT                                {ECO:0000269|PubMed:10411906,
FT                                ECO:0000269|PubMed:15094778}.
FT   MUTAGEN    1033   1033       S->A: Enhanced induction of apoptosis and
FT                                increased kinase activity.
FT                                {ECO:0000269|PubMed:15094778}.
FT   STRAND      673    675       {ECO:0000244|PDB:4BF2}.
FT   STRAND      681    683       {ECO:0000244|PDB:2CLQ}.
FT   STRAND      685    688       {ECO:0000244|PDB:4BF2}.
FT   STRAND      693    699       {ECO:0000244|PDB:4BF2}.
FT   TURN        700    702       {ECO:0000244|PDB:4BF2}.
FT   STRAND      705    712       {ECO:0000244|PDB:4BF2}.
FT   HELIX       725    729       {ECO:0000244|PDB:4BF2}.
FT   STRAND      740    746       {ECO:0000244|PDB:4BF2}.
FT   STRAND      749    755       {ECO:0000244|PDB:4BF2}.
FT   STRAND      758    761       {ECO:0000244|PDB:4BF2}.
FT   HELIX       762    768       {ECO:0000244|PDB:4BF2}.
FT   HELIX       777    796       {ECO:0000244|PDB:4BF2}.
FT   HELIX       806    808       {ECO:0000244|PDB:4BF2}.
FT   STRAND      809    812       {ECO:0000244|PDB:4BF2}.
FT   TURN        813    815       {ECO:0000244|PDB:4BF2}.
FT   STRAND      818    820       {ECO:0000244|PDB:4BF2}.
FT   TURN        823    825       {ECO:0000244|PDB:2CLQ}.
FT   STRAND      827    829       {ECO:0000244|PDB:2CLQ}.
FT   HELIX       843    845       {ECO:0000244|PDB:4BF2}.
FT   HELIX       848    853       {ECO:0000244|PDB:4BF2}.
FT   HELIX       854    857       {ECO:0000244|PDB:4BF2}.
FT   HELIX       860    876       {ECO:0000244|PDB:4BF2}.
FT   HELIX       882    884       {ECO:0000244|PDB:4BF2}.
FT   HELIX       887    897       {ECO:0000244|PDB:4BF2}.
FT   HELIX       909    918       {ECO:0000244|PDB:4BF2}.
FT   TURN        923    925       {ECO:0000244|PDB:4BF2}.
FT   HELIX       929    933       {ECO:0000244|PDB:4BF2}.
FT   HELIX       936    938       {ECO:0000244|PDB:4BF2}.
SQ   SEQUENCE   1374 AA;  154537 MW;  265BDC65968AF985 CRC64;
     MSTEADEGIT FSVPPFAPSG FCTIPEGGIC RRGGAAAVGE GEEHQLPPPP PGSFWNVESA
     AAPGIGCPAA TSSSSATRGR GSSVGGGSRR TTVAYVINEA SQGQLVVAES EALQSLREAC
     ETVGATLETL HFGKLDFGET TVLDRFYNAD IAVVEMSDAF RQPSLFYHLG VRESFSMANN
     IILYCDTNSD SLQSLKEIIC QKNTMCTGNY TFVPYMITPH NKVYCCDSSF MKGLTELMQP
     NFELLLGPIC LPLVDRFIQL LKVAQASSSQ YFRESILNDI RKARNLYTGK ELAAELARIR
     QRVDNIEVLT ADIVINLLLS YRDIQDYDSI VKLVETLEKL PTFDLASHHH VKFHYAFALN
     RRNLPGDRAK ALDIMIPMVQ SEGQVASDMY CLVGRIYKDM FLDSNFTDTE SRDHGASWFK
     KAFESEPTLQ SGINYAVLLL AAGHQFESSF ELRKVGVKLS SLLGKKGNLE KLQSYWEVGF
     FLGASVLAND HMRVIQASEK LFKLKTPAWY LKSIVETILI YKHFVKLTTE QPVAKQELVD
     FWMDFLVEAT KTDVTVVRFP VLILEPTKIY QPSYLSINNE VEEKTISIWH VLPDDKKGIH
     EWNFSASSVR GVSISKFEER CCFLYVLHNS DDFQIYFCTE LHCKKFFEMV NTITEEKGRS
     TEEGDCESDL LEYDYEYDEN GDRVVLGKGT YGIVYAGRDL SNQVRIAIKE IPERDSRYSQ
     PLHEEIALHK HLKHKNIVQY LGSFSENGFI KIFMEQVPGG SLSALLRSKW GPLKDNEQTI
     GFYTKQILEG LKYLHDNQIV HRDIKGDNVL INTYSGVLKI SDFGTSKRLA GINPCTETFT
     GTLQYMAPEI IDKGPRGYGK AADIWSLGCT IIEMATGKPP FYELGEPQAA MFKVGMFKVH
     PEIPESMSAE AKAFILKCFE PDPDKRACAN DLLVDEFLKV SSKKKKTQPK LSALSAGSNE
     YLRSISLPVP VLVEDTSSSS EYGSVSPDTE LKVDPFSFKT RAKSCGERDV KGIRTLFLGI
     PDENFEDHSA PPSPEEKDSG FFMLRKDSER RATLHRILTE DQDKIVRNLM ESLAQGAEEP
     KLKWEHITTL IASLREFVRS TDRKIIATTL SKLKLELDFD SHGISQVQVV LFGFQDAVNK
     VLRNHNIKPH WMFALDSIIR KAVQTAITIL VPELRPHFSL ASESDTADQE DLDVEDDHEE
     QPSNQTVRRP QAVIEDAVAT SGVSTLSSTV SHDSQSAHRS LNVQLGRMKI ETNRLLEELV
     RKEKELQALL HRAIEEKDQE IKHLKLKSQP IEIPELPVFH LNSSGTNTED SELTDWLRVN
     GADEDTISRF LAEDYTLLDV LYYVTRDDLK CLRLRGGMLC TLWKAIIDFR NKQT
//
ID   A0A024R528_HUMAN        Unreviewed;       143 AA.
AC   A0A024R528;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   02-NOV-2016, entry version 23.
DE   SubName: Full=Interleukin 1 receptor antagonist, isoform CRA_a {ECO:0000313|EMBL:EAW73624.1};
GN   Name=IL1RN {ECO:0000313|EMBL:EAW73624.1};
GN   ORFNames=hCG_1733963 {ECO:0000313|EMBL:EAW73624.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW73624.1};
RN   [1] {ECO:0000313|EMBL:EAW73624.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D.,
RA   Amanatides P., Ballew R.M., Huson D.H., Wortman J.R., Zhang Q.,
RA   Kodira C.D., Zheng X.H., Chen L., Skupski M., Subramanian G.,
RA   Thomas P.D., Zhang J., Gabor Miklos G.L., Nelson C., Broder S.,
RA   Clark A.G., Nadeau J., McKusick V.A., Zinder N., Levine A.J.,
RA   Roberts R.J., Simon M., Slayman C., Hunkapiller M., Bolanos R.,
RA   Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A.,
RA   Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K.,
RA   Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V.,
RA   Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z.,
RA   Guan P., Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A.,
RA   Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V.,
RA   Milshina N., Moore H.M., Naik A.K., Narayan V.A., Neelam B.,
RA   Nusskern D., Rusch D.B., Salzberg S., Shao W., Shue B., Sun J.,
RA   Wang Z., Wang A., Wang X., Wang J., Wei M., Wides R., Xiao C., Yan C.,
RA   Yao A., Ye J., Zhan M., Zhang W., Zhang H., Zhao Q., Zheng L.,
RA   Zhong F., Zhong W., Zhu S., Zhao S., Gilbert D., Baumhueter S.,
RA   Spier G., Carter C., Cravchik A., Woodage T., Ali F., An H., Awe A.,
RA   Baldwin D., Baden H., Barnstead M., Barrow I., Beeson K., Busam D.,
RA   Carver A., Center A., Cheng M.L., Curry L., Danaher S., Davenport L.,
RA   Desilets R., Dietz S., Dodson K., Doup L., Ferriera S., Garg N.,
RA   Gluecksmann A., Hart B., Haynes J., Haynes C., Heiner C., Hladun S.,
RA   Hostin D., Houck J., Howland T., Ibegwam C., Johnson J., Kalush F.,
RA   Kline L., Koduru S., Love A., Mann F., May D., McCawley S.,
RA   McIntosh T., McMullen I., Moy M., Moy L., Murphy B., Nelson K.,
RA   Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N.,
RA   Tse S., Vech C., Wang G., Wetter J., Williams S., Williams M.,
RA   Windsor S., Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F.,
RA   Guigo R., Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A.,
RA   Mi H., Lazareva B., Hatton T., Narechania A., Diemer K.,
RA   Muruganujan A., Guo N., Sato S., Bafna V., Istrail S., Lippert R.,
RA   Schwartz R., Walenz B., Yooseph S., Allen D., Basu A., Baxendale J.,
RA   Blick L., Caminha M., Carnes-Stine J., Caulk P., Chiang Y.H.,
RA   Coyne M., Dahlke C., Mays A., Dombroski M., Donnelly M., Ely D.,
RA   Esparham S., Fosler C., Gire H., Glanowski S., Glasser K., Glodek A.,
RA   Gorokhov M., Graham K., Gropman B., Harris M., Heil J., Henderson S.,
RA   Hoover J., Jennings D., Jordan C., Jordan J., Kasha J., Kagan L.,
RA   Kraft C., Levitsky A., Lewis M., Liu X., Lopez J., Ma D., Majoros W.,
RA   McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N., Nodell M.,
RA   Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW73624.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000256|SAAS:SAAS00562089}.
CC   -!- SIMILARITY: Belongs to the IL-1 family.
CC       {ECO:0000256|RuleBase:RU003752}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; CH471217; EAW73621.1; -; Genomic_DNA.
DR   EMBL; CH471217; EAW73623.1; -; Genomic_DNA.
DR   EMBL; CH471217; EAW73624.1; -; Genomic_DNA.
DR   RefSeq; NP_001305843.1; NM_001318914.1.
DR   RefSeq; NP_776215.1; NM_173843.2.
DR   RefSeq; XP_005263718.1; XM_005263661.4.
DR   RefSeq; XP_011509423.1; XM_011511121.1.
DR   UniGene; Hs.81134; -.
DR   ProteinModelPortal; A0A024R528; -.
DR   STRING; 9606.ENSP00000259206; -.
DR   Allergome; 11858; Hom s Anakinra.
DR   PRIDE; A0A024R528; -.
DR   GeneID; 3557; -.
DR   CTD; 3557; -.
DR   eggNOG; ENOG410IZQ4; Eukaryota.
DR   eggNOG; ENOG41119SQ; LUCA.
DR   GenomeRNAi; 3557; -.
DR   ExpressionAtlas; A0A024R528; baseline and differential.
DR   GO; GO:0005615; C:extracellular space; IEA:InterPro.
DR   GO; GO:0001960; P:negative regulation of cytokine-mediated signaling pathway; IEA:GOC.
DR   InterPro; IPR008996; Cytokine_IL1-like.
DR   InterPro; IPR020877; IL-1_CS.
DR   InterPro; IPR000975; IL-1_fam.
DR   InterPro; IPR027166; IL-1RA.
DR   InterPro; IPR003297; IL-1RA/IL-36.
DR   PANTHER; PTHR10078:SF21; PTHR10078:SF21; 1.
DR   Pfam; PF00340; IL1; 1.
DR   PRINTS; PR00264; INTERLEUKIN1.
DR   PRINTS; PR01360; INTRLEUKIN1X.
DR   SUPFAM; SSF50353; SSF50353; 1.
DR   PROSITE; PS00253; INTERLEUKIN_1; 1.
PE   3: Inferred from homology;
KW   Receptor {ECO:0000313|EMBL:EAW73624.1};
KW   Secreted {ECO:0000256|SAAS:SAAS00449276}.
SQ   SEQUENCE   143 AA;  16142 MW;  4CAD6784B890906B CRC64;
     MQAFRIWDVN QKTFYLRNNQ LVAGYLQGPN VNLEEKIDVV PIEPHALFLG IHGGKMCLSC
     VKSGDETRLQ LEAVNITDLS ENRKQDKRFA FIRSDSGPTT SFESAACPGW FLCTAMEADQ
     PVSLTNMPDE GVMVTKFYFQ EDE
//
ID   IL1RA_HUMAN             Reviewed;         177 AA.
AC   P18510; A8K4G1; Q14628; Q53SC2; Q7RTZ4; Q96GD6; Q9UPC0;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 1.
DT   02-NOV-2016, entry version 191.
DE   RecName: Full=Interleukin-1 receptor antagonist protein;
DE            Short=IL-1RN;
DE            Short=IL-1ra;
DE            Short=IRAP;
DE   AltName: Full=ICIL-1RA;
DE   AltName: Full=IL1 inhibitor;
DE   AltName: INN=Anakinra;
DE   Flags: Precursor;
GN   Name=IL1RN; Synonyms=IL1F3, IL1RA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2139180; DOI=10.1038/344633a0;
RA   Carter D.B., Deibel M.R. Jr., Dunn C.J., Tomich C.S.C., Laborde A.L.,
RA   Slightom J.L., Berger A.E., Bienkowski M.J., Sun F.F., McEwan R.N.,
RA   Harris P.K.W., Yem A.W., Waszak G.A., Chosay J.G., Sieu L.C.,
RA   Hardee M.M., Zurcher-Neely H.A., Reardon I.M., Heinrikson R.L.,
RA   Truesdell S.E., Shelly J.A., Eessalu T.E., Taylor B.M., Tracey D.E.;
RT   "Purification, cloning, expression and biological characterization of
RT   an interleukin-1 receptor antagonist protein.";
RL   Nature 344:633-638(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2137201; DOI=10.1038/343341a0;
RA   Eisenberg S.P., Evans R.J., Arend W.P., Verderber E., Brewer M.T.,
RA   Hannum C.H., Thompson R.C.;
RT   "Primary structure and functional expression from complementary DNA of
RT   a human interleukin-1 receptor antagonist.";
RL   Nature 343:341-346(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=1828896; DOI=10.1073/pnas.88.12.5232;
RA   Eisenberg S.P., Brewer M.T., Verderber E., Heimdal P.,
RA   Brandhuber B.J., Thompson R.C.;
RT   "Interleukin 1 receptor antagonist is a member of the interleukin 1
RT   gene family: evolution of a cytokine control mechanism.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:5232-5236(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=1385987; DOI=10.1016/1043-4666(92)90041-O;
RA   Lennard A., Gorman P., Carrier M., Griffiths S., Scotney H., Sheer D.,
RA   Solari R.;
RT   "Cloning and chromosome mapping of the human interleukin-1 receptor
RT   antagonist gene.";
RL   Cytokine 4:83-89(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1 AND 3).
RX   PubMed=8992991;
RA   Jenkins J.K., Drong R.F., Shuck M.E., Bienkowski M.J., Slightom J.L.,
RA   Arend W.P., Smith M.F. Jr.;
RT   "Intracellular IL-1 receptor antagonist promoter: cell type-specific
RT   and inducible regulatory regions.";
RL   J. Immunol. 158:748-755(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=1827201; DOI=10.1073/pnas.88.9.3681;
RA   Haskill S., Martin G., van Le L., Morris J., Peace A., Bigler C.F.,
RA   Jaffe G.J., Hammerberg C., Sporn S.A., Fong S., Arend W.P., Ralph P.;
RT   "cDNA cloning of an intracellular form of the human interleukin 1
RT   receptor antagonist associated with epithelium.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:3681-3685(1991).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RX   PubMed=7629520; DOI=10.1084/jem.182.2.623;
RA   Muzio M., Polentarutti N., Sironi M., Poli G., De Gioia L.,
RA   Introna M., Mantovani A., Colotta F.;
RT   "Cloning and characterization of a new isoform of the interleukin 1
RT   receptor antagonist.";
RL   J. Exp. Med. 182:623-628(1995).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   SeattleSNPs variation discovery resource;
RL   Submitted (DEC-2002) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Esophagus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [13]
RP   PROTEIN SEQUENCE OF 26-45, AND GLYCOSYLATION AT ASN-109.
RX   PubMed=2137200; DOI=10.1038/343336a0;
RA   Hannum C.H., Wilcox C.J., Arend W.P., Joslin F.G., Dripps D.J.,
RA   Heimdal P.L., Armes L.G., Sommer A., Eisenberg S.P., Thompson R.C.;
RT   "Interleukin-1 receptor antagonist activity of a human interleukin-1
RT   inhibitor.";
RL   Nature 343:336-340(1990).
RN   [14]
RP   PROTEIN SEQUENCE OF 26-52.
RX   PubMed=2143761;
RA   Bienkowski M.J., Eessalu T.E., Berger A.E., Truesdell S.E.,
RA   Shelly J.A., Laborde A.L., Zurcher-Neely H.A., Reardon I.M.,
RA   Heinrikson R.L., Chosay J.G., Tracey D.E.;
RT   "Purification and characterization of interleukin 1 receptor level
RT   antagonist proteins from THP-1 cells.";
RL   J. Biol. Chem. 265:14505-14511(1990).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 35-177 (ISOFORM 4).
RX   PubMed=9514884; DOI=10.1006/bbrc.1998.8217;
RA   Weissbach L., Tran K., Colquhoun S.A., Champliaud M.-F., Towle C.A.;
RT   "Detection of an interleukin-1 intracellular receptor antagonist mRNA
RT   variant.";
RL   Biochem. Biophys. Res. Commun. 244:91-95(1998).
RN   [16]
RP   RECEPTOR-BINDING.
RX   PubMed=7989776;
RA   Giri J.G., Wells J., Dower S.K., McCall C.E., Guzman R.N., Slack J.,
RA   Bird T.A., Shanebeck K., Grabstein K.H., Sims J.E., Alderson M.R.;
RT   "Elevated levels of shed type II IL-1 receptor in sepsis. Potential
RT   role for type II receptor in regulation of IL-1 responses.";
RL   J. Immunol. 153:5802-5809(1994).
RN   [17]
RP   FUNCTION.
RX   PubMed=7775431; DOI=10.1074/jbc.270.23.13757;
RA   Greenfeder S.A., Nunes P., Kwee L., Labow M., Chizzonite R.A., Ju G.;
RT   "Molecular cloning and characterization of a second subunit of the
RT   interleukin 1 receptor complex.";
RL   J. Biol. Chem. 270:13757-13765(1995).
RN   [18]
RP   IDENTIFICATION (ISOFORM 2).
RX   PubMed=11991722; DOI=10.1006/geno.2002.6751;
RA   Nicklin M.J.H., Barton J.L., Nguyen M., Fitzgerald M.G., Duff W.G.,
RA   Kornman K.;
RT   "A sequence-based map of the nine genes of the human interleukin-1
RT   cluster.";
RL   Genomics 79:718-725(2002).
RN   [19]
RP   INVOLVEMENT IN MVCD4.
RX   PubMed=8786086; DOI=10.1007/BF02185776;
RA   Blakemore A.I.F., Cox A., Gonzalez A.-M., Maskil J.K., Hughes M.E.,
RA   Wilson R.M., Ward J.D., Duff G.W.;
RT   "Interleukin-1 receptor antagonist allele (IL1RN*2) associated with
RT   nephropathy in diabetes mellitus.";
RL   Hum. Genet. 97:369-374(1996).
RN   [20]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-109.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [21]
RP   INVOLVEMENT IN DIRA.
RX   PubMed=19494218; DOI=10.1056/NEJMoa0807865;
RA   Aksentijevich I., Masters S.L., Ferguson P.J., Dancey P., Frenkel J.,
RA   van Royen-Kerkhoff A., Laxer R., Tedgard U., Cowen E.W., Pham T.H.,
RA   Booty M., Estes J.D., Sandler N.G., Plass N., Stone D.L., Turner M.L.,
RA   Hill S., Butman J.A., Schneider R., Babyn P., El-Shanti H.I., Pope E.,
RA   Barron K., Bing X., Laurence A., Lee C.C., Chapelle D., Clarke G.I.,
RA   Ohson K., Nicholson M., Gadina M., Yang B., Korman B.D.,
RA   Gregersen P.K., van Hagen P.M., Hak A.E., Huizing M., Rahman P.,
RA   Douek D.C., Remmers E.F., Kastner D.L., Goldbach-Mansky R.;
RT   "An autoinflammatory disease with deficiency of the interleukin-1-
RT   receptor antagonist.";
RL   N. Engl. J. Med. 360:2426-2437(2009).
RN   [22]
RP   STRUCTURE BY NMR.
RX   PubMed=1534997; DOI=10.1021/bi00138a001;
RA   Stockman B.J., Scahill T.A., Roy M., Ulrich E.L., Strakalaitis N.A.,
RA   Brunner D.P., Yem A.W., Deibel M.R. Jr.;
RT   "Secondary structure and topology of interleukin-1 receptor antagonist
RT   protein determined by heteronuclear three-dimensional NMR
RT   spectroscopy.";
RL   Biochemistry 31:5237-5244(1992).
RN   [23]
RP   STRUCTURE BY NMR.
RX   PubMed=8045306; DOI=10.1016/0014-5793(94)00643-1;
RA   Stockman B.J., Scahill T.A., Strakalaitis N.A., Brunner D.P.,
RA   Yem A.W., Deibel M.R. Jr.;
RT   "Solution structure of human interleukin-1 receptor antagonist
RT   protein.";
RL   FEBS Lett. 349:79-83(1994).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS).
RX   PubMed=8175703;
RA   Vigers G.P.A., Caffes P., Evans R.J., Thompson R.C., Eisenberg S.P.,
RA   Brandhuber B.J.;
RT   "X-ray structure of interleukin-1 receptor antagonist at 2.0-A
RT   resolution.";
RL   J. Biol. Chem. 269:12874-12879(1994).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS).
RX   PubMed=7867645; DOI=10.1111/j.1432-1033.1995.tb20209.x;
RA   Schreuder H.A., Rondeau J.-M., Tardif C., Soffientini A., Sarubbi E.,
RA   Akeson A., Bowlin T.L., Yanofsky S., Barrett R.W.;
RT   "Refined crystal structure of the interleukin-1 receptor antagonist.
RT   Presence of a disulfide link and a cis-proline.";
RL   Eur. J. Biochem. 227:838-847(1995).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 32-177 IN COMPLEX WITH IL1R.
RX   PubMed=9062194; DOI=10.1038/386194a0;
RA   Schreuder H., Tardif C., Trump-Kallmeyer S., Soffientini A.,
RA   Sarubbi E., Akeson A., Bowlin T., Yanofsky S., Barrett R.W.;
RT   "A new cytokine-receptor binding mode revealed by the crystal
RT   structure of the IL-1 receptor with an antagonist.";
RL   Nature 386:194-200(1997).
RN   [27]
RP   VARIANT [LARGE SCALE ANALYSIS] THR-124.
RX   PubMed=18987736; DOI=10.1038/nature07485;
RA   Ley T.J., Mardis E.R., Ding L., Fulton B., McLellan M.D., Chen K.,
RA   Dooling D., Dunford-Shore B.H., McGrath S., Hickenbotham M., Cook L.,
RA   Abbott R., Larson D.E., Koboldt D.C., Pohl C., Smith S., Hawkins A.,
RA   Abbott S., Locke D., Hillier L.W., Miner T., Fulton L., Magrini V.,
RA   Wylie T., Glasscock J., Conyers J., Sander N., Shi X., Osborne J.R.,
RA   Minx P., Gordon D., Chinwalla A., Zhao Y., Ries R.E., Payton J.E.,
RA   Westervelt P., Tomasson M.H., Watson M., Baty J., Ivanovich J.,
RA   Heath S., Shannon W.D., Nagarajan R., Walter M.J., Link D.C.,
RA   Graubert T.A., DiPersio J.F., Wilson R.K.;
RT   "DNA sequencing of a cytogenetically normal acute myeloid leukaemia
RT   genome.";
RL   Nature 456:66-72(2008).
CC   -!- FUNCTION: Inhibits the activity of interleukin-1 by binding to
CC       receptor IL1R1 and preventing its association with the coreceptor
CC       IL1RAP for signaling. Has no interleukin-1 like activity. Binds
CC       functional interleukin-1 receptor IL1R1 with greater affinity than
CC       decoy receptor IL1R2; however, the physiological relevance of the
CC       latter association is unsure. {ECO:0000269|PubMed:7775431}.
CC   -!- INTERACTION:
CC       Q9NYB0:TERF2IP; NbExp=2; IntAct=EBI-1026330, EBI-750109;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Secreted.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cytoplasm.
CC   -!- SUBCELLULAR LOCATION: Isoform 3: Cytoplasm.
CC   -!- SUBCELLULAR LOCATION: Isoform 4: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=P18510-1; Sequence=Displayed;
CC       Name=2; Synonyms=icIL-1ra;
CC         IsoId=P18510-2; Sequence=VSP_002649;
CC       Name=3; Synonyms=icIL-1ra type II;
CC         IsoId=P18510-3; Sequence=VSP_002650;
CC       Name=4;
CC         IsoId=P18510-4; Sequence=VSP_002651;
CC   -!- TISSUE SPECIFICITY: The intracellular form of IL1RN is
CC       predominantly expressed in epithelial cells.
CC   -!- DISEASE: Microvascular complications of diabetes 4 (MVCD4)
CC       [MIM:612628]: Pathological conditions that develop in numerous
CC       tissues and organs as a consequence of diabetes mellitus. They
CC       include diabetic retinopathy, diabetic nephropathy leading to end-
CC       stage renal disease, and diabetic neuropathy. Diabetic retinopathy
CC       remains the major cause of new-onset blindness among diabetic
CC       adults. It is characterized by vascular permeability and increased
CC       tissue ischemia and angiogenesis. {ECO:0000269|PubMed:8786086}.
CC       Note=Disease susceptibility is associated with variations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Interleukin 1 receptor antagonist deficiency (DIRA)
CC       [MIM:612852]: A rare autoinflammatory disease of skin and bone
CC       resulting in sterile multifocal osteomyelitis, periostitis, and
CC       pustulosis from birth. The term autoinflammatory disease describes
CC       a group of disorders characterized by attacks of seemingly
CC       unprovoked inflammation without significant levels of
CC       autoantibodies and autoreactive T-cells.
CC       {ECO:0000269|PubMed:19494218}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- PHARMACEUTICAL: Available under the name Kineret (Amgen). Used for
CC       the reduction in signs and symptoms and slowing the progression of
CC       structural damage in moderately to severely active rheumatoid
CC       arthritis.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Interleukin-1 entry;
CC       URL="https://en.wikipedia.org/wiki/Interleukin_1";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/il1rn/";
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=IL1RN";
CC   -!- WEB RESOURCE: Name=Kineret professional medical information";
CC       URL="http://www.rxlist.com/kineret-drug.htm";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X53296; CAA37386.1; -; mRNA.
DR   EMBL; X52015; CAA36262.1; -; mRNA.
DR   EMBL; M63099; AAB41943.1; -; Genomic_DNA.
DR   EMBL; X64532; CAA45832.1; -; Genomic_DNA.
DR   EMBL; U65590; AAB92270.1; -; Genomic_DNA.
DR   EMBL; U65590; AAB92268.1; -; Genomic_DNA.
DR   EMBL; U65590; AAB92269.1; -; Genomic_DNA.
DR   EMBL; M55646; AAA59138.1; -; mRNA.
DR   EMBL; X84348; CAA59087.1; -; mRNA.
DR   EMBL; AY196903; AAN87150.1; -; Genomic_DNA.
DR   EMBL; AK290898; BAF83587.1; -; mRNA.
DR   EMBL; AK290926; BAF83615.1; -; mRNA.
DR   EMBL; AC024704; AAX93278.1; -; Genomic_DNA.
DR   EMBL; CH471217; EAW73625.1; -; Genomic_DNA.
DR   EMBL; BC009745; AAH09745.1; -; mRNA.
DR   EMBL; AF043143; AAC39672.1; -; mRNA.
DR   EMBL; BN000002; CAD29879.1; -; Genomic_DNA.
DR   CCDS; CCDS2113.1; -. [P18510-2]
DR   CCDS; CCDS2114.1; -. [P18510-3]
DR   CCDS; CCDS2115.1; -. [P18510-4]
DR   CCDS; CCDS46396.1; -. [P18510-1]
DR   PIR; A40956; A30368.
DR   PIR; I37893; A39386.
DR   RefSeq; NP_000568.1; NM_000577.4. [P18510-2]
DR   RefSeq; NP_001305843.1; NM_001318914.1. [P18510-4]
DR   RefSeq; NP_776213.1; NM_173841.2. [P18510-3]
DR   RefSeq; NP_776214.1; NM_173842.2. [P18510-1]
DR   RefSeq; NP_776215.1; NM_173843.2. [P18510-4]
DR   RefSeq; XP_005263718.1; XM_005263661.4. [P18510-4]
DR   RefSeq; XP_011509423.1; XM_011511121.1. [P18510-4]
DR   UniGene; Hs.81134; -.
DR   PDB; 1ILR; X-ray; 2.10 A; 1/2=26-177.
DR   PDB; 1ILT; X-ray; 2.00 A; A/B=26-177.
DR   PDB; 1IRA; X-ray; 2.70 A; X=26-177.
DR   PDB; 1IRP; NMR; -; A=26-177.
DR   PDB; 1ITN; Model; -; A=31-177.
DR   PDB; 2IRT; X-ray; 3.20 A; A/B=26-177.
DR   PDBsum; 1ILR; -.
DR   PDBsum; 1ILT; -.
DR   PDBsum; 1IRA; -.
DR   PDBsum; 1IRP; -.
DR   PDBsum; 1ITN; -.
DR   PDBsum; 2IRT; -.
DR   ProteinModelPortal; P18510; -.
DR   SMR; P18510; -.
DR   BioGrid; 109772; 10.
DR   IntAct; P18510; 3.
DR   MINT; MINT-1522172; -.
DR   STRING; 9606.ENSP00000259206; -.
DR   DrugBank; DB06372; Rilonacept.
DR   Allergome; 11858; Hom s Anakinra.
DR   BioMuta; IL1RN; -.
DR   DMDM; 124312; -.
DR   MaxQB; P18510; -.
DR   PaxDb; P18510; -.
DR   PeptideAtlas; P18510; -.
DR   PRIDE; P18510; -.
DR   DNASU; 3557; -.
DR   Ensembl; ENST00000259206; ENSP00000259206; ENSG00000136689. [P18510-3]
DR   Ensembl; ENST00000354115; ENSP00000329072; ENSG00000136689. [P18510-2]
DR   Ensembl; ENST00000361779; ENSP00000354816; ENSG00000136689. [P18510-4]
DR   Ensembl; ENST00000409052; ENSP00000387210; ENSG00000136689. [P18510-4]
DR   Ensembl; ENST00000409930; ENSP00000387173; ENSG00000136689. [P18510-1]
DR   GeneID; 3557; -.
DR   KEGG; hsa:3557; -.
DR   UCSC; uc002tiy.3; human. [P18510-1]
DR   CTD; 3557; -.
DR   DisGeNET; 3557; -.
DR   GeneCards; IL1RN; -.
DR   HGNC; HGNC:6000; IL1RN.
DR   HPA; CAB009633; -.
DR   HPA; HPA001482; -.
DR   MalaCards; IL1RN; -.
DR   MIM; 147679; gene.
DR   MIM; 612628; phenotype.
DR   MIM; 612852; phenotype.
DR   neXtProt; NX_P18510; -.
DR   OpenTargets; ENSG00000136689; -.
DR   Orphanet; 210115; Sterile multifocal osteomyelitis with periostitis and pustulosis.
DR   PharmGKB; PA29816; -.
DR   eggNOG; ENOG410IZQ4; Eukaryota.
DR   eggNOG; ENOG41119SQ; LUCA.
DR   GeneTree; ENSGT00530000062899; -.
DR   HOGENOM; HOG000231506; -.
DR   HOVERGEN; HBG052099; -.
DR   InParanoid; P18510; -.
DR   KO; K05481; -.
DR   OMA; IHGGKLC; -.
DR   OrthoDB; EOG091G0PWA; -.
DR   PhylomeDB; P18510; -.
DR   TreeFam; TF300203; -.
DR   BioCyc; ZFISH:ENSG00000136689-MONOMER; -.
DR   Reactome; R-HSA-446652; Interleukin-1 signaling.
DR   ChiTaRS; IL1RN; human.
DR   EvolutionaryTrace; P18510; -.
DR   GeneWiki; Interleukin_1_receptor_antagonist; -.
DR   GenomeRNAi; 3557; -.
DR   PRO; PR:P18510; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000136689; -.
DR   CleanEx; HS_IL1RN; -.
DR   ExpressionAtlas; P18510; baseline and differential.
DR   Genevisible; P18510; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:0005622; C:intracellular; NAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005125; F:cytokine activity; IBA:GO_Central.
DR   GO; GO:0005152; F:interleukin-1 receptor antagonist activity; IDA:BHF-UCL.
DR   GO; GO:0005149; F:interleukin-1 receptor binding; IDA:BHF-UCL.
DR   GO; GO:0045352; F:interleukin-1 Type I receptor antagonist activity; IDA:BHF-UCL.
DR   GO; GO:0045353; F:interleukin-1 Type II receptor antagonist activity; IDA:BHF-UCL.
DR   GO; GO:0005150; F:interleukin-1, Type I receptor binding; IPI:BHF-UCL.
DR   GO; GO:0005151; F:interleukin-1, Type II receptor binding; IPI:BHF-UCL.
DR   GO; GO:0006953; P:acute-phase response; IDA:BHF-UCL.
DR   GO; GO:0006955; P:immune response; NAS:UniProtKB.
DR   GO; GO:0030073; P:insulin secretion; IEA:Ensembl.
DR   GO; GO:0006629; P:lipid metabolic process; IEA:Ensembl.
DR   GO; GO:0034115; P:negative regulation of heterotypic cell-cell adhesion; IDA:BHF-UCL.
DR   GO; GO:2000660; P:negative regulation of interleukin-1-mediated signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0051384; P:response to glucocorticoid; IDA:BHF-UCL.
DR   InterPro; IPR008996; Cytokine_IL1-like.
DR   InterPro; IPR020877; IL-1_CS.
DR   InterPro; IPR000975; IL-1_fam.
DR   InterPro; IPR027166; IL-1RA.
DR   InterPro; IPR003297; IL-1RA/IL-36.
DR   PANTHER; PTHR10078:SF21; PTHR10078:SF21; 1.
DR   Pfam; PF00340; IL1; 1.
DR   PRINTS; PR00264; INTERLEUKIN1.
DR   PRINTS; PR01360; INTRLEUKIN1X.
DR   SUPFAM; SSF50353; SSF50353; 1.
DR   PROSITE; PS00253; INTERLEUKIN_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   Pharmaceutical; Polymorphism; Reference proteome; Secreted; Signal.
FT   SIGNAL        1     25       {ECO:0000269|PubMed:2137200,
FT                                ECO:0000269|PubMed:2143761}.
FT   CHAIN        26    177       Interleukin-1 receptor antagonist
FT                                protein.
FT                                /FTId=PRO_0000015328.
FT   CARBOHYD    109    109       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:2137200}.
FT   DISULFID     91    141
FT   VAR_SEQ       1     34       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:9514884}.
FT                                /FTId=VSP_002651.
FT   VAR_SEQ       1     21       MEICRGLRSHLITLLLFLFHS -> MAL (in isoform
FT                                2). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:1827201}.
FT                                /FTId=VSP_002649.
FT   VAR_SEQ       1     21       MEICRGLRSHLITLLLFLFHS -> MALADLYEEGGGGGGE
FT                                GEDNADSK (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:7629520}.
FT                                /FTId=VSP_002650.
FT   VARIANT     124    124       A -> T (in dbSNP:rs45507693).
FT                                {ECO:0000269|PubMed:18987736}.
FT                                /FTId=VAR_049573.
FT   STRAND       36     42       {ECO:0000244|PDB:1ILR}.
FT   TURN         43     45       {ECO:0000244|PDB:1IRP}.
FT   STRAND       47     51       {ECO:0000244|PDB:1ILR}.
FT   STRAND       54     58       {ECO:0000244|PDB:1ILR}.
FT   HELIX        62     67       {ECO:0000244|PDB:1ILR}.
FT   STRAND       71     76       {ECO:0000244|PDB:1ILR}.
FT   TURN         77     79       {ECO:0000244|PDB:1ILR}.
FT   STRAND       80     85       {ECO:0000244|PDB:1ILR}.
FT   TURN         86     89       {ECO:0000244|PDB:1ILR}.
FT   STRAND       90     97       {ECO:0000244|PDB:1ILR}.
FT   STRAND      100    106       {ECO:0000244|PDB:1ILR}.
FT   HELIX       110    112       {ECO:0000244|PDB:1ILR}.
FT   HELIX       118    123       {ECO:0000244|PDB:1ILR}.
FT   STRAND      124    130       {ECO:0000244|PDB:1ILR}.
FT   STRAND      133    141       {ECO:0000244|PDB:1ILR}.
FT   STRAND      145    151       {ECO:0000244|PDB:1ILR}.
FT   STRAND      157    160       {ECO:0000244|PDB:1ILR}.
FT   STRAND      162    168       {ECO:0000244|PDB:1ILR}.
FT   STRAND      171    175       {ECO:0000244|PDB:1ILR}.
SQ   SEQUENCE   177 AA;  20055 MW;  D1690776A7394057 CRC64;
     MEICRGLRSH LITLLLFLFH SETICRPSGR KSSKMQAFRI WDVNQKTFYL RNNQLVAGYL
     QGPNVNLEEK IDVVPIEPHA LFLGIHGGKM CLSCVKSGDE TRLQLEAVNI TDLSENRKQD
     KRFAFIRSDS GPTTSFESAA CPGWFLCTAM EADQPVSLTN MPDEGVMVTK FYFQEDE
//
ID   H0YCE1_HUMAN            Unreviewed;        76 AA.
AC   H0YCE1;
DT   22-FEB-2012, integrated into UniProtKB/TrEMBL.
DT   22-FEB-2012, sequence version 1.
DT   02-NOV-2016, entry version 26.
DE   SubName: Full=Cell migration-inducing and hyaluronan-binding protein {ECO:0000313|Ensembl:ENSP00000431426};
DE   Flags: Fragment;
GN   Name=CEMIP {ECO:0000313|Ensembl:ENSP00000431426};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000431426, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000431426, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000431426}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2012) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000431426}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC023302; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC027808; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; H0YCE1; -.
DR   STRING; 9606.ENSP00000220244; -.
DR   PaxDb; H0YCE1; -.
DR   PeptideAtlas; H0YCE1; -.
DR   PRIDE; H0YCE1; -.
DR   Ensembl; ENST00000495041; ENSP00000431426; ENSG00000103888.
DR   UCSC; uc059mkn.1; human.
DR   HGNC; HGNC:29213; CEMIP.
DR   OpenTargets; ENSG00000103888; -.
DR   eggNOG; ENOG410IFCM; Eukaryota.
DR   eggNOG; ENOG410XQ01; LUCA.
DR   GeneTree; ENSGT00780000121902; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   ExpressionAtlas; H0YCE1; baseline and differential.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:H0YCE1};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   NON_TER       1      1       {ECO:0000313|Ensembl:ENSP00000431426}.
SQ   SEQUENCE   76 AA;  8980 MW;  1CD5B8A8F2E6E6BB CRC64;
     XINFNKGDWI RVGLCYPRGT TFSILSDVHN RLLKQTSKTG VFVRTLQMDK VEQSYPGRSH
     YYWDEDSGKQ RTISWR
//
ID   H0YL56_HUMAN            Unreviewed;       145 AA.
AC   H0YL56;
DT   22-FEB-2012, integrated into UniProtKB/TrEMBL.
DT   22-FEB-2012, sequence version 1.
DT   02-NOV-2016, entry version 26.
DE   SubName: Full=Cell migration-inducing and hyaluronan-binding protein {ECO:0000313|Ensembl:ENSP00000453066};
DE   Flags: Fragment;
GN   Name=CEMIP {ECO:0000313|Ensembl:ENSP00000453066};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000453066, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000453066, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000453066}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2012) to UniProtKB.
CC   -!- CAUTION: The sequence shown here is derived from an Ensembl
CC       automatic analysis pipeline and should be considered as
CC       preliminary data. {ECO:0000313|Ensembl:ENSP00000453066}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC023302; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC027808; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   ProteinModelPortal; H0YL56; -.
DR   STRING; 9606.ENSP00000220244; -.
DR   PaxDb; H0YL56; -.
DR   PeptideAtlas; H0YL56; -.
DR   PRIDE; H0YL56; -.
DR   Ensembl; ENST00000560027; ENSP00000453066; ENSG00000103888.
DR   UCSC; uc059mkm.1; human.
DR   HGNC; HGNC:29213; CEMIP.
DR   OpenTargets; ENSG00000103888; -.
DR   eggNOG; ENOG410IFCM; Eukaryota.
DR   eggNOG; ENOG410XQ01; LUCA.
DR   GeneTree; ENSGT00780000121902; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   ExpressionAtlas; H0YL56; baseline and differential.
PE   1: Evidence at protein level;
KW   Complete proteome {ECO:0000313|Proteomes:UP000005640};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:H0YL56};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   NON_TER       1      1       {ECO:0000313|Ensembl:ENSP00000453066}.
SQ   SEQUENCE   145 AA;  16799 MW;  528A738E89B6AD40 CRC64;
     XRGAICSGCY AQMYIQAYKT SNLRMKIIKN DFPSHPLYLE GALTRSTHYQ QYQPVVTLQK
     GYTIHWDQTA PAELAIWLIN FNKGDWIRVG LCYPRGTTFS ILSDVHNRLL KQTSKTGVFV
     RTLQMDKVEQ SYPGRSHYYW DEDSG
//
ID   CEMIP_HUMAN             Reviewed;        1361 AA.
AC   Q8WUJ3; Q6L9J5; Q9H1K5; Q9NPN9; Q9ULM1;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   13-APR-2004, sequence version 2.
DT   02-NOV-2016, entry version 118.
DE   RecName: Full=Cell migration-inducing and hyaluronan-binding protein;
DE            EC=3.2.1.35;
DE   Flags: Precursor;
GN   Name=CEMIP; Synonyms=KIAA1199;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANTS CYS-187; HIS-187 AND TYR-783, AND
RP   VARIANTS ARG-783; ILE-1109 AND ALA-1169.
RX   PubMed=14577002; DOI=10.1007/s10038-003-0079-2;
RA   Abe S., Usami S., Nakamura Y.;
RT   "Mutations in the gene encoding KIAA1199 protein, an inner-ear protein
RT   expressed in Deiters' cells and the fibrocytes, as the cause of
RT   nonsyndromic hearing loss.";
RL   J. Hum. Genet. 48:564-570(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=16157444; DOI=10.1016/j.canlet.2005.07.028;
RA   Michishita E., Garces G., Barrett J.C., Horikawa I.;
RT   "Upregulation of the KIAA1199 gene is associated with cellular
RT   mortality.";
RL   Cancer Lett. 239:71-77(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 349-1361 (ISOFORM 1), AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=10574462; DOI=10.1093/dnares/6.5.337;
RA   Nagase T., Ishikawa K., Kikuno R., Hirosawa M., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XV.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:337-345(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 558-1361.
RG   The European IMAGE consortium;
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 862-1361.
RX   PubMed=11247670; DOI=10.1006/geno.2000.6466;
RA   Wines M.E., Lee L., Katari M.S., Zhang L., DeRossi C., Shi Y.,
RA   Perkins S., Feldman M., McCombie W.R., Holdener B.C.;
RT   "Identification of mesoderm development (mesd) candidate genes by
RT   comparative mapping and genome sequence analysis.";
RL   Genomics 72:88-98(2001).
RN   [8]
RP   TISSUE SPECIFICITY.
RX   PubMed=12471561; DOI=10.1086/345398;
RA   Abe S., Katagiri T., Saito-Hisaminato A., Usami S., Inoue Y.,
RA   Tsunoda T., Nakamura Y.;
RT   "Identification of CRYM as a candidate responsible for nonsyndromic
RT   deafness, through cDNA microarray analysis of human cochlear and
RT   vestibular tissues.";
RL   Am. J. Hum. Genet. 72:73-82(2003).
RN   [9]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=19434458; DOI=10.1245/s10434-009-0469-6;
RA   Matsuzaki S., Tanaka F., Mimori K., Tahara K., Inoue H., Mori M.;
RT   "Clinicopathologic significance of KIAA1199 overexpression in human
RT   gastric cancer.";
RL   Ann. Surg. Oncol. 16:2042-2051(2009).
RN   [10]
RP   PROBABLE FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=21772334; DOI=10.1038/bjc.2011.268;
RA   Birkenkamp-Demtroder K., Maghnouj A., Mansilla F., Thorsen K.,
RA   Andersen C.L., Oster B., Hahn S., Orntoft T.F.;
RT   "Repression of KIAA1199 attenuates Wnt-signalling and decreases the
RT   proliferation of colon cancer cells.";
RL   Br. J. Cancer 105:552-561(2011).
RN   [11]
RP   TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=22970280; DOI=10.1371/journal.pone.0044661;
RA   Kuscu C., Evensen N., Kim D., Hu Y.J., Zucker S., Cao J.;
RT   "Transcriptional and epigenetic regulation of KIAA1199 gene expression
RT   in human breast cancer.";
RL   PLoS ONE 7:E44661-E44661(2012).
RN   [12]
RP   FUNCTION IN CANCER, INTERACTION WITH HSPA5, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=23990668; DOI=10.1093/jnci/djt224;
RA   Evensen N.A., Kuscu C., Nguyen H.L., Zarrabi K., Dufour A., Kadam P.,
RA   Hu Y.J., Pulkoski-Gross A., Bahou W.F., Zucker S., Cao J.;
RT   "Unraveling the role of KIAA1199, a novel endoplasmic reticulum
RT   protein, in cancer cell migration.";
RL   J. Natl. Cancer Inst. 105:1402-1416(2013).
RN   [13]
RP   INTERACTION WITH EPHA2 AND ITPR3, GLYCOSYLATION, SUBCELLULAR LOCATION,
RP   AND TISSUE SPECIFICITY.
RX   PubMed=23936024; DOI=10.1371/journal.pone.0069473;
RA   Tiwari A., Schneider M., Fiorino A., Haider R., Okoniewski M.J.,
RA   Roschitzki B., Uzozie A., Menigatti M., Jiricny J., Marra G.;
RT   "Early insights into the function of KIAA1199, a markedly
RT   overexpressed protein in human colorectal tumors.";
RL   PLoS ONE 8:E69473-E69473(2013).
RN   [14]
RP   FUNCTION IN HYALURONIC ACID DEGRADATION, CATALYTIC ACTIVITY, ENZYME
RP   REGULATION, HYALURONIC ACID-BINDING, INTERACTION WITH CLATHRIN,
RP   SUBCELLULAR LOCATION, INDUCTION, AND CHARACTERIZATION OF VARIANTS
RP   CYS-187; HIS-187; ARG-783 AND ILE-1109.
RX   PubMed=23509262; DOI=10.1073/pnas.1215432110;
RA   Yoshida H., Nagaoka A., Kusaka-Kikushima A., Tobiishi M., Kawabata K.,
RA   Sayo T., Sakai S., Sugiyama Y., Enomoto H., Okada Y., Inoue S.;
RT   "KIAA1199, a deafness gene of unknown function, is a new hyaluronan
RT   binding protein involved in hyaluronan depolymerization.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:5612-5617(2013).
RN   [15]
RP   FUNCTION IN HYALURONIC ACID DEGRADATION, CATALYTIC ACTIVITY,
RP   GLYCOSYLATION, SUBCELLULAR LOCATION, PROTEOLYTIC PROCESSING, AND
RP   SIGNAL SEQUENCE CLEAVAGE SITE.
RX   PubMed=24269685; DOI=10.1016/j.febslet.2013.11.017;
RA   Yoshida H., Nagaoka A., Nakamura S., Tobiishi M., Sugiyama Y.,
RA   Inoue S.;
RT   "N-Terminal signal sequence is required for cellular trafficking and
RT   hyaluronan-depolymerization of KIAA1199.";
RL   FEBS Lett. 588:111-116(2014).
CC   -!- FUNCTION: Mediates depolymerization of hyaluronic acid (HA) via
CC       the cell membrane-associated clathrin-coated pit endocytic
CC       pathway. Binds to hyaluronic acid. Hydrolyzes high molecular
CC       weight hyaluronic acid to produce an intermediate-sized product, a
CC       process that may occur through rapid vesicle endocytosis and
CC       recycling without intracytoplasmic accumulation or digestion in
CC       lysosomes. Involved in hyaluronan catabolism in the dermis of the
CC       skin and arthritic synovium. Positively regulates epithelial-
CC       mesenchymal transition (EMT), and hence tumor cell growth,
CC       invasion and cancer dissemination. In collaboration with
CC       HSPA5/BIP, promotes cancer cell migration in a calcium and PKC-
CC       dependent manner. May be involved in hearing.
CC       {ECO:0000269|PubMed:23509262, ECO:0000269|PubMed:23990668,
CC       ECO:0000269|PubMed:24269685}.
CC   -!- CATALYTIC ACTIVITY: Random hydrolysis of (1->4)-linkages between
CC       N-acetyl-beta-D-glucosamine and D-glucuronate residues in
CC       hyaluronate. {ECO:0000269|PubMed:23509262,
CC       ECO:0000269|PubMed:24269685}.
CC   -!- ENZYME REGULATION: Activity is up-regulated by histamine.
CC       {ECO:0000269|PubMed:23509262}.
CC   -!- SUBUNIT: Interacts with EPHA2 and ITPR3. Interacts with HSPA5/BIP;
CC       the interaction induces calcium leakage from the endoplasmic
CC       reticulum and cell migration. Interacts with clathrin heavy
CC       chain/CLTC. {ECO:0000269|PubMed:23509262,
CC       ECO:0000269|PubMed:23936024, ECO:0000269|PubMed:23990668}.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Endoplasmic reticulum.
CC       Cell membrane. Membrane, clathrin-coated pit. Secreted.
CC       Note=Retained in the endoplasmic reticulum (ER) in a HSPA5/BIP-
CC       dependent manner. Colocalized with clathrin heavy chain/CLTC in
CC       clathrin-coated vesicles. Strongly detected in the cytoplasm of
CC       breast carcinoma cells, whereas poorly detected in adjacent normal
CC       epithelial cells, stromal cells, or benign breast tissues.
CC       Localized in the nucleus and cytoplasm of colon adenocarcinomas.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8WUJ3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8WUJ3-2; Sequence=VSP_009814, VSP_009815;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in dermal and in synovial
CC       fibroblasts. Strongly expressed in gastric cancers compared with
CC       the paired normal tissues. Strongly expressed in both ductal
CC       carcinoma and invasive breast cancer cells compared with benign
CC       epithelial cells (at protein level). Strongly expressed in brain,
CC       placenta, prostate, breast, lung and testis. Expressed in
CC       fibroblasts, epithelial cells and cancer cells. In ear, it is
CC       specifically expressed in inner ear. Expressed in cochlea and
CC       vestibule tissues. Strongly expressed in gastric cancers compared
CC       with the paired normal tissues. Strongly expressed in colon
CC       adenocarcinomas compared with normal colonic mucosas. Strongly
CC       expressed in breast cancer as compared to normal breast tissue.
CC       {ECO:0000269|PubMed:10574462, ECO:0000269|PubMed:12471561,
CC       ECO:0000269|PubMed:16157444, ECO:0000269|PubMed:19434458,
CC       ECO:0000269|PubMed:21772334, ECO:0000269|PubMed:22970280,
CC       ECO:0000269|PubMed:23936024, ECO:0000269|PubMed:23990668}.
CC   -!- INDUCTION: Up-regulated by histamine. Up-regulated by the adapter
CC       protein complex 1 (AP-1) and NF-kappaB/RELA. Down-regulated by
CC       transforming growth factor TGFB1. {ECO:0000269|PubMed:22970280,
CC       ECO:0000269|PubMed:23509262}.
CC   -!- DOMAIN: The signal sequence is essential in mediating its proper
CC       translocation, hyaluronic acid (HA) degradation activity and
CC       secretion.
CC   -!- PTM: N-glycosylated; glycosylation is not necessary for HA-
CC       binding. {ECO:0000269|PubMed:23936024,
CC       ECO:0000269|PubMed:24269685}.
CC   -!- SIMILARITY: Belongs to the TMEM2 family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 G8 domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00817}.
CC   -!- SIMILARITY: Contains 4 PbH1 repeats. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB103330; BAD02451.1; -; mRNA.
DR   EMBL; CH471136; EAW99111.1; -; Genomic_DNA.
DR   EMBL; BC020256; AAH20256.1; -; mRNA.
DR   EMBL; AB033025; BAA86513.1; -; mRNA.
DR   EMBL; AL359061; CAB94391.1; -; mRNA.
DR   EMBL; AY007811; AAG41059.1; -; mRNA.
DR   CCDS; CCDS10315.1; -. [Q8WUJ3-1]
DR   RefSeq; NP_001280227.1; NM_001293298.1. [Q8WUJ3-1]
DR   RefSeq; NP_001280233.1; NM_001293304.1. [Q8WUJ3-1]
DR   RefSeq; NP_061159.1; NM_018689.2. [Q8WUJ3-1]
DR   UniGene; Hs.459088; -.
DR   ProteinModelPortal; Q8WUJ3; -.
DR   SMR; Q8WUJ3; -.
DR   BioGrid; 121452; 2.
DR   IntAct; Q8WUJ3; 1.
DR   STRING; 9606.ENSP00000220244; -.
DR   iPTMnet; Q8WUJ3; -.
DR   PhosphoSitePlus; Q8WUJ3; -.
DR   BioMuta; KIAA1199; -.
DR   DMDM; 46396475; -.
DR   PaxDb; Q8WUJ3; -.
DR   PeptideAtlas; Q8WUJ3; -.
DR   PRIDE; Q8WUJ3; -.
DR   Ensembl; ENST00000220244; ENSP00000220244; ENSG00000103888. [Q8WUJ3-1]
DR   Ensembl; ENST00000356249; ENSP00000348583; ENSG00000103888. [Q8WUJ3-1]
DR   Ensembl; ENST00000394685; ENSP00000378177; ENSG00000103888. [Q8WUJ3-1]
DR   Ensembl; ENST00000611615; ENSP00000480324; ENSG00000103888. [Q8WUJ3-2]
DR   GeneID; 57214; -.
DR   KEGG; hsa:57214; -.
DR   UCSC; uc002bfw.2; human. [Q8WUJ3-1]
DR   CTD; 57214; -.
DR   DisGeNET; 57214; -.
DR   GeneCards; CEMIP; -.
DR   HGNC; HGNC:29213; CEMIP.
DR   HPA; HPA007090; -.
DR   HPA; HPA044676; -.
DR   MIM; 608366; gene.
DR   neXtProt; NX_Q8WUJ3; -.
DR   OpenTargets; ENSG00000103888; -.
DR   PharmGKB; PA134967531; -.
DR   eggNOG; ENOG410IFCM; Eukaryota.
DR   eggNOG; ENOG410XQ01; LUCA.
DR   GeneTree; ENSGT00780000121902; -.
DR   HOGENOM; HOG000290723; -.
DR   HOVERGEN; HBG052198; -.
DR   InParanoid; Q8WUJ3; -.
DR   KO; K19031; -.
DR   OMA; RHPWSFI; -.
DR   OrthoDB; EOG091G00JT; -.
DR   PhylomeDB; Q8WUJ3; -.
DR   TreeFam; TF316575; -.
DR   Reactome; R-HSA-2142850; Hyaluronan biosynthesis and export.
DR   GeneWiki; KIAA1199; -.
DR   GenomeRNAi; 57214; -.
DR   PRO; PR:Q8WUJ3; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000103888; -.
DR   CleanEx; HS_KIAA1199; -.
DR   ExpressionAtlas; Q8WUJ3; baseline and differential.
DR   Genevisible; Q8WUJ3; HS.
DR   GO; GO:0005905; C:clathrin-coated pit; IEA:UniProtKB-SubCell.
DR   GO; GO:0030665; C:clathrin-coated vesicle membrane; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0032050; F:clathrin heavy chain binding; IDA:UniProtKB.
DR   GO; GO:0046923; F:ER retention sequence binding; IDA:UniProtKB.
DR   GO; GO:0005540; F:hyaluronic acid binding; IDA:UniProtKB.
DR   GO; GO:0004415; F:hyalurononglucosaminidase activity; IDA:UniProtKB.
DR   GO; GO:0030213; P:hyaluronan biosynthetic process; TAS:Reactome.
DR   GO; GO:0030214; P:hyaluronan catabolic process; IMP:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; IDA:UniProtKB.
DR   GO; GO:0010800; P:positive regulation of peptidyl-threonine phosphorylation; IDA:UniProtKB.
DR   GO; GO:1900020; P:positive regulation of protein kinase C activity; IDA:UniProtKB.
DR   GO; GO:0090314; P:positive regulation of protein targeting to membrane; IDA:UniProtKB.
DR   GO; GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; IDA:UniProtKB.
DR   GO; GO:0007605; P:sensory perception of sound; IMP:UniProtKB.
DR   Gene3D; 2.160.20.10; -; 2.
DR   InterPro; IPR019316; G8_domain.
DR   InterPro; IPR012334; Pectin_lyas_fold.
DR   InterPro; IPR011050; Pectin_lyase_fold/virulence.
DR   InterPro; IPR025155; WxxW_domain.
DR   Pfam; PF10162; G8; 1.
DR   Pfam; PF13330; Mucin2_WxxW; 1.
DR   SMART; SM01225; G8; 1.
DR   SUPFAM; SSF51126; SSF51126; 5.
DR   PROSITE; PS51484; G8; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Coated pit; Complete proteome;
KW   Cytoplasm; Endoplasmic reticulum; Glycoprotein; Glycosidase;
KW   Hyaluronic acid; Hydrolase; Membrane; Nucleus; Polymorphism;
KW   Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL        1     30       {ECO:0000269|PubMed:24269685}.
FT   CHAIN        31   1361       Cell migration-inducing and hyaluronan-
FT                                binding protein.
FT                                /FTId=PRO_0000021538.
FT   DOMAIN       44    166       G8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00817}.
FT   REPEAT      572    594       PbH1 1.
FT   REPEAT      595    617       PbH1 2.
FT   REPEAT      719    741       PbH1 3.
FT   REPEAT      798    819       PbH1 4.
FT   REGION      295    591       Necessary for its endoplasmic reticulum
FT                                (ER) retention and interaction with
FT                                HSPA5. {ECO:0000269|PubMed:23990668}.
FT   CARBOHYD    119    119       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    165    165       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    312    312       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    370    370       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    420    420       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    889    889       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    921    921       N-linked (GlcNAc...). {ECO:0000255}.
FT   VAR_SEQ     978    992       NWLVRHPDCINVPDW -> KWHSLASKAASGPSG (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_009814.
FT   VAR_SEQ     993   1361       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_009815.
FT   VARIANT     187    187       R -> C (in a family with non-syndromic
FT                                hearing loss; reduces hyaluronic acid
FT                                degradation activity; dbSNP:rs368854657).
FT                                {ECO:0000269|PubMed:14577002,
FT                                ECO:0000269|PubMed:23509262}.
FT                                /FTId=VAR_018165.
FT   VARIANT     187    187       R -> H (in two unrelated families with
FT                                non-syndromic hearing loss; reduces
FT                                hyaluronic acid (HA) degradation
FT                                activity; dbSNP:rs144446375).
FT                                {ECO:0000269|PubMed:14577002,
FT                                ECO:0000269|PubMed:23509262}.
FT                                /FTId=VAR_018166.
FT   VARIANT     783    783       H -> R (does not inhibit hyaluronic acid
FT                                degradation activity; dbSNP:rs12441101).
FT                                {ECO:0000269|PubMed:14577002,
FT                                ECO:0000269|PubMed:23509262}.
FT                                /FTId=VAR_018167.
FT   VARIANT     783    783       H -> Y (in a sporadic case of non-
FT                                syndromic hearing loss).
FT                                {ECO:0000269|PubMed:14577002}.
FT                                /FTId=VAR_018168.
FT   VARIANT    1109   1109       V -> I (does not inhibit hyaluronic acid
FT                                degradation activity; dbSNP:rs751807711).
FT                                {ECO:0000269|PubMed:14577002,
FT                                ECO:0000269|PubMed:23509262}.
FT                                /FTId=VAR_018169.
FT   VARIANT    1169   1169       P -> A (common polymorphism;
FT                                dbSNP:rs16972583).
FT                                {ECO:0000269|PubMed:14577002}.
FT                                /FTId=VAR_018170.
FT   CONFLICT    558    564       HFHLAGD -> TRPPTRP (in Ref. 6; CAB94391).
FT                                {ECO:0000305}.
FT   CONFLICT    862    862       H -> T (in Ref. 7; AAG41059).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1361 AA;  152998 MW;  40CDFFB84F99516C CRC64;
     MGAAGRQDFL FKAMLTISWL TLTCFPGATS TVAAGCPDQS PELQPWNPGH DQDHHVHIGQ
     GKTLLLTSSA TVYSIHISEG GKLVIKDHDE PIVLRTRHIL IDNGGELHAG SALCPFQGNF
     TIILYGRADE GIQPDPYYGL KYIGVGKGGA LELHGQKKLS WTFLNKTLHP GGMAEGGYFF
     ERSWGHRGVI VHVIDPKSGT VIHSDRFDTY RSKKESERLV QYLNAVPDGR ILSVAVNDEG
     SRNLDDMARK AMTKLGSKHF LHLGFRHPWS FLTVKGNPSS SVEDHIEYHG HRGSAAARVF
     KLFQTEHGEY FNVSLSSEWV QDVEWTEWFD HDKVSQTKGG EKISDLWKAH PGKICNRPID
     IQATTMDGVN LSTEVVYKKG QDYRFACYDR GRACRSYRVR FLCGKPVRPK LTVTIDTNVN
     STILNLEDNV QSWKPGDTLV IASTDYSMYQ AEEFQVLPCR SCAPNQVKVA GKPMYLHIGE
     EIDGVDMRAE VGLLSRNIIV MGEMEDKCYP YRNHICNFFD FDTFGGHIKF ALGFKAAHLE
     GTELKHMGQQ LVGQYPIHFH LAGDVDERGG YDPPTYIRDL SIHHTFSRCV TVHGSNGLLI
     KDVVGYNSLG HCFFTEDGPE ERNTFDHCLG LLVKSGTLLP SDRDSKMCKM ITEDSYPGYI
     PKPRQDCNAV STFWMANPNN NLINCAAAGS EETGFWFIFH HVPTGPSVGM YSPGYSEHIP
     LGKFYNNRAH SNYRAGMIID NGVKTTEASA KDKRPFLSII SARYSPHQDA DPLKPREPAI
     IRHFIAYKNQ DHGAWLRGGD VWLDSCRFAD NGIGLTLASG GTFPYDDGSK QEIKNSLFVG
     ESGNVGTEMM DNRIWGPGGL DHSGRTLPIG QNFPIRGIQL YDGPINIQNC TFRKFVALEG
     RHTSALAFRL NNAWQSCPHN NVTGIAFEDV PITSRVFFGE PGPWFNQLDM DGDKTSVFHD
     VDGSVSEYPG SYLTKNDNWL VRHPDCINVP DWRGAICSGC YAQMYIQAYK TSNLRMKIIK
     NDFPSHPLYL EGALTRSTHY QQYQPVVTLQ KGYTIHWDQT APAELAIWLI NFNKGDWIRV
     GLCYPRGTTF SILSDVHNRL LKQTSKTGVF VRTLQMDKVE QSYPGRSHYY WDEDSGLLFL
     KLKAQNEREK FAFCSMKGCE RIKIKALIPK NAGVSDCTAT AYPKFTERAV VDVPMPKKLF
     GSQLKTKDHF LEVKMESSKQ HFFHLWNDFA YIEVDGKKYP SSEDGIQVVV IDGNQGRVVS
     HTSFRNSILQ GIPWQLFNYV ATIPDNSIVL MASKGRYVSR GPWTRVLEKL GADRGLKLKE
     QMAFVGFKGS FRPIWVTLDT EDHKAKIFQV VPIPVVKKKK L
//
